Psyllid ID: psy7023
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 364 | 2.2.26 [Sep-21-2011] | |||||||
| Q93105 | 1393 | Insulin-like receptor OS= | N/A | N/A | 0.697 | 0.182 | 0.680 | 1e-98 | |
| Q9PVZ4 | 1362 | Insulin receptor OS=Xenop | N/A | N/A | 0.744 | 0.198 | 0.646 | 8e-97 | |
| P06213 | 1382 | Insulin receptor OS=Homo | yes | N/A | 0.774 | 0.204 | 0.614 | 4e-96 | |
| P15208 | 1372 | Insulin receptor OS=Mus m | yes | N/A | 0.774 | 0.205 | 0.610 | 9e-96 | |
| Q05688 | 640 | Insulin-like growth facto | no | N/A | 0.656 | 0.373 | 0.695 | 2e-95 | |
| P15127 | 1383 | Insulin receptor OS=Rattu | yes | N/A | 0.774 | 0.203 | 0.607 | 3e-95 | |
| Q9WTL4 | 1300 | Insulin receptor-related | no | N/A | 0.703 | 0.196 | 0.657 | 5e-95 | |
| Q64716 | 1300 | Insulin receptor-related | no | N/A | 0.703 | 0.196 | 0.653 | 6e-95 | |
| P24062 | 1370 | Insulin-like growth facto | no | N/A | 0.656 | 0.174 | 0.695 | 9e-95 | |
| P08069 | 1367 | Insulin-like growth facto | no | N/A | 0.656 | 0.174 | 0.691 | 4e-94 |
| >sp|Q93105|INSR_AEDAE Insulin-like receptor OS=Aedes aegypti GN=InR PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 360 bits (923), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 175/257 (68%), Positives = 205/257 (79%), Gaps = 3/257 (1%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAE 168
YK D WEV R+ + L+ELG GSFG+VY+G++ R PCAIK NE+A+ REK
Sbjct: 1013 YKVDDWEVERNHIIQLEELGQGSFGMVYKGILTQLRGEKCNQPCAIKTVNESATAREKDS 1072
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET--DVER 226
FL EASVMK F+THHVV+L GVVS+G+PTLVIMELM GDLK+YLR RPD E D
Sbjct: 1073 FLLEASVMKQFNTHHVVRLLGVVSQGDPTLVIMELMANGDLKSYLRRHRPDYENGEDPSP 1132
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
PPTL +I+QMA E+ADGMAYL+ KKFVHRDLAARNCMVADD+TVK+GDFGMTRDIYET+
Sbjct: 1133 QPPTLRQIIQMAIEIADGMAYLSAKKFVHRDLAARNCMVADDMTVKIGDFGMTRDIYETD 1192
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
YYRKG++GFLPVRWMAPESLKDG+F+S SDV+SYGVVLWEMATLASQPYQGL+N+QVL +
Sbjct: 1193 YYRKGTKGFLPVRWMAPESLKDGIFSSSSDVFSYGVVLWEMATLASQPYQGLTNDQVLRY 1252
Query: 347 VKGKSSNEYKVNPPISL 363
V E N P +L
Sbjct: 1253 VIDGGVMERPENCPDNL 1269
|
This receptor probably binds an insulin related protein and has a tyrosine-protein kinase activity. Aedes aegypti (taxid: 7159) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1 |
| >sp|Q9PVZ4|INSR_XENLA Insulin receptor OS=Xenopus laevis GN=insr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (907), Expect = 8e-97, Method: Compositional matrix adjust.
Identities = 179/277 (64%), Positives = 210/277 (75%), Gaps = 6/277 (2%)
Query: 90 PAGG--TTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RS 146
PAG T++ P L + +Y D WEV R K+ +L ELG GSFG+VY G+ KD +
Sbjct: 981 PAGPLYTSSNPEYLSASE---VYIPDEWEVPRDKINLLRELGQGSFGMVYEGIAKDIIKG 1037
Query: 147 LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGG 206
E A+K NE+AS RE+ EFLNEASVMKAF+ HHVV+L GVVS+G PTLVIMELM
Sbjct: 1038 EPEVRVAVKTVNESASLRERIEFLNEASVMKAFNCHHVVRLLGVVSKGQPTLVIMELMAH 1097
Query: 207 GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266
GDLK+YLRS RPDAE + R PTL I+QMAAE++DGMAYL KKFVHRDLAARNCMVA
Sbjct: 1098 GDLKSYLRSLRPDAENNPGRLAPTLKEIIQMAAEISDGMAYLNAKKFVHRDLAARNCMVA 1157
Query: 267 DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWE 326
DD VK+GDFGMTRDIYET+YYRKG +G LPVRWM+PESLKDGVFT+ SDVWS+GVVLWE
Sbjct: 1158 DDYAVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTAFSDVWSFGVVLWE 1217
Query: 327 MATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPISL 363
+ +LA QPYQGLSNEQVL +V S ++ N P L
Sbjct: 1218 ITSLAEQPYQGLSNEQVLKFVMDGGSLDHPENCPPRL 1254
|
Receptor tyrosine kinase which mediates actions of insulin. May be required for forelimb regeneration. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|P06213|INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | Back alignment and function description |
|---|
Score = 352 bits (902), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 180/293 (61%), Positives = 211/293 (72%), Gaps = 11/293 (3%)
Query: 60 IFLFLIRVAVILTGSGGPAVTTTTVATPTTPAGG--TTTPPNQLMGGD--DDKLYKKDSW 115
IF+FL V + G P P G ++ P L D +Y D W
Sbjct: 963 IFVFLFSVVI------GSIYLFLRKRQPDGPLGPLYASSNPEYLSASDVFPCSVYVPDEW 1016
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEAS 174
EV R K+T+L ELG GSFG+VY G +D + AE A+K NE+AS RE+ EFLNEAS
Sbjct: 1017 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 1076
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
VMK F HHVV+L GVVS+G PTLV+MELM GDLK+YLRS RP+AE + R PPTL +
Sbjct: 1077 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 1136
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
+QMAAE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+YYRKG +G
Sbjct: 1137 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 1196
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
LPVRWMAPESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 1197 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 1249
|
Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosines residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|P15208|INSR_MOUSE Insulin receptor OS=Mus musculus GN=Insr PE=1 SV=2 | Back alignment and function description |
|---|
Score = 350 bits (898), Expect = 9e-96, Method: Compositional matrix adjust.
Identities = 179/293 (61%), Positives = 210/293 (71%), Gaps = 11/293 (3%)
Query: 60 IFLFLIRVAVILTGSGGPAVTTTTVATPTTPAGG--TTTPPNQLMGGD--DDKLYKKDSW 115
IF+FL V + G P P G ++ P L D +Y D W
Sbjct: 953 IFVFLFSVVI------GSIYLFLRKRQPDGPMGPLYASSNPEYLSASDVFPSSVYVPDEW 1006
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEAS 174
EV R K+T+L ELG GSFG+VY G KD + AE A+K NE+AS RE+ EFLNEAS
Sbjct: 1007 EVPREKITLLRELGQGSFGMVYEGNAKDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 1066
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
VMK F HHVV+L GVVS+G PTLV+MELM GDLK++LRS RPDAE + R PPTL +
Sbjct: 1067 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSHLRSLRPDAENNPGRPPPTLQEM 1126
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
+QM AE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+YYRKG +G
Sbjct: 1127 IQMTAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 1186
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
LPVRWM+PESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 1187 LLPVRWMSPESLKDGVFTASSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 1239
|
Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosines residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). When present in a hybrid receptor with IGF1R, binds IGF1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q05688|IGF1R_BOVIN Insulin-like growth factor 1 receptor (Fragment) OS=Bos taurus GN=IGF1R PE=2 SV=1 | Back alignment and function description |
|---|
Score = 349 bits (896), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 167/240 (69%), Positives = 195/240 (81%), Gaps = 1/240 (0%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+ ELG GSFG+VY G+ K + E AIK NE AS RE+
Sbjct: 259 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 318
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F+ HHVV+L GVVS+G PTLVIMELM GDLK+YLRS RP+ E + +
Sbjct: 319 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 378
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PP+LS+++QMA E+ADGMAYL KFVHRDLAARNCMVA+D TVK+GDFGMTRDIYET+Y
Sbjct: 379 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 438
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWM+PESLKDGVFT+HSDVWS+GVVLWE+ATLA QPYQGLSNEQVL +V
Sbjct: 439 YRKGGKGLLPVRWMSPESLKDGVFTTHSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 498
|
Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R (By similarity). When present in a hybrid receptor with INSR, binds IGF1. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|P15127|INSR_RAT Insulin receptor OS=Rattus norvegicus GN=Insr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (894), Expect = 3e-95, Method: Compositional matrix adjust.
Identities = 178/293 (60%), Positives = 209/293 (71%), Gaps = 11/293 (3%)
Query: 60 IFLFLIRVAVILTGSGGPAVTTTTVATPTTPAGG--TTTPPNQLMGGD--DDKLYKKDSW 115
IF+FL V + G P P G ++ P L D +Y D W
Sbjct: 964 IFVFLFSVVI------GSIYLFLRKRQPDGPMGPLYASSNPEYLSASDVFPSSVYVPDEW 1017
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEAS 174
EV R K+T+L ELG GSFG+VY G KD + E A+K NE+AS RE+ EFLNEAS
Sbjct: 1018 EVPREKITLLRELGQGSFGMVYEGNAKDIIKGEVETRVAVKTVNESASLRERIEFLNEAS 1077
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
VMK F HHVV+L GVVS+G PTLV+MELM GDLK++LRS RPDAE + R PPTL +
Sbjct: 1078 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSHLRSLRPDAENNPGRPPPTLQEM 1137
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
+QM AE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+YYRKG +G
Sbjct: 1138 IQMTAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 1197
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
LPVRWM+PESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 1198 LLPVRWMSPESLKDGVFTASSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 1250
|
Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosines residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). When present in a hybrid receptor with IGF1R, binds IGF1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q9WTL4|INSRR_MOUSE Insulin receptor-related protein OS=Mus musculus GN=Insrr PE=1 SV=2 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 169/257 (65%), Positives = 197/257 (76%), Gaps = 1/257 (0%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH-PCAIKVANENASEREKA 167
+Y D WEV R ++ I+ ELG GSFG+VY GL + + E P A+K NE AS RE+
Sbjct: 966 MYVPDEWEVPREQIAIIRELGQGSFGMVYEGLARGLEAGEESTPVALKTVNELASARERV 1025
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFL EASVMKAF HHVV+L GVVS+G PTLVIMELM GDLK++LRS RP+AE +
Sbjct: 1026 EFLKEASVMKAFKCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSHLRSLRPEAENNPGLP 1085
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
P LS ++QMA E+ADGMAYLA KKFVHRDLAARNCMV+ D TVK+GDFGMTRD+YET+Y
Sbjct: 1086 QPALSDMIQMAGEIADGMAYLAAKKFVHRDLAARNCMVSQDFTVKIGDFGMTRDVYETDY 1145
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWMAPESLKDG+FT+HSDVWS+GVVLWE+ TLA QPYQGLSNEQVL +V
Sbjct: 1146 YRKGGKGLLPVRWMAPESLKDGIFTTHSDVWSFGVVLWEIVTLAEQPYQGLSNEQVLKFV 1205
Query: 348 KGKSSNEYKVNPPISLS 364
E N PI L
Sbjct: 1206 MDGGVLEELENCPIQLQ 1222
|
Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q64716|INSRR_RAT Insulin receptor-related protein OS=Rattus norvegicus GN=Insrr PE=1 SV=3 | Back alignment and function description |
|---|
Score = 347 bits (891), Expect = 6e-95, Method: Compositional matrix adjust.
Identities = 168/257 (65%), Positives = 198/257 (77%), Gaps = 1/257 (0%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH-PCAIKVANENASEREKA 167
+Y D WEV R ++ I+ ELG GSFG+VY GL + + E P A+K NE AS RE+
Sbjct: 966 MYVPDEWEVPREQIAIIRELGQGSFGMVYEGLARGLEAGEESTPVALKTVNELASARERV 1025
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFL EASVMKAF HHVV+L GVVS+G PTLVIMELM GDLK++LRS RP+AE +
Sbjct: 1026 EFLKEASVMKAFKCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSHLRSLRPEAENNPGLP 1085
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
P LS ++QMA E+ADGMAYLA KKFVHRDLAARNCMV+ D TVK+GDFGMTRD+YET+Y
Sbjct: 1086 QPALSDMIQMAGEIADGMAYLAAKKFVHRDLAARNCMVSQDFTVKIGDFGMTRDVYETDY 1145
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWMAPESLKDG+FT+HSDVWS+GVVLWE+ TLA QPYQGLSNEQVL +V
Sbjct: 1146 YRKGGKGLLPVRWMAPESLKDGIFTTHSDVWSFGVVLWEIVTLAEQPYQGLSNEQVLKFV 1205
Query: 348 KGKSSNEYKVNPPISLS 364
E + + PI L
Sbjct: 1206 MDGGVLEEQEDCPIQLQ 1222
|
Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|P24062|IGF1R_RAT Insulin-like growth factor 1 receptor OS=Rattus norvegicus GN=Igf1r PE=2 SV=2 | Back alignment and function description |
|---|
Score = 347 bits (889), Expect = 9e-95, Method: Compositional matrix adjust.
Identities = 167/240 (69%), Positives = 195/240 (81%), Gaps = 1/240 (0%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+ ELG GSFG+VY G+ K + E AIK NE AS RE+
Sbjct: 987 VYVPDEWEVAREKITMNRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 1046
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F+ HHVV+L GVVS+G PTLVIMELM GDLK+YLRS RP+ E ++
Sbjct: 1047 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEVENNLVLI 1106
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PP+LS+++QMA E+ADGMAYL KFVHRDLAARNCMVA+D TVK+GDFGMTRDIYET+Y
Sbjct: 1107 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 1166
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWM+PESLKDGVFT+HSDVWS+GVVLWE+ATLA QPYQGLSNEQVL +V
Sbjct: 1167 YRKGGKGLLPVRWMSPESLKDGVFTTHSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 1226
|
Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R (By similarity). When present in a hybrid receptor with INSR, binds IGF1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|P08069|IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (884), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 166/240 (69%), Positives = 195/240 (81%), Gaps = 1/240 (0%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+ ELG GSFG+VY G+ K + E AIK NE AS RE+
Sbjct: 986 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 1045
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F+ HHVV+L GVVS+G PTLVIMELM GDLK+YLRS RP+ E + +
Sbjct: 1046 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 1105
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PP+LS+++QMA E+ADGMAYL KFVHRDLAARNCMVA+D TVK+GDFGMTRDIYET+Y
Sbjct: 1106 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 1165
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWM+PESLKDGVFT++SDVWS+GVVLWE+ATLA QPYQGLSNEQVL +V
Sbjct: 1166 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 1225
|
When present in a hybrid receptor with INSR, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 364 | ||||||
| 345487749 | 1759 | PREDICTED: insulin-like receptor isoform | 0.656 | 0.135 | 0.733 | 1e-101 | |
| 307214044 | 1408 | Insulin-like receptor [Harpegnathos salt | 0.700 | 0.181 | 0.707 | 1e-101 | |
| 270015135 | 1363 | insulin-like receptor [Tribolium castane | 0.656 | 0.175 | 0.731 | 1e-101 | |
| 189233909 | 1450 | PREDICTED: similar to insulin receptor, | 0.656 | 0.164 | 0.731 | 1e-101 | |
| 307185461 | 1515 | Insulin-like receptor [Camponotus florid | 0.695 | 0.166 | 0.717 | 1e-100 | |
| 326370574 | 1702 | insulin receptor-2 [Solenopsis invicta] | 0.695 | 0.148 | 0.713 | 1e-100 | |
| 348522143 | 1343 | PREDICTED: insulin receptor [Oreochromis | 0.780 | 0.211 | 0.626 | 1e-100 | |
| 332027409 | 1413 | Insulin-like receptor [Acromyrmex echina | 0.695 | 0.179 | 0.713 | 1e-100 | |
| 432917948 | 1387 | PREDICTED: insulin receptor-like [Oryzia | 0.766 | 0.201 | 0.635 | 6e-99 | |
| 410923925 | 1360 | PREDICTED: insulin receptor-like [Takifu | 0.766 | 0.205 | 0.618 | 9e-98 |
| >gi|345487749|ref|XP_001606180.2| PREDICTED: insulin-like receptor isoform 1 [Nasonia vitripennis] gi|345487751|ref|XP_003425750.1| PREDICTED: insulin-like receptor isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 375 bits (963), Expect = e-101, Method: Compositional matrix adjust.
Identities = 176/240 (73%), Positives = 202/240 (84%), Gaps = 1/240 (0%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R KV +L ELGNGSFG+VY G+ KD + E CA+K NENA++RE+
Sbjct: 1189 VYIPDEWEVPRKKVHLLKELGNGSFGMVYEGIAKDVVKGKPEMRCAVKTVNENATDRERV 1248
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F+THHVV+L GVVS+G PTLV+MELM GDLK YLRS RPD + R
Sbjct: 1249 EFLNEASVMKGFNTHHVVRLLGVVSQGQPTLVVMELMVNGDLKTYLRSHRPDVCENFSRQ 1308
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL+RI++MA E+ADGMAYLA KKFVHRDLAARNCMV+DDLTVK+GDFGMTRD+YET+Y
Sbjct: 1309 PPTLNRIMRMALEIADGMAYLAAKKFVHRDLAARNCMVSDDLTVKIGDFGMTRDVYETDY 1368
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG++G LPVRWMAPESLKDGVFTS SDVWSYGVVLWEM TLASQPYQGLSN+QVL +V
Sbjct: 1369 YRKGTKGLLPVRWMAPESLKDGVFTSFSDVWSYGVVLWEMVTLASQPYQGLSNDQVLRYV 1428
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307214044|gb|EFN89247.1| Insulin-like receptor [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 375 bits (963), Expect = e-101, Method: Compositional matrix adjust.
Identities = 181/256 (70%), Positives = 207/256 (80%), Gaps = 1/256 (0%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+ +L ELGNGSFG+VY G+ +D + E CA+K NENA++R++
Sbjct: 874 VYVPDEWEVPRKKIELLRELGNGSFGMVYEGVARDVVKGNPEVRCAVKTVNENATDRQRI 933
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMKAF+THHV+KL GVVS+G PTLV+MELM GDLK YLRS RPD + R
Sbjct: 934 EFLNEASVMKAFNTHHVIKLLGVVSQGQPTLVVMELMVNGDLKTYLRSHRPDVCENFSRQ 993
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL RI+QMA E+ADGMAYLA KKFVHRDLAARNCMVA+DLTVK+GDFGMTRDIYET+Y
Sbjct: 994 PPTLKRIVQMAIEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY 1053
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG++G LPVRWMAPESLKDGVFTS SDVWSYGVVLWEM TLASQPYQGLSN+QVL +V
Sbjct: 1054 YRKGTKGLLPVRWMAPESLKDGVFTSFSDVWSYGVVLWEMVTLASQPYQGLSNDQVLRYV 1113
Query: 348 KGKSSNEYKVNPPISL 363
E N P SL
Sbjct: 1114 IEGGVMERPENCPDSL 1129
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270015135|gb|EFA11583.1| insulin-like receptor [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 374 bits (960), Expect = e-101, Method: Compositional matrix adjust.
Identities = 177/242 (73%), Positives = 203/242 (83%), Gaps = 3/242 (1%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE 168
+Y D WEV R K+ ++ ELG GSFG+VY G+ +D R A+ CA+K NE+A+ RE+ E
Sbjct: 979 VYVPDEWEVPRKKIELIRELGQGSFGMVYEGIAQDVRGKAQIKCAVKTVNEHATNRERLE 1038
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET---DVE 225
FLNEASVMKAFDT HVV+L GVVS+G PTLVIMELM GDLK YLRS RPDAE
Sbjct: 1039 FLNEASVMKAFDTAHVVRLLGVVSQGQPTLVIMELMANGDLKTYLRSHRPDAEVYDPATA 1098
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
+ PPTL +ILQMA E+ADGMAYL+ KKFVHRDLAARNCMVA+DLTVK+GDFGMTRDIYET
Sbjct: 1099 KQPPTLKQILQMAIEIADGMAYLSAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 1158
Query: 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+YYRKG++G LPVRWMAPESLKDGVFTS+SDVWSYGVVLWEMATLASQPYQGLSN+QVL
Sbjct: 1159 DYYRKGTKGLLPVRWMAPESLKDGVFTSNSDVWSYGVVLWEMATLASQPYQGLSNDQVLR 1218
Query: 346 WV 347
+V
Sbjct: 1219 YV 1220
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|189233909|ref|XP_972770.2| PREDICTED: similar to insulin receptor, partial [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 374 bits (960), Expect = e-101, Method: Compositional matrix adjust.
Identities = 177/242 (73%), Positives = 203/242 (83%), Gaps = 3/242 (1%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE 168
+Y D WEV R K+ ++ ELG GSFG+VY G+ +D R A+ CA+K NE+A+ RE+ E
Sbjct: 1066 VYVPDEWEVPRKKIELIRELGQGSFGMVYEGIAQDVRGKAQIKCAVKTVNEHATNRERLE 1125
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET---DVE 225
FLNEASVMKAFDT HVV+L GVVS+G PTLVIMELM GDLK YLRS RPDAE
Sbjct: 1126 FLNEASVMKAFDTAHVVRLLGVVSQGQPTLVIMELMANGDLKTYLRSHRPDAEVYDPATA 1185
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
+ PPTL +ILQMA E+ADGMAYL+ KKFVHRDLAARNCMVA+DLTVK+GDFGMTRDIYET
Sbjct: 1186 KQPPTLKQILQMAIEIADGMAYLSAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 1245
Query: 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+YYRKG++G LPVRWMAPESLKDGVFTS+SDVWSYGVVLWEMATLASQPYQGLSN+QVL
Sbjct: 1246 DYYRKGTKGLLPVRWMAPESLKDGVFTSNSDVWSYGVVLWEMATLASQPYQGLSNDQVLR 1305
Query: 346 WV 347
+V
Sbjct: 1306 YV 1307
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307185461|gb|EFN71461.1| Insulin-like receptor [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 371 bits (953), Expect = e-100, Method: Compositional matrix adjust.
Identities = 183/255 (71%), Positives = 205/255 (80%), Gaps = 2/255 (0%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAE 168
Y D WEV R KV ++ ELGNGSFG+VY GL KD + E CA+K NENA++RE+ E
Sbjct: 985 YVPDEWEVARKKVQLIRELGNGSFGMVYEGLAKDVVKDQPEVRCAVKTVNENATDRERIE 1044
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
FLNEASVMKAF+THHVV+L GVVS+G PTLV+MELM GDLK YLRS RPD + + P
Sbjct: 1045 FLNEASVMKAFNTHHVVRLLGVVSQGQPTLVVMELMVNGDLKTYLRSHRPDV-CENSKHP 1103
Query: 229 PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY 288
PTL ILQMA E+ADGM+YLA KKFVHRDLAARNCMVA+DLTVK+GDFGMTRDIYET+YY
Sbjct: 1104 PTLRDILQMAVEIADGMSYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 1163
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
RKGS+G LPVRWMAPESLKDGVFTS SDVWSYGVVLWEM TLASQPYQGLSN+QVL +V
Sbjct: 1164 RKGSKGLLPVRWMAPESLKDGVFTSFSDVWSYGVVLWEMVTLASQPYQGLSNDQVLRYVI 1223
Query: 349 GKSSNEYKVNPPISL 363
E N P SL
Sbjct: 1224 EGGVMERPENCPDSL 1238
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|326370574|gb|ADZ56366.1| insulin receptor-2 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 370 bits (950), Expect = e-100, Method: Compositional matrix adjust.
Identities = 182/255 (71%), Positives = 205/255 (80%), Gaps = 2/255 (0%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAE 168
Y D WEV R K+ +L ELGNGSFG+VY GL KD + E CA+K NENA++RE+ E
Sbjct: 1171 YVPDEWEVPRKKIQLLRELGNGSFGMVYEGLAKDVVKGKPEVRCAVKTVNENATDRERIE 1230
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
FLNEASVMKAF+THHVV+L GVVS+G PTLV+MELM GDLK YLRS RPD + + P
Sbjct: 1231 FLNEASVMKAFNTHHVVRLLGVVSQGQPTLVVMELMVNGDLKTYLRSHRPDV-CENSKQP 1289
Query: 229 PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY 288
PTL ILQMA E+ADGM+YL+ KKFVHRDLAARNCMVA+DLTVK+GDFGMTRDIYET+YY
Sbjct: 1290 PTLREILQMAVEIADGMSYLSAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 1349
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
RKGS+G LPVRWMAPESLKDGVFTS SDVWSYGVVLWEM TLASQPYQGLSN+QVL +V
Sbjct: 1350 RKGSKGLLPVRWMAPESLKDGVFTSFSDVWSYGVVLWEMVTLASQPYQGLSNDQVLRYVI 1409
Query: 349 GKSSNEYKVNPPISL 363
E N P SL
Sbjct: 1410 EGGVMERPENCPDSL 1424
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|348522143|ref|XP_003448585.1| PREDICTED: insulin receptor [Oreochromis niloticus] | Back alignment and taxonomy information |
|---|
Score = 369 bits (948), Expect = e-100, Method: Compositional matrix adjust.
Identities = 181/289 (62%), Positives = 219/289 (75%), Gaps = 5/289 (1%)
Query: 60 IFLFLIRVAVILTGSGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLR 119
I F++ + V L G + P+ P ++ P + + D ++Y++D WEV R
Sbjct: 925 IICFVLVLCVALVGF--VMFKKSQTQGPSGPIYASSNP--EYLSTDGKQVYEEDEWEVPR 980
Query: 120 SKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKA 178
K+TIL ELG GSFG+VY G+ KD + E A+K NE+AS RE+ EFLNEASVMKA
Sbjct: 981 EKITILRELGQGSFGMVYEGIAKDIVKGEGETRVAVKTVNESASLRERIEFLNEASVMKA 1040
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
F HHVV+L GVVS+G PTLV+MELM GDLK++LRS RPDAE + R PPTL ++QMA
Sbjct: 1041 FSCHHVVRLLGVVSKGQPTLVVMELMTHGDLKSFLRSLRPDAENNPGRPPPTLKEMIQMA 1100
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
AE+ADGMAYL KKFVHRDLAARNCMVA DLTVK+GDFGMTRDIYET+YYRKG +G LPV
Sbjct: 1101 AEIADGMAYLNAKKFVHRDLAARNCMVAHDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 1160
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
RWMAPESLKDGVFT+HSD WS+GVVLWE++TLA QPYQG+SNEQVL +V
Sbjct: 1161 RWMAPESLKDGVFTAHSDCWSFGVVLWEVSTLAEQPYQGMSNEQVLKFV 1209
|
Source: Oreochromis niloticus Species: Oreochromis niloticus Genus: Oreochromis Family: Cichlidae Order: Perciformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|332027409|gb|EGI67492.1| Insulin-like receptor [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 369 bits (948), Expect = e-100, Method: Compositional matrix adjust.
Identities = 182/255 (71%), Positives = 205/255 (80%), Gaps = 2/255 (0%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAE 168
Y D WEV R K+ +L ELGNGSFG+VY GL +D + E CA+K NENA++RE+ E
Sbjct: 884 YVPDEWEVPRKKIQLLRELGNGSFGMVYEGLARDVVKGKPEVRCAVKTVNENATDRERIE 943
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
FLNEASVMKAF+THHVV+L GVVS+G PTLV+MELM GDLK YLRS RPD + + P
Sbjct: 944 FLNEASVMKAFNTHHVVRLLGVVSQGQPTLVVMELMVNGDLKTYLRSHRPDV-CENSKQP 1002
Query: 229 PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY 288
PTL ILQMA E+ADGM+YLA KKFVHRDLAARNCMVA+DLTVK+GDFGMTRDIYET+YY
Sbjct: 1003 PTLRDILQMAVEIADGMSYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 1062
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
RKGS+G LPVRWMAPESLKDGVFTS SDVWSYGVVLWEM TLASQPYQGLSN+QVL +V
Sbjct: 1063 RKGSKGLLPVRWMAPESLKDGVFTSFSDVWSYGVVLWEMVTLASQPYQGLSNDQVLRYVI 1122
Query: 349 GKSSNEYKVNPPISL 363
E N P SL
Sbjct: 1123 EGGVMERPENCPDSL 1137
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|432917948|ref|XP_004079577.1| PREDICTED: insulin receptor-like [Oryzias latipes] | Back alignment and taxonomy information |
|---|
Score = 367 bits (941), Expect = 6e-99, Method: Compositional matrix adjust.
Identities = 183/288 (63%), Positives = 218/288 (75%), Gaps = 9/288 (3%)
Query: 61 FLFLIRVAVILTGSGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRS 120
F+ L+ V+V +G P+ P ++ P + + +D +Y++D WEV R
Sbjct: 974 FVLLLLVSV----AGFVVFKKNQTQGPSGPIYASSNP--EYLSAND--VYEEDEWEVPRD 1025
Query: 121 KVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
K+ IL ELG GSFG+VY GL KD + E A+K NE+AS RE+ EFLNEASVMKAF
Sbjct: 1026 KIHILRELGQGSFGMVYEGLAKDIVKGEGETHVAVKTVNESASLRERIEFLNEASVMKAF 1085
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
HHVV+L GVVS+G PTLV+MELM GDLK+YLRS RPDAE + R PPTL ++QMAA
Sbjct: 1086 TCHHVVRLLGVVSKGQPTLVVMELMTHGDLKSYLRSLRPDAENNPGRPPPTLKEMIQMAA 1145
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299
E+ADGMAYL KKFVHRDLAARNCMVA DLTVK+GDFGMTRDIYET+YYRKG +G LPVR
Sbjct: 1146 EIADGMAYLNAKKFVHRDLAARNCMVAHDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 1205
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
WMAPESLKDGVFT+HSD WS+GVVLWE++TLA QPYQGLSNEQVL +V
Sbjct: 1206 WMAPESLKDGVFTAHSDCWSFGVVLWEISTLAEQPYQGLSNEQVLKFV 1253
|
Source: Oryzias latipes Species: Oryzias latipes Genus: Oryzias Family: Adrianichthyidae Order: Beloniformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|410923925|ref|XP_003975432.1| PREDICTED: insulin receptor-like [Takifugu rubripes] | Back alignment and taxonomy information |
|---|
Score = 363 bits (931), Expect = 9e-98, Method: Compositional matrix adjust.
Identities = 178/288 (61%), Positives = 218/288 (75%), Gaps = 9/288 (3%)
Query: 61 FLFLIRVAVILTGSGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRS 120
F+ L+ VAV G + P+ P ++ P + + +D +Y++D WEV R
Sbjct: 947 FVLLLLVAV----GGFVMFKKSQTQGPSGPIYASSNP--EYLSAND--VYEEDEWEVPRD 998
Query: 121 KVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
K++IL ELG G+FG+VY G+ KD + E A+K NE+A+ R++ EFLNEASVMKAF
Sbjct: 999 KISILRELGQGTFGMVYEGIAKDIVKGEGESHVAVKTVNESANLRQRIEFLNEASVMKAF 1058
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
HHVV+L GVVS+G PTLV+MELM GDLK+YLRS RPDAE + R PPTL ++QMAA
Sbjct: 1059 SCHHVVRLMGVVSKGQPTLVVMELMTNGDLKSYLRSLRPDAENNPGRPPPTLKEMIQMAA 1118
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299
E+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+YYRKG +G LPVR
Sbjct: 1119 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 1178
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
WMAPESLKDGVFT+HSD WS+GVVLWE++TL+ QPYQGLSNEQVL +V
Sbjct: 1179 WMAPESLKDGVFTAHSDCWSFGVVLWEISTLSEQPYQGLSNEQVLKFV 1226
|
Source: Takifugu rubripes Species: Takifugu rubripes Genus: Takifugu Family: Tetraodontidae Order: Tetraodontiformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 364 | ||||||
| UNIPROTKB|P06213 | 1382 | INSR "Insulin receptor" [Homo | 0.656 | 0.172 | 0.7 | 2.7e-90 | |
| ZFIN|ZDB-GENE-020503-3 | 1353 | insra "insulin receptor a" [Da | 0.662 | 0.178 | 0.706 | 2.7e-90 | |
| UNIPROTKB|F1NRT9 | 989 | INSR "Tyrosine-protein kinase | 0.656 | 0.241 | 0.708 | 3.1e-90 | |
| UNIPROTKB|F1MV64 | 1382 | INSR "Tyrosine-protein kinase | 0.656 | 0.172 | 0.7 | 3.5e-90 | |
| UNIPROTKB|F1NJT2 | 1328 | INSR "Tyrosine-protein kinase | 0.656 | 0.179 | 0.708 | 1e-89 | |
| MGI|MGI:96575 | 1372 | Insr "insulin receptor" [Mus m | 0.656 | 0.174 | 0.695 | 1.1e-89 | |
| UNIPROTKB|Q93105 | 1393 | InR "Insulin-like receptor" [A | 0.697 | 0.182 | 0.680 | 2.1e-89 | |
| UNIPROTKB|F1LN53 | 1357 | Insr "Tyrosine-protein kinase | 0.656 | 0.176 | 0.691 | 2.7e-89 | |
| UNIPROTKB|F1LPL6 | 1369 | Insr "Tyrosine-protein kinase | 0.656 | 0.174 | 0.691 | 3e-89 | |
| RGD|2917 | 1383 | Insr "insulin receptor" [Rattu | 0.656 | 0.172 | 0.691 | 3.5e-89 |
| UNIPROTKB|P06213 INSR "Insulin receptor" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 884 (316.2 bits), Expect = 2.7e-90, Sum P(2) = 2.7e-90
Identities = 168/240 (70%), Positives = 195/240 (81%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+L ELG GSFG+VY G +D + AE A+K NE+AS RE+
Sbjct: 1010 VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 1069
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F HHVV+L GVVS+G PTLV+MELM GDLK+YLRS RP+AE + R
Sbjct: 1070 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 1129
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL ++QMAAE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+Y
Sbjct: 1130 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 1189
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWMAPESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 1190 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 1249
|
|
| ZFIN|ZDB-GENE-020503-3 insra "insulin receptor a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 906 (324.0 bits), Expect = 2.7e-90, P = 2.7e-90
Identities = 171/242 (70%), Positives = 202/242 (83%)
Query: 107 DKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASERE 165
D++Y+ D WEV R K+T+L ELG GSFG+VY G KD + ++ A+K NE+AS RE
Sbjct: 979 DEVYEPDEWEVPREKITLLRELGQGSFGMVYEGNGKDIVKGESQTRVAVKTVNESASLRE 1038
Query: 166 KAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVE 225
+ EFLNEASVMKAF HHVV+L GVVS+G PTLV+MELM GDLK++LRS RPD+E +
Sbjct: 1039 RIEFLNEASVMKAFSCHHVVRLLGVVSKGQPTLVVMELMTHGDLKSFLRSLRPDSENNPG 1098
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
R PPTL ++QMAAE+ADGMAYL KKFVHRDLAARNCMVA+DLTVK+GDFGMTRDIYET
Sbjct: 1099 RPPPTLKEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 1158
Query: 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+YYRKG +G LPVRWMAPESLKDGVFT+HSD WS+GVVLWE++TLA QPYQGLSNEQVL
Sbjct: 1159 DYYRKGGKGLLPVRWMAPESLKDGVFTAHSDCWSFGVVLWEVSTLAEQPYQGLSNEQVLK 1218
Query: 346 WV 347
+V
Sbjct: 1219 FV 1220
|
|
| UNIPROTKB|F1NRT9 INSR "Tyrosine-protein kinase receptor" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
Identities = 170/240 (70%), Positives = 198/240 (82%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+L ELG GSFG+VY G+ KD + E A+K NE+AS RE+
Sbjct: 617 VYVPDEWEVPREKITLLRELGQGSFGMVYEGIAKDIVKGELETRVAVKTVNESASLRERI 676
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F HHVV+L GVVS+G PTLV+MELM GDLK+YLRS RPDAE + R
Sbjct: 677 EFLNEASVMKGFSCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPDAENNPGRP 736
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL ++QMAAE+ADGMAYL KKFVHRDLAARNCMVA+D TVK+GDFGMTRDIYET+Y
Sbjct: 737 PPTLREMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 796
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWMAPESLKDGVFT++SDVWS+GVVLWE+++LA QPYQGLSNEQVL +V
Sbjct: 797 YRKGGKGLLPVRWMAPESLKDGVFTTYSDVWSFGVVLWEISSLAEQPYQGLSNEQVLKFV 856
|
|
| UNIPROTKB|F1MV64 INSR "Tyrosine-protein kinase receptor" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 3.5e-90, Sum P(2) = 3.5e-90
Identities = 168/240 (70%), Positives = 195/240 (81%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+L ELG GSFG+VY G +D + AE A+K NE+AS RE+
Sbjct: 1010 VYVPDEWEVPREKITLLRELGQGSFGMVYEGNARDIVKGEAETRVAVKTVNESASLRERI 1069
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F HHVV+L GVVS+G PTLV+MELM GDLK+YLRS RP+AE + R
Sbjct: 1070 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 1129
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL ++QMAAE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+Y
Sbjct: 1130 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 1189
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWMAPESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 1190 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 1249
|
|
| UNIPROTKB|F1NJT2 INSR "Tyrosine-protein kinase receptor" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 900 (321.9 bits), Expect = 1.0e-89, P = 1.0e-89
Identities = 170/240 (70%), Positives = 198/240 (82%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+L ELG GSFG+VY G+ KD + E A+K NE+AS RE+
Sbjct: 956 VYVPDEWEVPREKITLLRELGQGSFGMVYEGIAKDIVKGELETRVAVKTVNESASLRERI 1015
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F HHVV+L GVVS+G PTLV+MELM GDLK+YLRS RPDAE + R
Sbjct: 1016 EFLNEASVMKGFSCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPDAENNPGRP 1075
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL ++QMAAE+ADGMAYL KKFVHRDLAARNCMVA+D TVK+GDFGMTRDIYET+Y
Sbjct: 1076 PPTLREMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 1135
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWMAPESLKDGVFT++SDVWS+GVVLWE+++LA QPYQGLSNEQVL +V
Sbjct: 1136 YRKGGKGLLPVRWMAPESLKDGVFTTYSDVWSFGVVLWEISSLAEQPYQGLSNEQVLKFV 1195
|
|
| MGI|MGI:96575 Insr "insulin receptor" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 878 (314.1 bits), Expect = 1.1e-89, Sum P(2) = 1.1e-89
Identities = 167/240 (69%), Positives = 194/240 (80%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+L ELG GSFG+VY G KD + AE A+K NE+AS RE+
Sbjct: 1000 VYVPDEWEVPREKITLLRELGQGSFGMVYEGNAKDIIKGEAETRVAVKTVNESASLRERI 1059
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F HHVV+L GVVS+G PTLV+MELM GDLK++LRS RPDAE + R
Sbjct: 1060 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSHLRSLRPDAENNPGRP 1119
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL ++QM AE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+Y
Sbjct: 1120 PPTLQEMIQMTAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 1179
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWM+PESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 1180 YRKGGKGLLPVRWMSPESLKDGVFTASSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 1239
|
|
| UNIPROTKB|Q93105 InR "Insulin-like receptor" [Aedes aegypti (taxid:7159)] | Back alignment and assigned GO terms |
|---|
Score = 899 (321.5 bits), Expect = 2.1e-89, P = 2.1e-89
Identities = 175/257 (68%), Positives = 205/257 (79%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS-LAEHPCAIKVANENASEREKAE 168
YK D WEV R+ + L+ELG GSFG+VY+G++ R PCAIK NE+A+ REK
Sbjct: 1013 YKVDDWEVERNHIIQLEELGQGSFGMVYKGILTQLRGEKCNQPCAIKTVNESATAREKDS 1072
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET--DVER 226
FL EASVMK F+THHVV+L GVVS+G+PTLVIMELM GDLK+YLR RPD E D
Sbjct: 1073 FLLEASVMKQFNTHHVVRLLGVVSQGDPTLVIMELMANGDLKSYLRRHRPDYENGEDPSP 1132
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
PPTL +I+QMA E+ADGMAYL+ KKFVHRDLAARNCMVADD+TVK+GDFGMTRDIYET+
Sbjct: 1133 QPPTLRQIIQMAIEIADGMAYLSAKKFVHRDLAARNCMVADDMTVKIGDFGMTRDIYETD 1192
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
YYRKG++GFLPVRWMAPESLKDG+F+S SDV+SYGVVLWEMATLASQPYQGL+N+QVL +
Sbjct: 1193 YYRKGTKGFLPVRWMAPESLKDGIFSSSSDVFSYGVVLWEMATLASQPYQGLTNDQVLRY 1252
Query: 347 VKGKSSNEYKVNPPISL 363
V E N P +L
Sbjct: 1253 VIDGGVMERPENCPDNL 1269
|
|
| UNIPROTKB|F1LN53 Insr "Tyrosine-protein kinase receptor" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 2.7e-89, Sum P(2) = 2.7e-89
Identities = 166/240 (69%), Positives = 193/240 (80%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+L ELG GSFG+VY G KD + E A+K NE+AS RE+
Sbjct: 985 VYVPDEWEVPREKITLLRELGQGSFGMVYEGNAKDIIKGEVETRVAVKTVNESASLRERI 1044
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F HHVV+L GVVS+G PTLV+MELM GDLK++LRS RPDAE + R
Sbjct: 1045 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSHLRSLRPDAENNPGRP 1104
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL ++QM AE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+Y
Sbjct: 1105 PPTLQEMIQMTAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 1164
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWM+PESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 1165 YRKGGKGLLPVRWMSPESLKDGVFTASSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 1224
|
|
| UNIPROTKB|F1LPL6 Insr "Tyrosine-protein kinase receptor" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 3.0e-89, Sum P(2) = 3.0e-89
Identities = 166/240 (69%), Positives = 193/240 (80%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+L ELG GSFG+VY G KD + E A+K NE+AS RE+
Sbjct: 997 VYVPDEWEVPREKITLLRELGQGSFGMVYEGNAKDIIKGEVETRVAVKTVNESASLRERI 1056
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F HHVV+L GVVS+G PTLV+MELM GDLK++LRS RPDAE + R
Sbjct: 1057 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSHLRSLRPDAENNPGRP 1116
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL ++QM AE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+Y
Sbjct: 1117 PPTLQEMIQMTAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 1176
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWM+PESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 1177 YRKGGKGLLPVRWMSPESLKDGVFTASSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 1236
|
|
| RGD|2917 Insr "insulin receptor" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 3.5e-89, Sum P(2) = 3.5e-89
Identities = 166/240 (69%), Positives = 193/240 (80%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+L ELG GSFG+VY G KD + E A+K NE+AS RE+
Sbjct: 1011 VYVPDEWEVPREKITLLRELGQGSFGMVYEGNAKDIIKGEVETRVAVKTVNESASLRERI 1070
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F HHVV+L GVVS+G PTLV+MELM GDLK++LRS RPDAE + R
Sbjct: 1071 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSHLRSLRPDAENNPGRP 1130
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PPTL ++QM AE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+Y
Sbjct: 1131 PPTLQEMIQMTAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 1190
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWM+PESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 1191 YRKGGKGLLPVRWMSPESLKDGVFTASSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 1250
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P15127 | INSR_RAT | 2, ., 7, ., 1, 0, ., 1 | 0.6075 | 0.7747 | 0.2039 | yes | N/A |
| P06213 | INSR_HUMAN | 2, ., 7, ., 1, 0, ., 1 | 0.6143 | 0.7747 | 0.2040 | yes | N/A |
| P15208 | INSR_MOUSE | 2, ., 7, ., 1, 0, ., 1 | 0.6109 | 0.7747 | 0.2055 | yes | N/A |
| P09208 | INSR_DROME | 2, ., 7, ., 1, 0, ., 1 | 0.6494 | 0.6538 | 0.1110 | yes | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 364 | |||
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-156 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-132 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-123 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-118 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-113 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-107 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-105 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-84 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-82 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-78 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-74 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-70 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-70 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-68 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-67 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-66 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-65 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-63 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-62 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-62 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-61 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-61 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-61 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-61 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-60 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-59 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-59 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-58 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-58 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-57 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-57 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-56 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-56 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-56 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-55 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-55 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-55 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-55 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-55 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-55 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-54 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-54 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-53 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-53 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-53 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-53 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-53 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-52 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-52 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-51 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-51 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-51 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-51 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-50 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-49 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-49 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-48 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-46 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-46 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-45 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-45 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-45 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-44 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-44 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-43 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-43 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-43 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-43 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-42 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-42 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-41 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-41 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-41 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-41 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-41 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-41 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-40 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-38 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-35 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-35 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-33 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-32 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-32 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-30 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-29 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-18 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-18 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 439 bits (1130), Expect = e-156
Identities = 172/247 (69%), Positives = 196/247 (79%), Gaps = 1/247 (0%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRS-LAEHPCAIKVANENASEREKAEFLNEA 173
WE+ R K+T++ ELG GSFG+VY GL K E AIK NENAS RE+ EFLNEA
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA 60
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
SVMK F+ HHVV+L GVVS G PTLV+MELM GDLK+YLRS RP+AE + PPTL +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
+QMAAE+ADGMAYLA KKFVHRDLAARNCMVA+DLTVK+GDFGMTRDIYET+YYRKG +
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353
G LPVRWMAPESLKDGVFT+ SDVWS+GVVLWEMATLA QPYQGLSNE+VL +V
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240
Query: 354 EYKVNPP 360
+ N P
Sbjct: 241 DLPENCP 247
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 378 bits (972), Expect = e-132
Identities = 166/234 (70%), Positives = 192/234 (82%), Gaps = 1/234 (0%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEA 173
WEV R K+T+L ELG GSFG+VY G +D + AE A+K NE+AS RE+ EFLNEA
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 60
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
SVMK F HHVV+L GVVS+G PTLV+MELM GDLK+YLRS RP+AE + R PPTL
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
++QMAAE+ADGMAYL KKFVHRDLAARNCMVA D TVK+GDFGMTRDIYET+YYRKG +
Sbjct: 121 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
G LPVRWMAPESLKDGVFT+ SD+WS+GVVLWE+ +LA QPYQGLSNEQVL +V
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 356 bits (915), Expect = e-123
Identities = 162/234 (69%), Positives = 192/234 (82%), Gaps = 1/234 (0%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEA 173
WEV R K+T+ ELG GSFG+VY G+ K + E AIK NE AS RE+ EFLNEA
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
SVMK F+ HHVV+L GVVS+G PTLVIMELM GDLK+YLRS RP+ E + ++PP+L +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
++QMA E+ADGMAYL KFVHRDLAARNCMVA+D TVK+GDFGMTRDIYET+YYRKG +
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
G LPVRWM+PESLKDGVFT++SDVWS+GVVLWE+ATLA QPYQG+SNEQVL +V
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 342 bits (881), Expect = e-118
Identities = 115/227 (50%), Positives = 152/227 (66%), Gaps = 9/227 (3%)
Query: 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT 181
+ + +LG G+FG VY+G +K E A+K E ASE E+ EFL EAS+MK
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++V+L GV ++G P ++ E M GGDL ++LR TL +LQMA ++
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---------KLTLKDLLQMALQI 111
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
A GM YL K FVHRDLAARNC+V ++L VK+ DFG++RDIYE +YYRK G LP++WM
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM 171
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
APESLKDG FTS SDVWS+GV+LWE+ TL QPY G+SNE+VL ++
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 331 bits (850), Expect = e-113
Identities = 118/223 (52%), Positives = 159/223 (71%), Gaps = 2/223 (0%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVV 185
+LG G+FG VY+G +K + A+K E+ASE E+ +FL EA VMK +VV
Sbjct: 1 KKLGEGAFGEVYKGKLKG-KDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
+L GV +E P +++E M GGDL +YLR RP + E+S +L +L A ++A GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSP-EKSTLSLKDLLSFAIQIAKGM 118
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
YLA KKFVHRDLAARNC+V +DL VK+ DFG++RD+Y+ +YYRK + G LP+RWMAPES
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 306 LKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
LKDG+FTS SDVWS+GV+LWE+ TL + PY GLSNE+VL +++
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 314 bits (808), Expect = e-107
Identities = 111/227 (48%), Positives = 155/227 (68%), Gaps = 9/227 (3%)
Query: 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT 181
+T+ +LG G+FG VY+G +K E A+K E+ASE++ EFL EA +M+ D
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++VKL GV +E P +++ME M GGDL +YLR RP +LS +L A ++
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--------LSLSDLLSFALQI 112
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
A GM YL K F+HRDLAARNC+V ++L VK+ DFG++RD+Y+ +YY+ G LP+RWM
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV-KGGKLPIRWM 171
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
APESLK+G FTS SDVWS+GV+LWE+ TL +PY G+SN +VL ++K
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 309 bits (795), Expect = e-105
Identities = 115/227 (50%), Positives = 156/227 (68%), Gaps = 10/227 (4%)
Query: 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT 181
+T+ +LG G+FG VY+G +K + A+K E+ASE++ EFL EA +M+ D
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+VVKL GV +E P ++ME M GGDL +YLR RP +LS +L A ++
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---------KLSLSDLLSFALQI 111
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
A GM YL K F+HRDLAARNC+V ++L VK+ DFG++RD+Y+ +YYRK G LP+RWM
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG-GKLPIRWM 170
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
APESLK+G FTS SDVWS+GV+LWE+ TL QPY G+SNE+VL ++K
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 9e-84
Identities = 109/238 (45%), Positives = 147/238 (61%), Gaps = 5/238 (2%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRG-LIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
V R + + ELG G+FG V+ G + A+K E AS + +F EA
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP----T 230
++ F ++VK YGV +EG+P +++ E M GDL +LRS PDA P T
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK 290
LS++LQ+A ++A GM YLA + FVHRDLA RNC+V DL VK+GDFGM+RD+Y T+YYR
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV 180
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
G LP+RWM PES+ FT+ SDVWS+GVVLWE+ T QP+ GLSNE+V+ +
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 252 bits (644), Expect = 1e-82
Identities = 113/231 (48%), Positives = 146/231 (63%), Gaps = 16/231 (6%)
Query: 128 LGNGSFGLVYRGLIKDF--RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVV 185
LG+G+FG VY G D A+K + A+++EK EFL EA +M F+ ++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP---TLSRILQMAAEVA 242
KL GV P +IMELM GGDL +YLR R VER P TL +L + +VA
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDAR------VERFGPPLLTLKELLDICLDVA 116
Query: 243 DGMAYLADKKFVHRDLAARNCMVAD-----DLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
G YL F+HRDLAARNC+V++ D VK+GDFG+ RDIY+++YYRK G LP
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
VRWMAPESL DG FT+ SDVWS+GV++WE+ TL QPY L+N++VL V
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 1e-78
Identities = 108/249 (43%), Positives = 154/249 (61%), Gaps = 7/249 (2%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLA-EHPCAIKVANENASEREKAEFLNEAS 174
EV R +T+L LG+G+FG VY GL + A E A+K E+ SE+++++FL EA
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+M F+ ++V+L GV E P +++ELM GGDLK++LR RP E S T+ +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE---RPSSLTMKDL 118
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---DLTVKVGDFGMTRDIYETEYYRKG 291
L A +VA G YL + F+HRD+AARNC++ K+ DFGM RDIY YYRKG
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351
R LP++WM PE+ DG+FTS +DVWS+GV+LWE+ +L PY G +N++V+ +V G
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238
Query: 352 SNEYKVNPP 360
+ P
Sbjct: 239 RLDPPKGCP 247
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 1e-74
Identities = 99/251 (39%), Positives = 152/251 (60%), Gaps = 23/251 (9%)
Query: 116 EVLRSKVTILDELGNGSFGLVYR----GLIKDFRSLAEHPC--AIKVANENASEREKAEF 169
E R+ + + ++G G+FG V++ GL+ E A+K+ E AS +A+F
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPY-----EPFTMVAVKMLKEEASADMQADF 55
Query: 170 LNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS-- 227
EA++M FD ++VKL GV + G P ++ E M GDL +LR P A+ + S
Sbjct: 56 QREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 228 --------PPTLS--RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277
P LS L +A +VA GMAYL+++KFVHRDLA RNC+V +++ VK+ DFG
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
++R+IY +YY+ +P+RWM PES+ +T+ SDVW+YGVVLWE+ + QPY G
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
Query: 338 LSNEQVLNWVK 348
+++E+V+ +V+
Sbjct: 236 MAHEEVIYYVR 246
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 2e-70
Identities = 105/250 (42%), Positives = 147/250 (58%), Gaps = 6/250 (2%)
Query: 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVM 176
+ R + + ELG G+FG V+ + + A + ASE + +F EA ++
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 177 KAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAE-----TDVERSPPTL 231
H+V+ YGV +EG P L++ E M GDL +LRS PDA+ DV TL
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
++L +A+++A GM YLA FVHRDLA RNC+V L VK+GDFGM+RDIY T+YYR G
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV-KGK 350
R LP+RWM PES+ FT+ SD+WS+GVVLWE+ T QP+ LSN + + + +G+
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241
Query: 351 SSNEYKVNPP 360
+ PP
Sbjct: 242 ELERPRTCPP 251
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 4e-70
Identities = 96/245 (39%), Positives = 150/245 (61%), Gaps = 14/245 (5%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHP----CAIKVANENASEREKAEFL 170
WE+ R ++T+ LG G+FG V + + L A+K+ ++A+E++ ++ +
Sbjct: 7 WELPRDRLTLGKPLGEGAFGQVVKA---EAVGLDNPNETSTVAVKMLKDDATEKDLSDLV 63
Query: 171 NEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRP---DAETDVER 226
+E +MK H +++ L GV ++ P V++E G+L+++LR+ RP A D R
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 227 SPP---TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
P T ++ A +VA GM +LA KK +HRDLAARN +V +D +K+ DFG+ RDI+
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
+YYRK + G LPV+WMAPE+L D V+T SDVWS+GV+LWE+ TL PY G+ E++
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243
Query: 344 LNWVK 348
+K
Sbjct: 244 FKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 2e-68
Identities = 102/240 (42%), Positives = 144/240 (60%), Gaps = 7/240 (2%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRG-LIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
E+ S V L+ELG G+FG VY+G L L+ AIK ENA + + EF EA
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+M ++V L GV ++ PT ++ E + GDL +L P ++ E T+
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 235 L------QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY 288
L +A ++A GM YL+ FVHRDLAARNC+V + LTVK+ DFG++RDIY +YY
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
R S+ LPVRWM PE++ G FT+ SD+WS+GVVLWE+ + QPY G SN++V+ ++
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 3e-67
Identities = 96/244 (39%), Positives = 144/244 (59%), Gaps = 20/244 (8%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
S VTI +G G FG V RG +K E AIK +S++++ +FL EAS+M F
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLK-LPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
D ++++L GVV++ P ++I E M G L +LR E D + + L +L+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR------ENDGKFTVGQLVGMLR--- 113
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE--YYRKGSRGFLP 297
+A GM YL++ +VHRDLAARN +V +L KV DFG++R + ++E Y KG G +P
Sbjct: 114 GIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG--GKIP 171
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV-KGKSSNEYK 356
+RW APE++ FTS SDVWS+G+V+WE+ + +PY +SN+ V+ V G Y+
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-----YR 226
Query: 357 VNPP 360
+ PP
Sbjct: 227 LPPP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 211 bits (537), Expect = 3e-66
Identities = 102/234 (43%), Positives = 145/234 (61%), Gaps = 9/234 (3%)
Query: 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANE---NASEREKAEFLNEA 173
+ R + + ELG G+FG V+ + + +L I VA + +AS+ + +F EA
Sbjct: 2 IKRHNIVLKRELGEGAFGKVF---LAECYNLCPEQDKILVAVKTLKDASDNARKDFHREA 58
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPT--- 230
++ H+VK YGV EG+P +++ E M GDL +LR+ PDA E + P
Sbjct: 59 ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK 290
S++L +A ++A GM YLA + FVHRDLA RNC+V ++L VK+GDFGM+RD+Y T+YYR
Sbjct: 119 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
G LP+RWM PES+ FT+ SDVWS GVVLWE+ T QP+ LSN +V+
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 7e-65
Identities = 89/240 (37%), Positives = 137/240 (57%), Gaps = 14/240 (5%)
Query: 119 RSKVTILDELGNGSFGLVY------------RGLIKDFRSLAEHPCAIKVANENASEREK 166
R + +++LG G FG V+ + ++ + A A+KV +AS+ +
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 167 AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVER 226
+FL E ++ ++ +L GV + P +IME M GDL +L+ +
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 227 SPP-TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
S + S +L MA ++A GM YL FVHRDLA RNC+V + T+K+ DFGM+R++Y +
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLA-SQPYQGLSNEQVL 344
+YYR R LP+RWMA ES+ G FT+ SDVW++GV LWE+ TL QPY+ L+++QV+
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 2e-63
Identities = 92/233 (39%), Positives = 138/233 (59%), Gaps = 20/233 (8%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVA-----NENASEREKAEFLNEASVMKAFDTH 182
LG G FG V G + + +KVA + + E EFL+EA+ MK FD
Sbjct: 7 LGEGEFGSVMEGQLS-----QDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 183 HVVKLYGVVSEGNPT------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
+V+KL GV E + +VI+ M GDL ++L R E+ P L +L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLP--LQTLLK 117
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL 296
++A GM YL+++ F+HRDLAARNCM+ +D+TV V DFG+++ IY +YYR+G +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349
PV+W+A ESL D V+TS SDVW++GV +WE+AT PY G+ N ++ ++++
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH 230
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 2e-62
Identities = 87/233 (37%), Positives = 130/233 (55%), Gaps = 16/233 (6%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE R + T+ +LG+G FG V+ GL K+ AIK+ ++ ++ +F E
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRV-----RVAIKIL-KSDDLLKQQDFQKEVQ 54
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+K H++ L+ V S G P +I ELM G L +LRS E V +
Sbjct: 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS----PEGQVLPVAS----L 106
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
+ MA +VA+GMAYL ++ +HRDLAARN +V +DL KV DFG+ R I E Y +
Sbjct: 107 IDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK- 165
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
+P +W APE+ G F++ SDVWS+G++L+EM T PY G++N +V + +
Sbjct: 166 -IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 4e-62
Identities = 99/248 (39%), Positives = 147/248 (59%), Gaps = 7/248 (2%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA 178
R + + ELG G+FG V+ + + A ++ + + +F EA ++
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPT------LS 232
H+VK YGV +G+P +++ E M GDL +LR+ PDA V+ P LS
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGS 292
++L +A+++A GM YLA + FVHRDLA RNC+V +L VK+GDFGM+RD+Y T+YYR G
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV-KGKS 351
LP+RWM PES+ FT+ SDVWS+GV+LWE+ T QP+ LSN +V+ + +G+
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243
Query: 352 SNEYKVNP 359
+V P
Sbjct: 244 LERPRVCP 251
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 1e-61
Identities = 89/231 (38%), Positives = 141/231 (61%), Gaps = 12/231 (5%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
+E+ R +T+ +G G FG VY+G+ + + A+K S + +FL EA
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPEN-EKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+M+ FD H+VKL GV++E NP ++MEL G+L++YL+ V + L+ +
Sbjct: 60 IMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQ---------VNKYSLDLASL 109
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
+ + +++ +AYL K+FVHRD+AARN +V+ VK+GDFG++R + + YY K S+G
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKG 168
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
LP++WMAPES+ FTS SDVW +GV +WE+ L +P+QG+ N V+
Sbjct: 169 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 2e-61
Identities = 88/219 (40%), Positives = 127/219 (57%), Gaps = 13/219 (5%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
ELG+G+FG V +G+ +S E A+K + K EFL EASVM D +V+
Sbjct: 2 ELGHGNFGSVVKGVYLM-KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
L GV +G P +++MEL G L YL+ +R +S + ++A +VA GMA
Sbjct: 61 LIGV-CKGEPLMLVMELAPLGPLLKYLK----------KRREIPVSDLKELAHQVAMGMA 109
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI-YETEYYRKGSRGFLPVRWMAPES 305
YL K FVHRDLAARN ++ + K+ DFGM+R + ++YYR + G P++W APE
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 306 LKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
+ G F+S SDVWSYGV LWE + ++PY + +V+
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 7e-61
Identities = 84/215 (39%), Positives = 126/215 (58%), Gaps = 14/215 (6%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
+G G+FG VY+G++K +A +K K +FL EA ++K +D ++VKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVA-----VKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
GV + P ++MEL+ GG L +LR + T+ ++LQM+ + A GM Y
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLR--KKKNRL-------TVKKLLQMSLDAAAGMEY 108
Query: 248 LADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK 307
L K +HRDLAARNC+V ++ +K+ DFGM+R+ Y +P++W APE+L
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 308 DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
G +TS SDVWSYG++LWE +L PY G+SN+Q
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 7e-61
Identities = 99/214 (46%), Positives = 130/214 (60%), Gaps = 19/214 (8%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
+G G FG VY G + D H CA+K N E +FL E +MK F +V+ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIH-CAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 188 YGVV--SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
G+ SEG+P LV++ M GDL+N++RS E PT+ ++ +VA GM
Sbjct: 62 LGICLPSEGSP-LVVLPYMKHGDLRNFIRS---------ETHNPTVKDLIGFGLQVAKGM 111
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY----RKGSRGFLPVRWM 301
YLA KKFVHRDLAARNCM+ + TVKV DFG+ RDIY+ EYY G++ LPV+WM
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK--LPVKWM 169
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335
A ESL+ FT+ SDVWS+GV+LWE+ T + PY
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 5e-60
Identities = 85/234 (36%), Positives = 127/234 (54%), Gaps = 18/234 (7%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE+ R + + +LG G FG V+ G A+K FL EA
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTW-----NGTTKVAVKTLKPGTMS--PEAFLQEAQ 53
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+MK +V+LY V SE P ++ E M G L ++L+ E L ++
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK--------SGEGKKLRLPQL 105
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY-RKGSR 293
+ MAA++A+GMAYL + ++HRDLAARN +V ++L K+ DFG+ R I + EY R+G++
Sbjct: 106 VDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAK 165
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
P++W APE+ G FT SDVWS+G++L E+ T PY G++N +VL V
Sbjct: 166 --FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 2e-59
Identities = 89/244 (36%), Positives = 147/244 (60%), Gaps = 10/244 (4%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPC--AIKVANENASEREKAEFLN 171
WE R ++ + LG G FG V R +S + A+K+ +NA++++ A+ ++
Sbjct: 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS 66
Query: 172 EASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRP---DAETDVERS 227
E +MK H +++ L GV ++ P VI+E G+L+ +LR+ RP D D+ +
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 228 PP---TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
P + ++ A +VA GM YL ++ +HRDLAARN +V +D +K+ DFG+ R +++
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
+YY+K S G LPV+WMAPE+L D V+T SDVWS+G+++WE+ TL PY G+ E++
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
Query: 345 NWVK 348
++
Sbjct: 247 KLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 6e-59
Identities = 93/238 (39%), Positives = 140/238 (58%), Gaps = 19/238 (7%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHP-CAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
LG G FG V + + A + A+K+ ENAS E + L+E +++K + HV+K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCR----------------PDAETDVERSPPT 230
LYG S+ P L+I+E G L+++LR R D T
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER--ALT 125
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK 290
+ ++ A +++ GM YLA+ K VHRDLAARN +VA+ +K+ DFG++RD+YE + Y K
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
S+G +PV+WMA ESL D ++T+ SDVWS+GV+LWE+ TL PY G++ E++ N +K
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 2e-58
Identities = 84/225 (37%), Positives = 125/225 (55%), Gaps = 17/225 (7%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
S++T L ELG+G FG+V+ G + +A IK+ E A + +F+ EA VM
Sbjct: 4 SELTFLKELGSGQFGVVHLGKWRGKIDVA-----IKMIREGAMSED--DFIEEAKVMMKL 56
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
++V+LYGV ++ P ++ E M G L NYLR + T+ +L M +
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW---------LLDMCS 107
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299
+V + M YL F+HRDLAARNC+V +D VKV DFG+ R + + +Y F PV+
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVK 166
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
W PE F+S SDVWS+GV++WE+ + PY+ SN +V+
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-58
Identities = 82/235 (34%), Positives = 135/235 (57%), Gaps = 5/235 (2%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMK 177
RS + + LG G FG V+ K E +K + E ++EF E + +
Sbjct: 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFR 63
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP-TLSRILQ 236
+VV+L G+ E P +I+E GDLK +LR+ + E + PP + + +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKL--KPPPLSTKQKVA 121
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL 296
+ ++A GM +L++ +FVHRDLAARNC+V+ VKV +++D+Y +EYY K +
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALI 180
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351
P+RW+APE++++ F++ SDVWS+GV++WE+ T P+ GLS+E+VLN ++
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 2e-57
Identities = 94/245 (38%), Positives = 150/245 (61%), Gaps = 12/245 (4%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYR----GLIKDFRSLAEHPCAIKVANENASEREKAEFL 170
WE+ R+++T+ LG G FG V G+ KD + A+K+ ++A++++ ++ +
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKD-KPNKPVTVAVKMLKDDATDKDLSDLV 65
Query: 171 NEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRP---DAETDVER 226
+E +MK H +++ L G ++ P V++E G+L+ YLR+ RP D D +
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 227 SPP---TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
P T ++ A +VA GM YLA +K +HRDLAARN +V +D +K+ DFG+ RD++
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
+YY+K + G LPV+WMAPE+L D V+T SDVWS+GV+LWE+ TL PY G+ E++
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
Query: 344 LNWVK 348
+K
Sbjct: 246 FKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 9e-57
Identities = 94/245 (38%), Positives = 147/245 (60%), Gaps = 12/245 (4%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYR----GLIKDFRSLAEHPCAIKVANENASEREKAEFL 170
WE R K+T+ LG G FG V G+ KD + A+K+ ++A+E++ ++ +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKD-KPKEAVTVAVKMLKDDATEKDLSDLV 68
Query: 171 NEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRP---DAETDVER 226
+E +MK H +++ L G ++ P VI+E G+L+ YLR+ RP + D+ R
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 227 SPP---TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
P T ++ +VA GM YLA +K +HRDLAARN +V ++ +K+ DFG+ RD+
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
+YY+K + G LPV+WMAPE+L D V+T SDVWS+GV++WE+ TL PY G+ E++
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
Query: 344 LNWVK 348
+K
Sbjct: 249 FKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 1e-56
Identities = 88/229 (38%), Positives = 126/229 (55%), Gaps = 17/229 (7%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA 178
+T L ELG G FG+V G + ++ AIK+ E + + EF+ EA VM
Sbjct: 3 PKDLTFLKELGTGQFGVVKYGKWR-----GQYDVAIKMIKEGSMSED--EFIEEAKVMMK 55
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
+V+LYGV ++ P ++ E M G L NYLR S++L+M
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE---------HGKRFQPSQLLEMC 106
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
+V +GMAYL K+F+HRDLAARNC+V D VKV DFG++R + + EY F PV
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PV 165
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
RW PE L F+S SDVW++GV++WE+ +L PY+ +N + + V
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 3e-56
Identities = 92/233 (39%), Positives = 132/233 (56%), Gaps = 24/233 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVA-----NENASEREKAEFLNEASVMKAFDTH 182
LG G FG V +K +E KVA + S + EFL EA+ MK FD
Sbjct: 7 LGKGEFGSVREAQLK-----SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHP 61
Query: 183 HVVKLYGVVSEGNPT------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR--I 234
+V+KL GV +VI+ M GDL +L R + P TL +
Sbjct: 62 NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR------IGEEPFTLPLQTL 115
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
++ ++A GM YL+ K F+HRDLAARNCM+ +++TV V DFG+++ IY +YYR+G
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
LPV+W+A ESL D V+T+HSDVW++GV +WE+ T PY G+ N ++ N++
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 7e-56
Identities = 91/243 (37%), Positives = 135/243 (55%), Gaps = 14/243 (5%)
Query: 116 EVLRSKVTILDELGNGSFGLVY----RGLIK------DFRSLAEHP--CAIKVANENASE 163
E R ++T ++LG G FG V+ G+ K P A+K+ E+A++
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 164 REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETD 223
+ +FL E +M ++++L V +P +I E M GDL +L P +
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 224 VERSPPT-LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282
S ++ MA ++A GM YL+ FVHRDLA RNC+V + T+K+ DFGM+R++
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLA-SQPYQGLSNE 341
Y +YYR R LP+RWM+ ES+ G FT+ SDVW++GV LWE+ TL QPY LS+E
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
Query: 342 QVL 344
QV+
Sbjct: 241 QVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 2e-55
Identities = 95/245 (38%), Positives = 145/245 (59%), Gaps = 12/245 (4%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYR----GLIKDFRSLAEHPCAIKVANENASEREKAEFL 170
WEV R ++ + LG G FG V GL K+ + A+K+ +A+E++ ++ +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKE-KPNRVTKVAVKMLKSDATEKDLSDLI 71
Query: 171 NEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDA------ETD 223
+E +MK H +++ L G ++ P VI+E G+L+ YLR+ RP T
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 224 VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
V + ++ A +VA GM YLA KK +HRDLAARN +V +D +K+ DFG+ RDI+
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
+YY+K + G LPV+WMAPE+L D ++T SDVWS+GV+LWE+ TL PY G+ E++
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
Query: 344 LNWVK 348
+K
Sbjct: 252 FKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 3e-55
Identities = 85/215 (39%), Positives = 136/215 (63%), Gaps = 15/215 (6%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
LG G+FG V++G +KD + P A+K E+ + K +FL+EA ++K +D ++VKL
Sbjct: 3 LGKGNFGEVFKGTLKD-----KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL 57
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
GV ++ P ++MEL+ GGD ++LR + + +T ++++ A + A GMAY
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT---------KQLVKFALDAAAGMAY 108
Query: 248 LADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK 307
L K +HRDLAARNC+V ++ +K+ DFGM+R + Y G + +P++W APE+L
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-IPIKWTAPEALN 167
Query: 308 DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
G ++S SDVWSYG++LWE +L PY G++N+Q
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 3e-55
Identities = 87/246 (35%), Positives = 135/246 (54%), Gaps = 25/246 (10%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
W + ++ + +G G FG V G A+K ++++ + FL EAS
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGD------YRGQKVAVKCLKDDSTAAQA--FLAEAS 52
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
VM ++V+L GVV +GNP ++ E M G L +YLRS R R+ TL++
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS-R-------GRAVITLAQQ 104
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
L A +V +GM YL +K FVHRDLAARN +V++DL KV DFG+ + E + +
Sbjct: 105 LGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGK- 160
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354
LPV+W APE+L++ F++ SDVWS+G++LWE+ + PY + + V+ V+
Sbjct: 161 -LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE----KG 215
Query: 355 YKVNPP 360
Y++ P
Sbjct: 216 YRMEAP 221
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 6e-55
Identities = 92/246 (37%), Positives = 135/246 (54%), Gaps = 19/246 (7%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE+ R+ +T+ +LG G +G VY G+ K + A+K E+ E E EFL EA+
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTV----AVKTLKEDTMEVE--EFLKEAA 54
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
VMK ++V+L GV + P +I E M G+L +YLR C + + + +
Sbjct: 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC------NRQEVNAVV--L 106
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
L MA +++ M YL K F+HRDLAARNC+V ++ VKV DFG++R + Y
Sbjct: 107 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354
F P++W APESL F+ SDVW++GV+LWE+AT PY G+ L+ V
Sbjct: 167 F-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEKG 221
Query: 355 YKVNPP 360
Y++ P
Sbjct: 222 YRMERP 227
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 6e-55
Identities = 90/242 (37%), Positives = 135/242 (55%), Gaps = 13/242 (5%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHP----------CAIKVANENASERE 165
E R ++ + ++LG G FG V+ + A+K+ + ++
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 166 KAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVE 225
+ +FL E +M ++++L GV +P +I E M GDL +L ++
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 226 RSPPTLSR--ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
+ P++S +L MA ++A GM YLA FVHRDLA RNC+V + T+K+ DFGM+R++Y
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLA-SQPYQGLSNEQ 342
+YYR R LP+RWMA ES+ G FT+ SDVW++GV LWEM TL QPY LS+EQ
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
Query: 343 VL 344
V+
Sbjct: 241 VI 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 8e-55
Identities = 85/234 (36%), Positives = 128/234 (54%), Gaps = 18/234 (7%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE+ R+ + +L +LG G FG V+ GL + P A+K + +FL EA
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNN-----TTPVAVKTLK--PGTMDPKDFLAEAQ 53
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+MK +++LY V + P ++ ELM G L YL+ L ++
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ--------GGAGRALKLPQL 105
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY-YRKGSR 293
+ MAA+VA GMAYL + ++HRDLAARN +V ++ KV DFG+ R I E Y R+G++
Sbjct: 106 IDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAK 165
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
P++W APE+ F+ SDVWS+G++L E+ T PY G++N +VL V
Sbjct: 166 --FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 4e-54
Identities = 92/245 (37%), Positives = 143/245 (58%), Gaps = 13/245 (5%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHP--CAIKVANENASEREKAEFLNEA 173
E+ S V ++ELG +FG +Y+G + + +H AIK + + ++ EF EA
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHL--YLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYL--RS------CRPDAETDVE 225
S+M ++V L GVV++ P ++ E + GDL +L RS C D + V
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV- 117
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
+S L +A ++A GM YL+ FVH+DLAARN ++ + L VK+ D G++R+IY
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+YYR + LP+RWM PE++ G F+S SD+WS+GVVLWE+ + QPY G SN++V+
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237
Query: 346 WVKGK 350
V+ +
Sbjct: 238 MVRKR 242
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 7e-54
Identities = 86/249 (34%), Positives = 135/249 (54%), Gaps = 22/249 (8%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAE----------HP--CAIKVANENASEREK 166
R + ++LG G FG V+ + + + L P A+K+ +A++ +
Sbjct: 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR 63
Query: 167 AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRS------CRPDA 220
+FL E ++ ++++L GV + +P +I E M GDL +L S
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 221 ETDVERSP---PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277
+ + S +L +A ++A GM YL+ FVHRDLA RNC+V ++LT+K+ DFG
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLA-SQPYQ 336
M+R++Y +YYR R LP+RWMA E + G FT+ SDVW++GV LWE+ L QPY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243
Query: 337 GLSNEQVLN 345
L++EQV+
Sbjct: 244 ELTDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-53
Identities = 86/226 (38%), Positives = 124/226 (54%), Gaps = 23/226 (10%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEH-PCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
+LG+GSFG+V RG S + P A+K + +FL EA++M + D ++
Sbjct: 1 KKLGDGSFGVVRRGEWST--SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
++LYGVV +P +++ EL G L + LR +S + A ++A+G
Sbjct: 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLR--------KDALGHFLISTLCDYAVQIANG 109
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR------DIYETEYYRKGSRGFLPV 298
M YL K+F+HRDLAARN ++A D VK+GDFG+ R D Y E + K +P
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK-----VPF 164
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
W APESL+ F+ SDVW +GV LWEM T +P+ GLS Q+L
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL 210
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 2e-53
Identities = 77/233 (33%), Positives = 137/233 (58%), Gaps = 3/233 (1%)
Query: 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVM 176
+ R +VT+ D L G+FG ++ G++ D + E +K ++ASE + L E+ ++
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLL 62
Query: 177 KAFDTHHVVKLYGVVSE-GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
+++ + V E G P V+ M G+LK +L+ CR E + ++ T +++
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCR-LGEANNPQALST-QQLV 120
Query: 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF 295
MA ++A GM+YL + +H+D+AARNC++ ++L VK+ D ++RD++ +Y+ G
Sbjct: 121 HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 296 LPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
PV+WMA ESL + ++S SDVWS+GV+LWE+ TL PY + ++ ++K
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 3e-53
Identities = 91/244 (37%), Positives = 143/244 (58%), Gaps = 17/244 (6%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
S V I + +G G FG V RG +K E AIK +E+++ +FL+EAS+M F
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLK-LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
D +++ L GVV++ P ++I E M G L ++LR + D + T+ +++ M
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR--QNDGQF-------TVIQLVGMLR 113
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE---YYRKGSRGFL 296
+A GM YL++ +VHRDLAARN +V +L KV DFG++R + + Y G +
Sbjct: 114 GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356
P+RW APE++ FTS SDVWSYG+V+WE+ + +PY +SN+ V+N ++ +Y+
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----QDYR 229
Query: 357 VNPP 360
+ PP
Sbjct: 230 LPPP 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 3e-53
Identities = 93/234 (39%), Positives = 142/234 (60%), Gaps = 13/234 (5%)
Query: 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPC-AIKVANENASEREKAEFLNEASVMKAFD 180
+ + LG G FG V G + S+ + +K+A SE E +FL+EA MK FD
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME--DFLSEAVCMKEFD 58
Query: 181 THHVVKLYGVV-----SEGNPT-LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+V++L GV SEG P+ +VI+ M GDL ++L R D + PT +
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG---DCPQYLPT-QML 114
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
++ ++A GM YL+ K F+HRDLAARNCM+ +++ V V DFG+++ IY +YYR+G
Sbjct: 115 VKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+PV+W+A ESL D V+T+ SDVWS+GV +WE+AT PY G+ N ++ ++++
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 6e-53
Identities = 96/250 (38%), Positives = 145/250 (58%), Gaps = 21/250 (8%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASV 175
E+ S +T +G G FG V+RG++K E AIK +E+++ +FL+EAS+
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILK-MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASI 59
Query: 176 MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
M F H++++L GVV++ P ++I E M G L YLR + D E S L +
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR------DHDGEFSSYQL---V 110
Query: 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR---DIYETEYYRKGS 292
M +A GM YL+D +VHRDLAARN +V +L KV DFG++R D E Y G
Sbjct: 111 GMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG- 169
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352
G +P+RW APE++ FTS SDVWS+G+V+WE+ + +PY +SN +V+ K+
Sbjct: 170 -GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-----KAI 223
Query: 353 NE-YKVNPPI 361
N+ +++ P+
Sbjct: 224 NDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 1e-52
Identities = 92/230 (40%), Positives = 128/230 (55%), Gaps = 18/230 (7%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYR----GLIKDFRSLAEHPCAIKVANENASEREKAEFL 170
WE R+ ++ LG G+FG V GL K + A+K+ A E+ +
Sbjct: 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMK---VAVKMLKPTAHSSEREALM 86
Query: 171 NEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
+E +M H ++V L G + G P LVI E GDL N+LR R S
Sbjct: 87 SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR--------ESFL 138
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI-YETEYY 288
TL +L + +VA GMA+LA K +HRDLAARN ++ VK+ DFG+ RDI ++ Y
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338
KG+ LPV+WMAPES+ + V+T SDVWSYG++LWE+ +L S PY G+
Sbjct: 199 VKGN-ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 3e-52
Identities = 93/246 (37%), Positives = 142/246 (57%), Gaps = 21/246 (8%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
S + I +G G FG V G +K E P AIK +E+++ +FL+EAS+M F
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLK-LPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF 62
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
D +++ L GVV++ P +++ E M G L +LR + D + T+ +++ M
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQF-------TVIQLVGMLR 113
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR---DIYETEYYRKGSRGFL 296
+A GM YL+D +VHRDLAARN +V +L KV DFG++R D E Y +G G +
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG--GKI 171
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE-Y 355
P+RW APE++ FTS SDVWSYG+V+WE+ + +PY +SN+ V+ K+ E Y
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-----KAIEEGY 226
Query: 356 KVNPPI 361
++ P+
Sbjct: 227 RLPAPM 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 5e-52
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
LG G FG VY K AIK+ + S E L E ++K + ++VKL
Sbjct: 1 LGEGGFGTVYLARDKK----TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKL 56
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
YGV + N ++ME GG LK+ L+ + IL++ ++ +G+ Y
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEG---------KLSEDEILRILLQILEGLEY 107
Query: 248 LADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
L +HRDL N ++ +D+ VK+ DFG+++ + + K G +MAPE L
Sbjct: 108 LHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG--TPAYMAPEVL 165
Query: 307 KDGV-FTSHSDVWSYGVVLWEMATLAS 332
++ SD+WS GV+L+E+ L
Sbjct: 166 LGKGYYSEKSDIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-51
Identities = 85/229 (37%), Positives = 119/229 (51%), Gaps = 14/229 (6%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVV 185
DE+GNG FG V G S A +K +A+ E+ FL E + + +V+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKAR--VVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
+ G E P L+++E GDLKNYLRS R + + +MA EVA G+
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNR-----GMVAQMAQKDVLQRMACEVASGL 113
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPE- 304
+L F+H DLA RNC + DL+VK+GD+G+ + Y +YY +P+RW+APE
Sbjct: 114 LWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 305 ------SLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
L T S++WS GV +WE+ T A QPY LS+EQVL V
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-51
Identities = 85/223 (38%), Positives = 132/223 (59%), Gaps = 14/223 (6%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
LG+G+FG VY+G+ + P AIKV E S + E L+EA VM + D HVV+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
G+ + +I +LM G L +Y+R+ + D S +L ++A GM+Y
Sbjct: 75 LGI-CLSSQVQLITQLMPLGCLLDYVRNHK-----DNIGS----QYLLNWCVQIAKGMSY 124
Query: 248 LADKKFVHRDLAARNCMVADDLTVKVGDFGMTR--DIYETEYYRKGSRGFLPVRWMAPES 305
L +K+ VHRDLAARN +V VK+ DFG+ + D+ E EY+ +G G +P++WMA ES
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG--GKVPIKWMALES 182
Query: 306 LKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+ ++T SDVWSYGV +WE+ T ++PY+G+ ++ + ++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 7e-51
Identities = 82/217 (37%), Positives = 127/217 (58%), Gaps = 13/217 (5%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVV 185
+ +G G+FG V+ G ++ + P A+K E KA+FL EA ++K + ++V
Sbjct: 1 ERIGRGNFGEVFSGRLRADNT----PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 56
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
+L GV ++ P ++MEL+ GGD +LR+ P + + ++QM A GM
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLK---------VKELIQMVENAAAGM 107
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
YL K +HRDLAARNC+V + +K+ DFGM+R+ + Y G +PV+W APE+
Sbjct: 108 EYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 306 LKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
L G ++S SDVWS+G++LWE +L + PY LSN+Q
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 9e-51
Identities = 86/225 (38%), Positives = 129/225 (57%), Gaps = 17/225 (7%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
S++T++ E+G+G FGLV+ G + R +A IK E A E +F+ EA VM
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVA-----IKTIREGAMSEE--DFIEEAQVMMKL 56
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+V+LYGV +E +P ++ E M G L +YLR+ +R + +L M
Sbjct: 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA---------QRGKFSQETLLGMCL 107
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299
+V +GMAYL +HRDLAARNC+V ++ VKV DFGMTR + + +Y F PV+
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVK 166
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
W +PE ++S SDVWS+GV++WE+ + PY+ SN +V+
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 4e-50
Identities = 88/229 (38%), Positives = 131/229 (57%), Gaps = 16/229 (6%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
E+GNG FG V G + +K +AS +E+ +FL EA ++ ++++
Sbjct: 2 EIGNGWFGKVILGEV--NSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
G +E P L++ME GDLK YLRSCR E P + + +MA E+A G+
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRK-----AELMTPDPTTLQRMACEIALGLL 114
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
+L F+H DLA RNC++ DLTVK+GD+G++ + Y+ +YY + ++P+RW+APE L
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE-L 173
Query: 307 KDGVF--------TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
D V T S+VWS GV +WE+ L SQPY+ LS+EQVL +
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-49
Identities = 83/231 (35%), Positives = 135/231 (58%), Gaps = 19/231 (8%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WEV R + ++ +LG G FG V+ G +A IK + + E FL EA+
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVA-----IKSLKQGSMSPEA--FLAEAN 53
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+MK +V+LY VV++ P +I E M G L ++L++ E T++++
Sbjct: 54 LMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--------PEGIKLTINKL 104
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY-RKGSR 293
+ MAA++A+GMA++ K ++HRDL A N +V++ L K+ DFG+ R I + EY R+G++
Sbjct: 105 IDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAK 164
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
P++W APE++ G FT SDVWS+G++L E+ T PY G++N +V+
Sbjct: 165 --FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-49
Identities = 88/228 (38%), Positives = 126/228 (55%), Gaps = 17/228 (7%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
S++T + ELG+G FG+V+ G + A+ AIK NE A E +F+ EA VM
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWR-----AQIKVAIKAINEGAMSEE--DFIEEAKVMMKL 56
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+V+LYGV ++ P ++ E M G L NYLR + D+ +L M
Sbjct: 57 SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM---------LLSMCQ 107
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299
+V +GM YL F+HRDLAARNC+V+ VKV DFGMTR + + EY F PV+
Sbjct: 108 DVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVK 166
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
W PE ++S SDVWS+GV++WE+ T P++ SN +V+ +
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 4e-48
Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
+LG G FG V A+K N + E+ +++F E +++ D ++VK
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 187 LYGVVSE--GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
GV + G +IME + G L++YL+ R L R+L ++++ G
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN---------LKRLLLFSSQICKG 121
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE-TEYYRKGSRGFLPVRWMAP 303
M YL ++++HRDLAARN +V + VK+ DFG+ + + E +YY G P+ W AP
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEMATL 330
E L+ F+S SDVWS+GV L+E+ T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-46
Identities = 81/231 (35%), Positives = 129/231 (55%), Gaps = 18/231 (7%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE+ R + ++ +LG G FG V+ G + +A V FL EA+
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVA-------VKTLKPGTMSVQAFLEEAN 53
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+MK +V+LY VV++ P +I E M G L ++L+S E L ++
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS--------DEGGKVLLPKL 105
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY-RKGSR 293
+ +A++A+GMAY+ K ++HRDL A N +V++ L K+ DFG+ R I + EY R+G++
Sbjct: 106 IDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 165
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
P++W APE++ G FT SDVWS+G++L+E+ T PY G+SN V+
Sbjct: 166 --FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 7e-46
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
IL++LG GSFG VY +D ++ AIKV + ++++ L E ++K
Sbjct: 2 EILEKLGEGSFGKVYLA--RDKKT--GKLVAIKVIKKKKIKKDRERILREIKILKKLKHP 57
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
++V+LY V + + ++ME GGDL + L+ +E ++
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE----------DEARFYLRQIL 107
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK--GSRGFLPVRW 300
+ YL K VHRDL N ++ +D VK+ DFG+ R + E G+ +
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE-----Y 162
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
MAPE L + D+WS GV+L+E+ T P+ G L
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGKP-PFPGDDQLLEL 205
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 9e-46
Identities = 91/233 (39%), Positives = 134/233 (57%), Gaps = 18/233 (7%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE + D +G G+FG V R +IK + + AIK+ E ASE + +F E
Sbjct: 1 WE----DIKFEDVIGEGNFGQVIRAMIK--KDGLKMNAAIKMLKEFASENDHRDFAGELE 54
Query: 175 VMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDV-----ERSP 228
V+ H +++ L G + +E G+L ++LR R ETD +
Sbjct: 55 VLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRV-LETDPAFAKEHGTA 113
Query: 229 PTLS--RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
TL+ ++LQ A++VA GM YL++K+F+HRDLAARN +V ++L K+ DFG++R E
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG---EE 170
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339
Y K + G LPVRWMA ESL V+T+ SDVWS+GV+LWE+ +L PY G++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-45
Identities = 96/251 (38%), Positives = 136/251 (54%), Gaps = 37/251 (14%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE-FLNEA 173
W + K+T+ + +G G FG V +G E+ KVA +N A+ FL E
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQG---------EY-TGQKVAVKNIKCDVTAQAFLEET 50
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
+VM ++V+L GV+ N ++MELM G+L N+LR+ R+ ++ +
Sbjct: 51 AVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRT--------RGRALVSVIQ 101
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
+LQ + +VA+GM YL KK VHRDLAARN +V++D KV DFG+ R GS
Sbjct: 102 LLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR---------VGSM 152
Query: 294 GF----LPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349
G LPV+W APE+LK F+S SDVWSYGV+LWE+ + PY +S L VK
Sbjct: 153 GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS----LKEVKE 208
Query: 350 KSSNEYKVNPP 360
Y++ PP
Sbjct: 209 CVEKGYRMEPP 219
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 6e-45
Identities = 91/250 (36%), Positives = 132/250 (52%), Gaps = 19/250 (7%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE+ R + ++ +LGNG FG V+ G A+K E FL EA
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-----GNTKVAVKTLKPGTMSPES--FLEEAQ 53
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+MK +V+LY VVSE P ++ E M G L ++L+ D E L +
Sbjct: 54 IMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK--------DGEGRALKLPNL 104
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY-RKGSR 293
+ MAA+VA GMAY+ ++HRDL + N +V D L K+ DFG+ R I + EY R+G++
Sbjct: 105 VDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353
P++W APE+ G FT SDVWS+G++L E+ T PY G++N +VL V+
Sbjct: 165 --FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
Query: 354 EYKVNPPISL 363
+ PISL
Sbjct: 223 PCPQDCPISL 232
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 7e-45
Identities = 75/234 (32%), Positives = 120/234 (51%), Gaps = 13/234 (5%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASV 175
E+ + I LG G FG + RG +K S E P AI S++++ FL EA
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLK-LPSKRELPVAIHTLRAGCSDKQRRGFLAEALT 59
Query: 176 MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
+ FD ++V+L GV++ GN +++ E M G L ++LR +++
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---------HEGQLVAGQLM 110
Query: 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG-MTRDIYETEYYRKGSRG 294
M +A GM YL++ +VH+ LAA +V DL K+ F + D E Y +
Sbjct: 111 GMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKS 170
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
PV W APE+++ F+S SDVWS+G+V+WE+ + +PY +S + V+ V+
Sbjct: 171 --PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-44
Identities = 85/245 (34%), Positives = 129/245 (52%), Gaps = 13/245 (5%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRG-LIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
E+ S V ++ELG FG VY+G L AIK + A + EF +EA
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYL--RSCRPD-AETDVERS---- 227
+ ++V L GVV++ P +I DL +L RS D TD +++
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 228 --PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
P + + ++A GM +L+ VH+DLA RN +V D L VK+ D G+ R++Y
Sbjct: 121 LEPADF---VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+YY+ LP+RWM+PE++ G F+ SD+WSYGVVLWE+ + QPY G SN+ V+
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237
Query: 346 WVKGK 350
++ +
Sbjct: 238 MIRNR 242
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 9e-44
Identities = 94/279 (33%), Positives = 141/279 (50%), Gaps = 56/279 (20%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEA 173
WE R ++ + LG G+FG V + +S + A+K+ E A+ E + E
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTEL 61
Query: 174 SVMKAFDTH-HVVKLYGVVSE-GNPTLVIMELMGGGDLKNYLRSCR-------------- 217
++ H +VV L G ++ G P +VI+E G+L NYLRS R
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKR 121
Query: 218 --------------------------------PDAETDVE-----RSPPTLSRILQMAAE 240
D E D E + P TL ++ + +
Sbjct: 122 EMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQ 181
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY-ETEYYRKGSRGFLPVR 299
VA GM +LA +K +HRDLAARN +++++ VK+ DFG+ RDIY + +Y RKG LP++
Sbjct: 182 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARLPLK 240
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338
WMAPES+ D V+T+ SDVWS+GV+LWE+ +L + PY G+
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-43
Identities = 88/222 (39%), Positives = 126/222 (56%), Gaps = 14/222 (6%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH-HV 184
D +G G+FG V + IK + AIK E AS+ + +F E V+ H ++
Sbjct: 1 DVIGEGNFGQVLKARIK--KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDV-----ERSPPTLS--RILQM 237
+ L G + +E G+L ++LR R ETD + TLS ++L
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV-LETDPAFAIANSTASTLSSQQLLHF 117
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
AA+VA GM YL+ K+F+HRDLAARN +V ++ K+ DFG++R E Y K + G LP
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLP 174
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339
VRWMA ESL V+T++SDVWSYGV+LWE+ +L PY G++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-43
Identities = 88/228 (38%), Positives = 128/228 (56%), Gaps = 14/228 (6%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
+ + D +G G+FG V + IK + AIK E AS+ + +F E V+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIK--KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 180 DTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETD-----VERSPPTLS- 232
H +++ L G + +E G+L ++LR R ETD + TLS
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV-LETDPAFAIANSTASTLSS 123
Query: 233 -RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
++L AA+VA GM YL+ K+F+HRDLAARN +V ++ K+ DFG++R E Y K
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKK 180
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339
+ G LPVRWMA ESL V+T++SDVWSYGV+LWE+ +L PY G++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 94/285 (32%), Positives = 148/285 (51%), Gaps = 58/285 (20%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEA 173
WE R ++ + LG+G+FG V + + + A+K+ E A+ E ++E
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSEL 61
Query: 174 SVMKAFDTH-HVVKLYGVVSEGN-PTLVIMELMGGGDLKNYLRSCR-------------- 217
++ H +VV L G ++ N P +VI+E G+L N+LR+ R
Sbjct: 62 KILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQR 121
Query: 218 -------------------------------------PDAET-DVERSPPTLSRILQMAA 239
P ET D+ +SP T+ ++ +
Sbjct: 122 GRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSF 181
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY-ETEYYRKGSRGFLPV 298
+VA GM +LA +K +HRDLAARN +++++ VK+ DFG+ RDIY + +Y RKGS LP+
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS-ARLPL 240
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS-NEQ 342
+WMAPES+ D V+T+ SDVWS+GV+LWE+ +L + PY G+ NE+
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 9e-43
Identities = 87/219 (39%), Positives = 126/219 (57%), Gaps = 16/219 (7%)
Query: 128 LGNGSFGLVYRGL-IKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
LG+G+FG VY+G+ I D ++ + P AIKV EN S + E L+EA VM + +V +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENV-KIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
L G+ LV +LM G L +Y+R + + +L ++A GM+
Sbjct: 74 LLGICLTSTVQLV-TQLMPYGCLLDYVRENKDRIGS---------QDLLNWCVQIAKGMS 123
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR--DIYETEYYRKGSRGFLPVRWMAPE 304
YL + + VHRDLAARN +V VK+ DFG+ R DI ETEY+ G G +P++WMA E
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG--GKVPIKWMALE 181
Query: 305 SLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
S+ FT SDVWSYGV +WE+ T ++PY G+ ++
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 78/219 (35%), Positives = 125/219 (57%), Gaps = 15/219 (6%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-ANENASEREKAEFLNEASVMKAFDTHHVV 185
ELG+G+FG V +G+ K +S E A+K+ N+N K E L EA+VM+ D ++V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKS--EKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIV 59
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
++ G+ E +++MEL G L +L+ + E + I ++ +V+ GM
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKN----------ITELVHQVSMGM 108
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE-YYRKGSRGFLPVRWMAPE 304
YL + FVHRDLAARN ++ K+ DFG+++ + E YY+ + G PV+W APE
Sbjct: 109 KYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 305 SLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
+ F+S SDVWS+GV++WE + +PY+G+ +V
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 4e-42
Identities = 89/235 (37%), Positives = 126/235 (53%), Gaps = 19/235 (8%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE+ R + + +LG G FG V+ G +A IK E FL EA
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVA-----IKTLKPGTMSPEA--FLQEAQ 53
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
VMK +V+LY VVSE P ++ E M G L ++L+ E P L
Sbjct: 54 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK-----GEMGKYLRLPQL--- 104
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY-RKGSR 293
+ MAA++A GMAY+ +VHRDL A N +V ++L KV DFG+ R I + EY R+G++
Sbjct: 105 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 164
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
P++W APE+ G FT SDVWS+G++L E+ T PY G+ N +VL+ V+
Sbjct: 165 --FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 87/247 (35%), Positives = 132/247 (53%), Gaps = 27/247 (10%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
W + ++ +L +G G FG V G D+R A+K +A+ + FL EAS
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLG---DYRGNK---VAVKCIKNDATAQA---FLAEAS 51
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIM-ELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
VM ++V+L GV+ E L I+ E M G L +YLRS RS
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--------RGRSVLGGDC 103
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
+L+ + +V + M YL FVHRDLAARN +V++D KV DFG+T++ T+ K
Sbjct: 104 LLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--- 160
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353
LPV+W APE+L++ F++ SDVWS+G++LWE+ + PY + + V+ V+
Sbjct: 161 --LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----K 214
Query: 354 EYKVNPP 360
YK++ P
Sbjct: 215 GYKMDAP 221
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 73/226 (32%), Positives = 127/226 (56%), Gaps = 13/226 (5%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
ELG+G+FG V +G+ K + + AIKV + + E + EA +M D ++V+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID--VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
+ GV E +++ME+ GG L +L ++ T+S ++++ +V+ GM
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSG---------KKDEITVSNVVELMHQVSMGMK 109
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI-YETEYYRKGSRGFLPVRWMAPES 305
YL K FVHRDLAARN ++ + K+ DFG+++ + + YY+ S G P++W APE
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 306 LKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351
+ F+S SDVWSYG+ +WE + +PY+ + +V+++++
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK 215
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 89/235 (37%), Positives = 129/235 (54%), Gaps = 19/235 (8%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE+ R + + +LG G FG V+ G +A IK E FL EA
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVA-----IKTLKPGTMMPEA--FLQEAQ 53
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+MK +V LY VVSE P ++ E MG G L ++L+ E D + L ++
Sbjct: 54 IMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLK------EGDGKYL--KLPQL 104
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY-RKGSR 293
+ MAA++ADGMAY+ ++HRDL A N +V D+L K+ DFG+ R I + EY R+G++
Sbjct: 105 VDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
P++W APE+ G FT SDVWS+G++L E+ T PY G+ N +VL V+
Sbjct: 165 --FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 86/236 (36%), Positives = 129/236 (54%), Gaps = 17/236 (7%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
LG+G+FG VY+GL + P AIK E S + E L+EA VM + D HV +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
G+ L I +LM G L +Y+R + + + +L ++A GM Y
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGS---------QYLLNWCVQIAKGMNY 124
Query: 248 LADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY--ETEYYRKGSRGFLPVRWMAPES 305
L +++ VHRDLAARN +V VK+ DFG+ + + E EY+ +G G +P++WMA ES
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG--GKVPIKWMALES 182
Query: 306 LKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPI 361
+ ++T SDVWSYGV +WE+ T S+PY G+ ++ + ++ E PPI
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 85/247 (34%), Positives = 133/247 (53%), Gaps = 20/247 (8%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASV 175
E+ R KV LG+G+FG VY+G+ + P AIK+ NE + EF++EA +
Sbjct: 8 ELKRVKV-----LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 62
Query: 176 MKAFDTHHVVKLYGVVSEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
M + D H+V+L GV +PT+ ++ +LM G L +Y+ + + + + +
Sbjct: 63 MASMDHPHLVRLLGVCL--SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQL---------L 111
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
L ++A GM YL +++ VHRDLAARN +V VK+ DFG+ R + E G
Sbjct: 112 LNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354
+P++WMA E + FT SDVWSYGV +WE+ T +PY G+ ++ + ++ E
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE---KGE 228
Query: 355 YKVNPPI 361
PPI
Sbjct: 229 RLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 6e-41
Identities = 99/311 (31%), Positives = 140/311 (45%), Gaps = 71/311 (22%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYR----GLIKDFRSLAEHPCAIKVANEN 160
D +L + WE R + LG G+FG V GL K+ L A+K+ +
Sbjct: 23 DPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLR---VAVKMLKAS 79
Query: 161 ASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKN-------- 211
A E+ ++E ++ H ++V L G + G P LVI E GDL N
Sbjct: 80 AHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139
Query: 212 --------------------------YLRS--------------CRP------------D 219
Y+RS RP D
Sbjct: 140 FLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199
Query: 220 AETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279
E + P L +L+ +++VA GM +LA K +HRD+AARN ++ D K+ DFG+
Sbjct: 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 280 RDIY-ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG- 337
RDI ++ Y KG+ LPV+WMAPES+ D V+T SDVWSYG++LWE+ +L PY G
Sbjct: 260 RDIMNDSNYVVKGN-ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
Query: 338 LSNEQVLNWVK 348
L N + VK
Sbjct: 319 LVNSKFYKMVK 329
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 81/228 (35%), Positives = 119/228 (52%), Gaps = 15/228 (6%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
E+GNG FG V I +A +K NAS +E+ EFL + + ++++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVAR--VVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
G E P L++ E GDLK+YL E R+ L + +MA E+A G+
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQ-----EQWHRRNSQLL-LLQRMACEIAAGVT 113
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPE-- 304
++ F+H DLA RNC + DLTVKVGD+G+ Y+ +Y +P+RW+APE
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 305 -SLKDGVFTS----HSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
G+ T+ S+VW+ GV LWE+ A+QPY LS+ +VLN V
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 80/231 (34%), Positives = 126/231 (54%), Gaps = 19/231 (8%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
WE+ R + + +LG G FG V+ +A V FL EA+
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVA-------VKTMKPGSMSVEAFLAEAN 53
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
VMK +VKL+ VV++ P +I E M G L ++L+S E S L ++
Sbjct: 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKS--------DEGSKQPLPKL 104
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY-RKGSR 293
+ +A++A+GMA++ + ++HRDL A N +V+ L K+ DFG+ R I + EY R+G++
Sbjct: 105 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 164
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
P++W APE++ G FT SDVWS+G++L E+ T PY G+SN +V+
Sbjct: 165 --FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 19/224 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDT 181
+L +LG+GSFG VY+ K + A+K + + ++ E +++
Sbjct: 2 ELLRKLGSGSFGTVYKAKHKGTGKIV----AVKILKKRSEKSKKDQTARREIRILRRLSH 57
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++V+L + + ++ME GGDL +YL P +E + ++ +A ++
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKK----------IALQI 107
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
G+ YL +HRDL N ++ ++ VK+ DFG+ + + ++ G +M
Sbjct: 108 LRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTP--WYM 165
Query: 302 APESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
APE L G + DVWS GV+L+E+ T P+ G + L
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLT-GKPPFSGENILDQL 208
|
Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-35
Identities = 73/212 (34%), Positives = 117/212 (55%), Gaps = 21/212 (9%)
Query: 125 LDELGNGSFGLV----YRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD 180
+ +LG G+FG V Y L + + A+K ++++ +F E ++K+
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVV----AVKKL-QHSTAEHLRDFEREIEILKSLQ 63
Query: 181 THHVVKLYGVV-SEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
++VK GV S G L ++ME + G L++YL+ R + ++L A
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH---------RKLLLYA 114
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI-YETEYYRKGSRGFLP 297
+++ GM YL K++VHRDLA RN +V + VK+GDFG+T+ + + EYY+ G P
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
+ W APESL + F+ SDVWS+GVVL+E+ T
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
LG G FG V A+K ++ + + E +++K ++VK
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 187 LYGVVSEGNPT--LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
G SE +IME + G L++YL + L+++L A ++ +G
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----------PKHKLNLAQLLLFAQQICEG 119
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE-TEYYRKGSRGFLPVRWMAP 303
MAYL + ++HRDLAARN ++ +D VK+GDFG+ + + E EYYR G PV W A
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEMAT 329
E LK+ F+ SDVWS+GV L+E+ T
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 71/217 (32%), Positives = 116/217 (53%), Gaps = 12/217 (5%)
Query: 128 LGNGSFGLVYRGL-IKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
LG+G FG V++G+ I + S+ + P AIK + + + E + M + D ++V+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSI-KIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
L G+ G ++ +L G L +++R R P R+L ++A GM
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSL------DP---QRLLNWCVQIAKGMY 123
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
YL + + VHR+LAARN ++ D V++ DFG+ +Y + S P++WMA ES+
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 307 KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
G +T SDVWSYGV +WEM + ++PY G+ +V
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-33
Identities = 58/131 (44%), Positives = 89/131 (67%), Gaps = 3/131 (2%)
Query: 210 KNYLRSCRPDAET-DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268
K+ +AE D+ + TL ++ + +VA GM +LA +K +HRDLAARN +++++
Sbjct: 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN 215
Query: 269 LTVKVGDFGMTRDIY-ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
VK+ DFG+ RDIY + +Y RKG LP++WMAPE++ D V+T SDVWS+GV+LWE+
Sbjct: 216 NVVKICDFGLARDIYKDPDYVRKGD-ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
Query: 328 ATLASQPYQGL 338
+L + PY G+
Sbjct: 275 FSLGASPYPGV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL-NEASVMKAFDTHHVVK 186
LG GSFG VY L KD L A+K + E+ E L E ++ + ++V+
Sbjct: 8 LGRGSFGSVYLALDKDTGEL----MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 187 LYGV-VSEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR-ILQMAAEVAD 243
YG E TL + +E + GG L + L+ E + + +R IL+
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK----YTRQILE------- 112
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL--PVRWM 301
G+AYL VHRD+ N +V D VK+ DFG + + +G+ P WM
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTGSVRGTP-YWM 170
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335
APE ++ + +D+WS G + EMAT P+
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD 180
IL+++G G FG VY+ K AIKV S+ +K + +NE ++K
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEV----AIKVIKLE-SKEKKEKIINEIQILKKCK 55
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRS-CRPDAETDVERSPPTLSRILQMAA 239
++VK YG + + ++ME GG LK+ L+S + E+ + + + +
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI-------AYVCK--- 105
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK---GSRGFL 296
E+ G+ YL +HRD+ A N ++ D VK+ DFG++ + R G+
Sbjct: 106 ELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPY-- 162
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335
WMAPE + + +D+WS G+ E+A PY
Sbjct: 163 ---WMAPEVINGKPYDYKADIWSLGITAIELAEGKP-PY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 61/135 (45%), Positives = 89/135 (65%), Gaps = 4/135 (2%)
Query: 217 RPDAETDVERSPP-TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275
R +T + SP + ++ + +VA+GM +LA K VHRDLAARN ++ + VK+ D
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICD 282
Query: 276 FGMTRDI-YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
FG+ RDI ++ Y KGS FLP++WMAPES+ + ++T+ SDVWS+G++LWE+ TL P
Sbjct: 283 FGLARDIMRDSNYISKGST-FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
Query: 335 YQGLS-NEQVLNWVK 348
Y L NEQ N +K
Sbjct: 342 YPELPMNEQFYNAIK 356
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 57/110 (51%), Positives = 77/110 (70%), Gaps = 2/110 (1%)
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI-YETEYY 288
T +L +VA GM +LA K VHRDLAARN ++A VK+ DFG+ RDI +++ Y
Sbjct: 235 TTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYV 294
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338
KGS FLPV+WMAPES+ D ++T+ SDVWSYG++LWE+ +L PY G+
Sbjct: 295 SKGST-FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
T+L+ +G GSFG VY+ + K AIKV + +E E + E +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKR----TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC 56
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+ ++ K YG +G+ +IME GGG + L+ + D I +
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY-----------IAFILR 105
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG--FLP 297
EV G+ YL ++ +HRD+ A N +++++ VK+ DFG++ + T R G F
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF-- 163
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
WMAPE +K + +D+WS G+ E+A P L +VL
Sbjct: 164 --WMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHPMRVL 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 66/243 (27%), Positives = 115/243 (47%), Gaps = 37/243 (15%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAF 179
K I+ ++G GSFG VY K L +K + N SE+E+ + LNE ++K
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKL----YVLKEIDLSNMSEKEREDALNEVKILKKL 56
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+ +++K Y E ++ME GGDL ++ + + + P +IL
Sbjct: 57 NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGK------PFPEEQILDWFV 110
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE-----------TEYY 288
++ + YL +K +HRD+ +N + + VK+GDFG+++ + T YY
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYY 169
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS-NEQVLNWV 347
++PE ++ + SD+WS G VL+E+ TL P++G + E L +
Sbjct: 170 ------------LSPELCQNKPYNYKSDIWSLGCVLYELCTL-KHPFEGENLLELALKIL 216
Query: 348 KGK 350
KG+
Sbjct: 217 KGQ 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 52/106 (49%), Positives = 74/106 (69%), Gaps = 2/106 (1%)
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY-ETEYYRKGS 292
+L + +VA GM++LA K +HRDLAARN ++ K+ DFG+ RDI ++ Y KG+
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338
LPV+WMAPES+ + V+T SDVWSYG++LWE+ +L S PY G+
Sbjct: 276 -ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 65/190 (34%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 153 AIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--GNPTLVIMELMGGGDLK 210
A+K + A+ E +++ ++VK G+ +E GN +IME + G LK
Sbjct: 37 AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 96
Query: 211 NYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270
YL P + + L + L+ A ++ GM YL +++VHRDLAARN +V +
Sbjct: 97 EYL----PRNKNKI-----NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ 147
Query: 271 VKVGDFGMTRDIY-ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
VK+GDFG+T+ I + EYY PV W APE L F SDVWS+GV L+E+ T
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
Query: 330 LASQPYQGLS 339
++
Sbjct: 208 YCDSESSPMT 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFD 180
IL +LG GSFG VY + A+KV + + K FL E ++ + +
Sbjct: 3 RILRKLGEGSFGEVYLARDR-------KLVALKVLAKKLESKSKEVERFLREIQILASLN 55
Query: 181 TH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
++VKLY + ++ME + GG L++ L+ + P + S L + A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIG-------RKGPLSESEALFILA 108
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLT-VKVGDFGMTRDIYETEYYRKGSRGFLPV 298
++ + YL K +HRD+ N ++ D VK+ DFG+ + + +
Sbjct: 109 QILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 299 ----RWMAPESLKDGVF---TSHSDVWSYGVVLWEMATLASQPYQGLSNE 341
+MAPE L +S SD+WS G+ L+E+ T P++G N
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFEGEKNS 217
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDTH 182
IL+++G GSFG+V+ K R + A+K + + RE+ E ++EA V+ D+
Sbjct: 4 ILNKIGKGSFGVVF----KVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
++++ Y + ++ME GDL L+ R P ++ + ++
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR--------GRPLPEDQVWRFFIQIL 111
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR----------DIYETEYYRKGS 292
G+A+L KK +HRD+ + N + VK+GD G+ + I T YY
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYY---- 167
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
++PE +D + SDVW+ GVVL+E T
Sbjct: 168 --------LSPELCEDKPYNEKSDVWALGVVLYECCT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
T L+ +G GSFG V++G+ D R+ + AIK+ + +E E + E +V+ D+
Sbjct: 7 TKLERIGKGSFGEVFKGI--DNRT--QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+V K YG +G +IME +GGG + LR+ P +I M E+
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEIL 111
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMA 302
G+ YL +K +HRD+ A N ++++ VK+ DFG+ + +T+ R G P WMA
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG-TPF-WMA 169
Query: 303 PESLKDGVFTSHSDVWSYGVVLWEMA 328
PE ++ + S +D+WS G+ E+A
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELA 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 73/238 (30%), Positives = 119/238 (50%), Gaps = 25/238 (10%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
T L+++G GSFG V++G+ D R+ + AIK+ + +E E + E +V+ D+
Sbjct: 7 TKLEKIGKGSFGEVFKGI--DNRT--QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+V K YG + +IME +GGG + L E P ++I + E+
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREIL 111
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMA 302
G+ YL +K +HRD+ A N ++++ VK+ DFG+ + +T+ R G P WMA
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG-TPF-WMA 169
Query: 303 PESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360
PE +K + S +D+WS G+ E+A P+ L +VL + K NPP
Sbjct: 170 PEVIKQSAYDSKADIWSLGITAIELAK-GEPPHSELHPMKVLFLIP-------KNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 59/237 (24%), Positives = 113/237 (47%), Gaps = 34/237 (14%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPC-AIKVAN-ENASEREKAEFLNEASVMKAFD 180
+L +LG GS+G VY+ + L+++ A+K + + S++E+ + +NE ++ + +
Sbjct: 3 KVLKKLGKGSYGSVYK-----VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
+++ +GN ++ME GDL + + +R I ++ +
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAIS------KRKKKRKLIPEQEIWRIFIQ 111
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG--------MTRDIYETEYYRKGS 292
+ G+ L ++K +HRDL + N ++ + VK+GD G M + T +Y
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHY---- 167
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349
MAPE K ++ SD+WS G +L+EMAT A P++ S + + V+
Sbjct: 168 --------MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP-PFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
T L+ +G GSFG VY+G+ D R+ + AIK+ + +E E + E +V+ D+
Sbjct: 7 TKLERIGKGSFGEVYKGI--DNRT--KEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
++ + YG +G +IME +GGG + L+ P + I + E+
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----------GPLEETYIATILREIL 111
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMA 302
G+ YL ++ +HRD+ A N ++++ VK+ DFG+ + +T+ R G P WMA
Sbjct: 112 KGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG-TPF-WMA 169
Query: 303 PESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
PE +K + +D+WS G+ E+A P L +VL
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAK-GEPPNSDLHPMRVL 210
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-24
Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 26/209 (12%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDTH 182
IL++LG GS+G VY+ + K+ AIK V E + E + E S++K D+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKE----TGQVVAIKVVPVEEDLQ----EIIKEISILKQCDSP 58
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
++VK YG + ++ME G G + + ++ +T E ++ IL +
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN---KTLTEEE---IAAILY---QTL 109
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK---GSRGFLPVR 299
G+ YL K +HRD+ A N ++ ++ K+ DFG++ + +T R G+ P
Sbjct: 110 KGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT----PF- 164
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMA 328
WMAPE +++ + + +D+WS G+ EMA
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMA 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-24
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 124 ILDELGNGSFGLVYRGL-IKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
+L+ +G GSFG V + D + L K + N +E+EK + ++E ++++
Sbjct: 4 VLETIGKGSFGTVRKVRRKSDGKILV-----WKEIDYGNMTEKEKQQLVSEVNILRELKH 58
Query: 182 HHVVKLYG-VVSEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
++V+ Y ++ N TL ++ME GGDL ++ C+ ER I ++
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKK------ERKYIEEEFIWRILT 112
Query: 240 EVADGMAY-----LADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE---------- 284
++ + +HRDL N + + VK+GDFG+ + +
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172
Query: 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
T YY M+PE L + SD+WS G +++E+ L S P+ + Q
Sbjct: 173 TPYY------------MSPEQLNHMSYDEKSDIWSLGCLIYELCAL-SPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-23
Identities = 70/241 (29%), Positives = 111/241 (46%), Gaps = 32/241 (13%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIK---VANENASEREKAEFLN-EASVMKAFDTHH 183
LG+GSFG VY GL D A+K +A++ + +E + L E +++ +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDF----FAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+V+ G E + + +EL+ GG L L+ E I ++
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP----------VIRLYTRQILL 113
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR--KGSRGFLPVRWM 301
G+ YL D+ VHRD+ N +V + VK+ DFGM + + E + + KGS WM
Sbjct: 114 GLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGS-----PYWM 168
Query: 302 APESL-KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360
APE + + G + +D+WS G + EMAT P+ L + + G+S K PP
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLEGVAAV-FKIGRS----KELPP 222
Query: 361 I 361
I
Sbjct: 223 I 223
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNE 172
D WE I+ ELG+G+FG VY+ K+ A A K+ + E E +F+ E
Sbjct: 5 DIWE-------IIGELGDGAFGKVYKAQHKETGLFA----AAKIIQIESEE-ELEDFMVE 52
Query: 173 ASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
++ ++V LY N +++E GG L D+ T
Sbjct: 53 IDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL---------DSIMLELERGLTEP 103
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGS 292
+I + ++ + + +L K +HRDL A N ++ D VK+ DFG++ T R
Sbjct: 104 QIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163
Query: 293 RGFLPVRWMAP-----ESLKDGVFTSHSDVWSYGVVLWEMA 328
G P WMAP E+ KD + +D+WS G+ L E+A
Sbjct: 164 IG-TP-YWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 123 TILDELGNGSFGLVYRGLIK---DFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKA 178
+ D +G G+FG+VY+GL DF AIK ++ E E + E ++K
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDF-------VAIKQISLEKIKEEALKSIMQEIDLLKN 55
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
++VK G + + +I+E G L+ ++ P E+ V + ++LQ
Sbjct: 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV---YVYQVLQ-- 110
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
G+AYL ++ +HRD+ A N + D VK+ DFG+ + + G
Sbjct: 111 -----GLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG--TP 163
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338
WMAPE ++ ++ SD+WS G + E+ T + PY L
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDL 202
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 17/225 (7%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH 183
+++ +G G+ +VY + AIK + + E E M + +
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEK----VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
VVK Y G+ ++M + GG L + ++S P D ++ +L+ EV
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD----EAIIATVLK---EVLK 113
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL---PVRW 300
G+ YL +HRD+ A N ++ +D +VK+ DFG++ + + + R P W
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC-W 172
Query: 301 MAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
MAPE ++ + +D+WS+G+ E+AT A+ PY +VL
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAA-PYSKYPPMKVL 216
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 7e-22
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 34/224 (15%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD 180
+++ +G G++G VY+ K L AIK+ + E E E E ++++ +
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLV----AIKIMDIIEDEEE--EIKEEYNILRKYS 60
Query: 181 THH-VVKLYGVVSEGNPTLV------IMELMGGG---DL-KNYLRSCRPDAETDVERSPP 229
H + YG + NP +MEL GGG DL K + + E
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-------E 113
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR 289
++ IL+ E G+AYL + K +HRD+ +N ++ + VK+ DFG++ + T R
Sbjct: 114 WIAYILR---ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 290 KGSRGFLPVRWMAPESL-----KDGVFTSHSDVWSYGVVLWEMA 328
G P WMAPE + D + + SDVWS G+ E+A
Sbjct: 171 NTFIG-TPY-WMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-22
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
LG G++G VY GL + +A + +N A+E+E + E ++K+ ++V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
G + N + ME + GG + + L P E P + + ++ DG+AY
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE-------PVFCKYTK---QILDGVAY 117
Query: 248 LADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR----WMAP 303
L + VHRD+ N M+ + +K+ DFG R + + S + WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEMAT----LASQP 334
E + + + SD+WS G ++EMAT LAS
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 71/237 (29%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNE 172
+ WE I+ ELG+G+FG VY+ K+ +LA A KV E SE E +++ E
Sbjct: 12 EVWE-------IIGELGDGAFGKVYKAKNKETGALA----AAKVI-ETKSEEELEDYMVE 59
Query: 173 ASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
++ + ++VKL G +++E GG + + E D + P +
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQ 113
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGS 292
I + E + YL K +HRDL A N ++ D +K+ DFG++ +T R
Sbjct: 114 VICRQMLE---ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF 170
Query: 293 RGFLPVRWMAP-----ESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
G P WMAP E++KD + +D+WS G+ L EMA + P+ L+ +VL
Sbjct: 171 IG-TPY-WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-EPPHHELNPMRVL 224
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 72/238 (30%), Positives = 115/238 (48%), Gaps = 29/238 (12%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
++ WE I+ ELG+G+FG VY+ K+ LA A KV + SE E +++
Sbjct: 4 EEFWE-------IIGELGDGAFGKVYKAQNKETGVLA----AAKVI-DTKSEEELEDYMV 51
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
E ++ + D ++VKL N +++E GG + + ++ER P T
Sbjct: 52 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM--------LELER-PLTE 102
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
+I + + + + YL + K +HRDL A N + D +K+ DFG++ T R
Sbjct: 103 PQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162
Query: 292 SRGFLPVRWMAPESL-----KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
G P WMAPE + KD + +DVWS G+ L EMA + P+ L+ +VL
Sbjct: 163 FIG-TPY-WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQI-EPPHHELNPMRVL 217
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 9e-21
Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 104 GDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGL-IKDFRSLAEHPCAIKVANENAS 162
GD +LY + E + G G+ G VY+ + AIK
Sbjct: 15 GDPRELY--KNLEKI----------GEGASGEVYKATDRATGKE-----VAIKKMRLRKQ 57
Query: 163 EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET 222
+E +NE +MK ++V Y G+ V+ME M GG L + +
Sbjct: 58 NKELI--INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN------ 109
Query: 223 DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282
V + P ++ + + EV G+ YL + +HRD+ + N +++ D +VK+ DFG +
Sbjct: 110 FVRMNEPQIAYVCR---EVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
Query: 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMA 328
+ + R G P WMAPE +K + D+WS G++ EMA
Sbjct: 167 TKEKSKRNSVVG-TPY-WMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 9e-21
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH 183
+ LG GS G+VY+ K + A+K + + E + + L E +++ ++ +
Sbjct: 5 RVKVLGQGSSGVVYKVRHKPTGKIY----ALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
VVK YG + +++E M GG L + L+ P L+ I A ++
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK-------IPEPVLAYI---ARQILK 110
Query: 244 GMAYL-ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMA 302
G+ YL + +HRD+ N ++ VK+ DFG+++ + T G V +M+
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVG--TVTYMS 168
Query: 303 PESLKDGVFTSHSDVWSYGVVLWEMAT 329
PE ++ ++ +D+WS G+ L E A
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECAL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-20
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 37/218 (16%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCA----IKVANENASEREKAEFLNEASVMKAFDTHH 183
LG GSFG VY L+KD +++AE I V N +E +A EA ++ D
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKLDHPA 63
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+VK + E + +I E G DL L + +T E +++ + ++
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE------NQVCEWFIQLLL 117
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR----------DIYETEYYRKGSR 293
G+ Y+ ++ +HRDL A+N + ++L +K+GDFG++R T YY
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYY----- 171
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLA 331
M+PE+LK + S SD+WS G +L+EM LA
Sbjct: 172 -------MSPEALKHQGYDSKSDIWSLGCILYEMCCLA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-19
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 15/217 (6%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMKAFD 180
I ++G G F +VY+ + + A+K E + + + L E ++K D
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVV----ALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
+V+K E N +++EL GDL ++ + ER+ I + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT------IWKYFVQ 114
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300
+ + ++ K+ +HRD+ N + VK+GD G+ R + ++ S P +
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY-Y 172
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
M+PE + + + SD+WS G +L+EMA L S P+ G
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQS-PFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-19
Identities = 60/226 (26%), Positives = 115/226 (50%), Gaps = 17/226 (7%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAF 179
+ I+ ++G GSFG +Y L K +S +EH C IK + +EK E ++
Sbjct: 1 RYEIIKKIGEGSFGKIY--LAKA-KSDSEH-CVIKEIDLTKMPVKEKEASKKEVILLAKM 56
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
++V + E ++ME GGDL R + + V S +IL
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMK-----RINRQRGVLFSE---DQILSWFV 108
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADD-LTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
+++ G+ ++ D+K +HRD+ ++N ++ + + K+GDFG+ R + ++ G P
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG-TPY 167
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
+++PE ++ + + +D+WS G VL+E+ TL P++G + Q++
Sbjct: 168 -YLSPEICQNRPYNNKTDIWSLGCVLYELCTL-KHPFEGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 45/232 (19%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFDT 181
+G GSF V K+ AIK+ ++ +EK E V+ +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKE----TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 182 H-HVVKLYGVV-SEGNPTLVIMELMGGGDLKNYLR--SCRPDAETDVERSPPTLSRILQM 237
H ++KLY E N V +E G+L Y+R + T
Sbjct: 61 HPGIIKLYYTFQDEENLYFV-LEYAPNGELLQYIRKYGSLDEKCT------------RFY 107
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG-----------------MTR 280
AAE+ + YL K +HRDL N ++ D+ +K+ DFG T
Sbjct: 108 AAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 281 DIYETEYYRKGSRGFLPV---RWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
+ E R+ F V +++PE L + SD+W+ G ++++M T
Sbjct: 168 IDSQIEKNRRRFASF--VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-19
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH 183
++ +G+G++G VY+ L AIKV + + E S++K +
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELV----AIKVIKLEPGD-DFEIIQQEISMLKECRHPN 61
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKN-YLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+V +G + ++ME GGG L++ Y + P +E +I + E
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE----------LQIAYVCRETL 111
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMA 302
G+AYL + +HRD+ N ++ +D VK+ DFG++ + T RK G WMA
Sbjct: 112 KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP--YWMA 169
Query: 303 PESL---KDGVFTSHSDVWSYGVVLWEMATLASQP 334
PE + G + D+W+ G+ E+A L QP
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAEL--QP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (211), Expect = 9e-19
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDT 181
L++LG G++G+VY+ +D ++ A+K + +N E + L E S++K
Sbjct: 2 EKLEKLGEGTYGVVYKA--RDKKT--GEIVALKKIRLDNEEEGIPSTALREISLLKELKH 57
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++VKL V+ ++ E DLK YL SP + I+ +
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPL------SPNLIKSIMYQ---L 107
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI------YETE----YYRKG 291
G+AY + +HRDL +N ++ D +K+ DFG+ R Y E +YR
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR-- 165
Query: 292 SRGFLPVRWMAPESL-KDGVFTSHSDVWSYGVVLWEMAT 329
APE L +++ D+WS G + EM T
Sbjct: 166 ----------APEILLGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 124 ILDELGNGSFGLVYRGLIKD----FRSLAEHPCAIKVANEN----ASEREKA--EFLNEA 173
+L+ LG+G+FG VY+ K+ +L E I V N ER+K+ + ++E
Sbjct: 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKE----INVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 174 SVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
+++K H ++V+ Y E + ++M+L+ G L + S + + E
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE------ 113
Query: 233 RILQMAAEVADGMAYL-ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
RI + ++ + YL +K+ VHRDL N M+ +D V + DFG+ +
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV 173
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
L + PE +K+ + +DVW++G +L++M TL QP
Sbjct: 174 VGTIL---YSCPEIVKNEPYGEKADVWAFGCILYQMCTL--QP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 59/224 (26%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVM---KAFDT 181
L+ +G G++G VYRG A+K+ N + + + ++ E +++ +
Sbjct: 6 LELIGRGAYGAVYRGK----HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++ K YG +G +IME GG ++ +++ P AE +S I++ EV
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAE-------KYISVIIR---EV 110
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
+ Y+ +HRD+ A N +V + VK+ DFG+ + + R G P WM
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG-TPY-WM 168
Query: 302 APESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
APE + +G + + +D+WS G+ ++EMAT + PY + + +
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMAT-GNPPYSDVDAFRAM 211
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 56/232 (24%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 126 DELGNGSFGLVYRGL---IKDFRSLAEHPCAIKVANENASEREKAE-FLNEASVMKAFDT 181
+ LG G+F +++G+ + D+ L + +KV + S R +E F AS+M
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD--KSHRNYSESFFEAASMMSQLSH 58
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
H+V YGV G+ ++++ E + G L YL+ ++ +S L++A ++
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK---------NKNLINISWKLEVAKQL 109
Query: 242 ADGMAYLADKKFVHRDLAARNCMVA---DDLT-----VKVGDFGMTRDIYETEYYRKGSR 293
A + +L DK H ++ A+N ++ D T +K+ D G++ + E +
Sbjct: 110 AWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE--- 166
Query: 294 GFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
+ W+ PE +++ + +D WS+G LWE+ + +P L +++ L
Sbjct: 167 ---RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 36/215 (16%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
L ELG G+ G+V + L + A+K +E + + L E ++ ++ ++
Sbjct: 6 LGELGAGNSGVVSKVLHRP----TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI 61
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP-PTLSRILQMAAEVAD 243
V YG + ME M GG L L+ + R P L +I A V
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-------GRIPERILGKI---AVAVLK 111
Query: 244 GMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE--------TEYYRKGSRG 294
G+ YL +K K +HRD+ N +V +K+ DFG++ + T Y
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSY------ 165
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
MAPE ++ ++ SD+WS G+ L E+AT
Sbjct: 166 ------MAPERIQGNDYSVKSDIWSLGLSLIELAT 194
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 128 LGNGSFGLVYRGLI------KDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT 181
LG G+F +Y+G++ E +KV + R+ F AS+M
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD--HRDSLAFFETASLMSQLSH 60
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
H+VKLYGV + +++ E + G L +L E++ +L L +A ++
Sbjct: 61 KHLVKLYGV-CVRDENIMVEEYVKFGPLDVFLHR---------EKNNVSLHWKLDVAKQL 110
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADD-------LTVKVGDFGMTRDIYETEYYRKGSRG 294
A + YL DKK VH ++ +N +VA +K+ D G+ + E
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV----- 165
Query: 295 FLPVRWMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLS 339
+ W+APE +++G T +D WS+G L E+ + +P LS
Sbjct: 166 -ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDT 181
IL +G G+ G+V++ R E A+K VA + L E ++A
Sbjct: 3 KILGRIGEGAHGIVFKAKD---RETGE-TVALKKVALRRLEGGIPNQALREIKALQACQH 58
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+VVKL V G+ +++ME M DL LR P +++ +
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEE---------RPLPEAQVKSYMRML 108
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV--R 299
G+AY+ +HRDL N +++ D +K+ DFG+ R ++ E R S V R
Sbjct: 109 LKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSH---QVATR 164
Query: 300 W-MAPESL----KDGVFTSHSDVWSYGVVLWEMATLASQP 334
W APE L K + D+W+ G + E+ L P
Sbjct: 165 WYRAPELLYGARK---YDPGVDLWAVGCIFAEL--LNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 128 LGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFL-NEASVMKAFDTHHVV 185
LG G+FG VY D R LA + ++ +++ L E ++K +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVK--QVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
+ YG + + + ME M GG +K+ L++ ET V R + ++ +G+
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTET-VTR---------KYTRQILEGV 117
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RWMAPE 304
YL VHRD+ N + VK+GDFG ++ + G + WM+PE
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 305 SLKDGVFTSHSDVWSYGVVLWEMAT 329
+ + +DVWS G + EM T
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 1e-16
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH- 182
+++ +GNG++G VY+G LA AIKV + E E E E +++K + H
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQLA----AIKVMDVTGDEEE--EIKQEINMLKKYSHHR 63
Query: 183 HVVKLYGVVSEGNPT------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
++ YG + NP ++ME G G + + +++ + + + I
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE--------EWIAY 115
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL 296
+ E+ G+++L K +HRD+ +N ++ ++ VK+ DFG++ + T R G
Sbjct: 116 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG-- 173
Query: 297 PVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMA 328
WMAPE + D + SD+WS G+ EMA
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
LG G++G+VY +D + + AIK E S R E ++ ++V+
Sbjct: 16 LGKGTYGIVYAA--RDLST--QVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQY 70
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
G SE + ME + GG L LRS + D E I+ ++ +G+ Y
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRS-KWGPLKDNE------QTIIFYTKQILEGLKY 123
Query: 248 LADKKFVHRDLAARNCMVAD-DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
L D + VHRD+ N +V VK+ DFG ++ + + G L ++MAPE +
Sbjct: 124 LHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTL--QYMAPEVI 181
Query: 307 KDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPI 361
G + + +D+WS G + EMAT P+ L Q + G +K++P I
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMAT-GKPPFIELGEPQAAMFKVGM----FKIHPEI 233
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 61/261 (23%), Positives = 109/261 (41%), Gaps = 49/261 (18%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
L++LG G++ VY+G + + A+K + +A E + + E S+MK ++
Sbjct: 5 LEKLGEGTYATVYKGRNRTTGEIV----ALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
V+L+ V+ N +++ E M DLK Y+ +T R + + ++ G
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK-DLKKYM-------DTHGVRGALDPNTVKSFTYQLLKG 112
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI----------YETEYYRKGSRG 294
+A+ + + +HRDL +N ++ +K+ DFG+ R T +YR
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYR----- 167
Query: 295 FLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL--------- 344
AP+ L +++ D+WS G ++ EM T + G +NE L
Sbjct: 168 -------APDVLLGSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLLKIFRIMGT 219
Query: 345 ----NWVKGKSSNEYKVNPPI 361
W EYK P
Sbjct: 220 PTESTWPGISQLPEYKPTFPR 240
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD 180
K+ L LG G+ G V + +K+ + A+K + + + + L E + K+
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIF----ALKTITTDPNPDLQKQILRELEINKSCK 57
Query: 181 THHVVKLYGV-VSEGNPTLVI-MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
+ ++VK YG + E + ++ I ME GG L + + + +R ++L
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK-------KRGGRIGEKVLGKI 110
Query: 239 AE-VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE--------TEYYR 289
AE V G++YL +K +HRD+ N ++ VK+ DFG++ ++ T +Y
Sbjct: 111 AESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFY- 169
Query: 290 KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMA 328
MAPE ++ ++ SDVWS G+ L E+A
Sbjct: 170 -----------MAPERIQGKPYSITSDVWSLGLTLLEVA 197
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFD 180
+ LG GSFG V K + A+K+ ++ + K LNE ++++
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKG----SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
+V LYG + + ++ME + GG+L ++LR R P ++R AA+
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG--------RFPEPVARF--YAAQ 109
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300
V + YL V+RDL N ++ D +K+ DFG + + Y G+ P +
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGT----P-EY 164
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMA 328
+APE + + D W+ G++++EM
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 28/217 (12%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH- 182
+++ +GNG++G VY+G LA AIKV + +E E+ E E +++K + H
Sbjct: 20 LVEVVGNGTYGQVYKGRHVKTGQLA----AIKVMD--VTEDEEEEIKLEINMLKKYSHHR 73
Query: 183 HVVKLYGVVSEGNPT------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
++ YG + +P ++ME G G + + +++ + +A + I
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE--------DWIAY 125
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL 296
+ E+ G+A+L K +HRD+ +N ++ ++ VK+ DFG++ + T R G
Sbjct: 126 ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG-T 184
Query: 297 PVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMA 328
P WMAPE + D + SD+WS G+ EMA
Sbjct: 185 PY-WMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 48/219 (21%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEF-LNEASVMK-------- 177
LG GSFG V L++ + A+KV + +R++ E L E +++
Sbjct: 1 LGKGSFGKVL--LVRKKDT--GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIV 56
Query: 178 ----AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
AF T KLY +++E GG+L ++L R +R
Sbjct: 57 KLHYAFQTEE--KLY----------LVLEYAPGGELFSHLSKEG--------RFSEERAR 96
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK--- 290
AAE+ + YL ++RDL N ++ D +K+ DFG+ +++
Sbjct: 97 FY--AAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
G+ + +APE L + D WS GV+L+EM T
Sbjct: 155 GTPEY-----LAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-16
Identities = 61/247 (24%), Positives = 111/247 (44%), Gaps = 35/247 (14%)
Query: 128 LGNGSFGLVYRGL---------IK--DFRSLAEHPCAIKVANENASEREKAEFLNEASVM 176
+G+GSFG VY G+ +K + S++ K + +A RE +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE-------IALL 60
Query: 177 KAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
K ++V+ G + + + +E + GG + L + ET V + +IL+
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN---FVRQILK 117
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL 296
G+ YL ++ +HRD+ N +V + +K+ DFG+++ + E + G
Sbjct: 118 -------GLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGAR 169
Query: 297 P-----VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351
P V WMAPE +K +T +D+WS G ++ EM T P+ + Q + + +
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIGENA 228
Query: 352 SNEYKVN 358
S E N
Sbjct: 229 SPEIPSN 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
+ LG+G+ G VY K + L A+KV + + + + ++E ++ D+ ++
Sbjct: 6 QEILGHGNGGTVY----KAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP--TLSRILQMAAEVA 242
+ YG N + E M GG L DV R P L RI A V
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSL-------------DVYRKIPEHVLGRI---AVAVV 105
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE---TEYYRKGSRGFLPVR 299
G+ YL K +HRD+ N +V VK+ DFG++ + Y G+ +
Sbjct: 106 KGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV--GTNAY---- 159
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335
MAPE + + HSDVWS G+ E+A L PY
Sbjct: 160 -MAPERISGEQYGIHSDVWSLGISFMELA-LGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL-NEASVMKAFDTHH 183
+++G G+FG VY + D L A+K ++ + + + +E V++ +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELM----AVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+VK YGV + ME GG L+ L R E + ++ +
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV----------YTLQLLE 110
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE-TEYYRKGSRGFL--PVRW 300
G+AYL VHRD+ N + + +K+GDFG + T + + P +
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA-Y 169
Query: 301 MAPESLKDGVFTSH---SDVWSYGVVLWEMATLASQPYQGLSNE 341
MAPE + G H +D+WS G V+ EMAT +P+ L NE
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 9e-16
Identities = 62/237 (26%), Positives = 107/237 (45%), Gaps = 23/237 (9%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
++G GS G+V K + A+K+ + +R + F NE +M+ + +VV+
Sbjct: 28 KIGEGSTGIVCIAREKH----SGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVE 82
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
+Y G V+ME + GG L + + R + E +I + V +
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE-----------QIATVCESVLQALC 131
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
YL + +HRD+ + + ++ D VK+ DFG I + RK G P WMAPE +
Sbjct: 132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG-TPY-WMAPEVI 189
Query: 307 KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG----KSSNEYKVNP 359
+ + D+WS G+++ EM PY S Q + ++ K N +K++P
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISP 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-16
Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 36/229 (15%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFL 170
D+WE I++ +G G++G V++ L K S A A+K+ + + E +AE+
Sbjct: 18 DTWE-------IIETIGKGTYGKVFKVLNKKNGSKA----AVKILDPIHDIDEEIEAEY- 65
Query: 171 NEASVMKAFDTH-HVVKLYGV-----VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDV 224
+++KA H +VVK YG+ V G+ +++EL GG + + ++ E
Sbjct: 66 ---NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE--- 119
Query: 225 ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
P ++ IL E G+ +L K +HRD+ N ++ + VK+ DFG++ +
Sbjct: 120 RMEEPIIAYILH---EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 285 TEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMA 328
T R S G P WMAPE + D + + DVWS G+ E+
Sbjct: 177 TRLRRNTSVG-TPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMKAFDT 181
I ++G G F VYR L P A+K + + +A+ + E ++K +
Sbjct: 6 IEKKIGRGQFSEVYRATC----LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+V+K Y E N +++EL GDL ++ + E++ + + ++
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKT------VWKYFVQL 115
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
+ ++ ++ +HRD+ N + VK+GD G+ R + ++ S P +M
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY-YM 173
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
+PE + + + SD+WS G +L+EMA L S P+ G
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQS-PFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMKAFDTHHVV 185
+G G+FG V+ L++D S EH A+KV E +++ NE V+K ++
Sbjct: 9 VGTGTFGRVH--LVRDRIS--EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFII 64
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
+L+ + ++ME + GG+L +YLR+ R + A+E+ +
Sbjct: 65 RLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--------RFSNSTGLFY--ASEIVCAL 114
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
YL K+ V+RDL N ++ + +K+ DFG + + + + G+ +L APE
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYL-----APEV 169
Query: 306 LKDGVFTSHSDVWSYGVVLWEM 327
++ D W+ G++++EM
Sbjct: 170 IQSKGHNKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 128 LGNGSFGLVYRGLIKDFRSL-----AEHPCAIKVANENASEREK---AEFLNEASVMKAF 179
+G G++G VY L + E P R+K +E +K
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELP---ATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 180 DTHHVVKLYGVVSEGNPTLVI-MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
D ++V+ G L I +E + GG + + LR+ E + R
Sbjct: 66 DHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRF---------FT 114
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR---DIYETEY--YRKGSR 293
+V +G+AYL K +HRDL A N +V D K+ DFG+++ DIY+ + +GS
Sbjct: 115 EQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS- 173
Query: 294 GFLPVRWMAPE--SLKDGVFTSHSDVWSYGVVLWEM 327
V WMAPE +++ D+WS G V+ EM
Sbjct: 174 ----VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFDTHHVV 185
LG G FG V +K + A K ++ ++ K E LNE +++ + +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMY----ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 186 KL-YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
L Y ++ + LV M LM GGDLK ++ +V +R + AA++ G
Sbjct: 57 SLAYAFETKDDLCLV-MTLMNGGDLKYHI--------YNVGEPGFPEARAIFYAAQIICG 107
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE--TEYYRKGSRGFLPVRWMA 302
+ +L ++ V+RDL N ++ D V++ D G+ ++ R G+ G+ MA
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY-----MA 162
Query: 303 PESLKDGVFTSHSDVWSYGVVLWEM 327
PE L+ V+ D ++ G L+EM
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH- 182
IL ++G G+F V + + ++ + AIK ++ E+ L E ++ H
Sbjct: 3 ILGKIGEGTFSEVLK--AQSRKTGKYY--AIKCMKKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 183 HVVKLYGVVSE---GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
++++L V+ + G L + ELM +L ++ + P R+
Sbjct: 59 NILRLIEVLFDRKTGRLAL-VFELMDM-NLYELIKG---------RKRPLPEKRVKSYMY 107
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE----TEYYRKGSRGF 295
++ + ++ HRD+ N ++ DD +K+ DFG R IY TEY
Sbjct: 108 QLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEY-------- 158
Query: 296 LPVRWM-APES-LKDGVFTSHSDVWSYGVVLWEMATL 330
+ RW APE L DG + D+W+ G V +E+ +L
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL 195
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 43/185 (23%), Positives = 81/185 (43%), Gaps = 23/185 (12%)
Query: 154 IKVANENASEREKA--EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKN 211
+ +SE+E+ E +M + H++++ G E + + +E M GG + +
Sbjct: 33 VTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSH 92
Query: 212 YLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT- 270
L E + ++L+ G++YL + + +HRD+ N ++ D T
Sbjct: 93 LLSKYGAFKEAVIIN---YTEQLLR-------GLSYLHENQIIHRDVKGANLLI--DSTG 140
Query: 271 --VKVGDFG----MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+++ DFG + ++ G + +MAPE L+ + DVWS G V+
Sbjct: 141 QRLRIADFGAAARLAAKGTGAGEFQGQLLG--TIAFMAPEVLRGEQYGRSCDVWSVGCVI 198
Query: 325 WEMAT 329
EMAT
Sbjct: 199 IEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA 178
RS + ++G GS G+V + D + A+K + +R + F NE +M+
Sbjct: 18 RSYLDNFVKIGEGSTGIVC--IATDKST--GRQVAVKKMDLRKQQRRELLF-NEVVIMRD 72
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
+ ++V++Y G+ V+ME + GG L + + R + E +I +
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIATVC 121
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
V +++L + +HRD+ + + ++ D VK+ DFG + + RK G P
Sbjct: 122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG-TPY 180
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
WMAPE + + + D+WS G+++ EM
Sbjct: 181 -WMAPEVISRLPYGTEVDIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH 183
++ +G+G++G VY+ + LA AIKV E + A E +MK +
Sbjct: 13 LIQRIGSGTYGDVYKARNVNTGELA----AIKVIKLEPGE-DFAVVQQEIIMMKDCKHSN 67
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+V +G + + ME GGG L++ P +E S+I ++ E
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE----------SQIAYVSRETLQ 117
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAP 303
G+ YL K +HRD+ N ++ D+ VK+ DFG++ I T RK G P WMAP
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIG-TPY-WMAP 175
Query: 304 ESL---KDGVFTSHSDVWSYGVVLWEMATL 330
E + G + D+W+ G+ E+A L
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAEL 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 54/228 (23%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF--------LNEAS 174
++ +LG+G+FG VY K+ L AIK + K +F L E
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELV----AIK--------KMKKKFYSWEECMNLREVK 49
Query: 175 VMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYL-RSCRPDAETDVERSPPTLS 232
++ + H ++VKL V E + + E M G + R +P +E+ + RS +
Sbjct: 50 SLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVI-RS--IIY 106
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE----TEY- 287
+ILQ G+A++ F HRDL N +V+ VK+ DFG+ R+I T+Y
Sbjct: 107 QILQ-------GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV 159
Query: 288 ----YRKGSRGFLPVRWMAPES-LKDGVFTSHSDVWSYGVVLWEMATL 330
YR APE L+ ++S D+W+ G ++ E+ TL
Sbjct: 160 STRWYR------------APEILLRSTSYSSPVDIWALGCIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMK 177
+ I ++G G F VYR L P A+K E + + + + E ++K
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCL----LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLK 57
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
+ +V+K E N +++EL GDL ++ + ER+ + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT------VWKY 111
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
++ + ++ ++ +HRD+ N + VK+GD G+ R + ++ S P
Sbjct: 112 FVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTP 170
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
+M+PE + + + SD+WS G +L+EMA L S P+ G
Sbjct: 171 Y-YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-PFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
++G GS G+V +K L A+K + +R + F NE +M+ + +VV+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLV----AVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVE 81
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
+Y G+ V+ME + GG L + + R + E +I + V ++
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLKALS 130
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
L + +HRD+ + + ++ D VK+ DFG + + RK G WMAPE +
Sbjct: 131 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG--TPYWMAPELI 188
Query: 307 KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK-------GKSSNEYKVNP 359
+ D+WS G+++ EM PY NE L +K K N +KV+P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVD-GEPPY---FNEPPLKAMKMIRDNLPPKLKNLHKVSP 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 58/239 (24%), Positives = 108/239 (45%), Gaps = 20/239 (8%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
+ ++G GSFG L+K + + ++ S +E+ E E +V+ ++
Sbjct: 5 VKKIGEGSFGKAI--LVKS-KEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
V+ E ++M+ GGDL + + R +IL ++
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG--------VLFPEDQILDWFVQICLA 113
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPE 304
+ ++ D+K +HRD+ ++N + D T+K+GDFG+ R + T + G P +++PE
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIG-TPY-YLSPE 171
Query: 305 SLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPISL 363
++ + + SD+W+ G VL+EM TL G VL ++G PP+S
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-------PPVSS 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDT 181
L ++G G++G+VY+ K + AIK + SE L E ++K +
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIV----AIKKIKLRFESEGIPKTALREIKLLKELNH 57
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+++KL V ++ E M DL ++ D + + + L +
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIK----DRQRGL--PESLIKSYLYQ---L 107
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE-----TEYYRKGSRGFL 296
G+A+ +HRDL N ++ + +K+ DFG+ R T Y +
Sbjct: 108 LQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY--------V 159
Query: 297 PVRWM-APESL-KDGVFTSHSDVWSYGVVLWEMATL 330
RW APE L D +++ D+WS G + E+ +
Sbjct: 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 78/263 (29%), Positives = 120/263 (45%), Gaps = 67/263 (25%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEA-SVMKAFDTHH 183
L E+G G+FG V + L K ++ A+K E+E+ L + VM++ D +
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIM----AVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPY 64
Query: 184 VVKLYGVV-SEGNPTLVIMELMGGGDLKNY------LRSCRPDAETDVERSPPTLSRIL- 235
+VK YG + EG+ + MELM K Y L+S P+ IL
Sbjct: 65 IVKFYGALFREGD-CWICMELMDISLDKFYKYVYEVLKSVIPE-------------EILG 110
Query: 236 QMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFGM----------TRDIYE 284
++A + YL ++ K +HRD+ N ++ + +K+ DFG+ TRD
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA-- 168
Query: 285 TEYYRKGSRGFLPVRWMAPE----SLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340
G R P +MAPE S +DG + SDVWS G+ L+E+AT PY ++
Sbjct: 169 ------GCR---P--YMAPERIDPSARDG-YDVRSDVWSLGITLYEVAT-GKFPYPKWNS 215
Query: 341 --EQVLNWVKGKSSNEYKVNPPI 361
+Q+ VKG +PPI
Sbjct: 216 VFDQLTQVVKG--------DPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
+G GS+G V L++ R+ + K+ NAS RE+ EA ++ ++V
Sbjct: 8 VGKGSYGEV--SLVRH-RTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 188 YGVVSEGNPTL--VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
Y EG L ++M GGDL + L+ E + P +++++ ++A +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLK------EQKGKLLPE--NQVVEWFVQIAMAL 115
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
YL +K +HRDL +N + +KVGD G+ R + E + + P +M+PE
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPY-YMSPEL 173
Query: 306 LKDGVFTSHSDVWSYGVVLWEMATL 330
+ + SDVW+ G ++EMATL
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATL 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE-KAEFLNEASVMKAFDTHHVVK 186
LG G FG V + R+ + ++ + +R+ ++ LNE +++ ++ VV
Sbjct: 8 LGKGGFGEVCACQV---RATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSC-RPDAETDVERSPPTLSRILQMAAEVADGM 245
L + +++ +M GGDLK ++ + P E + R L AAE+ G+
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE---------RALFYAAEILCGL 115
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
L + V+RDL N ++ D +++ D G+ I E E R G G V +MAPE
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR-GRVG--TVGYMAPEV 172
Query: 306 LKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
L + +T D W G +++EM P++G
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH 183
++ +G+G++G VY+ LA A+K+ + + + E ++K +
Sbjct: 13 LIQRVGSGTYGDVYKARNLHTGELA----AVKIIKLEPGD-DFSLIQQEIFMVKECKHCN 67
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+V +G + ME GGG L++ P +E +I + E
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----------QIAYVCRETLQ 117
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAP 303
G+AYL K +HRD+ N ++ D+ VK+ DFG+ I T RK G P WMAP
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIG-TPY-WMAP 175
Query: 304 ESL---KDGVFTSHSDVWSYGVVLWEMATLASQP 334
E K+G + D+W+ G+ E+A L QP
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAEL--QP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 51/229 (22%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAE-HPCAIK-VANENASEREKAEFLNEASVMK---A 178
L E+G G++G VY+ R L A+K V + E L E +++K +
Sbjct: 3 ELAEIGEGAYGTVYKA-----RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES 57
Query: 179 FDTHHVVKLYGV-----VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS- 232
F+ ++V+L V ++ E + DL YL C P L
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC----------PKPGLPP 106
Query: 233 -RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE------- 284
I + ++ G+ +L + VHRDL +N +V D VK+ DFG+ R IY
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTS 165
Query: 285 ---TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL 330
T +YR APE L + + D+WS G + E+
Sbjct: 166 VVVTLWYR------------APEVLLQSSYATPVDMWSVGCIFAELFRR 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 25/227 (11%)
Query: 125 LDELGNGSFGLVYRGLI-KDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFDTH 182
L LG GSFG V+ L+ K A A+KV + + R++ E ++ + +
Sbjct: 1 LKVLGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA--EVN 56
Query: 183 H--VVKL-YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
H +VKL Y +EG L I++ + GGDL L E DV+ A
Sbjct: 57 HPFIVKLHYAFQTEGKLYL-ILDFLRGGDLFTRLSKEVMFTEEDVKFYL----------A 105
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL-PV 298
E+A + +L ++RDL N ++ ++ +K+ DFG+++ E+ + K + F V
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTV 162
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+MAPE + T +D WS+GV+++EM T S P+QG ++ +
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKDRKETMT 208
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 66/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 97 PPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV 156
P N M G + D+WE I++ +G G++G VY+ K SLA A+K+
Sbjct: 6 PYNSSMLGLESLGDPTDTWE-------IIETIGKGTYGKVYKVTNKKDGSLA----AVKI 54
Query: 157 ANENASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSE-----GNPTLVIMELMGGGDLK 210
+ + E+ E E +++++ H +VVK YG+ + G +++EL GG +
Sbjct: 55 LDPISDVDEEIE--AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVT 112
Query: 211 NYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270
++ + E +S IL A G+ +L + + +HRD+ N ++ +
Sbjct: 113 ELVKGLLICGQRLDE---AMISYILYGALL---GLQHLHNNRIIHRDVKGNNILLTTEGG 166
Query: 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLW 325
VK+ DFG++ + T R S G P WMAPE + D + + DVWS G+
Sbjct: 167 VKLVDFGVSAQLTSTRLRRNTSVG-TPF-WMAPEVIACEQQYDYSYDARCDVWSLGITAI 224
Query: 326 EMA 328
E+
Sbjct: 225 ELG 227
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-14
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 15/206 (7%)
Query: 128 LGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
LG G+FG VY D R LA + S +E + E ++K +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETS-KEVSALECEIQLLKNLQHERIVQ 68
Query: 187 LYGVVSE-GNPTLVI-MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
YG + + TL I ME M GG +K+ L++ E+ V R + ++ +G
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES-VTR---------KYTRQILEG 118
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RWMAP 303
M+YL VHRD+ N + VK+GDFG ++ + G R WM+P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEMAT 329
E + + +DVWS G + EM T
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE-KAEFLNEASVMKAFDTHHVVK 186
LG G FG V + R+ + K+ + +R+ ++ LNE +++ ++ VV
Sbjct: 8 LGKGGFGEVCACQV---RATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
L + +++ LM GGDLK ++ E E R + AAE+ G+
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHM---GEAGFEEG-----RAVFYAAEICCGLE 116
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
L ++ V+RDL N ++ D +++ D G+ + E + KG G V +MAPE +
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-KGRVG--TVGYMAPEVV 173
Query: 307 KDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336
K+ +T D W+ G +L+EM P+Q
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIA-GQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 22/225 (9%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---SEREKAEFLNEASVMKAFDTHHV 184
LG GSFG V+ +K AIK ++ + + + + + A++ +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFF----AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 58
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSC-RPDAETDVERSPPTLSRILQMAAEVAD 243
LY +ME + GGDL +++SC + D L R AAE+
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFD-----------LPRATFYAAEIIC 107
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAP 303
G+ +L K V+RDL N ++ D +K+ DFGM ++ + K ++AP
Sbjct: 108 GLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAP 165
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
E L + + D WS+GV+L+EM + P+ G E++ ++
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEM-LIGQSPFHGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
++G GS G+V K A+K + +R + F NE +M+ + +VV
Sbjct: 29 KIGEGSTGIVCIATEKH----TGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVD 83
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
+Y G+ V+ME + GG L + + R + E +I + V ++
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIATVCLSVLRALS 132
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
YL ++ +HRD+ + + ++ D +K+ DFG + + RK G WMAPE +
Sbjct: 133 YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG--TPYWMAPEVI 190
Query: 307 KDGVFTSHSDVWSYGVVLWEM 327
+ + D+WS G+++ EM
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEM 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 28/224 (12%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDT 181
+L +G G+FG V +D + + A+K N+ + LNE +++ +
Sbjct: 4 LLRVIGKGAFGKVCIVQKRDTKKMF----AMKYMNKQKCVEKGSVRNVLNERRILQELNH 59
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+V L+ + ++++L+ GGDL+ +L +E V + E+
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV--------KFW--ICEI 109
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM----TRDIYETEYYRKGSRGFLP 297
+ YL K +HRD+ N ++ + V + DF + T D T G+ G+
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGY-- 165
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341
MAPE L ++ D WS GV +E +PY+G S
Sbjct: 166 ---MAPEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPYRGHSRT 205
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
T ++++G G++G+VY+G K + K+ E+ E + + E S++K
Sbjct: 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMK---KIRLESEEEGVPSTAIREISLLKELQHP 59
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
++V L V+ + + +I E + DLK YL S D E L +ILQ
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQ------ 112
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD------IYETE----YYRKGS 292
G+ + ++ +HRDL +N ++ + +K+ DFG+ R +Y E +YR
Sbjct: 113 -GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR--- 168
Query: 293 RGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMAT 329
APE L +++ D+WS G + EMAT
Sbjct: 169 ---------APEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL-NEASVMK 177
+ K T +++G G+ G VY + AIK N ++ K E + NE VM+
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAI----DVATGQEVAIK--QMNLQQQPKKELIINEILVMR 71
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
++V G+ V+ME + GG L + + D +I +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE-----------GQIAAV 120
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
E + +L + +HRD+ + N ++ D +VK+ DFG I + R G P
Sbjct: 121 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG-TP 179
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
WMAPE + + D+WS G++ EM
Sbjct: 180 Y-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 126 DELGNGSFGLVYRGLIKDFR----SLAEHPCAIKVANE--NASEREKA-EFLNEASVMKA 178
+ LG G+ +Y G++ + IKV + + S R+ + F AS+M+
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
H+V LYGV +++ E + G L ++ ++DV +P ++A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR-----KSDVLTTPWKF----KVA 111
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVA-DDLTVKVGDFGMTRD--IYETEYYRKGSRGF 295
++A ++YL DK VH ++ +N ++A + + + G F D I T R+
Sbjct: 112 KQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER 171
Query: 296 LPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEM 327
+P W+APE ++D + +D WS+G LWE+
Sbjct: 172 IP--WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-13
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL-NEASVMK 177
+ K T +++G G+ G VY + D + E + + N ++ K E + NE VM+
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAI--DIATGQE----VAIKQMNLQQQPKKELIINEILVMR 71
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
++V G+ V+ME + GG L + + ET ++ +I +
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEG-----QIAAV 120
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
E + +L + +HRD+ + N ++ D +VK+ DFG I + R G
Sbjct: 121 CRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--T 178
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335
WMAPE + + D+WS G++ EM PY
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKV-ANENASEREKAE--------FLNEASVMKA 178
LG G FG V L+ +++ E AIK + R++ E F S
Sbjct: 7 LGRGHFGKV---LLAEYKKTGEL-YAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
F +V L+ + +ME GGDL ++ TDV P R + A
Sbjct: 63 F----LVNLFACFQTEDHVCFVMEYAAGGDLMMHI-------HTDVFSEP----RAVFYA 107
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
A V G+ YL + K V+RDL N ++ + VK+ DFG+ + E + + F
Sbjct: 108 ACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGT 164
Query: 299 -RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
++APE L + +T D W GV+++EM + P+ G E+V +
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEM-LVGESPFPGDDEEEVFD 211
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 35/229 (15%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVA-NENASEREKAEF---LNEASV 175
++ +LDELG G++G VY+ L + P + +A E E ++++F + E +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHR--------PTGVTMAMKEIRLELDESKFNQIIMELDI 52
Query: 176 MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDL-KNYLRSCRPDAETDVERSP-PTLSR 233
+ + ++V YG + ME M G L K Y E P L R
Sbjct: 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLY------AGGVATEGIPEDVLRR 106
Query: 234 ILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGS 292
I V G+ +L ++ +HRD+ N +V + VK+ DFG++ ++ + K +
Sbjct: 107 I---TYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTN 161
Query: 293 RGFLPVRWMAPESLKDG------VFTSHSDVWSYGVVLWEMATLASQPY 335
G +MAPE +K G +T SDVWS G+ + EMA L PY
Sbjct: 162 IGCQ--SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA-LGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV---ANENASEREKAEFLNEASVMKAFDT 181
L + G+FG VY L K RS ++ AIKV ++ A + A +M ++
Sbjct: 1 LKPISKGAFGSVY--LAKK-RSTGDY-FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES 56
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+V KLY + ++ME + GGD + +++ E Q AEV
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE----------DWAKQYIAEV 106
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
G+ L + +HRD+ N ++ +K+ DFG++R+ E + + ++
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYL 160
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMAT 329
APE++ SD WS G V++E
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 170 LNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP- 228
+ E V+ ++ ++V YG + ME M GG L L+ R P
Sbjct: 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--------RIPE 98
Query: 229 PTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
L +I + V G+ YL +K K +HRD+ N +V +K+ DFG++ + ++
Sbjct: 99 NILGKI---SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154
Query: 288 YRKGSRGFLPVR-WMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
+ F+ R +M+PE L+ +T SD+WS G+ L EMA
Sbjct: 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 7e-13
Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDTHHVVK 186
+G G+FG+V+ K + L IK E ++ E+ NE V+K ++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLV----IIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYL-RSCRP--DAETDVERSPPTLSRILQMAAEVAD 243
Y E +++ME GG L Y+ + C D +T IL ++
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT-----------ILHFFVQILL 112
Query: 244 GMAYLADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYETE--YYRKGSRGFLPVRW 300
+ ++ K +HRDL +N ++ + VK+GDFG+++ + Y G+ ++
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYI---- 168
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATL 330
+PE + + SD+W+ G VL+E+A+L
Sbjct: 169 -SPELCEGKPYNQKSDIWALGCVLYELASL 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 128 LGNGSFG--LVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDTHHV 184
LG G+FG +YR R+ + K N SE+E+ + LNE ++ ++
Sbjct: 8 LGKGAFGEATLYR------RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
+ Y + N L+ ME GG L Y + R + E +L ++
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTL--YDKIVRQKGQLFEEEM------VLWYLFQIVSA 113
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPE 304
++Y+ +HRD+ N + +K+GDFG+++ I +EY + P +M+PE
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGTPY-YMSPE 171
Query: 305 SLKDGVFTSHSDVWSYGVVLWEMATL 330
+ + SD+W+ G VL+E+ TL
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTL 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 8e-13
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL-NEASVMK 177
+ K T +++G G+ G VY + D + E + + N ++ K E + NE VM+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM--DVATGQE----VAIRQMNLQQQPKKELIINEILVMR 72
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
++V G+ V+ME + GG L + + ET ++ +I +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEG-----QIAAV 121
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
E + +L + +HRD+ + N ++ D +VK+ DFG I + R G
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--T 179
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
WMAPE + + D+WS G++ EM
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASV-MKAFDTH 182
L E+G+G+ G VY+ K + A+K ++ E L + V +K+ D
Sbjct: 19 NLGEIGSGTCGQVYKMRFKKTGHVM----AVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL-QMAAEV 241
++VK YG + + MELM K R P E IL +M +
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPE-----------DILGKMTVAI 123
Query: 242 ADGMAYLADKKFV-HRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300
+ YL +K V HRD+ N ++ VK+ DFG++ + +++ + S G +
Sbjct: 124 VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR-SAGCAA--Y 180
Query: 301 MAPESL----KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE-QVL 344
MAPE + + + +DVWS G+ L E+AT PY+ E +VL
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKNCKTEFEVL 228
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 22/167 (13%)
Query: 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259
+ME + GGDL +++ E R AAE+ G+ +L ++ ++RDL
Sbjct: 74 VMEYVNGGDLMFHIQRSGRFDE----------PRARFYAAEIVLGLQFLHERGIIYRDLK 123
Query: 260 ARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RWMAPESLKDGVFTSHSDVW 318
N ++ + +K+ DFGM + E + F ++APE L + D W
Sbjct: 124 LDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWW 180
Query: 319 SYGVVLWEMATLASQ-PYQGLSNEQVLNWVKGKSSNEYKVNPPISLS 364
+ GV+L+EM LA Q P++G +++ + +V P LS
Sbjct: 181 ALGVLLYEM--LAGQSPFEGDDEDELFQSILED-----EVRYPRWLS 220
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHP-----CAIKVANENASEREKAEFLNEASVMKA 178
+ +LG G+ G V S +H A KV + A + + L E +M
Sbjct: 9 TISDLGAGNGGSV---------SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE 59
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
+ ++V YG N + ME M G L + + P + + ++A
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK----------KGGPIPVEILGKIA 109
Query: 239 AEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
V +G+ YL + + +HRD+ N +V +K+ DFG++ E + F+
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVG 164
Query: 298 VR-WMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
+M+PE ++ G +T SDVWS G+ + E+A
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 56/224 (25%), Positives = 106/224 (47%), Gaps = 43/224 (19%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDTHH 183
L+++G G++G V++ ++ + A+K V ++ E + L E ++K +
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIV----ALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 184 VVKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+V+LY V+ S+ TLV DLK Y SC D + ++ +S + ++L+
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC--DQDLKKYFDSCNGDIDPEIVKS--FMFQLLK------ 110
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF-LPVR-- 299
G+A+ +HRDL +N ++ + +K+ DFG+ +R F +PVR
Sbjct: 111 -GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGL-------------ARAFGIPVRCY 156
Query: 300 -------WMAPESLKDG--VFTSHSDVWSYGVVLWEMATLASQP 334
W P + G ++++ D+WS G + E+A A +P
Sbjct: 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN-AGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 26/215 (12%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFDTHHVV 185
LG G FG V L+K A+K + + +E +++ + +V
Sbjct: 1 LGVGGFGRVE--LVKVKSKNRTF--ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
KLY + ++ME GG+L LR D +R A V
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILR--------DRGLFDEYTARFY--IACVVLAF 106
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV---RWMA 302
YL ++ ++RDL N ++ + VK+ DFG + + G + + ++A
Sbjct: 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK------SGQKTWTFCGTPEYVA 160
Query: 303 PESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
PE + + + D WS G++L+E+ T P+
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLT-GRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF--LNEASVMKAFDTHHVV 185
LG G FG V ++ + A K + ++ K E LNE +++ ++ VV
Sbjct: 8 LGKGGFGEVCACQVRATGKMY----ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
L + +++ LM GGDLK ++ + + R + AAE+ G+
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--------ERAVFYAAEITCGL 115
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
L ++ V+RDL N ++ D +++ D G+ +I E E R G G V +MAPE
Sbjct: 116 EDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR-GRVG--TVGYMAPEV 172
Query: 306 LKDGVFTSHSDVWSYGVVLWEM 327
+K+ +T D W G +++EM
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-12
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL-NEASVMK 177
+ K T +++G G+ G V+ D + + + + N ++ K E + NE VMK
Sbjct: 18 KKKYTRYEKIGQGASGTVFTA--IDV-ATGQE---VAIKQINLQKQPKKELIINEILVMK 71
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYL-RSCRPDAETDVERSPPTLSRILQ 236
++V G+ V+ME + GG L + + +C +A+ I
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQ------------IAA 119
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL 296
+ E + +L + +HRD+ + N ++ D +VK+ DFG I + R G
Sbjct: 120 VCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG-- 177
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335
WMAPE + + D+WS G++ EM PY
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 21/148 (14%)
Query: 200 IMELMGGGDLKNYLRSC-RPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258
+ME + GGDL +++S R D +R AAE+ G+ +L K ++RDL
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFD-----------EARARFYAAEIICGLQFLHKKGIIYRDL 122
Query: 259 AARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL---PVRWMAPESLKDGVFTSHS 315
N ++ D +K+ DFGM + +G P ++APE LK +
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCK----ENMNGEGKASTFCGTP-DYIAPEILKGQKYNESV 177
Query: 316 DVWSYGVVLWEMATLASQPYQGLSNEQV 343
D WS+GV+L+EM + P+ G +++
Sbjct: 178 DWWSFGVLLYEM-LIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 22/225 (9%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---SEREKAEFLNEASVMKAFDTHHV 184
LG GSFG V L+ + + E+ A+K ++ + + + + + A++ +
Sbjct: 3 LGKGSFGKV---LLAELKGKGEY-FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
LY +ME + GGDL +++ ++ L R AAE+ G
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQ----------DKGRFDLYRATFYAAEIVCG 108
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RWMAP 303
+ +L K ++RDL N M+ D +K+ DFGM + E + + F ++AP
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGTPDYIAP 165
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
E L+ +T D WS+GV+L+EM + P+ G +++ ++
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEM-LIGQSPFHGDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE-KAEFLNEASVMKAFDTHHVVK 186
LG G FG V + R+ + K+ + +R+ +A LNE +++ ++ VV
Sbjct: 8 LGKGGFGEVCACQV---RATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
L + +++ +M GGDLK ++ + + D +R+ + AAE+ G+
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDEQRA-------IFYAAELCCGLE 116
Query: 247 YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
L ++ V+RDL N ++ D +++ D G+ I E E R G G V +MAPE +
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR-GRVG--TVGYMAPEVI 173
Query: 307 KDGVFTSHSDVWSYGVVLWEM 327
+ +T D W G +++EM
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
ELG G+ G+V + K + A K+ + + + + E V+ ++ ++V
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIM----ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 67
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
YG + ME M GG L L+ + R P + + +++ V G+A
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKEAK--------RIPEEI--LGKVSIAVLRGLA 117
Query: 247 YLADK-KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR-WMAPE 304
YL +K + +HRD+ N +V +K+ DFG++ + ++ + F+ R +M+PE
Sbjct: 118 YLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPE 172
Query: 305 SLKDGVFTSHSDVWSYGVVLWEMA 328
L+ ++ SD+WS G+ L E+A
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELA 196
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
LD+LG G++ VY+G K L ++ A+K E + E S++K ++
Sbjct: 11 LDKLGEGTYATVYKGRSK----LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 185 VKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
V L+ ++ +E + TLV L DLK YL C + + + ++
Sbjct: 67 VTLHDIIHTEKSLTLVFEYL--DKDLKQYLDDCG---------NSINMHNVKLFLFQLLR 115
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR--DIYETEYYRKGSRGFLPVRWM 301
G+ Y +K +HRDL +N ++ + +K+ DFG+ R I Y + + W
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE-----VVTLWY 170
Query: 302 APESLKDGV--FTSHSDVWSYGVVLWEMAT 329
P + G +++ D+W G + +EM+T
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 51/238 (21%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF----LNEASVMKAF 179
+ ++G G++G VY+ K L A+K E EK F + E +++
Sbjct: 3 KIAQIGEGTYGQVYKARNKKTGELV----ALKKIRM---ENEKEGFPITAIREIKLLQKL 55
Query: 180 DTHHVVKLYGVV-SEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
++V+L +V S+G ++ ++ E M DL L S +V+ + + ++
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS------PEVKFTESQIKCYMKQ 108
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE------------T 285
E G+ YL +HRD+ N ++ +D +K+ DFG+ R Y T
Sbjct: 109 LLE---GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYTNRVIT 164
Query: 286 EYYRKGSRGFLPVRWMAPESL-KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
+YR PE L + D+WS G +L E+ +QG S E
Sbjct: 165 LWYR------------PPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQG-STEL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 12/129 (9%)
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
AAE+A G+ +L K ++RDL N M+ + +K+ DFGM + E + K +R F
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCG 163
Query: 298 V-RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQ-PYQGLSNEQVLNWVKGKSSNEY 355
++APE + + D W++GV+L+EM LA Q P+ G +++ S E+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM--LAGQPPFDGEDEDELFQ-----SIMEH 216
Query: 356 KVNPPISLS 364
V+ P SLS
Sbjct: 217 NVSYPKSLS 225
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 53/217 (24%), Positives = 85/217 (39%), Gaps = 41/217 (18%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREK-AEFLNEASVMKAFDTH 182
L E+G+GSFG VY AIK + + EK + + E ++
Sbjct: 20 LREIGHGSFGAVYFA----RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 183 HVVKLYGVVSEGNPTLVIME--LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
+ ++ G + ++ME L D+ +V + P I +
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDI------------LEVHKKPLQEVEIAAICHG 123
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM------TRDIYETEYYRKGSRG 294
G+AYL + +HRD+ A N ++ + TVK+ DFG T Y
Sbjct: 124 ALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPY------- 176
Query: 295 FLPVRWMAPE---SLKDGVFTSHSDVWSYGVVLWEMA 328
WMAPE ++ +G + DVWS G+ E+A
Sbjct: 177 -----WMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
L++LG G++ V++G K L E+ A+K E + E S++K ++
Sbjct: 11 LEKLGEGTYATVFKGRSK----LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
V L+ +V ++ E + DLK Y+ C + ++ + ++ G
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG---------NIMSMHNVKIFLYQILRG 116
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYETEYYRKGSRGFLPVRWMAP 303
+AY +K +HRDL +N ++ + +K+ DFG+ R T+ Y S + + + P
Sbjct: 117 LAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY---SNEVVTLWYRPP 173
Query: 304 ES-LKDGVFTSHSDVWSYGVVLWEMAT 329
+ L +++ D+W G + +EMA+
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN----EASVMKAFDTHH 183
LG G+FG VY L D + E A+K + E ++ +N E ++K
Sbjct: 10 LGQGAFGRVY--LCYDADTGRE--LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 184 VVKLYGVVSEG-NPTLVI-MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+V+ YG + + TL I ME M GG +K+ L+S E +V R + ++
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTR---------KYTRQI 115
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RW 300
+G++YL VHRD+ N + VK+GDFG ++ + G + W
Sbjct: 116 LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
M+PE + + +D+WS G + EM T
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 47/217 (21%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN---ASER-----------EKAEFLNEA 173
LG G FG V CA++V N A ++ EK L E
Sbjct: 1 LGKGGFGEV---------------CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-EK 44
Query: 174 SVMKAFDTHHVVKL-YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
+++ ++ +V L Y S+ + LV M LM GGDLK ++ + E +E +
Sbjct: 45 EILEKVNSPFIVNLAYAFESKTHLCLV-MSLMNGGDLKYHIYNV---GERGLE-----ME 95
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE--TEYYRK 290
R++ +A++ G+ +L V+RD+ N ++ D ++ D G+ ++ + T R
Sbjct: 96 RVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
G+ G+ MAPE LK+ ++ D ++ G ++EM
Sbjct: 156 GTNGY-----MAPEILKEEPYSYPVDWFAMGCSIYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
LD+LG G++ V++G K L E+ A+K E + E S++K ++
Sbjct: 10 LDKLGEGTYATVFKGRSK----LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 185 VKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
V L+ ++ +E TLV L DLK YL +C + ++ + ++
Sbjct: 66 VTLHDIIHTERCLTLVFEYL--DSDLKQYLDNCG---------NLMSMHNVKIFMFQLLR 114
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYETEYYRKGSRGFLPVRWMA 302
G++Y +K +HRDL +N ++ + +K+ DFG+ R T+ Y S + + +
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY---SNEVVTLWYRP 171
Query: 303 PESLKDGV-FTSHSDVWSYGVVLWEMAT 329
P+ L +++ D+W G +L+EMAT
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 46/185 (24%), Positives = 88/185 (47%), Gaps = 7/185 (3%)
Query: 163 EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET 222
ER+ A +E + A D +VK + + L+IME GGDL ++ +
Sbjct: 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK------QR 159
Query: 223 DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282
E P + + ++ + + +K +HRDL + N + +K+GDFG ++
Sbjct: 160 LKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219
Query: 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
++ S ++APE + ++ +D+WS GV+L+E+ TL +P++G S +
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL-HRPFKGPSQRE 278
Query: 343 VLNWV 347
++ V
Sbjct: 279 IMQQV 283
|
Length = 478 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 121 KVTILDELGNGSFG---LVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMK 177
+ +L +G GSFG LV ++ E + S +E +V+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKE--------AVLL 52
Query: 178 AFDTHHVVKLYGVVSEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
A H + + E + L ++ME GGDL ++ R + ILQ
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE--------DTILQ 104
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI-----YETEYYRKG 291
++ G+ ++ +K+ +HRD+ ++N + + VK+GDFG R + Y Y G
Sbjct: 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--G 162
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339
+ ++P PE ++ + + SD+WS G +L+E+ TL P+Q S
Sbjct: 163 TPYYVP-----PEIWENMPYNNKSDIWSLGCILYELCTL-KHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
+G+G+ G VY K A+KV N + + + E +++ + +VVK
Sbjct: 82 IGSGAGGTVY----KVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKC 137
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
+ + V++E M GG L+ E+ ++R ++ G+AY
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEG--------THIADEQFLADVAR------QILSGIAY 183
Query: 248 LADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPE--- 304
L + VHRD+ N ++ VK+ DFG++R + +T S G + +M+PE
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG--TIAYMSPERIN 241
Query: 305 -SLKDGVFTSHS-DVWSYGVVLWE 326
L G + ++ D+WS GV + E
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
+ ELG G+ G+V++ K + A K+ + + + + E V+ ++ ++
Sbjct: 10 ISELGAGNGGVVFKVSHKPSGLIM----ARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL-QMAAEVAD 243
V YG + ME M GG L L+ E +IL +++ V
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----------QILGKVSIAVIK 114
Query: 244 GMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR-WM 301
G+ YL +K K +HRD+ N +V +K+ DFG++ + ++ + F+ R +M
Sbjct: 115 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYM 169
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMA 328
+PE L+ ++ SD+WS G+ L EMA
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMA 196
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 22/167 (13%)
Query: 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259
+ME + GGDL +++ E + + AAE++ G+ +L + ++RDL
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKE----------PQAVFYAAEISVGLFFLHRRGIIYRDLK 128
Query: 260 ARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RWMAPESLKDGVFTSHSDVW 318
N M+ + +K+ DFGM + E +R F ++APE + + D W
Sbjct: 129 LDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 319 SYGVVLWEMATLASQ-PYQGLSNEQVLNWVKGKSSNEYKVNPPISLS 364
+YGV+L+EM LA Q P+ G +++ +S E+ V+ P SLS
Sbjct: 186 AYGVLLYEM--LAGQPPFDGEDEDELF-----QSIMEHNVSYPKSLS 225
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVV 185
LG G+FG V L+++ + + A+K+ + ++ E A L E+ V++ +
Sbjct: 3 LGKGTFGKVI--LVREKATGKYY--AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
L + +ME GG+L +L R +E R AE+ +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----------DRARFYGAEIVSAL 108
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
YL V+RDL N M+ D +K+ DFG+ ++ ++APE
Sbjct: 109 GYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 166
Query: 306 LKDGVFTSHSDVWSYGVVLWEM 327
L+D + D W GVV++EM
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 42/223 (18%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF---LNEASVMKAFDTHHV 184
LG GS GLV+ S + C +VA + + L E +++ D ++
Sbjct: 13 LGCGSNGLVF--------SAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI 64
Query: 185 VKLYGVVSEGNPTL--------------VIMELMGGGDLKNYLRSCRPDAETDVERSPPT 230
VK+Y V+ L ++ E M DL N L E+ P +
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-----------EQGPLS 112
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYETEYYR 289
++ G+ Y+ +HRDL N + +DL +K+GDFG+ R I + Y
Sbjct: 113 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSH 171
Query: 290 KG--SRGFLPVRWMAPE-SLKDGVFTSHSDVWSYGVVLWEMAT 329
KG S G + + +P L +T D+W+ G + EM T
Sbjct: 172 KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF---LNEASVMKAFDTHHV 184
+ G++G V+ L K + AIKV + A K + L E ++ + +V
Sbjct: 1 ISKGAYGRVF--LAK--KKSTGDIYAIKVIKK-ADMIRKNQVDQVLTERDILSQAQSPYV 55
Query: 185 VKL-YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
VKL Y + N LV ME + GGDL + L + V ++RI AE+
Sbjct: 56 VKLYYSFQGKKNLYLV-MEYLPGGDLASLLEN--------VGSLDEDVARIY--IAEIVL 104
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR---- 299
+ YL +HRDL N ++ + +K+ DFG+++ R
Sbjct: 105 ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 300 --WMAPESLKDGVFTSHSDVWSYGVVLWE 326
++APE + + D WS G +L+E
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYE 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 51/217 (23%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
++++G G++G+VY+ ++ + E K+ + +E + + E S++K + ++
Sbjct: 5 VEKIGEGTYGVVYKA--RN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
VKL V+ N ++ E + DLK ++ + S L I ++ G
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPL--------SGIPLPLIKSYLFQLLQG 112
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF-LPVR---- 299
+A+ + +HRDL +N ++ + +K+ DFG+ +R F +PVR
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL-------------ARAFGVPVRTYTH 159
Query: 300 ------WMAPESLKDGVFTSHS-DVWSYGVVLWEMAT 329
+ APE L + S + D+WS G + EM T
Sbjct: 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 65/242 (26%), Positives = 102/242 (42%), Gaps = 44/242 (18%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHP-CAIKVA----NENASERE--KAEFLNEASVM 176
I+ +G G G VY LA P C+ +VA E+ SE K FL EA +
Sbjct: 6 IIRLIGKGGMGEVY---------LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKI- 55
Query: 177 KAFDTHH--VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRP----DAETDVERSPPT 230
A D H +V +Y + S+G+P M + G LK+ L+S E + S
Sbjct: 56 -AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE---- 286
I ++ + Y+ K +HRDL N ++ V + D+G E
Sbjct: 115 FLSIFH---KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 287 ---YYRKG---SRGFLPVR------WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
+ S +P + +MAPE L + +D+++ GV+L++M TL S P
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL-SFP 230
Query: 335 YQ 336
Y+
Sbjct: 231 YR 232
|
Length = 932 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 33/214 (15%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMK---AFDTH 182
E+G G++G VY+ +D S H A+K V + + + E +++K AFD
Sbjct: 7 EIGVGAYGTVYKA--RDPHS--GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHP 62
Query: 183 HVVKLYGVVS------EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPT---LSR 233
++V+L V + E TLV + DL+ YL ++ PP
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHV--DQDLRTYL-----------DKVPPPGLPAET 109
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
I + + G+ +L VHRDL N +V VK+ DFG+ R IY +
Sbjct: 110 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR-IY--SCQMALTP 166
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
+ + + APE L + + D+WS G + EM
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
LG G+FG V L+++ S + I ++ E A L E+ V+K + L
Sbjct: 3 LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
+ +ME + GG+L +L R +E R AE+ + Y
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSE----------DRTRFYGAEIVSALDY 110
Query: 248 LADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK 307
L K V+RDL N M+ D +K+ DFG+ ++ K G ++APE L+
Sbjct: 111 LHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG--TPEYLAPEVLE 168
Query: 308 DGVFTSHSDVWSYGVVLWEM 327
D + D W GVV++EM
Sbjct: 169 DNDYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 30/227 (13%)
Query: 108 KLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK- 166
+L+ KD E L S L E+G+GSFG VY +D R+ +E K++ EK
Sbjct: 6 ELFFKDDPEKLFSD---LREIGHGSFGAVY--FARDVRN-SEVVAIKKMSYSGKQSNEKW 59
Query: 167 AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIME--LMGGGDLKNYLRSCRPDAETDV 224
+ + E ++ + ++ G + ++ME L DL +V
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL------------LEV 107
Query: 225 ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
+ P I + G+AYL +HRD+ A N ++++ VK+GDFG +
Sbjct: 108 HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167
Query: 285 TEYYRKGSRGFLPVRWMAPE---SLKDGVFTSHSDVWSYGVVLWEMA 328
+ WMAPE ++ +G + DVWS G+ E+A
Sbjct: 168 ANXFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS--RILQMAAEVADGMAYLADKKFVHR 256
++M +M GGDL+ ++ +V+ P R A++ G+ +L ++ ++R
Sbjct: 70 LVMTIMNGGDLRYHI--------YNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR 121
Query: 257 DLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSD 316
DL N ++ +D V++ D G+ ++ + + KG G +MAPE L+ + D
Sbjct: 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG--TPGFMAPELLQGEEYDFSVD 179
Query: 317 VWSYGVVLWEM 327
++ GV L+EM
Sbjct: 180 YFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTH-HV 184
LG GSFG V +K+ L A+KV ++ + + + E ++ H +
Sbjct: 3 LGKGSFGKVMLARLKESGRLY----AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 58
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
+LY + +ME + GGDL +++ R E +R AAE+
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----------ARARFYAAEITSA 108
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RWMAP 303
+ +L DK ++RDL N ++ + K+ DFGM + E + K + F ++AP
Sbjct: 109 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAP 165
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEM 327
E L++ ++ D W+ GV+L+EM
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 26/232 (11%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--EKAEFLNEASVMKAFD 180
IL ++G G +G V+ KD + A+K ++ + E L E ++
Sbjct: 4 QILTQVGQGGYGQVFLAKKKDTGEI----VALKRMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
+ +VKL + + ME + GGD + L + V + +M
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN------LGVLSEDHARFYMAEMFEA 113
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300
V D + L ++HRDL N ++ +K+ DFG+++ I GS P +
Sbjct: 114 V-DALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGS----P-DY 164
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV----LNWVK 348
MAPE L+ + D WS G +L+E P+ G + + W +
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLC-GFPPFSGSTPNETWENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
EA +++A + +++L G + T +I+ DL YL + R A D
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICD-------- 183
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT---RDIYETEYY 288
IL + V + YL + + +HRD+ A N + V +GDFG DI +YY
Sbjct: 184 --ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ--GL-----SNE 341
G G + APE L + D+WS G+VL+EMAT ++ GL S+
Sbjct: 242 --GWAGTIATN--APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDR 297
Query: 342 QVLNWVK--GKSSNEYKVNPPISL 363
Q+ ++ G NE+ ++ +L
Sbjct: 298 QIKLIIRRSGTHPNEFPIDAQANL 321
|
Length = 391 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN----EASVMKAFDTHH 183
LG G+FG VY L D + E A+K + +E ++ +N E ++K
Sbjct: 10 LGRGAFGEVY--LCYDADTGRE--LAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 184 VVKLYGVVS--EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+V+ YG + E + +E M GG +K+ L++ E R +ILQ
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT---RQILQ----- 117
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RW 300
G++YL VHRD+ N + VK+GDFG ++ I G + W
Sbjct: 118 --GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
M+PE + + +DVWS + EM T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAF 179
K I+ ++G G++G VY+ KD L A+K V +N E + E +++
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGEL----VALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 180 DTHHVVKLYGVVSEGNPTL----------VIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
+ ++V L +V++ L ++ E M DL L S D
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSED------ 116
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR 289
I ++ +G+ Y K F+HRD+ N ++ + +K+ DFG+ R +Y +E R
Sbjct: 117 ---HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESR 172
Query: 290 KGSRGFLPVRWMAPE-SLKDGVFTSHSDVWSYGVVLWEMAT 329
+ + + + PE L + + DVWS G +L E+ T
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMK---AFDTHH 183
E+G G++G V++ +D ++ +V + E + E +V++ F+ +
Sbjct: 8 EIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 184 VVKLYGVVS------EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
VV+L+ V + E TLV + DL YL P+ P I M
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHV--DQDLTTYLDKV-PEPGV-----PT--ETIKDM 115
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
++ G+ +L + VHRDL +N +V +K+ DFG+ R IY ++ +
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYS---FQMALTSVVV 171
Query: 298 VRWM-APESLKDGVFTSHSDVWSYGVVLWEM 327
W APE L + + D+WS G + EM
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK--AEFLNEASVMKAFDT 181
++ +G G+FG V+ L++D + A+KV ++ + A E ++ D+
Sbjct: 5 VIKVIGRGAFGEVW--LVRDKDT--GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+VKLY + ++ME M GGDL N L + P +R AE+
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL--------IRKDVFPEETARFY--IAEL 110
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI---YETEYYRKGSRGFL-- 296
+ + F+HRD+ N ++ D +K+ DFG+ + + + EYY S L
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 297 -------------PVR---------WMAPESLKDGVFTSHSDVWSYGVVLWEM 327
VR ++APE L+ + D WS GV+L+EM
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDTHH 183
++++G G++G+VY+ +D + A+K + E E + + E S++K + +
Sbjct: 4 VEKIGEGTYGVVYKA--RDKLT--GEIVALKKIRLETEDEGVPSTAIREISLLKELNHPN 59
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+V+L VV N ++ E + DLK Y+ S P D L ++LQ
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSS-PLTGLDPPLIKSYLYQLLQ------- 110
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF-LPVR--- 299
G+AY + +HRDL +N ++ + +K+ DFG+ +R F +PVR
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL-------------ARAFGVPVRTYT 157
Query: 300 ------WM-APESLKDGVFTSHS-DVWSYGVVLWEMAT 329
W APE L S D+WS G + EM
Sbjct: 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 60/248 (24%), Positives = 100/248 (40%), Gaps = 36/248 (14%)
Query: 87 PTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS 146
P+T G+ P + +L+ K+ E L + L E+G+GSFG VY +D R+
Sbjct: 1 PSTSRAGSLKDP------EIAELFFKEDPEKLFTD---LREIGHGSFGAVY--FARDVRT 49
Query: 147 LAEHPCAIKVANENASEREK-AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIME--L 203
E K++ EK + + E ++ + ++ G + ++ME L
Sbjct: 50 -NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108
Query: 204 MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNC 263
DL +V + P I + G+AYL +HRD+ A N
Sbjct: 109 GSASDL------------LEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 156
Query: 264 MVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPE---SLKDGVFTSHSDVWSY 320
++ + VK+ DFG + WMAPE ++ +G + DVWS
Sbjct: 157 LLTEPGQVKLADFGSASIASPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSL 210
Query: 321 GVVLWEMA 328
G+ E+A
Sbjct: 211 GITCIELA 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDT 181
++ ELG G++G+V ++ + E AIK + N + + L E +++ F
Sbjct: 3 ELIKELGQGAYGIVCS--ARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 182 H-HVVKLYG--VVSEG--NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
H ++ LY +V G N + ELM DL +RS +P + + S I Q
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQ------SFIYQ 113
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGS-RGF 295
+ G+ Y+ +HRDL N +V D +K+ DFG+ R E G +
Sbjct: 114 ILC----GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 296 LPVRWM-APE-SLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
+ RW APE L +T DVWS G +L E+ L +P
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL--LGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259
+ME + GGDL ++ E + AAE+A G+ +L K ++RDL
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKE----------PHAVFYAAEIAIGLFFLHSKGIIYRDLK 128
Query: 260 ARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RWMAPESLKDGVFTSHSDVW 318
N M+ + +K+ DFGM + E + ++ F ++APE + + D W
Sbjct: 129 LDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 319 SYGVVLWEMATLASQ-PYQGLSNEQVLNWVKGKSSNEYKVNPPISLS 364
++GV+L+EM LA Q P++G +++ +S E+ V P S+S
Sbjct: 186 AFGVLLYEM--LAGQAPFEGEDEDELF-----QSIMEHNVAYPKSMS 225
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 25/228 (10%)
Query: 104 GDDDKLYKKD--SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA 161
K D SW++ S + + LG GSFG V I + E+ AIK +
Sbjct: 2 KAAYMFTKPDTSSWKL--SDFEMGETLGTGSFGRVR---IAKHKGTGEY-YAIKCLKKRE 55
Query: 162 SEREKA--EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPD 219
+ K E S++ +V + + N ++E + GG+L +LR
Sbjct: 56 ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK---- 111
Query: 220 AETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279
R P +++ AE+ YL K ++RDL N ++ + VKV DFG
Sbjct: 112 ----AGRFPNDVAKF--YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA 165
Query: 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
+ + + + G+ +L APE ++ D W+ GV+L+E
Sbjct: 166 KKVPDRTFTLCGTPEYL-----APEVIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 43/228 (18%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVM 176
+ S+ ++ +G+G++G+V + + + AIK + + L E ++
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAI----DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKIL 58
Query: 177 KAFDTHHVVKLYGV----VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
+ F +++ + + ++ V+M+LM DL + + S +P E + L
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRY---FLY 114
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI---------Y 283
++L+ G+ Y+ +HRDL N +V +D +++GDFGM R + +
Sbjct: 115 QLLR-------GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
Query: 284 ETEYYRKGSRGFLPVRWM-APE---SLKDGVFTSHSDVWSYGVVLWEM 327
TEY + RW APE SL + +T+ D+WS G + EM
Sbjct: 168 MTEY--------VATRWYRAPELLLSLPE--YTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 56/233 (24%), Positives = 101/233 (43%), Gaps = 40/233 (17%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
L++LG GS+ VY+G+ + + A+KV + E + EAS++K ++
Sbjct: 10 LEKLGEGSYATVYKGISR----INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS--RILQMAAEVA 242
V L+ ++ + E M DL Y+ + P L + ++
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHT-DLAQYM-----------IQHPGGLHPYNVRLFMFQLL 113
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR------DIYETEYYRKGSRGFL 296
G+AY+ + +HRDL +N +++ +K+ DFG+ R Y +E +
Sbjct: 114 RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE---------V 164
Query: 297 PVRWMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQP-YQGLSN--EQVL 344
W P + G ++S D+W G + EM L QP + G+S+ EQ+
Sbjct: 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEM--LQGQPAFPGVSDVFEQLE 215
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 41/258 (15%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL 170
K D E ++ ++ ++GNG FG V+ L+K R+ E C ++ EREK++ +
Sbjct: 4 KYDDGESRLNEYEVIKKIGNGRFGEVF--LVKHKRT-QEFFCWKAISYRGLKEREKSQLV 60
Query: 171 NEASVMKAFDTHHVVKLYG-VVSEGNPTL-VIMELMGGGDLKNYLRSC-------RPDAE 221
E +VM+ ++V+ +++ N L ++ME GDL ++ C A
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 222 TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV-------------ADD 268
D+ R L L + DG ++ +HRDL +N + A++
Sbjct: 121 VDITRQ---LLHALAYCHNLKDGP---NGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 269 LT----VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL--KDGVFTSHSDVWSYGV 322
L K+GDFG++++I E G P W +PE L + + SD+W+ G
Sbjct: 175 LNGRPIAKIGDFGLSKNI-GIESMAHSCVG-TPYYW-SPELLLHETKSYDDKSDMWALGC 231
Query: 323 VLWEMATLASQPYQGLSN 340
+++E+ + P+ +N
Sbjct: 232 IIYELCS-GKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 29/221 (13%)
Query: 124 ILDELGNGSFGLVYRGL-IKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
IL +LG G+FG VY+ IK R +A K+ N + L E ++K
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALK----KILMHNEKDGFPITALREIKILKKLKHP 67
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDV------ERSPPTLSRILQ 236
+VV L + + + + P + D+ T S+I
Sbjct: 68 NVVPL--------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC 119
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK-----G 291
++ +G+ YL + +HRD+ A N ++ + +K+ DFG+ R K G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 292 SRGFLPV---RWM-APE-SLKDGVFTSHSDVWSYGVVLWEM 327
+R + + RW PE L + +T+ D+W G V EM
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 51/223 (22%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
LD+LG GS+ VY+G K L A+K E + EAS++K ++
Sbjct: 10 LDKLGEGSYATVYKGRSK----LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 185 VKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA---- 239
V L+ ++ ++ TLV E + DLK Y+ C L M
Sbjct: 66 VTLHDIIHTKKTLTLV-FEYLDT-DLKQYMDDC---------------GGGLSMHNVRLF 108
Query: 240 --EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR------DIYETE----Y 287
++ G+AY ++ +HRDL +N ++++ +K+ DFG+ R Y E +
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW 168
Query: 288 YRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMAT 329
YR P+ L +++ D+W G + +EMAT
Sbjct: 169 YR------------PPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 45/199 (22%), Positives = 92/199 (46%), Gaps = 33/199 (16%)
Query: 169 FLNEASVMKAFDTHHVVKLYGV---VSEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDV 224
NE ++ D+++++K+YG + + P L +I+E G L+ L D E D+
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKEKDL 119
Query: 225 ERSPPTLSRILQMAAEVADGMA--YLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282
+ L MA + G+ Y K +++L + + +V ++ +K+ G+
Sbjct: 120 -----SFKTKLDMAIDCCKGLYNLYKYTNK-PYKNLTSVSFLVTENYKLKIICHGL---- 169
Query: 283 YETEYYRKGSRGFLPVRWMA---PESLKDGVFTSH---SDVWSYGVVLWEMATLASQPYQ 336
S F V +M + L D +F+ + D++S GVVLWE+ T P++
Sbjct: 170 ----EKILSSPPFKNVNFMVYFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFT-GKIPFE 223
Query: 337 GLSNEQVLNWVKGKSSNEY 355
L+ +++ + + K+++
Sbjct: 224 NLTTKEIYDLIINKNNSLK 242
|
Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH--VV 185
LG G+FG V L+++ + + I ++ E A + E+ V++ +T H +
Sbjct: 3 LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ--NTRHPFLT 58
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
L + +ME GG+L +L R E R AE+ +
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----------ERARFYGAEIVSAL 108
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
YL + V+RD+ N M+ D +K+ DFG+ ++ K G ++APE
Sbjct: 109 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG--TPEYLAPEV 166
Query: 306 LKDGVFTSHSDVWSYGVVLWEM 327
L+D + D W GVV++EM
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 107 DKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK 166
D K + +EV++ +G G+FG V L++ + + + E +
Sbjct: 37 DLRMKAEDYEVVKV-------IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDS 87
Query: 167 AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVER 226
A F E +M ++ VV+L+ + ++ME M GGDL N + + DV
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM------SNYDV-- 139
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
P +R AEV + + F+HRD+ N ++ +K+ DFG + +
Sbjct: 140 -PEKWARF--YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196
Query: 287 YYRKGSRGFLPVRWMAPESLK----DGVFTSHSDVWSYGVVLWEM 327
R + P +++PE LK DG + D WS GV L+EM
Sbjct: 197 MVRCDTAVGTP-DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 105 DDDKLY--KKDSWEVLRS-KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA 161
DDD L K+ + EV+ S T++ L GS G V+ + P +K+
Sbjct: 48 DDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT----KPGQPDPVVLKIG---- 99
Query: 162 SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAE 221
+K L EA +++ + V+++ + G T +++ DL YL
Sbjct: 100 ---QKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTK------ 149
Query: 222 TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR- 280
P + + L + ++ +G+ YL ++ +HRD+ N + D V +GD G +
Sbjct: 150 ---RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206
Query: 281 DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
+ + G G V APE L + S +D+WS G+VL+EM
Sbjct: 207 PVVAPAFL--GLAG--TVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH 183
++ +G G+FG V L++ S + + E + A F E +M ++
Sbjct: 47 VVKVIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
VV+L+ + ++ME M GGDL N + + DV P ++ AEV
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLM------SNYDV---PEKWAKF--YTAEVVL 153
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAP 303
+ + +HRD+ N ++ +K+ DFG + ET R + P +++P
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP-DYISP 212
Query: 304 ESLK----DGVFTSHSDVWSYGVVLWEM 327
E LK DG + D WS GV L+EM
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 37/231 (16%)
Query: 107 DKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK 166
D YK D E+ L E+G+GSFG VY F + + + V + S ++
Sbjct: 12 DLFYKDDPEEIFVG----LHEIGHGSFGAVY------FATNSHTNEVVAVKKMSYSGKQT 61
Query: 167 AE----FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIME--LMGGGDLKNYLRSCRPDA 220
E + E ++ + ++ G + + ++ME L DL
Sbjct: 62 NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDL----------- 110
Query: 221 ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280
+V + P I + G+AYL +HRD+ A N ++ + VK+ DFG
Sbjct: 111 -LEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS 169
Query: 281 DIYETEYYRKGSRGFLPVRWMAPE---SLKDGVFTSHSDVWSYGVVLWEMA 328
+ WMAPE ++ +G + DVWS G+ E+A
Sbjct: 170 KSSPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 31/241 (12%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASV-MKAFDT 181
+++ELG G++G+V + ++ A+K + +E+ L + + M++ D
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIM----AVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+ V YG + + ME+M K Y + L +I A +
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTI----PEDILGKI---AVSI 112
Query: 242 ADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFG----MTRDIYETEYYRKGSRGFL 296
+ YL K +HRD+ N ++ + VK+ DFG + + +T G + +
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI--DAGCKPY- 169
Query: 297 PVRWMAPE----SLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN--EQVLNWVKGK 350
MAPE L + SDVWS G+ + E+AT PY +Q+ V+
Sbjct: 170 ----MAPERINPELNQKGYDVKSDVWSLGITMIELATGR-FPYDSWKTPFQQLKQVVEEP 224
Query: 351 S 351
S
Sbjct: 225 S 225
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVV 185
LG G+FG V L+K+ A+K+ + ++ E A L E V++ +
Sbjct: 3 LGKGTFGKVI--LVKE--KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
L + +ME GG+L +L R +E R AE+ +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----------DRARFYGAEIVSAL 108
Query: 246 AYL-ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPE 304
YL ++K V+RDL N M+ D +K+ DFG+ ++ + K G ++APE
Sbjct: 109 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG--TPEYLAPE 166
Query: 305 SLKDGVFTSHSDVWSYGVVLWEM 327
L+D + D W GVV++EM
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 54/238 (22%), Positives = 89/238 (37%), Gaps = 69/238 (28%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE-FLNEASVMKAFDT 181
+L +G+G++G+V + K AIK + + A+ L E +++
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKR----TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 182 HHVVKLYGV-VSEGNPTL----VIMELMGGGDLKNYLRSCRPDAETD---VERSPPTLSR 233
+++ L + ++ ELM ETD V +SP L+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM----------------ETDLHKVIKSPQPLTD 102
Query: 234 ------ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE--- 284
+ Q+ G+ YL +HRDL N +V + +K+ DFG+ R +
Sbjct: 103 DHIQYFLYQILR----GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 285 -----TEY-----YRKGSRGFLPVRWMAPE---SLKDGVFTSHSDVWSYGVVLWEMAT 329
TEY YR APE S +T D+WS G + E+ T
Sbjct: 159 EKGFLTEYVVTRWYR------------APELLLSSSR--YTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 28/209 (13%)
Query: 150 HPCAIKVANENASEREK--AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV--IMELMG 205
H AIK+ +A E E A F E ++ ++V L E P L+ + E +
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDS-GEAPPGLLFAVFEYVP 62
Query: 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265
G R+ R D R++ +V D +A ++ VHRDL +N MV
Sbjct: 63 G-------RTLREVLAADGALPAGETGRLM---LQVLDALACAHNQGIVHRDLKPQNIMV 112
Query: 266 A---DDLTVKVGDFGM------TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSD 316
+ KV DFG+ RD R P + APE L+ T +SD
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTP-TYCAPEQLRGEPVTPNSD 171
Query: 317 VWSYGVVLWEMATLASQP-YQGLSNEQVL 344
++++G++ E L Q QG S ++L
Sbjct: 172 LYAWGLIFLE--CLTGQRVVQGASVAEIL 198
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 23/223 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA--EFLNEASVMKAFDTHHVV 185
LG GSFG R ++ +++ P AIK ++ ++K +E ++ + V
Sbjct: 38 LGTGSFG---RVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
LYG + + +++E + GG+ +LR + R P + AA++
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--------RFPNDVGCF--YAAQIVLIF 144
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
YL V+RDL N ++ D +K+ DFG + + Y G+ ++APE
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTP-----EYIAPEI 199
Query: 306 LKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
L + +D W+ G+ ++E+ + P+ +NE +L + K
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEI-LVGCPPF--YANEPLLIYQK 239
|
Length = 340 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 69/281 (24%), Positives = 107/281 (38%), Gaps = 76/281 (27%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK------VANENASEREKAE--FLN 171
S + +G G+FG V D +L A+K V N + KAE L
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALY----AMKTLRKADVLMRNQAAHVKAERDILA 56
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
EA D VVKLY + + +M+ + GGD+ + L + L
Sbjct: 57 EA------DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL--------IRLGIFEEDL 102
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT---RDIYETEYY 288
+R AE+ + + F+HRD+ N ++ D +K+ DFG+ R ++++YY
Sbjct: 103 ARF--YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 289 RKGSRG--------------------FLPVR------------------WMAPESLKDGV 310
+KG L R ++APE L
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220
Query: 311 FTSHSDVWSYGVVLWEMATLASQP-----YQGLSNEQVLNW 346
+T D WS GV+L+EM L QP + +V+NW
Sbjct: 221 YTQLCDWWSVGVILYEM--LVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVM-KAFDTHHV 184
+G GSFG V L K A+KV + A ++E+ + E +V+ K +
Sbjct: 3 IGKGSFGKVL--LAK--HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
V L+ + +++ + GG+L +L+ ERS P R AAE+A
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQR---------ERSFPE-PRARFYAAEIASA 108
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RWMAP 303
+ YL ++RDL N ++ V + DFG+ ++ E K + F ++AP
Sbjct: 109 LGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---KTTSTFCGTPEYLAP 165
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEM 327
E L+ + D W G VL+EM
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 40/219 (18%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
++++G G++G+VY+ +D R E K+ E E + + E S++K ++
Sbjct: 7 VEKIGEGTYGVVYKA--RD-RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
V+L VV ++ E + DLK ++ S PD + L +IL+ G
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILR-------G 114
Query: 245 MAYLADKKFVHRDLAARNCMVADDLT--VKVGDFGMTRDIYETEYYRKGSRGF-LPVR-- 299
+AY + +HRDL +N ++ D T +K+ DFG+ +R F +PVR
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLI-DRRTNALKLADFGL-------------ARAFGIPVRTF 160
Query: 300 --------WMAPESLKDG-VFTSHSDVWSYGVVLWEMAT 329
+ APE L +++ D+WS G + EM
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 128 LGNGSFGLV-YRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDTHHVV 185
LG+G+ G V + D P A+KV + E SE +K E + D +V
Sbjct: 40 LGSGATGTVLCAKRVSD-----GEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIV 94
Query: 186 KL---YGVVSEGNPTLVIMELM-----GGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
K + NP V+M + GDL+ ++S T E L +Q+
Sbjct: 95 KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLL--FIQV 152
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
V ++ K +HRD+ + N ++ + VK+GDFG ++ +Y R F
Sbjct: 153 LLAVH----HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDDVGRTFCG 207
Query: 298 V-RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
++APE + ++ +D++S GV+L+E+ TL +P+ G + E+V++
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL-KRPFDGENMEEVMH 255
|
Length = 496 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 73/289 (25%), Positives = 111/289 (38%), Gaps = 73/289 (25%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIK--VANENASEREKAEFLNEASVMKAFDTHHVV 185
LG G+FG V D +L K V N N KAE ++ D VV
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAE----RDILAEADNEWVV 64
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
KLY + + +M+ + GGD+ + L +E P L+R AE+ +
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLL--------IRMEVFPEVLARF--YIAELTLAI 114
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT---RDIYETEYYRKGSR--------- 293
+ F+HRD+ N ++ D +K+ DFG+ R + ++YY+KGS
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 294 ---------------GFLPVR------------------WMAPESLKDGVFTSHSDVWSY 320
L R ++APE L +T D WS
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 321 GVVLWEMAT-----LASQPYQGLSNEQVLNWVKGKSSNEYKVNPPISLS 364
GV+L+EM LA P + + +V+NW N + P + LS
Sbjct: 235 GVILFEMLVGQPPFLAPTPTE--TQLKVINW-----ENTLHIPPQVKLS 276
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 54/231 (23%), Positives = 88/231 (38%), Gaps = 47/231 (20%)
Query: 128 LGNGSFGLVYRGL---------IKDFRSLAEHPCAIKVANENASEREKAE-------FLN 171
LG G++G V + IK + I+++N+ +R+ L
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVK-------IIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
E +M +++ L V EG+ ++M++M DLK + E+ V+ L
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVK---CIL 125
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
+IL G+ L F+HRDL+ N + K+ DFG+ R Y
Sbjct: 126 LQILN-------GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 292 SRGFLPVR-----------WM-APESLKDG-VFTSHSDVWSYGVVLWEMAT 329
S+ R W APE L + D+WS G + E+ T
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 51/224 (22%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK--VANENASEREKAEF--LNEASVMKA 178
+LG G++ +VY+ K AIK E ++ F L E +++
Sbjct: 3 EKGKKLGEGTYAVVYKARDK----ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE 58
Query: 179 FDTHHVVKLYGV-VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
+++ L V + N LV E M DL+ ++ + +P + + M
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLV-FEFMET-DLEKVIKD------KSIVLTPADIKSYMLM 110
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE----------TEY 287
G+ YL +HRDL N ++A D +K+ DFG+ R T +
Sbjct: 111 TLR---GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW 167
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHS-----DVWSYGVVLWE 326
YR APE L F + D+WS G + E
Sbjct: 168 YR------------APELL----FGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 43/177 (24%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
F AS+M H+ ++GV G+ +++ E + G L LR E+
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---------EKGR 113
Query: 229 PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA----DDLT---VKVGDFGMTRD 281
++ + +A ++A ++YL DK VH ++ A+N ++A + T +K+ D G++
Sbjct: 114 VPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT 173
Query: 282 IYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQG 337
E + R + W+APE + G ++ +D WS+G L E+ P +
Sbjct: 174 ALSRE--ERVER----IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 7e-08
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 42/227 (18%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL 170
K DS+E L ++LG GS+ VY+G K L A+KV E +
Sbjct: 3 KADSYEKL-------EKLGEGSYATVYKGKSKVNGKLV----ALKVIRLQEEEGTPFTAI 51
Query: 171 NEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPT 230
EAS++K ++V L+ ++ ++ E + DL Y+ ++ P
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYM-----------DKHPGG 99
Query: 231 L--SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR------DI 282
L + ++ G++Y+ + +HRDL +N +++D +K+ DFG+ R
Sbjct: 100 LHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159
Query: 283 YETEYYRKGSRGFLPVRWMAPESLKDGV--FTSHSDVWSYGVVLWEM 327
Y E + W P + G +++ D+W G + EM
Sbjct: 160 YSNE---------VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPC-----AIKVANENA--SEREKAEFLNEASVM-KAF 179
+G GSFG V LA+ A+KV + ++E+ + E +V+ K
Sbjct: 3 IGKGSFGKVL---------LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL 53
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+V L+ +++ + GG+L +L+ R E R AA
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE----------PRARFYAA 103
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299
EVA + YL ++RDL N ++ V + DFG+ ++ E E G
Sbjct: 104 EVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG--TPE 161
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEM 327
++APE L+ + D W G VL+EM
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMKAFDT 181
IL +G G+FG V +K+ A+ A+K+ N E E A F E V+ D
Sbjct: 5 ILKVIGRGAFGEVAVVKLKN----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+ L+ + N ++M+ GGDL L +R P ++R AE+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-------DRLPEDMARF--YLAEM 111
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
+ + +VHRD+ N ++ + +++ DFG + E + P ++
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP-DYI 170
Query: 302 APESLK-----DGVFTSHSDVWSYGVVLWEM 327
+PE L+ G + D WS GV ++EM
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 44/225 (19%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDTHH 183
L+ +G G++G+VYR +D S A+K V +N + L E +++ +
Sbjct: 12 LNRIGEGTYGIVYRA--RDTTS--GEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 184 VVKLYGVVSEGNPTLVIMELMG--GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+V+L VV G I +M DL + L D +P + S++ + ++
Sbjct: 68 IVELKEVVV-GKHLDSIFLVMEYCEQDLASLL---------DNMPTPFSESQVKCLMLQL 117
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE-----------TEYYRK 290
G+ YL + +HRDL N ++ D +K+ DFG+ R Y T +YR
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPKVVTLWYR- 175
Query: 291 GSRGFLPVRWMAPESL-KDGVFTSHSDVWSYGVVLWEMATLASQP 334
APE L +T+ D+W+ G +L E+ LA +P
Sbjct: 176 -----------APELLLGCTTYTTAIDMWAVGCILAEL--LAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVM-KAFDTHHV 184
+G GSFG V L K R L A+KV + + +E+ + E +V+ K +
Sbjct: 3 IGKGSFGKVL--LAK--RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL 58
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
V L+ +++ + GG+L +L+ ERS P R AAE+A
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQR---------ERSFPE-PRARFYAAEIASA 108
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD---IYETEYYRKGSRGFLPVRWM 301
+ YL V+RDL N ++ V + DFG+ ++ +T G+ +L
Sbjct: 109 LGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYL----- 163
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEM 327
APE ++ + + D W G VL+EM
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 46/216 (21%)
Query: 131 GSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF----LNEASVMKAFDTHHVVK 186
G++G+VYR K + A+K + E+EK F L E +++ ++V
Sbjct: 16 GTYGVVYRARDKKTGEI----VALK---KLKMEKEKEGFPITSLREINILLKLQHPNIVT 68
Query: 187 LYGVV--SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
+ VV S + ++ME + DLK+ + + + P S + + ++ G
Sbjct: 69 VKEVVVGSNLDKIYMVMEYVEH-DLKSLM---------ETMKQPFLQSEVKCLMLQLLSG 118
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE----------TEYYRKGSRG 294
+A+L D +HRDL N ++ + +K+ DFG+ R+ T +YR
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR----- 173
Query: 295 FLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMAT 329
APE L +++ D+WS G + E+ T
Sbjct: 174 -------APELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN---ENASEREKAEFLNEASVMKAFDT 181
L +G+G+ G+V + ++ E AIK + +N + ++A E +MK +
Sbjct: 29 LKPIGSGAQGIVCAA----YDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVNH 82
Query: 182 HHVVKLYGV------VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
+++ L V + E ++MELM +L ++ E D ER L ++L
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQML 136
Query: 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI---------YETE 286
G+ +L +HRDL N +V D T+K+ DFG+ R T
Sbjct: 137 C-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
YYR APE + + + D+WS G ++ EM
Sbjct: 190 YYR------------APEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFL 170
K WEV + L ++G+G++G V L D R+ A+ AIK + SE
Sbjct: 8 KTIWEV-PDRYRDLKQVGSGAYGTVCSAL--DRRTGAK--VAIKKLYRPFQSELFAKRAY 62
Query: 171 NEASVMKAFDTHHVVKLYGVVS------EGNPTLVIMELMGGGDLKNYLRSCRPDAETDV 224
E ++K +V+ L V + + ++M MG DL ++ + +
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSED--- 118
Query: 225 ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
RI + ++ G+ Y+ +HRDL N V +D +K+ DFG+ R +
Sbjct: 119 --------RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT-D 169
Query: 285 TEYYRKGSRGFLPVRWM-APESLKDGV-FTSHSDVWSYGVVLWEMAT 329
+E G++ RW APE + + + +T D+WS G ++ EM T
Sbjct: 170 SEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 59/263 (22%), Positives = 109/263 (41%), Gaps = 34/263 (12%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAF-DTH 182
L+++G G++G VY+ K+ L A+K E E L E S+++ ++
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLV----ALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 183 HVVKLYGVV----SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
++V+L V G P+L ++ DLK ++ S + T+ +
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLP--AKTIKSFM--- 116
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTV-KVGDFGMTRDIYETEYYRKGSRGFLP 297
++ G+A+ +HRDL +N +V + K+ D G+ R + + + +
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--SIPVKSYTHEIVT 174
Query: 298 VRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLA------SQPYQ--------GLSNEQ 342
+ + APE L +++ D+WS G + EM+ S+ Q G EQ
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234
Query: 343 VLNWVKG-KSSNEYKVNPPISLS 364
V V + +E+ P LS
Sbjct: 235 VWPGVSKLRDWHEFPQWKPQDLS 257
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVM-KAFDTHHV 184
+G GSFG V L+ ++ E A+KV + A ++E+ ++E +V+ K +
Sbjct: 3 IGKGSFGKV---LLARHKA-EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
V L+ + +++ + GG+L +L+ R E R AAE+A
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE----------PRARFYAAEIASA 108
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPE 304
+ YL V+RDL N ++ + + DFG+ ++ E G ++APE
Sbjct: 109 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG--TPEYLAPE 166
Query: 305 SLKDGVFTSHSDVWSYGVVLWEM 327
L + D W G VL+EM
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 48/230 (20%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH 183
+L LG G++G V+ L++ KV +A + + L +A++++ T
Sbjct: 4 LLRVLGTGAYGKVF--LVR------------KVGGHDAGKLYAMKVLKKATIVQKAKTAE 49
Query: 184 VVKLYGVVSE---GNPTLV--------------IMELMGGGDLKNYLRSCRPDAETDVER 226
+ V E P LV I++ + GG+L +L R
Sbjct: 50 HTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----------R 99
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
T S + AE+ + +L ++RD+ N ++ + V + DFG++++ E
Sbjct: 100 EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159
Query: 287 YYRKGSRGFL-PVRWMAPESLKDGVFTSHSDV---WSYGVVLWEMATLAS 332
R S F + +MAPE ++ G H WS GV+ +E+ T AS
Sbjct: 160 EERAYS--FCGTIEYMAPEVIRGGS-GGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 17/130 (13%)
Query: 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259
I++LM GGDL +L +E ++ AAE+ G+ ++ ++ V+RDL
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRF----------YAAEIILGLEHMHNRFVVYRDLK 124
Query: 260 ARNCMVADDLTVKVGDFGMTRDIYETEYYRK-GSRGFLPVRWMAPESLKDGV-FTSHSDV 317
N ++ + V++ D G+ D + + + G+ G+ MAPE L+ GV + S +D
Sbjct: 125 PANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGY-----MAPEVLQKGVAYDSSADW 179
Query: 318 WSYGVVLWEM 327
+S G +L+++
Sbjct: 180 FSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 26/166 (15%)
Query: 172 EASVMKAFDTHHVVKLYGVVS------EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVE 225
E ++K +V+ L V + E N ++ LMG DL N ++ C+ + V+
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-CQKLTDDHVQ 123
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
+ ++ G+ Y+ +HRDL N V +D +K+ DFG+ R +
Sbjct: 124 F----------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173
Query: 286 EYYRKGSRGFLPVRWM-APESLKDGV-FTSHSDVWSYGVVLWEMAT 329
G++ RW APE + + + + D+WS G ++ E+ T
Sbjct: 174 ------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 7e-07
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 125 LDELGNGSFGLV---YRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT 181
L +G+G+ G+V Y ++ R++A + N+ ++R E + +MK +
Sbjct: 22 LKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNH 75
Query: 182 HHVVKLYGV------VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
+++ L V + E ++MELM +L ++ E D ER L ++L
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQML 129
Query: 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI---------YETE 286
G+ +L +HRDL N +V D T+K+ DFG+ R T
Sbjct: 130 C-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
YYR APE + + + D+WS G ++ EM
Sbjct: 183 YYR------------APEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMKAFDTHHVV 185
+G G+FG V L++ S + A+K+ + E + A F E +M ++ +V
Sbjct: 51 IGRGAFGEVQ--LVRHKSSKQVY--AMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIV 106
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
+L+ + ++ME M GGDL N + + D+ P +R AEV +
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMSN------YDI---PEKWARF--YTAEVVLAL 155
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPES 305
+ F+HRD+ N ++ +K+ DFG + R + P +++PE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTP-DYISPEV 214
Query: 306 LK----DGVFTSHSDVWSYGVVLWEM 327
LK DG + D WS GV L+EM
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 2/102 (1%)
Query: 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNE 172
+WE+ R + + LG+G+FG V S + A+K+ A EK ++E
Sbjct: 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSE 90
Query: 173 ASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYL 213
+M H ++V L G ++G P +I E GDL +YL
Sbjct: 91 LKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 16/146 (10%)
Query: 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259
+ME + GGDL ++ R E R AAEV + +L ++RDL
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDE----------PRSRFYAAEVTLALMFLHRHGVIYRDLK 123
Query: 260 ARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV-RWMAPESLKDGVFTSHSDVW 318
N ++ + K+ DFGM + E + F ++APE L++ + D W
Sbjct: 124 LDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180
Query: 319 SYGVVLWEMATLASQPYQGLSNEQVL 344
+ GV+++EM +A QP NE L
Sbjct: 181 ALGVLMYEM--MAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL--NEA---SVMKAFDTH 182
+G G FG VY D + A+K ++ + ++ E L NE S++ D
Sbjct: 2 IGRGGFGEVYGCRKADTGKMY----AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+V + + I++LM GGDL +L +E ++ A E+
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF----------YATEII 107
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK-GSRGFLPVRWM 301
G+ ++ ++ V+RDL N ++ + V++ D G+ D + + + G+ G+ M
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGY-----M 162
Query: 302 APESLKDGV-FTSHSDVWSYGVVLWEM 327
APE L+ G + S +D +S G +L+++
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 33/105 (31%), Positives = 47/105 (44%), Gaps = 2/105 (1%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEA 173
WE R + + LG+G+FG V G RS A+K+ A EK ++E
Sbjct: 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSEL 91
Query: 174 SVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCR 217
+M H ++V L G ++ P +I E GDL NYL R
Sbjct: 92 KIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNR 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 31/96 (32%), Positives = 42/96 (43%), Gaps = 22/96 (22%)
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV------ 298
+ Y+ +HRDL N ++ D VK+ DFG+ R + E E + PV
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN-----PVLTDYVA 174
Query: 299 -RWM-APESLKDGVFTSHS-----DVWSYGVVLWEM 327
RW APE L S D+WS G +L EM
Sbjct: 175 TRWYRAPEIL----LGSTRYTKGVDMWSVGCILGEM 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 46/220 (20%), Positives = 85/220 (38%), Gaps = 35/220 (15%)
Query: 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL---NEA 173
V+R + IL L GS G V+ + +K + + + L +
Sbjct: 89 VVRMQYNILSSLTPGSEGEVF--VCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHR 146
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP-TLS 232
+++ + + V M + + D T V+RS P L
Sbjct: 147 AIINLIHAYR-----------WKSTVCM----------VMPKYKCDLFTYVDRSGPLPLE 185
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG----MTRDIYETEYY 288
+ + + + + +AYL + +HRD+ N + + +GDFG + + Y
Sbjct: 186 QAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMA 328
G G L +PE L + + +D+WS G+VL+EM+
Sbjct: 246 --GWSGTLETN--SPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMKAFDT 181
I+ +G G+FG V +K E A+K+ N E E A F E +V+ D
Sbjct: 5 IIKVIGRGAFGEVAVVKMKH----TERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+ L+ + N ++M+ GGDL L +R P ++R AE+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE-------DRLPEDMARF--YIAEM 111
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
+ + +VHRD+ N ++ + +++ DFG + + + P ++
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP-DYI 170
Query: 302 APE---SLKDGV--FTSHSDVWSYGVVLWEM 327
+PE +++DG+ + D WS GV ++EM
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 50/226 (22%), Positives = 88/226 (38%), Gaps = 47/226 (20%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK---VANENASEREKAEFLNEASVMK 177
K +L +G G++G+V + K + AIK + ++ ++ A L E V++
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIV----AIKKFKESEDDEDVKKTA--LREVKVLR 55
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR---- 233
++V L ++ E + + L +E SP L
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVE----RTLLE--------LLEASPGGLPPDAVR 103
Query: 234 --ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE------T 285
I Q+ +AY +HRD+ N +V++ +K+ DFG R + T
Sbjct: 104 SYIWQLL----QAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159
Query: 286 EYYRKGSRGFLPVRWM-APESL-KDGVFTSHSDVWSYGVVLWEMAT 329
+Y + RW APE L D + DVW+ G ++ E+
Sbjct: 160 DY--------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 58/244 (23%), Positives = 99/244 (40%), Gaps = 56/244 (22%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-----VANENASEREKAEFLNEASVMKAF 179
L +G+G+ G+V F ++ A+K N+ ++R E + ++K
Sbjct: 26 LKPIGSGAQGIVCAA----FDTVLGINVAVKKLSRPFQNQTHAKRAYRELV----LLKCV 77
Query: 180 DTHHVVKLYGV------VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
+ +++ L V + E ++MELM +L + E D ER L +
Sbjct: 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQ 131
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE--------- 284
+L G+ +L +HRDL N +V D T+K+ DFG+ R
Sbjct: 132 MLC-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV 184
Query: 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
T YYR APE + + + D+WS G ++ E+ S +QG + +
Sbjct: 185 TRYYR------------APEVILGMGYKENVDIWSVGCIMGELVK-GSVIFQG--TDHID 229
Query: 345 NWVK 348
W K
Sbjct: 230 QWNK 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 58/276 (21%), Positives = 105/276 (38%), Gaps = 40/276 (14%)
Query: 75 GGPAVTTTTVATPT-----TPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELG 129
GP+ + A+ P P Q DD+ + ++D+L
Sbjct: 107 DGPSGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFL---------AHFRVIDDLP 157
Query: 130 NGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL----------------NEA 173
G+FG + I R+ E A + N + K E L NE
Sbjct: 158 AGAFGKI---FICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEI 214
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
+ + +++K+ ++ T +I + DL +++ D D + P L +
Sbjct: 215 LALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMY----DEAFDWKDRP-LLKQ 268
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
+ ++ + Y+ DKK +HRD+ N + D + +GDFG T +E E
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKEREAFDYG 327
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
V +PE L + +D+WS G++L +M +
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 65/273 (23%), Positives = 107/273 (39%), Gaps = 72/273 (26%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIK----VANENASEREKAEFLNEASVMKAFDTHH 183
LG G+FG V D ++L K + N+ A + + + L EA D
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEW 62
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
VV+LY + + +M+ + GGD+ + L + P L+R AE+
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--------IRMGIFPEDLARF--YIAELTC 112
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT---RDIYETEYYRKG------SRG 294
+ + F+HRD+ N ++ D +K+ DFG+ R ++++YY+ G S
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 295 F----------------LPVRW--------------------MAPESLKDGVFTSHSDVW 318
F P+ +APE L +T D W
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 319 SYGVVLWEMAT-----LASQPYQGLSNEQVLNW 346
S GV+L+EM LA P + + +V+NW
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLE--TQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 35/215 (16%)
Query: 130 NGSFGLVYRGLIKDFRSLAEHPCAIKVANENA----SEREKAEFLNEASVMKAFDTHHVV 185
NG++G VY K+ R A+K N+ ++ ++ E ++ + VV
Sbjct: 11 NGAYGAVYLVRHKETR----QRFAMKKINKQNLILRNQIQQV--FVERDILTFAENPFVV 64
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
++ ++ME + GGD L++ P ++R+ AE +
Sbjct: 65 SMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--------LPVDMARM--YFAETVLAL 114
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFG--------MTRDIYETEYYRKGSRGFLP 297
YL + VHRDL N ++ +K+ DFG +T ++YE + K +R FL
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG-HIEKDTREFLD 173
Query: 298 VR------WMAPESLKDGVFTSHSDVWSYGVVLWE 326
+ ++APE + + D W+ G++L+E
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 38/165 (23%), Positives = 77/165 (46%), Gaps = 19/165 (11%)
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+V L+ + +++E + GGDL +++ R + P +R AAE+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR--------KLPEEHARF--YAAEICI 107
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG--SRGFLPV-RW 300
+ +L ++ ++RDL N ++ D +K+ D+GM + E G + F +
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNY 162
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+APE L+ + D W+ GV+++EM P+ +++ +N
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 48/217 (22%), Positives = 91/217 (41%), Gaps = 30/217 (13%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKA 178
+K +L +G G++G+V + K+ + + AIK + +E K L E +++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIV----AIKKFKDSEENEEVKETTLRELKMLRT 56
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
++V+L ++ E + KN L E PP ++
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVE----KNMLELL----EEMPNGVPP--EKVRSYI 106
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE------TEYYRKGS 292
++ + + VHRD+ N +++ + +K+ DFG R++ E TEY
Sbjct: 107 YQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY----- 161
Query: 293 RGFLPVRWM-APESLKDGVFTSHSDVWSYGVVLWEMA 328
+ RW +PE L + D+WS G +L E++
Sbjct: 162 ---VATRWYRSPELLLGAPYGKAVDMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 62/261 (23%), Positives = 107/261 (40%), Gaps = 54/261 (20%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANE-NASEREKAEFLN-EASVMKAFDTH 182
L +G G+FG V KD H A+K+ + + E+E+ + E ++ D+
Sbjct: 6 LKVIGRGAFGEVRLVQKKD----TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
VVK++ + +IME + GGD+ L + D T+ E +L +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAI----- 114
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT---RDIYETEYYR---------- 289
D + L F+HRD+ N ++ VK+ DFG+ + + TE+YR
Sbjct: 115 DSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 290 --------------KGSRGFLPVR------WMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
K +R L ++APE + D WS GV+++EM
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM-L 230
Query: 330 LASQPYQGLSNEQ----VLNW 346
+ P+ + ++ V+NW
Sbjct: 231 IGYPPFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 28/93 (30%), Positives = 41/93 (44%), Gaps = 21/93 (22%)
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR---------DIYETEYYRKGSRG 294
G+ +L +HRDL N +V D T+K+ DFG+ R T YYR
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR----- 184
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
APE + + + D+WS G ++ EM
Sbjct: 185 -------APEVILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 26/97 (26%)
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG------------MTRDIYETEYYRKG 291
G+ YL +HRD+ N +V + +K+ DFG MT+++ T+YYR
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYR-- 171
Query: 292 SRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEM 327
APE L +TS D+WS G + E+
Sbjct: 172 ----------APEILMGSRHYTSAVDIWSVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 12/90 (13%)
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR--DIYETEYYRKGSRGFLPVRWM 301
G+ Y+ +HRDL N V +D +K+ DFG+ R D T G++ RW
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT--------GYVVTRWY 180
Query: 302 -APESLKDGV-FTSHSDVWSYGVVLWEMAT 329
APE + + + + D+WS G ++ EM T
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 61/261 (23%), Positives = 105/261 (40%), Gaps = 54/261 (20%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANE-NASEREK-AEFLNEASVMKAFDTH 182
L +G G+FG V KD H A+K+ + + E+E+ A E ++ D
Sbjct: 6 LKVIGRGAFGEVRLVQKKD----TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
VVK++ + +IME + GGD+ L + D ++ +L +
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAI----- 114
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT---RDIYETEYYR---------- 289
D + L F+HRD+ N ++ VK+ DFG+ + + TE+YR
Sbjct: 115 DAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 290 --------------KGSRGFLPVR------WMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
K +R L ++APE + D WS GV+++EM
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM-L 230
Query: 330 LASQPYQGLSNEQ----VLNW 346
+ P+ + ++ V+NW
Sbjct: 231 IGYPPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 36/147 (24%), Positives = 71/147 (48%), Gaps = 18/147 (12%)
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+V L+ + ++E + GGDL +++ R + P +R +AE++
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--------KLPEEHARF--YSAEISL 107
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG--SRGFLPV-RW 300
+ YL ++ ++RDL N ++ + +K+ D+GM + E R G + F +
Sbjct: 108 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNY 162
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEM 327
+APE L+ + D W+ GV+++EM
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 26/165 (15%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVA------NENASEREKAEFLNEASVM 176
I+ + G+FG VY G K+ L A+KV N+N + +AE A
Sbjct: 7 VIVKPISRGAFGKVYLGRKKNNSKLY----AVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 177 KAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLR-SCRPDAETDVERSPPTLSRIL 235
F +V LY + N ++ME + GGD+K+ L D E V
Sbjct: 63 SPF----IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV----------- 107
Query: 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280
+ +EVA + YL +HRDL N +++++ +K+ DFG+++
Sbjct: 108 KYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 53/227 (23%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF----LNEASVMKA 178
L +G G++G+V S P +KVA + S E F L E +++
Sbjct: 8 QNLSYIGEGAYGMVC--------SATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRR 59
Query: 179 FDTHHVVKLYGVV-----SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPT--L 231
F +++ + ++ N ++ ELM ETD+ + T L
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELM----------------ETDLYKLIKTQHL 103
Query: 232 S---------RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282
S +IL+ G+ Y+ +HRDL N ++ + +K+ DFG+ R
Sbjct: 104 SNDHIQYFLYQILR-------GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156
Query: 283 YETEYYRKGSRGFLPVRWM-APE-SLKDGVFTSHSDVWSYGVVLWEM 327
+ ++ RW APE L +T D+WS G +L EM
Sbjct: 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 52/230 (22%), Positives = 100/230 (43%), Gaps = 48/230 (20%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS-VMKAFDTH 182
+L LG G++G V+ L++ KV+ ++ + + L +A+ V KA T
Sbjct: 4 LLKVLGTGAYGKVF--LVR------------KVSGHDSGKLYAMKVLKKATIVQKAKTTE 49
Query: 183 H----------------VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVER 226
H +V L+ +I++ + GG+L +L +R
Sbjct: 50 HTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL----------SQR 99
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
+ + E+ + +L ++RD+ N ++ + V + DFG++++ +E E
Sbjct: 100 ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159
Query: 287 YYRKGSRGFL-PVRWMAPESLKDGVFTSHS---DVWSYGVVLWEMATLAS 332
R S F + +MAP+ ++ G H D WS GV+++E+ T AS
Sbjct: 160 VERAYS--FCGTIEYMAPDIVRGGD-GGHDKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 19/117 (16%)
Query: 223 DVERSPPTL--SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280
D+E+ P L SR+ + ++ G+ + +HRD+ N +V+ VK+ DFG R
Sbjct: 89 DLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148
Query: 281 ------DIYETEYYRKGSRGFLPVRWM-APESL-KDGVFTSHSDVWSYGVVLWEMAT 329
++Y T+Y + RW APE L D + D+W+ G ++ EM T
Sbjct: 149 TLAAPGEVY-TDY--------VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 37/123 (30%)
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL----TVKVGDFGMTRDIY 283
P + +L ++ +G+ YL +HRDL N +V + VK+GD G+ R
Sbjct: 107 PSMVKSLLW---QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 284 E-------------TEYYRKGSRGFLPVRWMAPESL---KDGVFTSHSDVWSYGVVLWEM 327
T +YR APE L + +T D+W+ G + E+
Sbjct: 164 APLKPLADLDPVVVTIWYR------------APELLLGARH--YTKAIDIWAIGCIFAEL 209
Query: 328 ATL 330
TL
Sbjct: 210 LTL 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 40/206 (19%), Positives = 84/206 (40%), Gaps = 26/206 (12%)
Query: 146 SLAEHPC-----AIKVAN-ENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199
LA+H A+K N ++ S+ + E + +++ + V
Sbjct: 17 HLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYV 76
Query: 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259
+ LM G ++ L++ P+ P I + +V + + Y+ K F+HR +
Sbjct: 77 VSPLMAYGSCEDLLKTHFPEG------LPELA--IAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 260 ARNCMVADDLTVKVGDFGMTRDIYE-------TEYYRKGSRGFLPVRWMAPESLKDGV-- 310
A + +++ D V + + + + + K S LP W++PE L+ +
Sbjct: 129 ASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP--WLSPEVLQQNLQG 186
Query: 311 FTSHSDVWSYGVVLWEMATLASQPYQ 336
+ SD++S G+ E+A P++
Sbjct: 187 YNEKSDIYSVGITACELAN-GHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 53/247 (21%), Positives = 94/247 (38%), Gaps = 42/247 (17%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREK-AEFLNEASVMKAFDTHHV 184
LG G G V+ L++ A+KV ++ +R K L E ++ D +
Sbjct: 8 LLGKGDVGRVF--LVRL--KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244
LY ++M+ GG+L L +P + ++R AAEV
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPG-----KCLSEEVARFY--AAEVLLA 115
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM-----TRDIYETEYYRKGSRGFLPVR 299
+ YL V+RDL N ++ + + + DF + ++ RKGSR
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 300 ----------------------WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
++APE + S D W+ G++L+EM + P++G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM-LYGTTPFKG 234
Query: 338 LSNEQVL 344
+ ++
Sbjct: 235 SNRDETF 241
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 24/86 (27%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM-A 302
G+ Y+ +HRDL N V +D +++ DFG+ R + G++ RW A
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MTGYVATRWYRA 183
Query: 303 PESLKDGVFTSHS-DVWSYGVVLWEM 327
PE + + + + + D+WS G ++ E+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 33/131 (25%), Positives = 66/131 (50%), Gaps = 18/131 (13%)
Query: 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259
++E + GGDL +++ R + P +R +AE++ + +L ++ ++RDL
Sbjct: 74 VIEFVSGGDLMFHMQRQR--------KLPEEHARF--YSAEISLALNFLHERGIIYRDLK 123
Query: 260 ARNCMVADDLTVKVGDFGMTRDIYETEYYRKG--SRGFLPV-RWMAPESLKDGVFTSHSD 316
N ++ + +K+ D+GM + E R G + F ++APE L+ + D
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCK-----EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 317 VWSYGVVLWEM 327
W+ GV+++EM
Sbjct: 179 WWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 20/133 (15%)
Query: 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258
++ LMG DL N ++ + +D I + ++ G+ Y+ +HRDL
Sbjct: 97 LVTHLMGA-DLNNIVKCQK---LSD--------DHIQFLVYQILRGLKYIHSAGIIHRDL 144
Query: 259 AARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW-MAPE-SLKDGVFTSHSD 316
N V +D +K+ DFG+ R T+ G++ RW APE L + D
Sbjct: 145 KPSNIAVNEDCELKILDFGLAR---HTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVD 198
Query: 317 VWSYGVVLWEMAT 329
+WS G ++ E+ T
Sbjct: 199 IWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 48/226 (21%), Positives = 93/226 (41%), Gaps = 32/226 (14%)
Query: 152 CAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDL 209
A+KV ++ ++ + F E ++ ++ + +L + + ++ME GGDL
Sbjct: 29 YAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL 88
Query: 210 KNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269
+ L + D+ + AE+ + + +VHRD+ N ++
Sbjct: 89 LSLLNRYEDQFDEDMAQF---------YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG 139
Query: 270 TVKVGDFG----MTRDIYETEYYRKGSRGFLPV---RWMAPESLK------DGVFTSHSD 316
+K+ DFG +T + K LPV ++APE L G + D
Sbjct: 140 HIKLADFGSAARLTAN--------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECD 191
Query: 317 VWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPIS 362
WS GV+ +EM S ++G S + N + + ++ +P +S
Sbjct: 192 WWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 37/214 (17%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
+GNGSFG+VY + D AIK ++ + + E +MK + +++ L
Sbjct: 74 IGNGSFGVVYEAICID----TSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFL 124
Query: 188 YGVV-------SEGNPTL-VIMELMGG---GDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
+E N L V+ME + +K+Y R+ + P L
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN---------NHALPLFLVKL- 174
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDL-TVKVGDFGMTRDIYETEYYRKGSRGF 295
+ ++ +AY+ K HRDL +N ++ + T+K+ DFG +++ + S +
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR----SVSY 230
Query: 296 LPVR-WMAPE-SLKDGVFTSHSDVWSYGVVLWEM 327
+ R + APE L +T+H D+WS G ++ EM
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 56/242 (23%), Positives = 105/242 (43%), Gaps = 52/242 (21%)
Query: 124 ILDELGNGSFGLVY---------RGLIKDFRSLAEHPCAI----KVANENASEREKAEFL 170
+L LG G++G V+ G + + L + A+ K +ER E +
Sbjct: 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQK--AALVQKAKTVEHTRTERNVLEHV 61
Query: 171 NEA----SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVER 226
++ ++ AF T KL+ +I++ + GG++ +L +E +V
Sbjct: 62 RQSPFLVTLHYAFQTE--AKLH----------LILDYVSGGEMFTHLYQRDNFSEDEV-- 107
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
R + E+ + +L V+RD+ N ++ + V + DFG++++ E
Sbjct: 108 ------RF--YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
Query: 287 YYRKGSRGFL-PVRWMAPESLKDGVFTSHS---DVWSYGVVLWEMATLASQPY--QGLSN 340
R S F + +MAPE ++ H D WS G++++E+ T AS P+ +G N
Sbjct: 160 KERTYS--FCGTIEYMAPEIIRGK--GGHGKAVDWWSLGILIFELLTGAS-PFTLEGERN 214
Query: 341 EQ 342
Q
Sbjct: 215 TQ 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 15/91 (16%)
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE-----TEYYRKGSRGFLPV 298
G+ Y+ +HRDL N ++ + +K+ DFG+ R E TEY
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV--------VT 171
Query: 299 RWM-APESLKD-GVFTSHSDVWSYGVVLWEM 327
RW APE L + +T+ DVWS G + E+
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMK---AFDTH 182
+G G+FG VY+ KD R + A+KV ++ +++E A + E +++ ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIY----AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESP 56
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+V L + ++ + M GG+L +L+ + +R+ + AE+
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK---EGRFSEDRAKFYI-------AELV 106
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL-PVRWM 301
+ +L V+RDL N ++ + + DFG+++ K + F ++
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KTTNTFCGTTEYL 163
Query: 302 APESL-KDGVFTSHSDVWSYGVVLWEM 327
APE L + +T H D WS GV+++EM
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 27/102 (26%), Positives = 41/102 (40%), Gaps = 17/102 (16%)
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-----DIYETEYYRKGSRG 294
+ + + +HRD+ N ++ +K+ DFG R T+Y
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY------- 160
Query: 295 FLPVRWM-APESL-KDGVFTSHSDVWSYGVVLWEMATLASQP 334
+ RW APE L D + DVW+ G V E+ L QP
Sbjct: 161 -VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAEL--LTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 35/124 (28%), Positives = 57/124 (45%), Gaps = 15/124 (12%)
Query: 208 DLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267
DL YL R P L+++ +A ++ + Y+ + +HRD+ N +V
Sbjct: 245 DLYTYL-GARL--------RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295
Query: 268 DLTVKVGDFG---MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ +GDFG R + T ++ G G V APE L +T D+WS G+V+
Sbjct: 296 PEDICLGDFGAACFARGSWSTPFHY-GIAG--TVDTNAPEVLAGDPYTPSVDIWSAGLVI 352
Query: 325 WEMA 328
+E A
Sbjct: 353 FEAA 356
|
Length = 461 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 33/241 (13%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
SK L ++G G+FG V++ + + KV EN E L E +++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKA---RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL 68
Query: 180 DTHHVVKLYGVV-SEGNPT-------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
+VV L + ++ P ++ E DL L + +V+ + +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL------SNKNVKFTLSEI 121
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
++++M + +G+ Y+ K +HRD+ A N ++ D +K+ DFG+ R ++
Sbjct: 122 KKVMKM---LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSK---NS 175
Query: 292 SRGFLPVR----WM-APES-LKDGVFTSHSDVWSYGVVLWEMATLASQP-YQGLSNEQVL 344
R W PE L + + D+W G ++ EM T P QG + + L
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT--RSPIMQGNTEQHQL 233
Query: 345 N 345
Sbjct: 234 T 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 33/122 (27%), Positives = 52/122 (42%), Gaps = 13/122 (10%)
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
E V+ D+ VV LY + +IME + GGDL L +E DV R
Sbjct: 51 ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE-DVTRF---- 105
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE---YY 288
AE + + F+HRD+ N ++ +K+ DFG++ ++ YY
Sbjct: 106 -----YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160
Query: 289 RK 290
+K
Sbjct: 161 QK 162
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 34/121 (28%), Positives = 51/121 (42%), Gaps = 30/121 (24%)
Query: 222 TDVER---SPPTLSRILQ-MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277
TD+ R S P + +Q ++ G+ Y+ VHRDL N ++ ++ +K+ DFG
Sbjct: 94 TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFG 153
Query: 278 MTR-------DIYETEYYRKGSRGFLPVRWMAPESL----KDGVFTSHSDVWSYGVVLWE 326
+ R T YYR APE + K V D+WS G + E
Sbjct: 154 LARIQDPQMTGYVSTRYYR------------APEIMLTWQKYDV---EVDIWSAGCIFAE 198
Query: 327 M 327
M
Sbjct: 199 M 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 28/98 (28%), Positives = 44/98 (44%), Gaps = 21/98 (21%)
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR--------DIYETEYYRKGSRGF 295
+ Y+ HRDL +N + D +K+ DFG+ R I+ T+Y
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-------- 166
Query: 296 LPVRWM-APESLKDGVFTSHS---DVWSYGVVLWEMAT 329
+ RW APE L F+ ++ D+WS G + E+ T
Sbjct: 167 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 48/208 (23%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---SEREKAEFLNEASVMKAFDTHHV 184
LG G +G V++ + K + A+KV + ++++ A E ++++A +
Sbjct: 4 LGKGGYGKVFQ-VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM-AAEVAD 243
V L G +I+E + GG+L +L ER + +E++
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL-----------EREGIFMEDTACFYLSEISL 111
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD-IYETEYYRKGSRGFL-PVRWM 301
+ +L + ++RDL N ++ VK+ DFG+ ++ I+E + F + +M
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV----THTFCGTIEYM 167
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMAT 329
APE L D WS G ++++M T
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 364 | |||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| KOG0986|consensus | 591 | 100.0 | ||
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0577|consensus | 948 | 100.0 | ||
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024|consensus | 563 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG2052|consensus | 513 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0668|consensus | 338 | 99.98 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1027|consensus | 903 | 99.96 | ||
| KOG0576|consensus | 829 | 99.96 | ||
| KOG0665|consensus | 369 | 99.96 | ||
| KOG1345|consensus | 378 | 99.95 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1164|consensus | 322 | 99.94 | ||
| KOG1167|consensus | 418 | 99.94 | ||
| KOG1163|consensus | 341 | 99.94 | ||
| KOG1165|consensus | 449 | 99.93 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG0603|consensus | 612 | 99.87 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1166|consensus | 974 | 99.85 | ||
| KOG0590|consensus | 601 | 99.85 | ||
| KOG1240|consensus | 1431 | 99.84 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0195|consensus | 448 | 99.81 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG0606|consensus | 1205 | 99.8 | ||
| KOG4158|consensus | 598 | 99.78 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG1033|consensus | 516 | 99.71 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG1023|consensus | 484 | 99.67 | ||
| KOG0590|consensus | 601 | 99.64 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG0601|consensus | 524 | 99.47 | ||
| KOG1243|consensus | 690 | 99.46 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| KOG3087|consensus | 229 | 99.41 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.26 | |
| KOG0606|consensus | 1205 | 99.25 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| KOG0601|consensus | 524 | 99.17 | ||
| KOG1266|consensus | 458 | 99.12 | ||
| KOG3741|consensus | 655 | 99.06 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.02 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.92 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.89 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.78 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.62 | |
| KOG1235|consensus | 538 | 98.54 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.46 | |
| KOG2137|consensus | 700 | 98.44 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.44 | |
| KOG0576|consensus | 829 | 98.35 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.34 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.33 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.26 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.85 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.84 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| KOG2268|consensus | 465 | 97.74 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.63 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.63 | |
| PLN02236 | 344 | choline kinase | 97.31 | |
| KOG1826|consensus | 2724 | 97.29 | ||
| KOG2270|consensus | 520 | 97.27 | ||
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.26 | |
| KOG1035|consensus | 1351 | 97.19 | ||
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.17 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.73 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.64 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.59 | |
| KOG1236|consensus | 565 | 96.54 | ||
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.52 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.52 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.47 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.4 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.34 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.32 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.11 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.67 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.11 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.01 | |
| PF00017 | 77 | SH2: SH2 domain; InterPro: IPR000980 The Src homol | 94.95 |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-57 Score=427.46 Aligned_cols=319 Identities=34% Similarity=0.539 Sum_probs=263.1
Q ss_pred cccccCCCcceEEEeccccccccccCCCCcceEEeecCCc--cceeeeeeeeeeeeeCCCCCC--ccccccCCCCC----
Q psy7023 18 GFLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTK--FNIFLFLIRVAVILTGSGGPA--VTTTTVATPTT---- 89 (364)
Q Consensus 18 ~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~sg~~~--~~~~~~~~~~~---- 89 (364)
.||.++|+.|+|+||+| |..++.|+++++.++... ..+.|++|+.. ..++.. .......+..+
T Consensus 96 ~ll~p~~~~G~flvR~s-----e~~~g~yslsv~~~~~~~~~~~v~hyri~~~----~~~~~~~~~~~~~~F~~l~~lv~ 166 (468)
T KOG0197|consen 96 QLLAPENKEGAFLVRES-----ESDKGDYSLSVREGDSGGLGAKVKHYRIRQL----DGGGLYPYIDERELFSSLQQLVN 166 (468)
T ss_pred hhcCCCCCccceeeecc-----cCCcCCeeEEEEeccccCCccceeeeeeeEc----CCCCeecCCCHHHhhhhHHHHHh
Confidence 79999999999999999 789999999999998665 37999999985 444322 22211111110
Q ss_pred ---------CCCCCCCCCCCCCCCCCcccccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc
Q psy7023 90 ---------PAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN 160 (364)
Q Consensus 90 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~ 160 (364)
.......................+.|++.++.+++++.||+|-||+||+|.++. ..+||+|.++..
T Consensus 167 ~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-----~~~vavk~ik~~ 241 (468)
T KOG0197|consen 167 YYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNG-----STKVAVKTIKEG 241 (468)
T ss_pred hhhccCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcC-----CCcccceEEecc
Confidence 000111111000000111122278899999999999999999999999999996 668999999876
Q ss_pred cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHH
Q psy7023 161 ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240 (364)
Q Consensus 161 ~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~q 240 (364)
... .+.|.+|+++|++|+|+|||++++++..++.+|||||||+.|+|.+||+. .....+...+++.|+.|
T Consensus 242 ~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--------~~~~~l~~~~Ll~~a~q 311 (468)
T KOG0197|consen 242 SMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--------REGGLLNLPQLLDFAAQ 311 (468)
T ss_pred ccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--------cCCCccchHHHHHHHHH
Confidence 433 46788999999999999999999999998899999999999999999986 24556788899999999
Q ss_pred HHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHH
Q psy7023 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSY 320 (364)
Q Consensus 241 il~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 320 (364)
|++||+||+++++|||||...||||+++..+||+|||+|+.+.++.+...... ..+..|+|||.+..++++.++|||||
T Consensus 312 IaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~-kfPIkWtAPEa~~~~~FS~kSDVWSF 390 (468)
T KOG0197|consen 312 IAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG-KFPIKWTAPEALNYGKFSSKSDVWSF 390 (468)
T ss_pred HHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC-CCCceecCHHHHhhCCcccccceeeh
Confidence 99999999999999999999999999999999999999997666666554443 45889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCCCC
Q psy7023 321 GVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPI 361 (364)
Q Consensus 321 G~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 361 (364)
||+||||+|.|+.||.++++.++++.|++|++++-|..||-
T Consensus 391 GVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 391 GVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPD 431 (468)
T ss_pred hhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCH
Confidence 99999999999999999999999999999999999999985
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=371.28 Aligned_cols=218 Identities=23% Similarity=0.456 Sum_probs=195.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.+|.+.++||+|+||+||+|+++. .+..||||.+.... .....+.+..|+.+|+.++|||||+++++....+.+|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~----~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKK----SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccceehhhccCcceEEEEEeEecc----CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 688999999999999999999988 46789999887664 5566777889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC------CcEE
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD------LTVK 272 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~------~~~k 272 (364)
||||||+||+|.+|++.. +.+++..++.++.||+.||++||+++||||||||+|||++.. -.+|
T Consensus 86 lVMEyC~gGDLs~yi~~~----------~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRR----------GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EEEEeCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 999999999999999863 367888999999999999999999999999999999999864 5689
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||+|+.+...... ....|+|.|||||++...+|+.|+|+||+|++||+|++ |.+||...+..|++..++++..
T Consensus 156 IADFGfAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~-g~~Pf~a~t~~eL~~~~~k~~~ 231 (429)
T KOG0595|consen 156 IADFGFARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLT-GKPPFDAETPKELLLYIKKGNE 231 (429)
T ss_pred ecccchhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHHHhcccc
Confidence 9999999988755432 23346899999999999999999999999999999999 9999999999999999988876
Q ss_pred ccc
Q psy7023 353 NEY 355 (364)
Q Consensus 353 ~~~ 355 (364)
...
T Consensus 232 ~~~ 234 (429)
T KOG0595|consen 232 IVP 234 (429)
T ss_pred ccC
Confidence 533
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=357.72 Aligned_cols=218 Identities=23% Similarity=0.351 Sum_probs=195.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.++|+++++||+|+||+||.++.++ +++.+|+|++++... ..+.+..+.|..||..++||.||+++-.|++.+.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d----t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD----TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc----cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 3689999999999999999999886 578899999986543 3346788899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+|+|+||+.||+|..+|++ ...+++..+.-++.+|+.||.|||++|||||||||+|||+|.+|+++|+||
T Consensus 100 LylVld~~~GGeLf~hL~~----------eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQR----------EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred EEEEEeccCCccHHHHHHh----------cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEecc
Confidence 9999999999999999975 456788889999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|+++........+ ....||+.|||||++.+..|+.++|+||||+++|||++ |.+||.+.+..++.+.|.+++..
T Consensus 170 gL~k~~~~~~~~t--~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~-G~pPF~~~~~~~~~~~I~~~k~~ 243 (357)
T KOG0598|consen 170 GLCKEDLKDGDAT--RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLT-GKPPFYAEDVKKMYDKILKGKLP 243 (357)
T ss_pred ccchhcccCCCcc--ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhh-CCCCCcCccHHHHHHHHhcCcCC
Confidence 9998655443322 23567999999999999999999999999999999999 89999999999999999988833
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=348.76 Aligned_cols=223 Identities=25% Similarity=0.391 Sum_probs=200.2
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+..++.+.++.||+|..|+||+++++. +++.+|+|++.........+++.+|+++++.+.||+||.+|+.|..+..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~----t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKP----TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcC----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 344677888999999999999999998 5788999999877788888999999999999999999999999999884
Q ss_pred -eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEe
Q psy7023 197 -TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 197 -~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+.|+||||++|+|.++++.. +.+++..+..++.+|++||.|||. ++||||||||+||||+..|++|||
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~----------g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV----------GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEec
Confidence 99999999999999999862 457889999999999999999995 999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL-----SNEQVLNWVKG 349 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~-----~~~~~~~~i~~ 349 (364)
|||.++.+..+ .....+||..|||||.+.+..|+.++||||||++++|+++ |+.||... +.-+++.+|..
T Consensus 222 DFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~-GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 222 DFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI-GRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred cccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh-CCCCCCCcCCCCCCHHHHHHHHhc
Confidence 99999987766 2344567889999999999999999999999999999999 89999764 78889999988
Q ss_pred CccccccCC
Q psy7023 350 KSSNEYKVN 358 (364)
Q Consensus 350 ~~~~~~~~~ 358 (364)
+.+...|..
T Consensus 297 ~ppP~lP~~ 305 (364)
T KOG0581|consen 297 EPPPRLPEG 305 (364)
T ss_pred CCCCCCCcc
Confidence 877666543
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=357.96 Aligned_cols=230 Identities=21% Similarity=0.324 Sum_probs=193.4
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH------HHHHHHHHHHHHHhcCCcceeEEEE
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER------EKAEFLNEASVMKAFDTHHVVKLYG 189 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~il~~l~h~~iv~l~~ 189 (364)
+.+++.|.+.+.||+|+||.|-+|..+. +++.||||++++..... ......+|+++|++|.|||||++++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~----tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d 243 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKK----TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD 243 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcc----cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence 4477899999999999999999999887 68889999998653222 2234579999999999999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD- 268 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~- 268 (364)
+|+..+..|+||||++||+|.+++-..+ .+.+..-..+++||+.|+.|||++||+||||||+|||+..+
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk----------~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~ 313 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVANK----------YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA 313 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhcc----------ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC
Confidence 9999999999999999999999997643 34445567899999999999999999999999999999866
Q ss_pred --CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCC---CCchhHHHHHHHHHHHHhCCCCCCCCCCHHH-
Q psy7023 269 --LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF---TSHSDVWSYGVVLWEMATLASQPYQGLSNEQ- 342 (364)
Q Consensus 269 --~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~el~t~g~~P~~~~~~~~- 342 (364)
..+||+|||+|+...+..+. ....|||.|.|||++.+..+ ..++|||||||+||-+++ |.+||.+.....
T Consensus 314 e~~llKItDFGlAK~~g~~sfm---~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs-G~pPFS~~~~~~s 389 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGEGSFM---KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS-GYPPFSEEYTDPS 389 (475)
T ss_pred cceEEEecccchhhccccceeh---hhhcCCccccChhheecCCeecccchheeeeccceEEEEec-cCCCcccccCCcc
Confidence 78999999999987755432 33457999999999987663 347899999999999999 999999876666
Q ss_pred HHHHHhcCccc-cccCCCCCCC
Q psy7023 343 VLNWVKGKSSN-EYKVNPPISL 363 (364)
Q Consensus 343 ~~~~i~~~~~~-~~~~~~~~s~ 363 (364)
+.++|.+|... .++.|-.||.
T Consensus 390 l~eQI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 390 LKEQILKGRYAFGPLQWDRISE 411 (475)
T ss_pred HHHHHhcCcccccChhhhhhhH
Confidence 88888766554 5578887775
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=358.06 Aligned_cols=215 Identities=23% Similarity=0.424 Sum_probs=193.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.+|+..+.||+|||+.||.+++.+ ++..||+|++.+.. .....+.+.+|++|.+.|+|||||+++++|++.+.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~----tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD----TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC----CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce
Confidence 589999999999999999999866 47789999997642 344567788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|||+|+|..++|..++++ .+++++.+++.+++||+.||.|||+++|||||||..|+|++++.++||+|||
T Consensus 94 YivLELC~~~sL~el~Kr----------rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKR----------RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred EEEEEecCCccHHHHHHh----------cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccc
Confidence 999999999999999974 4567888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+|..+...... ..+..|||.|+|||++.....+..+||||+||++|.|++ |++||+..+-.+++..|+...
T Consensus 164 LAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~-G~PPFetk~vkety~~Ik~~~ 234 (592)
T KOG0575|consen 164 LATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV-GRPPFETKTVKETYNKIKLNE 234 (592)
T ss_pred eeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhh-CCCCcccchHHHHHHHHHhcC
Confidence 99988754322 223457999999999999999999999999999999999 999999999999999997654
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=339.10 Aligned_cols=221 Identities=22% Similarity=0.392 Sum_probs=194.8
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEE-EEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYG-VVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~-~~~~~~ 195 (364)
...+|+++++||+|+||+||++.+.. ++..+|.|.++-.. +....+....|+.+|++|+|||||++++ .|.+++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~----~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLL----DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeecc----CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 34689999999999999999999876 57789999887443 4555678899999999999999999998 555555
Q ss_pred c-eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCEEEcCCCc
Q psy7023 196 P-TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD--KK--FVHRDLAARNCMVADDLT 270 (364)
Q Consensus 196 ~-~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~--~~--iiHrDlkp~NILl~~~~~ 270 (364)
. ++||||+|++|+|...++..+ .+.+.+++..+++++.|++.||.++|. .+ |+||||||.||+++.+|.
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv 166 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFK------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV 166 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHH------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence 5 899999999999999998754 356678999999999999999999999 45 999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||+|||+++.+...... ....+|||.||+||++.+.+|+.++||||+||++|||+. -++||.+.+-.++.+.|.+|
T Consensus 167 vKLGDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca-L~~PF~g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA-LQSPFYGDNLLSLCKKIEQG 243 (375)
T ss_pred eeeccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh-cCCCcccccHHHHHHHHHcC
Confidence 999999999988765432 344578999999999999999999999999999999999 89999999999999999999
Q ss_pred c
Q psy7023 351 S 351 (364)
Q Consensus 351 ~ 351 (364)
.
T Consensus 244 d 244 (375)
T KOG0591|consen 244 D 244 (375)
T ss_pred C
Confidence 4
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=328.63 Aligned_cols=214 Identities=25% Similarity=0.391 Sum_probs=192.7
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.++|++++.||.|+||.|.+++.+. ++..+|+|++++.. ..+..+...+|..+|+.+.||.++++++.|.+.+.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~----~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKH----SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEcc----CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 3688999999999999999999987 57789999998654 33445678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+|+||||++||.|..++++.+ +++++.++-+|.||+.||+|||+++|++|||||+|||+|.+|.+||+||
T Consensus 119 lymvmeyv~GGElFS~Lrk~~----------rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG----------RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC----------CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEec
Confidence 999999999999999999744 4566778899999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|+.+.....+ ..|||.|+|||++....|+.++|+|||||++|||+. |.+||.+.++.++.+.|..++-
T Consensus 189 GFAK~v~~rT~T-----lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla-G~pPF~~~~~~~iY~KI~~~~v 258 (355)
T KOG0616|consen 189 GFAKRVSGRTWT-----LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA-GYPPFYDDNPIQIYEKILEGKV 258 (355)
T ss_pred cceEEecCcEEE-----ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc-CCCCCcCCChHHHHHHHHhCcc
Confidence 999987665332 246899999999999999999999999999999999 9999999999999999987753
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=370.90 Aligned_cols=250 Identities=38% Similarity=0.740 Sum_probs=231.9
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
...++.+.+.+..+.||+|.||+||+|+..... ......||||.++........++|.+|++++..++|||||+++|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 456788899999999999999999999865533 2346789999999988888899999999999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCC----ccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP----PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~----~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~ 267 (364)
.+++.+++|+|||..|||.+||+.+.+.........+ ++..+.+.||.||+.||+||-++.+|||||..+|+||.+
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 9999999999999999999999998887776544444 899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+..|||+|||+++.+...+++........+.+||+||.|+.++|+.++||||+||+|||+++.|..||.+.+++|+++.|
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 99999999999999999999988878888999999999999999999999999999999999999999999999999999
Q ss_pred hcCccccccCCCCCC
Q psy7023 348 KGKSSNEYKVNPPIS 362 (364)
Q Consensus 348 ~~~~~~~~~~~~~~s 362 (364)
++|.-.+-|.+||.+
T Consensus 719 ~~g~lL~~Pe~CP~~ 733 (774)
T KOG1026|consen 719 RAGQLLSCPENCPTE 733 (774)
T ss_pred HcCCcccCCCCCCHH
Confidence 999999999999964
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=347.63 Aligned_cols=216 Identities=22% Similarity=0.352 Sum_probs=189.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCc
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~ 196 (364)
.+|.+++.||.|+|++|++|+.+. +++.||||++.+.-.- ...+-+..|-.+|.+| .||.|++|+-.|+++..
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~----t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKA----TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred hhcchhheeccccceeEEEeeecC----CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 689999999999999999999888 6888999999765322 2234567899999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+|+|+||+++|+|.++|++. +.+.+...+.++.||+.||+|||++|||||||||+|||+|.|+++||+||
T Consensus 149 LYFvLe~A~nGdll~~i~K~----------Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY----------GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh----------CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeec
Confidence 99999999999999999874 35666778899999999999999999999999999999999999999999
Q ss_pred ccccccCcccee---------ee--CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 277 GMTRDIYETEYY---------RK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 277 g~a~~~~~~~~~---------~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
|.|+.+...... .. ....+||-.|++||++.++..+..+|+|+||||||+|+. |.+||.+.++--+++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla-G~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA-GQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc-CCCCCccccHHHHHH
Confidence 999877543221 11 245788999999999999999999999999999999999 999999999988888
Q ss_pred HHhcC
Q psy7023 346 WVKGK 350 (364)
Q Consensus 346 ~i~~~ 350 (364)
.|...
T Consensus 298 kI~~l 302 (604)
T KOG0592|consen 298 KIQAL 302 (604)
T ss_pred HHHHh
Confidence 88654
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=343.93 Aligned_cols=230 Identities=20% Similarity=0.350 Sum_probs=197.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
-.++|+++++||+|+||.||+|+-++ ++..+|+|++++... ..+.+.++.|-.+|...++|.||+++-.|++.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~----Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKD----TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred CcccchhheeeccccceeEEEEEEcc----CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 34789999999999999999999888 578899999987643 344567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
.+||||||++||++..+|.. ...+++..+..++.+++.|++.||+.|+|||||||+|+|||..|++||+|
T Consensus 215 ~LYLiMEylPGGD~mTLL~~----------~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMR----------KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred eeEEEEEecCCccHHHHHHh----------cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecc
Confidence 99999999999999999964 45788899999999999999999999999999999999999999999999
Q ss_pred cccccccCcc----------------------ceee----e-------------------CCCCCCCccccCcccccCCC
Q psy7023 276 FGMTRDIYET----------------------EYYR----K-------------------GSRGFLPVRWMAPESLKDGV 310 (364)
Q Consensus 276 Fg~a~~~~~~----------------------~~~~----~-------------------~~~~~~~~~y~aPE~~~~~~ 310 (364)
||++.-+... +... . ....+|||.|||||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 9998533210 0000 0 01236799999999999999
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc-cccccCCCCCC
Q psy7023 311 FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS-SNEYKVNPPIS 362 (364)
Q Consensus 311 ~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~s 362 (364)
|+..+|+||||||+|||+. |.+||.+.++.++...|.... ...+|....+|
T Consensus 365 Y~~~cDwWSLG~ImyEmLv-GyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s 416 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLV-GYPPFCSETPQETYRKIVNWRETLKFPEEVDLS 416 (550)
T ss_pred CCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhhhccCCCcCccc
Confidence 9999999999999999999 999999999999999887654 23666666655
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=342.16 Aligned_cols=232 Identities=31% Similarity=0.525 Sum_probs=196.6
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
..+++......+.+.||+|+||+||+|.+++ ...||+|++.... .....++|.+|+.+|.+++|||||++++++
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g-----~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRG-----TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCC-----ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 4455556677778889999999999999986 3349999987543 233367899999999999999999999999
Q ss_pred eeCC-ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEEcCCC
Q psy7023 192 SEGN-PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK-FVHRDLAARNCMVADDL 269 (364)
Q Consensus 192 ~~~~-~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~-iiHrDlkp~NILl~~~~ 269 (364)
.+.. ..++||||+++|+|.+++... ....+++..++.++.||++||.|||+++ ||||||||+||||+.++
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~ 180 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG 180 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC
Confidence 9877 799999999999999999862 3567899999999999999999999999 99999999999999997
Q ss_pred -cEEEeecccccccCccceeeeCCCCCCCccccCccccc--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 270 -TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK--DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 270 -~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
++||+|||+++...... ...+...||+.|||||++. ...|+.++||||||+++|||+| +..||.+..+.++...
T Consensus 181 ~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t-~~~Pf~~~~~~~~~~~ 257 (362)
T KOG0192|consen 181 KTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT-GEIPFEDLAPVQVASA 257 (362)
T ss_pred CEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH-CCCCCCCCCHHHHHHH
Confidence 99999999998766543 2223356789999999999 6689999999999999999999 8999999999777766
Q ss_pred H-hcCccccccCCCC
Q psy7023 347 V-KGKSSNEYKVNPP 360 (364)
Q Consensus 347 i-~~~~~~~~~~~~~ 360 (364)
+ .++.+.+.|..++
T Consensus 258 v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 258 VVVGGLRPPIPKECP 272 (362)
T ss_pred HHhcCCCCCCCccCC
Confidence 6 4666666555443
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=343.27 Aligned_cols=226 Identities=21% Similarity=0.342 Sum_probs=192.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-- 194 (364)
..+.|+.+++||+|.||.||+|++.. +++.||+|.+..+. ..+...-..+|+.||++|+||||+++.+...+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~----tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLE----TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecc----cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 34689999999999999999999877 57889999887654 334455677999999999999999999998765
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
..+|||+|||+. +|..++.. ..-.|++.++..+++||+.||+|||.+||+|||||.+|||||.+|.+||+
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~---------p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSS---------PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred ceEEEEEecccc-hhhhhhcC---------CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEec
Confidence 789999999976 99988864 45578999999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcCcc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV-KGKSS 352 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i-~~~~~ 352 (364)
|||+|+....... ...+..+.|..|.|||.+++. .|+.++|+||+||||.||++ |++.|++.++.+-++.| +-...
T Consensus 261 DFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~-gkPI~~G~tEveQl~kIfklcGS 338 (560)
T KOG0600|consen 261 DFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL-GKPILQGRTEVEQLHKIFKLCGS 338 (560)
T ss_pred cccceeeccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc-CCCCcCCccHHHHHHHHHHHhCC
Confidence 9999996655432 235556679999999999875 49999999999999999999 99999999988877766 43444
Q ss_pred ccccCCC
Q psy7023 353 NEYKVNP 359 (364)
Q Consensus 353 ~~~~~~~ 359 (364)
....+|+
T Consensus 339 P~e~~W~ 345 (560)
T KOG0600|consen 339 PTEDYWP 345 (560)
T ss_pred CChhccc
Confidence 4444566
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.69 Aligned_cols=216 Identities=26% Similarity=0.425 Sum_probs=191.6
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEee
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSE 193 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~ 193 (364)
.-.++|.++++||+|+||+|+++..+. ++..+|||++++.. ...+.+..+.|.+|+... +||.+++++..|+.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~----~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKG----TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcC----CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 344789999999999999999999998 46689999998764 455577888999999887 59999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+++|+||||+.||++..+++ ...+++.++.-+++.|+.||.|||++||||||||.+|||+|.+|.+||
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~-----------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIH-----------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEe-----------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEe
Confidence 999999999999999655443 356888999999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+|||+++...... ...++..|||.|||||++.+..|+.++|+|||||+||||+. |+.||.+.+++|+.+.|...
T Consensus 510 ADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~-Gq~PF~gddEee~FdsI~~d 583 (694)
T KOG0694|consen 510 ADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV-GESPFPGDDEEEVFDSIVND 583 (694)
T ss_pred cccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Confidence 9999998654322 24455678999999999999999999999999999999999 99999999999999998765
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=322.91 Aligned_cols=212 Identities=22% Similarity=0.333 Sum_probs=182.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|+.+.++|+|+||+||++++++ +++.||||.+.+..+ ....+-.++|+++|++++|+|+|.++++|.....++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~----TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD----TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC----cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 478889999999999999999998 578899999887655 444566789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
||+|||+. ++.+-+... ...++...+..++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+
T Consensus 78 LVFE~~dh-TvL~eLe~~---------p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERY---------PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred EEeeecch-HHHHHHHhc---------cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchh
Confidence 99999976 666666652 23466788999999999999999999999999999999999999999999999
Q ss_pred ccccCc-cceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 279 TRDIYE-TEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 279 a~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
|+.+.. .+.+ +..+-|..|.|||.+.+ .+|+..+||||+||++.||++ |.+-|++.++-+.+-.|+.
T Consensus 148 AR~L~~pgd~Y---TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~-G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 148 ARTLSAPGDNY---TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT-GEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred hHhhcCCcchh---hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc-CCcCCCCcchHHHHHHHHH
Confidence 998874 2222 23334678999999987 679999999999999999999 9999999888776666554
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=364.17 Aligned_cols=243 Identities=45% Similarity=0.778 Sum_probs=222.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccc-cccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSL-AEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
+.+...++.+.||+|.||.||.|...+.... ....||+|.+++..+..+..+|++|..+|+.++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 5567888999999999999999998775432 155699999999988999999999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..+|++|||+||+|..||++.++... ....++..+++.++.||++|+.||+++++|||||..+|+||+....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~---~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPF---QPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccC---CCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999998765554 356789999999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
||+|+++.+.++++.......+.+|||||.+.++.++.++|||||||+|||++|.|..||.+.++.+++..+..+.+++.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~ 925 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP 925 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence 99999999999988888877789999999999999999999999999999999999999999999999997766669999
Q ss_pred cCCCCCC
Q psy7023 356 KVNPPIS 362 (364)
Q Consensus 356 ~~~~~~s 362 (364)
|..||-.
T Consensus 926 P~~CP~~ 932 (1025)
T KOG1095|consen 926 PSYCPEK 932 (1025)
T ss_pred CCCCChH
Confidence 9999853
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=342.05 Aligned_cols=308 Identities=34% Similarity=0.560 Sum_probs=248.9
Q ss_pred cceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeeeeeeeCCCCCCccccccCCCCC--------CC-CC---
Q psy7023 26 RGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVAVILTGSGGPAVTTTTVATPTT--------PA-GG--- 93 (364)
Q Consensus 26 ~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sg~~~~~~~~~~~~~~--------~~-~~--- 93 (364)
-|.||+||| |.+-+-++.|++. -+.++||.|... ..|.-.++..+...... -+ +.
T Consensus 173 nGSFLVRES-----EsSpgQ~sISlRy----eGRVyHYRINt~----~dgK~yvt~EsrF~TLaELVHHHStvADGLitt 239 (1157)
T KOG4278|consen 173 NGSFLVRES-----ESSPGQYSISLRY----EGRVYHYRINTD----NDGKMYVTQESRFRTLAELVHHHSTVADGLITT 239 (1157)
T ss_pred ccceEEeec-----cCCCcceeEEEEe----cceEEEEEeecc----CCccEEEeehhhhhHHHHHHhhccccccceeEe
Confidence 599999999 7888888888885 246899998874 34433333222111110 00 00
Q ss_pred -CCCCCCCCCCCCCcccccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHH
Q psy7023 94 -TTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNE 172 (364)
Q Consensus 94 -~~~~~~~~~~~~~~~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E 172 (364)
--+.|.........-.-..+.||.-+.+..+..+||-|.||.||.|.|+.. ...||||.++++.. ..++|+.|
T Consensus 240 LhYPApK~nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky----slTvAVKtLKEDtM--eveEFLkE 313 (1157)
T KOG4278|consen 240 LHYPAPKKNKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTM--EVEEFLKE 313 (1157)
T ss_pred eeccCccCCCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeecc----ceeeehhhhhhcch--hHHHHHHH
Confidence 000111000000011113478999999999999999999999999999983 56799999987754 46899999
Q ss_pred HHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC
Q psy7023 173 ASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK 252 (364)
Q Consensus 173 ~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~ 252 (364)
+.+|+.++|||+|+++++|..+-.+|||+|||..|+|.+||+++. +...+.-.+++|+.||..||+||..++
T Consensus 314 AAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn--------r~ev~avvLlyMAtQIsSaMeYLEkkn 385 (1157)
T KOG4278|consen 314 AAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECN--------RSEVPAVVLLYMATQISSAMEYLEKKN 385 (1157)
T ss_pred HHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhc--------hhhcchhHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999999999999999854 334556678999999999999999999
Q ss_pred ceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCC
Q psy7023 253 FVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLAS 332 (364)
Q Consensus 253 iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~ 332 (364)
+|||||...|+||.++..+|++|||+++.+....+..... ...++.|.|||.+....++.++|||+|||+|||+.|.|-
T Consensus 386 FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGM 464 (1157)
T KOG4278|consen 386 FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGM 464 (1157)
T ss_pred hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999887766544333 334789999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhcCccccccCCCCC
Q psy7023 333 QPYQGLSNEQVLNWVKGKSSNEYKVNPPI 361 (364)
Q Consensus 333 ~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 361 (364)
.||.+.+..++++.+++|++++-|..||-
T Consensus 465 sPYPGidlSqVY~LLEkgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 465 SPYPGIDLSQVYGLLEKGYRMDGPEGCPP 493 (1157)
T ss_pred CCCCCccHHHHHHHHhccccccCCCCCCH
Confidence 99999999999999999999999999985
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=336.52 Aligned_cols=224 Identities=21% Similarity=0.321 Sum_probs=191.4
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC----HHHHHHHHHHHHHHHhcC-CcceeEEEEEE
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS----EREKAEFLNEASVMKAFD-THHVVKLYGVV 191 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~il~~l~-h~~iv~l~~~~ 191 (364)
....+|.+.+.||+|+||+|++|.+.. ++..||+|++++... ....+.+.+|+.++++++ ||||+++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~----t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL----TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc----CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 455799999999999999999998876 468899998876411 133456678999999999 99999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-Cc
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD-LT 270 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~-~~ 270 (364)
.....+|+||||+.||+|++++.+ ..++.+..+..+++|++.|++|||++||+||||||+|||++.+ ++
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~----------~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVN----------KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHH----------cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC
Confidence 999999999999999999999975 3456678899999999999999999999999999999999999 99
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FT-SHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+||+|||++..... .........|++.|+|||++.+.. |+ .++||||+||+||.|++ |..||.+.+...++..|.
T Consensus 160 ~Kl~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~-G~~PF~d~~~~~l~~ki~ 236 (370)
T KOG0583|consen 160 LKLSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC-GRLPFDDSNVPNLYRKIR 236 (370)
T ss_pred EEEeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCccHHHHHHHHh
Confidence 99999999987741 112234456799999999999988 85 78999999999999999 999999998888888877
Q ss_pred cCccccccCC
Q psy7023 349 GKSSNEYKVN 358 (364)
Q Consensus 349 ~~~~~~~~~~ 358 (364)
.+. ..+|.+
T Consensus 237 ~~~-~~~p~~ 245 (370)
T KOG0583|consen 237 KGE-FKIPSY 245 (370)
T ss_pred cCC-ccCCCC
Confidence 764 344443
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=340.44 Aligned_cols=240 Identities=34% Similarity=0.669 Sum_probs=208.6
Q ss_pred ccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccc--ccCHHHHHHHHHHHHHHHhcCCcceeEE
Q psy7023 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANE--NASEREKAEFLNEASVMKAFDTHHVVKL 187 (364)
Q Consensus 110 ~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~l 187 (364)
.....|+...++..+.++||+|+||.||+|..+.........||+|..+. ........+|++|+++|++++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 34677999999999999999999999999998875442233399999884 3566778899999999999999999999
Q ss_pred EEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7023 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267 (364)
Q Consensus 188 ~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~ 267 (364)
||+......+++|||+|.||+|.++|++. ...++..+...++.+.+.||+|||++++|||||-.+|+|++.
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~---------~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKN---------KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK 297 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC
Confidence 99999999999999999999999999873 225788899999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
++.+||+|||+++.-. .+.........+.+|+|||.+..+.|+.++|||||||++||+++.|..||.+....++..+|
T Consensus 298 ~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred CCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 9999999999987654 22222222245789999999999999999999999999999999888899999999999999
Q ss_pred -hcCccccccCCCC
Q psy7023 348 -KGKSSNEYKVNPP 360 (364)
Q Consensus 348 -~~~~~~~~~~~~~ 360 (364)
..++++..+.-+|
T Consensus 376 ~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTP 389 (474)
T ss_pred HhcCccCCCCCCCH
Confidence 7788887766544
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=310.04 Aligned_cols=226 Identities=20% Similarity=0.351 Sum_probs=190.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.+|..+++||+|.||.||+|++.. +++.||||.++... .+......++|++.|+.++|+||+.++++|...+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~----t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE----TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC----CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 478889999999999999999877 57889999887553 2333556789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
||+|||+. +|...++. ....++..++..++.++++||+|||++.|+||||||+|+|++++|.+||+|||+
T Consensus 78 lVfEfm~t-dLe~vIkd---------~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 78 LVFEFMPT-DLEVVIKD---------KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEEEeccc-cHHHHhcc---------cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccc
Confidence 99999965 99999985 556788899999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcCcccccc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV-KGKSSNEYK 356 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~ 356 (364)
|+.+....... +..+.|..|.|||.+.+.+ |+..+||||.|||+.||+- +.+.|+|.++-|-+..| +.-.-....
T Consensus 148 Ar~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll-r~P~fpG~sDidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 148 ARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL-RVPFFPGDSDIDQLSKIFRALGTPTPD 224 (318)
T ss_pred hhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc-cCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence 99877554322 2225578899999987755 8999999999999999998 88888988876666655 433344555
Q ss_pred CCCCCC
Q psy7023 357 VNPPIS 362 (364)
Q Consensus 357 ~~~~~s 362 (364)
.||..+
T Consensus 225 ~WP~~~ 230 (318)
T KOG0659|consen 225 QWPEMT 230 (318)
T ss_pred cCcccc
Confidence 666543
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.89 Aligned_cols=226 Identities=20% Similarity=0.438 Sum_probs=202.2
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
..++.+|++.+.||+|.||+|-+|..+. .++.||||.++++. ++.+.-.+.+|++||..|+||||+.+|++|+.
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~----sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN 124 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHK----SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN 124 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhcc----CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence 3467899999999999999999998655 58899999998765 44556678899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+.+.|||||..+|.|+||+.+ ...+++.+...+++||+.|+.|+|+++++|||||.+|||+|+++++||
T Consensus 125 kdKIvivMEYaS~GeLYDYiSe----------r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKI 194 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISE----------RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKI 194 (668)
T ss_pred CceEEEEEEecCCccHHHHHHH----------hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeee
Confidence 9999999999999999999975 456788899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+|||++..+.+..+.. ...|.|-|.+||++.+.+| ++.+|-||||++||.|+. |.+||+|.+...++.||..|..
T Consensus 195 ADFGLSNly~~~kfLq---TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVy-GtMPFDG~Dhk~lvrQIs~GaY 270 (668)
T KOG0611|consen 195 ADFGLSNLYADKKFLQ---TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVY-GTMPFDGRDHKRLVRQISRGAY 270 (668)
T ss_pred eccchhhhhccccHHH---HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhh-cccccCCchHHHHHHHhhcccc
Confidence 9999998877765543 3456888999999999998 578999999999999998 9999999999999999999988
Q ss_pred ccccCCC
Q psy7023 353 NEYKVNP 359 (364)
Q Consensus 353 ~~~~~~~ 359 (364)
.+++.+.
T Consensus 271 rEP~~PS 277 (668)
T KOG0611|consen 271 REPETPS 277 (668)
T ss_pred cCCCCCc
Confidence 8776543
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=322.10 Aligned_cols=224 Identities=23% Similarity=0.389 Sum_probs=194.7
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.|..-.+.|++..+||.|..++||+|++.. .+..||||+++-+......+.+.+|++.|+.++||||++++..|..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p----~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIP----TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecc----cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 344455799999999999999999999887 4678999999988877778999999999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
+..+|+||.||.+|++.++++..-+ ..+.+..+..|++++++||.|||++|.||||||+.||||+++|.|||
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~--------~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYP--------DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHcc--------ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEE
Confidence 9999999999999999999997543 23677889999999999999999999999999999999999999999
Q ss_pred eecccccccCccceee-eC-CCCCCCccccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 274 GDFGMTRDIYETEYYR-KG-SRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~-~~-~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+|||.+..+.+..... .. ....+++.|||||+++. ..|+.|+||||||++..||++ |+.||..+.+.+++-.-.+
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~-G~aPf~k~pPmkvLl~tLq 246 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH-GHAPFSKYPPMKVLLLTLQ 246 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc-CCCCcccCChHHHHHHHhc
Confidence 9999987766543211 11 44577999999999643 459999999999999999999 9999999999887754333
Q ss_pred C
Q psy7023 350 K 350 (364)
Q Consensus 350 ~ 350 (364)
+
T Consensus 247 n 247 (516)
T KOG0582|consen 247 N 247 (516)
T ss_pred C
Confidence 3
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=314.64 Aligned_cols=226 Identities=22% Similarity=0.345 Sum_probs=189.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEe--eCCc
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVS--EGNP 196 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~ 196 (364)
+.|+.+.+|++|+||.||+|+++. +++.||+|.++-+. .....-..++|+.+|.+++|||||.+-++.. +-+.
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~----t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKK----TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCC----cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 678899999999999999999988 56779999987543 2222345678999999999999999999876 4467
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+|+|||||+. +|...+...+ .++...++..++.|+++|++|||.+.|+||||||+|+|+.+.|.+||+||
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~---------q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMK---------QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhcc---------CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEeccc
Confidence 9999999977 9999998732 46788899999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCcccc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK-GKSSNE 354 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~ 354 (364)
|+|+.+.... ...+..+.|..|.|||.+.+.+ |+.++||||+|||+.||++ +.+-|+|.++.+-++.|- .-.-..
T Consensus 222 GLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~-~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 222 GLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT-QKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred chhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh-cCCCCCCCchHHHHHHHHHHhCCCc
Confidence 9999877652 3345556689999999998765 8999999999999999999 899999999887777663 222334
Q ss_pred ccCCCCCC
Q psy7023 355 YKVNPPIS 362 (364)
Q Consensus 355 ~~~~~~~s 362 (364)
...||.++
T Consensus 299 e~iwpg~~ 306 (419)
T KOG0663|consen 299 EAIWPGYS 306 (419)
T ss_pred cccCCCcc
Confidence 44666665
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=338.21 Aligned_cols=218 Identities=24% Similarity=0.365 Sum_probs=193.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.-|++++.||.|+.|.|-+|++.. +++.+|||++.+. ..+.....+.+|+-||+.+.|||++++|+++++..++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~----TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE----TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cceeccccccCCCCceehhhhccc----ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 457789999999999999998877 6888999998765 2334456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+|+||++||.|++++.+ .+++++.+.++++.||+.|+.|||..+|+||||||+|+|++..+++||+|||
T Consensus 88 ylvlEyv~gGELFdylv~----------kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVR----------KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred EEEEEecCCchhHHHHHh----------hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccc
Confidence 999999999999999975 4567788899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
+|.......... ...|.|+|.|||++.+.+| +.++||||+|||||.|+| |..||++.+...++..|++|....+
T Consensus 158 MAsLe~~gklLe---TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt-G~LPFdDdNir~LLlKV~~G~f~MP 232 (786)
T KOG0588|consen 158 MASLEVPGKLLE---TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT-GKLPFDDDNIRVLLLKVQRGVFEMP 232 (786)
T ss_pred eeecccCCcccc---ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh-CCCCCCCccHHHHHHHHHcCcccCC
Confidence 998655544332 2346899999999999999 568999999999999999 9999999999999999999976544
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=333.24 Aligned_cols=214 Identities=23% Similarity=0.407 Sum_probs=191.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|.+.+.||+|+||.||+|+.|. +...||+|.+.+. ..+.+.+.+.+|++|++.++||||+.++++|+...++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~----t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY----TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc----ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence 478888999999999999999887 5778999988754 45556788999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|+||+.| +|+.++.. ...++++.+..++.+++.||.|||+++|+|||+||.|||++.+|.+|+||||+
T Consensus 78 vVte~a~g-~L~~il~~----------d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQ----------DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred EEehhhhh-hHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhh
Confidence 99999976 99999974 45688899999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|+.+..+... .+...|||.|||||.+.+..|+..+|+|||||++|||++ |++||-..+..++++.|....
T Consensus 147 Ar~m~~~t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~-G~PPF~a~si~~Lv~~I~~d~ 216 (808)
T KOG0597|consen 147 ARAMSTNTSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYV-GQPPFYARSITQLVKSILKDP 216 (808)
T ss_pred hhhcccCcee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhc-CCCCchHHHHHHHHHHHhcCC
Confidence 9987765433 334457999999999999999999999999999999999 999999888888888776543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.90 Aligned_cols=228 Identities=22% Similarity=0.342 Sum_probs=190.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|.++. .++.||+|++.... .......+.+|+.+++.++|+||+++++.+.+...+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD----TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeE
Confidence 468899999999999999998876 46789999987532 223345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||++||+|.+++.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMK----------KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred EEEEcCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeecc
Confidence 999999999999999975 2357788999999999999999999999999999999999999999999999
Q ss_pred cccccCcccee---------------------------------eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHH
Q psy7023 278 MTRDIYETEYY---------------------------------RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324 (364)
Q Consensus 278 ~a~~~~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 324 (364)
+++.+...... .......+|+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 98754321100 001123578999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCc-cccccCCCCCC
Q psy7023 325 WEMATLASQPYQGLSNEQVLNWVKGKS-SNEYKVNPPIS 362 (364)
Q Consensus 325 ~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~s 362 (364)
|||++ |..||.+.+..+....+.... ...++.+.++|
T Consensus 227 ~ell~-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 264 (363)
T cd05628 227 YEMLI-GYPPFCSETPQETYKKVMNWKETLIFPPEVPIS 264 (363)
T ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCC
Confidence 99999 899999999888888876543 33455555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=324.57 Aligned_cols=241 Identities=35% Similarity=0.643 Sum_probs=191.7
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~ 192 (364)
|++..++|++.++||+|+||.||+|.+.... ......||+|+++..........+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 6677889999999999999999999864322 2245689999998665555667899999999999 8999999999887
Q ss_pred e-CCceEEEEecCCCCCHHHHHHhcCCCCC--------------------------------------------------
Q psy7023 193 E-GNPTLVIMELMGGGDLKNYLRSCRPDAE-------------------------------------------------- 221 (364)
Q Consensus 193 ~-~~~~~lv~e~~~ggsL~~~l~~~~~~~~-------------------------------------------------- 221 (364)
. +..+++||||+++|+|.+++........
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 5 4468999999999999999986431100
Q ss_pred --CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCcc
Q psy7023 222 --TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299 (364)
Q Consensus 222 --~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~ 299 (364)
......++++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++...............+++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 001124578889999999999999999999999999999999999999999999999986544332222223334678
Q ss_pred ccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCccccc
Q psy7023 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQVLNWVKGKSSNEY 355 (364)
Q Consensus 300 y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~~~~~i~~~~~~~~ 355 (364)
|+|||++.+..++.++|||||||++|||++.|..||.+... .++...+..+.....
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA 298 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCC
Confidence 99999999999999999999999999999778999987654 445556665554433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=330.29 Aligned_cols=213 Identities=23% Similarity=0.422 Sum_probs=185.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCC-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGN- 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~- 195 (364)
+.++|.++++||.|+||.||+|+.+. .+..||||.+++....-+..--++|++.|+++. ||||+++.+++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~----~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE----TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC----CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 45799999999999999999999887 466699999987654444444568999999998 999999999999887
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
.+|+|||||+. +|++.++. ....++++.+..|+.||++||+|+|++|+.|||+||+|||+.....+||+|
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~---------R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKD---------RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhh---------cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecc
Confidence 99999999955 99999986 467899999999999999999999999999999999999999888999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
||+|+.+.....++. .+.|..|+|||++.. +-|+.+.||||+|||++|+++ -++-|+|.++-+-+..|.
T Consensus 154 FGLARev~SkpPYTe---YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~s-LrPLFPG~sE~Dqi~KIc 223 (538)
T KOG0661|consen 154 FGLAREVRSKPPYTE---YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYS-LRPLFPGASEIDQIYKIC 223 (538)
T ss_pred cccccccccCCCcch---hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHH-hcccCCCCcHHHHHHHHH
Confidence 999998877655443 344778999999864 558999999999999999999 899999998876665554
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=313.67 Aligned_cols=230 Identities=23% Similarity=0.362 Sum_probs=194.6
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
-+.|++++.||+|.-|+||++..++ +...+|+|++.+... .....+...|.+||+.++||.+++||..|+.++.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~----t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRG----TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecC----CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 3688999999999999999999988 457899999987643 2334567789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.|+|||||+||+|+...+++ ..+.++++.++.++.+++.||+|||.+|||+|||||+||||.++|++.|+||
T Consensus 152 ~cl~meyCpGGdL~~LrqkQ--------p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQ--------PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred eEEEEecCCCccHHHHHhhC--------CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeec
Confidence 99999999999999998873 4567889999999999999999999999999999999999999999999999
Q ss_pred ccccccCcc----------------------------------c--------------------eeeeCCCCCCCccccC
Q psy7023 277 GMTRDIYET----------------------------------E--------------------YYRKGSRGFLPVRWMA 302 (364)
Q Consensus 277 g~a~~~~~~----------------------------------~--------------------~~~~~~~~~~~~~y~a 302 (364)
.++...... . ...+....+||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 987532110 0 0011223456888999
Q ss_pred cccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCCCCC
Q psy7023 303 PESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPIS 362 (364)
Q Consensus 303 PE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~s 362 (364)
||++.+...+.++|+|+|||++|||+. |..||.|.++++++.+|... ...+|..+.+|
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLy-G~TPFKG~~~~~Tl~NIv~~-~l~Fp~~~~vs 361 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLY-GTTPFKGSNNKETLRNIVGQ-PLKFPEEPEVS 361 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHh-CCCCcCCCCchhhHHHHhcC-CCcCCCCCcch
Confidence 999999999999999999999999999 89999999999999888655 33455555444
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=331.03 Aligned_cols=226 Identities=27% Similarity=0.433 Sum_probs=200.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.+..|....+||+|+.|.||.|+... .+..||||.+....... .+-+++|+.+|+..+|+|||++++.|...+.+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~----~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKIS----TKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred hhhhhcchhhhccccccceeeeeecc----CCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 45678889999999999999998776 46679999987655432 46688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+|||||+||+|.|.+.. ..+++.++..|.++++.||+|||.+||||||||.+|||++.+|.+||+|||
T Consensus 346 WVVMEym~ggsLTDvVt~-----------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFG 414 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTK-----------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFG 414 (550)
T ss_pred EEEEeecCCCchhhhhhc-----------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeee
Confidence 999999999999999865 237889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
++..+..... ....-+|||.|||||++....|+.++||||||+|++||+. |.+||-..++-..+..|......+...
T Consensus 415 Fcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMve-GEPPYlnE~PlrAlyLIa~ng~P~lk~ 491 (550)
T KOG0578|consen 415 FCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPKLKN 491 (550)
T ss_pred eeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhc-CCCCccCCChHHHHHHHhhcCCCCcCC
Confidence 9988776654 4455678999999999999999999999999999999999 999999888888888888887777777
Q ss_pred CCCCC
Q psy7023 358 NPPIS 362 (364)
Q Consensus 358 ~~~~s 362 (364)
+..+|
T Consensus 492 ~~klS 496 (550)
T KOG0578|consen 492 PEKLS 496 (550)
T ss_pred ccccC
Confidence 76665
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=330.40 Aligned_cols=219 Identities=21% Similarity=0.301 Sum_probs=189.7
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-Cc-----ceeE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-TH-----HVVK 186 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~-----~iv~ 186 (364)
-..+.+..+|++++.||+|+||+|.+|.+.. +++.||||+++... ....+...|+.+|..|+ |. |+|+
T Consensus 179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~----T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr 252 (586)
T KOG0667|consen 179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHK----TGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVR 252 (586)
T ss_pred EecceeEEEEEEEEEecccccceeEEEEecC----CCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence 3345566799999999999999999999887 57789999998654 34556667999999997 43 8999
Q ss_pred EEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 187 l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
++++|...+++|||+|.+ ..+|+++++.+ ....+++..++.|+.||+.||.+||+.+|||+||||+||||.
T Consensus 253 m~d~F~fr~HlciVfELL-~~NLYellK~n--------~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~ 323 (586)
T KOG0667|consen 253 MLDYFYFRNHLCIVFELL-STNLYELLKNN--------KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLK 323 (586)
T ss_pred eeeccccccceeeeehhh-hhhHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeec
Confidence 999999999999999999 56999999984 456689999999999999999999999999999999999997
Q ss_pred C--CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 267 D--DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 267 ~--~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+ ...+||+|||.|+...+..+.-.+ +..|+|||++.+.+|+.+.||||||||++||++ |.+.|+|.++.+.+
T Consensus 324 ~~~r~~vKVIDFGSSc~~~q~vytYiQ-----SRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~t-G~PLfpG~ne~DQl 397 (586)
T KOG0667|consen 324 DPKRSRIKVIDFGSSCFESQRVYTYIQ-----SRFYRAPEVILGLPYDTAIDMWSLGCILAELFT-GEPLFPGDNEYDQL 397 (586)
T ss_pred cCCcCceeEEecccccccCCcceeeee-----ccccccchhhccCCCCCccceeehhhhHHhHhc-CccccCCCCHHHHH
Confidence 5 347999999999987766553333 445999999999999999999999999999999 89999999999988
Q ss_pred HHHhcCcc
Q psy7023 345 NWVKGKSS 352 (364)
Q Consensus 345 ~~i~~~~~ 352 (364)
..|.+--.
T Consensus 398 ~~I~e~lG 405 (586)
T KOG0667|consen 398 ARIIEVLG 405 (586)
T ss_pred HHHHHHhC
Confidence 88765433
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=307.12 Aligned_cols=230 Identities=21% Similarity=0.359 Sum_probs=197.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
.+.+.|++.++||+|.|+.|+++.++. +++.+|+|+++... .....+.+.+|++|.+.|+||||+++.+.+.+..
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~----tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKT----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhcc----chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 355789999999999999999998776 57888999887432 3335678889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCcEE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVK 272 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~---~~~~~k 272 (364)
..|+|+|+|+|++|..-|..+ .-+++..+...++||+++|.|+|.+||||||+||+|+|+. ....+|
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R----------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred eeEEEEecccchHHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCcee
Confidence 999999999999998666532 2356677888999999999999999999999999999995 345799
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||+|..+.+.. .-....|||.|||||++...+|+..+|||+.|++||-|+. |.+||.+.+...++++|.+|..
T Consensus 154 L~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~-G~~PF~~~~~~rlye~I~~g~y 229 (355)
T KOG0033|consen 154 LADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYEQIKAGAY 229 (355)
T ss_pred ecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhcccc
Confidence 99999999887332 2233467999999999999999999999999999999999 9999999999999999976654
Q ss_pred -ccccCCCCCCCC
Q psy7023 353 -NEYKVNPPISLS 364 (364)
Q Consensus 353 -~~~~~~~~~s~~ 364 (364)
++.++|+.||.|
T Consensus 230 d~~~~~w~~is~~ 242 (355)
T KOG0033|consen 230 DYPSPEWDTVTPE 242 (355)
T ss_pred CCCCcccCcCCHH
Confidence 577799999864
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=331.38 Aligned_cols=225 Identities=28% Similarity=0.484 Sum_probs=191.5
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYG 189 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~ 189 (364)
....|++..+.+.++..||+|.||+||+|+|.+ .||||+++... ..+..+.|++|+.++++-+|.||+-+.|
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG 455 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG 455 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence 347899999999999999999999999999987 49999998543 4556789999999999999999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
++..... .||+.+|+|-+|+.+++. ....+....+++||+||++||.|||.++|||||||..|||+.+++
T Consensus 456 ~~~~p~~-AIiTqwCeGsSLY~hlHv---------~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~ 525 (678)
T KOG0193|consen 456 ACMNPPL-AIITQWCEGSSLYTHLHV---------QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL 525 (678)
T ss_pred hhcCCce-eeeehhccCchhhhhccc---------hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC
Confidence 9998766 999999999999999985 445678889999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
+|||+|||++..-..-..........+...|||||+++. .+|+..+||||||+++|||+| |..||.....++++-+
T Consensus 526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELlt-g~lPysi~~~dqIifm 604 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLT-GELPYSIQNRDQIIFM 604 (678)
T ss_pred cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHh-CcCCcCCCChhheEEE
Confidence 999999999863221111111111223567999999964 458999999999999999999 9999998888888888
Q ss_pred HhcCccc
Q psy7023 347 VKGKSSN 353 (364)
Q Consensus 347 i~~~~~~ 353 (364)
+-+|+.+
T Consensus 605 VGrG~l~ 611 (678)
T KOG0193|consen 605 VGRGYLM 611 (678)
T ss_pred ecccccC
Confidence 8777544
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=309.87 Aligned_cols=243 Identities=67% Similarity=1.096 Sum_probs=202.5
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
|++..++|++.+.||+|+||.||+|.++.. .......||+|++..........++.+|+.+++.++|+||+++++++.+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 567788999999999999999999987642 1224567999998765555556778999999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
+...++||||+++++|.+++.+.............+++..+..++.|++.||+|||+.+++|+||||+|||+++++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999999875433332222345678889999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||++................+++.|+|||.+.+..++.++||||||+++|||++++..||.+.+..+.++.+..+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999986655444333333445678999999998889999999999999999999889999999998888887776554
Q ss_pred cccC
Q psy7023 354 EYKV 357 (364)
Q Consensus 354 ~~~~ 357 (364)
+.+.
T Consensus 241 ~~~~ 244 (277)
T cd05062 241 DKPD 244 (277)
T ss_pred CCCC
Confidence 4433
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=316.66 Aligned_cols=229 Identities=22% Similarity=0.353 Sum_probs=187.7
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-------------HHHHHHHHHHHHHHhcCCc
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-------------REKAEFLNEASVMKAFDTH 182 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~il~~l~h~ 182 (364)
....+.|++++.||+|.||.|-+|++.. .++.||||++.+.... ...+...+|+.||++|+||
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~----~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~ 168 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV----DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP 168 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC----CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence 3445789999999999999999998776 5778999999754211 1135788999999999999
Q ss_pred ceeEEEEEEee--CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCC-ccHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7023 183 HVVKLYGVVSE--GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP-PTLSRILQMAAEVADGMAYLADKKFVHRDLA 259 (364)
Q Consensus 183 ~iv~l~~~~~~--~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~-~~~~~~~~i~~qil~~L~~LH~~~iiHrDlk 259 (364)
|||+|+++..+ .+.+|||+|||..|.+... ....+ +++.+++.++++++.||+|||.+||||||||
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-----------p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIK 237 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-----------PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIK 237 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccC-----------CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccc
Confidence 99999999975 5789999999998877432 12333 8899999999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEeecccccccCcc---ceeeeCCCCCCCccccCcccccCCC---C-CCchhHHHHHHHHHHHHhCCC
Q psy7023 260 ARNCMVADDLTVKVGDFGMTRDIYET---EYYRKGSRGFLPVRWMAPESLKDGV---F-TSHSDVWSYGVVLWEMATLAS 332 (364)
Q Consensus 260 p~NILl~~~~~~kL~DFg~a~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~---~-~~~~DiwslG~il~el~t~g~ 332 (364)
|+|+||+++|++||+|||.+...... .....-...+|||.|+|||...++. + +.+.||||+||+||.|+. |+
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf-G~ 316 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF-GQ 316 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh-cc
Confidence 99999999999999999998765221 1112223357899999999987733 3 568899999999999999 99
Q ss_pred CCCCCCCHHHHHHHHhcCccccccCCCCC
Q psy7023 333 QPYQGLSNEQVLNWVKGKSSNEYKVNPPI 361 (364)
Q Consensus 333 ~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 361 (364)
.||-+....++++.|... +..+|..+.|
T Consensus 317 ~PF~~~~~~~l~~KIvn~-pL~fP~~pe~ 344 (576)
T KOG0585|consen 317 LPFFDDFELELFDKIVND-PLEFPENPEI 344 (576)
T ss_pred CCcccchHHHHHHHHhcC-cccCCCcccc
Confidence 999999999999999877 4566666544
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=309.01 Aligned_cols=230 Identities=24% Similarity=0.384 Sum_probs=188.3
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcc-eeEEEEEEeeCC-
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHH-VVKLYGVVSEGN- 195 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~- 195 (364)
...|+.+++||+|+||+||+|+.+. ++..||+|.+.-... +.......+|+.+|+.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~----~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR----TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec----CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 4568888899999999999999887 467899999876544 334456678999999999999 999999998777
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 196 -----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 196 -----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
.+++|+||++ -+|..++....+.. ..++...+..+++||+.||+|||+++|+||||||+||||+++|.
T Consensus 86 ~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLD-RDLKKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV 158 (323)
T ss_pred ccccceEEEEEEeec-ccHHHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc
Confidence 8999999995 59999998754221 24555789999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+||+|||+|+...-+. ...+...+|..|.|||++.+. .|+...||||+|||++||++ +++-|.+.++.+.+..|-+
T Consensus 159 lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred EeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHH
Confidence 9999999998554322 234555678899999999987 58999999999999999999 8999999888777766632
Q ss_pred C-ccccccCCCCCC
Q psy7023 350 K-SSNEYKVNPPIS 362 (364)
Q Consensus 350 ~-~~~~~~~~~~~s 362 (364)
. .-.....||.++
T Consensus 236 ~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVS 249 (323)
T ss_pred HcCCCCccCCCCcc
Confidence 2 222334555544
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=314.62 Aligned_cols=213 Identities=24% Similarity=0.396 Sum_probs=175.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC--ce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN--PT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~ 197 (364)
.++...+.||+|+||.||++.+++ .+...|||......... .+.+.+|+.+|++++|||||++++...... .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~----~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK----TGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecC----CCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 467778899999999999999886 36779999887654333 667889999999999999999999754433 68
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeec
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-DLTVKVGDF 276 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kL~DF 276 (364)
+++|||+.+|+|.+++... .. .+++..++.+++||++||+|||++|||||||||+|||++. ++.+||+||
T Consensus 92 ~i~mEy~~~GsL~~~~~~~--------g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDF 162 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRY--------GG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADF 162 (313)
T ss_pred EeeeeccCCCcHHHHHHHc--------CC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccC
Confidence 9999999999999999873 22 6889999999999999999999999999999999999999 799999999
Q ss_pred ccccccCc-cceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Q psy7023 277 GMTRDIYE-TEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQG-LSNEQVLNWV 347 (364)
Q Consensus 277 g~a~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~-~~~~~~~~~i 347 (364)
|++..... ...........+|+.|||||++..+. ...++|||||||++.||+| |.+||.. ....+.+-.+
T Consensus 163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T-g~~PW~~~~~~~~~~~~i 235 (313)
T KOG0198|consen 163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT-GKPPWSEFFEEAEALLLI 235 (313)
T ss_pred ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC-CCCcchhhcchHHHHHHH
Confidence 99987664 11112233456789999999999633 3459999999999999999 7999988 4444433333
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=324.28 Aligned_cols=227 Identities=22% Similarity=0.288 Sum_probs=185.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
+|+++++||+|+||+||+|+++. .+..||+|++.... .......+.+|+.+++.++|+||+++++.+.+++.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD----TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEE
Confidence 68899999999999999999876 46789999987532 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 78 lv~E~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM----------GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCC
Confidence 999999999999999752 3467788899999999999999999999999999999999999999999999
Q ss_pred ccccCccce---------------------------------------------eeeCCCCCCCccccCcccccCCCCCC
Q psy7023 279 TRDIYETEY---------------------------------------------YRKGSRGFLPVRWMAPESLKDGVFTS 313 (364)
Q Consensus 279 a~~~~~~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~ 313 (364)
+..+..... ........+|+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 753321000 00011235688999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-ccccccCCCCCC
Q psy7023 314 HSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK-SSNEYKVNPPIS 362 (364)
Q Consensus 314 ~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~s 362 (364)
++|||||||++|||++ |++||.+.++.+....+... .....+.++.+|
T Consensus 228 ~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 276 (382)
T cd05625 228 LCDWWSVGVILYEMLV-GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLS 276 (382)
T ss_pred eeeEEechHHHHHHHh-CCCCCCCCCHHHHHHHHHccCCCcCCCCcccCC
Confidence 9999999999999999 89999988887766655442 233444444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=323.30 Aligned_cols=214 Identities=23% Similarity=0.307 Sum_probs=180.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.|++++.||+|+||+||+|+++. ++..||+|++.... .......+.+|+.+++.++|+||+++++++.+.+.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD----THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEE
Confidence 68899999999999999999876 46789999986532 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus 78 lv~E~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM----------EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 999999999999999752 3467788889999999999999999999999999999999999999999999
Q ss_pred ccccCcccee---------------------------------------------eeCCCCCCCccccCcccccCCCCCC
Q psy7023 279 TRDIYETEYY---------------------------------------------RKGSRGFLPVRWMAPESLKDGVFTS 313 (364)
Q Consensus 279 a~~~~~~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 313 (364)
+..+...... .......+|+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 7643210000 0011235788999999999989999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 314 HSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 314 ~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
++|||||||++|||+| |..||...+..+....+..
T Consensus 228 ~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~ 262 (381)
T cd05626 228 LCDWWSVGVILFEMLV-GQPPFLAPTPTETQLKVIN 262 (381)
T ss_pred ccceeehhhHHHHHHh-CCCCCcCCCHHHHHHHHHc
Confidence 9999999999999999 8999998877766655543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=322.32 Aligned_cols=228 Identities=22% Similarity=0.341 Sum_probs=188.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|+++. +++.||+|++.... .......+.+|+.+++.++|+||+++++++.+++..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD----TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeE
Confidence 478999999999999999999876 46789999987542 223345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 77 ~lv~E~~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMK----------KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred EEEECCCCCcHHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecc
Confidence 999999999999999975 2357888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceee------------------------------------eCCCCCCCccccCcccccCCCCCCchhHHHHH
Q psy7023 278 MTRDIYETEYYR------------------------------------KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYG 321 (364)
Q Consensus 278 ~a~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 321 (364)
++..+....... ......+|+.|+|||++....++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 987543211000 00123478899999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHhcCc-cccccCCCCCC
Q psy7023 322 VVLWEMATLASQPYQGLSNEQVLNWVKGKS-SNEYKVNPPIS 362 (364)
Q Consensus 322 ~il~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~s 362 (364)
|++|||++ |..||.+.+..+....+.... ....+.+.++|
T Consensus 227 ~il~el~~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 267 (364)
T cd05599 227 VIMYEMLV-GYPPFCSDNPQETYRKIINWKETLQFPDEVPLS 267 (364)
T ss_pred hHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 99999999 899999988888877775543 23444444433
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.83 Aligned_cols=242 Identities=69% Similarity=1.123 Sum_probs=201.8
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
|++..++|++.+.||+|+||.||+|.+++. .......||+|.++..........+.+|+.+++.++|+||+++++++.+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 677889999999999999999999987642 2223567999998766555556678899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+..++||||+++|+|.++++......+.......++...+..++.|++.||.|||+++|+||||||+|||+++++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999999875543332223455678889999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||+++...............++..|+|||.+.++.++.++|+|||||++|||++++..||.+.+..++.+.+..+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986655444333344445677999999998899999999999999999999889999999988888877666544
Q ss_pred ccc
Q psy7023 354 EYK 356 (364)
Q Consensus 354 ~~~ 356 (364)
+.+
T Consensus 241 ~~~ 243 (288)
T cd05061 241 DQP 243 (288)
T ss_pred CCC
Confidence 433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=323.29 Aligned_cols=215 Identities=21% Similarity=0.307 Sum_probs=181.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||++.++. .++.||+|++.... .......+.+|+++++.++||||+++++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD----TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC----CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCee
Confidence 368899999999999999998876 46789999886432 233456788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIK----------YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred EEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999975 2346778888999999999999999999999999999999999999999999
Q ss_pred cccccCcccee------------e---------------------------------eCCCCCCCccccCcccccCCCCC
Q psy7023 278 MTRDIYETEYY------------R---------------------------------KGSRGFLPVRWMAPESLKDGVFT 312 (364)
Q Consensus 278 ~a~~~~~~~~~------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~ 312 (364)
+++........ . ......+|+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 98643211000 0 00113578899999999999999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 313 SHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 313 ~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
.++|||||||++|||+| |.+||.+.+..+.+..+..
T Consensus 227 ~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 262 (377)
T cd05629 227 QECDWWSLGAIMFECLI-GWPPFCSENSHETYRKIIN 262 (377)
T ss_pred CceeeEecchhhhhhhc-CCCCCCCCCHHHHHHHHHc
Confidence 99999999999999999 8999998888777776654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=316.16 Aligned_cols=212 Identities=22% Similarity=0.341 Sum_probs=186.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.+.||+|+||.||+|+++. +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG----TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 689999999999999999999876 46789999987542 223346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+.+++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 94 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA----------GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred EEEEcCCCCChHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999752 346778888999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++........ ...+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+..+.+..+.
T Consensus 164 ~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 231 (329)
T PTZ00263 164 FAKKVPDRTF-----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA-GYPPFFDDTPFRIYEKILAGR 231 (329)
T ss_pred CceEcCCCcc-----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC
Confidence 9986644322 2246788999999999999999999999999999999 899999988888888887764
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=304.28 Aligned_cols=242 Identities=70% Similarity=1.132 Sum_probs=203.5
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
|++..++|++.+.||+|+||.||+|.++... ......|++|.+...........+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 5677889999999999999999999887533 224578999998766555666788899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
....++||||+++++|.+++.......+.......+++..+..++.|++.||.|||+++++||||||+|||+++++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999999865433322223345788899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||+|+|.+||.+.+..++.+.+..+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 99999986655443333333445678999999998889999999999999999998789999999999999888866554
Q ss_pred ccc
Q psy7023 354 EYK 356 (364)
Q Consensus 354 ~~~ 356 (364)
..+
T Consensus 241 ~~~ 243 (277)
T cd05032 241 DLP 243 (277)
T ss_pred CCC
Confidence 444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.38 Aligned_cols=237 Identities=37% Similarity=0.630 Sum_probs=215.1
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
|+-.+..+|.++||.|.||+|++|+++.-. .....||||.++....++.+.+|+.|+.||-+.+||||++|.++.....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pg-kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPG-KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCC-CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 555577889999999999999999988643 3467899999999999999999999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
.+.||+|||++|+|..||++ ...+++.-++.-|++.|+.||.||-++++|||||...||||+.+..+|++|
T Consensus 704 PvMIiTEyMENGsLDsFLR~---------~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsD 774 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQ---------NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSD 774 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhh---------cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecc
Confidence 99999999999999999997 345688889999999999999999999999999999999999999999999
Q ss_pred cccccccCccc-eeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 276 FGMTRDIYETE-YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 276 Fg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
||+++.+.+.. ......-+..+.+|.|||.+...+++.++||||+|+++||.++.|..||.++++.++++.|++|++.+
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP 854 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP 854 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC
Confidence 99999876554 22223334458899999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCC
Q psy7023 355 YKVNPPIS 362 (364)
Q Consensus 355 ~~~~~~~s 362 (364)
+|.+||..
T Consensus 855 pPmDCP~a 862 (996)
T KOG0196|consen 855 PPMDCPAA 862 (996)
T ss_pred CCCCCcHH
Confidence 99999964
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.53 Aligned_cols=231 Identities=37% Similarity=0.686 Sum_probs=189.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcc------------cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCccee
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFR------------SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVV 185 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~------------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv 185 (364)
..++|++.++||+|+||.||+|.++... ......||+|++..........++.+|+.++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 3468999999999999999999875422 1134479999998766666677899999999999999999
Q ss_pred EEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC---------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7023 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET---------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHR 256 (364)
Q Consensus 186 ~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~---------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHr 256 (364)
++++++.+.+..++||||+++++|.+++......... ......+++..+..++.||+.||+|||+.||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9999999999999999999999999999764321111 1122457888999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCC
Q psy7023 257 DLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL-ASQPY 335 (364)
Q Consensus 257 Dlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~-g~~P~ 335 (364)
||||+|||+++++.+||+|||+++...............++..|+|||++....++.++||||||+++|||+++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999876554433333334457789999999988999999999999999999863 56799
Q ss_pred CCCCHHHHHHHHh
Q psy7023 336 QGLSNEQVLNWVK 348 (364)
Q Consensus 336 ~~~~~~~~~~~i~ 348 (364)
.+.+..++.+.+.
T Consensus 243 ~~~~~~~~~~~~~ 255 (304)
T cd05096 243 GELTDEQVIENAG 255 (304)
T ss_pred CcCCHHHHHHHHH
Confidence 8888777766543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=302.68 Aligned_cols=232 Identities=32% Similarity=0.569 Sum_probs=194.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
...+|++.+.||+|+||.||+|.++... .....||+|+++..........+.+|+.++++++||||+++++++..++..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPS-KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCC-CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 3468999999999999999999876422 246789999998776666667899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++++||||||+|||++.++.++++|||
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH---------EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCc
Confidence 9999999999999999752 2357888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
.+......... ......++..|+|||.+.+..++.++|||||||++|||++.|..||.+.+..++++.+.++...+.+.
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd05064 153 RLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR 231 (266)
T ss_pred ccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC
Confidence 87654322111 11222335679999999999999999999999999998866899999999999999988876655444
Q ss_pred CCC
Q psy7023 358 NPP 360 (364)
Q Consensus 358 ~~~ 360 (364)
.+|
T Consensus 232 ~~~ 234 (266)
T cd05064 232 NCP 234 (266)
T ss_pred CCC
Confidence 433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=320.13 Aligned_cols=228 Identities=22% Similarity=0.344 Sum_probs=189.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||++.++. ++..||+|++.... .......+.+|+.++..++|++|+++++.+.+.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD----TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 368899999999999999999876 46789999986432 233356778899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||++||+|.+++.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 77 ~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMK----------KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred EEEEeCCCCccHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999975 2356788899999999999999999999999999999999999999999999
Q ss_pred cccccCcccee---------------------------------eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHH
Q psy7023 278 MTRDIYETEYY---------------------------------RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324 (364)
Q Consensus 278 ~a~~~~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 324 (364)
++..+...... .......+|+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 98754321100 001123578899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCc-cccccCCCCCC
Q psy7023 325 WEMATLASQPYQGLSNEQVLNWVKGKS-SNEYKVNPPIS 362 (364)
Q Consensus 325 ~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~s 362 (364)
|||+| |.+||.+.+..+....+.... ...++...++|
T Consensus 227 yel~t-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 264 (360)
T cd05627 227 YEMLI-GYPPFCSETPQETYRKVMNWKETLVFPPEVPIS 264 (360)
T ss_pred eeccc-CCCCCCCCCHHHHHHHHHcCCCceecCCCCCCC
Confidence 99999 899999988888887776532 33444444444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=322.42 Aligned_cols=216 Identities=23% Similarity=0.294 Sum_probs=181.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|+++. +++.||+|++.... .......+.+|+.+++.++|+||+++++.+.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD----TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC----CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEE
Confidence 478999999999999999999876 47789999986432 122345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~E~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR----------LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred EEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999975 2346778888999999999999999999999999999999999999999999
Q ss_pred cccccCccce-----------------------------------------eeeCCCCCCCccccCcccccCCCCCCchh
Q psy7023 278 MTRDIYETEY-----------------------------------------YRKGSRGFLPVRWMAPESLKDGVFTSHSD 316 (364)
Q Consensus 278 ~a~~~~~~~~-----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 316 (364)
++..+..... ........+|+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 9753310000 00011235788999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 317 VWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 317 iwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
||||||++|||++ |..||.+.+..+....+...
T Consensus 227 iwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~ 259 (376)
T cd05598 227 WWSVGVILYEMLV-GQPPFLADTPAETQLKVINW 259 (376)
T ss_pred eeeccceeeehhh-CCCCCCCCCHHHHHHHHhcc
Confidence 9999999999999 89999998887777666543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=314.01 Aligned_cols=211 Identities=23% Similarity=0.380 Sum_probs=183.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||.||+|+++. ++..||+|++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD----TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEE
Confidence 368999999999999999999876 467899999875432 23346688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~e~~~g~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNN----------LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred EEEEeCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCc
Confidence 999999999999999975 2346778899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
++..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 213 (333)
T cd05600 147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC-GFPPFSGSTPNETWENLKYW 213 (333)
T ss_pred CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh-CCCCCCCCCHHHHHHHHHhc
Confidence 9976543 1223346788999999999999999999999999999999 89999998888887776543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=319.36 Aligned_cols=231 Identities=23% Similarity=0.336 Sum_probs=189.9
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
......+|++.+.||+|+||.||++.++. +++.+|+|++.+.. .......+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKS----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECC----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34455789999999999999999999876 46789999986432 2233456788999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+++..|+||||+++|+|.+++... .++...+..++.||+.||+|||+++|+||||||+|||+++++.+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~-----------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEE
Confidence 999999999999999999999641 356788899999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV----FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|+|||++......... ......+|+.|+|||++.... ++.++|||||||++|+|++ |..||.+.+..+.+..+.
T Consensus 183 L~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~-G~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05621 183 LADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV-GDTPFYADSLVGTYSKIM 260 (370)
T ss_pred EEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence 9999999866433221 122345788999999997543 7889999999999999999 899999888888887776
Q ss_pred cCc-cccccCCCCCC
Q psy7023 349 GKS-SNEYKVNPPIS 362 (364)
Q Consensus 349 ~~~-~~~~~~~~~~s 362 (364)
... ...++.+..+|
T Consensus 261 ~~~~~~~~p~~~~~s 275 (370)
T cd05621 261 DHKNSLNFPEDVEIS 275 (370)
T ss_pred hCCcccCCCCcccCC
Confidence 543 33444443333
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=309.14 Aligned_cols=212 Identities=23% Similarity=0.373 Sum_probs=184.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.+.||+|+||.||+|.++. +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC----CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeE
Confidence 368899999999999999999876 46789999986432 223355688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 77 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNS----------GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred EEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecC
Confidence 9999999999999999752 346778889999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++........ ...+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.+.+..+.
T Consensus 147 ~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~ 214 (291)
T cd05612 147 FAKKLRDRTW-----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKILAGK 214 (291)
T ss_pred cchhccCCcc-----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 9986543321 2245788999999999889999999999999999999 899999988888888877664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=315.83 Aligned_cols=243 Identities=35% Similarity=0.601 Sum_probs=194.2
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
...|+..+++|++.++||+|+||+||+|++... .......||+|+++........+.+.+|+.+++.+ +||||+++++
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 345667778999999999999999999975322 22246689999997665555567889999999999 8999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC-----------------------------------------------
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET----------------------------------------------- 222 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~----------------------------------------------- 222 (364)
++..++..++||||+++|+|.++++........
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 999999999999999999999999764310000
Q ss_pred ------------------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCc
Q psy7023 223 ------------------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 223 ------------------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~ 284 (364)
......+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 00123578889999999999999999999999999999999999999999999999986654
Q ss_pred cceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhcCcccc
Q psy7023 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS-NEQVLNWVKGKSSNE 354 (364)
Q Consensus 285 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~-~~~~~~~i~~~~~~~ 354 (364)
...........++..|+|||++.+..++.++|||||||++|||+++|..||.+.. .....+.+..+....
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 337 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC
Confidence 3322222222345679999999999999999999999999999987899998765 345566666665443
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=307.73 Aligned_cols=230 Identities=34% Similarity=0.579 Sum_probs=192.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|++.+.||+|+||+||+|.+..........||+|+++........+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 579999999999999999999876554445679999987665556677899999999999999999999998864 5789
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+||+.+|+|.+++.+. ...++...+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 86 v~e~~~~g~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred eeecCCCCCHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccc
Confidence 99999999999999862 234677888999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNP 359 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 359 (364)
+................+..|+|||.+.+..++.++||||||+++|||++.|..||.+....++.+.+..+.....+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 236 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Confidence 87654332222222333567999999999999999999999999999998789999998888887777776655544443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=314.51 Aligned_cols=229 Identities=23% Similarity=0.350 Sum_probs=199.3
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH--HHHHHHHHHHHHHhcC-CcceeEEEEEEe
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--EKAEFLNEASVMKAFD-THHVVKLYGVVS 192 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~il~~l~-h~~iv~l~~~~~ 192 (364)
+.....|++.+.||+|.||.||+++.+. ++..+|+|++.+..... ....+.+|+++|+++. ||||+.++++|+
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~----tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKS----TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecC----CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 4456789999999999999999999887 47889999998665432 3467889999999998 999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD---- 268 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~---- 268 (364)
+...+++|||++.||.|++.+... .+++..+..+++|++.++.|||+.||+||||||+|+|+...
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~ 175 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGS 175 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCC
Confidence 999999999999999999999862 27889999999999999999999999999999999999743
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+.+|++|||++....... ......||+.|+|||++....|+..+||||+|+++|.|+. |.+||.+.+..+....|.
T Consensus 176 ~~ik~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~-G~~PF~~~~~~~~~~~i~ 251 (382)
T KOG0032|consen 176 GRIKLIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS-GVPPFWGETEFEIFLAIL 251 (382)
T ss_pred CcEEEeeCCCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh-CCCCCcCCChhHHHHHHH
Confidence 579999999998776622 2233457899999999999999999999999999999998 999999988877777775
Q ss_pred cC-ccccccCCCCCCC
Q psy7023 349 GK-SSNEYKVNPPISL 363 (364)
Q Consensus 349 ~~-~~~~~~~~~~~s~ 363 (364)
.+ ..+..++|+.+|.
T Consensus 252 ~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 252 RGDFDFTSEPWDDISE 267 (382)
T ss_pred cCCCCCCCCCccccCH
Confidence 55 4468888988875
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=318.89 Aligned_cols=217 Identities=29% Similarity=0.475 Sum_probs=193.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
..|+.++.||+|.||.||+|.+.. +++.||+|+++.+....+.+.+.+|+.+|..++++||.++|+.+..+..+|+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~----t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK----TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccchhccccccceeeeeeecc----ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 467778999999999999999887 5788999999988888888899999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
+||||.||++.+.++.... +.+..+..++++++.||.|||..+.||||||+.|||+..+|.+||+|||++
T Consensus 89 iMey~~gGsv~~lL~~~~~----------~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNI----------LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred HHHHhcCcchhhhhccCCC----------CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEeccee
Confidence 9999999999999976433 244556679999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
..+......+ ...+|||.|||||+++...|+.++||||||++.+||++ |.+||....++.++..|-+..+.
T Consensus 159 ~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~-GePP~s~~hPmrvlflIpk~~PP 229 (467)
T KOG0201|consen 159 GQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAK-GEPPHSKLHPMRVLFLIPKSAPP 229 (467)
T ss_pred eeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhc-CCCCCcccCcceEEEeccCCCCC
Confidence 8776654433 56678999999999998899999999999999999999 99999999998777776555443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=306.31 Aligned_cols=212 Identities=24% Similarity=0.447 Sum_probs=178.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.++||+|+||+||+|.++. ++..||+|+++..........+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL----TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC----CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 579999999999999999998876 4678999988754433334567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++ +|.+++... ...++...+..++.||+.||+|||++||+||||||+|||+++++.+||+|||++
T Consensus 81 v~e~~~~-~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 81 VFEYLDS-DLKQYLDNC---------GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred EEeCCCc-CHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcce
Confidence 9999975 999998752 234677889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+....... ......+++.|+|||++.+ ..++.++|||||||++|+|+| |++||.+.+..+.+..+.
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 151 RAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT-GRPMFPGSTVKEELHLIF 217 (288)
T ss_pred eeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence 75433221 1122345788999999875 568999999999999999999 899999888877776554
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=315.93 Aligned_cols=240 Identities=35% Similarity=0.624 Sum_probs=191.8
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
.+.|....++|++.+.||+|+||.||+|.+.... ......||+|+++..........+.+|+.+++.+ +|+||+++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 3456677789999999999999999999875432 2245579999998766555667788999999999 8999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCC-------------------------------------------------
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDA------------------------------------------------- 220 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~------------------------------------------------- 220 (364)
++...+..++||||+++|+|.++++......
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999999999999997532100
Q ss_pred -----------CCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceee
Q psy7023 221 -----------ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR 289 (364)
Q Consensus 221 -----------~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~ 289 (364)
.......++++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 000112357888999999999999999999999999999999999999999999999998654433222
Q ss_pred eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhcCc
Q psy7023 290 KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ-VLNWVKGKS 351 (364)
Q Consensus 290 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~-~~~~i~~~~ 351 (364)
......+++.|+|||++.+..++.++|||||||++|+|++.|..||......+ ....+..+.
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~ 332 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY 332 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc
Confidence 22222345679999999988999999999999999999976899998765544 334444443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.23 Aligned_cols=216 Identities=21% Similarity=0.319 Sum_probs=185.9
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
...++|++.+.||+|+||.||+|.++.. ....||+|.+.... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNE---DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECC---CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 3446899999999999999999987652 23579999886432 233456788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRN----------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999752 356788899999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|||++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+...+.+.+..+.
T Consensus 174 DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~~ 244 (340)
T PTZ00426 174 DFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV-GCPPFYANEPLLIYQKILEGI 244 (340)
T ss_pred cCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhc-CCCCCCCCCHHHHHHHHhcCC
Confidence 999997654322 12346788999999998889999999999999999999 899999988888888887664
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=301.26 Aligned_cols=240 Identities=42% Similarity=0.773 Sum_probs=200.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.+.||+|+||.||+|.+.... ......|++|.+..........++.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 57889999999999999999876532 23456799999986666666778999999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCc------cCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETD------VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~------~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
++|||+++++|.+++.......+.. .....+++..+..++.|++.||+|||+++++|+||||+||++++++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 9999999999999998754433211 1124678889999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++................+++.|+|||.+.+..++.++|||||||++|||++.|..||.+.+..++.+.+..+..
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~ 244 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999998665443333333444577899999999889999999999999999999868899999999999998887766
Q ss_pred ccccCCC
Q psy7023 353 NEYKVNP 359 (364)
Q Consensus 353 ~~~~~~~ 359 (364)
...+..+
T Consensus 245 ~~~~~~~ 251 (283)
T cd05048 245 LPCPEDC 251 (283)
T ss_pred CCCcccC
Confidence 5544433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.59 Aligned_cols=208 Identities=25% Similarity=0.340 Sum_probs=178.4
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEec
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~ 203 (364)
+.||+|+||.||+|.++. .++.||+|+++... .......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKA----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeC
Confidence 369999999999999876 47789999987543 233456678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccC
Q psy7023 204 MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283 (364)
Q Consensus 204 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~ 283 (364)
+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 77 ANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999975 2356788899999999999999999999999999999999999999999999987533
Q ss_pred ccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 284 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
.... ......+++.|+|||++.+..++.++|||||||++|||+| |..||.+.+..++.+.+..+
T Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05571 147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME 210 (323)
T ss_pred cCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhc-CCCCCCCCCHHHHHHHHHcC
Confidence 2211 1122346889999999999999999999999999999999 89999988888888777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=318.05 Aligned_cols=240 Identities=36% Similarity=0.692 Sum_probs=219.3
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
...+++.++..++.+.||.|.||.||.|.+.+-.......||||+.+.+......+.|+.|+.+|+.++||||++++|++
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 45678888889999999999999999999876544446679999999888888889999999999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
.+ ...|||||+++-|.|..|++. ....++...+..++.||..||+|||++++|||||...||||.....+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~---------nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQ---------NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCV 530 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHh---------ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCccee
Confidence 97 689999999999999999986 34567888899999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||+++.+.+..++... .+..+..|||||.+.-.+++.++|||-|||++||++..|..||++..+.++.-.|++|.
T Consensus 531 KLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe 609 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE 609 (974)
T ss_pred eecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC
Confidence 99999999999988877655 55678999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC
Q psy7023 352 SNEYKVNPPIS 362 (364)
Q Consensus 352 ~~~~~~~~~~s 362 (364)
+.+-|++||-.
T Consensus 610 RlP~P~nCPp~ 620 (974)
T KOG4257|consen 610 RLPCPPNCPPA 620 (974)
T ss_pred CCCCCCCCChH
Confidence 99999999853
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=315.34 Aligned_cols=231 Identities=23% Similarity=0.330 Sum_probs=189.8
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.+...++|++.+.||+|+||.||++.++. +++.+|+|++.... .......+.+|+.+++.++||||+++++.+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKS----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECC----CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34455899999999999999999999887 46789999986422 2233456778999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
.++..|+||||+++|+|.++++.. .++...+..++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEE
Confidence 999999999999999999998641 356778889999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV----FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|+|||++......... ......+|+.|+|||++.... ++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 183 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~ 260 (371)
T cd05622 183 LADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIM 260 (371)
T ss_pred EEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence 9999999866433221 122345688999999987543 7889999999999999999 899999988888887776
Q ss_pred cCc-cccccCCCCCC
Q psy7023 349 GKS-SNEYKVNPPIS 362 (364)
Q Consensus 349 ~~~-~~~~~~~~~~s 362 (364)
... ...++.+..+|
T Consensus 261 ~~~~~~~~~~~~~~s 275 (371)
T cd05622 261 NHKNSLTFPDDNDIS 275 (371)
T ss_pred cCCCcccCCCcCCCC
Confidence 543 34454444443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=289.19 Aligned_cols=215 Identities=20% Similarity=0.349 Sum_probs=188.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|-||.||+|+.+. +...||+|++-+..- .....++.+|++|-..|+||||+++|++|.+...+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekk----s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKK----SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred hhccccccccCCccccEeEeeecc----CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 789999999999999999999887 467799999875532 23356788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
||++||...|+|+..+... ...+++++....+..|++.||.|+|.++||||||||+|+|++..+.+||+|||
T Consensus 98 yLilEya~~gel~k~L~~~--------~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEG--------RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred EEEEEecCCchHHHHHHhc--------ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence 9999999999999999852 23446667788899999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
.+.....+ ......+|..|.+||...+..++..+|+|++|++.||++. |.+||...+..+++..|.+-.
T Consensus 170 wsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflv-g~ppFes~~~~etYkrI~k~~ 238 (281)
T KOG0580|consen 170 WSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLV-GLPPFESQSHSETYKRIRKVD 238 (281)
T ss_pred ceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHh-cCCchhhhhhHHHHHHHHHcc
Confidence 98754422 2233456889999999999999999999999999999999 999999999999999887654
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=302.15 Aligned_cols=245 Identities=37% Similarity=0.699 Sum_probs=200.9
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCccc---ccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS---LAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKL 187 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l 187 (364)
.+.|++..++|.+.+.||+|+||.||+|.+..... .....+|+|.++.........++.+|+.+++.+ +|+||+++
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 44678888999999999999999999998754321 123569999998665555567788999999999 89999999
Q ss_pred EEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCC------CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAE------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 188 ~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
++++...+..|+||||+.+++|.+++....+... .......+++..++.++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 9999999999999999999999999987543211 0012235788999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
|||+++++.+||+|||.+.................++.|+|||++.+..++.++|||||||++|+|+++|..||.+....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999876644332222222333567999999998889999999999999999999889999998888
Q ss_pred HHHHHHhcCcccccc
Q psy7023 342 QVLNWVKGKSSNEYK 356 (364)
Q Consensus 342 ~~~~~i~~~~~~~~~ 356 (364)
++.+.+..+...+.+
T Consensus 250 ~~~~~~~~~~~~~~~ 264 (307)
T cd05098 250 ELFKLLKEGHRMDKP 264 (307)
T ss_pred HHHHHHHcCCCCCCC
Confidence 888888877655443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=302.08 Aligned_cols=203 Identities=25% Similarity=0.389 Sum_probs=173.8
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
|++.+.||+|+||+||+|.++. +++.||+|.+..... ......+.+|+.++++++|++|+++++++.+++..++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEec----CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEE
Confidence 7788999999999999999876 467899998864432 2223467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+++|+||||||+|||+++++.++|+|||++
T Consensus 78 v~e~~~~g~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 78 VLTIMNGGDLKFHIYNM--------GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred EEEecCCCcHHHHHHhh--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999888642 2235778899999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
......... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.
T Consensus 150 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~ 206 (285)
T cd05631 150 VQIPEGETV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPFRKRKE 206 (285)
T ss_pred EEcCCCCee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHh-CCCCCCCCCc
Confidence 765433221 22346888999999999999999999999999999999 8999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=298.54 Aligned_cols=238 Identities=36% Similarity=0.685 Sum_probs=196.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||+|+||+||+|.+...+......+++|.+...........+.+|+.++++++|+||+++++++..+...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 67889999999999999999875444445778999998765555556788899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCC-------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAET-------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
||||+++++|.+++......... ......+++..+..++.|++.||+|||+++++|+||||+|||+++++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 99999999999999754321110 11123578888999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++................++..|+|||.+.+..++.++||||||+++|||+++|.+||.+.+..++.+.+..+..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 244 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999998765443333333333466799999998888999999999999999999878999998888888888877765
Q ss_pred ccccC
Q psy7023 353 NEYKV 357 (364)
Q Consensus 353 ~~~~~ 357 (364)
.+.+.
T Consensus 245 ~~~~~ 249 (283)
T cd05090 245 LPCSE 249 (283)
T ss_pred CCCCC
Confidence 54443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=315.79 Aligned_cols=218 Identities=23% Similarity=0.390 Sum_probs=194.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc-e
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP-T 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~-~ 197 (364)
++|..++++|+|+||.+++++++. ....+++|.+.-. .........++|+.+++++.|||||.+.+.|.+++. +
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~----~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKS----DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhcc----CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 578899999999999999998877 3557888877643 345556678899999999999999999999999888 9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
+|||+||+||+|.+.|.+.+ ...++++++..++.|++.|+.|||+++|+|||||+.|||++.++.++|.|||
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k--------~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK--------GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh--------hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchh
Confidence 99999999999999998743 3567889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+|+.+..... ......||+.||+||++.+.+|+.++|||||||++|||++ -+++|.+.+...+...|.++..
T Consensus 152 laK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~-lk~aF~a~~m~~Li~ki~~~~~ 223 (426)
T KOG0589|consen 152 LAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT-LKPAFKASNMSELILKINRGLY 223 (426)
T ss_pred hhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh-cccccCccchHHHHHHHhhccC
Confidence 9998876642 2334467999999999999999999999999999999999 8999999999999999988873
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=307.14 Aligned_cols=214 Identities=23% Similarity=0.363 Sum_probs=181.0
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCc-ceeEEEEEEeeCCce
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPT 197 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~-~iv~l~~~~~~~~~~ 197 (364)
+|++++.||+|+||.||+|.++. +++.||+|++.... .....+.+..|..+++.+.|+ +|+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEE
Confidence 48899999999999999999876 46789999987542 233456778899999999775 688899999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 77 ~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQ----------VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecC
Confidence 999999999999999975 2346778899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++......... .....+++.|+|||++.+..++.++|||||||++|+|+| |+.||.+.+..+++..+....
T Consensus 147 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05587 147 MCKENIFGGKT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQSIMEHN 217 (324)
T ss_pred cceecCCCCCc--eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Confidence 98743222111 112245788999999999999999999999999999999 899999999888888776543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=296.73 Aligned_cols=230 Identities=35% Similarity=0.654 Sum_probs=195.0
Q ss_pred eEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEe
Q psy7023 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 123 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
++.+.||.|.||.||+|.++.........|+||+++........+.+.+|++++++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46788999999999999998444446788999999776666668899999999999999999999999998888999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++|+|.+++... ....+++..+..|+.|++.||+|||+++++|+||+++|||+++++.+||+|||++...
T Consensus 82 ~~~~g~L~~~L~~~--------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--------NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp --TTEBHHHHHHHT--------CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccc--------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999873 2456788999999999999999999999999999999999999999999999999876
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCCC
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 360 (364)
..............+..|+|||.+.+..++.++||||||+++|||++++..||.+.+..++.+.+.++...+.+..++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchh
Confidence 433333333334456789999999988899999999999999999998889999999999999998888776655443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=313.94 Aligned_cols=230 Identities=22% Similarity=0.327 Sum_probs=188.7
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
....++|++.+.||+|+||.||+|.++. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKS----SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECC----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 3445789999999999999999999876 46789999986432 22234457789999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
++..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL 183 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999864 13567788899999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG----VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+|||++......... ......+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 184 ~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05596 184 ADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred EeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh-CCCCcCCCCHHHHHHHHHc
Confidence 999998765433221 12233568899999998653 37889999999999999999 8999999888888877765
Q ss_pred Cc-cccccCCCCCC
Q psy7023 350 KS-SNEYKVNPPIS 362 (364)
Q Consensus 350 ~~-~~~~~~~~~~s 362 (364)
.. ...++.+..+|
T Consensus 262 ~~~~~~~~~~~~~s 275 (370)
T cd05596 262 HKNSLTFPDDIEIS 275 (370)
T ss_pred CCCcCCCCCcCCCC
Confidence 43 34455444443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.57 Aligned_cols=224 Identities=21% Similarity=0.317 Sum_probs=188.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
..|.+.+.||+|+||.||+|..... .+..|++|.+... .......+.+|+.+++.++||||+++++++..++..|+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~---~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD---PKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC---CCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 4599999999999999999986652 1456888876543 33445567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++|+|.+++.... ....++++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 143 v~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 999999999999986521 12345788899999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
+...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++++.+..+...+
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 290 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT-LHRPFKGPSQREIMQQVLYGKYDP 290 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCC
Confidence 87654332222333457889999999999999999999999999999999 899999998888888887665443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=306.50 Aligned_cols=208 Identities=24% Similarity=0.342 Sum_probs=177.5
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEec
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~ 203 (364)
+.||+|+||.||++.++. .+..||+|++.... .......+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKA----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECC----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeC
Confidence 369999999999999876 47789999987542 233455677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccC
Q psy7023 204 MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283 (364)
Q Consensus 204 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~ 283 (364)
+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||++....
T Consensus 77 ~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 77 ANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999998864 2356788999999999999999999999999999999999999999999999987533
Q ss_pred ccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 284 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
..... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..+.+...
T Consensus 147 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05595 147 SDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME 210 (323)
T ss_pred CCCCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC
Confidence 22211 122346888999999999999999999999999999999 89999988888887776543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=306.39 Aligned_cols=207 Identities=23% Similarity=0.330 Sum_probs=177.7
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
||+|+||+||+|+++. +++.||+|++.... .......+.+|+.++++++||||+++++++...+..|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRD----TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCC
Confidence 6999999999999876 46779999986532 23345677889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+|+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 77 GGELFHHLQR----------EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999975 234678889999999999999999999999999999999999999999999998754332
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
.. ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.+.+..+.
T Consensus 147 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~ 209 (312)
T cd05585 147 DD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFYDENVNEMYRKILQEP 209 (312)
T ss_pred CC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHh-CCCCcCCCCHHHHHHHHHcCC
Confidence 21 1122346889999999999999999999999999999999 899999988888887776553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=311.86 Aligned_cols=243 Identities=36% Similarity=0.603 Sum_probs=195.5
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYG 189 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~ 189 (364)
...|+..+++|+++++||+|+||.||+|.+.... ......||+|++.........+.+++|+++++++. ||||+++++
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4568888899999999999999999999875432 22345799999987666666678999999999996 999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC-----------------------------------------------
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET----------------------------------------------- 222 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~----------------------------------------------- 222 (364)
++.+.+..|+|||||++|+|.+++.........
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999999764311000
Q ss_pred ---------------------------------------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7023 223 ---------------------------------------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNC 263 (364)
Q Consensus 223 ---------------------------------------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI 263 (364)
......+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 00113477888999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HH
Q psy7023 264 MVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQ 342 (364)
Q Consensus 264 Ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~ 342 (364)
|+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++.|..||..... ..
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 99999999999999998654433222223334567899999999989999999999999999999868889987654 44
Q ss_pred HHHHHhcCcccc
Q psy7023 343 VLNWVKGKSSNE 354 (364)
Q Consensus 343 ~~~~i~~~~~~~ 354 (364)
+...+..+....
T Consensus 349 ~~~~~~~~~~~~ 360 (400)
T cd05105 349 FYNKIKSGYRMA 360 (400)
T ss_pred HHHHHhcCCCCC
Confidence 555666654443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=299.99 Aligned_cols=245 Identities=36% Similarity=0.695 Sum_probs=201.5
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCc---ccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDF---RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLY 188 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~ 188 (364)
..|++...+|.+.+.||+|+||.||+|.+... .......|++|.............+.+|+.+++.+ +||||++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 34677788999999999999999999976421 12234579999987655555667889999999999 899999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
+++......++||||+.+++|.+++.+....... ......+++..+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999999875432111 0123457888999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 263 ILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
||+++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|+++|..||.+.+..+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999999876543332223333446679999999988899999999999999999998889999999999
Q ss_pred HHHHHhcCccccccC
Q psy7023 343 VLNWVKGKSSNEYKV 357 (364)
Q Consensus 343 ~~~~i~~~~~~~~~~ 357 (364)
+.+.+..+.....+.
T Consensus 248 ~~~~~~~~~~~~~~~ 262 (304)
T cd05101 248 LFKLLKEGHRMDKPA 262 (304)
T ss_pred HHHHHHcCCcCCCCC
Confidence 999888776654443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=305.94 Aligned_cols=214 Identities=23% Similarity=0.372 Sum_probs=180.8
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCce
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~ 197 (364)
+|.+++.||+|+||.||+|.++. ++..||+|++.... .......+..|..++..+ .|++|+++++++...+..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEE
Confidence 47889999999999999999876 46789999987543 223344567788888877 578999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 77 ~lv~E~~~~g~L~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQ----------VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCC
Confidence 999999999999999865 2346778899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+++........ .....+++.|+|||++.+..++.++|||||||++|||+| |..||.+.+..++++.+....
T Consensus 147 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05616 147 MCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEHN 217 (323)
T ss_pred CceecCCCCCc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 98754322211 122346889999999999999999999999999999999 899999999888888776553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=306.92 Aligned_cols=208 Identities=25% Similarity=0.357 Sum_probs=177.8
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEec
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~ 203 (364)
+.||+|+||.||++.++. .+..||+|++.... .......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKA----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeC
Confidence 369999999999999876 47789999987542 233456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccC
Q psy7023 204 MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283 (364)
Q Consensus 204 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~ 283 (364)
+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 77 ~~~g~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 77 VNGGELFFHLSR----------ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999998864 2357788999999999999999999999999999999999999999999999987543
Q ss_pred ccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 284 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
.... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.+.+..+
T Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 210 (328)
T cd05593 147 TDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME 210 (328)
T ss_pred Cccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhh-CCCCCCCCCHHHHHHHhccC
Confidence 2211 1122346888999999999999999999999999999999 89999988888877766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=309.65 Aligned_cols=227 Identities=20% Similarity=0.316 Sum_probs=187.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|.+.+.||+|+||+||++.++. .+..||+|+++.... ......+.+|+.+++.++|+||+++++++.+.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA----TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeE
Confidence 368899999999999999999876 467899999875432 23456678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRY---------EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred EEEECCCCCCCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCC
Confidence 9999999999999999762 2357888899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCccccc------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLK------DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++......... ......+++.|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~~ 225 (330)
T cd05601 148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGTSAKTYNNIMNFQ 225 (330)
T ss_pred CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc-CCCCCCCCCHHHHHHHHHcCC
Confidence 99866543322 112234678899999986 4567889999999999999999 899999888877777765543
Q ss_pred c-ccccCCCCC
Q psy7023 352 S-NEYKVNPPI 361 (364)
Q Consensus 352 ~-~~~~~~~~~ 361 (364)
. ..++..+.+
T Consensus 226 ~~~~~~~~~~~ 236 (330)
T cd05601 226 RFLKFPEDPKV 236 (330)
T ss_pred CccCCCCCCCC
Confidence 2 344443333
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.72 Aligned_cols=215 Identities=22% Similarity=0.340 Sum_probs=181.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||++.++. .++.||+|++.+.. .......+.+|+.+++.++|+||+++++++.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN----TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeE
Confidence 478999999999999999999876 46789999986422 223455688899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred EEEEecCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999752 2356788899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKD-----GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
++..+....... .....+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 148 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05597 148 SCLRLLADGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMN 222 (331)
T ss_pred ceeecCCCCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh-CCCCCCCCCHHHHHHHHHc
Confidence 987654332211 122346889999999863 457889999999999999999 8999998887777776654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=307.94 Aligned_cols=216 Identities=23% Similarity=0.338 Sum_probs=182.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+++++. .++.||+|++.+.. .......+.+|..+++.++|++|+++++++.+.+..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH----TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC----CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 478999999999999999999876 46779999986532 223345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||++||+|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEeCCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEecc
Confidence 9999999999999999752 2356778889999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKD-----GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
++.......... .....+++.|+|||++.+ +.++.++||||||+++|+|++ |..||.+.+..+.+..+...
T Consensus 148 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05624 148 SCLKMNQDGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNH 223 (331)
T ss_pred ceeeccCCCcee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh-CCCCccCCCHHHHHHHHHcC
Confidence 987654432211 122346889999999875 467889999999999999999 89999988887777766543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.46 Aligned_cols=212 Identities=26% Similarity=0.402 Sum_probs=178.5
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHH---HhcCCcceeEEEEEEeeCCc
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVM---KAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il---~~l~h~~iv~l~~~~~~~~~ 196 (364)
|++++.||+|+||.||+|.++. ++..||+|+++... .....+.+.+|+.++ +.++||||+++++++...+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK----TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCE
Confidence 6788999999999999999876 46789999987542 222345666776665 46689999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.|+||||+++++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+||
T Consensus 77 ~~lv~E~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT-----------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcc
Confidence 9999999999999888753 24788899999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..++++.+..+.
T Consensus 146 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05589 146 GLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV-GESPFPGDDEEEVFDSIVNDE 217 (324)
T ss_pred cCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 99875332221 1223346888999999999999999999999999999999 899999999888888776653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=299.98 Aligned_cols=208 Identities=25% Similarity=0.349 Sum_probs=169.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC-----
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG----- 194 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~----- 194 (364)
-+|.-.+++|+|+||.||.|.... .+..||||..-.+..- -.+|+++|+.++|||||++.-+|...
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e----~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRE----TEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcC----CCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 468888999999999999999887 3778999977554322 22599999999999999999888632
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEE
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD-LTVKV 273 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kL 273 (364)
-...+|||||+. +|.++++... .....++.-.++-+..||++||.|||+.||+||||||.|||||.+ |.+||
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYT------RANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHh------hcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEe
Confidence 245689999965 9999998532 123455666788899999999999999999999999999999976 89999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
||||.|+.+..++.....- .+..|+|||.+.+. .|+.+.||||.||++.||+- |++-|+|.+..+.+..|
T Consensus 168 cDFGSAK~L~~~epniSYi---cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~-g~plFpG~s~~dQL~eI 238 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPNISYI---CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK-GQPLFPGDSSVDQLVEI 238 (364)
T ss_pred ccCCcceeeccCCCceeEE---EeccccCHHHHcCccccCceeEEhhhhHHHHHHhc-CCcccCCCCHHHHHHHH
Confidence 9999999887765443222 25569999998775 48999999999999999998 89999998776555443
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=299.94 Aligned_cols=246 Identities=35% Similarity=0.698 Sum_probs=201.3
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcc---cccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR---SLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLY 188 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~ 188 (364)
..|+....+|.+.++||+|+||.||+|.+.... ......+|+|.++..........+.+|+.+++++ +||||++++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 456777889999999999999999999864321 1235578999988665556667889999999999 699999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
+++...+..++||||+++|+|.+++......... ......+++..+..++.|++.||.|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999989999999999999999999875432111 1123458889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 263 ILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
||+++++.+||+|||+++................+..|+|||++.+..++.++||||||+++|+|+++|..||.+.+..+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999866543322222223334579999999988899999999999999999998899999999999
Q ss_pred HHHHHhcCccccccCC
Q psy7023 343 VLNWVKGKSSNEYKVN 358 (364)
Q Consensus 343 ~~~~i~~~~~~~~~~~ 358 (364)
+++.+..+...+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~ 260 (314)
T cd05099 245 LFKLLREGHRMDKPSN 260 (314)
T ss_pred HHHHHHcCCCCCCCCC
Confidence 9998887765554433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=297.15 Aligned_cols=245 Identities=38% Similarity=0.708 Sum_probs=203.9
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCccc-ccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS-LAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGV 190 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~ 190 (364)
..|++.+++|++.+.||+|+||.||++.++.... .....+++|.+..........++.+|+.+++++ +|+||++++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4567778899999999999999999998765331 234679999988665556667788999999999 89999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCc------cCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETD------VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCM 264 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~------~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIL 264 (364)
+..++..+++|||+.+++|.++++......+.. .....+++..+..++.|++.||+|||+++|+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 999999999999999999999998654322211 12346889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 265 VADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 265 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++.|..||.+....++.
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 99999999999999987665443333333334567999999998899999999999999999998789999999888888
Q ss_pred HHHhcCccccccC
Q psy7023 345 NWVKGKSSNEYKV 357 (364)
Q Consensus 345 ~~i~~~~~~~~~~ 357 (364)
+.+..+...+.+.
T Consensus 245 ~~~~~~~~~~~~~ 257 (293)
T cd05053 245 KLLKEGYRMEKPQ 257 (293)
T ss_pred HHHHcCCcCCCCC
Confidence 8888776555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.08 Aligned_cols=241 Identities=33% Similarity=0.637 Sum_probs=198.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.+|.+.++||+|+||.||+|.+..+. ......||+|+++........+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 56888999999999999999876532 22457899999986665555677889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCC------CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAE------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+++||+.+++|.+++........ .......+++..+..++.|++.||+|||++||+||||||+|||+++++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999999999999964322111 011234578888999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+++|..||.+....++++.+..+..
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~ 244 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999988665443333233334467899999998888999999999999999999988999999999999999888776
Q ss_pred ccccCCCC
Q psy7023 353 NEYKVNPP 360 (364)
Q Consensus 353 ~~~~~~~~ 360 (364)
...+..++
T Consensus 245 ~~~~~~~~ 252 (283)
T cd05091 245 LPCPDDCP 252 (283)
T ss_pred CCCCCCCC
Confidence 55544443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=301.48 Aligned_cols=210 Identities=22% Similarity=0.403 Sum_probs=174.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||+|+||+||+|.++. .++.||+|++...........+.+|+.+++.++||||+++++++.+....++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKV----NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECC----CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 689999999999999999999875 4678999998755433334567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+. ++|.+++... ...++...+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 81 v~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 81 VFEYVH-TDLCQYMDKH---------PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred EEECCC-cCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcc
Confidence 999995 6898888652 234677889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQVLNW 346 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~~~~~ 346 (364)
........ ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..+ .+.++.
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 216 (303)
T cd07869 151 RAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ-GVAAFPGMKDIQDQLER 216 (303)
T ss_pred eeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCccHHHHHHH
Confidence 75432221 1122345788999999865 457889999999999999999 8999987543 344443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=296.57 Aligned_cols=238 Identities=45% Similarity=0.822 Sum_probs=198.2
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.++|.+.+.||+|+||.||+|.+.+.. ......||+|.++........+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 367889999999999999999876531 2346789999998766665667899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCC----ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAET----DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
++||||+++++|.+++......... ......+++..+..++.|++.||.|||+++++||||||+|||++.++.++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999999999999875321111 123345788899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||++.................++.|+|||++.+..++.++||||||+++|||++.|..||.+.+..+..+.+..+...
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999976544333222333344678999999999999999999999999999998788999988889999988877655
Q ss_pred ccc
Q psy7023 354 EYK 356 (364)
Q Consensus 354 ~~~ 356 (364)
..+
T Consensus 244 ~~~ 246 (280)
T cd05049 244 QRP 246 (280)
T ss_pred CCC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=297.04 Aligned_cols=216 Identities=22% Similarity=0.349 Sum_probs=181.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee---
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--- 193 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--- 193 (364)
...+|..++.||+|+||.|+.|.++. ++..||||.+... ...-..++..+|+++|+.++|+||+.+.+++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~----t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKR----TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcC----CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 34677778999999999999999887 4688999988733 344556788899999999999999999999854
Q ss_pred --CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 194 --GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 194 --~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
-+.+|+|+|+| +.+|...++. ...++...+..++.|++.||.|+|+.+|+||||||+|+|++.+..+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~----------~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKS----------QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHc----------CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCE
Confidence 46789999999 5599999975 3347888999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
||+|||+|+...........+..+.|..|.|||++.. ..|+.+.||||+|||+.||++ |++-|.|.+.-+-++.|.+
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~-gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT-GKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc-CCCCCCCCchHHHHHHHHH
Confidence 9999999998765422222344455788999998754 569999999999999999999 9999999887766665543
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=310.23 Aligned_cols=210 Identities=30% Similarity=0.502 Sum_probs=176.7
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
.........+.|.-...||+|+||.||+|...+ +..||||.+....... ..+|.+|+.++.+++|||+|+++|+
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-----~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-----GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEECC-----CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 334444455778878899999999999999886 4789999887655432 4569999999999999999999999
Q ss_pred EeeCC-ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEEc
Q psy7023 191 VSEGN-PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK---FVHRDLAARNCMVA 266 (364)
Q Consensus 191 ~~~~~-~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~---iiHrDlkp~NILl~ 266 (364)
|.+.+ ..+||+|||++|+|.+++.... .. +++|..+.+||.++++||+|||... ||||||||+|||+|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~-------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKK-------GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCC-------CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 99988 4999999999999999998521 11 7899999999999999999999853 99999999999999
Q ss_pred CCCcEEEeecccccccCc-cceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 267 DDLTVKVGDFGMTRDIYE-TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 267 ~~~~~kL~DFg~a~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
++.+.||+|||+|+.... ........ .+|..|+|||.+..+..+.++||||||++|.||+| |+.|.+.
T Consensus 212 ~~~~aKlsDFGLa~~~~~~~~~~~~~~--~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElit-gr~~~d~ 280 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEGDTSVSTTV--MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELIT-GRKAVDQ 280 (361)
T ss_pred CCCCEEccCccCcccCCccccceeeec--CCCCccCChhhhccCCcCcccccccchHHHHHHHh-CCcccCC
Confidence 999999999999976544 22211110 46788999999999999999999999999999999 7777764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.70 Aligned_cols=213 Identities=21% Similarity=0.317 Sum_probs=178.6
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEccccc---CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEE
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIM 201 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 201 (364)
++.||+|+||.||+++..... ..++.||+|+++... .......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccC-CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 357999999999999865422 247789999987532 2233456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 202 ELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 202 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
||+++++|.+++.. ...+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 80 EYLSGGELFMHLER----------EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred eCCCCchHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999999975 23456778888999999999999999999999999999999999999999999875
Q ss_pred cCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 282 IYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.++.+..+.
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~pf~~~~~~~~~~~~~~~~ 216 (323)
T cd05584 150 SIHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT-GAPPFTAENRKKTIDKILKGK 216 (323)
T ss_pred cccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhc-CCCCCCCCCHHHHHHHHHcCC
Confidence 4332211 122346889999999999889999999999999999999 899999988888888776654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=310.63 Aligned_cols=215 Identities=24% Similarity=0.383 Sum_probs=184.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|.++. +++.||+|+++... .......+.+|+.+++.++|+||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD----TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeE
Confidence 478999999999999999999876 47789999987542 123456788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++++|.+++.+. ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK----------DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCC
Confidence 9999999999999999752 457788999999999999999999999999999999999999999999999
Q ss_pred cccccCccc---------------------------eeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q psy7023 278 MTRDIYETE---------------------------YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL 330 (364)
Q Consensus 278 ~a~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~ 330 (364)
++....... .........+++.|+|||++.+..++.++|||||||++|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~- 225 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY- 225 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc-
Confidence 997655432 0011223356889999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhc
Q psy7023 331 ASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 331 g~~P~~~~~~~~~~~~i~~ 349 (364)
|..||.+.+..+....+..
T Consensus 226 g~~Pf~~~~~~~~~~~i~~ 244 (350)
T cd05573 226 GFPPFYSDTLQETYNKIIN 244 (350)
T ss_pred CCCCCCCCCHHHHHHHHhc
Confidence 8999998888777776655
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.07 Aligned_cols=217 Identities=24% Similarity=0.351 Sum_probs=182.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.++||+|+||+||++.++. .++.+|+|++.+.. .......+.+|+.+++.++|++|+++++.+.+.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC----CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEE
Confidence 368999999999999999999876 46779999986422 222344578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~ey~~~g~L~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEEeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999752 2356788899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++......... ......+++.|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~ 224 (332)
T cd05623 148 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHK 224 (332)
T ss_pred hheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc-CCCCCCCCCHHHHHHHHhCCC
Confidence 98755432221 122235688999999986 3458899999999999999999 899999988888888776543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=293.92 Aligned_cols=227 Identities=34% Similarity=0.588 Sum_probs=190.6
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
..+|++++.||+|+||+||+|.+.........+||+|+............+.+|+.+++.+.|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 368899999999999999999977654444456899998876666667788999999999999999999999875 4578
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+++||+++|+|.++++.. ...+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 85 l~~~~~~~g~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---------KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCc
Confidence 999999999999999752 33578889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
++................++.|+|||.+.+..++.++|||||||++|||++.|..||......++...+..+...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ 232 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence 98665433222222223456799999999889999999999999999999878999998888888888877655443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=317.86 Aligned_cols=227 Identities=22% Similarity=0.300 Sum_probs=189.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN- 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~- 195 (364)
...+|.+.+.||+|+||+||+|.++. .++.||+|++.... .......+.+|+.++..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVS----DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcC----CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 44799999999999999999998776 46789999986543 3455667889999999999999999988775332
Q ss_pred -------ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 196 -------PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 196 -------~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
.+++||||+++|+|.++++... .....+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~------~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRA------KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN 179 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC
Confidence 3689999999999999997532 123467888999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++++.+.
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt-G~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMHKTL 258 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHh
Confidence 9999999999986544322222333456889999999999999999999999999999999 899999998888888777
Q ss_pred cCccccc
Q psy7023 349 GKSSNEY 355 (364)
Q Consensus 349 ~~~~~~~ 355 (364)
.+...+.
T Consensus 259 ~~~~~~~ 265 (496)
T PTZ00283 259 AGRYDPL 265 (496)
T ss_pred cCCCCCC
Confidence 6654433
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=302.88 Aligned_cols=208 Identities=27% Similarity=0.436 Sum_probs=174.8
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|.++. ++..||+|+++... .....+.+..|..++..+ +||||+++++++..++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG----TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECC----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence 369999999999999876 46779999987543 222344556677777654 89999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~gg~L~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 77 YLNGGDLMFHIQS----------SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999875 235678889999999999999999999999999999999999999999999999754
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+++..+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~ 211 (316)
T cd05592 147 MNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI-GQSPFHGEDEDELFDSILND 211 (316)
T ss_pred CCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Confidence 33221 1223346889999999999899999999999999999999 89999999888888877654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=303.63 Aligned_cols=209 Identities=23% Similarity=0.400 Sum_probs=177.7
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|.++. +++.||+|++.... .......+..|..+++.+ +||||+++++++...+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE----SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcC----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEc
Confidence 369999999999999876 46789999987542 223345677888888876 69999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 77 y~~~g~L~~~i~~~----------~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 77 FVNGGDLMFHIQKS----------RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred CCCCchHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99999999998752 34678889999999999999999999999999999999999999999999998754
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++++.+..+.
T Consensus 147 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~~ 212 (320)
T cd05590 147 IFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILNDE 212 (320)
T ss_pred CcCCCc--ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC
Confidence 322211 122346889999999999999999999999999999999 899999999999888887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=308.71 Aligned_cols=223 Identities=37% Similarity=0.695 Sum_probs=201.8
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
...|..+++..+.++||+|-||.|.++.... ..+||+|+++.........+|.+|+++|.+|+||||++++++|.
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-----~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-----PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecC-----ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 3457788999999999999999999998764 78999999999888888899999999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
.++.+++|+|||+.|+|.+|+.+..... .......+|+.||+.||+||.+.++|||||.+.|+|++.++++|
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt--------~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iK 677 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPT--------AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIK 677 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcc--------cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEE
Confidence 9999999999999999999998742111 23345667999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT-LASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-~g~~P~~~~~~~~~~~~i~ 348 (364)
|+|||.++.+...+++......+.+.+|||+|.+..++++.++|+|+||+++||+++ ....||...+++++++...
T Consensus 678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred ecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 999999999999999998888889999999999999999999999999999999764 3678999999999998654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=301.61 Aligned_cols=211 Identities=23% Similarity=0.373 Sum_probs=184.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..++|++++.||+|+||.||++.++. .+..+|+|++..........++.+|++++++++||||+++++++..++..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKP----SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECC----CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 45789999999999999999999876 46779999988665556667899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeec
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df 148 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA----------KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDF 148 (331)
T ss_pred EEEeecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccC
Confidence 9999999999999999752 3467888999999999999999986 6999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
|++....... .....+++.|+|||++.+..++.++|||||||++|||+| |+.||...+..++...+
T Consensus 149 g~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~ 214 (331)
T cd06649 149 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI-GRYPIPPPDAKELEAIF 214 (331)
T ss_pred cccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Confidence 9987654322 122346788999999999999999999999999999999 89999888877766544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.28 Aligned_cols=228 Identities=38% Similarity=0.668 Sum_probs=193.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||+|+||+||+|.++.... ....|++|.++..........+.+|+.++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGK-KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCC-CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 578999999999999999999875321 3567999998876666667789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+|||+++++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 83 ITEYMENGSLDKFLREN---------DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred EEEcCCCCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchh
Confidence 99999999999999752 236788899999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
.................++.|+|||.+.+..++.++||||||+++|+|++.|..||......++.+.+.++...+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM 231 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 876522221122223346789999999988999999999999999999987899999888888888888776554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=300.85 Aligned_cols=244 Identities=36% Similarity=0.698 Sum_probs=200.9
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCccc---ccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS---LAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLY 188 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~ 188 (364)
..|++...+|++++.||+|+||.||+|.+..... .....||+|+.+........+++.+|+++++++ +|+||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 5688888999999999999999999998654221 123468999988665566677899999999999 899999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
+++..++..+++|||+++|+|.+++.+..+.... ......+++..+..++.|++.||+|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 9999999999999999999999999864321110 1123457888999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 263 ILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+++|..||.+.+..+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999866543322222233335679999999999999999999999999999998899999999999
Q ss_pred HHHHHhcCcccccc
Q psy7023 343 VLNWVKGKSSNEYK 356 (364)
Q Consensus 343 ~~~~i~~~~~~~~~ 356 (364)
....+..+...+.+
T Consensus 245 ~~~~~~~~~~~~~~ 258 (334)
T cd05100 245 LFKLLKEGHRMDKP 258 (334)
T ss_pred HHHHHHcCCCCCCC
Confidence 98888776555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=303.53 Aligned_cols=209 Identities=22% Similarity=0.345 Sum_probs=177.7
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|.++. .+..||+|++.... .....+.+..|.++++.+ +||||+++++++...+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG----TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECC----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEe
Confidence 369999999999999876 46789999987542 223345677889998876 89999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 77 YVNGGDLMFQIQRS----------RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99999999998752 34677888999999999999999999999999999999999999999999998754
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
...... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++++.+..+.
T Consensus 147 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 147 ILNGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA-GQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred ccCCcc--ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc-CCCCCCCCCHHHHHHHHHcCC
Confidence 322211 122346788999999999999999999999999999999 899999999999888887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=302.23 Aligned_cols=214 Identities=23% Similarity=0.385 Sum_probs=180.1
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCC-cceeEEEEEEeeCCce
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDT-HHVVKLYGVVSEGNPT 197 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~ 197 (364)
+|++.+.||+|+||+||+|.++. +++.||+|++.... .....+.+..|..+++.+.| ++|+++++++...+..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEE
Confidence 36788999999999999999876 46789999987542 22334567789999988865 5788899999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 77 ~lv~Ey~~~g~L~~~i~~----------~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQ----------VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEcCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccc
Confidence 999999999999999865 2357788999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.+.+....
T Consensus 147 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05615 147 MCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQSIMEHN 217 (323)
T ss_pred cccccCCCCcc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 98754332211 112336788999999999899999999999999999999 899999998888888776543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=290.10 Aligned_cols=223 Identities=35% Similarity=0.709 Sum_probs=190.0
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
|++..++|+++++||+|+||.||+|.+.+ ...|++|.+.... ...+.+.+|+.++++++|+||+++++.+...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNN-----STKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecC-----CceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 55667899999999999999999998764 4568999876533 2356788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..+++|||+++++|.+++++. ....+++..+..++.|++.||+|||+.+++|+||||+||++++++.++|+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~ 145 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSD--------EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIA 145 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEEC
Confidence 9999999999999999999752 23456778899999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|||++.......... .....++..|+|||.+....++.++||||||+++|+|+|+|..||.+....++...+..+...
T Consensus 146 dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 223 (261)
T cd05072 146 DFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM 223 (261)
T ss_pred CCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999998765433221 122234567999999998889999999999999999999789999998888888888776544
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=291.45 Aligned_cols=236 Identities=44% Similarity=0.842 Sum_probs=194.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
..+.|.+.+.||+|+||.||+|.++... ......|++|.............+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467999999999999999999886521 113567999988766656556778999999999999999999999998899
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL---TVKV 273 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~---~~kL 273 (364)
.++||||+++++|.+++........ ....+++..+..++.||+.||+|||+++++|+||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPE---RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999987543222 223578899999999999999999999999999999999998754 6999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||+++................+..|+|||++.+..++.++|||||||++|||++.|..||.+.+..++.+.+..+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999987654433333333334567999999998899999999999999999998799999998888888877666554
Q ss_pred ccc
Q psy7023 354 EYK 356 (364)
Q Consensus 354 ~~~ 356 (364)
+++
T Consensus 241 ~~~ 243 (277)
T cd05036 241 DPP 243 (277)
T ss_pred CCC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=293.37 Aligned_cols=229 Identities=30% Similarity=0.511 Sum_probs=188.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|++++.||+|+||+||+|.+.........++++|............++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 57888999999999999999987644433456888988655444555678889999999999999999998764 56789
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+++++||||||+|||+++++.+||+|||++
T Consensus 86 i~e~~~~gsL~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---------HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred EEEeCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 9999999999999975 2335788899999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVN 358 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 358 (364)
+...............++..|+|||.+.+..++.++||||||+++|||++.|..||.+....++.+.++.+.....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQI 235 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCC
Confidence 8654332222222233466799999999889999999999999999999878999999888888888877665544333
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.39 Aligned_cols=224 Identities=37% Similarity=0.683 Sum_probs=189.6
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
|++.+++|++.+.||+|++|.||+|.++. ...||+|.++.... ..+++.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNN-----TTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecC-----CeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 56677899999999999999999998764 45699999875432 245688999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..++||||+++++|.+++... ....+++..+..++.|++.||.|||+++++|+||||+||++++++.++|+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~ 145 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGG--------AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVA 145 (261)
T ss_pred CCeeeeeecccCCcHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEEC
Confidence 9999999999999999999752 23457888999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
|||++........... .....+..|+|||.+.+..++.++|+||||+++|+|+|+|+.||.+.+..+++..+..+....
T Consensus 146 dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 224 (261)
T cd05068 146 DFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP 224 (261)
T ss_pred CcceEEEccCCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999986653322111 111124579999999988999999999999999999998899999999888888887665443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=303.13 Aligned_cols=209 Identities=24% Similarity=0.363 Sum_probs=173.4
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHH-HHHHhcCCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEA-SVMKAFDTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~-~il~~l~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|+++. .+..||+|++..... ......+..|. .+++.++|+||+++++++...+..|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECC----CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEe
Confidence 369999999999999876 467799999875321 12233444444 45678999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++++|.+++.. ...++...+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 77 YINGGELFYHLQR----------ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999999999975 234567788889999999999999999999999999999999999999999998754
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
..... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..++++.+....
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05602 147 IEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNKP 212 (325)
T ss_pred ccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc-CCCCCCCCCHHHHHHHHHhCC
Confidence 33221 1222346889999999999999999999999999999999 899999988888888876553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=287.33 Aligned_cols=217 Identities=38% Similarity=0.735 Sum_probs=182.7
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
+.||+|+||.||+|.++. .++.+|+|.............+.+|++++++++|+||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA----DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEec----CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 369999999999999876 4678999988766556666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++.. ....+++..+..++.|++.||+|||+++|+|+||||+|||++.++.+||+|||++......
T Consensus 77 ~~~L~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 77 GGDFLTFLRT---------EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred CCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccc
Confidence 9999999974 2234678889999999999999999999999999999999999999999999998765433
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
...........+..|+|||.+.++.++.++||||||+++|+|+++|..||...+..+....+..+.....
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 217 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC 217 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence 2221111122245699999999989999999999999999999878999998888887777766554443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=302.36 Aligned_cols=209 Identities=24% Similarity=0.368 Sum_probs=174.8
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHH-HHHhcCCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEAS-VMKAFDTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~-il~~l~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|.++. +++.||+|++.... ......++.+|.. +++.++||||+++++.+...+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA----DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEc
Confidence 369999999999999876 47789999986532 1222344555554 5678999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||++...
T Consensus 77 ~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 77 YVNGGELFFHLQR----------ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999875 235677889999999999999999999999999999999999999999999998754
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.+.+..+.
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 147 IEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred ccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhc-CCCCCCCCCHHHHHHHHHcCC
Confidence 32221 1223346889999999999999999999999999999999 899999988888888776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=300.21 Aligned_cols=218 Identities=28% Similarity=0.494 Sum_probs=194.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+-|.++.+||+|+||.||+|.++. ++..+|||....+ .+.+++..|+.||++++.+++|++|+.+.....+|+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~E----sG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRE----SGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhc----cCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 456788999999999999999887 6888999987654 456789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|||||..|++.|.++. .++++++.++..+++..++||+|||...-||||||..|||++.+|..||+|||.|
T Consensus 106 VMEYCGAGSiSDI~R~---------R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVA 176 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRA---------RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVA 176 (502)
T ss_pred ehhhcCCCcHHHHHHH---------hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhcccc
Confidence 9999999999999985 6778999999999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 356 (364)
..+.+.... .....|||.|||||++..-.|+.++||||||++..||.. |++||.+..+......|..+++..|.
T Consensus 177 GQLTDTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAE-G~PPYsDIHPMRAIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 177 GQLTDTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAE-GRPPYSDIHPMRAIFMIPTKPPPTFK 250 (502)
T ss_pred chhhhhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhc-CCCCcccccccceeEeccCCCCCCCC
Confidence 877665433 334467999999999999999999999999999999999 99999999998877777766655543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=301.66 Aligned_cols=209 Identities=25% Similarity=0.358 Sum_probs=174.4
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHH-HHHhcCCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEAS-VMKAFDTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~-il~~l~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|+++. .+..||+|++.+.. .......+.+|.. +++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS----DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECC----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEc
Confidence 369999999999999876 46789999986532 1222344555554 6788999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 77 YVNGGELFFHLQR----------ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999988864 234667888899999999999999999999999999999999999999999998754
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++.+.+..+.
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05603 147 VEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDVSQMYDNILHKP 212 (321)
T ss_pred CCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc-CCCCCCCCCHHHHHHHHhcCC
Confidence 32221 1223346888999999999899999999999999999999 899999988888888877654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=299.74 Aligned_cols=209 Identities=26% Similarity=0.432 Sum_probs=175.8
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||.||+|.++. ++..||+|+++.... ......+..|..+++.. +||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG----KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECC----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEEC
Confidence 469999999999999886 467899999875431 22345566788888764 89999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+.+++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 77 ~~~~g~L~~~i~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 77 FLNGGDLMFHIQD----------KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999865 234677889999999999999999999999999999999999999999999998743
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++.+.+..+.
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~Pf~~~~~~~~~~~~~~~~ 212 (316)
T cd05620 147 VFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI-GQSPFHGDDEDELFESIRVDT 212 (316)
T ss_pred ccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 22111 1122346888999999999999999999999999999999 899999988888888876553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=301.66 Aligned_cols=238 Identities=37% Similarity=0.667 Sum_probs=189.8
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~ 192 (364)
|++.+++|++.+.||+|+||.||+|.+.+.. ..+.+.||+|+++..........+.+|+.+++++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 7778889999999999999999999765432 2345789999987655555566788999999999 8999999999876
Q ss_pred e-CCceEEEEecCCCCCHHHHHHhcCCCCC--------------------------------------------------
Q psy7023 193 E-GNPTLVIMELMGGGDLKNYLRSCRPDAE-------------------------------------------------- 221 (364)
Q Consensus 193 ~-~~~~~lv~e~~~ggsL~~~l~~~~~~~~-------------------------------------------------- 221 (364)
. +..++++|||+++++|.+++........
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 5678999999999999999975432100
Q ss_pred -CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccc
Q psy7023 222 -TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300 (364)
Q Consensus 222 -~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y 300 (364)
......++++..+..++.||+.||+|||+++|+||||||+|||+++++.++|+|||++..+.............++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 0001236789999999999999999999999999999999999999999999999999876543332223333446679
Q ss_pred cCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhcCcc
Q psy7023 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ-VLNWVKGKSS 352 (364)
Q Consensus 301 ~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~-~~~~i~~~~~ 352 (364)
+|||++.+..++.++|||||||++|||++.|..||.+....+ +...++.+..
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 294 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC
Confidence 999999999999999999999999999986889998755433 4445554443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=292.65 Aligned_cols=235 Identities=39% Similarity=0.709 Sum_probs=192.6
Q ss_pred ceeEeceeeeecceEEEEEEEcCccc-ccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRS-LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++.+.||+|+||.||+|.+..... .....+++|.+..........++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998754221 13456899988766666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCC--------------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAET--------------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~--------------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl 265 (364)
++||+.+++|.+++......... .....++++..+..++.|++.||+|||+++++||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999999864322111 0122467889999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 266 ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 266 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|+|+|..||.+..+.++.+
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999765443322222222345679999999888899999999999999999987899999999999888
Q ss_pred HHhcCccccc
Q psy7023 346 WVKGKSSNEY 355 (364)
Q Consensus 346 ~i~~~~~~~~ 355 (364)
.+..+...+.
T Consensus 241 ~~~~~~~~~~ 250 (290)
T cd05045 241 LLKTGYRMER 250 (290)
T ss_pred HHhCCCCCCC
Confidence 8877654443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=303.68 Aligned_cols=208 Identities=25% Similarity=0.345 Sum_probs=176.6
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEec
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~ 203 (364)
+.||+|+||.||++.++. .+..||+|++.... .......+.+|+++++.++||||+++++++...+..|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeC
Confidence 369999999999998776 47789999987542 223345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 204 MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 204 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 77 ANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999998864 2357788999999999999999997 79999999999999999999999999998754
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
...... .....+++.|+|||++.+..++.++|||||||++|+|+| |..||.+.+..+..+.+...
T Consensus 147 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-G~~Pf~~~~~~~~~~~i~~~ 211 (325)
T cd05594 147 IKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME 211 (325)
T ss_pred CCCCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeecc-CCCCCCCCCHHHHHHHHhcC
Confidence 322211 112346888999999999999999999999999999999 89999988888777776544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=304.38 Aligned_cols=244 Identities=33% Similarity=0.597 Sum_probs=194.7
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYG 189 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~ 189 (364)
...|++..++|.+.++||+|+||.||+|+++.. .......||+|+++........+.+++|+.+|.++. ||||+++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 345888889999999999999999999997643 122456799999987655555667899999999997 999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC-----------------------------------------------
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET----------------------------------------------- 222 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~----------------------------------------------- 222 (364)
++...+..++||||+.+|+|.+++++.+.....
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 999999999999999999999999865321000
Q ss_pred -----------------------------------------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 223 -----------------------------------------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 223 -----------------------------------------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
......+++..++.++.|++.||+|||+.+++||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 001234677889999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+++|..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999976543222122222345678999999998889999999999999999998788999876554
Q ss_pred HH-HHHHhcCccccc
Q psy7023 342 QV-LNWVKGKSSNEY 355 (364)
Q Consensus 342 ~~-~~~i~~~~~~~~ 355 (364)
+. .+.+..+...+.
T Consensus 349 ~~~~~~~~~~~~~~~ 363 (401)
T cd05107 349 EQFYNAIKRGYRMAK 363 (401)
T ss_pred HHHHHHHHcCCCCCC
Confidence 44 445555544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.38 Aligned_cols=227 Identities=40% Similarity=0.720 Sum_probs=192.0
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
|++...+|.+.+.||+|+||.||+|.++. .+..|++|.+.... ....++.+|+++++.++|+||+++++++..+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEec----CCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 45566789999999999999999999876 46779999887543 2356788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..++||||+++++|.+++... ....+++..+..++.|++.||+|||+++++||||||+|||+++++.+||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~ 146 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLREC--------NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 146 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeC
Confidence 9999999999999999999752 22346788899999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
|||++.......... ......+..|+|||.+.+..++.++||||||+++|||+++|..||.+.+..+..+.+..+...+
T Consensus 147 df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (263)
T cd05052 147 DFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME 225 (263)
T ss_pred CCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 999998665433221 1122235679999999988999999999999999999987899999988888888888765554
Q ss_pred cc
Q psy7023 355 YK 356 (364)
Q Consensus 355 ~~ 356 (364)
.+
T Consensus 226 ~~ 227 (263)
T cd05052 226 RP 227 (263)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=298.48 Aligned_cols=209 Identities=27% Similarity=0.462 Sum_probs=175.6
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHh-cCCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKA-FDTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~-l~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|.++. ++..||+|+++.... ......+..|..+++. ++||||+++++++.+.+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECC----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEe
Confidence 469999999999999876 467799999875421 2234456678888876 499999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++...
T Consensus 77 y~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 77 YLNGGDLMFHIQSC----------HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 99999999999752 34677888999999999999999999999999999999999999999999998753
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++++.+....
T Consensus 147 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05619 147 MLGDAK--TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI-GQSPFHGHDEEELFQSIRMDN 212 (316)
T ss_pred CCCCCc--eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 222111 112345788999999999899999999999999999999 899999999888888876554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=295.41 Aligned_cols=212 Identities=19% Similarity=0.328 Sum_probs=176.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.+.||+|+||+||+|+++. ++..||+|++..... ....+.+.+|+.+++.++|+||+++++++...+..|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE----TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC----CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEE
Confidence 378999999999999999999876 467799998875432 233566788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||++++.+..+.. ....+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+
T Consensus 77 lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 77 LVFEYVEKNMLELLEE----------MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred EEEecCCCCHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 9999998866654432 123577888999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+......... ......+++.|+|||++.+..++.++|||||||++|||++ |++||.+.+..+.+..+
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 147 ARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSD-GQPLFPGESEIDQLFTI 213 (287)
T ss_pred cccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9865433211 1122345788999999998889999999999999999999 89999987766555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=290.15 Aligned_cols=235 Identities=41% Similarity=0.780 Sum_probs=194.1
Q ss_pred ccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.+|.+.+.||+|+||+||++.+... .......+++|.+.... ......+.+|+.++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46889999999999999999986442 12235668999886543 34466789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCC---ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAET---DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
++||||+++++|.+++......... ......+++..+..++.|++.||+|||++|++||||||+|||+++++.++|+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 9999999999999999865432111 1122358899999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
|||++................+++.|+|||.+.+..++.++||||||+++|+|+|+|.+||...+..+..+.+..+....
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~ 242 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 242 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99999866544333333333446789999999988999999999999999999997899999988888888888776543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=289.27 Aligned_cols=229 Identities=34% Similarity=0.609 Sum_probs=194.0
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
..+|++++.||+|+||+||+|.++.........+++|............++.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 368899999999999999999987655444567999998877666666788999999999999999999999887 7899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+++|+||||+|||+++++.+||+|||+
T Consensus 85 ~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 85 LITQLMPLGCLLDYVRN---------HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred EEEecCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcc
Confidence 99999999999999975 233478889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
++................+..|+|||.+....++.++|+||||+++|||++.|..||.+....++.+.+..+.....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence 9866543322222222235679999999888899999999999999999987899999998888888888776554443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=300.47 Aligned_cols=209 Identities=21% Similarity=0.352 Sum_probs=171.7
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC-----
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG----- 194 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~----- 194 (364)
+|++.++||+|+||.||+|.++. .+..||+|.+.... ......++.+|+.++++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 76 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH----TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC----CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence 58899999999999999999876 46789999886432 223345788999999999999999999987533
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
...|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 77 ~~~~lv~e~~~-~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 77 KDIYVVFELME-SDLHQVIKA----------NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred ceEEEEEecCC-CCHHHHHHh----------cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEc
Confidence 34799999995 699998864 2357788999999999999999999999999999999999999999999
Q ss_pred ecccccccCccce-eeeCCCCCCCccccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 275 DFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 275 DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
|||+++....... ........+++.|+|||++.+ ..++.++|||||||++|+|+| |++||.+.+..+.++
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t-g~~pf~~~~~~~~~~ 218 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLD 218 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Confidence 9999975432221 111123346888999999876 678999999999999999999 899998877655443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=288.84 Aligned_cols=218 Identities=38% Similarity=0.629 Sum_probs=176.5
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
++||+|+||+||+|..... .....+++|.+...........+.+|+.+++.++|+||+++++.+......++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecC--CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 3699999999999976542 23557889987765555556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+|+|.+++....... ....++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||++......
T Consensus 79 ~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 79 LGDLKNYLRSNRGMV-----AQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCcHHHHHHhccccc-----cccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccc
Confidence 999999998643211 123456778899999999999999999999999999999999999999999998754433
Q ss_pred ceeeeCCCCCCCccccCcccccC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKD-------GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
..........+++.|+|||++.. ..++.++|||||||++|||+++|..||....+.+.+..+...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc
Confidence 32222233344677999998743 356789999999999999999889999988887777655433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.50 Aligned_cols=221 Identities=38% Similarity=0.660 Sum_probs=185.2
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
|++..++|++.++||+|+||.||+|.+++ ...|++|.+...... .+++.+|++++++++|+||+++++.+.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecC-----CceEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 56677899999999999999999998765 345999998753332 3568899999999999999999998754
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
...++||||+++++|.+++.+. ....+++..+..++.|++.||+|||+++++|+||||+||++++++.++|+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~ 144 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGE--------MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 144 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhc--------cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEec
Confidence 5689999999999999999752 22356788899999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|||.+.......... .....++..|+|||.+.+..++.++||||||+++|+|+|+|..||.+....++.+.+..+..
T Consensus 145 dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~ 221 (262)
T cd05071 145 DFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221 (262)
T ss_pred cCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC
Confidence 999997665433221 11223456799999998889999999999999999999988999998888888887766543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=294.49 Aligned_cols=214 Identities=22% Similarity=0.383 Sum_probs=174.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhc---CCcceeEEEEEEe---
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAF---DTHHVVKLYGVVS--- 192 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l---~h~~iv~l~~~~~--- 192 (364)
++|++++.||+|+||+||+|.+... .+..||+|.++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN---GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC---CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 4789999999999999999987532 256799998764332 22234455677777766 6999999999885
Q ss_pred --eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 193 --EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 193 --~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
.....++||||++ ++|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||+++++.
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC
Confidence 3456899999996 5999999752 2345788899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+..
T Consensus 149 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 149 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred EEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHc-CCCCcCCCCHHHHHHHHHH
Confidence 9999999987654331 1223345788999999998899999999999999999999 8999999888777776654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=285.32 Aligned_cols=217 Identities=39% Similarity=0.691 Sum_probs=185.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||+|+||.||++.++. ...+|+|.+...... ...+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-----~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-----QIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-----CceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 578899999999999999998765 457899987644322 3568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+||++++++.+||+|||.+
T Consensus 77 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 77 VTEFMENGCLLNYLRQR---------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred EEEcCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCc
Confidence 99999999999999752 234678889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
.......... ......+..|+|||.+.+..++.++|+||||+++|+|+++|+.||...+..+.++.+.++...
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~ 220 (256)
T cd05114 148 RYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL 220 (256)
T ss_pred cccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC
Confidence 8654433322 122234567999999998889999999999999999999789999999988888888876544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=302.01 Aligned_cols=204 Identities=20% Similarity=0.310 Sum_probs=170.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc---CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCc
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~ 196 (364)
+|++++.||+|+||+||+++.... ...+..||+|++.+.. .....+.+.+|+.+++.+ +|+||+++++++..++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG-HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc-CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 488999999999999999986532 2247889999986532 223345677899999999 58999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 80 ~~lv~e~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQ----------RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred EEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999999965 235678889999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
|+++........ ......+++.|+|||++.+.. ++.++|||||||++|||+| |..||..
T Consensus 150 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~ 209 (332)
T cd05614 150 GLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT-GASPFTL 209 (332)
T ss_pred cCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhc-CCCCCCC
Confidence 999765433221 112234688999999998654 7889999999999999999 8999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=300.96 Aligned_cols=209 Identities=22% Similarity=0.339 Sum_probs=174.7
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHH-HHHhcCCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEAS-VMKAFDTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~-il~~l~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|.++. ++..||+|++.... .......+..|.. +++.++||||+++++++...+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL----DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEc
Confidence 469999999999999876 47789999986542 2223345555655 5677999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+.+|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 77 FVNGGELFFHLQR----------ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999998864 235778899999999999999999999999999999999999999999999998753
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.+.+..+.
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 147 IAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY-GLPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred CCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc-CCCCCCCCCHHHHHHHHHcCC
Confidence 32211 1223346888999999999999999999999999999999 899999988888888776553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=283.76 Aligned_cols=227 Identities=22% Similarity=0.364 Sum_probs=193.5
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-------CHHHHHHHHHHHHHHHhc-CCcceeEEEEE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-------SEREKAEFLNEASVMKAF-DTHHVVKLYGV 190 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~il~~l-~h~~iv~l~~~ 190 (364)
-.+|.-.+.||.|..++|.++.++. ++..+|+|++.... ..+..++-.+|+.||+++ .||+|+++.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~----t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKE----TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcc----cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3567777889999999999998877 57778888876321 233455667899999998 79999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
|+.+..+++|+|.|+.|.|+|++.+ .-.++++....|++|+++|++|||.++||||||||+|||++++.+
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts----------~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTS----------KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN 161 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhh----------heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc
Confidence 9999999999999999999999975 346788899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD------GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+||+|||+++.+......+ ...|||.|.|||.+.. ..|+..+|+|++|+|+|.|+. |-+||......-++
T Consensus 162 i~isDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa-GcpPFwHRkQmlML 237 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA-GCPPFWHRKQMLML 237 (411)
T ss_pred eEEeccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc-CCCchhHHHHHHHH
Confidence 9999999999887765433 3356999999999864 347788999999999999999 89999888888888
Q ss_pred HHHhcC-ccccccCCCCCCC
Q psy7023 345 NWVKGK-SSNEYKVNPPISL 363 (364)
Q Consensus 345 ~~i~~~-~~~~~~~~~~~s~ 363 (364)
..|.+| +.+..|.|..||.
T Consensus 238 R~ImeGkyqF~speWadis~ 257 (411)
T KOG0599|consen 238 RMIMEGKYQFRSPEWADISA 257 (411)
T ss_pred HHHHhcccccCCcchhhccc
Confidence 877655 4568889988875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=291.58 Aligned_cols=208 Identities=25% Similarity=0.377 Sum_probs=175.8
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.|++.+.||+|+||+||++.+.. .++.||+|++..... ......+.+|+.+++.++|+||+++++.+..++..+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC----CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEE
Confidence 47889999999999999998765 467899998865322 222345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+++++||||||+||++++++.++|+|||+
T Consensus 77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNM--------GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEeccCCCcHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999988652 234578889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+......... ....+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+.....
T Consensus 149 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~-g~~pf~~~~~~~~~ 210 (285)
T cd05605 149 AVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVKR 210 (285)
T ss_pred ceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHH-CCCCCCCCchhhHH
Confidence 8765433221 12245788999999998889999999999999999999 89999887654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=286.06 Aligned_cols=223 Identities=36% Similarity=0.692 Sum_probs=188.6
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
|++.+++|+++++||+|+||.||+|..++ +..||+|.+...... ...+.+|+.++++++|+||+++++++. .
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNG-----HTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCC-----CceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 67888999999999999999999998764 567999988754432 357889999999999999999999875 4
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..+++|||+.+++|.+++... ....++...+..++.|++.||+|||+.+++|+||||+||++++++.++|+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~ 144 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTP--------EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIA 144 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEc
Confidence 6789999999999999998752 23457788899999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
|||++.......... .....++..|+|||.+....++.++||||||+++|+|+++|.+||.+.+..++++.+.++...+
T Consensus 145 dfg~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05067 145 DFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223 (260)
T ss_pred cCcceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Confidence 999987665332221 1122235679999999988899999999999999999987899999988888888887765544
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=296.85 Aligned_cols=211 Identities=24% Similarity=0.388 Sum_probs=181.4
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+..++|++.++||+|+||.||++.++. ++..+|+|++...........+.+|+++++.++|+||+++++++.+++.
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKP----SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECC----CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence 456799999999999999999999876 4677999988766555566789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEee
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
.++||||+.+++|.+++... ..++...+..++.|++.||.|||+. +|+|+||||+|||+++++.+||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~D 147 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 147 (333)
T ss_pred EEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEee
Confidence 99999999999999999752 2466788899999999999999975 799999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
||++....... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||......++...
T Consensus 148 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~ 213 (333)
T cd06650 148 FGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI-GRYPIPPPDAKELELM 213 (333)
T ss_pred CCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcchhHHHHH
Confidence 99987553321 112245778999999998889999999999999999999 8999987766655443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=299.26 Aligned_cols=199 Identities=24% Similarity=0.411 Sum_probs=167.2
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
..+|+++++||+|+||+||+|.++. .++.||+|++...........+.+|+++++.++|+||+++++++...+.++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRP----TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECC----CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 3678889999999999999998876 467899999876655566678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.+.. ......+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 149 lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 149 VLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred EEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccccc
Confidence 999999999985432 234567788999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDG-----VFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
++.+..... ......++..|+|||++... ..+.++|||||||++|||++ |+.||...
T Consensus 215 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~ 276 (353)
T PLN00034 215 SRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL-GRFPFGVG 276 (353)
T ss_pred ceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Confidence 986543321 11223568889999988532 23568999999999999999 89999743
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=290.05 Aligned_cols=239 Identities=38% Similarity=0.747 Sum_probs=196.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
..++|++.+.||+|+||.||+|.++.. .......||+|++..........++.+|+.++++++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 457899999999999999999987531 1224678999998876665666789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCc------------cCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETD------------VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCM 264 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~------------~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIL 264 (364)
.++||||+++++|.+++.......... .....+++..++.++.|++.||+|||+++++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 999999999999999998654322211 12245788899999999999999999999999999999999
Q ss_pred EcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 265 VADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 265 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++.|..||.+.+..++.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999876544332222222334567999999998899999999999999999998788899988888888
Q ss_pred HHHhcCcccccc
Q psy7023 345 NWVKGKSSNEYK 356 (364)
Q Consensus 345 ~~i~~~~~~~~~ 356 (364)
..+..+.....+
T Consensus 243 ~~~~~~~~~~~~ 254 (288)
T cd05050 243 YYVRDGNVLSCP 254 (288)
T ss_pred HHHhcCCCCCCC
Confidence 888776654433
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=285.46 Aligned_cols=225 Identities=37% Similarity=0.685 Sum_probs=190.8
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
|++.+++|++.+.||+|+||.||+|.+++ ...+++|.+...... .+++.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~-----~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNG-----TTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcC-----CceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 56778999999999999999999998765 466899988754332 45788999999999999999999999998
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
...++||||+++++|.+++.+. ....+++..+..++.|++.||+|||+++++|+||||+||++++++.++|+
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~--------~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~ 145 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSG--------EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIA 145 (261)
T ss_pred CceEEEEeccCCCCHHHHHhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999999752 22457888999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
|||++.......... ......+..|+|||.+.+..++.++|+||||+++|+|+++|+.||.+.+..+.++.+..+....
T Consensus 146 d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 224 (261)
T cd05034 146 DFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP 224 (261)
T ss_pred ccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999987665322111 1112234579999999988899999999999999999998899999998888888887765443
Q ss_pred c
Q psy7023 355 Y 355 (364)
Q Consensus 355 ~ 355 (364)
.
T Consensus 225 ~ 225 (261)
T cd05034 225 R 225 (261)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=286.20 Aligned_cols=224 Identities=37% Similarity=0.677 Sum_probs=187.7
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
|++..++|+++++||+|+||.||+|.++. +..+++|.+...... .+.+.+|+.++++++|+||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNG-----NTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecC-----CceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 56778899999999999999999998764 456899988754332 3568899999999999999999998864
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
...+++|||+++++|.+++.+. ....+++..+..++.|++.||+|||+++++|+||||+||++++++.++|+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~ 144 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDG--------EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIA 144 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeC
Confidence 5689999999999999999752 23356888999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
|||++.......... .....++..|+|||.+.+..++.++|+||||+++|+|+++|.+||.+.+..+.++.+..+...+
T Consensus 145 dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05070 145 DFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223 (260)
T ss_pred CceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999997654433211 1122235579999999888899999999999999999998899999988888888887765443
Q ss_pred c
Q psy7023 355 Y 355 (364)
Q Consensus 355 ~ 355 (364)
.
T Consensus 224 ~ 224 (260)
T cd05070 224 C 224 (260)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=289.51 Aligned_cols=232 Identities=36% Similarity=0.600 Sum_probs=189.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.+.||+|+||.||+|.+++... ...+++|.++........+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGL--KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCC--cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 578999999999999999998876321 2347888887555555567789999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+||||+++++|.+++.+....... ......+++..+..++.|++.||+|||++||+||||||+|||+++++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999999864432211 11224578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++...... ........+..|+|||.+.+..++.++|||||||++|||++.|..||.+.+..++.+.+..+..
T Consensus 160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred ECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999998643221 1111122245699999999888999999999999999999768999999998888888877655
Q ss_pred cccc
Q psy7023 353 NEYK 356 (364)
Q Consensus 353 ~~~~ 356 (364)
.+.+
T Consensus 237 ~~~~ 240 (297)
T cd05089 237 MEKP 240 (297)
T ss_pred CCCC
Confidence 4443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=288.19 Aligned_cols=223 Identities=39% Similarity=0.702 Sum_probs=191.1
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
||....+|+++++||+|+||.||+|.++. +..+++|++..... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~-----~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKN-----RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecC-----CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 45566789999999999999999999876 66799999875533 2356788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..++||||+++++|.+++.+. ....+++..+..++.|++.||.|||++||+|+||||+|||+++++.+||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~ 146 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSP--------EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVA 146 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEc
Confidence 9999999999999999999752 23456888999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|||.+........... ....+..|+|||.+....++.++||||||+++|+|+++|..||.+.+..+++..+..+...
T Consensus 147 d~g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 223 (261)
T cd05148 147 DFGLARLIKEDVYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM 223 (261)
T ss_pred cccchhhcCCcccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC
Confidence 9999976654332222 2234667999999998889999999999999999999789999998888888888766543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=287.36 Aligned_cols=237 Identities=44% Similarity=0.804 Sum_probs=193.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.+|.+.++||+|+||.||++..... .......+++|.+... .......+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 46788999999999999999976542 2224567889987644 344567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCC-----ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAET-----DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+++|||+++++|.+++....+.... ......+++..+..++.|++.||+|||+.+++|+||||+|||+++++.+|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 9999999999999999875432111 11224578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++................+++.|+|||.+.+..++.++|||||||++|||+++|.+||......+.++.+..+..
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE 242 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence 99999987655443333333333467899999999999999999999999999999988999988888888887777655
Q ss_pred cccc
Q psy7023 353 NEYK 356 (364)
Q Consensus 353 ~~~~ 356 (364)
.+.+
T Consensus 243 ~~~~ 246 (280)
T cd05092 243 LERP 246 (280)
T ss_pred CCCC
Confidence 4443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=285.67 Aligned_cols=229 Identities=38% Similarity=0.648 Sum_probs=190.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||+|+||.||+|.++.... ....|++|.++.........++..|+.+++.++||||+++++++..+...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK-REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC-CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 568899999999999999999876332 2456999998876566667889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 83 ITEFMENGALDSFLRQN---------DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred EEecCCCCcHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccc
Confidence 99999999999999752 235678899999999999999999999999999999999999999999999998
Q ss_pred cccCccceeee---CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccccc
Q psy7023 280 RDIYETEYYRK---GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 280 ~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 356 (364)
........... ......+..|+|||.+....++.++||||||+++|||++.|..||...+..++.+.+......+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 233 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP 233 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc
Confidence 76543322111 111112457999999999999999999999999999887688999998888888888766544444
Q ss_pred CC
Q psy7023 357 VN 358 (364)
Q Consensus 357 ~~ 358 (364)
..
T Consensus 234 ~~ 235 (269)
T cd05065 234 MD 235 (269)
T ss_pred cc
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=283.37 Aligned_cols=221 Identities=32% Similarity=0.654 Sum_probs=183.8
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCC
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGG 206 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~g 206 (364)
.||+|+||.||+|.++... .+..||+|+..........+.+.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~--~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK--KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCC--CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999876322 2456999999876655566789999999999999999999998864 578999999999
Q ss_pred CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccc
Q psy7023 207 GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286 (364)
Q Consensus 207 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~ 286 (364)
++|.+++.. ....+++..++.++.|++.||+|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 79 ~~L~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 79 GPLNKFLSG---------KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred CCHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 999999874 23457889999999999999999999999999999999999999999999999997554332
Q ss_pred e-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCC
Q psy7023 287 Y-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNP 359 (364)
Q Consensus 287 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 359 (364)
. .........++.|+|||.+....++.++||||||+++|+|++.|..||.+....++...+.++...+.+..+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAEC 223 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCC
Confidence 1 112222233567999999988889999999999999999997689999999998988888888766554443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=295.16 Aligned_cols=212 Identities=23% Similarity=0.445 Sum_probs=176.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|+++++||+|+||.||+|+++. .+..||+|.++..........+.+|+.++++++|+||+++++++..++..++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL----TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC----CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 579999999999999999998876 4667999988755443344567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++ +|.+++... ...++...+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++
T Consensus 82 v~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 82 VFEYLDK-DLKQYMDDC---------GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred EEeCCCC-CHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccc
Confidence 9999965 899888652 234677889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
......... .....+++.|+|||++.+ ..++.++||||||+++|+|+| |++||.+.+..+.+..+.
T Consensus 152 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 152 RAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS-GRPLFPGSTVEDELHLIF 218 (309)
T ss_pred eecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Confidence 754332211 122234778999999865 458899999999999999999 899999888766665443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=295.29 Aligned_cols=209 Identities=23% Similarity=0.385 Sum_probs=177.0
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|.++. ++..||+|++.+.. .......+.+|..+++.+ +||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG----TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECC----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence 369999999999999876 46789999987542 223345677899999888 79999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++++|.+++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 77 YVNGGDLMFHIQR----------SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999999999875 235778899999999999999999999999999999999999999999999998653
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+....
T Consensus 147 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~-G~~pf~~~~~~~~~~~i~~~~ 212 (318)
T cd05570 147 ILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA-GQSPFEGDDEDELFQSILEDE 212 (318)
T ss_pred CcCCCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCC
Confidence 222211 112235788999999999999999999999999999999 899999988888888776553
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=290.12 Aligned_cols=199 Identities=22% Similarity=0.355 Sum_probs=168.1
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
||+|+||+||++.++. +++.||+|.+...... ...+.+..|+.+++.++|+||+++.+++..+...++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRA----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEcc----CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCC
Confidence 6999999999998876 4678999988654322 223567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+|+|.+++.... .....+++..++.++.||+.||+|||+++|+||||||+|||+++++.++|+|||++..+...
T Consensus 77 ~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 77 GGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 999998886422 12346788999999999999999999999999999999999999999999999998765443
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+
T Consensus 151 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~ 201 (280)
T cd05608 151 QSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA-ARGPFRARG 201 (280)
T ss_pred Ccc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Confidence 221 122345788999999999999999999999999999999 899997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=300.12 Aligned_cols=212 Identities=25% Similarity=0.362 Sum_probs=179.1
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELM 204 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 204 (364)
+.||+|+||.||++..... ...+..||+|++..... ......+.+|++++++++||||+++++++..++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITG-PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEecc-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999876432 12478899999875432 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCc
Q psy7023 205 GGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 205 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~ 284 (364)
++++|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 81 RGGDLFTRLSK----------EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 99999999864 23578889999999999999999999999999999999999999999999999876543
Q ss_pred cceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 285 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
.... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 151 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~i~~~~ 214 (318)
T cd05582 151 HEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKDRKETMTMILKAK 214 (318)
T ss_pred CCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeecc-CCCCCCCCCHHHHHHHHHcCC
Confidence 3211 112346788999999998889999999999999999999 899999988888888776543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=296.99 Aligned_cols=194 Identities=21% Similarity=0.351 Sum_probs=166.4
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||.||+|.++. .+..||+|+++... .......+.+|..+++.+ +||||+++++++...+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK----TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEe
Confidence 369999999999999876 46789999987543 223345678899999988 79999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~g~L~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 77 FVSGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999998864 235788899999999999999999999999999999999999999999999998743
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
..... ......+++.|+|||++.+..++.++|+|||||++|+|+| |..||.
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~ 197 (329)
T cd05588 147 IRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFD 197 (329)
T ss_pred ccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH-CCCCcc
Confidence 22211 1122346888999999999999999999999999999999 899996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=284.29 Aligned_cols=224 Identities=38% Similarity=0.664 Sum_probs=189.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|++.+.||+|+||.||+|.++.... ....+|+|.++..........+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGK-REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCC-CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 578899999999999999998764321 2457999998766556666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+++++||||||+|||++.++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 83 VTEYMENGSLDAFLRK---------HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred EEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 9999999999999975 2235788889999999999999999999999999999999999999999999999
Q ss_pred cccCccceee-eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 280 RDIYETEYYR-KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 280 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
.......... .......+..|+|||.+.+..++.++|+||||+++|++++.|..||.+.+..+....+.++...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL 228 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC
Confidence 8665432211 1122223567999999998889999999999999999886589999998888888888877543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=284.68 Aligned_cols=230 Identities=39% Similarity=0.712 Sum_probs=188.0
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc----
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP---- 196 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~---- 196 (364)
|.+.+.||+|+||.||+|.++.... ....||+|.++... .......+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG-SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC-CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5678899999999999998765321 24679999887543 34456788999999999999999999998865443
Q ss_pred --eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 197 --TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 197 --~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
.++|+||+++++|.+++...... .....+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhcc----CCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEEC
Confidence 79999999999999998653211 122357888999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
|||+++................+..|+|||.+.+..++.++||||||+++|||+++|..||.+..+.++++.+..+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999876544333222223345679999999888899999999999999999998899999999999988888765544
Q ss_pred cc
Q psy7023 355 YK 356 (364)
Q Consensus 355 ~~ 356 (364)
.+
T Consensus 236 ~~ 237 (273)
T cd05035 236 QP 237 (273)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=309.55 Aligned_cols=233 Identities=35% Similarity=0.587 Sum_probs=208.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..++.++.++||+|+||+|++|.|+. .......||||.+..+........|++|+.+|.+|+|+|+++||+++.+ ...
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~-psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQ-PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccC-CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 44677788999999999999999987 3344678999999887766678999999999999999999999999998 788
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
-+|||+++.|+|.+.|++ .....+....+..++.||+.||.||..+++|||||...|||+.....+||+|||
T Consensus 186 mMV~ELaplGSLldrLrk--------a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK--------AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred hHHhhhcccchHHHHHhh--------ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence 899999999999999987 345677889999999999999999999999999999999999999999999999
Q ss_pred cccccCccc-eeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccccc
Q psy7023 278 MTRDIYETE-YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 278 ~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 356 (364)
+.+.+..++ .+........+..|.|||.++...++.++|||++||+||||+|+|..||.|....++++.|.++.+.+-|
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP 337 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP 337 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC
Confidence 999877544 3344444556778999999999999999999999999999999999999999999999999999998888
Q ss_pred CCCC
Q psy7023 357 VNPP 360 (364)
Q Consensus 357 ~~~~ 360 (364)
..|+
T Consensus 338 k~cs 341 (1039)
T KOG0199|consen 338 KYCS 341 (1039)
T ss_pred CCCh
Confidence 8775
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=291.42 Aligned_cols=231 Identities=35% Similarity=0.591 Sum_probs=188.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.+.||+|+||.||+|.++... ....+++|.++..........+.+|+.+++++ +|+||+++++++..++..|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCC--ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 57889999999999999999986522 12456788776555555667888999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+||||+++++|.++++........ ......+++..++.++.|++.||+|||++|++||||||+|||+++++.+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 999999999999999865432211 11234678899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++....... .......+..|+|||.+.+..++.++||||||+++|||+|.|..||.+.+..+..+.+..+..
T Consensus 165 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05088 165 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241 (303)
T ss_pred eCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence 99999986432111 111222356799999998888999999999999999999878899998888888888876654
Q ss_pred ccc
Q psy7023 353 NEY 355 (364)
Q Consensus 353 ~~~ 355 (364)
.+.
T Consensus 242 ~~~ 244 (303)
T cd05088 242 LEK 244 (303)
T ss_pred CCC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.93 Aligned_cols=236 Identities=32% Similarity=0.609 Sum_probs=196.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee-CCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE-GNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~ 196 (364)
-+++|++.+.||+|+||.||+|.++.........|++|.+...........+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4578999999999999999999987644334678999998866666667888999999999999999999998765 578
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++++||+.+++|.+++........ .....+++..+..++.|++.||+|||+++++|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEA--NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhcccccc--ccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999999976432211 12356889999999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
|+++.+.............++..|+|||.+.+..++.++||||||+++|||++.|++||...+..++...+..+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 9998765444333233333466799999999888999999999999999999878999998888888888877654433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=306.70 Aligned_cols=210 Identities=19% Similarity=0.323 Sum_probs=170.6
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCc------ceeEEEE
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH------HVVKLYG 189 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~------~iv~l~~ 189 (364)
+....+|+++++||+|+||+||+|.+.. .+..||||+++... .....+..|+.+++.++|. +++++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~----~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRK----RKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcC----CCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 3456789999999999999999999876 46789999986432 2233455677777777554 5889999
Q ss_pred EEeeC-CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcC
Q psy7023 190 VVSEG-NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVAD 267 (364)
Q Consensus 190 ~~~~~-~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~ 267 (364)
++..+ ...++|||++ +++|.+++.+ ...+++..+..++.||+.||+|||+ .|||||||||+|||++.
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~ 267 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMK----------HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMET 267 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEec
Confidence 88754 5789999998 7799999875 2357788999999999999999998 59999999999999987
Q ss_pred CC----------------cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCC
Q psy7023 268 DL----------------TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLA 331 (364)
Q Consensus 268 ~~----------------~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g 331 (364)
++ .+||+|||.+...... .....+|+.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt-G 341 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT-G 341 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh-C
Confidence 65 4999999987643221 223456889999999999999999999999999999999 8
Q ss_pred CCCCCCCCHHHHHHHHh
Q psy7023 332 SQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 332 ~~P~~~~~~~~~~~~i~ 348 (364)
++||.+.+..+.+..+.
T Consensus 342 ~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 342 KLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCCCCCCChHHHHHHHH
Confidence 99999888777666553
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=290.35 Aligned_cols=230 Identities=38% Similarity=0.708 Sum_probs=187.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcc------------cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCccee
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFR------------SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVV 185 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~------------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv 185 (364)
+.++|++.++||+|+||.||++.++... ......+|+|++..........++.+|+.+++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3568999999999999999998755321 1124568999988665555667899999999999999999
Q ss_pred EEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC-ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7023 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET-DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCM 264 (364)
Q Consensus 186 ~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIL 264 (364)
++++++...+..++||||+++++|.+++......... ......+++..+..++.|++.||+|||++|++|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 9999999999999999999999999999875432221 123345788899999999999999999999999999999999
Q ss_pred EcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCHHHH
Q psy7023 265 VADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL-ASQPYQGLSNEQV 343 (364)
Q Consensus 265 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~-g~~P~~~~~~~~~ 343 (364)
+++++.++|+|||++..+..............++.|++||....+.++.++|||||||++|||+++ +..||...+..+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 999999999999999866443322222223345689999998888899999999999999999984 6789988777666
Q ss_pred HHHH
Q psy7023 344 LNWV 347 (364)
Q Consensus 344 ~~~i 347 (364)
....
T Consensus 243 ~~~~ 246 (296)
T cd05095 243 IENT 246 (296)
T ss_pred HHHH
Confidence 5533
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=286.33 Aligned_cols=237 Identities=41% Similarity=0.778 Sum_probs=194.3
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..+|.+.+.||+|+||.||+|.+.... ......+++|.+.... ....+.+.+|+.++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 357889999999999999999865432 2235568888876543 33346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCC------CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAE------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
++||||+++++|.+++........ .......+++..++.++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 999999999999999986432110 01122357889999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+|+|||++................++..|+|||.+.+..++.++||||||+++|||+|+|..||...+..++++.+..+.
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 242 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence 99999999866554433333344456789999999999999999999999999999998899999888888888887776
Q ss_pred ccccc
Q psy7023 352 SNEYK 356 (364)
Q Consensus 352 ~~~~~ 356 (364)
..+.+
T Consensus 243 ~~~~~ 247 (291)
T cd05094 243 VLERP 247 (291)
T ss_pred CCCCC
Confidence 55443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=283.67 Aligned_cols=220 Identities=38% Similarity=0.684 Sum_probs=184.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|++.+.||+|+||.||++.++. ...+++|++...... ...+.+|+.++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-----KIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-----CccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 468889999999999999998764 457899988654322 3467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++... ...+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 77 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 77 VTEYMANGCLLNYLRER---------KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred EEecCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccc
Confidence 99999999999999752 235778899999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 356 (364)
+...+..... ......+..|+|||.+.+..++.++||||||+++|+|+++|..||...+..+....+..+.....+
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05059 148 RYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP 223 (256)
T ss_pred eecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 7654332221 111123457999999998899999999999999999999889999988888888888776544433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=283.10 Aligned_cols=222 Identities=38% Similarity=0.674 Sum_probs=185.3
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
|++..++|.+.+.||+|++|.||+|.++. ...+++|.+..... ..+.+.+|+.++++++|+|++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNG-----TTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcC-----CceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 56677889999999999999999998765 34589998765432 23568889999999999999999998864
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..++||||+.+++|.+++... ....+++..+..++.|++.||+|||+.+++|+||||+||++++++.++|+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~ 144 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEG--------DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIA 144 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEEC
Confidence 5689999999999999999752 22346788899999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|+|+|..||.+....+..+++..+...
T Consensus 145 dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05069 145 DFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222 (260)
T ss_pred CCccceEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999997654433221 112223567999999988889999999999999999999889999998888888888766543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=284.05 Aligned_cols=227 Identities=37% Similarity=0.687 Sum_probs=185.2
Q ss_pred eEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee------CC
Q psy7023 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE------GN 195 (364)
Q Consensus 123 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------~~ 195 (364)
.+.+.||+|+||.||+|.+.... ....+|+|.++... .....+.+.+|+.+++.++|+||+++++++.. ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDD--SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCC--CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 46788999999999999886532 12468999887543 34456778899999999999999999998642 23
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+.+|+|.+++...... .....+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhccc----CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECC
Confidence 568999999999999988642211 1223578899999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
||+++................++.|+|||.+.+..++.++||||||+++|||+++|..||.+....+..+.+..+...+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998765544333333334567899999999989999999999999999999988999999889999998887765443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=318.96 Aligned_cols=220 Identities=23% Similarity=0.336 Sum_probs=180.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.++||+|+||.||+|.+.. .++.||+|++.... .....+++.+|++++++++||||+++++++.+++..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~----tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV----CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC----CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEE
Confidence 589999999999999999999876 47789999987543 234456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCC-CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAE-TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
|+||||++|++|.+++........ ........+...++.++.||+.||+|||++||+||||||+|||++.++.++|+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEec
Confidence 999999999999999975321111 1112234567788999999999999999999999999999999999999999999
Q ss_pred ccccccCccce----------------eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 277 GMTRDIYETEY----------------YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 277 g~a~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
|+++....... ........+|+.|+|||++.+..++.++|||||||++|||+| |..||...+.
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT-G~~PF~~~~~ 236 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT-LSFPYRRKKG 236 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCcch
Confidence 99986521110 001112357889999999999999999999999999999999 8899987655
Q ss_pred HHHH
Q psy7023 341 EQVL 344 (364)
Q Consensus 341 ~~~~ 344 (364)
.++.
T Consensus 237 ~ki~ 240 (932)
T PRK13184 237 RKIS 240 (932)
T ss_pred hhhh
Confidence 4433
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=296.45 Aligned_cols=241 Identities=36% Similarity=0.642 Sum_probs=189.3
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~ 192 (364)
|+...++|++.+.||+|+||+||+|.+.... ....+.||+|+++..........+.+|+.+++++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 6667789999999999999999999865432 2356789999998665555567788999999999 6799999999876
Q ss_pred e-CCceEEEEecCCCCCHHHHHHhcCCCCCC-------------------------------------------------
Q psy7023 193 E-GNPTLVIMELMGGGDLKNYLRSCRPDAET------------------------------------------------- 222 (364)
Q Consensus 193 ~-~~~~~lv~e~~~ggsL~~~l~~~~~~~~~------------------------------------------------- 222 (364)
. +...++||||+++|+|.+++.........
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45789999999999999999764211000
Q ss_pred --------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCC
Q psy7023 223 --------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294 (364)
Q Consensus 223 --------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~ 294 (364)
......+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 001134678889999999999999999999999999999999999999999999998765433222222222
Q ss_pred CCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCccccc
Q psy7023 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQVLNWVKGKSSNEY 355 (364)
Q Consensus 295 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~~~~~i~~~~~~~~ 355 (364)
.++..|+|||.+.+..++.++||||||+++|+|+++|..||.+... .+....+..+.....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 303 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC
Confidence 3456799999999889999999999999999999878999987553 345555555554433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.98 Aligned_cols=217 Identities=40% Similarity=0.715 Sum_probs=184.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++++.||+|+||+||+|.+++ ...+|+|.+..... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-----~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-----CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 578999999999999999998764 44699998875432 23568899999999999999999999999899999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+.+++|.+++... ...+++..+..++.|++.||+|||+.+++|+||||+|||+++++.+||+|||.+
T Consensus 77 v~e~~~~~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 77 VTEYMSNGCLLNYLREH---------GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred EEEcCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccc
Confidence 99999999999999752 225678899999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+......... .....++..|+|||.+.+..++.++||||||+++|+|++.|..||...+..++.+.+.++...
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd05113 148 RYVLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL 220 (256)
T ss_pred eecCCCceee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC
Confidence 8665443322 112224567999999998889999999999999999998789999988888888888776544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.75 Aligned_cols=231 Identities=51% Similarity=0.898 Sum_probs=193.2
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
+.||+|+||.||+|.+.... .....|++|++.........+.+.+|+++++.++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD-GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCC-CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46999999999999987531 23678999999876655557788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++....... .......+++..+..++.|++.||+|||+++++|+||||+||++++++.++|+|||.+......
T Consensus 80 ~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 80 GGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred CCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999998632110 0011356889999999999999999999999999999999999999999999999999876654
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCC
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVN 358 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 358 (364)
..........+++.|+|||.+....++.++||||||+++|+|+++|..||.+.+..++.+.+..+.....+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEY 231 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 3222233344577899999998888999999999999999999977999999999999999887665554443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=294.86 Aligned_cols=195 Identities=22% Similarity=0.343 Sum_probs=166.4
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|.++. .++.||+|++..... ......+.+|+.+++++ +|++|+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK----NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEe
Confidence 369999999999999876 467899999876432 23455678899999888 69999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 77 YVNGGDLMFHMQR----------QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999998864 235788899999999999999999999999999999999999999999999998753
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 147 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~-g~~pf~~ 198 (327)
T cd05617 147 LGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFDI 198 (327)
T ss_pred cCCCCc--eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh-CCCCCCc
Confidence 222111 122346888999999999999999999999999999999 8999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=281.76 Aligned_cols=223 Identities=35% Similarity=0.667 Sum_probs=187.9
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
|++.+++|++.++||+|+||.||++.+.. ...+++|.+... ....+.+.+|+.++++++|+||+++++.+.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNK-----HTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecC-----CccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 67888999999999999999999998654 456899987653 2335678899999999999999999999887
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
...+++|||+++++|.+++.+. ....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~ 144 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIA 144 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhC--------CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEEC
Confidence 7889999999999999999762 22346778889999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
|||.+.......... .....++..|+|||.+....++.++|+||||+++|+|+|+|..||.+.+..++...+.++...+
T Consensus 145 d~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05073 145 DFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223 (260)
T ss_pred CCcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 999987654332211 1112235679999999988899999999999999999998899999988888888887765443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=287.30 Aligned_cols=230 Identities=38% Similarity=0.653 Sum_probs=188.8
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEE
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVV 191 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~ 191 (364)
.|+...++|.+.+.||+|+||.||+|.+... .......||+|.++........+.+.+|+.+++++ +|+||+++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 4566778999999999999999999986432 22346689999987665555567889999999999 799999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
...+..++||||+.+++|.++++.. ....+++..+..++.|++.||+|||+++|+|+||||+|||+++++.+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 180 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRK--------RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIV 180 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeE
Confidence 9999999999999999999999752 12237888999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhcC
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV-LNWVKGK 350 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~-~~~i~~~ 350 (364)
+|+|||++................++..|+|||.+.+..++.++||||||+++|+|+++|..||.+....+. .+.+..+
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~ 260 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC
Confidence 999999998664432211222223466799999999999999999999999999999878889987665443 3444444
Q ss_pred c
Q psy7023 351 S 351 (364)
Q Consensus 351 ~ 351 (364)
.
T Consensus 261 ~ 261 (302)
T cd05055 261 Y 261 (302)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=306.42 Aligned_cols=204 Identities=29% Similarity=0.554 Sum_probs=180.3
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
..+.||+..+...-++-||+|+.|.||+|+.+ ++.||||..+... ..+++-|++|+|+||+.+.++
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~------netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLH------NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeecc------CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeee
Confidence 45678998888888889999999999999887 5679999764321 237888999999999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
|...-.++||||||..|-|...|+. ...++...++.|.++|+.||.|||.++|||||||.-||||..+..
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka----------~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~ 250 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKA----------GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV 250 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhc----------cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce
Confidence 9999999999999999999999985 456788899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
|||+|||-++...+.. ....+.||..|||||++.+.+.+.|+|||||||+||||+| +..||.+.+...
T Consensus 251 VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT-~EiPYkdVdssA 318 (904)
T KOG4721|consen 251 VKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT-GEIPYKDVDSSA 318 (904)
T ss_pred EEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh-cCCCccccchhe
Confidence 9999999998776652 2334567899999999999999999999999999999999 899998877554
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=282.17 Aligned_cols=230 Identities=38% Similarity=0.709 Sum_probs=191.4
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
++.+.+|.+.+.||+|+||.||+|.+.+.. .....|++|...........+.+.+|+.++++++|+||+++++++.+ .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPE-NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCC-CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 345678999999999999999999876532 12457899988766655667789999999999999999999999876 5
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+++|+||||+|||++.++.++|+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d 150 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN---------KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGD 150 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEcc
Confidence 678999999999999999752 23467889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
||++........... .....+..|+|||.+....++.++||||||+++|||++.|..||.+.+..+.+..+..+.....
T Consensus 151 ~g~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (270)
T cd05056 151 FGLSRYLEDESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM 229 (270)
T ss_pred Cceeeecccccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 999876654432222 2223356799999998888999999999999999999668999999988888888877765544
Q ss_pred cC
Q psy7023 356 KV 357 (364)
Q Consensus 356 ~~ 357 (364)
+.
T Consensus 230 ~~ 231 (270)
T cd05056 230 PP 231 (270)
T ss_pred CC
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=286.24 Aligned_cols=231 Identities=38% Similarity=0.710 Sum_probs=191.4
Q ss_pred ccceeEeceeeeecceEEEEEEEcCccc------------ccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRS------------LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~------------~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~ 186 (364)
.++|+++++||+|+||.||+|.+..... .....||+|.+.........+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999998765332 2345689999887766666788999999999999999999
Q ss_pred EEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC-ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7023 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET-DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265 (364)
Q Consensus 187 l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl 265 (364)
+++++..++..++|||++++++|.+++......... ......+++..+..++.|++.||+|||+++|+|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 999999999999999999999999999864322111 1123467899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCHHHHH
Q psy7023 266 ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL-ASQPYQGLSNEQVL 344 (364)
Q Consensus 266 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~-g~~P~~~~~~~~~~ 344 (364)
++++.++|+|||+++...............+++.|+|||.+....++.++||||||+++|||+++ +..||...+..+++
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 99999999999999866544433333333456789999999988899999999999999999973 57889887777777
Q ss_pred HHHhc
Q psy7023 345 NWVKG 349 (364)
Q Consensus 345 ~~i~~ 349 (364)
+.+..
T Consensus 244 ~~~~~ 248 (296)
T cd05051 244 ENAGH 248 (296)
T ss_pred HHHHh
Confidence 76643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=289.57 Aligned_cols=227 Identities=33% Similarity=0.616 Sum_probs=188.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|+..+.||+|+||.||+|.+..........||+|.+..........++.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCcee
Confidence 57888999999999999999987654444557899998876555556678899999999999999999999875 45679
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+|||+++++.+||+|||++
T Consensus 86 v~e~~~~g~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---------KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred eehhcCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccc
Confidence 99999999999999752 234677889999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 356 (364)
+................+..|+|||.+.+..++.++||||||+++|||++.|..||.+....++.+.++.+.....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP 233 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 86654332222222234567999999998889999999999999999998688999988888888888776655443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=294.34 Aligned_cols=194 Identities=22% Similarity=0.361 Sum_probs=165.6
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||+||+|.++. +++.||+|+++... .......+.+|+.++.++ +||||+++++++...+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK----TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECC----CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEe
Confidence 369999999999999876 46789999987542 233455677899888876 89999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~~L~~~~~~----------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 77 YVNGGDLMFHMQR----------QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999998864 235778899999999999999999999999999999999999999999999998753
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~ 197 (329)
T cd05618 147 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFD 197 (329)
T ss_pred cCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh-CCCCCc
Confidence 32211 1122346888999999999999999999999999999999 899995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=281.73 Aligned_cols=226 Identities=38% Similarity=0.668 Sum_probs=188.7
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|+..+.||+|+||.||+|.++.... ....+++|.+.........+.+.+|++++++++|+||+++.+++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGR-KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCC-CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 4578889999999999999999875321 234799999876655556678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+++|+||||+||++++++.+||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 83 IITEYMENGALDKYLRD---------HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred EEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcc
Confidence 99999999999999975 224577888999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeee-CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 279 TRDIYETEYYRK-GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 279 a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
+........... ......+..|+|||.+....++.++||||||+++|||++.|..||...+..++...+..+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~ 230 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC
Confidence 876543322111 1112224579999999988899999999999999999976889999888888888887664443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=280.68 Aligned_cols=218 Identities=23% Similarity=0.357 Sum_probs=186.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
+|++.+.||+|+||.||++.++. ++..+++|.++........+.+.+|+.+++.++|+||+++++.+..++..|+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN----SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC----CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 57889999999999999998876 46779999886555555667888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
|||+++++|.+++... ....++...+..++.|++.||.|||+++|+|+||||+||++++++.++|+|||.+.
T Consensus 77 ~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 77 MEYCDGGDLMQKIKLQ--------RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EeeCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcce
Confidence 9999999999998752 23346788899999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
......... ....+++.|+|||++.+..++.++|+||||+++|+|++ |..||...+.......+..+...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 218 (255)
T cd08219 149 LLTSPGAYA--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT-LKHPFQANSWKNLILKVCQGSYK 218 (255)
T ss_pred eeccccccc--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhh-ccCCCCCCCHHHHHHHHhcCCCC
Confidence 654332211 12345778999999998889999999999999999999 89999988888777777666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.70 Aligned_cols=205 Identities=20% Similarity=0.303 Sum_probs=173.6
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
..+...+|++++.||+|+||.||++..++.. ....|++|.+.... ...+|+.++++++|+||+++++++...
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~--~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDE--QRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCc--cceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 3455678999999999999999999765422 46789999876432 345799999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
...++|||++. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~ 227 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDR----------SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG 227 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEc
Confidence 99999999995 689998843 3457889999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
|||++................+|+.|+|||++....++.++|||||||++|||++ |+.||.+..
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~ 291 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV-KNVTLFGKQ 291 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCC
Confidence 9999986655433333334457889999999999999999999999999999999 777886543
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=295.69 Aligned_cols=216 Identities=23% Similarity=0.375 Sum_probs=188.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.-|.+.+.||+|-|++|-+|++-- ++.+||||++++.... -....+++|++.|+.+.|||||++|++...+..+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVF----TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVF----TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhc----ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 568888999999999999997554 6889999999876543 33567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CCCcEEEeecc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA-DDLTVKVGDFG 277 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~-~~~~~kL~DFg 277 (364)
||+|+=++|+|+|||.+ ....+.+....++++||+.|+.|+|+..||||||||+|+.+. +-|-+||+|||
T Consensus 94 LiLELGD~GDl~DyImK---------He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMK---------HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred EEEEecCCchHHHHHHh---------hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecc
Confidence 99999999999999986 334567788999999999999999999999999999998765 67899999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFT-SHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
++..+...... ....|...|-|||++.+..|+ +++||||||||||-|+. |++||+..++.|.+..|.+.+.
T Consensus 165 FSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC-Gq~PFqeANDSETLTmImDCKY 236 (864)
T KOG4717|consen 165 FSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC-GQPPFQEANDSETLTMIMDCKY 236 (864)
T ss_pred ccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh-CCCccccccchhhhhhhhcccc
Confidence 99877665432 334567889999999999996 57899999999999988 9999999999999998887764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=295.04 Aligned_cols=206 Identities=21% Similarity=0.327 Sum_probs=171.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN- 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~- 195 (364)
+.++|++.+.||+|+||.||++.++. .+..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV----LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC----CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 44789999999999999999998776 47789999986543 2334567889999999999999999999986433
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 196 -----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 196 -----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
..|+||||+++ +|.+.+.. .++...+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIHM------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHhc------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC
Confidence 57999999965 67766642 2567788899999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+
T Consensus 162 ~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~ 231 (359)
T cd07876 162 LKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK-GSVIFQGTDHIDQW 231 (359)
T ss_pred EEEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence 99999999975433221 222345788999999999999999999999999999999 89999887765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=300.59 Aligned_cols=195 Identities=24% Similarity=0.381 Sum_probs=165.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+...+|++++.||+|+||.||+|.++. +++.||+|... ...+.+|++++++++||||+++++++..+..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~----~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNK----TCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECC----CCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 345689999999999999999999876 46789999643 2346789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++|+|++. ++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+||
T Consensus 158 ~~lv~e~~~-~~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAA----------KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred eEEEEecCC-CCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeC
Confidence 999999994 699988864 234678889999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
|++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||
T Consensus 227 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~ 283 (391)
T PHA03212 227 GAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT-CHDSL 283 (391)
T ss_pred Ccccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHH-CCCCc
Confidence 99865332211 11222356889999999999999999999999999999999 55554
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=280.92 Aligned_cols=215 Identities=40% Similarity=0.710 Sum_probs=174.9
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
+.||+|+||.||+|.+++.. ....+++|.+...........+.+|+.++++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGY--TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999876422 3567899988766555555678899999999999999999999999899999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+|+|.+++...... .....++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++......
T Consensus 79 ~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 79 LGDLKGYLRSCRKA-----ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCcHHHHHHHhhhc-----ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 99999999764321 1224556778889999999999999999999999999999999999999999999765444
Q ss_pred ceeeeCCCCCCCccccCcccccCC-------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDG-------VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
..........+++.|+|||++.+. .++.++||||||+++|||++.|..||....+.+.....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 222 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence 333333334457789999998642 35789999999999999996588999887777765543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=286.89 Aligned_cols=230 Identities=38% Similarity=0.692 Sum_probs=185.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCccc----------ccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEE
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRS----------LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l 187 (364)
...+|++.++||+|+||.||++.+..... .....||+|.............+.+|++++++++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45789999999999999999998754321 12335899998876566666789999999999999999999
Q ss_pred EEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCC--CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7023 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAE--TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265 (364)
Q Consensus 188 ~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl 265 (364)
++++...+..++||||+.+++|.+++........ .......+++..+..++.|++.||+|||+++++|+||||+|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 9999999999999999999999999975321100 01112346788899999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCHHHHH
Q psy7023 266 ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL-ASQPYQGLSNEQVL 344 (364)
Q Consensus 266 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~-g~~P~~~~~~~~~~ 344 (364)
++++.+||+|||++................++..|+|||++.++.++.++||||||+++|+|+++ +..||...+..+..
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 99999999999999765544333223333346789999999988999999999999999999983 56789887777766
Q ss_pred HHH
Q psy7023 345 NWV 347 (364)
Q Consensus 345 ~~i 347 (364)
..+
T Consensus 243 ~~~ 245 (295)
T cd05097 243 ENT 245 (295)
T ss_pred HHH
Confidence 544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=276.86 Aligned_cols=215 Identities=39% Similarity=0.756 Sum_probs=182.3
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
+.||+|+||.||+|...+ +..+|+|.+...........+.+|+.++++++||||+++++++...+..++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-----KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecC-----CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 368999999999998654 567999998876666666788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++... ...+++..+..++.|++.+|.|||++|++|+||||+||++++++.+||+|||++......
T Consensus 76 ~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 76 GGDFLSFLRKK---------KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 99999998642 234678889999999999999999999999999999999999999999999998754433
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
.... ......+..|+|||++....++.++||||||+++|+|++.|..||.+....+....+..+.....
T Consensus 147 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 215 (250)
T cd05085 147 IYSS-SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC 215 (250)
T ss_pred cccc-CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 2211 11223356799999999888999999999999999999878999999888888888877655443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=278.22 Aligned_cols=227 Identities=49% Similarity=0.896 Sum_probs=193.3
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIM 201 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 201 (364)
+++.+.||.|+||.||++.+..........||+|++...........+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 35678899999999999998764433457899999987766556778999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 202 ELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 202 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+++|+||||+||++++++.++|+|||++..
T Consensus 81 e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--------PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eccCCCCHHHHHHhhh--------hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCcee
Confidence 9999999999997522 11178889999999999999999999999999999999999999999999999987
Q ss_pred cCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 282 IYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
.......... ...+++.|+|||.+.+..++.++||||||+++|+|+++|.+||...+..++.+.+..+...+.+.
T Consensus 153 ~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 227 (258)
T smart00219 153 LYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPE 227 (258)
T ss_pred cccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 6654332221 22356789999999888899999999999999999998899999999999998888777655443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=283.75 Aligned_cols=202 Identities=18% Similarity=0.345 Sum_probs=171.8
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEee----CCceEE
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSE----GNPTLV 199 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~~~l 199 (364)
..||+|++|.||+|.+. ++.||+|.+..... ....+.+.+|+.+|++++||||+++++++.+ ....++
T Consensus 26 ~~i~~g~~~~v~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEEC------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEE
Confidence 46999999999999874 56899999875432 2234678899999999999999999999876 457899
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
||||+++|+|.+++.+. ..+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||+
T Consensus 100 v~Ey~~~g~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 100 ILEYCTRGYLREVLDKE----------KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred EEEeCCCCcHHHHHhhC----------CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 99999999999999752 3467788899999999999999984 999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
++....... ...+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+..
T Consensus 170 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~-g~~Pf~~~~~~~~~~~i~~ 236 (283)
T PHA02988 170 EKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT-GKIPFENLTTKEIYDLIIN 236 (283)
T ss_pred Hhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHh
Confidence 876543321 2335678999999976 679999999999999999999 8999999998888887743
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=300.62 Aligned_cols=211 Identities=23% Similarity=0.352 Sum_probs=169.7
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-- 194 (364)
....+|++++.||+|+||.||+|.++. .+..||+|.+..... ...+|+.+|+.++|+||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICID----TSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECC----CCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 345789999999999999999999876 467899998754322 234699999999999999999887431
Q ss_pred ------CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 195 ------NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 195 ------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
..+++||||+++ +|.+++.... .....+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~ 206 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYA------RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN 206 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCC
Confidence 246799999964 8888876422 123467888999999999999999999999999999999999966
Q ss_pred C-cEEEeecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 269 L-TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 269 ~-~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
+ .+||+|||+++.+..... .....+++.|+|||++.+. .|+.++|||||||++|||++ |.+||.+.+..+.+..
T Consensus 207 ~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~ 282 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVR 282 (440)
T ss_pred CCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence 4 799999999986543321 1123457889999998764 68999999999999999999 8999998877665544
Q ss_pred H
Q psy7023 347 V 347 (364)
Q Consensus 347 i 347 (364)
+
T Consensus 283 i 283 (440)
T PTZ00036 283 I 283 (440)
T ss_pred H
Confidence 4
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=278.50 Aligned_cols=219 Identities=42% Similarity=0.754 Sum_probs=178.7
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe-eCCceEEEEecC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS-EGNPTLVIMELM 204 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-~~~~~~lv~e~~ 204 (364)
+.||+|+||.||+|.+.+... ....||+|.+...........+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDG-QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCC-ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999998764322 356799998865555556678889999999999999999999765 456689999999
Q ss_pred CCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCc
Q psy7023 205 GGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 205 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~ 284 (364)
.+++|.+++.+. ....++..+..++.|++.||+|||+.+++||||||+|||+++++.+||+|||+++....
T Consensus 80 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~ 150 (262)
T cd05058 80 KHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD 150 (262)
T ss_pred CCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccC
Confidence 999999999752 22345677888999999999999999999999999999999999999999999976543
Q ss_pred cceee--eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 285 TEYYR--KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 285 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
..... ......++..|+|||.+....++.++||||||+++|||++++.+||...+..+....+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (262)
T cd05058 151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL 222 (262)
T ss_pred CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 32111 11122345679999999888899999999999999999998889999888888888777665443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=283.29 Aligned_cols=210 Identities=25% Similarity=0.375 Sum_probs=176.5
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
|+..+.||+|+||+||+|.+.. .++.+|+|.+..... ......+.+|++++++++|+||+++.+.+..++..++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l 77 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRA----TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECC----CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEE
Confidence 6778899999999999999876 467899998865432 2223457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+.+++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||++++++.++|+|||++
T Consensus 78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 78 VLTIMNGGDLKFHIYNM--------GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEeccCccHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 99999999999888652 2335788999999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
......... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+..+.+
T Consensus 150 ~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 150 VKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEV 213 (285)
T ss_pred eecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 654332211 12346788999999998899999999999999999999 89999887665444333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=277.57 Aligned_cols=218 Identities=34% Similarity=0.645 Sum_probs=180.5
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
+||+|+||.||+|.++... .+..+|+|+++... .....+++.+|+.+++.++|+||+++++++.. +..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK--SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCC--CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 5899999999999765322 36779999987543 23445678899999999999999999998864 57799999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++......
T Consensus 79 ~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 79 LGPLNKFLQK----------NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred CCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999999964 234678889999999999999999999999999999999999999999999999866543
Q ss_pred cee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 286 EYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 286 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
... .......++..|+|||.+....++.++|+||||+++|||++.|..||.+.+..++.+.++.+...+.+.
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 221 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQ 221 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 321 122223335689999999888899999999999999999986899999988889999888776544443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=296.03 Aligned_cols=207 Identities=24% Similarity=0.355 Sum_probs=171.9
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc---CCcceeEEEEEEeeCCceEEEEe
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF---DTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l---~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
||+|+||+||+|+++. .+..||+|++.... .......+..|..++..+ +||||+++++++...+..|+|||
T Consensus 1 lG~G~~g~Vy~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKD----TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECC----CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEc
Confidence 6999999999999876 46789999986432 122334455677777765 69999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+.+|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||++...
T Consensus 77 ~~~~g~L~~~l~~----------~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 77 YMSGGELFWHLQK----------EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred CCCCChHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999864 235678899999999999999999999999999999999999999999999998754
Q ss_pred CccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
...... .....+++.|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..++.+.+..+.
T Consensus 147 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 147 LTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC-GWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred CCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEecc-CCCCCCCCCHHHHHHHHHcCC
Confidence 332211 1223468889999998765 47899999999999999999 899999988888888776554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.14 Aligned_cols=211 Identities=23% Similarity=0.346 Sum_probs=175.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC----
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN---- 195 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~---- 195 (364)
+|++++.||+|+||+||++.+.. .++.||+|.+.... ......++.+|+.+++.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR----DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC----CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 46788999999999999998765 47789999886532 2234567889999999999999999999998766
Q ss_pred -ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 196 -PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 196 -~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
..|+||||+. ++|.+++.. ...++...+..++.||+.||+|||++||+||||||+|||+++++.+||+
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~ 145 (372)
T cd07853 77 EEIYVVTELMQ-SDLHKIIVS----------PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKIC 145 (372)
T ss_pred ceEEEEeeccc-cCHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEec
Confidence 7899999996 588888853 3457888999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|||+++....... .......+++.|+|||.+.+. .++.++|||||||++|||++ |++||.+.+..+.++.+.
T Consensus 146 Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 146 DFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG-RRILFQAQSPIQQLDLIT 218 (372)
T ss_pred cccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Confidence 9999875443221 112223457789999998874 47899999999999999999 899999888777666554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=280.00 Aligned_cols=216 Identities=36% Similarity=0.611 Sum_probs=173.1
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCC
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGG 206 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~g 206 (364)
.||+|+||+||+|...... ....+++|.............+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT--GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCC--CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5999999999999765422 23456677776655555667899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccc
Q psy7023 207 GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286 (364)
Q Consensus 207 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~ 286 (364)
|+|.+++++... .....+...+..++.||+.||+|||+.+++||||||+|||++.++.++|+|||++.......
T Consensus 80 ~~L~~~l~~~~~------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 80 GDLKSYLSQEQW------HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CcHHHHHHhhhc------ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence 999999986321 12245667788999999999999999999999999999999999999999999986433222
Q ss_pred eeeeCCCCCCCccccCcccccC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 287 YYRKGSRGFLPVRWMAPESLKD-------GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 287 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
.........++..|+|||++.. ..++.++||||||+++|||++++..||...++.+.+..+..+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 224 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh
Confidence 2222223345778999998753 235778999999999999998789999988887777665433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=322.73 Aligned_cols=230 Identities=24% Similarity=0.323 Sum_probs=198.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
-+++|.++++||+|+||.|.+++.+. +++.||+|++++.. ...+..-|..|-.+|...+.+-|+.++-.|++++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~----t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKS----TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeec----cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 45789999999999999999999988 57789999998632 2334567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
++|+|||||+||+|...+.+ ..++++.+++.++..|+.||+-||++|+|||||||+|||+|..|++||+|
T Consensus 149 ~LYlVMdY~pGGDlltLlSk----------~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSK----------FDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ceEEEEecccCchHHHHHhh----------cCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeecc
Confidence 99999999999999999975 23688899999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCccccc----C-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-c
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLK----D-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK-G 349 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~-~ 349 (364)
||.+-.+..... ......+|||.|++||++. + +.|+..+|+||+||++|||+. |..||...+-.+++..|. .
T Consensus 219 FGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly-G~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 219 FGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY-GETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred chhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc-CCCcchHHHHHHHHHHHhch
Confidence 999887765443 4455667899999999985 2 568999999999999999999 899999888889987774 4
Q ss_pred CccccccCCCCCCC
Q psy7023 350 KSSNEYKVNPPISL 363 (364)
Q Consensus 350 ~~~~~~~~~~~~s~ 363 (364)
...+.||....||.
T Consensus 297 k~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 297 KESLSFPDETDVSE 310 (1317)
T ss_pred hhhcCCCcccccCH
Confidence 44567775565663
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=276.73 Aligned_cols=221 Identities=38% Similarity=0.652 Sum_probs=183.6
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
++||+|+||.||+|.+..... ....+++|.+.........+++.+|+.+++.++|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG-KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCC-CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999998765322 246799999887665555678899999999999999999999876 457899999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++... ..+++..+..++.|++.+|+|||..+++|+||||+|||+++++.+||+|||+++.....
T Consensus 79 ~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 79 LGPLLKYLKKR----------REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999999752 25678899999999999999999999999999999999999999999999999866433
Q ss_pred cee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCC
Q psy7023 286 EYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVN 358 (364)
Q Consensus 286 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 358 (364)
... .......++..|+|||.+.+..++.++||||||+++|+|+++|.+||...+..++...+.++...+.+..
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEE 222 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCC
Confidence 221 1112222345799999999889999999999999999999878999999999899888887766554433
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=279.38 Aligned_cols=224 Identities=36% Similarity=0.597 Sum_probs=182.0
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
.||+|+||.||+|.++++. ....+++|..+..........+.+|+++++++ +||||+++++++...+..++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCC--CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 5899999999999987632 12457888887655555567888999999999 89999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 206 GGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
+++|.+++......... ......+++..+..++.|++.||+|||+++++|+||||+|||+++++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 99999999864422111 112345788999999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
...... ........+..|+|||++....++.++||||||+++|||++.|..||.+.+..++.+.+..+...+.
T Consensus 160 ~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 232 (270)
T cd05047 160 RGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232 (270)
T ss_pred cccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCC
Confidence 632211 1111122356799999998888999999999999999999768999999888888888876654443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=310.01 Aligned_cols=216 Identities=21% Similarity=0.345 Sum_probs=177.9
Q ss_pred ccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEE
Q psy7023 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLY 188 (364)
Q Consensus 110 ~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~ 188 (364)
..+...++-..+++|.+.|.+|||+.||+|.+.. .+..||+|.+-.. ++.....+.+|+.+|+.|. |+|||.++
T Consensus 27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~----~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yi 101 (738)
T KOG1989|consen 27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVK----GGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYI 101 (738)
T ss_pred CCceEEEECCEEEEEEEEEccCCcEEEEEEEecC----CCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEe
Confidence 3445667777899999999999999999999876 2388999988655 6677888999999999996 99999999
Q ss_pred EE-Eee------CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC--ceecCCC
Q psy7023 189 GV-VSE------GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLA 259 (364)
Q Consensus 189 ~~-~~~------~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--iiHrDlk 259 (364)
+. ... .-.++|.||||.||.|.|++..+ ....+++.++++|+.++++|+++||... |||||||
T Consensus 102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~R--------lq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLK 173 (738)
T KOG1989|consen 102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTR--------LQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLK 173 (738)
T ss_pred ccccccccCCCceeEEEeehhhccCCcHHHHHHHH--------HhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhh
Confidence 93 221 13568999999999999999863 2334889999999999999999999987 9999999
Q ss_pred CCCEEEcCCCcEEEeecccccccCcccee-------eeCCCCCCCccccCcccc---cCCCCCCchhHHHHHHHHHHHHh
Q psy7023 260 ARNCMVADDLTVKVGDFGMTRDIYETEYY-------RKGSRGFLPVRWMAPESL---KDGVFTSHSDVWSYGVVLWEMAT 329 (364)
Q Consensus 260 p~NILl~~~~~~kL~DFg~a~~~~~~~~~-------~~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~el~t 329 (364)
-+||||..+|+.||||||.+......... ...-....|+.|+|||++ .+...+.|+|||+|||+||-|+.
T Consensus 174 iENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy 253 (738)
T KOG1989|consen 174 IENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY 253 (738)
T ss_pred hhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH
Confidence 99999999999999999998744332210 011122348899999987 46678999999999999999998
Q ss_pred CCCCCCCCCC
Q psy7023 330 LASQPYQGLS 339 (364)
Q Consensus 330 ~g~~P~~~~~ 339 (364)
...||.+..
T Consensus 254 -~t~PFe~sg 262 (738)
T KOG1989|consen 254 -FTTPFEESG 262 (738)
T ss_pred -hCCCcCcCc
Confidence 889998763
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=281.93 Aligned_cols=218 Identities=24% Similarity=0.358 Sum_probs=190.9
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.+--++|..+++||+|.||+|.+++.+. +++.+|+|++++.. ...+...-+.|-++|+.++||.+..+.-.|+.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKa----t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKA----TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecc----cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 3445788899999999999999999887 57889999998754 44556677889999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+++|+||||..||.|+-++.. ..-+++.+.+.+..+|+.||.|||+++||.||||.+|+|+|.+|++||
T Consensus 240 ~drlCFVMeyanGGeLf~HLsr----------er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKi 309 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSR----------ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKI 309 (516)
T ss_pred CceEEEEEEEccCceEeeehhh----------hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEe
Confidence 9999999999999999988865 335666778889999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+|||+++.-.... .......|||.|.|||++.+..|+.++|+|.+||++|||+. |+.||...+.+.+++.|...
T Consensus 310 tDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmC-GRLPFyn~dh~kLFeLIl~e 383 (516)
T KOG0690|consen 310 TDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMC-GRLPFYNKDHEKLFELILME 383 (516)
T ss_pred eecccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHh-ccCcccccchhHHHHHHHhh
Confidence 9999998644333 33445567999999999999999999999999999999999 99999999999988877543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=276.27 Aligned_cols=218 Identities=25% Similarity=0.449 Sum_probs=186.1
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|.+.+.||+|++|.||+|.++. .+..|++|.+... ........+.+|+++++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA----DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC----CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence 47788999999999999999876 4677999987643 234556788899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++... ....++...+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++
T Consensus 77 v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 77 VMEYAENGDLHKLLKMQ--------RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEeCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccc
Confidence 99999999999999862 2345778889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
.......... ....+++.|+|||++.+..++.++|+||||+++++|++ |..||...+..+....+..+...
T Consensus 149 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08529 149 KLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPFDANNQGALILKIIRGVFP 219 (256)
T ss_pred eeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC
Confidence 7665433221 12235678999999999999999999999999999999 89999988888877777665543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=294.33 Aligned_cols=210 Identities=22% Similarity=0.323 Sum_probs=175.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-- 194 (364)
+.++|++.+.||+|+||.||+|.++. .++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI----LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC----CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 45789999999999999999998776 46779999987543 233456778999999999999999999987543
Q ss_pred ----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 195 ----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 195 ----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
...|+||||+++ +|.+++.. .++...+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHHh------------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc
Confidence 357999999965 78777743 2567788999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.
T Consensus 165 ~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~ 238 (364)
T cd07875 165 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKVI 238 (364)
T ss_pred EEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence 99999999976543321 122345788999999999999999999999999999999 899999888777665553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=281.28 Aligned_cols=226 Identities=48% Similarity=0.851 Sum_probs=185.6
Q ss_pred ceeeeecceEEEEEEEcCcc--cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEec
Q psy7023 126 DELGNGSFGLVYRGLIKDFR--SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~ 203 (364)
+.||+|+||.||+|++++.. ......+++|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 35899999999999887533 2234678999887655445567888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-----cEEEeeccc
Q psy7023 204 MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-----TVKVGDFGM 278 (364)
Q Consensus 204 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-----~~kL~DFg~ 278 (364)
+++++|.+++........ ....+++..+..++.|++.||+|||+++++|+||||+|||++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERF---GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhccc---CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999976332110 223467889999999999999999999999999999999999887 899999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
+.................+..|+|||.+.+..++.++||||||+++|+|+|.|..||...+..+....+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC
Confidence 9866544332222333446789999999999999999999999999999987889999888888888877655443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=289.52 Aligned_cols=217 Identities=24% Similarity=0.373 Sum_probs=184.6
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEee
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSE 193 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~ 193 (364)
+-..+|..+.+||+|+||.|-+|..+. +...+|||+++++. ...+.+--+.|-++|... +-|.+++++..|+.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkg----tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKG----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred eeecccceEEEeccCccceeeeecccC----cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 344789999999999999999998887 45669999998753 223344456688888776 45688999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
-+++|+||||+.||+|.-.+++..+ +.+..++.+|.+|+-||-+||++|||+||||.+|||++.+|++||
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~Gk----------FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGK----------FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcc----------cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEe
Confidence 9999999999999999999987543 444567789999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+|||+++.-.-...+++ ...|||.|+|||++...+|+.++|+||+|++||||+. |++||.+.+++++++.|.+-
T Consensus 492 ~DFGmcKEni~~~~TTk--TFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmla-GQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 492 ADFGMCKENIFDGVTTK--TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred eecccccccccCCccee--eecCCCcccccceEEecccccchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHc
Confidence 99999986544433333 3456999999999999999999999999999999999 99999999999999988654
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.01 Aligned_cols=247 Identities=40% Similarity=0.710 Sum_probs=216.4
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccc---cccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSL---AEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
.||+.+++.++.+.||+|.||.|++|..+..... ....||||.++......+.+.+..|+++|+.+ .|+||+.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 7999999999999999999999999986654433 26789999999888778889999999999999 6999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccC----C--CCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVE----R--SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNC 263 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~----~--~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI 263 (364)
.+...+.+++|+||+..|+|.++++..+........ . ..++..+++.++.||+.||+||++.++|||||-.+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 999999999999999999999999987611111111 1 3488999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecccccccCccceee-eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-HH
Q psy7023 264 MVADDLTVKVGDFGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS-NE 341 (364)
Q Consensus 264 Ll~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~-~~ 341 (364)
|+.++..+||+|||+|+......++. ..+.+..+.+|||||.+....|+.++||||+|++||||+|.|..||.+.. ..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 99999999999999999877766555 44443367889999999999999999999999999999999999999977 88
Q ss_pred HHHHHHhcCccccccCCCC
Q psy7023 342 QVLNWVKGKSSNEYKVNPP 360 (364)
Q Consensus 342 ~~~~~i~~~~~~~~~~~~~ 360 (364)
++++.+++|.+++.|..|+
T Consensus 530 ~l~~~l~~G~r~~~P~~c~ 548 (609)
T KOG0200|consen 530 ELLEFLKEGNRMEQPEHCS 548 (609)
T ss_pred HHHHHHhcCCCCCCCCCCC
Confidence 8899999999999998874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=281.73 Aligned_cols=212 Identities=23% Similarity=0.366 Sum_probs=183.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.+.||+|+||.||++.++. .++.+|+|++.... .....+.+.+|++++++++||||+++++++.+++..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG----SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeE
Confidence 468999999999999999999876 46789999886532 223456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+|||+++++.+||+|||
T Consensus 77 ~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS----------GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred EEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999752 356788899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..+.+..+.
T Consensus 147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 214 (290)
T cd05580 147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDDNPIQIYEKILEGK 214 (290)
T ss_pred CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC
Confidence 98866543 122235778999999988888999999999999999999 899999888777777776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=286.02 Aligned_cols=211 Identities=23% Similarity=0.460 Sum_probs=176.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|+++++||+|+||.||+|.++. ++..||+|.+...........+.+|+.+++.++|+||+++++++...+..++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL----TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC----CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 679999999999999999998876 4678999988754443344567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||++ ++|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+|||+++++.++|+|||++
T Consensus 82 v~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC---------GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred EEeccc-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcch
Confidence 999996 5999988752 234678889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
......... .....+++.|+|||++.+. .++.++||||||+++|+|+| |.+||.+.+..+.+..+
T Consensus 152 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-g~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 152 RAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST-GRPLFPGSTVEEQLHFI 217 (301)
T ss_pred hccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 754332211 1122346789999998654 47889999999999999999 89999988876665544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=277.00 Aligned_cols=216 Identities=37% Similarity=0.647 Sum_probs=181.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE-eeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV-SEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-~~~~~ 196 (364)
-..+|++.+.||+|+||.||++..+ +..+++|..+... ..+.+.+|+.++++++|+|++++++++ ..++.
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~------~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc------CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 3468899999999999999999765 5568999886543 245688999999999999999999975 45577
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++||||+++++|.+++++. ....+++..+..++.|++.||+|||++|++||||||+||++++++.+||+||
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred eEEEEECCCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCC
Confidence 89999999999999999762 2234678889999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
|++........ ....+..|+|||++.+..++.++|||||||++|+|++.|..||...+..++...+..+...+.
T Consensus 147 g~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd05082 147 GLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 220 (256)
T ss_pred ccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 99875433221 112345799999999888999999999999999999878999999888888888877655443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=283.23 Aligned_cols=203 Identities=25% Similarity=0.395 Sum_probs=172.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.|++.+.||+|+||+||++.++. +++.||+|.+..... ......+.+|+.++++++|++|+++++.+.+.+..+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC----CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEE
Confidence 36778899999999999999887 467899998764322 222355778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+.+++|.+++... ....+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||+
T Consensus 77 lv~e~~~g~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHM--------GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred EEEEecCCCcHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999998652 223477888999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
+......... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 149 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~ 205 (285)
T cd05630 149 AVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK 205 (285)
T ss_pred eeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCC
Confidence 8754432211 12246788999999999999999999999999999999 899998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=273.61 Aligned_cols=213 Identities=39% Similarity=0.758 Sum_probs=180.5
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
++||+|+||.||++.+++ ++.|++|.+...........+.+|++++++++|+||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-----~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-----NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeC-----CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 369999999999998764 667999988766555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++... ...++...+..++.|++.+|+|||+++++||||||+|||+++++.++|+|||++......
T Consensus 76 ~~~l~~~l~~~---------~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 76 GGSLLTFLRKK---------KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999752 234677889999999999999999999999999999999999999999999998765433
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
...........+..|+|||.+.+..++.++|+||||+++|+|+|+|..||......+..+.+..+..
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~ 213 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR 213 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC
Confidence 2222212222355699999999888999999999999999999988999998888777777766543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=280.88 Aligned_cols=196 Identities=22% Similarity=0.381 Sum_probs=165.6
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
||+|+||+||++..+. .++.||+|.+..... ......+..|++++++++||||+++++++..+...++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKN----TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEcc----CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCC
Confidence 6999999999999876 477899998864321 1223445679999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
|++|.+++... ....+++..+..++.|++.||+|||+.||+||||||+|||+++++.++|+|||++......
T Consensus 77 g~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 77 GGDLKYHIYNV--------GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 99999888652 2334678888999999999999999999999999999999999999999999998765443
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 149 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~p~~~~~ 198 (277)
T cd05607 149 KTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA-GRTPFKDHK 198 (277)
T ss_pred cee---eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCc
Confidence 221 12245778999999999889999999999999999999 889997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=274.84 Aligned_cols=217 Identities=39% Similarity=0.698 Sum_probs=186.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
...+|++.+.||+|+||.||+|... ++.|++|.+..... ..+++.+|+.+++.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~------~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR------GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL 75 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec------CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence 3468889999999999999999865 56799999876543 457788999999999999999999999989999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.++++.. ....+++..+..++.|++.||.|||+++++|+||||+||++++++.++|+|||
T Consensus 76 ~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSR--------GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred EEEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccc
Confidence 9999999999999999762 22357889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 355 (364)
.++....... ....+..|+|||.+....++.++||||||+++|+|++.|..||...+..++.+.+..+...+.
T Consensus 148 ~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd05039 148 LAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA 220 (256)
T ss_pred cccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 9986633221 122355799999999888999999999999999999768999999888888888877655433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=296.90 Aligned_cols=219 Identities=24% Similarity=0.404 Sum_probs=188.4
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELM 204 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 204 (364)
++||+|.||+||-|+++. +++.||||++.+.. ......++.+|+.||+.++||.||.+...|+..+.+++|||.+
T Consensus 570 evLGSGQFG~VYgg~hRk----tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRK----TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred hhccCCcceeeecceecc----cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 579999999999999887 68899999998654 2233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEEEeecccccc
Q psy7023 205 GGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD---LTVKVGDFGMTRD 281 (364)
Q Consensus 205 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~---~~~kL~DFg~a~~ 281 (364)
. |++.+.|-+ .+...+++.....++.||+.||.|||-++|+|+||||+|||+.+. ..+||||||+|+.
T Consensus 646 ~-GDMLEMILS--------sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 646 H-GDMLEMILS--------SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred c-chHHHHHHH--------hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 5 577777755 356678888888999999999999999999999999999999754 4799999999999
Q ss_pred cCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc-cccCCCC
Q psy7023 282 IYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN-EYKVNPP 360 (364)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~~~~~~ 360 (364)
+.+..+.+ ..+|||.|.|||++.++.|...-||||.|+|+|.-+. |..||.. .+++-+||+....+ +..+|..
T Consensus 717 IgEksFRr---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS-GTFPFNE--dEdIndQIQNAaFMyPp~PW~e 790 (888)
T KOG4236|consen 717 IGEKSFRR---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS-GTFPFNE--DEDINDQIQNAAFMYPPNPWSE 790 (888)
T ss_pred cchhhhhh---hhcCCccccCHHHHhhccccccccceeeeEEEEEEec-ccccCCC--ccchhHHhhccccccCCCchhh
Confidence 88876643 3357999999999999999999999999999999999 8888853 56888999888766 6667777
Q ss_pred CCC
Q psy7023 361 ISL 363 (364)
Q Consensus 361 ~s~ 363 (364)
||.
T Consensus 791 is~ 793 (888)
T KOG4236|consen 791 ISP 793 (888)
T ss_pred cCH
Confidence 763
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=282.61 Aligned_cols=210 Identities=24% Similarity=0.382 Sum_probs=170.6
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhc---CCcceeEEEEEEee---
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAF---DTHHVVKLYGVVSE--- 193 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l---~h~~iv~l~~~~~~--- 193 (364)
+|++++.||+|+||+||+|.++. +++.||+|.++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH----SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC----CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 58899999999999999999886 4778999988643221 1223455677777665 79999999998864
Q ss_pred --CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 194 --GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 194 --~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
....++||||+. ++|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||+++++.+
T Consensus 77 ~~~~~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 77 DRETKVTLVFEHVD-QDLRTYLDKV--------PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQV 147 (288)
T ss_pred CCCceEEEEEcccc-cCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 345899999997 4899998752 22347889999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+.+..+
T Consensus 148 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~~f~~~~~~~~~~~~ 219 (288)
T cd07863 148 KLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKI 219 (288)
T ss_pred EECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHh-CCcCcCCCCHHHHHHHH
Confidence 9999999976543221 122345778999999998899999999999999999998 89999887776665544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=291.80 Aligned_cols=207 Identities=22% Similarity=0.323 Sum_probs=172.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-- 194 (364)
..++|++++.||+|+||.||+|.+.. .++.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV----LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC----CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 45799999999999999999998765 46779999887543 333456778999999999999999999988643
Q ss_pred ----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 195 ----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 195 ----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
...|+||||+++ +|.+.+.. .++...+..++.|++.||+|||++||+||||||+|||+++++.
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~~------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~ 157 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC
Confidence 357999999965 77777643 3567788899999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+.
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~ 228 (355)
T cd07874 158 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWN 228 (355)
T ss_pred EEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 99999999976543321 122345788999999999999999999999999999999 899998877655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=257.68 Aligned_cols=226 Identities=19% Similarity=0.372 Sum_probs=190.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|...++||+|.||+||+|+.++ +...||+|...-+ .++......++|+-+++.++|.|||+++++...++.+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~----t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE----THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC----ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 45667899999999999999887 4667999977643 334445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+|||+. +|..|..+ -.+.+..+.+..++.|+++||.++|++++.|||+||.|+||+.+|++||+|||++
T Consensus 79 vfe~cdq-dlkkyfds---------lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 79 VFEFCDQ-DLKKYFDS---------LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred eHHHhhH-HHHHHHHh---------cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchh
Confidence 9999954 99999886 3456677889999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcCccccccC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV-KGKSSNEYKV 357 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~ 357 (364)
+.+.-+. ...+..+.|..|.+|.++.+.+ |+...|+||.|||+.|+..-|++.|++.+-.+-+..| +.-.......
T Consensus 149 rafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred hhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 8765442 3445566788999999998766 7899999999999999999999999999877766655 3444445566
Q ss_pred CCCCC
Q psy7023 358 NPPIS 362 (364)
Q Consensus 358 ~~~~s 362 (364)
||.++
T Consensus 227 wps~t 231 (292)
T KOG0662|consen 227 WPSMT 231 (292)
T ss_pred CCccc
Confidence 77664
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=290.61 Aligned_cols=216 Identities=25% Similarity=0.370 Sum_probs=185.8
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH--HHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--EKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.+-.+.|..-++||+||||.||-++.+. +++-+|.|.+.+..... -..-.++|..||.++..+.||.+--.|+.
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvra----TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRA----TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEec----chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 4455788889999999999999999887 57788888876543222 23346789999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+.+++||..|+||+|.-+|.. .....+++++++.++.+|+.||++||+.+||+||+||+|||+|+.|+++|
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn--------~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYN--------HGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred CCceEEEEEeecCCceeEEeec--------cCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEe
Confidence 9999999999999999988865 34467889999999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+|.|+|..+.+..... ..+||..|||||++.++.|+...|+|||||+||||+. |+.||.......-.+.|
T Consensus 329 SDLGLAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~-G~sPFr~~KeKvk~eEv 398 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA-GHSPFRQRKEKVKREEV 398 (591)
T ss_pred eccceEEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc-ccCchhhhhhhhhHHHH
Confidence 9999999888775433 2367999999999999999999999999999999999 99999876654444334
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=297.75 Aligned_cols=211 Identities=23% Similarity=0.314 Sum_probs=173.3
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
...|.+.+.||+|+||.||+|.+.. .++.||+|... ...+.+|+++|++++|+||+++++++..++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~----~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD----YPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC----CCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 4579999999999999999999876 46789999632 223567999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|||++. ++|.+++.. ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 237 lv~e~~~-~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGl 306 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGA---------RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGA 306 (461)
T ss_pred EEEEccC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCC
Confidence 9999994 699998864 223678999999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHhcC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL-------SNEQVLNWVKGK 350 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~-------~~~~~~~~i~~~ 350 (364)
++...............+|+.|+|||++.+..++.++|||||||+||||++++.++|... ...++.+.++..
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA 385 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence 976543322222223346889999999999999999999999999999999555555432 234555555543
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=280.42 Aligned_cols=218 Identities=27% Similarity=0.421 Sum_probs=180.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..+.|+++++||+|+||.||+|.++. .+..+++|++... .......+.+|+.+++.++|+||+++++.+..++..
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~----~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKE----TGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECC----CCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 34679999999999999999998876 4677999998654 344567788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|..++.+ ....+++..+..++.|++.+|+|||+.+++|+||||+||+++.++.++|+|||
T Consensus 85 ~lv~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg 155 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLE---------LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFG 155 (292)
T ss_pred EEEEecCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCc
Confidence 999999999999988864 22357788999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
++......... .....+++.|+|||.+. ...++.++|+|||||++|+|++ |.+||...+..+.+..+.+...
T Consensus 156 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 232 (292)
T cd06644 156 VSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEP 232 (292)
T ss_pred cceeccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc-CCCCCccccHHHHHHHHhcCCC
Confidence 88654332111 11223467899999984 3457889999999999999999 8899988777666666554433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=279.68 Aligned_cols=207 Identities=33% Similarity=0.563 Sum_probs=172.4
Q ss_pred cce-eEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--CCc
Q psy7023 120 SKV-TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--GNP 196 (364)
Q Consensus 120 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~ 196 (364)
++| ++++.||+|+||+||++..+......+..||+|+++..........+.+|++++++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 89999999999999998765544445778999998766554556778899999999999999999998765 346
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++||||+++++|.+++.. ..+++..+..++.|++.||+|||+++|+|+||||+|||+++++.++|+||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~df 151 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDF 151 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeec
Confidence 8999999999999999964 23788899999999999999999999999999999999999999999999
Q ss_pred ccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 277 GMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 277 g~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
|++......... .......++..|+|||.+.+..++.++||||||+++|+|+| |..||...
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~ 213 (283)
T cd05080 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSP 213 (283)
T ss_pred ccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHh-CCCCCCCC
Confidence 999866543221 11122234567999999998889999999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=276.73 Aligned_cols=201 Identities=29% Similarity=0.553 Sum_probs=173.2
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHH-HHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK-AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
|++++.||+|+||+||++.++. .+..+|+|++......... ....+|+.++++++|+||+++++++......++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK----NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT----TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC----CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccc
Confidence 7889999999999999999887 4668999999876543332 2345699999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
||++++++|.+++.. ...++...+..++.|++.||++||+.+++|+||||+|||+++++.++|+|||.+.
T Consensus 77 ~~~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQK----------NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEETTEBHHHHHHH----------HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred ccccccccccccccc----------ccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999973 3456889999999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCccccc-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLK-DGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
...... .......++..|+|||++. +..++.++||||||+++|+|++ |..||....
T Consensus 147 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~p~~~~~ 203 (260)
T PF00069_consen 147 KLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLT-GKLPFEESN 203 (260)
T ss_dssp ESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHH-SSSSSTTSS
T ss_pred cccccc--cccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 542211 1223344578899999998 7889999999999999999999 889998874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=312.56 Aligned_cols=224 Identities=21% Similarity=0.405 Sum_probs=181.1
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
..+....+|++++.||+|+||+||+|.++. .+..+|+|++... ........+..|+.+++.++||||++++++|.
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~----tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKR----TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECC----CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 445667899999999999999999999876 4678999988643 34445677899999999999999999999885
Q ss_pred e--CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCE
Q psy7023 193 E--GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-------KFVHRDLAARNC 263 (364)
Q Consensus 193 ~--~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-------~iiHrDlkp~NI 263 (364)
. ...+||||||+++++|.++|.... .....+++..++.|+.||+.||+|||+. +||||||||+||
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNI 156 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI 156 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHe
Confidence 4 456899999999999999997532 1234688899999999999999999984 499999999999
Q ss_pred EEcC-----------------CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccC--CCCCCchhHHHHHHHH
Q psy7023 264 MVAD-----------------DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVL 324 (364)
Q Consensus 264 Ll~~-----------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il 324 (364)
||+. .+.+||+|||++..+..... .....+++.|+|||++.+ ..++.++|||||||||
T Consensus 157 LL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL 233 (1021)
T PTZ00266 157 FLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233 (1021)
T ss_pred EeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence 9964 23589999999986543322 122346889999999864 4588999999999999
Q ss_pred HHHHhCCCCCCCCCC-HHHHHHHHhcCc
Q psy7023 325 WEMATLASQPYQGLS-NEQVLNWVKGKS 351 (364)
Q Consensus 325 ~el~t~g~~P~~~~~-~~~~~~~i~~~~ 351 (364)
|+|+| |..||...+ ..+++..+..+.
T Consensus 234 YELLT-Gk~PF~~~~~~~qli~~lk~~p 260 (1021)
T PTZ00266 234 YELCS-GKTPFHKANNFSQLISELKRGP 260 (1021)
T ss_pred HHHHH-CCCCCCcCCcHHHHHHHHhcCC
Confidence 99999 899997544 455566665554
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=279.90 Aligned_cols=217 Identities=27% Similarity=0.423 Sum_probs=183.1
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|++++.||+|+||+||++.++. .+..+++|++... .....+.+.+|+.++++++|+||+++++++..+...|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~----~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE----TGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC----CCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 3679999999999999999998875 4678999998654 3444577889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||+
T Consensus 79 lv~e~~~~~~L~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~ 149 (280)
T cd06611 79 ILIEFCDGGALDSIMLEL---------ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGV 149 (280)
T ss_pred EEeeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCcc
Confidence 999999999999998752 34578889999999999999999999999999999999999999999999998
Q ss_pred ccccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+......... .....+++.|+|||.+. ...++.++|+||||+++|+|++ |..||.+.+..+.+..++.+..
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 225 (280)
T cd06611 150 SAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ-MEPPHHELNPMRVLLKILKSEP 225 (280)
T ss_pred chhhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHh-CCCCcccCCHHHHHHHHhcCCC
Confidence 8654332211 12233577899999975 3446789999999999999999 8999998888777777766543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=276.72 Aligned_cols=231 Identities=35% Similarity=0.687 Sum_probs=190.4
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+++|++++.||+|+||+||+|+.+... ......+++|...........+.+.+|++++++++|+||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 468899999999999999999976542 2345679999887655544567899999999999999999999999998999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++......... .....+++..+..++.|++.||+|||+.+|+|+||||+|||++.++.++|+|||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~-~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEK-LKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred eEEEEecCCCcHHHHHHhccccccc-ccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999999764321111 122357889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++......... ......++..|+|||.+.+..++.++||||||+++|+|+++|..||.+....+++..++.+.
T Consensus 163 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 163 LSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred cccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 98754433221 12222346679999999888889999999999999999998899998888888887776543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=272.36 Aligned_cols=219 Identities=20% Similarity=0.313 Sum_probs=186.1
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++++.||.|+||.||.++... .+..+++|.+... .......++.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE----DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC----CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence 58899999999999999998765 4677899987643 234556678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
+|||+++++|.+++.+. ....++...+..++.|++.+|.|||+.+++|+||+|+||++++++.+||+|||++
T Consensus 77 ~~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 77 EMEYANGGTLYDKIVRQ--------KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEEecCCCcHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcce
Confidence 99999999999999752 1345678899999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-LKRTFDATNPLNLVVKIVQGNYTP 220 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCCCCC
Confidence 76544332 1222345788999999998889999999999999999999 789999888888887776665433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=272.00 Aligned_cols=217 Identities=22% Similarity=0.344 Sum_probs=181.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee-CCceE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE-GNPTL 198 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~ 198 (364)
.|++++.||+|++|.||++.++. .++.|++|.+.... .....+.+.+|++++++++|+|++++++.+.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT----DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC----CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence 48899999999999999999876 35679999886433 34445678899999999999999999998864 44679
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.+++... ....+++.++..++.|++.||++||++|++|+||||+||+++.++.++|+|||+
T Consensus 77 lv~e~~~~~~l~~~l~~~--------~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--------KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred EEecccCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccc
Confidence 999999999999999752 234578889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+........ ......+++.|+|||++.+..++.++|+||||+++++|++ |..||...+..+....+..+..
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~~~~~~~~~~~~~~ 219 (257)
T cd08223 149 ARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT-LKHAFNAKDMNSLVYRIIEGKL 219 (257)
T ss_pred eEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC
Confidence 876543221 1122345778999999999999999999999999999999 7889988877777766666544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=273.57 Aligned_cols=214 Identities=24% Similarity=0.392 Sum_probs=177.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC----HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS----EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
+.|++.+.||+|++|.||.|.+.. .+.+|++|.+..... ......+.+|+.++++++||||+++++++.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~----~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD----TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC----CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence 358889999999999999998765 467899998764322 223456888999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++|+||+++++|.+++... ..++...+..++.|++.||.|||+.+++|+||||+||++++++.++|+|
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY----------GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEee
Confidence 999999999999999999752 3466788899999999999999999999999999999999999999999
Q ss_pred cccccccCccceeee-CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 276 FGMTRDIYETEYYRK-GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
||++........... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...++.
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~ 220 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIA 220 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh-CCCCccccchHHHHHHHh
Confidence 999875543221111 012234678999999999889999999999999999999 889998766655544443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=290.06 Aligned_cols=207 Identities=20% Similarity=0.365 Sum_probs=172.9
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhcCCcceeEEEEEEeeC---
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFDTHHVVKLYGVVSEG--- 194 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--- 194 (364)
.++|++++.||+|+||+||+|.+.. ++..||+|.+...... .....+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTR----LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECC----CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 4789999999999999999998776 4678999998754322 2345677899999999999999999987532
Q ss_pred ---CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 195 ---NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 195 ---~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
...|++++++ +++|.++++. ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC-----------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCE
Confidence 4578999998 7799887753 347888999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
||+|||++....... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+
T Consensus 158 kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 158 RILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK-GKALFPGNDYIDQLKRI 228 (343)
T ss_pred EEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 999999998654321 22345788999999877 568899999999999999999 89999887766655544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=280.89 Aligned_cols=209 Identities=24% Similarity=0.390 Sum_probs=178.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||+|+||.||++.+.. ++..+++|.+..........++.+|++++++++||||+++++.+..++..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP----SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC----CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 368899999999999999998776 4567899988765555556778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
||||+++++|.+++++. ..+++..+..++.|++.||+|||+ .+++|+||||+|||+++++.+||+|||+
T Consensus 77 v~ey~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA----------GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred EeeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCC
Confidence 99999999999999752 346788899999999999999997 5999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+........ ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+
T Consensus 147 ~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 210 (308)
T cd06615 147 SGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI-GRYPIPPPDAKELEAMF 210 (308)
T ss_pred ccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCcchhhHHHhh
Confidence 875533211 22345778999999988889999999999999999999 88899876655554444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=278.39 Aligned_cols=216 Identities=20% Similarity=0.329 Sum_probs=181.0
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
+|++++.||+|+||.||++.++. .++.|++|.+..... ......+.+|+.+++.++||||+++++.+..++..+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~----~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKE----TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLC 77 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECC----CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEE
Confidence 68899999999999999999876 467899998875432 233457889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||++|++|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||+
T Consensus 78 lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 78 MVMEYVEGGDCATLLKNI----------GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred EEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCC
Confidence 999999999999999752 3467788889999999999999999999999999999999999999999998
Q ss_pred ccccCcccee-------------eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 279 TRDIYETEYY-------------RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 279 a~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
++........ .......++..|+|||.+....++.++|+||||+++|||++ |..||.+.+..+++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~-g~~pf~~~~~~~~~~ 226 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEELFG 226 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 8632111000 00111234667999999998889999999999999999999 889999888888888
Q ss_pred HHhcCc
Q psy7023 346 WVKGKS 351 (364)
Q Consensus 346 ~i~~~~ 351 (364)
.+..+.
T Consensus 227 ~~~~~~ 232 (305)
T cd05609 227 QVISDD 232 (305)
T ss_pred HHHhcc
Confidence 776554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=276.86 Aligned_cols=217 Identities=29% Similarity=0.472 Sum_probs=186.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||.|++|.||+|.++. .+..|++|++...........+.+|+++++.++|+||+++++++.++...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR----TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC----CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 368889999999999999999876 4778999998765545556778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+||+++++|.+++... ++++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||++
T Consensus 77 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG-----------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEeeCCCcHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 99999999999998641 5678899999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
........ ......+++.|+|||.+.+..++.++||||||+++|+|+| |..||...+..+....+..+....
T Consensus 146 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 217 (274)
T cd06609 146 GQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHPMRVLFLIPKNNPPS 217 (274)
T ss_pred eeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccCchHHHHHHhhhcCCCC
Confidence 87654321 1222345677999999998889999999999999999999 899998877777777666654433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=274.39 Aligned_cols=219 Identities=21% Similarity=0.381 Sum_probs=180.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccc--ccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANE--NASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.+.||+|+||.||+|+++. .+..||+|.+.. .........+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL----DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC----CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeE
Confidence 578999999999999999999876 467899997753 22344456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++|+||+++++|.+++..... ....++...+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKK------QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhh------ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccc
Confidence 999999999999999875321 22346788899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL--SNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~--~~~~~~~~i~~~~ 351 (364)
++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||... +..++.+.+..+.
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 224 (267)
T cd08228 152 LGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLFSLCQKIEQCD 224 (267)
T ss_pred cceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhc-CCCCCccccccHHHHHHHHhcCC
Confidence 98765433221 112235678999999998889999999999999999999 77787543 3345556655543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=301.24 Aligned_cols=200 Identities=28% Similarity=0.468 Sum_probs=173.5
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC------C
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG------N 195 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------~ 195 (364)
+..-+.||+|+||.||+++++. +++.||||..+.....+..+...+|+++|+++.|+|||+++++=+.. .
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnke----tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKE----TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred eeehhhhcCCccceeeeecccc----cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 3345679999999999999877 68889999998877677778899999999999999999999986543 4
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CC--cE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD--DL--TV 271 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~--~~--~~ 271 (364)
...+|||||.||||...+++. .....+++..++.++..+..||.|||++||+||||||.||++-. +| ..
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~P-------EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSP-------ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred cceEEEeecCCCcHHHHhcCc-------ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Confidence 568999999999999999862 23456899999999999999999999999999999999999953 33 46
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
||+|||.|+.+.++. .....+||..|.+||.+.. +.|+..+|.|||||++|+.+| |..||-
T Consensus 164 KLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT-G~lPF~ 225 (732)
T KOG4250|consen 164 KLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT-GELPFI 225 (732)
T ss_pred eeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc-cCCCCC
Confidence 999999999998876 3345678999999999985 778999999999999999999 888884
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=275.98 Aligned_cols=214 Identities=29% Similarity=0.456 Sum_probs=178.1
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
-|++++.||+|+||.||+|.++. .+..+++|.+.... ......+.+|+++++.++|+||+++++++..++..++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE----TGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC----CCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence 46788999999999999998876 45678888876443 34466788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
+||+++++|..++.. ...++++..+..++.|++.||.|||+.+++|+||||+|||++.++.++|+|||++.
T Consensus 81 ~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 151 (282)
T cd06643 81 IEFCAGGAVDAVMLE---------LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA 151 (282)
T ss_pred EEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccc
Confidence 999999999988864 23457888999999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
....... ......+++.|+|||++. ...++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~ 224 (282)
T cd06643 152 KNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSE 224 (282)
T ss_pred ccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc-CCCCccccCHHHHHHHHhhcC
Confidence 5543221 112234577899999984 3457789999999999999999 789999887777666555443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.85 Aligned_cols=216 Identities=29% Similarity=0.453 Sum_probs=185.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+-|.|+..||.|+||.||+|..+.+ ....|.|++.. ...++.+.++-|+.||..|+||+||++++.|..++.+|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket----~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKET----KLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccc----hhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence 3455678899999999999998874 44456677653 345667889999999999999999999999998899999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
+.|||.||-+...+-+ -...+++.++..+.+|++.||.|||+++|||||||..|||++-+|.++|+|||.+
T Consensus 107 liEFC~GGAVDaimlE---------L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVS 177 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLE---------LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVS 177 (1187)
T ss_pred EEeecCCchHhHHHHH---------hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccc
Confidence 9999999999988875 3467889999999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
....... .......|||+|||||++. +.+|+.++||||||++|.||.. +.+|-+..++..++-.|.+..+
T Consensus 178 AKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq-iEPPHhelnpMRVllKiaKSeP 252 (1187)
T KOG0579|consen 178 AKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEP 252 (1187)
T ss_pred ccchhHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc-cCCCccccchHHHHHHHhhcCC
Confidence 6544332 2345667899999999874 5679999999999999999999 8999999999998877765543
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.44 Aligned_cols=214 Identities=23% Similarity=0.388 Sum_probs=187.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHH-HHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE-KAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.-|.+.+.||+|.|++|.+|++.. ++..||||++++..-... .+.+.+|+++|+.+.|||||+++.+.+.+..+|
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~----t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHIL----TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecC----CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 578999999999999999999877 588899999987654332 355889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+.+|.+++++.+..+. .+..+..++.|++.|++|||+++|||||||++|||++.+.++||+|||+
T Consensus 132 lV~eya~~ge~~~yl~~~gr~----------~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRM----------KEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred EEEEeccCchhHHHHHhcccc----------hhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecccc
Confidence 999999999999999875433 3356778999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+..+...... ....+++.|.|||++.+..| ++.+|+||+|++||.|+. |..||.+.+-.++-+.+..++
T Consensus 202 S~~~~~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~-GsLPFDG~~lk~Lr~rvl~gk 271 (596)
T KOG0586|consen 202 STFFDYGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE-GSLPFDGQNLKELRPRVLRGK 271 (596)
T ss_pred ceeecccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee-cccccCCcccccccchheeee
Confidence 9887754432 23346788999999999888 578999999999999999 999999999988887665554
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=278.80 Aligned_cols=208 Identities=25% Similarity=0.429 Sum_probs=176.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
...+|++.+.||+|+||.||+|.++. .+..|++|.+...... ....+.+|+.+++.++|+||+++++.+..+...
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVA----TGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECC----CCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 44689999999999999999998765 4678999988754433 346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++.. ..++..++..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg 161 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (296)
T ss_pred EEeecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccc
Confidence 999999999999999864 235678899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...++.+.+
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~-g~~pf~~~~~~~~~ 225 (296)
T cd06654 162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRAL 225 (296)
T ss_pred cchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHhH
Confidence 9875443221 1122345778999999998889999999999999999999 89999877664443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=271.87 Aligned_cols=214 Identities=24% Similarity=0.422 Sum_probs=180.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|++.+.||+|+||.||+|.++. ++..+++|++...... ..+.+.+|+.++++++||||+++++.+..++..|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA----TGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC----CCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 4689999999999999999998876 3567999998755433 4577889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
++|||+++++|.+++... ...++...+..++.|++.||+|||+.+++|+||||+||++++++.++|+|||+
T Consensus 77 l~~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 147 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVT---------RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGV 147 (262)
T ss_pred EEEeCCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECcccc
Confidence 999999999999998752 24577889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDG---VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+......... .....++..|+|||.+... .++.++|+||||+++|+|+| |.+||.+.+..+....+..
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t-g~~p~~~~~~~~~~~~~~~ 218 (262)
T cd06613 148 SAQLTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE-LQPPMFDLHPMRALFLISK 218 (262)
T ss_pred chhhhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Confidence 8765432211 1122346679999999776 78999999999999999999 8999988776665554443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=270.19 Aligned_cols=217 Identities=38% Similarity=0.719 Sum_probs=183.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|++.+.||+|+||.||+|.+.. +..+++|.+...... ...+.+|++++++++||||+++++++......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-----KRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-----CCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 578899999999999999998764 456899988654332 3468889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++.. ....+++..+..++.|++.+|+|||+.+++|+||||+||+++.++.++|+|||.+
T Consensus 77 v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 77 VFEFMEHGCLSDYLRA---------QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred EEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999999875 2234677889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
.......... ......+..|+|||.+.++.++.++||||||+++|||++.|..||......++++.+..+...
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd05112 148 RFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL 220 (256)
T ss_pred eecccCcccc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC
Confidence 7654332211 112223567999999998889999999999999999998789999998888888888766443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=276.53 Aligned_cols=214 Identities=30% Similarity=0.533 Sum_probs=182.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
..|+.+++||+|+||.||+|.++. .+..||+|++...........+.+|+.++++++|+||+++++.+.++...++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR----TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc----CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 467888999999999999998876 4678999998766555566788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++.. .+++...+..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||++
T Consensus 80 v~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 80 IMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccc
Confidence 9999999999999864 23567788899999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
......... .....++..|+|||.+.+..++.++|+||||+++|||+| |..||...+..+....+..+.
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 217 (277)
T cd06640 149 GQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAK-GEPPNSDMHPMRVLFLIPKNN 217 (277)
T ss_pred eeccCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHH-CCCCCCCcChHhHhhhhhcCC
Confidence 765443221 112234667999999988889999999999999999999 899998887777666655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=280.24 Aligned_cols=217 Identities=20% Similarity=0.304 Sum_probs=182.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.+.||+|+||+||+|.+.. .+..||+|.+...... .....+.+|+++++.++|+||+++++.+..+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC----CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEE
Confidence 368899999999999999998876 4678999988765433 2456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+.+++|.+++... ....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||
T Consensus 77 ~lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQ--------PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred EEEEEecCCCCHHHHHHhC--------CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecc
Confidence 9999999999999998752 23457888899999999999999999999999999999999999999999999
Q ss_pred cccccCccceee---------------------------eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q psy7023 278 MTRDIYETEYYR---------------------------KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL 330 (364)
Q Consensus 278 ~a~~~~~~~~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~ 330 (364)
++.......... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~- 227 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY- 227 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh-
Confidence 986543221100 0112245778999999998889999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhc
Q psy7023 331 ASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 331 g~~P~~~~~~~~~~~~i~~ 349 (364)
|..||.+.+..+.+..+..
T Consensus 228 g~~pf~~~~~~~~~~~~~~ 246 (316)
T cd05574 228 GTTPFKGSNRDETFSNILK 246 (316)
T ss_pred CCCCCCCCchHHHHHHHhc
Confidence 8999998887776665553
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=271.10 Aligned_cols=214 Identities=39% Similarity=0.666 Sum_probs=180.1
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
++||+|++|.||+|.+.... .....||+|.+.........+.+.+|+.++++++|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG-GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCC-CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 36899999999999986532 12446999999876654567789999999999999999999999988 89999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++.+.. ...+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||++......
T Consensus 79 ~~~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 79 LGSLLDRLRKDA--------LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred CCcHHHHHHhcc--------cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccc
Confidence 999999998632 145788899999999999999999999999999999999999999999999999866442
Q ss_pred ce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 286 EY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 286 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
.. ........++..|+|||.+.+..++.++||||||+++|+|++.|..||...+..++...+..
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 21 11122233466799999999889999999999999999999878999998888887776653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.80 Aligned_cols=209 Identities=25% Similarity=0.422 Sum_probs=173.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
...+|++.+.||+|+||.||+|.++. .+..||+|++..... .....+.+|+.++++++||||+++++++..++..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~----~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLH----TGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECC----CCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 34689999999999999999999865 467899998865432 2345677899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++.. ..++++..+..++.|++.||+|||+.+|+|+||||+||++++++.++|+|||
T Consensus 82 ~iv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg 151 (267)
T cd06646 82 WICMEYCGGGSLQDIYHV----------TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFG 151 (267)
T ss_pred EEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCc
Confidence 999999999999999864 2346788899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
++........ ......+++.|+|||.+. ...++.++|+||||+++|||++ |..||...++.+..
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~-g~~p~~~~~~~~~~ 218 (267)
T cd06646 152 VAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMRAL 218 (267)
T ss_pred cceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh-CCCCccccchhhhh
Confidence 9876543221 112223567899999884 3457889999999999999999 78888765554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=275.60 Aligned_cols=208 Identities=27% Similarity=0.453 Sum_probs=174.0
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|++.+.||+|+||.||+|.+.. .++.|++|+++.... .....+.+|+.+++.++||||+++++.+...+..|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN----TGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC----CCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 3588899999999999999998776 467899998865432 33456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV----------TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV 152 (267)
T ss_pred EEEeccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccee
Confidence 99999999999999864 23577889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+........ ......++..|+|||++. ...++.++|+|||||++|+|++ +..||....+...+
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~-~~~p~~~~~~~~~~ 218 (267)
T cd06645 153 SAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMRAL 218 (267)
T ss_pred eeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc-CCCCcccccchhhH
Confidence 875543221 112234577899999874 4558889999999999999999 77888665544433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=271.53 Aligned_cols=222 Identities=20% Similarity=0.300 Sum_probs=179.1
Q ss_pred ccceeEe-ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEe----
Q psy7023 119 RSKVTIL-DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVS---- 192 (364)
Q Consensus 119 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~---- 192 (364)
.++|.+- ++||-|-.|.|-.+..+. ++.++|+|++... ....+|+++.-+. .|+|||.++++|+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~----T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKR----TQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred hhhheehhhhhccccCCceEEEEecc----chhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 3556554 479999999999998887 6788999998543 2344677765555 7999999999986
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CC
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---DL 269 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~~ 269 (364)
....+.+|||.|+||.|+..+++. ....+++.++..|++||..|+.|||+++|.||||||+|+|... +.
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~--------g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDR--------GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHc--------ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCc
Confidence 356788999999999999999873 3456899999999999999999999999999999999999974 56
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN----EQVLN 345 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~----~~~~~ 345 (364)
.+||+|||+|+.-..+... .....||.|.|||++...+|+...|+||+||++|-|+. |.+||..+.. ..+-.
T Consensus 202 ~lKLtDfGFAK~t~~~~~L---~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC-GyPPFYS~hg~aispgMk~ 277 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPGDL---MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKR 277 (400)
T ss_pred ceEecccccccccCCCccc---cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc-CCCcccccCCccCChhHHh
Confidence 7999999999865543221 12234889999999999999999999999999999998 9999975543 44666
Q ss_pred HHhcCcc-ccccCCCCCC
Q psy7023 346 WVKGKSS-NEYKVNPPIS 362 (364)
Q Consensus 346 ~i~~~~~-~~~~~~~~~s 362 (364)
.|+.|.. ++.+.|.-||
T Consensus 278 rI~~gqy~FP~pEWs~VS 295 (400)
T KOG0604|consen 278 RIRTGQYEFPEPEWSCVS 295 (400)
T ss_pred HhhccCccCCChhHhHHH
Confidence 7776654 3666676665
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=282.94 Aligned_cols=207 Identities=20% Similarity=0.312 Sum_probs=163.1
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--CCceEEEEe
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--GNPTLVIME 202 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv~e 202 (364)
..+||+|+||+||+|.+++.. ..+.||+|.+..... ...+.+|+.++++++||||+++++++.. +...|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~--~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCC--CCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 457999999999999876422 357899998865432 2346789999999999999999999854 456899999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCcEEEeeccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV----ADDLTVKVGDFGM 278 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl----~~~~~~kL~DFg~ 278 (364)
|+. ++|.+++......... .....++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred ccC-CCHHHHHHhccccccc-CCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 985 5999988753322111 123357889999999999999999999999999999999999 4567999999999
Q ss_pred ccccCcccee-eeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 279 TRDIYETEYY-RKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 279 a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
++........ .......+|+.|+|||++.+. .++.++||||+||++|+|++ |.+||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~~ 220 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ 220 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh-CCCCccCCc
Confidence 9865433211 112234568889999999774 58999999999999999999 889997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=276.78 Aligned_cols=194 Identities=26% Similarity=0.423 Sum_probs=168.7
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
+|++++.||+|+||.||+|.+.. ++..||+|++..........++.+|++++++++||||+++++.+...+..++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLL----TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcC----CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 67888999999999999998775 46779999987655555567799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
|||+++++|..+. .+++..+..++.|++.||+|||+.+|+|+||||+|||++.++.++|+|||++.
T Consensus 78 ~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 78 TEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred EecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 9999999986542 24567788999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 144 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~ 195 (279)
T cd06619 144 QLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL-GRFPYPQ 195 (279)
T ss_pred eccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHh-CCCCchh
Confidence 654332 122345778999999999899999999999999999999 8889864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=271.98 Aligned_cols=215 Identities=40% Similarity=0.649 Sum_probs=180.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|++.+.||+|+||.||++... +..|++|...... ....+.+|+.++++++|+||+++++++.. +..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 74 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEYT------GQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLY 74 (254)
T ss_pred HHHceeeeeeccCCCCceEecccC------CCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcE
Confidence 367999999999999999988532 5679999886542 23578899999999999999999999876 4579
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+.+++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 75 ~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 75 IVMELMSKGNLVNFLRTR--------GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred EEEECCCCCCHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcc
Confidence 999999999999999762 223567888999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccccc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 356 (364)
+....... .....+..|+|||.+.+..++.++|+||||+++|+|+++|.+||...+..+..+.+..+...+.+
T Consensus 147 ~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 219 (254)
T cd05083 147 ARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP 219 (254)
T ss_pred ceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCC
Confidence 87543221 11123457999999998899999999999999999998789999999988888888877655543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=274.70 Aligned_cols=221 Identities=19% Similarity=0.345 Sum_probs=180.1
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEEecC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIMELM 204 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~e~~ 204 (364)
+.||+|+|+.|--+.... ++..+|||++.+.. .....++.+|++++.++ .|+||++++++|+++..+|||||.|
T Consensus 84 e~LGeGAyasVqtcv~i~----t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQ----TGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhcCccceeeeeeeeec----cchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 469999999999887655 57889999998874 34567889999999999 6999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEEEeecccccc
Q psy7023 205 GGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD---LTVKVGDFGMTRD 281 (364)
Q Consensus 205 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~---~~~kL~DFg~a~~ 281 (364)
.||+|...|.+ ...+++.++.++.++|+.||.|||.+||.||||||+|||-.+. ..+|||||.+...
T Consensus 159 ~GGplLshI~~----------~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 159 RGGPLLSHIQK----------RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred cCchHHHHHHH----------hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 99999999986 4467778899999999999999999999999999999999754 3589999998764
Q ss_pred cCccc-----eeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-----------
Q psy7023 282 IYETE-----YYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN----------- 340 (364)
Q Consensus 282 ~~~~~-----~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~----------- 340 (364)
+.... ..+......|+..|||||++. ...|+.+.|.||||+|||-|+. |.+||.|...
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs-GYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS-GYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh-CCCCccCccCCcCCccCCCcc
Confidence 43221 112223334566799999863 2348999999999999999999 9999998754
Q ss_pred ----HHHHHHHhcCccc-cccCCCCCC
Q psy7023 341 ----EQVLNWVKGKSSN-EYKVNPPIS 362 (364)
Q Consensus 341 ----~~~~~~i~~~~~~-~~~~~~~~s 362 (364)
..+++.|++|+.. +...|--||
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS 334 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHIS 334 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhh
Confidence 3367788888654 555565555
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=295.69 Aligned_cols=213 Identities=24% Similarity=0.393 Sum_probs=182.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..|.-++.||.|+||.||.|++.. +...||||.+.... +.+....++.|+..|++++|||++.+.++|..+...
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~----n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVR----NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccC----ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 456668899999999999999877 46779999887442 344467899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|||||||- |+-.|++.- ..+++-+..+..|..+.+.||+|||+.+.||||||..|||+++.|.|||+|||
T Consensus 102 WLVMEYCl-GSAsDlleV---------hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 102 WLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred HHHHHHHh-ccHHHHHHH---------HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeecccc
Confidence 99999995 588888763 45577788999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
.|..... ...++|||.|||||++. .+.|+-++||||||++..||.. .++|+-.++....+-.|-++.+.
T Consensus 172 SAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE-RkPPlFnMNAMSALYHIAQNesP 243 (948)
T KOG0577|consen 172 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESP 243 (948)
T ss_pred chhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhh-cCCCccCchHHHHHHHHHhcCCC
Confidence 9865443 23457899999999985 5779999999999999999999 88998888888877777655443
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=298.77 Aligned_cols=198 Identities=30% Similarity=0.493 Sum_probs=172.4
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCC
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGG 206 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~g 206 (364)
+||+|.||+||.|++.+ +...+|||.+....+ +..+-+++|+.+.++|+|.|||+++|.+.+++.+-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~----tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD----TQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeecccc----ceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 69999999999999988 577899999876544 4567788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCccCCCCc--cHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CCCcEEEeecccccccC
Q psy7023 207 GDLKNYLRSCRPDAETDVERSPP--TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA-DDLTVKVGDFGMTRDIY 283 (364)
Q Consensus 207 gsL~~~l~~~~~~~~~~~~~~~~--~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~-~~~~~kL~DFg~a~~~~ 283 (364)
|+|.+.++. ..+++ .++.+..+.+||++||.|||.+.|||||||-+|+||+ -.|.+||+|||-++.+.
T Consensus 657 GSLSsLLrs---------kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 657 GSLSSLLRS---------KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred CcHHHHHHh---------ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 999999986 44455 6778899999999999999999999999999999997 57899999999998776
Q ss_pred ccceeeeCCCCCCCccccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 284 ETEYYRKGSRGFLPVRWMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 284 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
.-.. ......||..|||||++..++ |+.++|||||||++.||.| |++||......
T Consensus 728 ginP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT-GrPPF~Elgsp 784 (1226)
T KOG4279|consen 728 GINP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT-GRPPFVELGSP 784 (1226)
T ss_pred cCCc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc-CCCCeeecCCh
Confidence 5432 334456799999999997665 8899999999999999999 99999765543
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=254.12 Aligned_cols=227 Identities=24% Similarity=0.366 Sum_probs=189.3
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~ 193 (364)
.++..+....+..||+|++|.|=+-++.. .+...|+|.+.......++++.++|+.+..+. .+|.+|++|+.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~----sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQ----SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeecc----CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 66667777888899999999998777776 57889999998877778888999999987765 78999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~k 272 (364)
+..+|+.||.|+ .||..+-++.- .....+++.-+-+|+..++.||+|||++ .|||||+||+|||++.+|++|
T Consensus 117 egdvwIcME~M~-tSldkfy~~v~------~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVK 189 (282)
T KOG0984|consen 117 EGDVWICMELMD-TSLDKFYRKVL------KKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVK 189 (282)
T ss_pred cccEEEeHHHhh-hhHHHHHHHHH------hcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEE
Confidence 999999999995 48888876532 2445678888999999999999999976 899999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccC----CCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHH
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD----GVFTSHSDVWSYGVVLWEMATLASQPYQ-GLSNEQVLNWV 347 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~el~t~g~~P~~-~~~~~~~~~~i 347 (364)
+||||.+..+.++-..+. ..|-..|||||.+.. ..|+.++||||||++++||.+ ++.||. ..++-+.+.++
T Consensus 190 iCDFGIsG~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~-lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 190 ICDFGISGYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI-LRFPYESWGTPFQQLKQV 265 (282)
T ss_pred EcccccceeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh-ccccccccCCHHHHHHHH
Confidence 999999987776543321 122345999998853 468999999999999999999 899996 57788888888
Q ss_pred hcCcccccc
Q psy7023 348 KGKSSNEYK 356 (364)
Q Consensus 348 ~~~~~~~~~ 356 (364)
.+.+....|
T Consensus 266 Veep~P~Lp 274 (282)
T KOG0984|consen 266 VEEPSPQLP 274 (282)
T ss_pred hcCCCCCCc
Confidence 777655443
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=286.48 Aligned_cols=194 Identities=24% Similarity=0.399 Sum_probs=166.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
..|++++.||+|+||.||+|.++. .+..||+|+..... ...|+.++++++|+||+++++++......++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPG----QPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECC----CCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 479999999999999999999876 46679999854332 2458999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|||++. ++|.+++.. ....+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||++
T Consensus 135 v~e~~~-~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 135 VLPHYS-SDLYTYLTK---------RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred EEEccC-CcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccc
Confidence 999995 699998865 2345788999999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
+....... .....+++.|+|||++.+..++.++|||||||++|||++++.++|..
T Consensus 205 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 205 QFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 75332211 11234578899999999999999999999999999999977777764
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.38 Aligned_cols=214 Identities=24% Similarity=0.392 Sum_probs=174.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc----CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA----SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE-- 193 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-- 193 (364)
.+|++.+.||+|+||.||.|.++. ++..|++|.+.... .......+.+|+.++++++|+||+++++++.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~----~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD----TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC----CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 478899999999999999998876 46789999875321 22345678899999999999999999999875
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
...+++||||+++++|.+++.+. ..++...+..++.|++.||+|||+.+++|+||||+|||+++++.++|
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l 147 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSY----------GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKL 147 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEE
Confidence 35688999999999999999752 23567788899999999999999999999999999999999999999
Q ss_pred eecccccccCccceee-eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 274 GDFGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+|||++.......... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+.......+.
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~ 222 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIA 222 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhh-CCCCCCccchHHHHHHHh
Confidence 9999987554321111 1112235678999999998889999999999999999999 889998766555444443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.40 Aligned_cols=214 Identities=24% Similarity=0.431 Sum_probs=181.3
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCce
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~ 197 (364)
.++.+.+..||+|+.|+||+++.+. ++...|||.+.+....++.++++..+.++.+. +.|.||+.+++|..+..+
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs----~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRS----TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcc----cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 3566778899999999999999887 57789999999888888888999999888776 489999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeec
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
++.||.| +..+..+++. ...++++..+-.+...++.||.||..+ +|||||+||+|||+|+.|++|||||
T Consensus 167 ~IcMelM-s~C~ekLlkr---------ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKR---------IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred HHHHHHH-HHHHHHHHHH---------hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecc
Confidence 9999998 4466666664 345678888889999999999999864 8999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcC
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGL-SNEQVLNWVKGK 350 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~t~g~~P~~~~-~~~~~~~~i~~~ 350 (364)
|++..+.++....+ ..|-+.|||||.+.- ..|+.++||||||++++||.| |+.||.+. .+-+++..|.+.
T Consensus 237 GIsGrlvdSkAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT-g~yPy~~c~tdFe~ltkvln~ 310 (391)
T KOG0983|consen 237 GISGRLVDSKAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT-GQYPYKGCKTDFEVLTKVLNE 310 (391)
T ss_pred cccceeeccccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhc-ccCCCCCCCccHHHHHHHHhc
Confidence 99998877654433 345678999999964 468999999999999999999 89999973 456777766553
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=270.97 Aligned_cols=220 Identities=25% Similarity=0.429 Sum_probs=184.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||.|+||+||+|.... .+..+++|++...........+.+|+.+++.++|+||+++++.+...+..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP----NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC----CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 368899999999999999998765 4667999998765544466788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|||++++++|.++++...+ ...+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++
T Consensus 77 v~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYP-------RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEeccCCCcHHHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 9999999999999976321 235778889999999999999999999999999999999999999999999998
Q ss_pred cccCccceee--eCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 280 RDIYETEYYR--KGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 280 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
.......... ......++..|+|||++... .++.++|+||||+++|+|++ |..||...+..+.+..+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~ 223 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT-GAAPYSKYPPMKVLMLTLQND 223 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh-CCCCccccChhhhHHHHhcCC
Confidence 7665433221 11222356789999998877 78999999999999999999 899998877766665554443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=271.77 Aligned_cols=229 Identities=39% Similarity=0.711 Sum_probs=184.7
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC-----
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN----- 195 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~----- 195 (364)
|++.+.||+|+||.||+|.++... ..+..||+|++.... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED-GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC-CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567789999999999999876422 236789999887543 3344677889999999999999999999886432
Q ss_pred -ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 196 -PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 196 -~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
..++++||+.+|+|.+++...... .....++...+..++.|++.||+|||+++|+||||||+||++++++.+||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEEC
Confidence 247889999999999988642211 112346788899999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
|||+++................++.|++||.+....++.++||||||+++|+|+++|.+||.+.+..++...+..+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99999876544333333333446789999999988899999999999999999998899999988888888877665443
Q ss_pred c
Q psy7023 355 Y 355 (364)
Q Consensus 355 ~ 355 (364)
.
T Consensus 236 ~ 236 (273)
T cd05074 236 Q 236 (273)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=280.80 Aligned_cols=209 Identities=19% Similarity=0.270 Sum_probs=170.1
Q ss_pred Eeceeeee--cceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 124 ILDELGNG--SFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 124 ~~~~lG~G--~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
++++||+| +|++||++.++. ++..||+|.++.... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP----TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecc----cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence 56789999 789999999876 577899999876543 33455677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
|||+++++|.+++... ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++||+...
T Consensus 78 ~e~~~~~~l~~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 78 TSFMAYGSAKDLICTH--------FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EeccCCCcHHHHHHhh--------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 9999999999999752 12347788999999999999999999999999999999999999999999998654
Q ss_pred ccCccceee-----eCCCCCCCccccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 281 DIYETEYYR-----KGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 281 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~ 220 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLL 220 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHH-CCCCCCCcchhHHHH
Confidence 332211100 0111233566999999976 458999999999999999999 899998766555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=297.39 Aligned_cols=214 Identities=21% Similarity=0.313 Sum_probs=165.0
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccc-----------c----ceEEEEcccccCHHHHHHHHHHHHHHHhcC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAE-----------H----PCAIKVANENASEREKAEFLNEASVMKAFD 180 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~-----------~----~vaiK~~~~~~~~~~~~~~~~E~~il~~l~ 180 (364)
..+.++|+++++||+|+||+||++.++....... . .++.|... ........+.+|+.+|++++
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK--AGSRAAIQLENEILALGRLN 221 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh--cchHHHHHHHHHHHHHHhCC
Confidence 3355789999999999999999987654321110 0 00111111 12233556889999999999
Q ss_pred CcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7023 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAA 260 (364)
Q Consensus 181 h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp 260 (364)
|+||+++++++...+..|+|+|++ +++|.+++...... .........+..++.||+.||+|||++|||||||||
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~-----~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP 295 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFD-----WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL 295 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhcccc-----ccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 999999999999999999999998 46888887642211 112234567888999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 261 RNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 261 ~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
+|||++.++.+||+|||+++.+...... ......+++.|+|||++.+..++.++|||||||++|||++++..||.+.
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 9999999999999999999866543221 1122356889999999999999999999999999999999666777543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=271.15 Aligned_cols=215 Identities=22% Similarity=0.410 Sum_probs=177.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--------HHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--------EREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
+|.+...||+|++|.||+|.++. .+..+++|.+..... ....+.+.+|+.++++++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS----SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecC----CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Confidence 46778899999999999998765 367799997764321 122356788999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+.+..++||||+++++|.+++... ..++...+..++.|++.||+|||+++++|+||+|+||++++++.++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNY----------GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhc----------cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEE
Confidence 999999999999999999999752 3467788899999999999999999999999999999999999999
Q ss_pred EeecccccccCccceee----eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYR----KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|+|||.++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~ 225 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIG 225 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhh-CCCCCCCccHHHHHHHHh
Confidence 99999988665321111 1112234678999999998889999999999999999999 899998876655555554
Q ss_pred cC
Q psy7023 349 GK 350 (364)
Q Consensus 349 ~~ 350 (364)
..
T Consensus 226 ~~ 227 (267)
T cd06628 226 EN 227 (267)
T ss_pred cc
Confidence 44
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=274.14 Aligned_cols=205 Identities=33% Similarity=0.536 Sum_probs=171.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--CceE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG--NPTL 198 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~ 198 (364)
-|++++.||+|+||.||++.+.......+..|++|.++..........+.+|+.++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 46889999999999999998754444467889999987665555567899999999999999999999998764 6789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.+++.+. ...+++..+..++.|++.||+|||++|++||||||+|||+++++.++|+|||+
T Consensus 85 lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---------KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred EEEEccCCCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcc
Confidence 999999999999999652 23467888999999999999999999999999999999999999999999999
Q ss_pred ccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 279 TRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 279 a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
+......... .......++..|+|||.+.+..++.++||||||+++|+|+| +..|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt-~~~~~ 212 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-YCDSE 212 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc-CCCCC
Confidence 9866543221 11122334567999999988889999999999999999999 54443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.31 Aligned_cols=212 Identities=25% Similarity=0.429 Sum_probs=179.9
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
..+|++.+.||.|++|.||+|.+.. .+..|++|.+...... ....+.+|+.+++.++|+||+++++++...+..+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~----~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVA----TGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcC----CCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 3679999999999999999998765 4678999988654332 3467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|+||+++++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+||++++++.++|+|||+
T Consensus 93 lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~ 161 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-----------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF 161 (296)
T ss_pred EEEEecCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence 99999999999998864 2467889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~llt-g~~pf~~~~~~~~~~~~~~ 229 (296)
T cd06655 162 CAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIAT 229 (296)
T ss_pred chhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Confidence 8765433221 122235678999999998889999999999999999999 8999988776555554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=276.32 Aligned_cols=203 Identities=24% Similarity=0.456 Sum_probs=169.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||+|++|.||+|.++. .++.|++|.+...........+.+|+.++++++|+||+++++++.+.+..++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL----TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC----CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 679999999999999999998775 4678999998654433333456789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+.+ +|.+++... ...+++..+..++.|++.||.|||+++|+|+||||+|||+++++.+||+|||++
T Consensus 81 v~e~~~~-~L~~~~~~~---------~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 81 VFEYLDT-DLKQYMDDC---------GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred EEecCCC-CHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccc
Confidence 9999975 999998752 235678889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
+........ .....++..|+|||.+.+ ..++.++||||+|+++|+|++ |.+||.+..
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~ 208 (291)
T cd07844 151 RAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT-GRPLFPGST 208 (291)
T ss_pred cccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCc
Confidence 754322111 111234678999999875 457899999999999999999 889997655
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=276.77 Aligned_cols=213 Identities=25% Similarity=0.433 Sum_probs=177.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++++.||+|+||.||++.++. .+..||+|.+...........+.+|+.++++++|+||+++++.+...+..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP----TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC----CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 368899999999999999999875 4678999988765555556788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
||||+++++|..++.... ....+++..+..++.|++.||.|||. .+|+|+||||+||+++.++.++|+|||+
T Consensus 77 v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGV-------ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred EEeecCCCCHHHHHHhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999999987521 12357889999999999999999996 5999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCC------CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGV------FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+........ ....+++.|+|||.+.+.. ++.++|+|||||++|+|++ |..||...........+.
T Consensus 150 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 220 (286)
T cd06622 150 SGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPPETYANIFAQLS 220 (286)
T ss_pred cccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHh-CCCCCCCcchhhHHHHHH
Confidence 875533221 1223466799999985543 5789999999999999999 899998766655555443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=275.48 Aligned_cols=212 Identities=21% Similarity=0.328 Sum_probs=175.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEee-CCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSE-GNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~ 197 (364)
..|+++..||+|.||.||+|.-++++......+|+|.++...+ ...-....+|+.+++.++|||++.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5789999999999999999977665544456899998875432 1223456689999999999999999999876 7899
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----CcEEE
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD----LTVKV 273 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~----~~~kL 273 (364)
++++||.+. +|...|+-.+.. ....++...+..|+.||+.|+.|||++.|+||||||.||||..+ |.+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~-----~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRAS-----KAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccc-----hhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 999999976 999999864432 23467889999999999999999999999999999999999877 99999
Q ss_pred eecccccccCccceee-eCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 274 GDFGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
+|||+++.+...-..- .....+.|..|.|||.+.+.+ |+.+.|||+.|||+.||+| -.+.|.+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt-l~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT-LEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc-cCccccch
Confidence 9999999776543222 233345588999999998865 8999999999999999999 77777654
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=277.86 Aligned_cols=214 Identities=29% Similarity=0.529 Sum_probs=182.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
..|+..+.||+|+||.||+|.+.. .+..||+|.+.........+.+.+|+.++++++|+||+++++.+..++..++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR----TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC----CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 467788899999999999998765 4678999998766555566788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||++
T Consensus 80 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 80 IMEYLGGGSALDLLKP-----------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEccCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccc
Confidence 9999999999998853 24677889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
..+...... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||......+....+..+.
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 217 (277)
T cd06642 149 GQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAK-GEPPNSDLHPMRVLFLIPKNS 217 (277)
T ss_pred ccccCcchh--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHh-CCCCCcccchhhHHhhhhcCC
Confidence 765543211 112234677999999999889999999999999999999 899998777666666655443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.61 Aligned_cols=211 Identities=26% Similarity=0.464 Sum_probs=174.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-----CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-----SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
+|++.+.||+|+||+||+|.... +..+|+|.+.... .......+.+|++++++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~-----~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQ-----GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcC-----CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC
Confidence 47788999999999999997643 6679999876432 2233456889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++|+||+++++|.+++.+. .+++...+..++.|++.||+|||+.+|+|+||+|+||++++++.++|+|
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRF----------GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEecc
Confidence 999999999999999999752 2467788889999999999999999999999999999999999999999
Q ss_pred cccccccCccc----eeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 276 FGMTRDIYETE----YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 276 Fg~a~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
||++....... .........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~ 220 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASMDRLAAMFYI 220 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh-CCCccccCChHHHHHHh
Confidence 99987543211 1111122345778999999998889999999999999999999 89999876655544433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=269.14 Aligned_cols=220 Identities=21% Similarity=0.385 Sum_probs=181.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.+.||+|+||.||+|.++. ++..|++|.++.. ......+.+.+|++++++++|+||+++++.+...+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL----DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC----CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 579999999999999999999875 4677999987632 2333467788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++.... .....++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFK------KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEecCCCCCHHHHHHHhc------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccc
Confidence 99999999999999997532 123457888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCcc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL--SNEQVLNWVKGKSS 352 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~--~~~~~~~~i~~~~~ 352 (364)
++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||... +..++.+.+..+..
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 225 (267)
T cd08224 152 LGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEKCDY 225 (267)
T ss_pred eeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHH-CCCCcccCCccHHHHHhhhhcCCC
Confidence 98765433211 111234667999999998889999999999999999999 78888543 34455666655543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=270.11 Aligned_cols=205 Identities=28% Similarity=0.528 Sum_probs=168.3
Q ss_pred ceeeeecceEEEEEEEcCcc------cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 126 DELGNGSFGLVYRGLIKDFR------SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+.||+|+||.||+|.++... ......+++|+....... ...+.+|+.++++++|+||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 36899999999999987643 222346788877644322 5778899999999999999999999888 77899
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-------cEE
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-------TVK 272 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-------~~k 272 (364)
||||+++++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+|
T Consensus 78 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE---------KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred EEEcCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 99999999999999862 22577888999999999999999999999999999999999887 899
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG--VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|+|||++....... ...++..|+|||.+.+. .++.++||||||+++|+|++++..||...+..+......
T Consensus 149 l~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~ 220 (259)
T cd05037 149 LSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ 220 (259)
T ss_pred eCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh
Confidence 99999987654321 12235569999999876 789999999999999999998899998776555444433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=268.06 Aligned_cols=219 Identities=23% Similarity=0.374 Sum_probs=184.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++.+.||+|+||.||++..+. .++.|++|.+... .......++.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE----DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC----CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence 58899999999999999998775 4678999987643 234455678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+||+.+++|.+++... ....+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++
T Consensus 77 v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 77 VMDYCEGGDLYKKINAQ--------RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 99999999999999752 2234677889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
.......... ....+++.|+|||++.+..++.++|+||||+++|+|++ |..||...+..+....+..+...+
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd08218 149 RVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT-LKHAFEAGNMKNLVLKIIRGSYPP 220 (256)
T ss_pred eecCcchhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc-CCCCccCCCHHHHHHHHhcCCCCC
Confidence 7654432211 12234677999999998889999999999999999999 889998878777777766655443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=277.75 Aligned_cols=211 Identities=21% Similarity=0.403 Sum_probs=173.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++.+.||+|+||.||+|+++. .+..|++|.++.... ......+.+|+.++++++|+||+++++++.+....++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~----~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE----THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC----CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence 58889999999999999999876 466799998864322 2223467789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+||++ ++|.+++.. ....+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||++
T Consensus 77 v~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 77 VFEYCD-QDLKKYFDS---------CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchh
Confidence 999996 589888865 2345788999999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
........ ......+++.|+|||.+.+.. ++.++|||||||++|+|+||+.++|.+.+..+.++.+
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 147 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213 (284)
T ss_pred hccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence 75543221 112233467899999987654 7899999999999999999666667777766665554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=271.27 Aligned_cols=215 Identities=29% Similarity=0.521 Sum_probs=182.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+-|++++.||+|+||.||+|.++. .+..||+|+............+.+|+.++++++||||+++++++..+...++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR----TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC----CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 457788899999999999998765 4678999998765555556788899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++.. ..+++..+..++.|++.++.|||+.+++|+||||+||+++.++.++|+|||++
T Consensus 80 v~e~~~~~~l~~~i~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 80 IMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred EEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccc
Confidence 9999999999999863 24678889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
..+...... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+..+..
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 218 (277)
T cd06641 149 GQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPHSELHPMKVLFLIPKNNP 218 (277)
T ss_pred eecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCccchHHHHHHHhcCCC
Confidence 765433211 112234677999999988889999999999999999999 8999988877777776655543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=269.08 Aligned_cols=211 Identities=27% Similarity=0.496 Sum_probs=180.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++.+.||+|+||.||+|.++. .+..+++|.+..... .+++.+|++++++++|+||+++++.+......|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~----~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE----TGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC----CCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 678999999999999999999876 367799998865422 5788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
++||+.+++|.+++.. ....+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++
T Consensus 76 ~~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 76 VMEYCGAGSVSDIMKI---------TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred EEecCCCCcHHHHHHh---------CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999999999975 2345788999999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...++.+....+..
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~-g~~p~~~~~~~~~~~~~~~ 213 (256)
T cd06612 147 GQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE-GKPPYSDIHPMRAIFMIPN 213 (256)
T ss_pred hhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCcchhhhhhhhcc
Confidence 866543211 122234677999999998899999999999999999999 8999987766555544433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=273.18 Aligned_cols=212 Identities=21% Similarity=0.298 Sum_probs=175.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.+.||+|+||.||+|.++. .+..||+|.+..... ....+.+.+|+.++++++|+||+++++++......+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE----TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC----CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEE
Confidence 478999999999999999999875 467899998764432 223356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||++++.|..++.. ...+++..+..++.|++.+|+|||+.+++|+||||+||+++.++.++|+|||+
T Consensus 77 ~v~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 77 LVFEYCDHTVLNELEKN----------PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred EEEeccCccHHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECcccc
Confidence 99999998877776643 23478889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+......... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+.+..+.+..++
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~ 214 (286)
T cd07847 147 ARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT-GQPLWPGKSDVDQLYLIR 214 (286)
T ss_pred ceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Confidence 9866543211 112234667999999876 457899999999999999999 899999887766555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=273.15 Aligned_cols=207 Identities=24% Similarity=0.421 Sum_probs=171.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++.+.||+|++|.||+|.++. .+..|++|.+..... ......+.+|+.+++.++||||+++++++.+++..|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK----TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECC----CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence 47889999999999999999875 467899998864322 2234567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+. ++|.+++.... ....++...+..++.|++.||+|||+++++|+||||+|||+++++.++|+|||++
T Consensus 77 v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLP-------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EEecCC-CCHHHHHhcCC-------CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 999997 58999886522 2245788999999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
........ ......+++.|+|||++.+. .++.++||||||+++|+|+| |++||.+.+..+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~~~~~~~~~~ 209 (285)
T cd07861 149 RAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEID 209 (285)
T ss_pred eecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHH
Confidence 75433221 11223346789999988654 47889999999999999999 899998766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=276.43 Aligned_cols=206 Identities=25% Similarity=0.419 Sum_probs=175.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
...+|++++.||+|+||.||+|.++. .+..||+|.+...... ..+.+.+|+.+++.++|+||+++++++..++..
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA----TGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC----CCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 34789999999999999999998765 4678999988654333 346688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++.+ ..++...+..++.|++.+|.|||+.+++|+||||+|||++.++.++|+|||
T Consensus 92 ~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg 160 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 160 (297)
T ss_pred EEeecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCc
Confidence 999999999999999864 235677899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~t-g~~pf~~~~~~~ 222 (297)
T cd06656 161 FCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLR 222 (297)
T ss_pred cceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcch
Confidence 98755433211 122345778999999998889999999999999999999 899997765533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=273.05 Aligned_cols=212 Identities=26% Similarity=0.416 Sum_probs=179.1
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++.+.||+|+||.||+|.++. .+..|++|++..... ......+.+|+.++++++|+||+++++++..+...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE----TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC----CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence 58899999999999999999876 467899998875432 3445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+||+ +++|.+++.. ....+++..+..++.||+.+|+|||+.+++|+||||+||++++++.++|+|||++
T Consensus 77 v~e~~-~~~L~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 77 VMEYM-PSDLSEVLRD---------EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred Eeccc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 99999 9999999875 2245788999999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
........ .......++..|+|||.+.+.. ++.++||||||+++|+|+| |.+||.+.++.+.+..+.
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN-GSPLFPGENDIEQLAIVF 214 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc-CCcCcCCCCHHHHHHHHH
Confidence 86654321 1122234577899999986544 6889999999999999999 689998877766665554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=267.98 Aligned_cols=221 Identities=23% Similarity=0.422 Sum_probs=185.7
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe--eCCce
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVS--EGNPT 197 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~ 197 (364)
+|++++.||+|+||.||++.+.. .+..+++|++... ......+++.+|++++++++|+||+++++++. .+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS----DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC----CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence 47889999999999999998776 4677999988643 34455677889999999999999999999875 34568
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCEEEcCCCcEE
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA-----DKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH-----~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+++|||+++++|.+++.... ....++++..++.++.||+.||+||| +.+++|+||||+||++++++.+|
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCK------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred EEEehhccCCCHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEE
Confidence 99999999999999997632 12346788899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++.......... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..++.+.+..+..
T Consensus 151 l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 227 (265)
T cd08217 151 LGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA-LSPPFTARNQLQLASKIKEGKF 227 (265)
T ss_pred EecccccccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHH-CCCcccCcCHHHHHHHHhcCCC
Confidence 99999998765443211 12235778999999998889999999999999999999 8999998888888888877654
Q ss_pred cc
Q psy7023 353 NE 354 (364)
Q Consensus 353 ~~ 354 (364)
..
T Consensus 228 ~~ 229 (265)
T cd08217 228 RR 229 (265)
T ss_pred CC
Confidence 33
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=299.53 Aligned_cols=230 Identities=33% Similarity=0.554 Sum_probs=207.2
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIM 201 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 201 (364)
.+..++||+|+||+||+|.|--..+..+.+||||++..........++++|+.+|.+++|||++++++++.... +-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34456899999999999998777777789999999988877777889999999999999999999999998754 88999
Q ss_pred ecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 202 ELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 202 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
+||++|+|.||++. .+..+..+.++.|..||++||.|||.++++||||-.+||||.+-..+||+|||+++.
T Consensus 777 q~mP~G~LlDyvr~---------hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---------HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HhcccchHHHHHHH---------hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 99999999999997 445667789999999999999999999999999999999999999999999999997
Q ss_pred cCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCCCC
Q psy7023 282 IYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPI 361 (364)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 361 (364)
+......-....+..++.|||-|.+....|+.++|||||||++||++|-|..||.+...+|+-+.++.|.+.+-|+.|+|
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCti 927 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTI 927 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccH
Confidence 76554433344445578899999999999999999999999999999999999999999999999999999999999986
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=273.90 Aligned_cols=203 Identities=23% Similarity=0.399 Sum_probs=168.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|++.+.||+|+||.||+|.++. .+..|++|++...........+.+|+.+++.++|+||+++++++..++..|+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRI----NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcC----CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 679999999999999999998876 4678999998654433334466789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+. ++|.+++... ...++...+..++.|++.||+|||+.+|+|+||||+|||++.++.++|+|||++
T Consensus 81 v~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 81 VFEYMH-TDLAQYMIQH---------PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred EEeccc-CCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccc
Confidence 999995 6888877541 234567788889999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
+........ .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.+
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~f~~~~ 208 (291)
T cd07870 151 RAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ-GQPAFPGVS 208 (291)
T ss_pred cccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCch
Confidence 754332211 1222347789999998764 47889999999999999999 889997654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=266.15 Aligned_cols=218 Identities=22% Similarity=0.374 Sum_probs=183.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++.+.||+|+||.||++.++. .+..+++|.+.... .......+.+|+++++.++|+||+++++.+..++..++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA----DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC----CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence 58899999999999999998876 47789999886542 33456788899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEeeccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD-LTVKVGDFGM 278 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kL~DFg~ 278 (364)
||||+++++|.+++... ....+++..+..++.|++.+|+|||+++++|+||||+||+++++ +.++|+|||.
T Consensus 77 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 77 VMEYAPGGTLAEYIQKR--------CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEecCCCCCHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 99999999999999762 23346788899999999999999999999999999999999855 4689999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
+........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+..+...+
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd08220 149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS-LKRAFEAANLPALVLKIMSGTFAP 220 (256)
T ss_pred ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh-CCCCcccCchHHHHHHHHhcCCCC
Confidence 986644321 112335678999999998889999999999999999999 788999888777777776554433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=269.70 Aligned_cols=206 Identities=33% Similarity=0.575 Sum_probs=169.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--CCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--GNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~ 197 (364)
.+|++++.||+|+||.||++..+......+..|++|.+.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 578899999999999999998764444457789999986543 3445678899999999999999999998753 4568
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++.+. ...+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH---------RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred EEEEEecCCCCHHHHHHhc---------CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCc
Confidence 9999999999999999752 2346788899999999999999999999999999999999999999999999
Q ss_pred cccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 278 MTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 278 ~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
++......... ........+..|+|||++.+..++.++||||||+++|||++ +..|+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-~~~~~~ 212 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSC 212 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhh-cCCcCC
Confidence 99866433221 11122223456999999998889999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=290.81 Aligned_cols=221 Identities=22% Similarity=0.341 Sum_probs=191.4
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.++++++..||-||||.|=++..+.. ...+|+|++++. ......+.+..|-+||..++.|.||++|-.|.++..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~----~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQ----KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEeccc----chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 35677888999999999999887762 235788888754 344556778899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+|++||-|-||.|+..++..+ .+.......++..+++|++|||++|||+|||||+|+|++.+|-+||.||
T Consensus 495 vYmLmEaClGGElWTiLrdRg----------~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG----------SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC----------CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeeh
Confidence 999999999999999998754 3444566778999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc-cc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN-EY 355 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~ 355 (364)
|+|+.+..... .-...|||.|.|||++.+...+.++|.||||+++|||+| |.+||.+.++..+++.|.+|.-. ++
T Consensus 565 GFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~-G~pPFs~~dpmktYn~ILkGid~i~~ 640 (732)
T KOG0614|consen 565 GFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLT-GSPPFSGVDPMKTYNLILKGIDKIEF 640 (732)
T ss_pred hhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHhhhhhhhc
Confidence 99998876643 334567999999999999999999999999999999999 99999999999999998777543 55
Q ss_pred cC
Q psy7023 356 KV 357 (364)
Q Consensus 356 ~~ 357 (364)
|.
T Consensus 641 Pr 642 (732)
T KOG0614|consen 641 PR 642 (732)
T ss_pred cc
Confidence 53
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=271.80 Aligned_cols=208 Identities=24% Similarity=0.407 Sum_probs=167.1
Q ss_pred eeeeecceEEEEEEEcCc--------------------ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeE
Q psy7023 127 ELGNGSFGLVYRGLIKDF--------------------RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~--------------------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~ 186 (364)
.||+|+||.||+|..... +......|++|++.... .....++.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 599999999999975421 11223568999886543 233467888999999999999999
Q ss_pred EEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 187 l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
+++++.++...++||||+++++|..++.+ ....+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRK---------EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 99999999999999999999999999875 234567888999999999999999999999999999999998
Q ss_pred CCC-------cEEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 267 DDL-------TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 267 ~~~-------~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
+.+ .+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||++.|..||.+.
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 643 48999999876432221 1234567999998875 558999999999999999975589999887
Q ss_pred CHHHHHHHHhcC
Q psy7023 339 SNEQVLNWVKGK 350 (364)
Q Consensus 339 ~~~~~~~~i~~~ 350 (364)
...+....+...
T Consensus 226 ~~~~~~~~~~~~ 237 (274)
T cd05076 226 TPSEKERFYEKK 237 (274)
T ss_pred ChHHHHHHHHhc
Confidence 776665555443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=270.28 Aligned_cols=213 Identities=24% Similarity=0.475 Sum_probs=173.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeC--
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~-- 194 (364)
+.+.|++.+.||+|+||.||+|.++. .++.||+|.+..... ....+.+|+.+++++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~----~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK----TGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC----CCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 34678889999999999999998876 467899999865432 235678899999998 799999999998752
Q ss_pred ----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 195 ----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 195 ----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
...|+||||+.+++|.+++... ....+++..+..++.|++.||+|||+++|+|+||||+||++++++.
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~ 149 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE 149 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC
Confidence 4589999999999999999752 2345778889999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
++|+|||++........ ......+++.|+|||++. ...++.++|||||||++|||++ |..||..........
T Consensus 150 ~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~-g~~p~~~~~~~~~~~ 226 (272)
T cd06637 150 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRALF 226 (272)
T ss_pred EEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh-CCCCccccCHHHHHH
Confidence 99999999876543221 122334577899999986 3457889999999999999999 788997766555444
Q ss_pred HH
Q psy7023 346 WV 347 (364)
Q Consensus 346 ~i 347 (364)
.+
T Consensus 227 ~~ 228 (272)
T cd06637 227 LI 228 (272)
T ss_pred HH
Confidence 43
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=277.55 Aligned_cols=206 Identities=21% Similarity=0.326 Sum_probs=162.5
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe--eCCceEEEEec
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS--EGNPTLVIMEL 203 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lv~e~ 203 (364)
.+||+|+||+||+|..++.. ....||+|.+..... ...+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~--~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCC--ccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 57999999999999876532 357899998865432 235678999999999999999999885 45678999999
Q ss_pred CCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCcEEEeecccc
Q psy7023 204 MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV----ADDLTVKVGDFGMT 279 (364)
Q Consensus 204 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl----~~~~~~kL~DFg~a 279 (364)
+. ++|.+++........ ......+++..+..++.||+.||+|||+.+|+||||||+|||+ ++++.+||+|||++
T Consensus 82 ~~-~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 82 AE-HDLWHIIKFHRASKA-NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eC-CcHHHHHHhhhcccc-CCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 85 589888865322111 1123457888999999999999999999999999999999999 56679999999999
Q ss_pred cccCcccee-eeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 280 RDIYETEYY-RKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 280 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
+........ .......+++.|+|||++.+. .++.++|||||||++|||+| |.+||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~t-g~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHh-CCCCccccc
Confidence 866443221 112233457889999998764 47899999999999999999 889997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.55 Aligned_cols=217 Identities=22% Similarity=0.404 Sum_probs=178.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.+.||+|+||.||+|.++. .+..+++|.+.... ......++.+|+.+++.++|+||+++++++..++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC----CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeE
Confidence 468889999999999999999765 46789999775432 233456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
+++|||+++++|.+++.... .....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFK------KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCCHHHHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcch
Confidence 99999999999999987532 123457888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN--EQVLNWVKG 349 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~--~~~~~~i~~ 349 (364)
++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+... .+..+.+..
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T cd08229 152 LGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQ 222 (267)
T ss_pred hhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHh-CCCCcccccchHHHHhhhhhc
Confidence 98765433211 112235678999999998889999999999999999999 7889865432 344444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=270.71 Aligned_cols=220 Identities=25% Similarity=0.424 Sum_probs=177.0
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVV 191 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~ 191 (364)
+.+....++|++++.||+|+||.||++.++. .+..+++|+..... ....++.+|+.+++.+ +|+||+++++++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~----~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKK----NGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECC----CCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 4445567899999999999999999999876 46789999876432 2235677899999999 799999999987
Q ss_pred e-----eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 192 S-----EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 192 ~-----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
. .++..++||||+++++|.+++.... .....+++..+..++.|++.||.|||+.+++||||||+||+++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~ 158 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT 158 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC
Confidence 3 3467899999999999999887421 1234567888999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 267 DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-----GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 267 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
+++.++|+|||++......... .....+++.|+|||++.. ..++.++|||||||++|+|++ |..||...+..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~-g~~p~~~~~~~ 235 (286)
T cd06638 159 TEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD-GDPPLADLHPM 235 (286)
T ss_pred CCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc-CCCCCCCCchh
Confidence 9999999999998765433221 122245778999999853 447889999999999999999 88899877665
Q ss_pred HHHHHH
Q psy7023 342 QVLNWV 347 (364)
Q Consensus 342 ~~~~~i 347 (364)
+.+..+
T Consensus 236 ~~~~~~ 241 (286)
T cd06638 236 RALFKI 241 (286)
T ss_pred HHHhhc
Confidence 544443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=270.72 Aligned_cols=208 Identities=34% Similarity=0.631 Sum_probs=174.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--CCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--GNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~ 197 (364)
..|++.+.||+|+||.||+|.+.......+..+|+|++...........+.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999876543445788999998866554456789999999999999999999999886 5688
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---------RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---------ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccc
Confidence 9999999999999999752 2257788999999999999999999999999999999999999999999999
Q ss_pred cccccCccce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 278 MTRDIYETEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 278 ~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
.+........ .........+..|+|||.+.+..++.++||||||+++|||+| |..|+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~ 214 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQS 214 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeec-cCCCccc
Confidence 9987653221 111222233556999999988889999999999999999999 6777754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=265.82 Aligned_cols=214 Identities=23% Similarity=0.375 Sum_probs=175.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc----cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC-
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN----ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG- 194 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~- 194 (364)
.+|.+.+.||+|+||.||+|.++. ++..|++|.+... ........+.+|+.++++++|+||+++++.+.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD----TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC----CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 578999999999999999998775 4678999987532 1234456788999999999999999999998753
Q ss_pred -CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 195 -NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 195 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
..+++++||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||++++++.++|
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l 147 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAY----------GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKL 147 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEE
Confidence 4688999999999999999752 24667888999999999999999999999999999999999999999
Q ss_pred eecccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 274 GDFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+|||+++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+....+...++.
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~ 222 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFKIA 222 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCccCHHHHHHHHH
Confidence 999999765321110 01112235778999999998889999999999999999999 899998776555444443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=268.02 Aligned_cols=203 Identities=23% Similarity=0.447 Sum_probs=164.7
Q ss_pred ceeeeecceEEEEEEEcCcc--------cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 126 DELGNGSFGLVYRGLIKDFR--------SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~--------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.||+|+||+||+|+..... .....+|++|++.... ......+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 36899999999999864321 1124468899876543 33456788899999999999999999999998999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc-------
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT------- 270 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~------- 270 (364)
++||||+++++|..++.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 80 ~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHR---------KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred EEEEecccCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 999999999999988864 2345788889999999999999999999999999999999987664
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCccccc-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK-DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
++++|||++....... ...++..|+|||.+. +..++.++||||||+++|||+++|..||......+..
T Consensus 151 ~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (262)
T cd05077 151 IKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219 (262)
T ss_pred eEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH
Confidence 8999999986543221 123466799999887 4568999999999999999986689999876655543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=270.43 Aligned_cols=207 Identities=24% Similarity=0.520 Sum_probs=168.0
Q ss_pred ceeeeecceEEEEEEEcCcc---cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFR---SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||.||+|.++... .....++++|...... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 36999999999999876532 1235568888875432 3345678899999999999999999999999899999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--------EEEe
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT--------VKVG 274 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~--------~kL~ 274 (364)
|+++|+|.++++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. ++++
T Consensus 80 ~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 80 YVKFGSLDTYLKKN---------KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred cCCCCcHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEec
Confidence 99999999999752 225677888999999999999999999999999999999987765 6999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|||++....... ...+++.|+|||++.+. .++.++||||||+++|+|++|+.+||...+.........
T Consensus 151 d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 219 (258)
T cd05078 151 DPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE 219 (258)
T ss_pred ccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH
Confidence 999886543321 12346679999999874 478999999999999999996678888777665554433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=268.19 Aligned_cols=220 Identities=21% Similarity=0.388 Sum_probs=178.4
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeC-
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEG- 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~- 194 (364)
...++|.+.+.||+|+||.||++..+. .++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~----~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKK----DGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECC----CCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 345789999999999999999999876 47789999886532 2245677899999998 899999999998743
Q ss_pred ----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 195 ----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 195 ----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
+..++||||+++++|.++++... .....+++..+..++.|++.||+|||+.+++|+||||+||++++++.
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLL------ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC
Confidence 35899999999999999987421 12345788899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-----FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
+||+|||++.......... ....++..|+|||.+.... ++.++|||||||++|+|++ |++||...+..+.+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~-g~~p~~~~~~~~~~~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD-GDPPLFDMHPVKTLF 243 (291)
T ss_pred EEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh-CCCCCCCCcHHHHHH
Confidence 9999999987654332211 1223567899999986443 6789999999999999999 899998887766666
Q ss_pred HHhcCc
Q psy7023 346 WVKGKS 351 (364)
Q Consensus 346 ~i~~~~ 351 (364)
.+..+.
T Consensus 244 ~~~~~~ 249 (291)
T cd06639 244 KIPRNP 249 (291)
T ss_pred HHhcCC
Confidence 555443
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=278.79 Aligned_cols=208 Identities=23% Similarity=0.328 Sum_probs=174.1
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEE-EcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK-~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~ 192 (364)
..+-...|+++++||+||.+.||++..-+ ...+|+| +.....+.....-|.+|+..|.+| .|.+|+++++|-.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-----~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD-----KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC-----CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 44556789999999999999999998665 3344554 444555667788899999999999 5789999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
.++.+|+|||+= ..+|..+|++.. ..+....+..+..||+.|+.++|..||||.||||.|+|+-+ |.+|
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~---------~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LK 499 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKK---------SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLK 499 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhcc---------CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEE
Confidence 899999999985 569999998733 22333478889999999999999999999999999999976 5999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCC-----------CCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-----------FTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
|+|||+|..+............+||+.||+||.+.... .+.++||||||||||+|+. |++||....
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY-gktPf~~~~ 576 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY-GKTPFGQII 576 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh-cCCchHHHH
Confidence 99999999888777666677778999999999986433 3467999999999999998 999998765
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=268.21 Aligned_cols=215 Identities=24% Similarity=0.404 Sum_probs=178.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--CCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--GNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~ 197 (364)
++|+..++||.|++|.||++.++. .+..+|+|.+..........++.+|++++++++|+||+++++++.. .+.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN----TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC----CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 368889999999999999999876 4678999998765555556788999999999999999999998864 4478
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++..... ....++...+..++.||+.||+|||+.+++|+||+|+||++++++.++|+|||
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKK------RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecc
Confidence 999999999999998865321 23456788899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL-----SNEQVLNWVKG 349 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~-----~~~~~~~~i~~ 349 (364)
++........ ....++..|+|||.+.+..++.++||||||+++|+|++ |..||... ...++.+++..
T Consensus 151 ~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd06621 151 VSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ-NRFPFPPEGEPPLGPIELLSYIVN 222 (287)
T ss_pred cccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCcccCCCCChHHHHHHHhc
Confidence 9875543221 12234667999999999999999999999999999999 88899755 34555565554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.38 Aligned_cols=213 Identities=24% Similarity=0.425 Sum_probs=178.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
..|.....||+|+||.||+|.++. .+..|++|.+..... .....+.+|+.+++.++||||+++++.+..++..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKH----SGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcC----CCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 344455689999999999998765 467899999865433 234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+||+++++|.+++.. ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++
T Consensus 96 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~ 164 (297)
T cd06659 96 LMEFLQGGALTDIVSQ-----------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164 (297)
T ss_pred EEecCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhH
Confidence 9999999999988753 24678889999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+.+..+....
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~ 233 (297)
T cd06659 165 AQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSP 233 (297)
T ss_pred hhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccC
Confidence 755433211 122335778999999998889999999999999999999 899998877777777665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=270.00 Aligned_cols=246 Identities=29% Similarity=0.530 Sum_probs=219.8
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccc-cccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSL-AEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
...+.+.++++...+-+|.||.||.|.|++.+.. ..+.|.+|..+...++-....++.|.-++..+.|||+..+.++..
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3455677899999999999999999988876544 355688898888888888888999999999999999999999875
Q ss_pred -eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 193 -EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 193 -~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
+....++++.++.-|+|..|+..++.... ......+..++..++.|++.|++|||+.+|||.||..+|.+|++...+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~--~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDP--SYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCC--ccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 45677888999999999999998774333 233457778899999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|=.+++++...++..-+.....+..||+||.+.+..|+.++|+||||+++|||+|.|+.||...++.|+...+++|+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 99999999999999888888888889999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC
Q psy7023 352 SNEYKVNPPI 361 (364)
Q Consensus 352 ~~~~~~~~~~ 361 (364)
+...|.|||-
T Consensus 516 RlaQP~NCPD 525 (563)
T KOG1024|consen 516 RLAQPFNCPD 525 (563)
T ss_pred eecCCCCCcH
Confidence 9999999983
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.02 Aligned_cols=222 Identities=23% Similarity=0.344 Sum_probs=185.1
Q ss_pred cccccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCC--c--
Q psy7023 107 DKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT--H-- 182 (364)
Q Consensus 107 ~~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h--~-- 182 (364)
+..+.....+.+..+|++.+.+|+|.||.|-.+.++. ....||+|+++.... ..+..+-|+++|+++.+ |
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~----~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g 149 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE----TKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNG 149 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecC----CCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCC
Confidence 3334455567788999999999999999999999887 367899999975433 34556679999999933 2
Q ss_pred --ceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7023 183 --HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAA 260 (364)
Q Consensus 183 --~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp 260 (364)
-++.+.++|+..++.+||+|.+ |-|+++++.+ ....+++...+..|+.|+++++++||+.+++|.||||
T Consensus 150 ~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--------N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKP 220 (415)
T KOG0671|consen 150 KFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--------NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKP 220 (415)
T ss_pred ceEEEeeehhhhccCceEEEEecc-ChhHHHHhcc--------CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCCh
Confidence 4788899999999999999998 6699999987 3567889999999999999999999999999999999
Q ss_pred CCEEEcC--------------------CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHH
Q psy7023 261 RNCMVAD--------------------DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSY 320 (364)
Q Consensus 261 ~NILl~~--------------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 320 (364)
+|||+.+ +..++|+|||.|..-.+... ..+.|.+|.|||++++-.|+.++||||+
T Consensus 221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceee
Confidence 9999942 34689999999986554432 2234678999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 321 GVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 321 G~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
||||+|++| |...|+..++.|.++.++.
T Consensus 296 GCIL~Elyt-G~~LFqtHen~EHLaMMer 323 (415)
T KOG0671|consen 296 GCILVELYT-GETLFQTHENLEHLAMMER 323 (415)
T ss_pred eeEEEEeec-cceecccCCcHHHHHHHHH
Confidence 999999999 8999998888886655443
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=265.51 Aligned_cols=212 Identities=25% Similarity=0.398 Sum_probs=173.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc----CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--C
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA----SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--G 194 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~ 194 (364)
.|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.++++++|+||+++++++.. .
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVD----TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CccccceecCCCCEEEEEEEEcC----CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 57888999999999999998776 46789999875432 22345678899999999999999999998875 3
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
...++++||+++++|.+++... ..++...+..++.|++.||+|||+.+|+|+||||+||++++++.++|+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY----------GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEc
Confidence 6788999999999999999752 246778888999999999999999999999999999999999999999
Q ss_pred ecccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 275 DFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 275 DFg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
|||++......... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~-g~~pf~~~~~~~~~~~~ 221 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEAMAAIFKI 221 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHH-CCCCccccchHHHHHHH
Confidence 99998755332111 11112235678999999998889999999999999999999 89999877655544433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=285.15 Aligned_cols=217 Identities=23% Similarity=0.342 Sum_probs=180.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.+-|..++.||-|+||+|.++...++ ...+|+|.+.+.. ..........|..||..-+.+-||+||-.|++.+.
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT----~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDT----RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecch----hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 34588899999999999999987773 5678999886532 23345567789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+|+||+|++||++..+|-+. .-|.+..++.++.++..|+++.|++|+|||||||+|||||.+|++||+||
T Consensus 704 LYFVMdYIPGGDmMSLLIrm----------gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRM----------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred eEEEEeccCCccHHHHHHHh----------ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeec
Confidence 99999999999999999653 34566778889999999999999999999999999999999999999999
Q ss_pred ccccccC---ccceee-------------------------------------eCCCCCCCccccCcccccCCCCCCchh
Q psy7023 277 GMTRDIY---ETEYYR-------------------------------------KGSRGFLPVRWMAPESLKDGVFTSHSD 316 (364)
Q Consensus 277 g~a~~~~---~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 316 (364)
|++.-+. +..++. .....+||+.|+|||++....|+..+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 9985321 111000 011235689999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 317 VWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 317 iwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||.|||||||+. |++||.+.++.+....|...
T Consensus 854 wws~gvil~em~~-g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 854 WWSVGVILYEMLV-GQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hhHhhHHHHHHhh-CCCCccCCCCCcceeeeeeh
Confidence 9999999999999 99999998888776655543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=271.41 Aligned_cols=203 Identities=25% Similarity=0.418 Sum_probs=175.5
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|++++.||+|+||+||++.+.. .+..||+|++...........+.+|+++++.++||||+++++.+...+..+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP----TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC----CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 3688999999999999999998876 467799998876555555678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
+||||+++++|.+++.+ ...+++..+..++.|++.+|.|||+ .+++|+||||+||++++++.++|+|||
T Consensus 80 lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK----------GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred EEEecCCCCCHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCC
Confidence 99999999999999865 2346788899999999999999997 689999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
++........ ....++..|+|||++.+..++.++|+|||||++|+|+| |..||.....
T Consensus 150 l~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~ 207 (284)
T cd06620 150 VSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSNI 207 (284)
T ss_pred cccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh-CCCCCcccch
Confidence 9865432211 12345778999999988889999999999999999999 8999986544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=267.88 Aligned_cols=201 Identities=23% Similarity=0.402 Sum_probs=174.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.|++.+.||+|+||.||+|.++. ++..|++|++.... .....+.+.+|++++++++||||+++++.+.++...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD----TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc----CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEE
Confidence 48899999999999999998775 46779999887543 2244678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|+||+.+++|.+++... .+++...+..++.|+++||.|||+++++|+||+|+||++++++.++|+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK----------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EEEeCCCCCCHHHHHHhc----------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 999999999999999752 3567888999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
+........ .....++..|+|||.+....++.++|+||||+++|+|++ |..||...+
T Consensus 147 ~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 203 (258)
T cd05578 147 ATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPYRGHS 203 (258)
T ss_pred ccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHh-CCCCCCCCC
Confidence 876544321 112234667999999998889999999999999999999 899998776
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=268.84 Aligned_cols=212 Identities=25% Similarity=0.454 Sum_probs=176.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
+|++.++||.|++|.||+|+++. ++..|++|.++..........+.+|+.++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT----TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC----CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 48889999999999999999876 46789999987654444456677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
|||+++ +|.+++.... ....+++..+..++.|++.||+|||+++++|+||||+||++++++.++|+|||++.
T Consensus 77 ~e~~~~-~l~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 77 FEYMDK-DLKKYMDTHG-------VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EecCCc-cHHHHHHhcC-------CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 999975 8999887532 12457889999999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
....... ......++..|++||.+.+. .++.++||||||+++|+|++ |.+||.+.+..+.+..+
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 149 AFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLLKI 213 (284)
T ss_pred hhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Confidence 5543221 11122346779999988664 46889999999999999999 89999887776655544
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=267.95 Aligned_cols=212 Identities=25% Similarity=0.491 Sum_probs=178.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC---CcceeEEEEEEeeCCce
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD---THHVVKLYGVVSEGNPT 197 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~~~ 197 (364)
.|++++.||+|+||.||+|.++. .+..|++|.+..........++.+|+.+++.++ |||++++++++..+...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP----TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC----CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 47788899999999999999865 467899999876555555677889999999996 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.++++. ..+++..+..++.|++.||.|||+.||+|+||+|+||++++++.++|+|||
T Consensus 78 ~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCC
Confidence 999999999999999864 256788999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
++......... .....++..|+|||.+.++ .++.++|+||||+++|+|++ |..||.+.+.......+...
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 217 (277)
T cd06917 147 VAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT-GNPPYSDVDAFRAMMLIPKS 217 (277)
T ss_pred ceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh-CCCCCCCCChhhhhhccccC
Confidence 98766544321 2223457789999998754 46889999999999999999 89999887766555544433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=272.02 Aligned_cols=211 Identities=22% Similarity=0.324 Sum_probs=175.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH----HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE----REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+|++.+.||+|+||.||+|.++. .++.|++|.+...... .....+.+|++++++++|+||+++++++.+++.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE----TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC----CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence 47888999999999999999876 3678999998754322 234567789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++||||+ +++|.+++... ...+++..+..++.||++||+|||++|++|+||||+|||++.++.++|+||
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred EEEEEccc-CCCHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccc
Confidence 99999999 88999999752 135788899999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|++........ .......++.|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+.++.+.
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~-g~~~~~~~~~~~~~~~~~ 216 (298)
T cd07841 147 GLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIF 216 (298)
T ss_pred eeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc-CCccccCCccHHHHHHHH
Confidence 99976644321 1122234667999998865 457889999999999999999 688998877766665553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=262.78 Aligned_cols=215 Identities=24% Similarity=0.413 Sum_probs=184.1
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
+|++.+.||+|++|.||+|.++. .+..|++|.+...........+.+|+.++++++|+||+++++++...+..++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~----~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKP----TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcC----CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 67889999999999999999886 47789999987665545567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|||+++++|.+++... ..++...+..++.|++.+|+|||+ .+++|+||+|+||++++++.++|+|||.+
T Consensus 78 ~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 78 LEYMDGGSLADLLKKV----------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred EEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999752 457888999999999999999999 99999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCcc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL---SNEQVLNWVKGKSS 352 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~---~~~~~~~~i~~~~~ 352 (364)
.......... ....++..|+|||.+.+..++.++|+||||+++|+|+| |..||... ...++..++.....
T Consensus 148 ~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (264)
T cd06623 148 KVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL-GKFPFLPPGQPSFFELMQAICDGPP 220 (264)
T ss_pred eecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCccccccCHHHHHHHHhcCCC
Confidence 7664433221 11234667999999999889999999999999999999 89999776 55666666664443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=267.40 Aligned_cols=203 Identities=23% Similarity=0.424 Sum_probs=167.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHH-HHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASV-MKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~i-l~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.+.||+|+||.||++.++. ++..||+|.++.........++..|+.+ ++.++||||+++++++..++..|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP----TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC----CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 368899999999999999999876 4788999998765444444556666665 66679999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
+||||++ ++|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||
T Consensus 77 lv~e~~~-~~l~~~l~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYD------KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred EEhhhhc-ccHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 9999996 689888875321 224678999999999999999999997 99999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccC----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKD----GVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||..
T Consensus 150 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~ 209 (283)
T cd06617 150 ISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT-GRFPYDS 209 (283)
T ss_pred cccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHh-CCCCCCc
Confidence 9876543221 112234677999998865 446889999999999999999 8899965
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=274.40 Aligned_cols=213 Identities=23% Similarity=0.439 Sum_probs=178.1
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++.|.....||+|+||.||++.++. .+..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+..++..+
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKH----TGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECC----CCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 3556666789999999999998765 46789999886543 334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+||++++++.++|+|||+
T Consensus 96 lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~ 164 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-----------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGF 164 (292)
T ss_pred EEEeCCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcc
Confidence 99999999999998853 2367788999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+........ ......++..|+|||.+.+..++.++|+||||+++|||++ |..||.+.+..+.+..+...
T Consensus 165 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~ 233 (292)
T cd06658 165 CAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEPPLQAMRRIRDN 233 (292)
T ss_pred hhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Confidence 875433221 1122235778999999988889999999999999999999 88999887777666655543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.05 Aligned_cols=222 Identities=25% Similarity=0.393 Sum_probs=180.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++.+.||+|+||.||+|.+.. .+..|++|.++.... ......+.+|+.++++++|+||+++++.+...+..++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD----TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC----CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence 58889999999999999998765 467899999875543 2456788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+|+|+||+|+||++++++.+||+|||++
T Consensus 77 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 77 FMEYCSGGTLEELLEHG----------RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred EEecCCCCcHHHHHhhc----------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 99999999999999752 23567788899999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeC--CCCCCCccccCcccccCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhcCccc
Q psy7023 280 RDIYETEYYRKG--SRGFLPVRWMAPESLKDGV---FTSHSDVWSYGVVLWEMATLASQPYQGLS-NEQVLNWVKGKSSN 353 (364)
Q Consensus 280 ~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~el~t~g~~P~~~~~-~~~~~~~i~~~~~~ 353 (364)
............ ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+ .......+..+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELDNEFQIMFHVGAGHKP 225 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh-CCCCccCCcchHHHHHHHhcCCCC
Confidence 766543321111 1123467899999998766 8899999999999999999 899997653 33344444444333
Q ss_pred cccC
Q psy7023 354 EYKV 357 (364)
Q Consensus 354 ~~~~ 357 (364)
..+.
T Consensus 226 ~~~~ 229 (264)
T cd06626 226 PIPD 229 (264)
T ss_pred CCCc
Confidence 3333
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=267.85 Aligned_cols=200 Identities=27% Similarity=0.448 Sum_probs=174.6
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
+|++.+.||+|++|.||++.++. .+..+++|.+..........++.+|++++++++||||+++++.+..++..+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRP----TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcC----CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 57788899999999999999876 46779999987766556667889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
+||+++++|.+++... ...++...+..++.|++.+|+|||+ .+++|+||||+||++++++.++|+|||.+
T Consensus 78 ~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 78 MEYMDGGSLDKILKEV---------QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred EEecCCCcHHHHHHHc---------cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999762 1467788899999999999999999 99999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
.......... ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 149 ~~~~~~~~~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~ 202 (265)
T cd06605 149 GQLVNSLAKT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT-GRFPYPPE 202 (265)
T ss_pred hhhHHHHhhc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCcc
Confidence 7554322111 345678999999999899999999999999999999 78888654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=276.50 Aligned_cols=210 Identities=21% Similarity=0.349 Sum_probs=171.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC----
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG---- 194 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~---- 194 (364)
.++|++.+.||+|+||.||+|.++. ++..||+|.+...........+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP----TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC----CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 4689999999999999999998876 46789999986544444556788899999999999999999887543
Q ss_pred -CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 195 -NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 195 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
...|+|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl 147 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIKT-----------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKI 147 (336)
T ss_pred cceEEEEehhcc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEE
Confidence 35799999996 488887753 35778889999999999999999999999999999999999999999
Q ss_pred eecccccccCccceee-eCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 274 GDFGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
+|||++.......... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |++||.+.+......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~-G~~~f~~~~~~~~~~ 220 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS-NRPLFPGKDYLHQLN 220 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 9999987654322211 1122345778999998754 468899999999999999999 899998776544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=264.86 Aligned_cols=209 Identities=25% Similarity=0.399 Sum_probs=172.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC---------HHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS---------EREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
+|.+.+.||+|+||.||+|..+. .+..+|+|.+..... ....+.+.+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT----TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeecC----CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence 57888999999999999998765 467899998753211 11234678899999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
...+..++||||+++++|.+++++. ..++...+..++.|++.||.|||+++++|+||+|+||++++++.+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY----------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC 147 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeE
Confidence 9999999999999999999999752 356778889999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+|+|||++................++..|+|||.+.... ++.++|+||||+++|+|++ |..||...+..+..
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~ 221 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRPWSDEEAIAAM 221 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh-CCCCCcCcchHHHH
Confidence 999999987654322111122233567899999987655 7889999999999999999 88999766554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=265.51 Aligned_cols=219 Identities=25% Similarity=0.452 Sum_probs=178.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCC-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGN- 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~- 195 (364)
..++|++.+.||+|++|.||+|.++. .+..+++|++..... ..+++.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK----TGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC----CCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 34789999999999999999999875 467899998865433 346788999999999 7999999999997644
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 196 -----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 196 -----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
..++||||+++++|.+++.... .....+++..+..++.|++.||.|||+.+++|+||+|+||++++++.
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLR------KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE 151 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe
Confidence 4899999999999999987522 12346788899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-----GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
++|+|||++......... .....++..|+|||++.. ..++.++||||||+++|+|++ |..||...+....+.
T Consensus 152 ~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~ 228 (275)
T cd06608 152 VKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD-GKPPLCDMHPMRALF 228 (275)
T ss_pred EEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh-CCCCccccchHHHHH
Confidence 999999998755433211 122335778999998753 346788999999999999999 899998776665555
Q ss_pred HHhcCc
Q psy7023 346 WVKGKS 351 (364)
Q Consensus 346 ~i~~~~ 351 (364)
.+..+.
T Consensus 229 ~~~~~~ 234 (275)
T cd06608 229 KIPRNP 234 (275)
T ss_pred HhhccC
Confidence 555443
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=261.85 Aligned_cols=210 Identities=27% Similarity=0.440 Sum_probs=175.7
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc----CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA----SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+|+..+.||+|+||+||+|..+. .+..|++|.+.... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD----DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcC----CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 46777899999999999998875 36779999876432 23345678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++|+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY----------GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccC
Confidence 99999999999999999752 34677888999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|++........ .....+++.|++||.+.... ++.++|+||||+++|+|++ |..||......+....+.
T Consensus 147 ~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 215 (258)
T cd06632 147 GMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLEGVAAVFKIG 215 (258)
T ss_pred ccceecccccc---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcccCcHHHHHHHHH
Confidence 99876544331 12233567899999987776 8999999999999999999 899998776555544443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.19 Aligned_cols=203 Identities=23% Similarity=0.340 Sum_probs=173.5
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
||.|++|.||+|.++. .+..+++|++.... .....+.+.+|+.+++.++|+||+++++.+.+++..++|+||++
T Consensus 1 lg~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKS----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECC----CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCC
Confidence 6899999999999876 46789999987543 22445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++.+. ..++...+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 77 GGELWTILRDR----------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 99999999752 23677889999999999999999999999999999999999999999999999866543
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHh
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS--NEQVLNWVK 348 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~--~~~~~~~i~ 348 (364)
.. .....+++.|++||.+.+..++.++|+||||+++|+|++ |..||...+ ..+....+.
T Consensus 147 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 147 QK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT-GRPPFGEDDEDPMEIYNDIL 207 (262)
T ss_pred cc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHh-CCCCcCCCCCCHHHHHHHHh
Confidence 21 112234678999999988889999999999999999999 899998776 566666555
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=270.55 Aligned_cols=210 Identities=26% Similarity=0.431 Sum_probs=176.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
..+|++.+.||+|+||.||++.... .+..|++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA----TGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC----CCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 3689999999999999999998765 366799998864432 23467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 93 lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~ 161 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 161 (293)
T ss_pred EEEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcc
Confidence 99999999999999864 2356778899999999999999999999999999999999999999999998
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+.......... ....+++.|+|||.+....++.++|+||||+++|+|++ |..||...+..+.+..+
T Consensus 162 ~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~-g~~pf~~~~~~~~~~~~ 227 (293)
T cd06647 162 CAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLI 227 (293)
T ss_pred eeccccccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhheeeh
Confidence 87554432211 12235678999999988889999999999999999999 89999876655444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=271.59 Aligned_cols=214 Identities=23% Similarity=0.385 Sum_probs=176.2
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--C
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFDTHHVVKLYGVVSEG--N 195 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~ 195 (364)
.++|++.+.||+|+||.||+|.++. ++..||+|.+...... .....+.+|+.++++++|+||+++++++... +
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT----SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC----CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 3689999999999999999999876 4678999988643321 2223456799999999999999999998754 5
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+. ++|.+++... ...+++..+..++.||+.||+|||+.|++|+||||+||++++++.+||+|
T Consensus 82 ~~~lv~e~~~-~~l~~~l~~~---------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~d 151 (309)
T cd07845 82 SIFLVMEYCE-QDLASLLDNM---------PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIAD 151 (309)
T ss_pred eEEEEEecCC-CCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence 6899999996 4899988752 24578899999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
||++........ .......++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+.+..+.+..+..
T Consensus 152 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 152 FGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA-HKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred cceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence 999986654321 1122233667999999865 457899999999999999999 8999999888888776654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=267.46 Aligned_cols=197 Identities=24% Similarity=0.382 Sum_probs=166.3
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
||+|+||+||+|.++. .++.|++|.+.... .......+.+|+.++++++||||+++++++...+..|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKA----TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcC----CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCC
Confidence 6899999999998776 46789999886432 12234456789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||.+......
T Consensus 77 ~~~L~~~l~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 77 GGDLKYHIYNVG--------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCcHHHHHHHcC--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 999999997632 235788899999999999999999999999999999999999999999999998765432
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 149 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~ 199 (277)
T cd05577 149 KK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKE 199 (277)
T ss_pred Cc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhh-CCCCCCCCcc
Confidence 11 112234667999999988889999999999999999999 8999976544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=269.54 Aligned_cols=209 Identities=22% Similarity=0.328 Sum_probs=173.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.++||+|+||.||+|.++. .++.||+|.+...... ...+.+.+|+++++.++|+||+++++++..++..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE----TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC----CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEE
Confidence 368899999999999999999875 3678999987654322 23556889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|+||+++++|.++... ...+++..+..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||+
T Consensus 77 lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 77 LVFEFVDHTVLDDLEKY----------PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEEecCCccHHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999888877653 22467889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
+........ ......++..|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+..+.+.
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~-g~~~~~~~~~~~~~~ 211 (286)
T cd07846 147 ARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT-GEPLFPGDSDIDQLY 211 (286)
T ss_pred eeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc-CCCCCCCCchHHHHH
Confidence 876544321 1122335678999999875 347889999999999999999 789998766544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=265.04 Aligned_cols=204 Identities=23% Similarity=0.395 Sum_probs=170.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-----HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-----EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
.|+..+.||+|++|.||++.++. ++..+|+|++..... ......+.+|+.++++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~----~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK----TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcC----CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC
Confidence 36778899999999999998765 467899998864321 224567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEe
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-TVKVG 274 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kL~ 274 (364)
..++|+||+++++|.+++.+. .++++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY----------GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEc
Confidence 999999999999999999752 3567788999999999999999999999999999999998775 69999
Q ss_pred ecccccccCccceee--eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 275 DFGMTRDIYETEYYR--KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 275 DFg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
|||.+.......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~ 212 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAEK 212 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Confidence 999987654331111 1112235678999999988889999999999999999999 889997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.27 Aligned_cols=211 Identities=19% Similarity=0.275 Sum_probs=172.3
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
..-+-.+||++.+.||.|||+-||++..-. +.+.+|+|.+.-.. .++.+..++|++..++++|||+++++++...
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s----~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLS----TGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccC----cccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 334566899999999999999999998544 57779999887654 4567788999999999999999999887643
Q ss_pred C-----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEc
Q psy7023 194 G-----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLAARNCMVA 266 (364)
Q Consensus 194 ~-----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NILl~ 266 (364)
+ ...||+++|...|+|.+.+...+. ....+++.+++.|+.+|++||++||+.. +.||||||.|||+.
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~------kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls 163 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKI------KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS 163 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhh------cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec
Confidence 3 458999999999999999987652 3446889999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecccccccCccceeee-------CCCCCCCccccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 267 DDLTVKVGDFGMTRDIYETEYYRK-------GSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 267 ~~~~~kL~DFg~a~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
+++.++|.|||.+....-...... -....-|..|.|||.+.- ...+.++|||||||+||+|+. |.-||.
T Consensus 164 ~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf-~~sPfe 242 (302)
T KOG2345|consen 164 DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF-GESPFE 242 (302)
T ss_pred CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH-cCCcch
Confidence 999999999999875432111000 011122667999999854 446889999999999999999 888985
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=267.27 Aligned_cols=212 Identities=21% Similarity=0.314 Sum_probs=175.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.+.||+|+||.||+|.++. ++..|++|.++.... ......+.+|++++++++|+||+++++++..++..+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA----TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC----CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEE
Confidence 378999999999999999999876 367899998875432 333567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||++++.+..+..+ ...++...+..++.|++.||+|||+++++|+||+|+||++++++.+||+|||+
T Consensus 77 iv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 77 LVFEYVERTLLELLEAS----------PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred EEEecCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeec
Confidence 99999988666555542 23467889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+......... ......++..|+|||++.+. .++.++||||||+++|+|++ |.+||.+.+..+.+..+
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~~~ 214 (288)
T cd07833 147 ARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD-GEPLFPGDSDIDQLYLI 214 (288)
T ss_pred ccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 8766544321 11223346779999999888 78999999999999999999 88999877665544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=265.05 Aligned_cols=212 Identities=22% Similarity=0.415 Sum_probs=178.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
.|...+.||+|++|.||++.++. .+..+++|.++... ....+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS----TGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC----CCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 45556789999999999998765 36789999876433 23345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
+||+++++|.+++.. ..++...+..++.|++.||+|||+++++||||+|+||++++++.++|+|||.+.
T Consensus 95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccch
Confidence 999999999999864 246778899999999999999999999999999999999999999999999886
Q ss_pred ccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....++...
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 231 (285)
T cd06648 164 QVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPYFNEPPLQAMKRIRDNL 231 (285)
T ss_pred hhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHhcC
Confidence 54432211 122335778999999998889999999999999999999 889998877777777776664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=274.69 Aligned_cols=209 Identities=22% Similarity=0.317 Sum_probs=173.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-- 194 (364)
+..+|++++.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV----TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC----CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence 45789999999999999999998876 47789999986432 233445677899999999999999999988643
Q ss_pred ----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 195 ----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 195 ----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
...|+||||+. ++|.+.+.. .++...+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 90 ~~~~~~~~lv~e~~~-~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 90 LEEFQDVYLVMELMD-ANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred ccccCcEEEEEeccC-CCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC
Confidence 35799999995 588888753 1567788999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+||+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+..+
T Consensus 157 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 157 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GTVLFPGTDHIDQWNKI 229 (353)
T ss_pred EEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 99999999976543321 122235678999999999999999999999999999999 88999877765544433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=268.86 Aligned_cols=215 Identities=24% Similarity=0.388 Sum_probs=173.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC---
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN--- 195 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--- 195 (364)
++|++.++||+|+||.||+|.++. ++..||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKK----TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECC----CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 579999999999999999998876 47789999875432 2222345668999999999999999999986543
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 196 -----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 196 -----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
..++||||+. ++|.+++.. ....+++..+..++.|++.||+|||+++++|+||||+||+++.++.
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSN---------KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI 157 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc
Confidence 4599999995 588888864 2235788999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCcccee--eeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYY--RKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+||+|||++......... .......++..|+|||.+.+.. ++.++||||||+++|+|+| |.+||.+.+....+..+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t-~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLI 236 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 999999999765433221 1112233467799999886644 7889999999999999999 89999988776666554
Q ss_pred hc
Q psy7023 348 KG 349 (364)
Q Consensus 348 ~~ 349 (364)
.+
T Consensus 237 ~~ 238 (310)
T cd07865 237 SQ 238 (310)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=264.97 Aligned_cols=193 Identities=23% Similarity=0.357 Sum_probs=157.3
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHh---cCCcceeEEEEEEeeCCceEEEE
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKA---FDTHHVVKLYGVVSEGNPTLVIM 201 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~---l~h~~iv~l~~~~~~~~~~~lv~ 201 (364)
.||+|+||.||++.+.. .++.+|+|.+..... ......+.+|..+++. .+|+||+.+++++..++..++||
T Consensus 1 ~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEECC----CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEE
Confidence 48999999999998875 467899998865432 1222333445444443 47999999999999989999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 202 ELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 202 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
||+++++|.+++.. ...+++..+..++.|++.||+|||+++|+|+||||+|||+++++.++|+|||++..
T Consensus 77 e~~~~~~L~~~i~~----------~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 77 DLMNGGDLHYHLSQ----------HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred ecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999864 23578899999999999999999999999999999999999999999999999875
Q ss_pred cCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 282 IYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
...... ....+++.|+|||.+.. ..++.++||||+||++|+|++ |..||...
T Consensus 147 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 199 (279)
T cd05633 147 FSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQH 199 (279)
T ss_pred ccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcCCC
Confidence 543221 12245788999999864 558899999999999999999 88999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=268.35 Aligned_cols=212 Identities=23% Similarity=0.365 Sum_probs=175.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--Cc
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFDTHHVVKLYGVVSEG--NP 196 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~ 196 (364)
+.|++.+.||+|+||.||+|.++. .++.+++|.++..... .....+.+|+.++++++||||+++++++... +.
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK----TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC----CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 478899999999999999999876 4667999988644322 2234567899999999999999999998877 89
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.|+||||+. ++|.+++... ...+++..++.++.|++.||+|||+++++|+||||+|||+++++.++|+||
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~ 150 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETM---------KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDF 150 (293)
T ss_pred EEEEehhcC-cCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeec
Confidence 999999996 4999998752 235788999999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|++........ ......+++.|+|||.+.+.. ++.++|+||||+++|+|++ |.+||...+..+.+..+.
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~f~~~~~~~~~~~~~ 220 (293)
T cd07843 151 GLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLNKIF 220 (293)
T ss_pred CceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Confidence 99886654321 112233467899999987644 6889999999999999999 899999887777666553
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=265.28 Aligned_cols=213 Identities=25% Similarity=0.480 Sum_probs=172.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEe----
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVS---- 192 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~---- 192 (364)
....|++.+.||+|+||.||+|.++. .+..+|+|+.... .....++..|+.+++++ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~----~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVK----TGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcC----CCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 34688899999999999999999876 4678999987543 23345678899999998 7999999999985
Q ss_pred --eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 193 --EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 193 --~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
..+..|++|||+.+|+|.+++.... ...+++..+..++.|++.||+|||+.+|+|+||||+||++++++.
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTK--------GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC
Confidence 3467899999999999999997632 234667888999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
++|+|||++........ ......+++.|+|||.+. ...++.++|+||||+++|+|++ |..||....+.+...
T Consensus 160 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~ 236 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE-GAPPLCDMHPMRALF 236 (282)
T ss_pred EEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh-CCCCccccCHHhhhh
Confidence 99999999875533211 112234577899999986 3457889999999999999999 788997766554444
Q ss_pred HH
Q psy7023 346 WV 347 (364)
Q Consensus 346 ~i 347 (364)
.+
T Consensus 237 ~~ 238 (282)
T cd06636 237 LI 238 (282)
T ss_pred hH
Confidence 33
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=264.52 Aligned_cols=208 Identities=21% Similarity=0.401 Sum_probs=171.1
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeC--CceE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSEG--NPTL 198 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~--~~~~ 198 (364)
|++.++||+|+||.||+|.++. .+..||+|.++............+|+.+++++. |+||+++++++.++ +..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK----TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcC----CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 6788999999999999999875 467799998876433333344567899999885 99999999999987 8999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+++|+||||+||++++ +.+||+|||+
T Consensus 77 lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~ 145 (282)
T cd07831 77 LVFELMD-MNLYELIKGR---------KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGS 145 (282)
T ss_pred EEEecCC-ccHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccc
Confidence 9999996 5898888752 245788999999999999999999999999999999999999 9999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+......... ....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus 146 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~-~~~p~~~~~~~~~~~~~~ 212 (282)
T cd07831 146 CRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAKIH 212 (282)
T ss_pred ccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc-CCcCCCCCCHHHHHHHHH
Confidence 9866433221 12234678999997754 456889999999999999999 899999888766665553
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=266.66 Aligned_cols=209 Identities=24% Similarity=0.421 Sum_probs=172.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.|++++.||.|++|.||+|.++. .+..|++|.+..... ......+.+|++++++++||||+++++++.+++..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL----TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC----CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEE
Confidence 47889999999999999999876 467899998864432 2233568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+. ++|.+++... ....+++..+..++.|++.||+|||+.+++|+||+|+||++++++.+||+|||++
T Consensus 77 v~e~~~-~~l~~~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 77 VFEFLH-QDLKKFMDAS--------PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred Eeeccc-cCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccch
Confidence 999995 6899988752 2345788899999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
........ ......+++.|+|||.+.+.. ++.++||||||+++|+|+| |..||.+.+..+.+.
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~ 211 (284)
T cd07860 148 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLF 211 (284)
T ss_pred hhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence 75543211 112223467799999887655 5889999999999999999 788998766554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=258.10 Aligned_cols=221 Identities=26% Similarity=0.452 Sum_probs=187.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|.+.+.||+|+||.||++.+.. .+..+++|.+..... ......+.+|+++++.++|+|++++.+.+..+...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS----DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC----CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence 57889999999999999999875 467899998875432 3456778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+|++++++|.+++..... ....++...+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+
T Consensus 77 v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKK------EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEecCCCcHHHHHHHhhc------cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccce
Confidence 9999999999999986321 2356888999999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
......... .....+++.|+|||.+....++.++|+||+|+++++|++ |..||...+..++.+.+......+
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 222 (258)
T cd08215 151 KVLSSTVDL--AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT-LKHPFEGENLLELALKILKGQYPP 222 (258)
T ss_pred eecccCcce--ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc-CCCCCCCCcHHHHHHHHhcCCCCC
Confidence 765444311 122245678999999998889999999999999999999 899998888888777766554433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=265.87 Aligned_cols=211 Identities=25% Similarity=0.395 Sum_probs=175.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
...+|++.+.||+|+||+||+|.++. .+..|++|.+... .......++.+|+.+++.++||||+++++++...+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR----TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 34679999999999999999998875 4678999987643 23344567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+|+|+||+|+||++++++.++|+|
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~d 158 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEV---------HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLAD 158 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHH---------cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEee
Confidence 9999999996 588887764 223578889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
||++....... ...+++.|+|||++. ...++.++||||||+++|||+| |.+||.+.+.......+..
T Consensus 159 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 228 (307)
T cd06607 159 FGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQ 228 (307)
T ss_pred cCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhc
Confidence 99986543221 223467799999884 4568899999999999999999 8999988776665555543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=266.61 Aligned_cols=210 Identities=15% Similarity=0.211 Sum_probs=158.4
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHH----------HHHHHHHHHHHhcCCccee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK----------AEFLNEASVMKAFDTHHVV 185 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~~~E~~il~~l~h~~iv 185 (364)
++...+|++.+.||+|+||+||+|.+..... ....+++|+.......... .....+...++.+.|++|+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHC-INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcc-cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 4566899999999999999999999876422 1445677764432211100 1122344455667899999
Q ss_pred EEEEEEeeCC----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 186 KLYGVVSEGN----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 186 ~l~~~~~~~~----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
++++...... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+++|+||||||+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~ 155 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI----------KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE 155 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh----------ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9998765433 3467888873 4777776541 12356778899999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecccccccCcccee-----eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYY-----RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
|||++.++.++|+|||+++.+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~-g~~P~~ 234 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG-IKLPWK 234 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCC
Confidence 999999999999999999865432211 11122346889999999999999999999999999999999 899998
Q ss_pred CC
Q psy7023 337 GL 338 (364)
Q Consensus 337 ~~ 338 (364)
+.
T Consensus 235 ~~ 236 (294)
T PHA02882 235 GF 236 (294)
T ss_pred cc
Confidence 76
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=259.44 Aligned_cols=205 Identities=23% Similarity=0.370 Sum_probs=169.9
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHH-HhcCCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVM-KAFDTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il-~~l~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
+.||+|+||.||+|.++. .++.||+|++..... ......+..|..++ ...+|+|++++++++..++..|+|+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS----TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecC----CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEe
Confidence 569999999999998876 467899999865321 12223344555444 45589999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+++++|.++++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++...
T Consensus 78 ~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 78 YLNGGDCASLIKTL----------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred ccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 99999999999752 34678889999999999999999999999999999999999999999999988754
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..++.+.+..+.
T Consensus 148 ~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 209 (260)
T cd05611 148 LEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSRR 209 (260)
T ss_pred ccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhcc
Confidence 331 12234677999999988888999999999999999999 899999988888887776543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=263.76 Aligned_cols=215 Identities=27% Similarity=0.438 Sum_probs=182.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
....|++.+.||+|++|.||+|.++. .+..+++|++..... ....+.+|+++++.++|+||+++++.+...+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA----TGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc----CCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 44678889999999999999999875 367799999875443 456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+|+||+++++|.+++.... ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccc
Confidence 99999999999999998621 367888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
++......... .....+++.|++||.+.+..++.++|+||||+++|+|++ |..||...++.+....+...
T Consensus 162 ~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~-g~~p~~~~~~~~~~~~~~~~ 231 (286)
T cd06614 162 FAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE-GEPPYLREPPLRALFLITTK 231 (286)
T ss_pred hhhhhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Confidence 88654432211 112234677999999998889999999999999999999 89999988776666555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=254.87 Aligned_cols=211 Identities=30% Similarity=0.523 Sum_probs=179.7
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
+|.+.+.||+|++|.||++.++. .+..+++|++..... .....+.+|+++++.++|+|++++++++......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR----TGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC----CCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 47788999999999999999875 467799999876544 3457888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
+||+++++|.+++... ...+++..+..++.|++.+|.+||+++++|+||+|+||++++++.++|+|||.+.
T Consensus 76 ~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 76 MEFCSGGSLKDLLKST---------NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred EecCCCCcHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccc
Confidence 9999999999998752 2467889999999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
....... .....++..|++||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 211 (253)
T cd05122 147 QLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-GKPPYSELPPMKALFKIAT 211 (253)
T ss_pred ccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHh
Confidence 6654431 112234667999999988889999999999999999999 8899987755555544443
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=260.22 Aligned_cols=198 Identities=28% Similarity=0.456 Sum_probs=164.2
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecC
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELM 204 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 204 (364)
...||+|+||.||+|.++. .+..|++|.+.... ....+.+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~----~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLS----TQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred eEEEecCCceEEEEeEecC----CCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 3479999999999998775 46779999876543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCccCCCCc--cHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecccccc
Q psy7023 205 GGGDLKNYLRSCRPDAETDVERSPP--TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-DLTVKVGDFGMTRD 281 (364)
Q Consensus 205 ~ggsL~~~l~~~~~~~~~~~~~~~~--~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kL~DFg~a~~ 281 (364)
++++|.+++... ...+ +...+..++.|++.||+|||+++|+||||||+||+++. ++.++|+|||.+..
T Consensus 88 ~~~~L~~~l~~~---------~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 88 PGGSLSALLRSK---------WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred CCCCHHHHHHHh---------cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999752 1122 66778889999999999999999999999999999976 67999999999875
Q ss_pred cCccceeeeCCCCCCCccccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 282 IYETEYYRKGSRGFLPVRWMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
....... .....+++.|+|||.+.... ++.++|+||||+++|+|++ |.+||....
T Consensus 159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~-g~~p~~~~~ 215 (268)
T cd06624 159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKPPFIELG 215 (268)
T ss_pred cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh-CCCCCcccc
Confidence 5432211 11223577899999986644 7889999999999999999 889997544
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=259.66 Aligned_cols=218 Identities=25% Similarity=0.426 Sum_probs=185.1
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++.++||+|+||.||++.++. .+..+++|.+.... .......+.+|++++++++|+||+++++++......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS----DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC----CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence 47889999999999999998775 46779999886533 33445677899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+||+++++|.+++.... .....+++..+..++.|++.||+|||+.|++|+||+|+||++++++.+||+|||++
T Consensus 77 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 77 VMEYAPFGDLSKAISKRK------KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EehhcCCCCHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccch
Confidence 999999999999997632 12345788899999999999999999999999999999999999999999999998
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
........ ....+++.|++||.+.+..++.++|+||||+++|+|++ |..||...+..++...+..+...
T Consensus 151 ~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08530 151 KVLKKNMA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT-FAPPFEARSMQDLRYKVQRGKYP 219 (256)
T ss_pred hhhccCCc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCC
Confidence 76654311 11234678999999999889999999999999999999 89999998888777777655443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=259.50 Aligned_cols=216 Identities=23% Similarity=0.453 Sum_probs=179.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|.+.+.||+|+||.||++.++. .+..+++|.+.... .....+.+.+|+.+++.++|+||+++++.+...+..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS----DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC----CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence 57889999999999999999876 46678999886532 12334677899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeeccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-TVKVGDFGM 278 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kL~DFg~ 278 (364)
|+||+++++|.+++... ....+++..+..++.|++.||.|||+.+++|+||||+||++++++ .++|+|||.
T Consensus 77 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 77 VMEYCDGGDLMKRINRQ--------RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999999752 223467889999999999999999999999999999999999886 469999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+.......... ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+..+.
T Consensus 149 ~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 218 (257)
T cd08225 149 ARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT-LKHPFEGNNLHQLVLKICQGY 218 (257)
T ss_pred chhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhccc
Confidence 87664432211 12235778999999988889999999999999999999 889998877766666555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=260.99 Aligned_cols=209 Identities=23% Similarity=0.384 Sum_probs=177.3
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
||+|+||.||++.+.. .+..+++|++..... ......+.+|++++++++|+||+++++.+..+...|+|+||++
T Consensus 1 lg~g~~~~vy~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKS----TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECC----CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCC
Confidence 6899999999999875 467899999865432 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++.+. ..+++..+..++.||+.||+|||+.+++|+||+|+||++++++.++|+|||++......
T Consensus 77 ~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 77 GGDLASLLENV----------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 99999999752 25678899999999999999999999999999999999999999999999998754332
Q ss_pred ce------eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 286 EY------YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 286 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
.. ........++..|++||.+....++.++||||||+++|+|++ |..||......+..+.+..+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNGK 217 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC
Confidence 11 011222334678999999988889999999999999999999 899999888888888877643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=263.71 Aligned_cols=211 Identities=22% Similarity=0.370 Sum_probs=170.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.+.||+|++|+||+|.++. .++.|++|.+..... ......+.+|++++++++|+||+++++++..+...|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC----CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 578999999999999999999876 467799998864332 223456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-DLTVKVGDFG 277 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kL~DFg 277 (364)
+||||++ ++|.+++... ....+++..+..++.||+.||+|||+++++|+||+|+||++++ ++.+||+|||
T Consensus 78 lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSS--------PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEeccc-ccHHHHHHhC--------CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccc
Confidence 9999995 5888888652 2223467788899999999999999999999999999999985 5679999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
++........ ......+++.|+|||.+.+. .++.++||||||+++|+|+| |.+||.+.+..+.+..
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t-g~~pf~~~~~~~~~~~ 215 (294)
T PLN00009 149 LARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFK 215 (294)
T ss_pred cccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 9875433211 11122346789999988664 57899999999999999999 8999987766554443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=262.51 Aligned_cols=193 Identities=25% Similarity=0.382 Sum_probs=157.8
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHH---HHHHhcCCcceeEEEEEEeeCCceEEEE
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEA---SVMKAFDTHHVVKLYGVVSEGNPTLVIM 201 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~---~il~~l~h~~iv~l~~~~~~~~~~~lv~ 201 (364)
.||+|+||.||+|.+.. .++.||+|.+...... .....+.+|. ..++...||+|+.+++.+...+..++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEec----CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEE
Confidence 48999999999998765 4678999988653211 1112233343 3444568999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 202 ELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 202 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
||+.|++|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus 77 e~~~g~~L~~~l~~----------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 77 DLMNGGDLHYHLSQ----------HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred ecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999998864 23578899999999999999999999999999999999999999999999999876
Q ss_pred cCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 282 IYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
...... ....++..|+|||.+.++ .++.++||||+|+++|+|++ |..||.+.
T Consensus 147 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~-g~~p~~~~ 199 (278)
T cd05606 147 FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQH 199 (278)
T ss_pred cCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCC
Confidence 543221 123457889999999754 58999999999999999999 89999866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=263.54 Aligned_cols=213 Identities=23% Similarity=0.363 Sum_probs=170.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCCc-
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFD-THHVVKLYGVVSEGNP- 196 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~- 196 (364)
++|++.+.||+|+||.||+|.++. .++.||+|........ .....+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~----~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN----TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC----CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 368899999999999999999876 4678999987654322 22356788999999995 5999999999887665
Q ss_pred ----eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcE
Q psy7023 197 ----TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-DLTV 271 (364)
Q Consensus 197 ----~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-~~~~ 271 (364)
.|+||||+++ +|.+++...... ....+++..+..++.||+.||.|||+++|+||||||+||+++. ++.+
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~ 150 (295)
T cd07837 77 GKPSLYLVFEYLDS-DLKKFMDSNGRG-----PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLL 150 (295)
T ss_pred CCceEEEEeeccCc-CHHHHHHHhccc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeE
Confidence 8999999975 899998753211 1345788999999999999999999999999999999999998 8999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
||+|||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+..+.+.
T Consensus 151 kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~~ 222 (295)
T cd07837 151 KIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQLL 222 (295)
T ss_pred EEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Confidence 9999999875533211 1112234677999998865 457899999999999999999 789998776655443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=262.37 Aligned_cols=212 Identities=22% Similarity=0.375 Sum_probs=175.9
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--CceE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG--NPTL 198 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~ 198 (364)
|++.+.||+|+||.||+|.++. .+..+++|.+.... .......+.+|+.+++.++|+|++++++++... +..+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK----TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC----CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence 6788999999999999999876 36789999987653 233345688899999999999999999999987 8999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|+||+++ +|.+++... ...+++..+..++.|++.||+|||+.+++|+||||+|||+++++.++|+|||+
T Consensus 77 lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~ 146 (287)
T cd07840 77 MVFEYMDH-DLTGLLDSP---------EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146 (287)
T ss_pred EEeccccc-cHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccc
Confidence 99999975 898888642 24678889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+......... ......++..|+|||.+.+ ..++.++||||||+++|+|+| |..||...+..+.+..+.+
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 147 ARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred eeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence 8866544311 1122234667999998765 457899999999999999999 7999998887766665543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=262.81 Aligned_cols=215 Identities=22% Similarity=0.382 Sum_probs=182.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCCc
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGNP 196 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~ 196 (364)
++|.+.+.||+|+||.||+|.++. .+..|++|++.... .......+.+|+++++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE----TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC----CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce
Confidence 468899999999999999999876 47789999987532 2344567889999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++|||++++++|.+++.+. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCC
Confidence 99999999999999999752 26788999999999999999999999999999999999999999999999
Q ss_pred ccccccCcccee------------------eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 277 GMTRDIYETEYY------------------RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 277 g~a~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
|++......... .......++..|+|||++....++.++|+||||+++++|++ |..||...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 225 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT-GKPPFRGS 225 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCc
Confidence 998765443211 12222345678999999988889999999999999999999 89999988
Q ss_pred CHHHHHHHHhc
Q psy7023 339 SNEQVLNWVKG 349 (364)
Q Consensus 339 ~~~~~~~~i~~ 349 (364)
+..+.++.+..
T Consensus 226 ~~~~~~~~~~~ 236 (280)
T cd05581 226 NEYLTFQKILK 236 (280)
T ss_pred cHHHHHHHHHh
Confidence 77666665543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=263.96 Aligned_cols=212 Identities=24% Similarity=0.392 Sum_probs=175.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
.+..|...+.||+|+||.||++.+.. .+..+++|.+.... .......+.+|++++++++|+|++++++++.++.
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVR----TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcC----CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 34558889999999999999998876 46789999876432 3344567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+. |+|.+.+.. ...++++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|
T Consensus 99 ~~~lv~e~~~-g~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~d 168 (317)
T cd06635 99 TAWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLAD 168 (317)
T ss_pred eEEEEEeCCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEec
Confidence 9999999996 488888764 234577889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
||++...... ....+++.|+|||.+. .+.++.++||||||+++|+|++ |..||...+..+.+..+..+
T Consensus 169 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~ 239 (317)
T cd06635 169 FGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQN 239 (317)
T ss_pred CCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhc
Confidence 9988654322 1223567799999974 4568899999999999999999 78898877776666655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=253.72 Aligned_cols=213 Identities=26% Similarity=0.457 Sum_probs=180.0
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+|++.+.||+|++|.||++.++. .+..|++|....... ......+.+|++++++++|+|++++++++.+++..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE----TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC----CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence 57889999999999999998775 466799998875532 2456788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
+|||+++++|.+++... ..+++..+..++.|++.+|.|||++||+|+||||+||+++.++.++|+|||.+
T Consensus 77 v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 77 ILEYAENGSLRQIIKKF----------GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEecCCCCcHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccc
Confidence 99999999999999752 45788899999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+...
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 214 (254)
T cd06627 147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLNPMAALFRIVQD 214 (254)
T ss_pred eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhcc
Confidence 866543321 122234678999999988888999999999999999999 88999877665555444433
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=266.03 Aligned_cols=218 Identities=23% Similarity=0.388 Sum_probs=176.3
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
+...++|++.+.||+|+||.||+|.++. .+..|++|.++.... ......+.+|++++++++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKD----TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECC----CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 3455789999999999999999999876 467799998864432 22234677899999999999999999998764
Q ss_pred C----------ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7023 195 N----------PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCM 264 (364)
Q Consensus 195 ~----------~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIL 264 (364)
. .+++|+||+++ +|.+++.. ....+++..+..++.|++.||+|||+.+|+|+||||+||+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nil 148 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLES---------GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL 148 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 4 78999999975 78887764 2335788999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy7023 265 VADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343 (364)
Q Consensus 265 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~ 343 (364)
+++++.+||+|||++......... .......+..|+|||.+.+. .++.++|||||||++|+|++ |++||...+..+.
T Consensus 149 i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~-g~~~~~~~~~~~~ 226 (302)
T cd07864 149 LNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQ 226 (302)
T ss_pred ECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Confidence 999999999999998766443221 11122336679999988654 47889999999999999999 8999988777666
Q ss_pred HHHHhc
Q psy7023 344 LNWVKG 349 (364)
Q Consensus 344 ~~~i~~ 349 (364)
+..+.+
T Consensus 227 ~~~~~~ 232 (302)
T cd07864 227 LELISR 232 (302)
T ss_pred HHHHHH
Confidence 665544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=259.24 Aligned_cols=218 Identities=24% Similarity=0.459 Sum_probs=179.1
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc---------cCHHHHHHHHHHHHHHHh-cCCcceeEEEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN---------ASEREKAEFLNEASVMKA-FDTHHVVKLYGV 190 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~~E~~il~~-l~h~~iv~l~~~ 190 (364)
.|++.+.||+|+||.||+|.++.. .+..+++|.+... .......++.+|+.++++ ++|+||++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 77 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN---GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT 77 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC---CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee
Confidence 377889999999999999998752 2567899977532 223345567789988875 799999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCC
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~ 269 (364)
+.+++..++||||+++++|.+++.... .....++...++.++.|++.+|.|||+ .+++|+||||+|||+++++
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 78 FLENDRLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred EccCCeEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC
Confidence 999999999999999999999986522 123457888999999999999999996 7899999999999999999
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+.......+..
T Consensus 152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~ 227 (269)
T cd08528 152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLATKIVE 227 (269)
T ss_pred cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh-CCCcccccCHHHHHHHHhh
Confidence 99999999997654432 1223345778999999998889999999999999999999 7999988777776666655
Q ss_pred Cc
Q psy7023 350 KS 351 (364)
Q Consensus 350 ~~ 351 (364)
+.
T Consensus 228 ~~ 229 (269)
T cd08528 228 AV 229 (269)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=279.58 Aligned_cols=211 Identities=23% Similarity=0.418 Sum_probs=179.1
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceE---EEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC--ceE
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCA---IKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN--PTL 198 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~va---iK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~~ 198 (364)
...+||+|+|-+||+|.+.. .+..|| +|+-+...+.+..++|.+|+.+|+.|.|+||+++|++|.+.. .+.
T Consensus 44 ~~evLGrGafKtVYka~De~----~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEE----EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred hhhhcccccceeeeeccccc----cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 34579999999999998865 344444 444445556677789999999999999999999999998654 488
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEc-CCCcEEEee
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK--KFVHRDLAARNCMVA-DDLTVKVGD 275 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--~iiHrDlkp~NILl~-~~~~~kL~D 275 (364)
+|+|+|..|+|..|+++. +....+.++.|++||++||.|||++ .|||||||.+||||+ .-|.|||+|
T Consensus 120 ~iTEL~TSGtLr~Y~kk~----------~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH----------RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eeeecccCCcHHHHHHHh----------ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 999999999999999863 3456678999999999999999988 599999999999997 568999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCcccc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG-LSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~ 354 (364)
+|+|......... ...|||.|||||++. ..|+..+||||||+++.||+| +..||.. .++.+++..+..|...+
T Consensus 190 LGLAtl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT-~eYPYsEC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 190 LGLATLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT-SEYPYSECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred hhHHHHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh-ccCChhhhCCHHHHHHHHHcCCCHH
Confidence 9999877655332 246799999999998 789999999999999999999 8999975 77899999998887653
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=267.64 Aligned_cols=210 Identities=19% Similarity=0.307 Sum_probs=168.3
Q ss_pred ceeeee--cceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNG--SFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G--~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e 202 (364)
..||+| +||+||+|.++. .++.||+|+..... .....+.+.+|+.+++.++||||++++++|..++..++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP----TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcC----CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 456666 999999998865 47889999987543 34445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
|+.+++|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.++++||+.+...
T Consensus 80 ~~~~~~l~~~l~~~~--------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 80 FMAYGSANSLLKTYF--------PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred cccCCCHHHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 999999999998632 234678888999999999999999999999999999999999999999999865432
Q ss_pred Ccccee-----eeCCCCCCCccccCcccccCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 283 YETEYY-----RKGSRGFLPVRWMAPESLKDG--VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 283 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
...... ........+..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 223 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT-GRVPFQDMLRTQMLLQKL 223 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHh
Confidence 221110 001111234569999999764 47889999999999999999 899998877655554433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=282.67 Aligned_cols=221 Identities=25% Similarity=0.466 Sum_probs=188.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEe----
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVS---- 192 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~---- 192 (364)
..+.+++.++||.|.+|.||+++.++ .++.+|+|++....+.. +++..|.++++.+ .|||++.++++|.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~----~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVK----TGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeee----cCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 34678889999999999999999887 46678899887665443 4556688888887 7899999999986
Q ss_pred -eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 193 -EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 193 -~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
.++.+|||||||.||+.-|+++... ...+.+..+.+|++.++.||.+||.+.+||||||-.|||++.++.|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--------g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--------GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--------ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcE
Confidence 4678999999999999999998743 4567889999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-----VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
||+|||++..+..... +.....|||.|||||++... .|+..+|+||||++..||.- |.+|+-++.+.-.+..
T Consensus 163 KLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad-G~PPl~DmHPmraLF~ 239 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE-GAPPLCDMHPMRALFL 239 (953)
T ss_pred EEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC-CCCCccCcchhhhhcc
Confidence 9999999987765543 34455789999999999643 37889999999999999999 9999999999988887
Q ss_pred HhcCccccc
Q psy7023 347 VKGKSSNEY 355 (364)
Q Consensus 347 i~~~~~~~~ 355 (364)
|..+++...
T Consensus 240 IpRNPPPkL 248 (953)
T KOG0587|consen 240 IPRNPPPKL 248 (953)
T ss_pred CCCCCCccc
Confidence 766655433
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=266.74 Aligned_cols=211 Identities=23% Similarity=0.338 Sum_probs=170.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--Cc
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG--NP 196 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~ 196 (364)
+|.+.++||+|+||.||+|.++.. ..+..||+|.+.... .......+.+|+.++++++||||+++++++.+. ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~--~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG--KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC--CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 578899999999999999998652 136789999987632 122235677899999999999999999999987 88
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC----CCcEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD----DLTVK 272 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~----~~~~k 272 (364)
.++||||++ ++|.+++...... ....++...+..++.|++.||+|||+++|+||||||+|||++. ++.+|
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQA-----KRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccC-----CCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEE
Confidence 999999996 4888877643211 1236788899999999999999999999999999999999999 99999
Q ss_pred EeecccccccCccce-eeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 273 VGDFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 273 L~DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
|+|||++........ ........+++.|+|||++.+. .++.++||||||+++|+|++ |++||.+...
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~ 221 (316)
T cd07842 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREA 221 (316)
T ss_pred ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-cCCCCcCCcc
Confidence 999999886544322 1112223446789999988764 57899999999999999999 8999986554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=261.56 Aligned_cols=204 Identities=21% Similarity=0.342 Sum_probs=167.9
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc---CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCc
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~ 196 (364)
.|++.+.||+|+||.||++...... ..+..||+|++.... .....+.+.+|+.+++++ +|+||+++++.+..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~-~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC-CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 4788999999999999999875321 246789999986532 122346678899999999 58999999999999899
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++||||+++++|.+++.. ..+++...+..++.|++.||.|||+.+++||||||+|||+++++.+||+||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 80 LHLILDYINGGELFTHLSQ----------RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred EEEEEecCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999999975 234677889999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCC--CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG--VFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
|++......... ......++..|+|||.+... .++.++||||||+++|+|++ |..||..
T Consensus 150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~ 210 (290)
T cd05613 150 GLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPFTV 210 (290)
T ss_pred ccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc-CCCCCCc
Confidence 998765432211 11223357789999998753 46789999999999999999 8899964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=262.86 Aligned_cols=211 Identities=22% Similarity=0.416 Sum_probs=176.2
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIM 201 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 201 (364)
|....+||+|+||.||++..+. .+..|++|.+.... ......+.+|+.+++.++|+||+++++.+..++..++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~----~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS----SGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC----CCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 3344679999999999998876 47789999875433 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 202 ELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 202 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
||+++++|.+++.. ..+++..+..++.|++.+|+|||+.|++|+||+|+||++++++.++|+|||++..
T Consensus 97 e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 97 EFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred ecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEccccccee
Confidence 99999999988753 2467788999999999999999999999999999999999999999999998875
Q ss_pred cCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 282 IYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
....... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+.+..+..+.
T Consensus 166 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 232 (292)
T cd06657 166 VSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNL 232 (292)
T ss_pred ccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Confidence 5432211 122235678999999988889999999999999999999 889998877777666665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=266.12 Aligned_cols=215 Identities=25% Similarity=0.360 Sum_probs=172.0
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC---
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG--- 194 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--- 194 (364)
.++|++.++||+|+||.||+|.++. .+..+++|.+..... ......+.+|+++++.++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK----TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC----CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 3789999999999999999999876 466799998764322 22234567899999999999999999887543
Q ss_pred -----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 195 -----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 195 -----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
..+++|+||+.+ +|.+.+.. ....+++..+..++.|+++||+|||++||+|+||||+|||+++++
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~---------~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~ 152 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLEN---------PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG 152 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 346999999964 78777764 234578899999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCccceeee---------CCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 270 TVKVGDFGMTRDIYETEYYRK---------GSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
.++|+|||++........... .....+++.|+|||.+.+. .++.++||||||+++|+|++ |.+||.+.+
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~-g~~~~~~~~ 231 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKS 231 (311)
T ss_pred CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh-CCCCCCCCC
Confidence 999999999876543321111 1122346779999988654 47899999999999999999 899999888
Q ss_pred HHHHHHHHh
Q psy7023 340 NEQVLNWVK 348 (364)
Q Consensus 340 ~~~~~~~i~ 348 (364)
.....+.+.
T Consensus 232 ~~~~~~~~~ 240 (311)
T cd07866 232 DIDQLHLIF 240 (311)
T ss_pred HHHHHHHHH
Confidence 776665544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=261.31 Aligned_cols=229 Identities=24% Similarity=0.379 Sum_probs=185.3
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccc-ccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe---
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANE-NASEREKAEFLNEASVMKAFDTHHVVKLYGVVS--- 192 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--- 192 (364)
...+.|+-+.+||+|.||.||+|+.+. ++++||+|..-- ..........++|+.+|..++|+|++.+++.|.
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n----~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKN----TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcC----ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 344678888999999999999999887 467788775432 222333455678999999999999999888764
Q ss_pred -----eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7023 193 -----EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267 (364)
Q Consensus 193 -----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~ 267 (364)
+...+|+||.+|+. +|...+.. ....++..++..++.+++.||.|+|++.|+|||+||+|+||+.
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn---------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~ 159 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSN---------RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK 159 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcC---------ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC
Confidence 23458999999976 99998864 3356889999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCccc--eeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 268 DLTVKVGDFGMTRDIYETE--YYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+|.+||+|||+++.+.... .....+..+.|..|.+||.+.+.+ |+++.|||..||++.||+| +.+.+++.++.+.+
T Consensus 160 dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt-rspimqgnteqqql 238 (376)
T KOG0669|consen 160 DGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT-RSPIMQGNTEQQQL 238 (376)
T ss_pred CceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc-cCccccCChHHHHH
Confidence 9999999999998665432 233455566689999999987754 8999999999999999999 89999999998888
Q ss_pred HHHhc-CccccccCCCC
Q psy7023 345 NWVKG-KSSNEYKVNPP 360 (364)
Q Consensus 345 ~~i~~-~~~~~~~~~~~ 360 (364)
..|.+ ........||.
T Consensus 239 ~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 239 HLISQLCGSITKEVWPN 255 (376)
T ss_pred HHHHHHhccCCcccCCC
Confidence 77642 33445555654
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=261.64 Aligned_cols=218 Identities=27% Similarity=0.413 Sum_probs=174.5
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHh-cCCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA-FDTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~-l~h~~iv~l~~~~~~ 193 (364)
|+.-....+-+..||.|+||+|++-.++. .++..|||.+.....+.++.+++.|.....+ -+.||||++|+....
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~----sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKP----SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCc----cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 34444566667889999999999988877 6788999999988887888889888875554 578999999999888
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~k 272 (364)
++..|+.||+|+ .||..+.+... ..+...++++.+-.|+...+.||.||.. .+|||||+||+|||++..|.+|
T Consensus 135 EGdcWiCMELMd-~SlDklYk~vy-----~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 135 EGDCWICMELMD-ISLDKLYKRVY-----SVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred CCceeeeHHHHh-hhHHHHHHHHH-----HHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence 899999999994 47665544211 1345567888888999999999999986 4899999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|||||++..+.++...+ ...|-..|||||.+.. ..|+.++|+||||++|||+.| |..||.+-+. +++++.
T Consensus 209 LCDFGIcGqLv~SiAkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAt-G~fPyr~w~s--vfeql~ 280 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIAKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVAT-GNFPYRKWDS--VFEQLC 280 (361)
T ss_pred eecccchHhHHHHHHhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeec-CCCCcchHHH--HHHHHH
Confidence 99999998776653322 2233445999999954 358999999999999999999 8999987543 455444
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=262.72 Aligned_cols=206 Identities=27% Similarity=0.437 Sum_probs=167.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~ 198 (364)
++|+..+.||+|+||.||++.++. .+..||+|.+...........+.+|+.++.++. |+||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP----SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC----CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 356677899999999999998876 467899998876554555677889999999996 999999999999889999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++|||+. ++|.++...... .....+++..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYE-----VLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred EEEeccc-CCHHHHHHHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecc
Confidence 9999985 466655432100 1234678889999999999999999975 99999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDG---VFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
++......... ....+++.|+|||++.+. .++.++||||||+++|+|++ |.+||....
T Consensus 154 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~ 214 (288)
T cd06616 154 ISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT-GKFPYPKWN 214 (288)
T ss_pred hhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHh-CCCCchhcc
Confidence 98765433211 122346779999999876 68999999999999999999 899997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=266.57 Aligned_cols=208 Identities=22% Similarity=0.381 Sum_probs=171.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-- 194 (364)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTK----TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcC----CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 45789999999999999999998765 46789999887543 222345678899999999999999999988642
Q ss_pred ----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 195 ----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 195 ----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
...|++++++ +++|.++++. ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC
Confidence 3478888887 7799888753 24678889999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+||+|||++....... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+....+..+
T Consensus 159 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 159 LKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLI 230 (345)
T ss_pred EEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9999999987543321 12234678999999866 467889999999999999999 88999887766655544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=292.87 Aligned_cols=221 Identities=26% Similarity=0.400 Sum_probs=179.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE------
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV------ 191 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~------ 191 (364)
...+|+.+..||+||||.||+++.+- +++.||||.+.-..+......+.+|+.+|.+|+|||||+++..|
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKl----DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKL----DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecc----cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 34678889999999999999999876 68899999998776777778899999999999999999998765
Q ss_pred ---------------------------------------------------e---------------------e------
Q psy7023 192 ---------------------------------------------------S---------------------E------ 193 (364)
Q Consensus 192 ---------------------------------------------------~---------------------~------ 193 (364)
. +
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence 0 0
Q ss_pred ---------------------------C--------CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHH
Q psy7023 194 ---------------------------G--------NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238 (364)
Q Consensus 194 ---------------------------~--------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (364)
+ ..+||-||||+.-.|.+++++..... .....++++
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---------~~d~~wrLF 703 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---------QRDEAWRLF 703 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---------hhHHHHHHH
Confidence 0 23578899998877778777533211 245788999
Q ss_pred HHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccC----------------ccceeeeCCCCCCCccccC
Q psy7023 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY----------------ETEYYRKGSRGFLPVRWMA 302 (364)
Q Consensus 239 ~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~----------------~~~~~~~~~~~~~~~~y~a 302 (364)
+||++||.|+|++|||||||||.||+++++..|||+|||+|.... ........+..+||.-|+|
T Consensus 704 reIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 704 REILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 999999999999999999999999999999999999999998622 0111123455678889999
Q ss_pred cccccCCC---CCCchhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcCccccc
Q psy7023 303 PESLKDGV---FTSHSDVWSYGVVLWEMATLASQPYQ-GLSNEQVLNWVKGKSSNEY 355 (364)
Q Consensus 303 PE~~~~~~---~~~~~DiwslG~il~el~t~g~~P~~-~~~~~~~~~~i~~~~~~~~ 355 (364)
||++.+.. |+.|+||||||++|+||+. ||. .+....++..++.+..+.+
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~LR~g~iP~~ 836 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY----PFGTSMERASILTNLRKGSIPEP 836 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc----cCCchHHHHHHHHhcccCCCCCC
Confidence 99997655 9999999999999999986 675 6777788899997765443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=267.68 Aligned_cols=209 Identities=22% Similarity=0.382 Sum_probs=171.0
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC---
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG--- 194 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--- 194 (364)
..+|.+.+.||+|+||+||+|.+.. ++..|++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE----TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC----CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence 3589999999999999999998775 57789999886532 222345677899999999999999999987643
Q ss_pred --CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 195 --NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 195 --~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
...|+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+++++|+||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 80 AFNDVYIVYELMD-TDLHQIIRS----------SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred ccCcEEEEEeCCC-CCHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence 35899999995 689988864 24578889999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
|+|||++........ ......++..|+|||.+.. ..++.++||||||+++|+|++ |.+||.+.+..+.+.
T Consensus 149 L~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~ 219 (337)
T cd07858 149 ICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG-RKPLFPGKDYVHQLK 219 (337)
T ss_pred ECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Confidence 999999986543321 1122234678999998865 468899999999999999999 899998776544443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=256.40 Aligned_cols=195 Identities=20% Similarity=0.333 Sum_probs=160.5
Q ss_pred cceeEecee--eeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCc
Q psy7023 120 SKVTILDEL--GNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 120 ~~y~~~~~l--G~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~ 196 (364)
+.|++.+.+ |+|+||.||++..+. .+..+++|+......... |+.....+ +|+||+++++.+...+.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKP----TQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcC----CCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 456666665 999999999998776 467799998764322111 22222222 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEee
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-TVKVGD 275 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kL~D 275 (364)
.++||||+++++|.+++... .++++..+..++.|++.||.|||+.+++||||||+||+++.++ .++|+|
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE----------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999752 2678899999999999999999999999999999999999998 999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
||++....... ...++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 154 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~ 212 (267)
T PHA03390 154 YGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT-GKHPFKEDEDE 212 (267)
T ss_pred CccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCcc
Confidence 99987554322 1235778999999999899999999999999999999 88999865443
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=260.00 Aligned_cols=205 Identities=24% Similarity=0.414 Sum_probs=169.6
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
|++.+.||.|++|.||+|.++. .+..|++|++..... ......+.+|+.+++.++|+|++++++++.+++..+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL----TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC----CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence 5678899999999999999876 467899998864432 22235678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
|||++ ++|.+++.... ...+++..+..++.|++.||+|||+++++|+||+|+||++++++.++|+|||++.
T Consensus 77 ~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 77 FEFLD-LDLKKYMDSSP--------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EeccC-cCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 99995 69999987522 1357889999999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
....... ......+++.|+|||++.+. .++.++||||||+++|+|++ |.+||.+.+..+
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 207 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFPGDSEID 207 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 5533211 11122346789999988664 46889999999999999999 789998766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=269.37 Aligned_cols=210 Identities=24% Similarity=0.417 Sum_probs=171.5
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEe----e
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVS----E 193 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~----~ 193 (364)
..+|++.+.||+|+||.||+|.++. ++..|++|.+..... ......+.+|+.++++++|+||+++++++. .
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR----SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC----CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCC
Confidence 3689999999999999999999876 467899998875432 233566778999999999999999998875 3
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
....++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 80 FKDVYVVMDLME-SDLHHIIHS----------DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred CceEEEEEehhh-hhHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEe
Confidence 356899999995 689888863 234788999999999999999999999999999999999999999999
Q ss_pred eecccccccCccceee--eCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 274 GDFGMTRDIYETEYYR--KGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+|||++.......... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |++||.+.+..+.+
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~~~~~~ 221 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG-RRQLFPGKNYVHQL 221 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc-CCCccCCCChHHHH
Confidence 9999987654322111 1112345778999999865 458899999999999999999 89999877654433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=250.38 Aligned_cols=204 Identities=29% Similarity=0.476 Sum_probs=175.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--Cce
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG--NPT 197 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~ 197 (364)
+|.+.+.||+|++|.||+|.++. .+..|++|++..... ....+.+.+|+.++++++|+||+++++.+... ...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD----TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTL 76 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeE
Confidence 47788999999999999999875 467899998875432 34467888999999999999999999999988 889
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++|+||+++++|.+++... ..+++..+..++.|++.+|+|||+.+++|+||+|+||++++++.++|+|||
T Consensus 77 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~ 146 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKF----------GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFG 146 (260)
T ss_pred EEEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccc
Confidence 9999999999999999752 267888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
.+................++..|+|||.+....++.++||||||+++|+|++ |..||...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~ 207 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELG 207 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence 9886655432111222345678999999988889999999999999999999 899998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=267.37 Aligned_cols=213 Identities=24% Similarity=0.391 Sum_probs=171.8
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeC-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEG- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~- 194 (364)
+.++|++.+.||+|+||.||+|.++. .+..+++|.+... ........+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR----TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC----CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 45789999999999999999998875 3677999977542 2223345677899999999 999999999998643
Q ss_pred -CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 195 -NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 195 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
...|+||||++ ++|.+++... .+.+..+..++.||+.||+|||++||+|+||||+|||+++++.+||
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl 148 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRAN-----------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKL 148 (337)
T ss_pred CceEEEEecccc-cCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEE
Confidence 46899999996 5999888641 4567788889999999999999999999999999999999999999
Q ss_pred eecccccccCcccee---eeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 274 GDFGMTRDIYETEYY---RKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+|||++......... .......++..|+|||.+.+ ..++.++||||||+++|+|+| |++||.+....+....+
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t-g~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL-GKPLFPGTSTLNQLEKI 225 (337)
T ss_pred eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Confidence 999998865443221 11122345778999998865 457889999999999999999 89999887766554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=265.00 Aligned_cols=206 Identities=24% Similarity=0.383 Sum_probs=170.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN- 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~- 195 (364)
+.++|++++.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR----TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC----CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 46789999999999999999998775 46789999886433 2333456889999999999999999999987543
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 196 -----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 196 -----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||++++++.
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH-----------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 358999999 7799888753 24678899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
++|+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+....+.
T Consensus 157 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~ 226 (343)
T cd07880 157 LKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT-GKPLFKGHDHLDQLM 226 (343)
T ss_pred EEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 9999999987654321 12234678999999876 457889999999999999999 899998776544433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=258.63 Aligned_cols=219 Identities=26% Similarity=0.421 Sum_probs=174.9
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEe
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVS 192 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~ 192 (364)
.+....++|++.+.||+|+||.||+|.++. .+..||+|.++.........++..|+.++.+. .|+||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKK----TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECC----CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 344455789999999999999999999876 46789999987654444456677788777666 5999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ 271 (364)
+....|+||||+. ++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+
T Consensus 85 ~~~~~~~v~e~~~-~~l~~l~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~ 154 (296)
T cd06618 85 TDSDVFICMELMS-TCLDKLLKR---------IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNV 154 (296)
T ss_pred cCCeEEEEeeccC-cCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCE
Confidence 9999999999984 578877764 22367888899999999999999997 599999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV----FTSHSDVWSYGVVLWEMATLASQPYQGLS-NEQVLNW 346 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~el~t~g~~P~~~~~-~~~~~~~ 346 (364)
||+|||++..+...... ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.... ..+.+..
T Consensus 155 kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~ 230 (296)
T cd06618 155 KLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKNCKTEFEVLTK 230 (296)
T ss_pred EECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh-CCCCCCcchhHHHHHHH
Confidence 99999998765433221 1223466799999987554 7889999999999999999 889997533 3455555
Q ss_pred HhcC
Q psy7023 347 VKGK 350 (364)
Q Consensus 347 i~~~ 350 (364)
+...
T Consensus 231 ~~~~ 234 (296)
T cd06618 231 ILQE 234 (296)
T ss_pred HhcC
Confidence 5443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=265.12 Aligned_cols=214 Identities=22% Similarity=0.341 Sum_probs=172.8
Q ss_pred ccceeE-eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHH-------------HHHHHHHHHHHHhcCCcce
Q psy7023 119 RSKVTI-LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE-------------KAEFLNEASVMKAFDTHHV 184 (364)
Q Consensus 119 ~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~-------------~~~~~~E~~il~~l~h~~i 184 (364)
.++|.. .+.||+|+||+||+|.++. .+..||+|.+........ ...+.+|+++++.++|+||
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTL----TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECC----CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 456654 4679999999999999775 467899998764322210 1246789999999999999
Q ss_pred eEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7023 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCM 264 (364)
Q Consensus 185 v~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIL 264 (364)
+++++++..++..++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+++++|+||||+||+
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----------~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nil 151 (335)
T PTZ00024 83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDR----------KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIF 151 (335)
T ss_pred eeeeEEEecCCcEEEEEeccc-cCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeE
Confidence 999999999999999999996 599999864 234678899999999999999999999999999999999
Q ss_pred EcCCCcEEEeecccccccCccce------------eeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCC
Q psy7023 265 VADDLTVKVGDFGMTRDIYETEY------------YRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLA 331 (364)
Q Consensus 265 l~~~~~~kL~DFg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g 331 (364)
++.++.++|+|||.+........ ........+++.|+|||.+.+.. ++.++|+||||+++|+|++ |
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t-g 230 (335)
T PTZ00024 152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-G 230 (335)
T ss_pred ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh-C
Confidence 99999999999999876541110 01111223467799999987644 6889999999999999999 8
Q ss_pred CCCCCCCCHHHHHHHHh
Q psy7023 332 SQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 332 ~~P~~~~~~~~~~~~i~ 348 (364)
.+||.+.+..+.+..+.
T Consensus 231 ~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIF 247 (335)
T ss_pred CCCCCCCCHHHHHHHHH
Confidence 99999888777665543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=258.79 Aligned_cols=209 Identities=22% Similarity=0.364 Sum_probs=174.6
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
|++.+.||+|++|.||+|.++. .+..+++|.+...... .....+.+|++++++++|+||+++++++..++..++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL----TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCC----CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence 5677899999999999998765 4677999988754332 3456788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
+||+++ +|.+++.. ....+++..+..++.|++.||.|||+.+|+|+||||+||++++++.++|+|||.+.
T Consensus 77 ~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 77 FEFMDT-DLYKLIKD---------RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EeccCC-CHHHHHHh---------hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 999965 99888875 22467888999999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|+| |+.||.+.+..+.+..+
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPLFPGKSEIDQLFKI 211 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 665443 111223346679999998876 68999999999999999999 78999887765554433
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=283.57 Aligned_cols=147 Identities=25% Similarity=0.435 Sum_probs=131.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|.++++||+|+||+||+|.+.. .++.||+|++.... .......+.+|+.+++.++|+||+++++++.....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~----~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN----NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC----CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 689999999999999999999876 46789999986432 334456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+.+++|.+++... ..+++..++.++.||+.||+|||.++||||||||+||||+.++.+||+|||
T Consensus 80 ~lVmEy~~g~~L~~li~~~----------~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY----------GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 9999999999999999752 246678889999999999999999999999999999999999999999999
Q ss_pred ccc
Q psy7023 278 MTR 280 (364)
Q Consensus 278 ~a~ 280 (364)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=256.17 Aligned_cols=210 Identities=25% Similarity=0.415 Sum_probs=173.1
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhc---CCcceeEEEEEEeeCCc-
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAF---DTHHVVKLYGVVSEGNP- 196 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l---~h~~iv~l~~~~~~~~~- 196 (364)
|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++++ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN----TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECC----CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 6788899999999999999876 467899999874432 22234566788877766 59999999999987776
Q ss_pred ----eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 197 ----TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 197 ----~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
.+++|||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~--------~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCP--------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHcc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEE
Confidence 9999999964 8999887522 23578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|+|||++......... ....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+.+..+.+..+.
T Consensus 148 l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~-~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07838 148 IADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIF 219 (287)
T ss_pred EeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHh-CCCcccCCChHHHHHHHH
Confidence 9999998765433221 11234677999999999899999999999999999999 799999888777665553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=256.74 Aligned_cols=219 Identities=25% Similarity=0.383 Sum_probs=175.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc----cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN----ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+|.+.+.||+|+||.||++.+... ...+++|+.+.. .......++..|+.++++++||||+++++++.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA----VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC----CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 588999999999999999987653 333555554432 122234456679999999999999999999998899
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++|+||+++++|.+++.+.. .....+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+||
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELK------HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHh------hcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeeccc
Confidence 999999999999999987532 12346788999999999999999999999999999999999976 56999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|++.......... ....+++.|+|||.+.+..++.++|+||||+++|+|++ +..||...+..+....+..+...
T Consensus 150 g~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd08222 150 GVSRLLMGSCDLA--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFLSVVLRIVEGPTP 223 (260)
T ss_pred CceeecCCCcccc--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHcCCCC
Confidence 9987654432211 12234678999999988889999999999999999999 88899877776666666555433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=257.84 Aligned_cols=209 Identities=23% Similarity=0.411 Sum_probs=172.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.|...++||+|+||+||+|.+.. .+..|++|.+.... .......+.+|+++++.++|+|++++++++.+....
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~----~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSH----TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECC----CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 347777889999999999998765 46789999886432 233446788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+. ++|.+++.. ...++++..+..++.|++.+|.|||++|++|+||+|+||++++++.+||+|||
T Consensus 97 ~lv~e~~~-~~l~~~l~~---------~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 97 WLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred EEEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecC
Confidence 99999995 588888864 23357788899999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
++...... ....++..|+|||.+. ...++.++||||||+++|+|++ |..||...+....+..+..
T Consensus 167 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~ 234 (313)
T cd06633 167 SASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQ 234 (313)
T ss_pred CCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Confidence 88643221 1233567899999984 4568889999999999999999 8889987776665555543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=265.78 Aligned_cols=213 Identities=23% Similarity=0.398 Sum_probs=178.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC----
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN---- 195 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~---- 195 (364)
+|++.+.||+|++|.||+|.+.. .+..|++|.+..... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR----TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC----CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence 58899999999999999999765 467899998875432 344567889999999999999999999988765
Q ss_pred -ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 196 -PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 196 -~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
..|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+|||+++++.++|+
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 77 NDVYIVTELME-TDLHKVIKS----------PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred cceEEEecchh-hhHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEc
Confidence 7899999996 589888864 2367888999999999999999999999999999999999999999999
Q ss_pred ecccccccCcccee-eeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 275 DFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 275 DFg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
|||++......... .......+++.|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.+..+....+..
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~ 221 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYIDQLNLIVE 221 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHc-CCCCcCCCCHHHHHHHHHH
Confidence 99999865543210 112223457789999999887 78999999999999999999 8999998887776665543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=259.27 Aligned_cols=212 Identities=24% Similarity=0.400 Sum_probs=173.8
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
....|...+.||+|+||.||+|+++. .+..+++|.+... .......++.+|+++++.++|+|++++++++....
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVR----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcC----CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 34568888999999999999999876 4667999987532 23344567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+. ++|.+++.. ...+++...+..++.|++.||.|||+.+++|+||||+|||+++++.++|+|
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~---------~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~d 158 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGD 158 (308)
T ss_pred eeEEEEEccC-CCHHHHHHH---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECC
Confidence 9999999996 588888764 223467888999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
||++....... ...+++.|+|||.+. ...++.++|||||||++|+|++ |..||...+..+....+..+
T Consensus 159 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 229 (308)
T cd06634 159 FGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQN 229 (308)
T ss_pred cccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc-CCCCCccccHHHHHHHHhhc
Confidence 99987543321 223467899999974 3557889999999999999999 78898877665555444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=265.61 Aligned_cols=211 Identities=26% Similarity=0.443 Sum_probs=169.1
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC----
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG---- 194 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~---- 194 (364)
..+|++.+.||.|+||.||+|.++. ++..|++|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~----~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD----CDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC----CCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 4799999999999999999998876 467899998865443 3346688899999999999999999876543
Q ss_pred ----------CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7023 195 ----------NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCM 264 (364)
Q Consensus 195 ----------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIL 264 (364)
...|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nil 146 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVF 146 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 35789999996 589888753 24678899999999999999999999999999999999
Q ss_pred Ec-CCCcEEEeecccccccCccceee-eCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 265 VA-DDLTVKVGDFGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 265 l~-~~~~~kL~DFg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
++ +++.++|+|||.+.......... ......++..|+|||.+.. ..++.++|||||||++|+|++ |+.||.+.+..
T Consensus 147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~ 225 (342)
T cd07854 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKPLFAGAHEL 225 (342)
T ss_pred EcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Confidence 97 45678999999987653321111 1112234677999998754 457889999999999999999 88999877765
Q ss_pred HHHHHH
Q psy7023 342 QVLNWV 347 (364)
Q Consensus 342 ~~~~~i 347 (364)
+....+
T Consensus 226 ~~~~~~ 231 (342)
T cd07854 226 EQMQLI 231 (342)
T ss_pred HHHHHH
Confidence 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=257.16 Aligned_cols=208 Identities=27% Similarity=0.434 Sum_probs=172.0
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCCceEEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv 200 (364)
|++.+.||+|++|+||+|...+ .++.|++|.+.............+|+..+++++ |+||+++++++..++..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE----TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECC----CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 5778899999999999999876 366799998875543333344567999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
|||+ +++|.+++.... ...+++..+..++.|++.+|.|||+++++|+||+|+||++++++.++|+|||.+.
T Consensus 77 ~e~~-~~~l~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 77 FEYM-EGNLYQLMKDRK--------GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EecC-CCCHHHHHHhcc--------cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccce
Confidence 9999 789999987521 2457889999999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
........ ....++..|+|||++.. ..++.++|+||||+++++|++ |.+||...+..+.+..
T Consensus 148 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~-g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 148 EIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQLYK 210 (283)
T ss_pred eccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHh-CCCccCCCChHHHHHH
Confidence 65443221 12234667999998854 457899999999999999999 7899987766554443
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=261.73 Aligned_cols=213 Identities=26% Similarity=0.379 Sum_probs=169.8
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhc-CCcceeEEEEEEee----C
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAF-DTHHVVKLYGVVSE----G 194 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~----~ 194 (364)
+|++.+.||+|+||.||++.+.... .+..||+|.+..... ......+.+|+.+++++ .|+||+++++.... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS--EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC--cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4788999999999999999987531 256799998764322 22345678899999999 59999999987532 2
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
...|+++|++. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRS----------GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeC
Confidence 56789999985 699998864 3357788999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceee--eCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 275 DFGMTRDIYETEYYR--KGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 275 DFg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
|||++.......... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+.+....++.+
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~-g~~pf~~~~~~~~~~~~ 222 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG-RKPVFKGKDYVDQLNQI 222 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCcCCCCCCHHHHHHHH
Confidence 999998654332211 1122346788999998765 468999999999999999998 89999887765555443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=259.84 Aligned_cols=203 Identities=22% Similarity=0.341 Sum_probs=168.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee-CC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE-GN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~ 195 (364)
..++|++++.||.|+||.||+|.++. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQL----TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECC----CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 45789999999999999999998776 47789999875432 22334667789999999999999999999865 56
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++|+||+ +++|.++++. .+++...+..++.|+++||+|||+++|+|+||+|+|||+++++.++|+|
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS-----------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCc
Confidence 789999998 5689888753 2356677888999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
||.+....... ....+++.|+|||.+.+ ..++.++||||||+++|+|+| |.+||.+.....
T Consensus 152 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~~f~~~~~~~ 213 (328)
T cd07856 152 FGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE-GKPLFPGKDHVN 213 (328)
T ss_pred cccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 99987543221 12234667999998866 568999999999999999999 899998776543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=259.64 Aligned_cols=198 Identities=17% Similarity=0.275 Sum_probs=160.4
Q ss_pred cceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHH
Q psy7023 132 SFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLK 210 (364)
Q Consensus 132 ~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~ 210 (364)
++|.||.++.+. +++.||+|++... ........+.+|+.+++.++|+||+++++++...+..+++|||+++++|.
T Consensus 12 ~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKP----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecC----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344555555544 4778999998755 34555678999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcccee--
Q psy7023 211 NYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY-- 288 (364)
Q Consensus 211 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~-- 288 (364)
+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||.+.........
T Consensus 88 ~~l~~~~--------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 88 DLLKTHF--------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9998632 234677889999999999999999999999999999999999999999999988654332211
Q ss_pred ---eeCCCCCCCccccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 289 ---RKGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 289 ---~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~-g~~pf~~~~~~~ 217 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN-GHVPFKDMPATQ 217 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 11122234667999999876 358899999999999999999 899998765544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=249.30 Aligned_cols=205 Identities=25% Similarity=0.375 Sum_probs=175.3
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
||.|+||.||++.++. .+..+++|++..... ......+.+|+.++++++|+||+++++.+..++..++||||++
T Consensus 1 lg~G~~~~v~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKD----TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECC----CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCC
Confidence 6899999999998875 467899998875432 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
+++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||.+......
T Consensus 77 ~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 77 GGELFSHLSKE----------GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 99999999752 25678899999999999999999999999999999999999999999999998765443
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
.. ......++..|++||.+.+..++.++|+||||+++|+|++ |..||...+..++.+.+..
T Consensus 147 ~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~ 207 (250)
T cd05123 147 GS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPFYAEDRKEIYEKILK 207 (250)
T ss_pred CC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHhc
Confidence 21 1122234667999999998888999999999999999999 8999988887777777765
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=270.37 Aligned_cols=209 Identities=26% Similarity=0.391 Sum_probs=174.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~ 196 (364)
+.+.|++...+|.|+|+.|-.+.+.. +.+..++|++.+.... -.+|+.++... .||||+++.+.+.++..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~----t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP----TDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc----cccchhheeccccccc-----cccccchhhhhcCCCcceeecceecCCce
Confidence 56788999999999999999998877 4667899998765222 23467666655 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE-cCCCcEEEee
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV-ADDLTVKVGD 275 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl-~~~~~~kL~D 275 (364)
.|+|||++.|+.|.+.+...+ .+. ..+..|+++|+.|+.|||++|||||||||+|||+ ++.++++|+|
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~----------~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP----------EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred eeeeehhccccHHHHHHHhcc----------hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEE
Confidence 999999999999999887521 122 6777899999999999999999999999999999 6999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCcc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQVLNWVKGKSS 352 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~~~~~i~~~~~ 352 (364)
||.++..... ......|..|.|||++....|+.++||||||++||+|++ |+.||..... .++...|+.++.
T Consensus 460 FG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~-G~tp~~~~P~~~ei~~~i~~~~~ 531 (612)
T KOG0603|consen 460 FGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLT-GRTLFAAHPAGIEIHTRIQMPKF 531 (612)
T ss_pred echhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCccccCCchHHHHHhhcCCcc
Confidence 9999876655 111223667999999999999999999999999999999 8999986554 478888877753
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=264.26 Aligned_cols=235 Identities=23% Similarity=0.418 Sum_probs=187.7
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHH------HHHHHHHHHHHHhcCCcceeE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE------KAEFLNEASVMKAFDTHHVVK 186 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~E~~il~~l~h~~iv~ 186 (364)
.....+.++|-++..||+|||+.||+|.+-. ..+.||+|+-......++ .+...+|..|.+.|+||.||+
T Consensus 456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~----EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLT----EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred ccCcchHHHHHHHHHhccccHHHHHHhcccc----hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 3455678899999999999999999998765 478899998764433222 345678999999999999999
Q ss_pred EEEEEe-eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCE
Q psy7023 187 LYGVVS-EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK--KFVHRDLAARNC 263 (364)
Q Consensus 187 l~~~~~-~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--~iiHrDlkp~NI 263 (364)
+|++|. +.+.+|-|+|||+|.+|.-||+. .+.+++.++..|+.||+.||.||... .|||.||||.||
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQ----------hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNI 601 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ----------HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNI 601 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHh----------hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccE
Confidence 999997 56788999999999999999975 44677889999999999999999976 599999999999
Q ss_pred EEcC---CCcEEEeecccccccCccceee-----eCCCCCCCccccCcccccCC----CCCCchhHHHHHHHHHHHHhCC
Q psy7023 264 MVAD---DLTVKVGDFGMTRDIYETEYYR-----KGSRGFLPVRWMAPESLKDG----VFTSHSDVWSYGVVLWEMATLA 331 (364)
Q Consensus 264 Ll~~---~~~~kL~DFg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~el~t~g 331 (364)
|+.+ -|.+||+|||+++.+.+..+.. ..+.+.||-.|++||.+.-+ +.+.++||||+|||+|+.+. |
T Consensus 602 LLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY-G 680 (775)
T KOG1151|consen 602 LLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY-G 680 (775)
T ss_pred EEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc-c
Confidence 9965 4789999999999887665432 24456778999999987543 36889999999999999998 8
Q ss_pred CCCCCC-CCHHHHHHH--HhcCccccccCCCCCC
Q psy7023 332 SQPYQG-LSNEQVLNW--VKGKSSNEYKVNPPIS 362 (364)
Q Consensus 332 ~~P~~~-~~~~~~~~~--i~~~~~~~~~~~~~~s 362 (364)
+.||.. .+..++++. |....--.||.-|-+|
T Consensus 681 rKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVs 714 (775)
T KOG1151|consen 681 RKPFGHNQSQQDILQENTILKATEVQFPPKPVVS 714 (775)
T ss_pred CCCCCCchhHHHHHhhhchhcceeccCCCCCccC
Confidence 999964 444555542 3333334566555554
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=262.79 Aligned_cols=207 Identities=23% Similarity=0.379 Sum_probs=168.3
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC---
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG--- 194 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--- 194 (364)
..+|.+.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR----TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC----CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 4689999999999999999998865 46789999886532 222345678999999999999999999998754
Q ss_pred ---CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 195 ---NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 195 ---~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
...++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+++++||||||+|||++.++.+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 90 DEFQDFYLVMPYMQT-DLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred CCCceEEEEeccccc-CHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 346999999954 7766542 246778899999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+|+|||++....... ....+++.|+|||.+.+ ..++.++||||||+++|||++ |+.||.+.+....+..+.
T Consensus 157 kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~-g~~pf~~~~~~~~~~~~~ 228 (342)
T cd07879 157 KILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQIL 228 (342)
T ss_pred EEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence 999999987543221 12234667999999876 458899999999999999999 899999877655554443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=256.63 Aligned_cols=204 Identities=24% Similarity=0.339 Sum_probs=168.2
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC---HHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCc
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS---EREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~ 196 (364)
+|++.+.||+|++|.||++.+.... ..+..||+|+++.... ......+.+|+.+++++ +|+||+++++.+..+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc-cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 4788999999999999999865422 2367899998864321 22345678899999999 59999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++||||+.+++|.+++.. ...+++..+..++.|++.+|+|||+.+++|+||||+||+++.++.++|+||
T Consensus 80 ~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQ----------REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred EEEEEecCCCCcHHHHHhh----------cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEEC
Confidence 9999999999999999864 234678889999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
|++.......... .....++..|+|||.+.+.. .+.++|+||||+++|+|++ |..||..
T Consensus 150 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~ 210 (288)
T cd05583 150 GLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT-GASPFTV 210 (288)
T ss_pred ccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh-CCCCccc
Confidence 9987654432211 11223567899999987665 6889999999999999999 8999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=255.67 Aligned_cols=210 Identities=26% Similarity=0.417 Sum_probs=175.8
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
|++.+.||+|++|.||+|.... .+..+++|++.... .......+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK----TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecC----CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence 5677889999999999999876 46789999987653 233346677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
+||++ ++|.+++.+. ...+++..+..++.|++.||+|||+.+|+|+||+|+||++++++.++|+|||++.
T Consensus 77 ~e~~~-~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 77 FEYCD-MDLKKYLDKR---------PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred ecCcC-cCHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCccc
Confidence 99997 5999999762 1357889999999999999999999999999999999999999999999999987
Q ss_pred ccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 281 DIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
....... .......+..|+|||.+... .++.++||||||+++|||++ |.+||.+.+..+.+..+.
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~ 212 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT-GKPLFPGDSEIDQLFKIF 212 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHH
Confidence 6543321 11222335679999998776 78999999999999999999 799998887766665543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=263.70 Aligned_cols=210 Identities=22% Similarity=0.386 Sum_probs=174.2
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+.++|++.+.||+|++|.||+|.++. ++..||+|++.... .......+.+|+.++++++|+||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK----TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC----CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 34689999999999999999999876 46789999886542 22334567789999999999999999988765554
Q ss_pred ------eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 197 ------TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 197 ------~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+|+||||+||++++++.
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-----------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 156 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC
Confidence 89999998 6799998863 35788899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+.+..+.+
T Consensus 157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence 999999998765432 112234677999999865 357889999999999999999 8999988777666655543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.03 Aligned_cols=224 Identities=25% Similarity=0.364 Sum_probs=179.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
-++.-..+||.|.||.||-|...+ ++.-.|+|-++-... ......+.+|..++..+.|||+|+++++=...+.++
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~----tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLD----TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCC----ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 456667789999999999999877 456678887764332 333456778999999999999999999998889999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
|.||||++|+|.+.++..+ -..+.....+..|++.|++|||+.|||||||||+|||++.+|.+|++|||.
T Consensus 1311 IFMEyC~~GsLa~ll~~gr----------i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR----------IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHhccCcHHHHHHhcc----------hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccc
Confidence 9999999999999997532 233445567889999999999999999999999999999999999999999
Q ss_pred ccccCccceee--eCCCCCCCccccCcccccCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCcc
Q psy7023 279 TRDIYETEYYR--KGSRGFLPVRWMAPESLKDGV---FTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQVLNWVKGKSS 352 (364)
Q Consensus 279 a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~~~~~i~~~~~ 352 (364)
|..+..+.... ......||+.|||||++.+.. ...++|||||||++.||+| |+.||...++ -++.-.+-.|-.
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t-GkrPW~~~dne~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT-GKRPWAELDNEWAIMYHVAAGHK 1459 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec-CCCchhhccchhHHHhHHhccCC
Confidence 98776653111 112345799999999997644 4668999999999999999 8999987664 445556666655
Q ss_pred ccccCC
Q psy7023 353 NEYKVN 358 (364)
Q Consensus 353 ~~~~~~ 358 (364)
...|..
T Consensus 1460 Pq~P~~ 1465 (1509)
T KOG4645|consen 1460 PQIPER 1465 (1509)
T ss_pred CCCchh
Confidence 555544
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=268.03 Aligned_cols=199 Identities=22% Similarity=0.355 Sum_probs=170.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHH-------HHHHHHHHHHHHhcC---CcceeEEEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE-------KAEFLNEASVMKAFD---THHVVKLYG 189 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~il~~l~---h~~iv~l~~ 189 (364)
.+|..++++|.|+||.|++|.++. ....|++|.+.+..--.+ .-.+-.|++||..++ |+||+++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~----n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE----NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ccceeeeeccccccceEEEeeecc----cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 469999999999999999999987 467899999876532111 112336999999997 999999999
Q ss_pred EEeeCCceEEEEecC-CCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 190 VVSEGNPTLVIMELM-GGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~-~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
+|++++.+||+||-. +|.+|+++|.. ...+++.....|++|++.|+++||+.||||||||-+|+.++.+
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~----------kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEF----------KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN 706 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhc----------cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC
Confidence 999999999999985 35689999964 4467778899999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
|-+||+|||.+.......+.. ..||..|.|||++.+.+| +...|||+||++||.++. ...||..
T Consensus 707 g~~klidfgsaa~~ksgpfd~----f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy-kenpyyn 771 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGPFDV----FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY-KENPYYN 771 (772)
T ss_pred CeEEEeeccchhhhcCCCcce----eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe-ccCCCcC
Confidence 999999999998776665543 456888999999999998 667999999999999998 7888854
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=248.17 Aligned_cols=207 Identities=20% Similarity=0.321 Sum_probs=177.5
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
..|..-.++|.++++||+|+|++|.+++++.+ .+.+|+|++++.. ..++.+-...|-.+..+. +||.+|.++.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t----~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKT----DQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehccc----ceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence 44556668999999999999999999999884 5668999887653 233344556677777665 7999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
.|+.+.++++|.||++||+|.-++++ .+.++++.+..+..+|..||.|||++|||.||||.+|+|++.+|
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqr----------qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg 388 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQR----------QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG 388 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhh----------hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC
Confidence 99999999999999999999877764 44678888999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
++||+|+|.++.-...... .+...+||.|+|||++.+..|+..+|+|+||++++||+. |+.||.
T Consensus 389 hikltdygmcke~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemma-grspfd 452 (593)
T KOG0695|consen 389 HIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFD 452 (593)
T ss_pred ceeecccchhhcCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHc-CCCCcc
Confidence 9999999999865544332 344567999999999999999999999999999999999 899996
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=264.72 Aligned_cols=224 Identities=22% Similarity=0.315 Sum_probs=190.2
Q ss_pred CCcccccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCC---
Q psy7023 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT--- 181 (364)
Q Consensus 105 ~~~~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h--- 181 (364)
+...+|.....|.+..+|.+....|+|-|++|.+|.+.. .+..||||++... +-..+.=+.|++||++|..
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~----r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~ 490 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA----RGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADP 490 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccC----CCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCc
Confidence 334566777789999999999999999999999998776 3558999999753 2334556689999999943
Q ss_pred ---cceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7023 182 ---HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258 (364)
Q Consensus 182 ---~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl 258 (364)
.|+++|+..|...+++|||+|-+ ..+|.+.|++.+. .-.+....+..++.|++.||..|...||+|.||
T Consensus 491 Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~-------nvGL~ikaVRsYaqQLflALklLK~c~vlHaDI 562 (752)
T KOG0670|consen 491 EDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-------NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADI 562 (752)
T ss_pred hhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-------ccceeehHHHHHHHHHHHHHHHHHhcCeeeccc
Confidence 38999999999999999999998 6799999998653 334667789999999999999999999999999
Q ss_pred CCCCEEEcCC-CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 259 AARNCMVADD-LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 259 kp~NILl~~~-~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
||+||||++. ..+||||||.|....+++.++.. .+-.|.|||++.+-+|+...|+||+||+||||+| |+..|+|
T Consensus 563 KPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYL----VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYt-GkIlFpG 637 (752)
T KOG0670|consen 563 KPDNILVNESKNILKLCDFGSASFASENEITPYL----VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYT-GKILFPG 637 (752)
T ss_pred CccceEeccCcceeeeccCccccccccccccHHH----HHHhccCcceeecCcccCCccceeeceeeEEeec-cceecCC
Confidence 9999999875 56799999999877776543322 2345999999999999999999999999999999 8999999
Q ss_pred CCHHHHHHHH
Q psy7023 338 LSNEQVLNWV 347 (364)
Q Consensus 338 ~~~~~~~~~i 347 (364)
.++.+++...
T Consensus 638 ~TNN~MLrl~ 647 (752)
T KOG0670|consen 638 RTNNQMLRLF 647 (752)
T ss_pred CCcHHHHHHH
Confidence 9999998754
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=258.24 Aligned_cols=189 Identities=28% Similarity=0.528 Sum_probs=160.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHh--cCCcceeEEEEEEeeCC--
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA--FDTHHVVKLYGVVSEGN-- 195 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~--l~h~~iv~l~~~~~~~~-- 195 (364)
...++++.||+|.||.||+|... ++.||||++.. ...+.|.+|-+|.+. +.|+||+++++.-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~------~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD------NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc------CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 34567789999999999999876 57899999863 556788888888875 48999999999876544
Q ss_pred --ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEE
Q psy7023 196 --PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK---------KFVHRDLAARNCM 264 (364)
Q Consensus 196 --~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~---------~iiHrDlkp~NIL 264 (364)
.++||++|.+.|+|.+||+. ..++|....+|+..|++||+|||+. .|+|||||..|||
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~-----------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVL 348 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA-----------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVL 348 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh-----------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceE
Confidence 88999999999999999975 3578999999999999999999963 5999999999999
Q ss_pred EcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCC-C-----CchhHHHHHHHHHHHHh
Q psy7023 265 VADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-T-----SHSDVWSYGVVLWEMAT 329 (364)
Q Consensus 265 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~-----~~~DiwslG~il~el~t 329 (364)
|.+|+++-|+|||+|..+............+||.+|||||++.+... . .+.||||+|.+||||++
T Consensus 349 vK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S 419 (534)
T KOG3653|consen 349 VKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS 419 (534)
T ss_pred EccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999988776554444445788999999999976432 1 35899999999999987
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=254.53 Aligned_cols=209 Identities=24% Similarity=0.465 Sum_probs=167.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHh--cCCcceeEEEEEEeeC-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA--FDTHHVVKLYGVVSEG- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~--l~h~~iv~l~~~~~~~- 194 (364)
...+.++.+.||+|.||+||+|.|+ +..||||++.. .+.+.+.+|.+|.+. |+|+||+.+++.-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr------Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR------GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hhheeEEEEEecCccccceeecccc------CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 3467889999999999999999998 56799999853 345677888888876 5999999999875432
Q ss_pred ---CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCE
Q psy7023 195 ---NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK--------KFVHRDLAARNC 263 (364)
Q Consensus 195 ---~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--------~iiHrDlkp~NI 263 (364)
..+|||++|.+.|||+|||.. ..++....++++..++.||+|||.. .|.|||||..||
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-----------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-----------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-----------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 357999999999999999974 3567788999999999999999953 599999999999
Q ss_pred EEcCCCcEEEeecccccccCcc--ceeeeCCCCCCCccccCcccccCCC----CC--CchhHHHHHHHHHHHHh----CC
Q psy7023 264 MVADDLTVKVGDFGMTRDIYET--EYYRKGSRGFLPVRWMAPESLKDGV----FT--SHSDVWSYGVVLWEMAT----LA 331 (364)
Q Consensus 264 Ll~~~~~~kL~DFg~a~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~----~~--~~~DiwslG~il~el~t----~g 331 (364)
||.+++.+-|+|+|+|...... .........+||.+|||||++...- +. ..+||||||+++||++- ||
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999999999999999765443 2334455678899999999997543 21 35899999999999873 22
Q ss_pred -----CCCCCCC-----CHHHHHHHH
Q psy7023 332 -----SQPYQGL-----SNEQVLNWV 347 (364)
Q Consensus 332 -----~~P~~~~-----~~~~~~~~i 347 (364)
++||.+. +.+|+.+-+
T Consensus 428 i~eey~~Pyyd~Vp~DPs~eeMrkVV 453 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPSFEEMRKVV 453 (513)
T ss_pred EehhhcCCcccCCCCCCCHHHHhcce
Confidence 4787543 345565544
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=252.65 Aligned_cols=211 Identities=21% Similarity=0.350 Sum_probs=172.3
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC-----
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG----- 194 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~----- 194 (364)
+.+-.+.||.|+||+||.+++.. .++.|++|.+..-. .-...+++.+|+++|...+|.|++..++..+-.
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPR----dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPR----SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred cCCCCCcccccceeEEEeccCCC----CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 34445689999999999988765 58889998775432 223356788999999999999999988876532
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
..+|+++|+|. .+|..+|.+ ..+++...++-++.||++||.|||+.+|.||||||.|+|++.+..+|||
T Consensus 130 qEiYV~TELmQ-SDLHKIIVS----------PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 130 QELYVLTELMQ-SDLHKIIVS----------PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred HHHHHHHHHHH-hhhhheecc----------CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEec
Confidence 24688999984 488888854 4567778889999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|||+++.....+. ...+..+.|..|.|||++++.+ |+.+.||||.|||+.||+. .+..|+..++-+-++.|.
T Consensus 199 DFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg-RrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 199 DFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ-RKILFQAAGPIEQLQMII 271 (449)
T ss_pred ccccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh-hhhhhhccChHHHHHHHH
Confidence 9999986554332 2344445678899999999865 8999999999999999996 899999998888777654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-31 Score=234.80 Aligned_cols=220 Identities=28% Similarity=0.432 Sum_probs=183.6
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIM 201 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 201 (364)
|.+.+.||+|++|.||++...+ .+..+++|...........+.+.+|++.++.++|+|++++++++......++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG----TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC----CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 4567889999999999998875 367899999886554434678889999999999999999999999889999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 202 ELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 202 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
|++++++|.+++.... ..+++..+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 77 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 77 EYCEGGDLFDYLRKKG---------GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred eccCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 9999999999997632 1167788999999999999999999999999999999999999999999999886
Q ss_pred cCccceeeeCCCCCCCccccCcccc-cCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCcccccc
Q psy7023 282 IYETEYYRKGSRGFLPVRWMAPESL-KDGVFTSHSDVWSYGVVLWEMATLASQPYQG--LSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~t~g~~P~~~--~~~~~~~~~i~~~~~~~~~ 356 (364)
....... ......++..|++||.+ ....++.++|+|+||+++++|++ |+.||.. .+..++.+.+..++...+|
T Consensus 148 ~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 148 IHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW-GPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH-CCCCccccchhHHHHHHHHhcCCccccc
Confidence 6544200 11122345679999998 66678889999999999999999 8999987 4445888999888766554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=249.20 Aligned_cols=142 Identities=20% Similarity=0.341 Sum_probs=121.7
Q ss_pred cccccceeeec-cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-----Cc
Q psy7023 109 LYKKDSWEVLR-SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-----TH 182 (364)
Q Consensus 109 ~~~~~~~e~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-----h~ 182 (364)
+.+....+.+. .+|.+.++||.|-|++||+|.+.. ..+.||+|+.+.. +...+..+.|+.+|++++ |+
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq----~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~ 139 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ----NKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDP 139 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeecc----CCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 34455667787 899999999999999999999877 5778999998653 234566788999999983 33
Q ss_pred ---ceeEEEEEEe----eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-Cce
Q psy7023 183 ---HVVKLYGVVS----EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFV 254 (364)
Q Consensus 183 ---~iv~l~~~~~----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~ii 254 (364)
+||+|+++|. .+.++++|+|++ |.+|..+|.. ...+.++...++.|++||+.||.|||+. |||
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--------s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgII 210 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--------SNYRGLPLSCVKEICRQVLTGLDYLHRECGII 210 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--------hCCCCCcHHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 7999999997 467899999999 7799999987 4567789999999999999999999975 999
Q ss_pred ecCCCCCCEEE
Q psy7023 255 HRDLAARNCMV 265 (364)
Q Consensus 255 HrDlkp~NILl 265 (364)
|.||||+|||+
T Consensus 211 HTDlKPENvLl 221 (590)
T KOG1290|consen 211 HTDLKPENVLL 221 (590)
T ss_pred ccCCCcceeee
Confidence 99999999999
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=234.23 Aligned_cols=203 Identities=21% Similarity=0.350 Sum_probs=165.8
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEee--C
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSE--G 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~--~ 194 (364)
..++|++.+++|+|-+++||.|.... ...+++||++++. ..+.+.+|+.||+.|+ ||||++++++..+ .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~----~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT----NNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC----CCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 34789999999999999999998655 4678999999754 3456889999999996 9999999999875 4
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEE
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-DLTVKV 273 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kL 273 (364)
....||+||+++.+...... .++..++..++.|++.||.|||++||+|||+||.|++|+. ...++|
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~-------------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYP-------------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred cCchhHhhhhccccHHHHhh-------------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeee
Confidence 56789999998877665543 3566789999999999999999999999999999999995 457999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+|||+|........+.... -+..|--||.+.+- .|+..-|+|||||+|..|+....+.|.|.++.+-+
T Consensus 175 IDWGLAEFYHp~~eYnVRV---ASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL 243 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 243 (338)
T ss_pred eecchHhhcCCCceeeeee---ehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH
Confidence 9999998766554332221 13357889998664 48999999999999999999777777887765544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=241.71 Aligned_cols=181 Identities=18% Similarity=0.206 Sum_probs=151.6
Q ss_pred ecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHH
Q psy7023 131 GSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLK 210 (364)
Q Consensus 131 G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~ 210 (364)
|.+|.||++.++. +++.||+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++++|.
T Consensus 4 g~~~~v~~~~~~~----~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTR----TQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEcc----CCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 8999999999876 46789999986542 1223455555667999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeee
Q psy7023 211 NYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK 290 (364)
Q Consensus 211 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~ 290 (364)
+++.+. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||.+........
T Consensus 74 ~~l~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~--- 140 (237)
T cd05576 74 SHISKF----------LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD--- 140 (237)
T ss_pred HHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc---
Confidence 999752 2467889999999999999999999999999999999999999999999998765543211
Q ss_pred CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 291 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
....+..|+|||.+....++.++|+||+|+++|||++ |..|+..
T Consensus 141 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~~~~~ 184 (237)
T cd05576 141 --GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLT-GKTLVEC 184 (237)
T ss_pred --cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHH-Ccchhhc
Confidence 1223556999999988889999999999999999999 7776653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=256.10 Aligned_cols=218 Identities=20% Similarity=0.291 Sum_probs=157.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcc------------cccccceEEEEcccccCHHHHH--------------HHHH
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFR------------SLAEHPCAIKVANENASEREKA--------------EFLN 171 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~------------~~~~~~vaiK~~~~~~~~~~~~--------------~~~~ 171 (364)
-.++|++.++||+|+||+||+|.+.... ...++.||||.+...... ..+ ....
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchhHH
Confidence 3578999999999999999999753221 223567999998643321 122 2334
Q ss_pred HHHHHHhcCCcce-----eEEEEEEee--------CCceEEEEecCCCCCHHHHHHhcCCCC--------------CCcc
Q psy7023 172 EASVMKAFDTHHV-----VKLYGVVSE--------GNPTLVIMELMGGGDLKNYLRSCRPDA--------------ETDV 224 (364)
Q Consensus 172 E~~il~~l~h~~i-----v~l~~~~~~--------~~~~~lv~e~~~ggsL~~~l~~~~~~~--------------~~~~ 224 (364)
|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...... ....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766644 566676642 356899999999999999997532110 0111
Q ss_pred CCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcc
Q psy7023 225 ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPE 304 (364)
Q Consensus 225 ~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE 304 (364)
....+++..+..++.|++.+|+|||+++|+||||||+|||++.++.+||+|||++........ .......+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChh
Confidence 223456788999999999999999999999999999999999999999999999976543321 1122334478899999
Q ss_pred cccCCC--------------------CC--CchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 305 SLKDGV--------------------FT--SHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 305 ~~~~~~--------------------~~--~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
.+.... |+ .+.||||+||++|+|+++...||.+
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 986432 11 2469999999999999954457764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=280.53 Aligned_cols=186 Identities=20% Similarity=0.343 Sum_probs=155.9
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
.+...+.||+|+||.||+|.++. .+..||+|.+....... .+|++++++++||||+++++++.+.+..|+|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~-----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIK----NGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECC----CCcEEEEEEccCCcccc-----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 45566789999999999998865 46789999886433211 2468899999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA---DKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH---~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|||+++|+|.++++. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. |+
T Consensus 762 ~Ey~~~g~L~~~l~~-------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 762 HEYIEGKNLSEVLRN-------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred EeCCCCCcHHHHHhc-------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 999999999999953 567888999999999999999 6799999999999999998888775 66
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
........ ....+++.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 828 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t-g~~p~~ 879 (968)
T PLN00113 828 LPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT-GKSPAD 879 (968)
T ss_pred cccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHh-CCCCCC
Confidence 54332111 12245778999999999999999999999999999999 788885
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=259.40 Aligned_cols=211 Identities=18% Similarity=0.246 Sum_probs=143.8
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE------E
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV------V 191 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~------~ 191 (364)
..++|++.++||+|+||.||+|++..+....+..||+|.+...... +...+| .++...+.++..+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 3478999999999999999999988753344778999987643221 111111 1122222222222111 2
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCC----------CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAE----------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~----------~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
..+...++|+||+.+++|.+++........ ............+..++.||+.||+|||+++|+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 456789999999999999999975321000 0001111223456789999999999999999999999999
Q ss_pred CEEEcC-CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCC----------------------CCCchhHH
Q psy7023 262 NCMVAD-DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV----------------------FTSHSDVW 318 (364)
Q Consensus 262 NILl~~-~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~~Diw 318 (364)
|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+.... ++.++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999985 689999999999865433221 122345678999999764322 33456999
Q ss_pred HHHHHHHHHHhCCCCCC
Q psy7023 319 SYGVVLWEMATLASQPY 335 (364)
Q Consensus 319 slG~il~el~t~g~~P~ 335 (364)
||||+||||++ +..|+
T Consensus 364 SlGviL~el~~-~~~~~ 379 (566)
T PLN03225 364 SAGLIFLQMAF-PNLRS 379 (566)
T ss_pred HHHHHHHHHHh-CcCCC
Confidence 99999999998 55443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=225.49 Aligned_cols=205 Identities=27% Similarity=0.440 Sum_probs=172.8
Q ss_pred cceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHH
Q psy7023 132 SFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKN 211 (364)
Q Consensus 132 ~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~ 211 (364)
+||.||+|.++. .+..+++|++.........+.+.+|++.+++++|+||+++++.+......++++||+++++|.+
T Consensus 1 ~~g~v~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKK----TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECC----CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 589999999876 4678999998765443325788899999999999999999999999899999999999999999
Q ss_pred HHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeC
Q psy7023 212 YLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291 (364)
Q Consensus 212 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~ 291 (364)
++.... .++...+..++.+++.++.+||+.+++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 77 ~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~ 143 (244)
T smart00220 77 LLKKRG----------RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL 143 (244)
T ss_pred HHHhcc----------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence 997521 26778899999999999999999999999999999999999999999999988665432 11
Q ss_pred CCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCcccc
Q psy7023 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG-LSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 292 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~ 354 (364)
....++..|++||.+....++.++||||||+++++|++ |..||.. .+.....+.+..+....
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~ 206 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLT-GKPPFPGDDQLLELFKKIGKPKPPF 206 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCC
Confidence 22334667999999998889999999999999999999 8899987 66666777766655443
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=252.55 Aligned_cols=201 Identities=26% Similarity=0.399 Sum_probs=162.1
Q ss_pred EeceeeeecceE-EEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceEEEE
Q psy7023 124 ILDELGNGSFGL-VYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTLVIM 201 (364)
Q Consensus 124 ~~~~lG~G~~g~-V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~ 201 (364)
-.+.+|.|+.|+ ||+|... ++.||||.+-. +......+|+..|+.. +|||||++++.-.+....||..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye------~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE------GREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC------CceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 345789999875 7899875 67899997753 2334566899999988 7999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---C--CcEEEeec
Q psy7023 202 ELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---D--LTVKVGDF 276 (364)
Q Consensus 202 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~--~~~kL~DF 276 (364)
|.|.. +|.+++.......+. . ..-..+.++.|+++||++||+.+||||||||.||||+. + ..++|+||
T Consensus 583 ELC~~-sL~dlie~~~~d~~~--~----~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDf 655 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEM--Q----SDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDF 655 (903)
T ss_pred hHhhh-hHHHHHhccccchhh--c----ccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccc
Confidence 99965 999999874111111 1 11345678899999999999999999999999999975 3 47899999
Q ss_pred ccccccCccce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 277 GMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 277 g~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
|+++.+..... ........||-.|+|||++....-+.++|||||||++|+.++||.+||.+.-..
T Consensus 656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 99998765432 223455567889999999999998999999999999999999999999875544
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=251.56 Aligned_cols=214 Identities=24% Similarity=0.431 Sum_probs=184.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.+++|+++.++|+|+||.||+|+++. ++...|+|+++-.... +..-+.+|+-+++.++|+||+.+++.+...+.+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~----s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKR----SGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccc----cCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence 45789999999999999999999887 5677899988765443 345667899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|++||||.||+|.+.-+ ...++++-++..+.++.+.||+|||++|-+|||||-.|||+++.|.+|++|||
T Consensus 88 wicMEycgggslQdiy~----------~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfg 157 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFG 157 (829)
T ss_pred EEEEEecCCCcccceee----------ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccC
Confidence 99999999999998875 34578888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccc---cCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESL---KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
.+..+...-. +.....||+.|||||+. +.+.|...+|||++|++..|+-. -++|.-+..+.+.+..+-+
T Consensus 158 vsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e-Lqpplfdlhpmr~l~LmTk 229 (829)
T KOG0576|consen 158 VSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE-LQPPLFDLHPMRALFLMTK 229 (829)
T ss_pred chhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh-cCCcccccchHHHHHHhhc
Confidence 9876654433 23345679999999986 46679999999999999999998 6788878788887776543
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=225.93 Aligned_cols=207 Identities=21% Similarity=0.314 Sum_probs=166.6
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEee----
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSE---- 193 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~---- 193 (364)
..+|.-++.+|.|.- .|..|.+. ..+++||+|....... ....++..+|..++..+.|+||++++.+|.-
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~----v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQ----VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchh----hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 358888899999988 66666543 3578899997654422 2223556789999999999999999999852
Q ss_pred --CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 194 --GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 194 --~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
-..+|+|||+|. .+|...+.- .+....+..++.|++.|+.|||+.||+||||||+||++..++.+
T Consensus 91 ~~~~e~y~v~e~m~-~nl~~vi~~------------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 91 EEFQEVYLVMELMD-ANLCQVILM------------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred HHHHhHHHHHHhhh-hHHHHHHHH------------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhhe
Confidence 346799999995 489888762 23457889999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
||.|||+|+..... -..+..+.+..|.|||++.+..|...+||||+||++.||++ |..-|.|.+.-+-+.++
T Consensus 158 Ki~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~-~~Vlf~g~d~idQ~~ki 229 (369)
T KOG0665|consen 158 KILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL-GTVLFPGKDHIDQWNKI 229 (369)
T ss_pred eeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhh-ceEEecCchHHHHHHHH
Confidence 99999999854433 23344455778999999999999999999999999999999 88899987765544443
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=218.54 Aligned_cols=197 Identities=24% Similarity=0.424 Sum_probs=157.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEE-EeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGV-VSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~-~~~~~ 195 (364)
+.+.|.+.+.||+|.||.+-++.++. ++..+++|....... ..++|.+|..---.| .|.||+.-|++ |+..+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~----s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQ----SKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccC----CceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 44789999999999999999999988 577899998876543 357788888765555 56799987765 67778
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc--CCCcEEE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA--DDLTVKV 273 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~--~~~~~kL 273 (364)
.+++++||++-|+|.+-+.. ..+.+.....++.|+++||+|||++++||||||.+||||- +...+||
T Consensus 96 ~YvF~qE~aP~gdL~snv~~-----------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA-----------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred eEEEeeccCccchhhhhcCc-----------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEe
Confidence 88899999999999887643 3455677889999999999999999999999999999995 4568999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccC---CC--CCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD---GV--FTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~--~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
||||.++.....-..... +..|-+||.... +. ..+.+|+|.||+++|..+| |.+||+.
T Consensus 165 cDFG~t~k~g~tV~~~~~-----~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt-G~~PWQk 227 (378)
T KOG1345|consen 165 CDFGLTRKVGTTVKYLEY-----VNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT-GKFPWQK 227 (378)
T ss_pred eecccccccCceehhhhh-----hcccCCcHHHhhccccceEecccccchheeeeeeeeec-CCCcchh
Confidence 999998755433222111 234889997643 33 3678999999999999999 8999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-27 Score=202.02 Aligned_cols=185 Identities=31% Similarity=0.555 Sum_probs=157.5
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGG 207 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~gg 207 (364)
||+|++|.||++.... .+..+++|+..........+.+.+|++.++.+.|++|+++++++......++++|++.++
T Consensus 1 l~~g~~~~v~~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKK----TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecC----CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 6899999999998865 467899999886654334567889999999999999999999999989999999999999
Q ss_pred CHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecccccccCccc
Q psy7023 208 DLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-DLTVKVGDFGMTRDIYETE 286 (364)
Q Consensus 208 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kL~DFg~a~~~~~~~ 286 (364)
+|.+++.... ..++...+..++.+++.+|.+||+.+++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 77 ~l~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 77 SLKDLLKENE---------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 9999997521 35678899999999999999999999999999999999999 8999999999987655432
Q ss_pred eeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHH
Q psy7023 287 YYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEM 327 (364)
Q Consensus 287 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el 327 (364)
. ..........|++||.+... .++.+.|+|++|+++++|
T Consensus 148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 1 11112235679999999877 788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=221.67 Aligned_cols=171 Identities=16% Similarity=0.113 Sum_probs=128.3
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc----CHHHHHHHHHHHHHHHhcCCcceeE-EEEE
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA----SEREKAEFLNEASVMKAFDTHHVVK-LYGV 190 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~il~~l~h~~iv~-l~~~ 190 (364)
..+..+|.+.+.||+|+||+||+|.++.. .+..+|+|.+.... .......+.+|+++|++++|+|+++ +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGD---PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCC---CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 34567899999999999999999987642 24558999865331 2334567889999999999999885 5432
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEcCCC
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL-AARNCMVADDL 269 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl-kp~NILl~~~~ 269 (364)
+..|+||||++|++|.. +.. .. ...++.|++++|+|||++||+|||| ||+|||++.++
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~~---------~~-------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-ARP---------HG-------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hCc---------cc-------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC
Confidence 46799999999999962 210 00 1357889999999999999999999 99999999999
Q ss_pred cEEEeecccccccCccceeee------CCCCCCCccccCcccccCCC
Q psy7023 270 TVKVGDFGMTRDIYETEYYRK------GSRGFLPVRWMAPESLKDGV 310 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~ 310 (364)
.+||+|||+|+.+........ .....+++.|+|||.+...+
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 999999999986654321111 01223466799999886433
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=215.36 Aligned_cols=206 Identities=21% Similarity=0.275 Sum_probs=167.5
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCC----cceeEEEEEE-eeCC
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT----HHVVKLYGVV-SEGN 195 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h----~~iv~l~~~~-~~~~ 195 (364)
+|++.++||+|+||.||.+.+.... ...+|+|+.......... .+..|..+++.+.. +++..+++.. ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~---~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK---NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC---CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 8999999999999999999987633 456888887654332222 56678888888863 5899999999 5778
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-----Cc
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD-----LT 270 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~-----~~ 270 (364)
.-|+||+.+ |.+|.++.+.. ....++...+..++.|++.+|++||+.|+|||||||+|+++... ..
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~--------~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRN--------PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred eeEEEEecc-CccHHHHHHhC--------CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccce
Confidence 899999998 88999988652 24678899999999999999999999999999999999999865 46
Q ss_pred EEEeeccccc--ccCccce-----eee-CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 271 VKVGDFGMTR--DIYETEY-----YRK-GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 271 ~kL~DFg~a~--~~~~~~~-----~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
+.|.|||+++ ....... ... .....||.+|.++++..+...+.+.|+||++.++.+|+. |..||.+...
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~-g~LPW~~~~~ 242 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK-GSLPWEALEM 242 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc-CCCCCccccc
Confidence 9999999998 3222211 111 123347999999999999999999999999999999998 7899987664
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=218.84 Aligned_cols=208 Identities=21% Similarity=0.365 Sum_probs=167.5
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~ 195 (364)
.+...|.++++||.|.|++||++.+... ....+.||+|.+...... .++.+|+++|..+ .+.||+++.+.+..++
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~-~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQ-DTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhh-ccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3557899999999999999999987663 335788999988755433 4688899999999 5779999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEe
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-DLTVKVG 274 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kL~ 274 (364)
...+|+||++..+..++... ++...+..+++.++.||+++|.+|||||||||+|+|.+. .+.-.|+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEE
Confidence 99999999999999888864 457889999999999999999999999999999999985 5678999
Q ss_pred ecccccccCcc----------------------------------cee--------eeCCCCCCCccccCcccccCC-CC
Q psy7023 275 DFGMTRDIYET----------------------------------EYY--------RKGSRGFLPVRWMAPESLKDG-VF 311 (364)
Q Consensus 275 DFg~a~~~~~~----------------------------------~~~--------~~~~~~~~~~~y~aPE~~~~~-~~ 311 (364)
|||+|...... .+. .......||++|.|||++..- .-
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 99998621100 000 011233568999999998654 46
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCC-CCCCHHH
Q psy7023 312 TSHSDVWSYGVVLWEMATLASQPY-QGLSNEQ 342 (364)
Q Consensus 312 ~~~~DiwslG~il~el~t~g~~P~-~~~~~~~ 342 (364)
++++||||.|+|+.-+++ ++.|| ...+.-+
T Consensus 256 ttaiDiws~GVI~Lslls-~~~PFf~a~dd~~ 286 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLS-RRYPFFKAKDDAD 286 (418)
T ss_pred CCccceeeccceeehhhc-cccccccCccccc
Confidence 889999999999999999 67776 4444333
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=198.52 Aligned_cols=207 Identities=22% Similarity=0.370 Sum_probs=173.7
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCC-cceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT-HHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~ 195 (364)
+...+|+++++||+|+||.+|+|..-. .+..||||+-..... ..++..|..+.+.|++ ..|..+.-+..+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~----~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISIT----SGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeecc----CCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 456899999999999999999998776 578899998765433 2456779999999966 48888888888889
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD---LTVK 272 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~---~~~k 272 (364)
.-.+||+++ |-+|.+.+.- ....++...++-++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.
T Consensus 85 ynvlVMdLL-GPsLEdLfnf---------C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~ 154 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNF---------CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLY 154 (341)
T ss_pred cceeeeecc-CccHHHHHHH---------HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEE
Confidence 999999998 8899999875 44578889999999999999999999999999999999999744 4689
Q ss_pred EeecccccccCccc-----eeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 273 VGDFGMTRDIYETE-----YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 273 L~DFg~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
|+|||+|+...+.. .++......||.+|.+-....+...+...|+-|+|.+|..+-- |..||++....
T Consensus 155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnr-G~LPWQglka~ 227 (341)
T KOG1163|consen 155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNR-GSLPWQGLKAA 227 (341)
T ss_pred EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeec-CCCcccccchh
Confidence 99999998765532 2334445567889999888888778889999999999998887 99999987653
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=197.32 Aligned_cols=218 Identities=20% Similarity=0.361 Sum_probs=179.6
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~ 195 (364)
+..-.|+++++||+|+||+.+.|..-- .+.+||||.-.... +.-++..|.+..+.| ..++|..+|-+-.++.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~----nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLY----NNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred EecccceeccccccCcceeeecccccc----cCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 455689999999999999999997443 68899999865332 234566788888888 4679999998888888
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-----CCc
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-----DLT 270 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-----~~~ 270 (364)
+-.||+|++ |-||.|+..- ..+.++.+.++.+|.||+.-++|+|++.+|.|||||+|+||.. ...
T Consensus 98 ~NiLVidLL-GPSLEDLFD~---------CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDL---------CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHH---------hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCce
Confidence 889999998 8899999985 4567899999999999999999999999999999999999974 346
Q ss_pred EEEeecccccccCccce-----eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---HHH
Q psy7023 271 VKVGDFGMTRDIYETEY-----YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS---NEQ 342 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~---~~~ 342 (364)
+.|+|||+|+...+... +.......||.+||+-....+..-+.+.|+-|||-+++..+- |..||+|.. +.+
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLR-GsLPWQGLKA~tnK~ 246 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKADTNKE 246 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhcc-CCCccccccCcchHH
Confidence 89999999997765432 333444567899999999999999999999999999999997 999999754 456
Q ss_pred HHHHHhcCcc
Q psy7023 343 VLNWVKGKSS 352 (364)
Q Consensus 343 ~~~~i~~~~~ 352 (364)
-.+.|-+.++
T Consensus 247 kYeKIGe~Kr 256 (449)
T KOG1165|consen 247 KYEKIGETKR 256 (449)
T ss_pred HHHHhccccc
Confidence 6666644443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-24 Score=195.67 Aligned_cols=215 Identities=29% Similarity=0.498 Sum_probs=176.7
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH--HHHHHHHHHHHHHhcCCc-ceeEEEEEEeeCCceE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--EKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTL 198 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~il~~l~h~-~iv~l~~~~~~~~~~~ 198 (364)
|.+.+.||.|+||.||++.+. ..+++|.+....... ....+.+|+.+++.+.|+ +|+++.+.+......+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEE
Confidence 678889999999999999866 568889887655443 467889999999999988 7999999998777789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-TVKVGDFG 277 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kL~DFg 277 (364)
++++++.++++.+++...... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRK-------GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EEEecCCCCcHHHHHHhcccc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccC
Confidence 999999999999777652211 3577888999999999999999999999999999999999988 79999999
Q ss_pred cccccCccceee----eCCCCCCCccccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHH
Q psy7023 278 MTRDIYETEYYR----KGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGLS----NEQVLNW 346 (364)
Q Consensus 278 ~a~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~t~g~~P~~~~~----~~~~~~~ 346 (364)
.+.......... ......++..|++||.+.+ ..++...|+||+|++++++++ +..||.... ..+..+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~-~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccccHHHHHHH
Confidence 998554433221 2344556888999999987 578889999999999999999 888888766 3566666
Q ss_pred HhcCc
Q psy7023 347 VKGKS 351 (364)
Q Consensus 347 i~~~~ 351 (364)
+....
T Consensus 227 ~~~~~ 231 (384)
T COG0515 227 ILELP 231 (384)
T ss_pred HHhcC
Confidence 65444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=193.92 Aligned_cols=175 Identities=12% Similarity=0.089 Sum_probs=134.9
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH--HHHH------HHHHHHHHHhcCCcceeEE
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--EKAE------FLNEASVMKAFDTHHVVKL 187 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~------~~~E~~il~~l~h~~iv~l 187 (364)
+++..+|++++.||.|+||.||++.. + ...+|+|++.+..... .... +.+|++.+.++.|++|..+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~-----~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-D-----YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-C-----CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 45778999999999999999998644 2 4579999997554322 2222 5789999999999999999
Q ss_pred EEEEeeC--------CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7023 188 YGVVSEG--------NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259 (364)
Q Consensus 188 ~~~~~~~--------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlk 259 (364)
.+++... ...++||||++|.+|.++... +. ....+++.+|..+|+.|++|||+|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~--------------~~----~~~~~i~~~l~~lH~~gi~H~Dik 162 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEI--------------SE----DVKAKIKASIESLHQHGMVSGDPH 162 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhhc--------------cH----HHHHHHHHHHHHHHHcCCccCCCC
Confidence 8886533 358999999999999887421 11 245699999999999999999999
Q ss_pred CCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHh
Q psy7023 260 ARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329 (364)
Q Consensus 260 p~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 329 (364)
|+||+++++| ++|+|||......+.... ...++...|+.++|+|+||+++..+..
T Consensus 163 p~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 163 KGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred hHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9999999998 999999987644322111 113344557789999999999876654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=234.48 Aligned_cols=149 Identities=14% Similarity=0.166 Sum_probs=112.0
Q ss_pred hcCC-cceeEEEEEE-------eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH
Q psy7023 178 AFDT-HHVVKLYGVV-------SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA 249 (364)
Q Consensus 178 ~l~h-~~iv~l~~~~-------~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH 249 (364)
.++| +||++++++| .....+++++|++ +++|.+++.. ....++..+++.++.||+.||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---------PDRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---------ccccccHHHHHHHHHHHHHHHHHHH
Confidence 3445 4777777776 2335678889987 6699999974 2345788899999999999999999
Q ss_pred hCCceecCCCCCCEEEcCCC-------------------cEEEeecccccccCccc--------------eeeeCCCCCC
Q psy7023 250 DKKFVHRDLAARNCMVADDL-------------------TVKVGDFGMTRDIYETE--------------YYRKGSRGFL 296 (364)
Q Consensus 250 ~~~iiHrDlkp~NILl~~~~-------------------~~kL~DFg~a~~~~~~~--------------~~~~~~~~~~ 296 (364)
++|||||||||+||||+..+ .+||+|||+++...... .........+
T Consensus 98 ~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 98 SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 99999999999999996544 45555666554321100 0001112346
Q ss_pred CccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 297 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
|+.|||||++.+..|+.++|||||||+||||++ +.+|+..
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~-~~~~~~~ 217 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFC-PVSSREE 217 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhh-CCCchhh
Confidence 788999999999999999999999999999999 7777653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=185.26 Aligned_cols=140 Identities=18% Similarity=0.172 Sum_probs=106.7
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH-H------------------------HHHHHHHHHHHHhc
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER-E------------------------KAEFLNEASVMKAF 179 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~-~------------------------~~~~~~E~~il~~l 179 (364)
...||+|+||.||+|.+.+ ++.||+|+++...... . .....+|+++++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~-----g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05147 2 NGCISTGKEANVYHATTAN-----GEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL 76 (190)
T ss_pred CCccccccceEEEEEECCC-----CCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4679999999999998753 7789999987542110 0 11234599999999
Q ss_pred CCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHH-HhCCceecCC
Q psy7023 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYL-ADKKFVHRDL 258 (364)
Q Consensus 180 ~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~L-H~~~iiHrDl 258 (364)
.++++.....+.. ...+|||||++|+++...... ..+++...+..++.|++.+|+++ |+.||+||||
T Consensus 77 ~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDl 144 (190)
T cd05147 77 VTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----------DAPLSESKARELYLQVIQIMRILYQDCRLVHADL 144 (190)
T ss_pred HHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----------cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 8877644333222 223899999998777654322 23567888999999999999999 7999999999
Q ss_pred CCCCEEEcCCCcEEEeeccccccc
Q psy7023 259 AARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
||+|||++ ++.++|+|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 478999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=175.99 Aligned_cols=140 Identities=17% Similarity=0.142 Sum_probs=108.4
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-------------------------HHHHHHHHHHHHHHhc
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-------------------------REKAEFLNEASVMKAF 179 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~E~~il~~l 179 (364)
.+.||+|++|+||+|.+. +++.||+|+++..... .....+..|.+.+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05145 2 NGCISTGKEANVYHARTG-----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL 76 (190)
T ss_pred CceeecCCCcEEEEEEcC-----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999865 3788999998754211 0012245789999999
Q ss_pred CCcceeEEEEEEeeCCceEEEEecCCCCCHHHH-HHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecC
Q psy7023 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNY-LRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRD 257 (364)
Q Consensus 180 ~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrD 257 (364)
.|+++.....+... ..++||||++|+++... +.. ..++...+..++.|++.+|.++|. .||+|||
T Consensus 77 ~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrD 143 (190)
T cd05145 77 YEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGD 143 (190)
T ss_pred HhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh-----------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 99987544444333 24899999988765443 322 235667889999999999999999 9999999
Q ss_pred CCCCCEEEcCCCcEEEeecccccccC
Q psy7023 258 LAARNCMVADDLTVKVGDFGMTRDIY 283 (364)
Q Consensus 258 lkp~NILl~~~~~~kL~DFg~a~~~~ 283 (364)
|||+|||++ ++.++|+|||++....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999 7899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=174.72 Aligned_cols=184 Identities=13% Similarity=0.031 Sum_probs=131.2
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH---HHHHHHHHHHHHHHhcCC-cceeEEEEEEeeCCceEE
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE---REKAEFLNEASVMKAFDT-HHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~l 199 (364)
+...|++|+||+|+.+.. .+.+++.+.+...... -....+.+|+++|++|.| ++|++++++ +..++
T Consensus 6 ~~~~l~~~~f~~v~~~~~------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l 75 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL 75 (218)
T ss_pred cceeecCCCcceEEEeec------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence 345799999999997654 2566776666544321 112357889999999954 789999886 45799
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEcCCCcEEEeeccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL-AARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl-kp~NILl~~~~~~kL~DFg~ 278 (364)
+|||+.|.+|.+.+.. ....++.|++.+|+++|+.||+|||| ||+|||++.++.++|+|||+
T Consensus 76 vmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred EEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 9999999888654321 01247789999999999999999999 79999999999999999999
Q ss_pred ccccCcccee----e--------eCCCCCCCccccCcccccCC-CCC-CchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 279 TRDIYETEYY----R--------KGSRGFLPVRWMAPESLKDG-VFT-SHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 279 a~~~~~~~~~----~--------~~~~~~~~~~y~aPE~~~~~-~~~-~~~DiwslG~il~el~t~g~~P~~ 336 (364)
+......... . ..- ...++.|++|+...-- ..+ ...++++.|..+|.++|+ +.|..
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~-~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~-~~~~~ 208 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHK-RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTR-RVLHW 208 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHH-HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhc-cCCcc
Confidence 9854432210 0 000 1124556777654322 223 567999999999999994 44443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=170.41 Aligned_cols=117 Identities=19% Similarity=0.269 Sum_probs=97.3
Q ss_pred CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccc
Q psy7023 207 GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286 (364)
Q Consensus 207 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~ 286 (364)
|+|.++++. ...++++..++.++.|++.||+|||+.+ ||+|||+++++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~ 63 (176)
T smart00750 1 VSLADILEV---------RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ 63 (176)
T ss_pred CcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc
Confidence 689999975 2346889999999999999999999998 999999999999999 99987654322
Q ss_pred eeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHh
Q psy7023 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQVLNWVK 348 (364)
Q Consensus 287 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~~~~~i~ 348 (364)
..+++.|||||++.+..++.++|||||||++|||+| |+.||..... .+.+..+.
T Consensus 64 -------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 118 (176)
T smart00750 64 -------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALD-YELPYNEERELSAILEILL 118 (176)
T ss_pred -------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHh-CCCCccccchhcHHHHHHH
Confidence 135788999999999999999999999999999999 8889975433 34444443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-23 Score=199.95 Aligned_cols=200 Identities=24% Similarity=0.337 Sum_probs=163.4
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCCceEEEEecC
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFD-THHVVKLYGVVSEGNPTLVIMELM 204 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~e~~ 204 (364)
.+|+|+||.|++++-.. +...+.-+|+|+.++... .+.......|..++..++ ||.++++...++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~-g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAG-GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhc-cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 37899999999875333 333577788888765421 112224556888888886 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCc
Q psy7023 205 GGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 205 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~ 284 (364)
.||+|...+.+ ...+.......+...++-+++++|+.+|+|||+|++||+++.+|++++.|||.++...+
T Consensus 80 rgg~lft~l~~----------~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 80 RGGDLFTRLSK----------EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred ccchhhhcccc----------CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh
Confidence 99999887754 34566677788889999999999999999999999999999999999999999987665
Q ss_pred cceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 285 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
.... .++..|||||++. ....++|.||+|++++||+| |..||.+ ++..+|.+.
T Consensus 150 ~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~fellt-g~~pf~~----~~~~~Il~~ 202 (612)
T KOG0603|consen 150 EKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLT-GTLPFGG----DTMKRILKA 202 (612)
T ss_pred hhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhh-CCCCCch----HHHHHHhhh
Confidence 5433 4577899999998 57789999999999999999 8999988 666666553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=166.79 Aligned_cols=135 Identities=18% Similarity=0.253 Sum_probs=102.1
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-----CCcceeEEEEEEeeCC---c
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-----DTHHVVKLYGVVSEGN---P 196 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~l~~~~~~~~---~ 196 (364)
.+.||+|+||.||. +.. .... +||++...... ..+.+.+|+.+++.+ .||||++++++++++. .
T Consensus 7 ~~~LG~G~~~~Vy~--hp~----~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE----DAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cceecCCCceEEEE--CCC----CcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 35799999999995 443 2333 58887654322 346789999999999 5799999999999763 3
Q ss_pred eE-EEEec--CCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCEEEcC----C
Q psy7023 197 TL-VIMEL--MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM-AYLADKKFVHRDLAARNCMVAD----D 268 (364)
Q Consensus 197 ~~-lv~e~--~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L-~~LH~~~iiHrDlkp~NILl~~----~ 268 (364)
++ +|+|| +.+++|.+++++. .+++. ..++.|++.++ +|||+++||||||||+|||++. +
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-----------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-----------RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESE 145 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-----------cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCC
Confidence 34 78999 5579999999652 12233 35677888777 9999999999999999999974 3
Q ss_pred CcEEEeeccccc
Q psy7023 269 LTVKVGDFGMTR 280 (364)
Q Consensus 269 ~~~kL~DFg~a~ 280 (364)
..++|+||+.+.
T Consensus 146 ~~~~LiDg~G~~ 157 (210)
T PRK10345 146 VIPVVCDNIGES 157 (210)
T ss_pred CcEEEEECCCCc
Confidence 479999954443
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=197.57 Aligned_cols=201 Identities=16% Similarity=0.150 Sum_probs=155.7
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC---CcceeEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD---THHVVKL 187 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~l 187 (364)
.....++-...|.|-+.||+|+||+||+|...+ ++.||+|+-+.....+. .--.+++.+|+ -+.|+.+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-----~~~~alK~e~P~~~WEf----YI~~q~~~RLk~~~~~~~~~~ 759 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-----GKLVALKVEKPPNPWEF----YICLQVMERLKPQMLPSIMHI 759 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCC-----CcEEEEEeecCCCceee----eehHHHHHhhchhhhcchHHH
Confidence 344556677899999999999999999998775 78899999877654432 22234445554 2355556
Q ss_pred EEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7023 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267 (364)
Q Consensus 188 ~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~ 267 (364)
...+.-.+.-+||+||.+.|+|.+++.. .+-+++..+..+..||+..+++||..+|||+||||+|+||..
T Consensus 760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N~----------~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 760 SSAHVFQNASVLVSEYSPYGTLLDLINT----------NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRR 829 (974)
T ss_pred HHHHccCCcceeeeeccccccHHHhhcc----------CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeec
Confidence 5555566788999999999999999973 345667788899999999999999999999999999999952
Q ss_pred -------CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q psy7023 268 -------DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL 330 (364)
Q Consensus 268 -------~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~ 330 (364)
.--++|+|||.+-++.--....+-.....|-.+-.+|+..+..|+..+|.|.|+.+++.|+.|
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHH
Confidence 346899999998765432222122222335568899999999999999999999999999994
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-22 Score=200.12 Aligned_cols=206 Identities=21% Similarity=0.255 Sum_probs=154.5
Q ss_pred eEeceeeeecceEEEEEEEcCccc-ccccceEEEEcccccCHHHH-HHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEE
Q psy7023 123 TILDELGNGSFGLVYRGLIKDFRS-LAEHPCAIKVANENASEREK-AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 123 ~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~vaiK~~~~~~~~~~~-~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 200 (364)
.....+|.|++|.|+.+....... .....+.+| .......... ..+..|.-+-..+.|+|++..+..+.+....+-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 345689999999887766443221 122223333 1122222222 2266788888889999998887777766666666
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
||||++ +|+.++... ..++..++-.+++|++.|+.|+|.+||.|||+|++|++++.+|.+||+|||.+.
T Consensus 400 mE~~~~-Dlf~~~~~~----------~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSN----------GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred hhcccH-HHHHHHhcc----------cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcce
Confidence 999999 999999752 356677888999999999999999999999999999999999999999999987
Q ss_pred ccCcccee--eeCCCCCCCccccCcccccCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 281 DIYETEYY--RKGSRGFLPVRWMAPESLKDGVFTS-HSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 281 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
.+.-.-.. .......+...|+|||++.+..|++ ..||||.|++++.|.+ ++.||......
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~-~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL-GRFPWKVAKKS 531 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec-CCCcccccccc
Confidence 55433222 2233344566799999999999976 5899999999999999 79999755443
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-22 Score=199.83 Aligned_cols=211 Identities=17% Similarity=0.206 Sum_probs=158.4
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH---HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE---REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.+...+.||++.|=+|.+|+++. +. |++|++-+.... +...+.+.|++ .+..++||.+++.-+-..+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-----G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-----GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-----ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHH
Confidence 67778899999999999998775 33 888987654422 22333444555 5566999999998887788888
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|||-+|... +|+|.+. .++-+..-+.+.|+.|++.||..+|+.||+|+|||.+||||+.-.-+.|+||.
T Consensus 97 ylvRqyvkh-nLyDRlS----------TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLS----------TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred HHHHHHHhh-hhhhhhc----------cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhccc
Confidence 999999855 9999985 34445667788899999999999999999999999999999999999999998
Q ss_pred cccccCccceeeeC-----CCCCCCccccCcccccCCC-----------CCCchhHHHHHHHHHHHHhCCCCCCC-----
Q psy7023 278 MTRDIYETEYYRKG-----SRGFLPVRWMAPESLKDGV-----------FTSHSDVWSYGVVLWEMATLASQPYQ----- 336 (364)
Q Consensus 278 ~a~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-----------~~~~~DiwslG~il~el~t~g~~P~~----- 336 (364)
.-+...-++..+.. ...-.-.+|+|||.+.... .+++.||||+||++.||++-|++||.
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~ 245 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL 245 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH
Confidence 76543222111110 0001124699999885422 56789999999999999998999995
Q ss_pred ------CCCHHHHHHHHhc
Q psy7023 337 ------GLSNEQVLNWVKG 349 (364)
Q Consensus 337 ------~~~~~~~~~~i~~ 349 (364)
..+.+++++.|+.
T Consensus 246 aYr~~~~~~~e~~Le~Ied 264 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIED 264 (1431)
T ss_pred hHhccCccCHHHHHHhCcC
Confidence 3345566666554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=166.97 Aligned_cols=143 Identities=20% Similarity=0.223 Sum_probs=109.2
Q ss_pred ceeEeceeeeecceEEEEEE-EcCcccccccceEEEEcccccCH-----------------------HHHHHHHHHHHHH
Q psy7023 121 KVTILDELGNGSFGLVYRGL-IKDFRSLAEHPCAIKVANENASE-----------------------REKAEFLNEASVM 176 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~-~~~~~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~~~E~~il 176 (364)
-|.+.+.||+|+||.||+|. +.. .++.||+|+++..... .....+..|+.++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG----SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC----CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 332 3788999988743210 0123456899999
Q ss_pred HhcCCc--ceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC-c
Q psy7023 177 KAFDTH--HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK-F 253 (364)
Q Consensus 177 ~~l~h~--~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~-i 253 (364)
+++.+. .++++++. ...++||||++|.+|...... ........+..++.|++.+|.+||+.| |
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~g~i 170 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----------DVEPEEEEEFELYDDILEEMRKLYKEGEL 170 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----------cCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence 999763 34445542 235899999999888665421 123445567889999999999999999 9
Q ss_pred eecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 254 VHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 254 iHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
+|+||||+||+++ ++.++|+|||.+...
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999999 889999999988643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=158.26 Aligned_cols=135 Identities=19% Similarity=0.224 Sum_probs=111.7
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccC-------HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-------EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
+.||+|++|.||+|.+. +..+++|+...... ......+.+|+.++..+.|++|+....++...+..+
T Consensus 2 ~~l~~G~~~~vy~~~~~------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI 75 (211)
T ss_pred cccccCceEEEEEEeeC------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCE
Confidence 57999999999999863 55688887653221 112345778999999999999887777777778889
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||++|++|.+++.... . ....++.+++.+|.++|+.+++|+|++|+|||++ ++.++|+|||.
T Consensus 76 lv~e~~~G~~L~~~~~~~~-------------~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNG-------------M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EEEEEeCCcCHHHHHHhcc-------------H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCc
Confidence 9999999999999986421 1 6778999999999999999999999999999999 78999999999
Q ss_pred ccc
Q psy7023 279 TRD 281 (364)
Q Consensus 279 a~~ 281 (364)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 875
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.1e-21 Score=164.78 Aligned_cols=202 Identities=23% Similarity=0.412 Sum_probs=157.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++..++.+|...-.|+.|+|+|++. .++.|+++.. ...+....|.+|.-.|+...||||+.+++.+.....+.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 3445667899999999999999863 3456766533 34444567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC-ce-ecCCCCCCEEEcCCCcEEEe--
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK-FV-HRDLAARNCMVADDLTVKVG-- 274 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~-ii-HrDlkp~NILl~~~~~~kL~-- 274 (364)
++..||+.|+|+..+++.. .--...+++.+++.++++|++|||+.. +| ---|....++||++.+.+|.
T Consensus 264 ~isq~mp~gslynvlhe~t--------~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarisma 335 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQT--------SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMA 335 (448)
T ss_pred EeeeeccchHHHHHHhcCc--------cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecc
Confidence 9999999999999998732 223445688999999999999999874 33 44789999999999877764
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFT---SHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
|--++-. .......|.||+||.+...+-+ .++|+|||++++|||.| ...||.+.++.|.=-
T Consensus 336 d~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t-revpfadlspmecgm 399 (448)
T KOG0195|consen 336 DTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT-REVPFADLSPMECGM 399 (448)
T ss_pred cceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc-cccccccCCchhhhh
Confidence 4222211 1111225789999999876643 47999999999999999 899999998887543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=156.37 Aligned_cols=132 Identities=20% Similarity=0.238 Sum_probs=105.6
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEccccc--C-----HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--S-----EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~-----~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.||+|+||.||+|.+. +..+++|...... . .....++.+|+++++.++|+++.....++...+..++
T Consensus 1 ~ig~G~~~~vy~~~~~------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeecC------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEE
Confidence 3899999999999843 5678899854321 1 1123567789999999998876555555556677899
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++
T Consensus 75 v~e~~~g~~l~~~~~~~~----------------~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN----------------D-ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred EEEEECCccHHHHHhhcH----------------H-HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 999999999999875411 0 6889999999999999999999999999999 889999999998
Q ss_pred ccc
Q psy7023 280 RDI 282 (364)
Q Consensus 280 ~~~ 282 (364)
...
T Consensus 137 ~~~ 139 (199)
T TIGR03724 137 KYS 139 (199)
T ss_pred cCC
Confidence 753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.8e-20 Score=165.13 Aligned_cols=206 Identities=21% Similarity=0.300 Sum_probs=131.0
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHHHHHHhcCC----------cceeEEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDT----------HHVVKLY 188 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~il~~l~h----------~~iv~l~ 188 (364)
.+...+.||.|+++.||.+++.. ++.++|+|+.... ......+++.+|......+.+ -.++-.+
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~----t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE----TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT----TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred EEEEccccccCCceEEEEEEEcc----CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 45667789999999999999887 5788999976533 233346667766655544322 1233222
Q ss_pred EEE---------eeC---C-----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC
Q psy7023 189 GVV---------SEG---N-----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK 251 (364)
Q Consensus 189 ~~~---------~~~---~-----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~ 251 (364)
+.. ... . ..+++|+-+ .++|.+++........ ........-...+..|+++.+++||+.
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~---~~~~l~~~arl~lT~Q~I~lvA~Lh~~ 164 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ---THSPLAFAARLSLTVQMIRLVANLHSY 164 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT---TSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc---ccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence 222 111 1 336788888 5599888653211110 111223334456678999999999999
Q ss_pred CceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccC--------CCCCCchhHHHHHHH
Q psy7023 252 KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD--------GVFTSHSDVWSYGVV 323 (364)
Q Consensus 252 ~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~i 323 (364)
|++|+||||+|+|++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|+||++
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 9999999999999999999999999877644332211 112456899997643 247889999999999
Q ss_pred HHHHHhCCCCCCCCCCH
Q psy7023 324 LWEMATLASQPYQGLSN 340 (364)
Q Consensus 324 l~el~t~g~~P~~~~~~ 340 (364)
+|.|.+ +..||.....
T Consensus 240 ly~lWC-~~lPf~~~~~ 255 (288)
T PF14531_consen 240 LYSLWC-GRLPFGLSSP 255 (288)
T ss_dssp HHHHHH-SS-STCCCGG
T ss_pred HHHHHH-ccCCCCCCCc
Confidence 999999 8999986544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-19 Score=178.33 Aligned_cols=137 Identities=21% Similarity=0.226 Sum_probs=109.8
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcc-cc-c-----CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-EN-A-----SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~-~~-~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.|...+.||+|+||+||++.+... .+++|+.. +. . .....+++.+|+++++.++|++++....+...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 445678999999999999987642 23333221 11 1 11223568899999999999999888777777
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
....++||||++|++|.+++.. ...++.|++.+|.+||+.+++||||||+|||+ +++.++|
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~~------------------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLEG------------------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHHH------------------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEE
Confidence 7788999999999999998852 35689999999999999999999999999999 6779999
Q ss_pred eeccccccc
Q psy7023 274 GDFGMTRDI 282 (364)
Q Consensus 274 ~DFg~a~~~ 282 (364)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-19 Score=155.62 Aligned_cols=138 Identities=21% Similarity=0.223 Sum_probs=106.8
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH---------------------HHHHHHHHHHHHHHhcC
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE---------------------REKAEFLNEASVMKAFD 180 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~---------------------~~~~~~~~E~~il~~l~ 180 (364)
|.+.+.||+|+||.||++..++ ++.||+|++...... ........|..++..+.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPD-----GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhcCCccccCcceEEEEEEcCC-----CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 7778899999999999998653 778999986543210 11123567899999997
Q ss_pred Cc--ceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7023 181 TH--HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258 (364)
Q Consensus 181 h~--~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl 258 (364)
|+ .++..++ ....++||||++|++|.+.... .....++.+++.++.++|+.||+|+||
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~lh~~gi~H~Dl 151 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKAYKHGIIHGDL 151 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 77 4444443 2456899999999988765321 124568899999999999999999999
Q ss_pred CCCCEEEcCCCcEEEeecccccccCc
Q psy7023 259 AARNCMVADDLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~~~~~ 284 (364)
||+||++++++.++|+|||.+.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-20 Score=184.41 Aligned_cols=176 Identities=24% Similarity=0.443 Sum_probs=128.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|..++.|-.|+||.||+.+++.+ .+++|+|+-++.. +++. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~t----rqrfa~kiNkq~l-------ilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKET----RQRFAMKINKQNL-------ILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeecccc----ccchhhcccccch-------hhhc--cccccCCccee--------------
Confidence 5788899999999999999998874 5567775532211 1111 33333444443
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|+=...++.. ++++. +++.+++|||+.||+|||+||+|++|+.-|++|++|||++
T Consensus 136 -------gDc~tllk~~----------g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 136 -------GDCATLLKNI----------GPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred -------chhhhhcccC----------CCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhh
Confidence 2323333221 11121 3378999999999999999999999999999999999998
Q ss_pred cccCcc---------------ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 280 RDIYET---------------EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 280 ~~~~~~---------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+..... ++..+ ...+||.|+|||++....|+..+|+|++|+|+||.+. |..||.+.+++|++
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dK--qvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLV-gcvpffGdtpeelf 267 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDK--QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEELF 267 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhc--cccCCccccChhhhhhhccCCCccHHHHHHHHHHHhe-eeeeccCCCHHHHH
Confidence 643211 11111 2256999999999999999999999999999999999 89999999999999
Q ss_pred HHHhcC
Q psy7023 345 NWVKGK 350 (364)
Q Consensus 345 ~~i~~~ 350 (364)
.++...
T Consensus 268 g~visd 273 (1205)
T KOG0606|consen 268 GQVISD 273 (1205)
T ss_pred hhhhhh
Confidence 877543
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.8e-19 Score=162.09 Aligned_cols=145 Identities=21% Similarity=0.288 Sum_probs=106.2
Q ss_pred CCcceeEEEEEEe---------------------------eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHH
Q psy7023 180 DTHHVVKLYGVVS---------------------------EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232 (364)
Q Consensus 180 ~h~~iv~l~~~~~---------------------------~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~ 232 (364)
+|||||++..+|. ++..+|+||...+. +|..++-. ...+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----------~~~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----------RHRSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----------CCCchH
Confidence 6999999988762 34568999999865 99999864 234445
Q ss_pred HHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc--CCC--cEEEeecccccccCcc----ceeeeCCCCCCCccccCcc
Q psy7023 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVA--DDL--TVKVGDFGMTRDIYET----EYYRKGSRGFLPVRWMAPE 304 (364)
Q Consensus 233 ~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~--~~~--~~kL~DFg~a~~~~~~----~~~~~~~~~~~~~~y~aPE 304 (364)
...-|+.|+++|+.|||++||.|||+|.+|||+. +|+ .+.|+|||++-.-... .+.......-|.-.-||||
T Consensus 342 ~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence 6667899999999999999999999999999994 443 5789999986422110 0111011111234579999
Q ss_pred cccCCC------CCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 305 SLKDGV------FTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 305 ~~~~~~------~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
+...-+ .-.++|.|+.|.+.||+++ ...||.+
T Consensus 422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg-~~NPFY~ 459 (598)
T KOG4158|consen 422 IATAVPGPNAVVNYEKADTWAAGALAYEIFG-RSNPFYK 459 (598)
T ss_pred hhhcCCCCceeeccchhhhhhhhhhHHHHhc-cCCcccc
Confidence 885432 2358999999999999998 7888876
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=143.52 Aligned_cols=138 Identities=24% Similarity=0.288 Sum_probs=97.7
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH-HHHH----------------------HHHHHHHHHhcCC
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER-EKAE----------------------FLNEASVMKAFDT 181 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~----------------------~~~E~~il~~l~h 181 (364)
.+.||+|+||+||+|.+.+ +..||+|++....... .... ...|...+..+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~-----~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~ 76 (187)
T cd05119 2 GGPIGTGKEADVYLALDGD-----GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYE 76 (187)
T ss_pred CcccccccceeEEEEECCC-----CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHH
Confidence 4679999999999998663 6789999876532211 1111 1356666666654
Q ss_pred cc--eeEEEEEEeeCCceEEEEecCCCCCHHH-HHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecC
Q psy7023 182 HH--VVKLYGVVSEGNPTLVIMELMGGGDLKN-YLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRD 257 (364)
Q Consensus 182 ~~--iv~l~~~~~~~~~~~lv~e~~~ggsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrD 257 (364)
.. +.+.++. ...++||||++++++.. .+.... . ...+..++.+++.++.++|. .+|+|+|
T Consensus 77 ~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----------~-~~~~~~~~~~~~~~l~~lh~~~~ivH~D 140 (187)
T cd05119 77 AGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----------L-LEDPEELYDQILELMRKLYREAGLVHGD 140 (187)
T ss_pred cCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----------h-cccHHHHHHHHHHHHHHHhhccCcCcCC
Confidence 43 4445443 24589999999854421 111100 0 04567899999999999999 9999999
Q ss_pred CCCCCEEEcCCCcEEEeecccccccCc
Q psy7023 258 LAARNCMVADDLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 258 lkp~NILl~~~~~~kL~DFg~a~~~~~ 284 (364)
|||+||+++ ++.++|+|||.+.....
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CChhhEEEE-CCcEEEEECcccccccC
Confidence 999999999 89999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.6e-17 Score=143.91 Aligned_cols=134 Identities=15% Similarity=0.141 Sum_probs=100.4
Q ss_pred eee-eecceEEEEEEEcCcccccccceEEEEccccc------------CHHHHHHHHHHHHHHHhcCCcce--eEEEEEE
Q psy7023 127 ELG-NGSFGLVYRGLIKDFRSLAEHPCAIKVANENA------------SEREKAEFLNEASVMKAFDTHHV--VKLYGVV 191 (364)
Q Consensus 127 ~lG-~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~il~~l~h~~i--v~l~~~~ 191 (364)
.|| .||.|+||.+... +..+++|.+.... ......++.+|++++++++|++| +..+++.
T Consensus 38 ~lg~~~g~gtv~~v~~~------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred eeecCCCCccEEEEEeC------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 577 7888888887654 4567888764311 11234567889999999998874 6677664
Q ss_pred eeC-Cc---eEEEEecCCC-CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 192 SEG-NP---TLVIMELMGG-GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 192 ~~~-~~---~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
... .. .++|||+++| .+|.+++... +++.. .+.|++.+|.+||+.||+|+||||+|||++
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~ 176 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-----------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD 176 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-----------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc
Confidence 432 22 2599999997 6898888541 12222 357899999999999999999999999999
Q ss_pred CCCcEEEeecccccc
Q psy7023 267 DDLTVKVGDFGMTRD 281 (364)
Q Consensus 267 ~~~~~kL~DFg~a~~ 281 (364)
.++.++|+|||.+..
T Consensus 177 ~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 177 PDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCEEEEECCCccc
Confidence 999999999998853
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.6e-18 Score=163.56 Aligned_cols=125 Identities=26% Similarity=0.465 Sum_probs=108.2
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
..+||.|++|+..+|.+||..... ....++..++.++.|++.+++| ++.+|+|+||.||+...+..+||.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-------~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-------GEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-------ccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 468899999999999999975432 2234667889999999999999 999999999999999999999999
Q ss_pred ecccccccCccc----eeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHh
Q psy7023 275 DFGMTRDIYETE----YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329 (364)
Q Consensus 275 DFg~a~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 329 (364)
|||+........ .....+...+|..||+||.+.+..|+.++||||||++|+|+++
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 999987665544 2334566778999999999999999999999999999999987
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.7e-17 Score=132.58 Aligned_cols=131 Identities=20% Similarity=0.227 Sum_probs=109.1
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCC--cceeEEEEEEeeCCceEEEE
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT--HHVVKLYGVVSEGNPTLVIM 201 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h--~~iv~l~~~~~~~~~~~lv~ 201 (364)
+++.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++.+....+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~------~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD------EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC------CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence 35679999999999998653 5689998865543 4567889999999977 48999999888888999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 202 ELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK---KFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 202 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~---~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
||+.++.+..+ +......++.+++.+|+++|.. +++|+|++|+|||+++++.++++|||.
T Consensus 73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 99988766543 2234556889999999999985 699999999999999999999999998
Q ss_pred cc
Q psy7023 279 TR 280 (364)
Q Consensus 279 a~ 280 (364)
+.
T Consensus 136 ~~ 137 (155)
T cd05120 136 AG 137 (155)
T ss_pred cc
Confidence 75
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-16 Score=152.23 Aligned_cols=164 Identities=26% Similarity=0.466 Sum_probs=131.2
Q ss_pred HHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCc-e
Q psy7023 176 MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKF-V 254 (364)
Q Consensus 176 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~i-i 254 (364)
|+.+.|.|+.++++.+.++...++|.+||.-|+|.|.+.. ....+++.....+.++++.||+|+|...| .
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---------~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---------EDIKLDYFFILSFIRDISKGLAYLHNSPIGY 71 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---------cccCccHHHHHHHHHHHHHHHHHHhcCccee
Confidence 4678999999999999999999999999999999999985 34456677788899999999999998876 9
Q ss_pred ecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCC-------CCCchhHHHHHHHHHHH
Q psy7023 255 HRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-------FTSHSDVWSYGVVLWEM 327 (364)
Q Consensus 255 HrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~il~el 327 (364)
|+.++..|.+++....+||+|||+.....................|.|||.+.... .+.+.|+||+|++++|+
T Consensus 72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 99999999999999999999999987654211111111111134599999987642 35679999999999999
Q ss_pred HhCCCCCCCC----CCHHHHHHHHhc
Q psy7023 328 ATLASQPYQG----LSNEQVLNWVKG 349 (364)
Q Consensus 328 ~t~g~~P~~~----~~~~~~~~~i~~ 349 (364)
++ ...||.. .++.|+..++++
T Consensus 152 ~~-r~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 152 LF-RSGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred Hh-ccCccccccccCChHHHHHHHHh
Confidence 99 8889975 334567777777
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-17 Score=166.39 Aligned_cols=230 Identities=21% Similarity=0.296 Sum_probs=171.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~ 197 (364)
..|.+.+.||+|+|+.|-+...... ....++.|.+.... ......+...|..+-+.+. |+|++.+++...+.+..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~---~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRD---PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCC---CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 3566677799999999987765432 24456666555432 3333455566888888886 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCC-cEEEee
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA-DKKFVHRDLAARNCMVADDL-TVKVGD 275 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH-~~~iiHrDlkp~NILl~~~~-~~kL~D 275 (364)
++++++..|+++.+.+.. ......+......++.|+..++.|+| ..++.|+|+||+|.+++..+ .++++|
T Consensus 97 ~~~~~~s~g~~~f~~i~~--------~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISH--------PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred ccccCccccccccccccc--------CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCC
Confidence 999999999999988731 11113344456678999999999999 99999999999999999999 999999
Q ss_pred cccccccCc-cceeeeCCCCCC-CccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcC
Q psy7023 276 FGMTRDIYE-TEYYRKGSRGFL-PVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNEQ--VLNWVKGK 350 (364)
Q Consensus 276 Fg~a~~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~~--~~~~i~~~ 350 (364)
||+|..... ...........+ ++.|+|||...+..| ....|+||+|+++..+++ |..||....... ...++...
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~ 247 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT-GELPWDFPSRKDGRYSSWKSNK 247 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc-CCCCccccccccccceeecccc
Confidence 999987766 333333334445 888999999988544 678999999999999999 888997544333 33444444
Q ss_pred ccccccCCCCC
Q psy7023 351 SSNEYKVNPPI 361 (364)
Q Consensus 351 ~~~~~~~~~~~ 361 (364)
..+....|..+
T Consensus 248 ~~~~~~~~~~~ 258 (601)
T KOG0590|consen 248 GRFTQLPWNSI 258 (601)
T ss_pred cccccCccccC
Confidence 33344444443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-15 Score=146.25 Aligned_cols=140 Identities=21% Similarity=0.234 Sum_probs=99.7
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHH---------------------------------------
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK--------------------------------------- 166 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~--------------------------------------- 166 (364)
+.||+|++|+||+|+.++ ++.||||+.++.......
T Consensus 123 ~plasaSigQVh~A~l~~-----G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD-----GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred cceeeeehhheEEEEecC-----CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 579999999999999875 678999998754211110
Q ss_pred HHHHHHHHHHHhcC-----Ccce--eEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHH
Q psy7023 167 AEFLNEASVMKAFD-----THHV--VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239 (364)
Q Consensus 167 ~~~~~E~~il~~l~-----h~~i--v~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (364)
-.+.+|+..+.+++ ++++ .+++ .......+|||||++|++|.++...... .. ....++.
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~--~~~~~~~vLvmE~i~G~~L~~~~~~~~~---------~~---~~~~ia~ 263 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVY--WDRTSERVLTMEWIDGIPLSDIAALDEA---------GL---DRKALAE 263 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEe--hhhcCCceEEEEeECCcccccHHHHHhc---------CC---CHHHHHH
Confidence 12445666666652 2332 2333 2334557999999999999887753110 01 1234666
Q ss_pred HHHH-HHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCc
Q psy7023 240 EVAD-GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 240 qil~-~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~ 284 (364)
+++. .+..+|..|++|+|+||.||++++++.++|+|||++..+..
T Consensus 264 ~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 264 NLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6665 47889999999999999999999999999999999976653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.3e-15 Score=145.34 Aligned_cols=151 Identities=17% Similarity=0.165 Sum_probs=97.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH---------------------------------
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--------------------------------- 164 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~--------------------------------- 164 (364)
.-..|.. +.||+|++|+||+|+.++ +++.||||+..+.....
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~----~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKD----NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECC----CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 3455666 789999999999999886 37789999997542110
Q ss_pred HHH------HHHHHHHHHHhcC----CcceeEEEEEEe-eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHH
Q psy7023 165 EKA------EFLNEASVMKAFD----THHVVKLYGVVS-EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233 (364)
Q Consensus 165 ~~~------~~~~E~~il~~l~----h~~iv~l~~~~~-~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~ 233 (364)
..+ ++.+|+..+.+++ +.+.+.+-.++. -....+|||||++|+.+.++-.-.... .....+....
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g----~d~~~la~~~ 268 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG----TDMKLLAERG 268 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC----CCHHHHHHHH
Confidence 011 2345555555552 333333323332 245678999999999998753210000 0111223333
Q ss_pred HHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----cEEEeecccccccCc
Q psy7023 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL----TVKVGDFGMTRDIYE 284 (364)
Q Consensus 234 ~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~----~~kL~DFg~a~~~~~ 284 (364)
+..++.|+ ...|++|+|+||.||+++.++ .++++|||++..+..
T Consensus 269 v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33444444 469999999999999999988 999999999876654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.8e-14 Score=117.98 Aligned_cols=127 Identities=18% Similarity=0.191 Sum_probs=94.4
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce-eEEEEEEeeCCceEEEEec
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV-VKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lv~e~ 203 (364)
++.|+.|.++.||++... +..+++|+....... ...+..|+.+++.+.+.++ ++++.+.. ...++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~------~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA------NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC------CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEe
Confidence 356889999999998754 456999987654321 2345678999998866554 44554433 345899999
Q ss_pred CCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 204 MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKF-----VHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 204 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~i-----iHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
++|.++.+.. . ....++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++||+.
T Consensus 73 i~G~~l~~~~----------~--------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 73 IEGSELLTED----------F--------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred cCCCcccccc----------c--------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 9998775420 0 012356799999999999985 9999999999999 66899999998
Q ss_pred cc
Q psy7023 279 TR 280 (364)
Q Consensus 279 a~ 280 (364)
+.
T Consensus 134 a~ 135 (170)
T cd05151 134 AG 135 (170)
T ss_pred cc
Confidence 75
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.2e-13 Score=113.94 Aligned_cols=142 Identities=16% Similarity=0.155 Sum_probs=99.3
Q ss_pred ceeeeecceEEEEEEEcCcc--cccccceEEEEccccc------------C---------HHHHHH----HHHHHHHHHh
Q psy7023 126 DELGNGSFGLVYRGLIKDFR--SLAEHPCAIKVANENA------------S---------EREKAE----FLNEASVMKA 178 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~--~~~~~~vaiK~~~~~~------------~---------~~~~~~----~~~E~~il~~ 178 (364)
..||.|--+.||.|...+.. ...+..+|+|+.+... . ...... ..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754310 1124679999875321 0 000112 2379999999
Q ss_pred cCC--cceeEEEEEEeeCCceEEEEecCCCCCHHH-HHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHH-HhCCce
Q psy7023 179 FDT--HHVVKLYGVVSEGNPTLVIMELMGGGDLKN-YLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYL-ADKKFV 254 (364)
Q Consensus 179 l~h--~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~L-H~~~ii 254 (364)
+.. -+++.++++ ...+|||||+.+..+.. .++. ..++...+..+..+++.+|..| |+.|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----------~~~~~~~~~~i~~~i~~~l~~l~H~~glV 147 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----------AKLNDEEMKNAYYQVLSMMKQLYKECNLV 147 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----------cccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence 954 366777764 45689999997654422 2221 1233455677889999999999 899999
Q ss_pred ecCCCCCCEEEcCCCcEEEeecccccccC
Q psy7023 255 HRDLAARNCMVADDLTVKVGDFGMTRDIY 283 (364)
Q Consensus 255 HrDlkp~NILl~~~~~~kL~DFg~a~~~~ 283 (364)
|+||++.|||+++ +.++|+|||.+....
T Consensus 148 HGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999999974 689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.2e-14 Score=133.81 Aligned_cols=211 Identities=21% Similarity=0.234 Sum_probs=160.2
Q ss_pred ceeeeccceeEeceeee--ecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 114 SWEVLRSKVTILDELGN--GSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
..+.+...+.+.+.+|. |.+|.||.+.... ......+|+|.-+.... ......-++|+...+++ .|++.++.+.
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~--~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTN--SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCc--ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 34455677888899999 9999999987622 22577788887443222 11122334566666666 5889999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCEEE
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD----GMAYLADKKFVHRDLAARNCMV 265 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~----~L~~LH~~~iiHrDlkp~NILl 265 (364)
.++..+..|+-+|++ +.+|.++... ....++...++..+.+... ||.++|..+++|-|+||+||+.
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~---------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~ 255 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHT---------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT 255 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhc---------ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec
Confidence 999999999999999 5789888875 3334556677788888888 9999999999999999999999
Q ss_pred cCC-CcEEEeecccccccCccceeeeC---CCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 266 ADD-LTVKVGDFGMTRDIYETEYYRKG---SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 266 ~~~-~~~kL~DFg~a~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
.++ ..++++|||+...+.+....... -...+...|++||.+. +.++...|+|++|.++.+-.++-..|-.+
T Consensus 256 ~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 256 TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 999 89999999998877765532221 1113456799999886 56788999999999999999855555445
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.9e-13 Score=129.17 Aligned_cols=162 Identities=13% Similarity=0.185 Sum_probs=124.1
Q ss_pred cccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCC
Q psy7023 148 AEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227 (364)
Q Consensus 148 ~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~ 227 (364)
.+.+|.+.+.+.... .......+-++-|+.++||||+++++.++.++.+|||+|.+ ..|..++++.
T Consensus 36 ~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l----------- 101 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL----------- 101 (690)
T ss_pred cCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----------
Confidence 466777777765544 34455677889999999999999999999999999999998 3777777752
Q ss_pred CccHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccc
Q psy7023 228 PPTLSRILQMAAEVADGMAYLA-DKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306 (364)
Q Consensus 228 ~~~~~~~~~i~~qil~~L~~LH-~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 306 (364)
+...+...+.||+.||.||| +.+++|++|.-+.|+|+..|..||++|.++............... --.|..|+.+
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~--~~s~~~P~~~ 177 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYL--IESFDDPEEI 177 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchh--hhcccChhhc
Confidence 23566778999999999998 678999999999999999999999999987644332210010000 1126677766
Q ss_pred cCCCCCCchhHHHHHHHHHHHHh
Q psy7023 307 KDGVFTSHSDVWSYGVVLWEMAT 329 (364)
Q Consensus 307 ~~~~~~~~~DiwslG~il~el~t 329 (364)
.... ...|.|.|||++++++.
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~n 198 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFN 198 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhC
Confidence 4433 46799999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.3e-12 Score=107.53 Aligned_cols=131 Identities=21% Similarity=0.247 Sum_probs=100.7
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc------CH-HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA------SE-REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~------~~-~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
..+++|+-+.++.+.+.+ .++++|.-.+.. +. -...+..+|+.++.+++--.|...+-+..+.+...
T Consensus 2 ~~i~~GAEa~i~~~~~~g------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeeccC------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCE
Confidence 357889999999986653 346667543221 11 11345678999999997776666555666667788
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
|+|||++|..|.+.+... ...++..+-.-+.-||..||||+||.++||++..+. +.++|||+
T Consensus 76 I~me~I~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGL 137 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-----------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGL 137 (204)
T ss_pred EEEEEeCChhHHHHHHhc-----------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCc
Confidence 999999998899898752 134777888888999999999999999999998875 99999999
Q ss_pred cc
Q psy7023 279 TR 280 (364)
Q Consensus 279 a~ 280 (364)
+.
T Consensus 138 g~ 139 (204)
T COG3642 138 GE 139 (204)
T ss_pred cc
Confidence 86
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.6e-12 Score=106.83 Aligned_cols=144 Identities=19% Similarity=0.251 Sum_probs=106.1
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccc------c-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN------A-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.+..|-+|+-+.|+++.+. ++.+.||..... . ..-...+..+|+++|.+++--.|.-..-++.+...
T Consensus 11 ~l~likQGAEArv~~~~~~------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG 84 (229)
T ss_pred cceeeeccceeeEeeeccC------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC
Confidence 3567889999999999876 445566643221 1 12224567899999999977666666666666677
Q ss_pred eEEEEecCCC-CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEE
Q psy7023 197 TLVIMELMGG-GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL---TVK 272 (364)
Q Consensus 197 ~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~---~~k 272 (364)
-.|+|||++| -++.+++.+.-.. .........++++|-+.+.-||.++|||+||..+||++.+++ .+.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~--------~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMED--------ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccC--------cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceE
Confidence 7899999977 4788888763211 112233467899999999999999999999999999997655 358
Q ss_pred Eeecccccc
Q psy7023 273 VGDFGMTRD 281 (364)
Q Consensus 273 L~DFg~a~~ 281 (364)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.7e-11 Score=108.03 Aligned_cols=139 Identities=19% Similarity=0.225 Sum_probs=96.6
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCc--ceeEEEEEEeeC---CceEEE
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH--HVVKLYGVVSEG---NPTLVI 200 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~--~iv~l~~~~~~~---~~~~lv 200 (364)
+.|+.|.++.||++...+ +..+++|+............+.+|+++++.+.+. ++.+++.+.... +..++|
T Consensus 4 ~~l~~G~~n~~~~v~~~~-----g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-----GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEecC-----CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 468999999999987653 4679999876543322345678899999999764 457777776653 367899
Q ss_pred EecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh------------------------------
Q psy7023 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD------------------------------ 250 (364)
Q Consensus 201 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~------------------------------ 250 (364)
|||++|.++.+.+.. ..++..+...++.++++.|..||+
T Consensus 79 ~e~i~G~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (223)
T cd05154 79 MERVDGRVLRDRLLR-----------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD 147 (223)
T ss_pred EEEeCCEecCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence 999999877554310 112333333444444444444442
Q ss_pred --------------------------CCceecCCCCCCEEEcC--CCcEEEeeccccc
Q psy7023 251 --------------------------KKFVHRDLAARNCMVAD--DLTVKVGDFGMTR 280 (364)
Q Consensus 251 --------------------------~~iiHrDlkp~NILl~~--~~~~kL~DFg~a~ 280 (364)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 34799999999999998 6778999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.9e-11 Score=109.68 Aligned_cols=197 Identities=16% Similarity=0.131 Sum_probs=129.7
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEE----E---eeCC
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGV----V---SEGN 195 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~----~---~~~~ 195 (364)
..+.||+|+.+.+|-.-. ....+-|+......... .+ .+..|... .||-+-.=+.+ . ..+.
T Consensus 15 ~gr~LgqGgea~ly~l~e-------~~d~VAKIYh~Pppa~~-aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE-------VRDQVAKIYHAPPPAAQ-AQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCccccCCccceeeecch-------hhchhheeecCCCchHH-HH---HHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 456799999999994321 12234577665433221 11 12223332 55522211111 0 1223
Q ss_pred ceEEEEecCCCCC-HHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 196 PTLVIMELMGGGD-LKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 196 ~~~lv~e~~~ggs-L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
..-++|+.+.|.. +.++.+.. ...-......|..+++.+++++.+.+.||..|.+-+|+.++|+||++++.+.|.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~----tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV 159 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPA----TRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV 159 (637)
T ss_pred eeEEecccCCCccchhhhcCch----hhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence 3678899988752 33333211 111234567899999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
|=..-..... .....+.++...|.+||... +..-+...|.|.||+++++++.||++||.+.
T Consensus 160 dsDsfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 160 DSDSFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cccceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 8543322211 12233445678899999754 3445678999999999999999999999874
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.2e-12 Score=129.65 Aligned_cols=217 Identities=19% Similarity=0.223 Sum_probs=152.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.+.+.+.+-+|.++.++.+.-... +...++|+...... ..+.+....+-.++-..++|-+++..-.+......
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~s----gh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGS----GHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred ccceecccccCCCCcccccCCcccc----ccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 4556677788899999987654332 22233333322110 11122333344444444556666555555667889
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
+|+++|..+++|...++..... +..-.......+..++++||...++|+|++|.|+|...++..+++||+
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~----------saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCL----------SAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCc----------ccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccc
Confidence 9999999999999998864322 222233456678899999999999999999999999999999999998
Q ss_pred cccccCc-------------------------cc----eeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHH
Q psy7023 278 MTRDIYE-------------------------TE----YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMA 328 (364)
Q Consensus 278 ~a~~~~~-------------------------~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 328 (364)
....... .. .........+|+.|.+||.+.+......+|+|++|++++|.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 4321100 00 001233445689999999999999999999999999999999
Q ss_pred hCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 329 TLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 329 t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+ |.+||....+.++++.|-.+.
T Consensus 1030 ~-g~pp~na~tpq~~f~ni~~~~ 1051 (1205)
T KOG0606|consen 1030 T-GIPPFNAETPQQIFENILNRD 1051 (1205)
T ss_pred c-CCCCCCCcchhhhhhccccCC
Confidence 9 899999999999998776654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.5e-10 Score=101.82 Aligned_cols=105 Identities=16% Similarity=0.147 Sum_probs=79.8
Q ss_pred HHHHHHHHHHhcCCcce--eEEEEEEee-----CCceEEEEecCCCC-CHHHHHHhcCCCCCCccCCCCccHHHHHHHHH
Q psy7023 168 EFLNEASVMKAFDTHHV--VKLYGVVSE-----GNPTLVIMELMGGG-DLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239 (364)
Q Consensus 168 ~~~~E~~il~~l~h~~i--v~l~~~~~~-----~~~~~lv~e~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (364)
.+.+|...+.+|...+| ++++.+.+. ....+||||++++. +|.+++.... ..+.+......++.
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--------~~~~~~~~~~~ll~ 145 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--------TNPPDPRLKRMLIK 145 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--------ccCCCHHHHHHHHH
Confidence 36788888888854433 344555542 23578999999885 7999986421 12234456678999
Q ss_pred HHHHHHHHHHhCCceecCCCCCCEEEcC-------CCcEEEeeccccc
Q psy7023 240 EVADGMAYLADKKFVHRDLAARNCMVAD-------DLTVKVGDFGMTR 280 (364)
Q Consensus 240 qil~~L~~LH~~~iiHrDlkp~NILl~~-------~~~~kL~DFg~a~ 280 (364)
+++..+..||..||+|+|+++.|||++. +..+.|+||+.+.
T Consensus 146 ~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 146 RVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999999999999999999999999985 4689999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=2e-10 Score=98.41 Aligned_cols=126 Identities=23% Similarity=0.253 Sum_probs=80.0
Q ss_pred EEEEEEEcCcccccccceEEEEccccc-------------------------CHHHHHHHHHHHHHHHhcCCc--ceeEE
Q psy7023 135 LVYRGLIKDFRSLAEHPCAIKVANENA-------------------------SEREKAEFLNEASVMKAFDTH--HVVKL 187 (364)
Q Consensus 135 ~V~~a~~~~~~~~~~~~vaiK~~~~~~-------------------------~~~~~~~~~~E~~il~~l~h~--~iv~l 187 (364)
.||.|...+ +..+|+|+..... .........+|.+.|+++... +++++
T Consensus 1 ~Vy~~~~~~-----~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p 75 (188)
T PF01163_consen 1 DVYHAIDPD-----GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKP 75 (188)
T ss_dssp EEEEEEECT-----TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--E
T ss_pred CEEEEECCC-----CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcE
Confidence 377777654 5578888775321 011134566899999999766 56777
Q ss_pred EEEEeeCCceEEEEecCC--CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCEE
Q psy7023 188 YGVVSEGNPTLVIMELMG--GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY-LADKKFVHRDLAARNCM 264 (364)
Q Consensus 188 ~~~~~~~~~~~lv~e~~~--ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~-LH~~~iiHrDlkp~NIL 264 (364)
+++. .-.|||||++ |..+..+.... ++......++.+++..+.. +|+.||||+||.+.|||
T Consensus 76 ~~~~----~~~ivME~I~~~G~~~~~l~~~~------------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIl 139 (188)
T PF01163_consen 76 YDYN----RNVIVMEYIGEDGVPLPRLKDVD------------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNIL 139 (188)
T ss_dssp EEEE----TTEEEEE--EETTEEGGCHHHCG------------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEE
T ss_pred EEEe----CCEEEEEecCCCccchhhHHhcc------------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEE
Confidence 6553 3479999998 65554433321 0112345677788885555 57999999999999999
Q ss_pred EcCCCcEEEeeccccccc
Q psy7023 265 VADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 265 l~~~~~~kL~DFg~a~~~ 282 (364)
++++ .+.|+|||.+...
T Consensus 140 v~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EETT-CEEE--GTTEEET
T ss_pred eecc-eEEEEecCcceec
Confidence 9988 9999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.3e-11 Score=119.17 Aligned_cols=203 Identities=18% Similarity=0.165 Sum_probs=148.7
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHH-HHHHHHHHHHHHhc-CCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE-KAEFLNEASVMKAF-DTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~il~~l-~h~~iv~l~~~~~~ 193 (364)
-....+|..+..||.|.|+.|+....+ ..++..+++|...+...... ...-+.|+.+...+ .|.+++.++..|..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r---~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKR---PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeec---CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 345568889999999999999987633 22467788887765543322 22234567666666 68899999998888
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD-LTVK 272 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~-~~~k 272 (364)
....|+=.|||+++++...+.- ...+.....+++..|++.++.++|++.++|+|+||+||++..+ +..+
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~----------~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVT----------SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred cccccCchhhhcCcchhhhhHH----------HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhh
Confidence 8888999999999998766632 2234455678899999999999999999999999999999986 7889
Q ss_pred EeecccccccCccceeeeCCCCCCCcccc--CcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWM--APESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
+.|||+...+.-.... . ...-+++ +++......+-.++|++|||..+.+.+++-..+..
T Consensus 408 ~~~~~~~t~~~~~~~~----~-~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~ 468 (524)
T KOG0601|consen 408 LGDFGCWTRLAFSSGV----F-HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES 468 (524)
T ss_pred ccccccccccceeccc----c-cccccccccchhhccccccccccccccccccccccccCcccCcc
Confidence 9999988642211111 1 1122344 44455556678899999999999999985555544
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.5e-11 Score=105.38 Aligned_cols=160 Identities=19% Similarity=0.259 Sum_probs=115.5
Q ss_pred HHHHhcCCcceeEEEEEEee-----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHH
Q psy7023 174 SVMKAFDTHHVVKLYGVVSE-----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYL 248 (364)
Q Consensus 174 ~il~~l~h~~iv~l~~~~~~-----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~L 248 (364)
..+-++.|.|||+++.++.+ .....++.|||..|+|..+|++.+. ....+....+.+|+.||+.||.||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~------~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK------NQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH------hhhhhhHHHHHHHHHHHHhhhhhh
Confidence 44555679999999998864 3457889999999999999998653 344567788999999999999999
Q ss_pred HhC--CceecCCCCCCEEEcCCCcEEEeecccc--cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHH
Q psy7023 249 ADK--KFVHRDLAARNCMVADDLTVKVGDFGMT--RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324 (364)
Q Consensus 249 H~~--~iiHrDlkp~NILl~~~~~~kL~DFg~a--~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 324 (364)
|+- -|+|+++..+.|++..+|-+|+.--.-. ................+-++|.+||.=.....+.++|||++|...
T Consensus 193 hs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 193 HSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred hccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 987 5999999999999999998887632111 100000000011111224568899876666677899999999999
Q ss_pred HHHHhCCCCCCCCCC
Q psy7023 325 WEMATLASQPYQGLS 339 (364)
Q Consensus 325 ~el~t~g~~P~~~~~ 339 (364)
.+|..+.-.|=.+.+
T Consensus 273 lemailEiq~tnseS 287 (458)
T KOG1266|consen 273 LEMAILEIQSTNSES 287 (458)
T ss_pred HHHHHheeccCCCcc
Confidence 999985544444433
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.1e-09 Score=101.17 Aligned_cols=197 Identities=11% Similarity=0.137 Sum_probs=138.9
Q ss_pred ceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe----eCCceEEEEecCCC-C
Q psy7023 133 FGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS----EGNPTLVIMELMGG-G 207 (364)
Q Consensus 133 ~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~----~~~~~~lv~e~~~g-g 207 (364)
-.+.|++..+. ++..|++|.++-...... .....-+++++++.|.|||++.++|. .+..+++|++|.++ +
T Consensus 289 ~~Ttyk~~s~~----DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNV----DGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeecc----CCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 35677777654 577788888843221111 11123478899999999999999886 35678999999887 6
Q ss_pred CHHHHHHhcCCCC-----CCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 208 DLKNYLRSCRPDA-----ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 208 sL~~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
+|.++.-...++. .........++..++.++.|+..||.++|+.|+..+-|.|.+||++.+.+++|...|....+
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 7887765444333 12234556788999999999999999999999999999999999999989999988877554
Q ss_pred CccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhcCccc
Q psy7023 283 YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV-LNWVKGKSSN 353 (364)
Q Consensus 283 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~-~~~i~~~~~~ 353 (364)
..... |-+.. -.+-|.=.||.++..|.||-..-+......+. ++.|...+..
T Consensus 444 ~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~ 496 (655)
T KOG3741|consen 444 QEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTTYST 496 (655)
T ss_pred cCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhhhhH
Confidence 43320 11111 22579999999999999954444444334443 5555554443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-09 Score=95.15 Aligned_cols=135 Identities=19% Similarity=0.181 Sum_probs=100.3
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC---------------------HHHHHHHHHHHHHHHhcC
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS---------------------EREKAEFLNEASVMKAFD 180 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~E~~il~~l~ 180 (364)
+.+...||-|--+.||.|.+.. +.++++|.-..... .-......+|.++|++|.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-----g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~ 167 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-----GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY 167 (304)
T ss_pred HhhccccccCccceEEEEECCC-----CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence 3466789999999999998774 77899997643211 111334568999999996
Q ss_pred Cc--ceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7023 181 TH--HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258 (364)
Q Consensus 181 h~--~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl 258 (364)
.. .+++.+++ +...+|||+++|-.|...- +.......++..|++-+.-+-..||||+|+
T Consensus 168 ~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~~~GiVHGDl 228 (304)
T COG0478 168 PEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAYRRGIVHGDL 228 (304)
T ss_pred hcCCCCCCcccc----ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHHHcCccccCC
Confidence 55 67777664 5678999999986654321 112234456667777777777899999999
Q ss_pred CCCCEEEcCCCcEEEeeccccc
Q psy7023 259 AARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~ 280 (364)
.+=||+++++|.+.++||--+.
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred chheEEEecCCCEEEEeCcccc
Confidence 9999999999999999998664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.9e-09 Score=91.78 Aligned_cols=105 Identities=19% Similarity=0.160 Sum_probs=80.9
Q ss_pred HHHHHHHHHHHhcCCc--ceeEEEEEEeeC----CceEEEEecCCC-CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHH
Q psy7023 167 AEFLNEASVMKAFDTH--HVVKLYGVVSEG----NPTLVIMELMGG-GDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239 (364)
Q Consensus 167 ~~~~~E~~il~~l~h~--~iv~l~~~~~~~----~~~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (364)
....+|...+..|... .+++.+++.+.. ...++|+|++++ .+|.+++.... ..+......++.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----------~~~~~~~~~ll~ 125 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----------QLDPSQRRELLR 125 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----------ccchhhHHHHHH
Confidence 4566788888877544 345556665542 245899999988 47999987521 133455678999
Q ss_pred HHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEEEeecccccc
Q psy7023 240 EVADGMAYLADKKFVHRDLAARNCMVADDL---TVKVGDFGMTRD 281 (364)
Q Consensus 240 qil~~L~~LH~~~iiHrDlkp~NILl~~~~---~~kL~DFg~a~~ 281 (364)
+++..++-||..||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 126 ~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 126 ALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999999999999887 899999997753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=9e-09 Score=100.98 Aligned_cols=142 Identities=20% Similarity=0.240 Sum_probs=96.6
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH---------------------------------------HH
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER---------------------------------------EK 166 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~---------------------------------------~~ 166 (364)
..|+.++-|+||+|+.++ ++.||||+..+...+. ..
T Consensus 131 ~PiAsASIaQVH~A~L~s-----G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-----GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred CchhhhhHhhheeEEecC-----CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 579999999999999996 8899999987652210 01
Q ss_pred HHHHHHHHHHHhcC-----CcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHH
Q psy7023 167 AEFLNEASVMKAFD-----THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241 (364)
Q Consensus 167 ~~~~~E~~il~~l~-----h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi 241 (364)
-.+.+|+..+.+++ .+++.-..-+++-.+.-.|+|||++|..+.+...-.. ...+. ..++..+
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---------~g~d~---k~ia~~~ 273 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---------AGIDR---KELAELL 273 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---------cCCCH---HHHHHHH
Confidence 12345666666652 3344333334444567789999999999888853211 11222 2233333
Q ss_pred HHH-HHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCc
Q psy7023 242 ADG-MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 242 l~~-L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~ 284 (364)
+.+ +..+-..|++|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 274 ~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 274 VRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 333 3444458999999999999999999999999999876554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.9e-08 Score=85.86 Aligned_cols=138 Identities=15% Similarity=0.078 Sum_probs=96.8
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEcccccC-----HHHHHHHHHHHHHHHhcCCcc--eeEEEEEEe-e----CC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-----EREKAEFLNEASVMKAFDTHH--VVKLYGVVS-E----GN 195 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~il~~l~h~~--iv~l~~~~~-~----~~ 195 (364)
-|+||-+.|++....+ ..+-+|.-..... ..-...|.+|...+++|...+ ++++. ++. . .-
T Consensus 26 ~~rgG~SgV~r~~~~g------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~ 98 (216)
T PRK09902 26 YRRNGMSGVQCVERNG------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEW 98 (216)
T ss_pred cCCCCcceEEEEEeCC------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCce
Confidence 3568888888866543 2466665431110 112467889999999985443 44444 322 1 12
Q ss_pred ceEEEEecCCC-CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--EE
Q psy7023 196 PTLVIMELMGG-GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT--VK 272 (364)
Q Consensus 196 ~~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~--~k 272 (364)
..+||+|-++| -+|.+++.+. ...+.+......++.+++..++-||+.|+.|+|+.+.|||++.++. ++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~--------~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQH--------AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcC--------CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEE
Confidence 36799998754 6888888642 2234455666789999999999999999999999999999986677 99
Q ss_pred Eeeccccc
Q psy7023 273 VGDFGMTR 280 (364)
Q Consensus 273 L~DFg~a~ 280 (364)
++||.-++
T Consensus 171 lIDlEk~r 178 (216)
T PRK09902 171 FLDLEKSR 178 (216)
T ss_pred EEEhhccc
Confidence 99998765
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.8e-08 Score=83.21 Aligned_cols=139 Identities=16% Similarity=0.202 Sum_probs=91.0
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHH---------HHHHHHHHhcCCc---c
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF---------LNEASVMKAFDTH---H 183 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~---------~~E~~il~~l~h~---~ 183 (364)
.++..+|++++.+-......|.+-... +..+++|........ ..+.| .+++..+.++... .
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~------~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~ 99 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID------GKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTE 99 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC------CcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence 345678888888888777777665433 567889987654322 11111 2344444444332 2
Q ss_pred eeEEEEEEe-----eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7023 184 VVKLYGVVS-----EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258 (364)
Q Consensus 184 iv~l~~~~~-----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl 258 (364)
...++.+.+ .....++||||++|..|.+...- +. .++..+.+++.-||+.|+.|+|.
T Consensus 100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i--------------~e----~~~~ki~~~ikqlH~~G~~HGD~ 161 (229)
T PF06176_consen 100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIEDI--------------DE----DLAEKIVEAIKQLHKHGFYHGDP 161 (229)
T ss_pred cccceeeeeeeeccceeEEEEEEEEecCeecccchhc--------------CH----HHHHHHHHHHHHHHHcCCccCCC
Confidence 333232222 22455789999999888765421 11 24567788899999999999999
Q ss_pred CCCCEEEcCCCcEEEeeccccc
Q psy7023 259 AARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~ 280 (364)
+|.|+++++++ ++++||+..+
T Consensus 162 hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 162 HPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred CcCcEEEECCc-EEEEECcccc
Confidence 99999999665 9999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.6e-07 Score=81.98 Aligned_cols=72 Identities=19% Similarity=0.229 Sum_probs=53.5
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc--eeEEEEEEeeCCceEEEEec
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH--VVKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~~~~~~~~lv~e~ 203 (364)
..||+|..+.||+.. +..+++|....... .....+|.++++.+..-. +.+.+.+....+...+|||+
T Consensus 7 ~~i~~G~t~~~y~~~--------~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~ 75 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--------TGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYEL 75 (226)
T ss_pred eeecCCCCcceeEec--------CCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeee
Confidence 368999999999731 33577888765432 234678999999986543 56778888777888999999
Q ss_pred CCCCC
Q psy7023 204 MGGGD 208 (364)
Q Consensus 204 ~~ggs 208 (364)
++|.+
T Consensus 76 i~G~~ 80 (226)
T TIGR02172 76 IVGKR 80 (226)
T ss_pred cCCcc
Confidence 99863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.1e-06 Score=77.40 Aligned_cols=137 Identities=22% Similarity=0.198 Sum_probs=93.9
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHH-----------------------HHHHHHHHHHHHhcC--C
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE-----------------------KAEFLNEASVMKAFD--T 181 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~-----------------------~~~~~~E~~il~~l~--h 181 (364)
.|.+|--+.||+|...+ ...+|+|+.+....... ..-...|..-|+++. +
T Consensus 55 ~istGKEA~Vy~a~~~~-----~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG 129 (268)
T COG1718 55 CISTGKEANVYLAETGD-----GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG 129 (268)
T ss_pred eecCCcceEEEeeccCC-----CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence 57777788999987643 77899999864422111 111236888888874 3
Q ss_pred cceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCC
Q psy7023 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAA 260 (364)
Q Consensus 182 ~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp 260 (364)
-.+++.+.+.. -.|||||+....+ ........++...+...+..++++.+.-|-. .++||+||+.
T Consensus 130 VrvP~Pi~~~~----nVLvMEfIg~~g~----------pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSE 195 (268)
T COG1718 130 VRVPEPIAFRN----NVLVMEFIGDDGL----------PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSE 195 (268)
T ss_pred CCCCCceeecC----CeEEEEeccCCCC----------CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchh
Confidence 35556666544 3699999954211 0011122233333567788899999988887 8999999999
Q ss_pred CCEEEcCCCcEEEeecccccccC
Q psy7023 261 RNCMVADDLTVKVGDFGMTRDIY 283 (364)
Q Consensus 261 ~NILl~~~~~~kL~DFg~a~~~~ 283 (364)
=|||+. ++.+.|+||+-|....
T Consensus 196 yNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 196 YNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hheEEE-CCeEEEEECccccccC
Confidence 999999 8899999999886543
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.9e-07 Score=88.67 Aligned_cols=138 Identities=19% Similarity=0.279 Sum_probs=90.4
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH------------------------------H------HHHH
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER------------------------------E------KAEF 169 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------~------~~~~ 169 (364)
+.||..+.|+|++|+.++ +..||||+-++..... . .-.|
T Consensus 167 ~piaaASlaQVhrA~L~~-----G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-----GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred chhhhcchhheEEEEecC-----CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 479999999999999997 8889999987652221 0 1124
Q ss_pred HHHHHHHHhc----CCcc------eeEEEEEEeeCCceEEEEecCCCCCHHHH--HHhcCCCCCCccCCCCccHHHHHHH
Q psy7023 170 LNEASVMKAF----DTHH------VVKLYGVVSEGNPTLVIMELMGGGDLKNY--LRSCRPDAETDVERSPPTLSRILQM 237 (364)
Q Consensus 170 ~~E~~il~~l----~h~~------iv~l~~~~~~~~~~~lv~e~~~ggsL~~~--l~~~~~~~~~~~~~~~~~~~~~~~i 237 (364)
.+|++...++ .|-+ |++++-.+ .....|+||||+|..+.|. |++. .++... +
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-----------gi~~~~---i 305 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-----------GISPHD---I 305 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-----------CCCHHH---H
Confidence 4555544444 3434 44444333 3567899999999877644 4332 233333 3
Q ss_pred HHHHHHH-HHHHHhCCceecCCCCCCEEEcC----CCcEEEeecccccccCc
Q psy7023 238 AAEVADG-MAYLADKKFVHRDLAARNCMVAD----DLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 238 ~~qil~~-L~~LH~~~iiHrDlkp~NILl~~----~~~~kL~DFg~a~~~~~ 284 (364)
+..+.++ ++.+=..|++|+|-+|.||++.. ++.+.+-|||+...+..
T Consensus 306 ~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 306 LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3333333 22233568999999999999994 67899999999876544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.5e-06 Score=72.51 Aligned_cols=131 Identities=19% Similarity=0.268 Sum_probs=93.6
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCccee-EEEEEEeeCCceEE
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVV-KLYGVVSEGNPTLV 199 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~l~~~~~~~~~~~l 199 (364)
.....+.|++|.+|.||++.++. ..+|+|+-..+.. ...+..|+++|..+...++. +++.+-.+ ++
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~------~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i 89 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRG------GEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGED----FI 89 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccC------ceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechh----hh
Confidence 34456789999999999998874 4789998765543 35677899999999877664 45544332 45
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCCEEEcCCCcEEEeeccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA-ARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlk-p~NILl~~~~~~kL~DFg~ 278 (364)
.|||++|-.|.+.-... +. +-...+++.---|-..||-|..|+ |..++|..++.+.|+||..
T Consensus 90 ~me~i~G~~L~~~~~~~-------------~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~ 152 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG-------------DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDS 152 (201)
T ss_pred hhhhhcCcchhhhhhcc-------------cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccc
Confidence 59999998887766421 11 233445566555778899999986 5556666666999999998
Q ss_pred ccc
Q psy7023 279 TRD 281 (364)
Q Consensus 279 a~~ 281 (364)
|..
T Consensus 153 At~ 155 (201)
T COG2112 153 ATF 155 (201)
T ss_pred hhh
Confidence 863
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.6e-06 Score=76.47 Aligned_cols=75 Identities=17% Similarity=0.138 Sum_probs=51.2
Q ss_pred eeeecc-eEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCCceEEEEecCC
Q psy7023 128 LGNGSF-GLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 128 lG~G~~-g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
|-.|.. ..||+.... +.++.+|+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++
T Consensus 6 ~~~g~~~~~v~~~~~~------~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 6 VTEGQSGATVYRLDGK------NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred cCCCCCcCeEEEEcCC------CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 444554 788987533 2467888875432 234567888888884 3346678887776677899999999
Q ss_pred CCCHHHH
Q psy7023 206 GGDLKNY 212 (364)
Q Consensus 206 ggsL~~~ 212 (364)
|.+|...
T Consensus 76 G~~l~~~ 82 (244)
T cd05150 76 GVPAAAL 82 (244)
T ss_pred CccHhHh
Confidence 9776643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.5e-08 Score=97.13 Aligned_cols=101 Identities=24% Similarity=0.306 Sum_probs=77.8
Q ss_pred HHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecccccccCccceee------e-CCCCCCCccccCcccccCCC
Q psy7023 239 AEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR------K-GSRGFLPVRWMAPESLKDGV 310 (364)
Q Consensus 239 ~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~------~-~~~~~~~~~y~aPE~~~~~~ 310 (364)
.+++.||.|+|+. ++||++|.|++|.++..+.+||+.|+++........+. . .........|.|||.+....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3455999999965 89999999999999999999999999876544321111 0 01111235699999999988
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 311 FTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 311 ~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
.+.++|+||+|+++|.+..+|..-+.+..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~ 214 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANG 214 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccC
Confidence 89999999999999999976777666553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.6e-06 Score=75.28 Aligned_cols=78 Identities=21% Similarity=0.290 Sum_probs=55.5
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCc--ceeEEEEEEe---eCCceEE
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH--HVVKLYGVVS---EGNPTLV 199 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~--~iv~l~~~~~---~~~~~~l 199 (364)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.... .....++
T Consensus 2 i~~l~~G~~n~~~~v~~~~------~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~ 72 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD------GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL 72 (239)
T ss_dssp EEEEEESSSSEEEEEEETT------SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred CccCCCCCeeeEEEEEECC------cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence 4579999999999987653 37889987654 3456677889998888544 3556666432 3345789
Q ss_pred EEecCCCCCHHH
Q psy7023 200 IMELMGGGDLKN 211 (364)
Q Consensus 200 v~e~~~ggsL~~ 211 (364)
+|++++|..+..
T Consensus 73 ~~~~i~g~~~~~ 84 (239)
T PF01636_consen 73 LMEYIPGRPLDD 84 (239)
T ss_dssp EEEEESSEEHHH
T ss_pred EEEEeccccccc
Confidence 999999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.35 E-value=9.3e-08 Score=93.40 Aligned_cols=187 Identities=15% Similarity=0.107 Sum_probs=131.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc-eeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH-VVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~~~~ 198 (364)
..+...+-+++|+++++++.+...+ +....+.+... ....-++++|.+++||| .+..++.++.+...+
T Consensus 242 kws~~fh~fvK~altknpKkRptae-----klL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAE-----KLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW 310 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChh-----hheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence 3455566789999999998764432 22224443322 22334789999999999 777888888889999
Q ss_pred EEEecCCCC-CHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 199 VIMELMGGG-DLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 199 lv~e~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++++++.++ +...... .....+..-+...+.+.-+++++++|+.--+|+| ||+..+ +..+..||+
T Consensus 311 i~~~i~s~~rs~~~~~~---------~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMT---------VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred hhhhhhcCCccccccCC---------hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-ccccccccc
Confidence 999999776 2211110 1111223334556667778899999998778999 777666 688999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
....+.... ......+++.++|||+.....+....|.|++|.=..+|.- +.+|-
T Consensus 377 v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap-~~pPr 430 (829)
T KOG0576|consen 377 VPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAP-GLPPR 430 (829)
T ss_pred CCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCC-CCCCC
Confidence 987665543 2233456889999999999999999999999987777766 55443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.7e-06 Score=86.55 Aligned_cols=82 Identities=15% Similarity=0.224 Sum_probs=56.4
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-Ccce--eEEEEEEeeC---CceE
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHV--VKLYGVVSEG---NPTL 198 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~i--v~l~~~~~~~---~~~~ 198 (364)
++.|+.|.+..+|+....... ....+++|.............+.+|+++|+.+. |.++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~--~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG--SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC--cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 567899999999987655421 123567776654322222346778999999995 6654 7778877654 4678
Q ss_pred EEEecCCCCC
Q psy7023 199 VIMELMGGGD 208 (364)
Q Consensus 199 lv~e~~~ggs 208 (364)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-05 Score=69.26 Aligned_cols=132 Identities=23% Similarity=0.307 Sum_probs=91.9
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc---------------CHHHHHHHHHHHHHHHhcC------Ccce
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---------------SEREKAEFLNEASVMKAFD------THHV 184 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~E~~il~~l~------h~~i 184 (364)
..||+|+.=.||. +.. .....||+..... ......+..+|+.-...+. +.+|
T Consensus 7 ~~i~~G~~R~cy~--HP~-----dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i 79 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPD-----DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHI 79 (199)
T ss_pred cccccCCCceEEE--CCC-----CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccc
Confidence 4699999999994 333 3446788887654 1112345556666666555 6799
Q ss_pred eEEEEEEeeCCceEEEEecCCC------CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7023 185 VKLYGVVSEGNPTLVIMELMGG------GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258 (364)
Q Consensus 185 v~l~~~~~~~~~~~lv~e~~~g------gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl 258 (364)
.+++|+.+.+...-+|+|.+.+ .+|.+++++. .++. .+...+-+-.+||-+.+|+.+|+
T Consensus 80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----------~~~~----~~~~~L~~f~~~l~~~~Iv~~dl 144 (199)
T PF10707_consen 80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----------GLTE----ELRQALDEFKRYLLDHHIVIRDL 144 (199)
T ss_pred ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----------CccH----HHHHHHHHHHHHHHHcCCeecCC
Confidence 9999999999999999998754 3577777531 1222 23344455567888999999999
Q ss_pred CCCCEEEcCC---C-cEEEee-cccc
Q psy7023 259 AARNCMVADD---L-TVKVGD-FGMT 279 (364)
Q Consensus 259 kp~NILl~~~---~-~~kL~D-Fg~a 279 (364)
+|.||++... . .+.|+| ||..
T Consensus 145 ~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred CcccEEEEecCCCceEEEEEeCCCCc
Confidence 9999999643 2 588888 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.3e-06 Score=73.59 Aligned_cols=72 Identities=11% Similarity=0.166 Sum_probs=45.3
Q ss_pred ceeeeecce-EEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCc---ceeEEEEEEeeC---CceE
Q psy7023 126 DELGNGSFG-LVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH---HVVKLYGVVSEG---NPTL 198 (364)
Q Consensus 126 ~~lG~G~~g-~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~---~iv~l~~~~~~~---~~~~ 198 (364)
+.|+.|+.. .||+.. ..+++|+..... ....+.+|.++++.+... .+.++++..... ...+
T Consensus 3 ~~~~~gG~~n~vy~~~---------~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~ 70 (235)
T cd05155 3 EPVDSGGTDNATFRLG---------DDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPW 70 (235)
T ss_pred eeccCCCcccceEEcC---------CceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcce
Confidence 457777766 588641 236678755422 234678899999888532 345555544332 2348
Q ss_pred EEEecCCCCCH
Q psy7023 199 VIMELMGGGDL 209 (364)
Q Consensus 199 lv~e~~~ggsL 209 (364)
++|++++|.++
T Consensus 71 ~l~~~i~G~~l 81 (235)
T cd05155 71 SVYRWLEGETA 81 (235)
T ss_pred EEEEeecCCCC
Confidence 89999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.8e-05 Score=64.57 Aligned_cols=126 Identities=20% Similarity=0.262 Sum_probs=88.3
Q ss_pred cceeEeceeeeecc-eEEEEEEEcCcccccccceEEEEccc---c--------cCH---------HHHHHHHHHHHHHHh
Q psy7023 120 SKVTILDELGNGSF-GLVYRGLIKDFRSLAEHPCAIKVANE---N--------ASE---------REKAEFLNEASVMKA 178 (364)
Q Consensus 120 ~~y~~~~~lG~G~~-g~V~~a~~~~~~~~~~~~vaiK~~~~---~--------~~~---------~~~~~~~~E~~il~~ 178 (364)
.+++.++.||.|.- |.||++... ++.+|+|+... . ... .....|..|.+...+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgR 110 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGR 110 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHH
Confidence 68899999999999 999999876 56899999221 0 000 112346778887777
Q ss_pred cC---Ccce--eEEEEEEeeC------------------CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHH
Q psy7023 179 FD---THHV--VKLYGVVSEG------------------NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235 (364)
Q Consensus 179 l~---h~~i--v~l~~~~~~~------------------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~ 235 (364)
|+ +.++ |+.++|..-. -...||.||++... .++ .
T Consensus 111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------------~~~----~ 167 (207)
T PF13095_consen 111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------------PLQ----I 167 (207)
T ss_pred HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------------ccc----h
Confidence 74 4455 8888887311 12356777765432 111 1
Q ss_pred HHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 236 ~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
.-+.+|++-|..+|+.||+-+|+++.|.. .-+|+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 24567788889999999999999999987 4589999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.1e-06 Score=70.96 Aligned_cols=101 Identities=20% Similarity=0.213 Sum_probs=79.5
Q ss_pred HHHHHHHhcCC-cceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH
Q psy7023 171 NEASVMKAFDT-HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA 249 (364)
Q Consensus 171 ~E~~il~~l~h-~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH 249 (364)
+|.-+++.+.+ +++++++|+|.. ++|.||...+++...... .......+|..+.+||.++++.+++++
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-------l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-------LSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-------cccccccCHHHHHHHHHHHHHHHHHHh
Confidence 58888999876 599999999953 678899987766532000 012234578999999999999999999
Q ss_pred h---CCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 250 D---KKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 250 ~---~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
. ..+.-.|++|+|+-+++++++|++|...+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 7 45888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00023 Score=68.19 Aligned_cols=78 Identities=21% Similarity=0.218 Sum_probs=52.8
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEccccc----C--HHHHHHHHHHHHHHHhcC---CcceeEEEEEEeeCC
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA----S--EREKAEFLNEASVMKAFD---THHVVKLYGVVSEGN 195 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~----~--~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~ 195 (364)
.+.||.|.+..||++...+ ..+.++||...... . ....++...|.+.|+.+. ..++++++.+- .+
T Consensus 31 ~~elggGn~N~VyrV~~~~----g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~ 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE----GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EE 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCC----CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CC
Confidence 3578999999999998764 12468899754211 0 123456667888888762 23677777763 35
Q ss_pred ceEEEEecCCCCC
Q psy7023 196 PTLVIMELMGGGD 208 (364)
Q Consensus 196 ~~~lv~e~~~ggs 208 (364)
..++|||++++..
T Consensus 105 ~~~lVME~L~~~~ 117 (401)
T PRK09550 105 LAVTVMEDLSDHK 117 (401)
T ss_pred CCEEEEecCCCcc
Confidence 6789999998744
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00033 Score=64.63 Aligned_cols=146 Identities=15% Similarity=0.115 Sum_probs=82.9
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCc--ceeEEEEE------EeeCCc
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH--HVVKLYGV------VSEGNP 196 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~--~iv~l~~~------~~~~~~ 196 (364)
++.|..|....+|+.... +..+++|+... .. ...+..|+++++.+.+. .+++++.. ...++.
T Consensus 19 i~~i~~G~~n~~y~v~~~------~~~~vLr~~~~-~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 19 FEGISAGIENTNYFVTTD------SGRYVLTLFEK-VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred eecccCccccceEEEEeC------CCcEEEEEcCC-CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 456777877899987543 33588898764 21 24456688888887543 24454432 233456
Q ss_pred eEEEEecCCCCCHHH----H----------HHhcC-CCCCCccCCCCccHHHH----------HHHHHHHHHHHHHHHh-
Q psy7023 197 TLVIMELMGGGDLKN----Y----------LRSCR-PDAETDVERSPPTLSRI----------LQMAAEVADGMAYLAD- 250 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~----~----------l~~~~-~~~~~~~~~~~~~~~~~----------~~i~~qil~~L~~LH~- 250 (364)
.++|+++++|..+.. . ++... .............+... ......+..++.++.+
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999999866421 1 11110 00000000000011000 0011122334444443
Q ss_pred ------CCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 251 ------KKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 251 ------~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00032 Score=62.43 Aligned_cols=76 Identities=18% Similarity=0.231 Sum_probs=46.4
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc-eeEEEEEEeeCCceEEEEec
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH-VVKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~~~~lv~e~ 203 (364)
++.|..|-...+|+....+. ....|++|+....... .....+|+.+++.+...+ .++++..+. + .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~---~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKED---NQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCC---CCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEe
Confidence 34577788889998764310 1356888876543221 122346888888885443 344554433 2 379999
Q ss_pred CCCCCH
Q psy7023 204 MGGGDL 209 (364)
Q Consensus 204 ~~ggsL 209 (364)
++|.++
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00063 Score=62.97 Aligned_cols=78 Identities=12% Similarity=0.189 Sum_probs=55.1
Q ss_pred eEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCC---cceeEEEEEEee---CCc
Q psy7023 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT---HHVVKLYGVVSE---GNP 196 (364)
Q Consensus 123 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h---~~iv~l~~~~~~---~~~ 196 (364)
.-.+.||.|..+.||+....+ .++.+|..+... ....+..|...|+.+.. -.++++++++.. .+.
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~------~~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ------GNPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred heeeecCCccceeEEEEEcCC------CCEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 345679999999999875432 246677743311 12467789999998854 367888887754 366
Q ss_pred eEEEEecCCCCCH
Q psy7023 197 TLVIMELMGGGDL 209 (364)
Q Consensus 197 ~~lv~e~~~ggsL 209 (364)
.+||||+++|.++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998754
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.74 E-value=2.8e-05 Score=71.06 Aligned_cols=134 Identities=23% Similarity=0.237 Sum_probs=93.0
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-------------------CH--HHHHHHHHHHHHHHhcC
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-------------------SE--REKAEFLNEASVMKAFD 180 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-------------------~~--~~~~~~~~E~~il~~l~ 180 (364)
+.++..||-|--+.||.+.+.. +.+.++|.-.... +. -..-...+|...|+.|.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-----G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~ 168 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-----GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY 168 (465)
T ss_pred hhhccccccccccceEEEecCC-----CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence 4567789999999999988775 5556666543211 00 01223457889999884
Q ss_pred Cc--ceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7023 181 TH--HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258 (364)
Q Consensus 181 h~--~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl 258 (364)
.. -+++.+++ ++.++|||++.|..|...-+- .....+...+..-+--|-.+|+||+|.
T Consensus 169 e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----------------~d~~~ly~~lm~~Iv~la~~GlIHgDF 228 (465)
T KOG2268|consen 169 ERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV----------------EDPPTLYDDLMGLIVRLANHGLIHGDF 228 (465)
T ss_pred HcCCCCCCcccc----cceeeHHHhhcccceeeeeec----------------CChHHHHHHHHHHHHHHHHcCceeccc
Confidence 32 45555543 567899999998777544321 112234555666677788999999999
Q ss_pred CCCCEEEcCCCcEEEeeccccc
Q psy7023 259 AARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~ 280 (364)
.-=||+|++++.++++||--..
T Consensus 229 NEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred chheeEEecCCCEEEeechHhh
Confidence 9999999999999999998653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00082 Score=62.50 Aligned_cols=148 Identities=14% Similarity=0.151 Sum_probs=81.3
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc--eeEEEEE------EeeCC
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH--VVKLYGV------VSEGN 195 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~------~~~~~ 195 (364)
.++.++.|....+|+.... +..+++|+....... +.+..|.+++..|.... +++++.. ....+
T Consensus 26 ~i~~~~~G~~n~~y~v~t~------~~~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD------VGRYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred eccccCCccccceEEEEeC------CCcEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 3566777877899987533 235778876543222 23445677777774332 3444432 12245
Q ss_pred ceEEEEecCCCCCHH-----------HH---HHhcCCCCCCccCC--CCccHHHHH------------HHHHHHHHHHHH
Q psy7023 196 PTLVIMELMGGGDLK-----------NY---LRSCRPDAETDVER--SPPTLSRIL------------QMAAEVADGMAY 247 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~-----------~~---l~~~~~~~~~~~~~--~~~~~~~~~------------~i~~qil~~L~~ 247 (364)
..+++++|++|.++. .. ++.....-...... ....+.... .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999885431 11 11111100000000 000111000 111223334555
Q ss_pred HHh-------CCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 248 LAD-------KKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 248 LH~-------~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
+.. .+++|+|+++.||++++++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 532 589999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00047 Score=62.30 Aligned_cols=139 Identities=16% Similarity=0.119 Sum_probs=75.4
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce-eEEEEEEeeCCceEEEEecCCC
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV-VKLYGVVSEGNPTLVIMELMGG 206 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lv~e~~~g 206 (364)
+..|-...+|+... .+..+++|+.......- .....+|..+++.+....+ .+++.... -++||||++|
T Consensus 4 ~~~G~tn~~y~~~~------~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIEH------PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEEe------CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence 45577788897752 24568888765432111 0124568888888865433 34444332 3689999998
Q ss_pred CCHHH--------------HHHhcCCCCCCccCCCCccHH-HHHHHHHHH---------HHHHHHHHh--------CCce
Q psy7023 207 GDLKN--------------YLRSCRPDAETDVERSPPTLS-RILQMAAEV---------ADGMAYLAD--------KKFV 254 (364)
Q Consensus 207 gsL~~--------------~l~~~~~~~~~~~~~~~~~~~-~~~~i~~qi---------l~~L~~LH~--------~~ii 254 (364)
..+.. .+.+-.... ....++... .+..+..++ ...+..+-. ..++
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQP---RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 65431 111110000 001111111 111211111 111222221 2589
Q ss_pred ecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 255 HRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 255 HrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
|+|+.|.||++++++ +.|+||..+..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999887 78999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0028 Score=59.17 Aligned_cols=30 Identities=23% Similarity=0.278 Sum_probs=26.3
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 251 KKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 251 ~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
.++||+|++|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999977666899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00037 Score=64.55 Aligned_cols=79 Identities=19% Similarity=0.235 Sum_probs=47.1
Q ss_pred ceeeeecceEEEEEEEcCc--ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce-eEEEEEEeeCCceEEEEe
Q psy7023 126 DELGNGSFGLVYRGLIKDF--RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV-VKLYGVVSEGNPTLVIME 202 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lv~e 202 (364)
+.|..|-...||+....+. ....+..+++|+...... ......+|.++++.+...++ .+++..+.. .+|+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 3455566778888764321 011246788998655432 12345678888888854433 455555542 35899
Q ss_pred cCCCCCHH
Q psy7023 203 LMGGGDLK 210 (364)
Q Consensus 203 ~~~ggsL~ 210 (364)
|++|..+.
T Consensus 78 ~i~G~~l~ 85 (302)
T cd05156 78 FIPSRTLT 85 (302)
T ss_pred eeCCCcCC
Confidence 99886654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0019 Score=61.05 Aligned_cols=151 Identities=15% Similarity=0.168 Sum_probs=83.4
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCccee-EEEEEEeeCCceEEEEe
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVV-KLYGVVSEGNPTLVIME 202 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~l~~~~~~~~~~~lv~e 202 (364)
-+..|-.|-.-.+|+.............|++|+...... ... .-.+|..+++.+...++. ++++.+..+ .|++
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 344565588889999875432222346789998765432 111 225688888888655443 556665432 5789
Q ss_pred cCCCCCHHHH--------------HHhcCCCCCCccCCCCccHHHHHHHHHHH-----------------HHHHHHH---
Q psy7023 203 LMGGGDLKNY--------------LRSCRPDAETDVERSPPTLSRILQMAAEV-----------------ADGMAYL--- 248 (364)
Q Consensus 203 ~~~ggsL~~~--------------l~~~~~~~~~~~~~~~~~~~~~~~i~~qi-----------------l~~L~~L--- 248 (364)
|+++.+|... +++--.. ..........+.++..+..++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~-~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSL-DMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 9987665311 1110000 000001111223333332221 1112222
Q ss_pred -H----hCCceecCCCCCCEEEcC-CCcEEEeecccccc
Q psy7023 249 -A----DKKFVHRDLAARNCMVAD-DLTVKVGDFGMTRD 281 (364)
Q Consensus 249 -H----~~~iiHrDlkp~NILl~~-~~~~kL~DFg~a~~ 281 (364)
. ...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 235899999999999986 47899999998864
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.29 E-value=3.8e-05 Score=82.22 Aligned_cols=178 Identities=11% Similarity=0.003 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHhcCCcceeEEEEEEe--eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHH
Q psy7023 167 AEFLNEASVMKAFDTHHVVKLYGVVS--EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244 (364)
Q Consensus 167 ~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~ 244 (364)
+-...|...++...|+++.....-.. +....|.+++++.+|.+.+.|-+... +..+....-+....++.+..
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e------e~~~ld~~~v~~~~kvsvl~ 1347 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE------ESPDLDRSPVHLRHKVSVLN 1347 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc------cCCcchhchHHHHHHHHHhc
Confidence 33445666666778988877665443 34567899999999999999976431 12222223333333444666
Q ss_pred HHHHHhC-----CceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHH
Q psy7023 245 MAYLADK-----KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWS 319 (364)
Q Consensus 245 L~~LH~~-----~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 319 (364)
..-+|+. -.+|+++|+-|.+|..+-++|+.++|+.+..... .........++.|++|++...-.++.++|+|.
T Consensus 1348 ~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1348 RNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILR 1425 (2724)
T ss_pred cchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHH
Confidence 6666643 2689999999999999999999999999822111 11222334577899999998888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 320 YGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 320 lG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
.|+-+|+..- +..+|-......+-..++.+...
T Consensus 1426 ~s~~ly~rs~-~n~~fi~flq~~Lkgiidn~tf~ 1458 (2724)
T KOG1826|consen 1426 RSLSLYLRSD-GNAYFIFFLQPALKGIIDNHTFF 1458 (2724)
T ss_pred HHHHHHHHhc-ccHHHHHHHHHHHcCcccccccc
Confidence 9999999876 55555433333333334444333
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0041 Score=58.15 Aligned_cols=141 Identities=17% Similarity=0.170 Sum_probs=94.4
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEccccc------------------------CHHH-HHHHHHHHHHHHhc
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA------------------------SERE-KAEFLNEASVMKAF 179 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~------------------------~~~~-~~~~~~E~~il~~l 179 (364)
-..|..|--+.||.|...+ +..+|||+++.+. .... .--...|++-|+++
T Consensus 149 nGCiSTGKEANVYHat~~d-----G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEED-----GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred ccccccCccceeEeeecCC-----CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 3467788888999987665 5669999886431 1111 11233588888888
Q ss_pred CCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCC
Q psy7023 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDL 258 (364)
Q Consensus 180 ~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDl 258 (364)
....|.-.--+.. ....|||+|+.. +=+. ........++...+..+-.|++.-|.-|-+ .++||.||
T Consensus 224 ~~aGIP~PePIlL--k~hVLVM~FlGr-dgw~---------aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADL 291 (520)
T KOG2270|consen 224 NNAGIPCPEPILL--KNHVLVMEFLGR-DGWA---------APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADL 291 (520)
T ss_pred HhcCCCCCCceee--ecceEeeeeccC-CCCc---------CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccch
Confidence 7665542222222 345799999843 2111 111234456677788888888888888764 59999999
Q ss_pred CCCCEEEcCCCcEEEeecccccccC
Q psy7023 259 AARNCMVADDLTVKVGDFGMTRDIY 283 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~~~~ 283 (364)
.-=|+|+.+ |.+.|+|.+-+....
T Consensus 292 SEfN~Lyhd-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 292 SEFNLLYHD-GKLYIIDVSQSVEHD 315 (520)
T ss_pred hhhhheEEC-CEEEEEEccccccCC
Confidence 999999965 589999999876543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0096 Score=55.26 Aligned_cols=29 Identities=34% Similarity=0.474 Sum_probs=25.5
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 251 KKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 251 ~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0022 Score=67.68 Aligned_cols=159 Identities=18% Similarity=0.228 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHHhcCCcceeEEEEEEeeCCc----eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHH
Q psy7023 166 KAEFLNEASVMKAFDTHHVVKLYGVVSEGNP----TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241 (364)
Q Consensus 166 ~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~----~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi 241 (364)
.....-|...+.+..|+|++.++.+-.+... ..+..+++..-++...+.. ....+...++.+..+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----------v~~i~~~~~r~~~~~~ 295 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----------VGSIPLETLRILHQKL 295 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----------ccccCHHHHHHHHHHH
Confidence 3334457788888999999999988754322 2345677888888887764 3456677888899999
Q ss_pred HHHHHHHHhCCceecCCCCC---CEEEcCCCcEEEe--ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCc--
Q psy7023 242 ADGMAYLADKKFVHRDLAAR---NCMVADDLTVKVG--DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSH-- 314 (364)
Q Consensus 242 l~~L~~LH~~~iiHrDlkp~---NILl~~~~~~kL~--DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-- 314 (364)
++||+|+|+....|.-+..+ +--++.++.+.+. ||+.++...+...... ...+..+.+||......++.+
T Consensus 296 ~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~ 372 (1351)
T KOG1035|consen 296 LEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRL 372 (1351)
T ss_pred hhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhh
Confidence 99999999996666555554 4444566677777 9988876655433221 122445888998877666554
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 315 SDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 315 ~DiwslG~il~el~t~g~~P~~~ 337 (364)
.|+|.+|..+..+..+...+-..
T Consensus 373 ~dL~~lgll~~~~~~~~~i~~~~ 395 (1351)
T KOG1035|consen 373 TDLWCLGLLLLQLSQGEDISEKS 395 (1351)
T ss_pred hHHHHHHHHHhhhhhcCcccccc
Confidence 79999999999998855544333
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0037 Score=58.80 Aligned_cols=78 Identities=17% Similarity=0.276 Sum_probs=46.8
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce-eEEEEEEeeCCceEEEEec
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV-VKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lv~e~ 203 (364)
++.|..|-.-.+|+....+... ....|++|+...... ..-.-.+|..+++.+...++ ++++.++.. + +|.+|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~-~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~f 91 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENG-NEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSF 91 (330)
T ss_pred EEEeCCcccceEEEEEecCCCC-CCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeehh
Confidence 3445557778899886543211 134688898765432 11223468888888866555 356665532 2 58899
Q ss_pred CCCCCH
Q psy7023 204 MGGGDL 209 (364)
Q Consensus 204 ~~ggsL 209 (364)
++|..|
T Consensus 92 i~g~~l 97 (330)
T PLN02421 92 INARTL 97 (330)
T ss_pred hcCCCC
Confidence 987654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.012 Score=54.55 Aligned_cols=133 Identities=16% Similarity=0.204 Sum_probs=74.1
Q ss_pred ccceEEEEcc-cccCHHHHHHHHHHHHHHHhcCCc--ceeEEEEEEeeCC--ceEEEEecCCCCC---------------
Q psy7023 149 EHPCAIKVAN-ENASEREKAEFLNEASVMKAFDTH--HVVKLYGVVSEGN--PTLVIMELMGGGD--------------- 208 (364)
Q Consensus 149 ~~~vaiK~~~-~~~~~~~~~~~~~E~~il~~l~h~--~iv~l~~~~~~~~--~~~lv~e~~~ggs--------------- 208 (364)
++++++. .. ............+|..+++.+.-- -+...++.+.++. ..|.||+|++|..
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 4456666 32 123334455667788888887442 3445566665554 6799999998832
Q ss_pred ---HHHHHHhcCCCCCC---ccCC-CCccHHHHHHHHHHH--------------HHHHHHHHhC--------CceecCCC
Q psy7023 209 ---LKNYLRSCRPDAET---DVER-SPPTLSRILQMAAEV--------------ADGMAYLADK--------KFVHRDLA 259 (364)
Q Consensus 209 ---L~~~l~~~~~~~~~---~~~~-~~~~~~~~~~i~~qi--------------l~~L~~LH~~--------~iiHrDlk 259 (364)
|.++|.....-... .... ......++..+..+. ..-..|++.+ .++|+|++
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 22222211100000 0000 001111222222222 2234555543 48999999
Q ss_pred CCCEEEcCCCcEEEeeccccccc
Q psy7023 260 ARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 260 p~NILl~~~~~~kL~DFg~a~~~ 282 (364)
+.||++++++.+=|+||+.+..-
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccC
Confidence 99999999999999999998643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.025 Score=51.75 Aligned_cols=30 Identities=20% Similarity=0.328 Sum_probs=25.3
Q ss_pred CceecCCCCCCEEEcCCCc-EEEeecccccc
Q psy7023 252 KFVHRDLAARNCMVADDLT-VKVGDFGMTRD 281 (364)
Q Consensus 252 ~iiHrDlkp~NILl~~~~~-~kL~DFg~a~~ 281 (364)
.++|+|++|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999998555 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.057 Score=50.21 Aligned_cols=29 Identities=14% Similarity=0.137 Sum_probs=27.2
Q ss_pred CceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 252 KFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 252 ~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
+++|+|+.++|+|+++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.023 Score=53.62 Aligned_cols=82 Identities=16% Similarity=0.179 Sum_probs=48.4
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEccccc------CHHHHHHHHHHHHHHHhcC--Cc-ceeEEEEEEeeCCce
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA------SEREKAEFLNEASVMKAFD--TH-HVVKLYGVVSEGNPT 197 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~E~~il~~l~--h~-~iv~l~~~~~~~~~~ 197 (364)
.||.|...-||++...+ ..+.|+||....-. ..-...+..-|...|+... -| .+++++.+ +.+..
T Consensus 2 EigdGnlN~VfrV~~~~----g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE----GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCC----CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccc
Confidence 57899999999998643 23568888654211 1112334445777777652 23 45555543 33556
Q ss_pred EEEEecCCCC-CHHHHHH
Q psy7023 198 LVIMELMGGG-DLKNYLR 214 (364)
Q Consensus 198 ~lv~e~~~gg-sL~~~l~ 214 (364)
.+|||+++.. .|.+.+-
T Consensus 76 ~~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 76 VTVMEDLSHHKIARKGLI 93 (370)
T ss_pred eehHhhCccchHHHHHHH
Confidence 7899998553 3334443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0087 Score=56.76 Aligned_cols=60 Identities=13% Similarity=0.207 Sum_probs=42.0
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCEEEc
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYL-ADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~L-H~~~iiHrDlkp~NILl~ 266 (364)
...++-+|+.|.++..+++.. ..++.....++.-.+.|+-.+ --.+++|.|++|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-----------~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-----------SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhcc-----------cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 446778889999999988641 122334555666566664433 356899999999999995
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.053 Score=52.11 Aligned_cols=74 Identities=23% Similarity=0.315 Sum_probs=48.5
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccC---H---HHHHHHHHHHHHHHhcC---CcceeEEEEEEeeCC
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS---E---REKAEFLNEASVMKAFD---THHVVKLYGVVSEGN 195 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~---~---~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~ 195 (364)
.+.||.|..-.||+.... +..++||.-..... . -...+...|.+.|+.+. ..++++++.+.. +
T Consensus 37 ~~eiggGn~N~VyrV~~~------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d 108 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--T 108 (418)
T ss_pred EEEcCCCceeeEEEEEcC------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--C
Confidence 557899999999997653 23588887652111 0 12233344677776663 247888888877 4
Q ss_pred ceEEEEecCCC
Q psy7023 196 PTLVIMELMGG 206 (364)
Q Consensus 196 ~~~lv~e~~~g 206 (364)
..+++||++++
T Consensus 109 ~~vlvME~L~~ 119 (418)
T PLN02756 109 MALIGMRYLEP 119 (418)
T ss_pred CCEEEEeecCC
Confidence 56788999977
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.032 Score=53.52 Aligned_cols=81 Identities=16% Similarity=0.217 Sum_probs=47.1
Q ss_pred EeceeeeecceEEEEEEEcCcc--cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce-eEEEEEEeeCCceEEE
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFR--SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV-VKLYGVVSEGNPTLVI 200 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lv 200 (364)
.++.|..|-...+|++...... ....+.|.+++..... ...-.-.+|.++++.+...++ .++++.+.. ++|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~--~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l 127 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN--SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI 127 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC--ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence 3445655888899998754321 1111235555432211 111122458899999966654 456666653 589
Q ss_pred EecCCCCCHH
Q psy7023 201 MELMGGGDLK 210 (364)
Q Consensus 201 ~e~~~ggsL~ 210 (364)
.||++|.+|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999986653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.011 Score=55.36 Aligned_cols=74 Identities=19% Similarity=0.213 Sum_probs=55.3
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ 271 (364)
+....|++|++. |++|. .++ --.++++..|+.+.+..++-+..+ ..-|||+.-.||||+ +|++
T Consensus 297 e~~y~yl~~kdh-gt~is-~ik-------------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gnv 360 (488)
T COG5072 297 ETLYLYLHFKDH-GTPIS-IIK-------------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNV 360 (488)
T ss_pred CceEEEEEEecC-Cceee-eee-------------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCce
Confidence 445667888875 54543 221 123567778888888877777755 688999999999999 9999
Q ss_pred EEeeccccccc
Q psy7023 272 KVGDFGMTRDI 282 (364)
Q Consensus 272 kL~DFg~a~~~ 282 (364)
.|+||-+++.-
T Consensus 361 tLIDfklsRl~ 371 (488)
T COG5072 361 TLIDFKLSRLS 371 (488)
T ss_pred EEEEeeeeecc
Confidence 99999999843
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.076 Score=49.81 Aligned_cols=28 Identities=21% Similarity=0.141 Sum_probs=24.0
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 251 KKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 251 ~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.012 Score=56.22 Aligned_cols=76 Identities=20% Similarity=0.246 Sum_probs=47.2
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEccccc-----CHHHHHHHHHHHHHHHhcC--Cc-ceeEEEEEEeeCCc
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-----SEREKAEFLNEASVMKAFD--TH-HVVKLYGVVSEGNP 196 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~E~~il~~l~--h~-~iv~l~~~~~~~~~ 196 (364)
.+.||.|.-.-||++.+.. .+..|+||....-. -.-...+..-|.+.|+... -| ++++++.+- ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~----~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ----KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVM 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCC----CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHH
Confidence 5678999999999998742 23468888643211 1122345555778887762 23 556666543 345
Q ss_pred eEEEEecCCC
Q psy7023 197 TLVIMELMGG 206 (364)
Q Consensus 197 ~~lv~e~~~g 206 (364)
..+|||+++.
T Consensus 108 ~~~vMEdL~~ 117 (409)
T PRK12396 108 NCCVMEDLSD 117 (409)
T ss_pred hhHHHHhCcc
Confidence 6688888854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.13 Score=55.74 Aligned_cols=30 Identities=27% Similarity=0.389 Sum_probs=25.8
Q ss_pred CCceecCCCCCCEEEcCCC--cEE-Eeeccccc
Q psy7023 251 KKFVHRDLAARNCMVADDL--TVK-VGDFGMTR 280 (364)
Q Consensus 251 ~~iiHrDlkp~NILl~~~~--~~k-L~DFg~a~ 280 (364)
.++||.|+.+.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999875 555 99999875
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.16 Score=47.69 Aligned_cols=143 Identities=18% Similarity=0.199 Sum_probs=78.2
Q ss_pred eeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc------eeEEEE----EEeeCCce
Q psy7023 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH------VVKLYG----VVSEGNPT 197 (364)
Q Consensus 128 lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~------iv~l~~----~~~~~~~~ 197 (364)
|.+ .--.||+....+ ..+++|+...... ..++..|...|+.|.-.. +..+-| .+..+.+.
T Consensus 34 l~s-~eN~~f~~~~~~------g~~iLki~~~~~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 34 LNS-EENSNFRVQTED------GRYILKIYRPGWT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccc-ccCceEEEEecC------CCeEEEEecCCCC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 444 455688776553 3348999876522 244556788888773322 122211 12222377
Q ss_pred EEEEecCCCCCHHH---------------HHHhc-CCCCC-CccCCCCccHH-------------HHHHHHHHHHHHHHH
Q psy7023 198 LVIMELMGGGDLKN---------------YLRSC-RPDAE-TDVERSPPTLS-------------RILQMAAEVADGMAY 247 (364)
Q Consensus 198 ~lv~e~~~ggsL~~---------------~l~~~-~~~~~-~~~~~~~~~~~-------------~~~~i~~qil~~L~~ 247 (364)
+-+++|++|..+.. .++.. +.... .........+. .-.....++...++.
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 88899999877662 11111 11110 00001011111 001123344444444
Q ss_pred HHhC--------C--ceecCCCCCCEEEcCCCc-EEEeeccccc
Q psy7023 248 LADK--------K--FVHRDLAARNCMVADDLT-VKVGDFGMTR 280 (364)
Q Consensus 248 LH~~--------~--iiHrDlkp~NILl~~~~~-~kL~DFg~a~ 280 (364)
+.+. + +||+|+.|.|||++.+.. +-++||+.+.
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 4432 3 999999999999999885 8999999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.032 Score=48.77 Aligned_cols=86 Identities=16% Similarity=0.110 Sum_probs=60.0
Q ss_pred HHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHH
Q psy7023 167 AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246 (364)
Q Consensus 167 ~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~ 246 (364)
.-+.++.+++.++ ..|+++..- .+-.+-++.|+|-.... . ...++..=+.+|.
T Consensus 103 ~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i-------------------~----~~N~i~agi~~L~ 155 (308)
T PF07387_consen 103 ALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI-------------------N----FSNFITAGIKDLM 155 (308)
T ss_pred hhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc-------------------c----hhHHHHHhHHHHH
Confidence 4567788888876 578888743 44456688999843111 0 0112222256778
Q ss_pred HHHh--CCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 247 YLAD--KKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 247 ~LH~--~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
-.|+ .+.+|+|..|+|||-|+.|.+||.|-+..
T Consensus 156 ~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 156 DFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 8884 37999999999999999999999998753
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.13 Score=47.41 Aligned_cols=75 Identities=21% Similarity=0.293 Sum_probs=45.8
Q ss_pred eEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC---CcceeEEEEEEeeCCceEE
Q psy7023 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD---THHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 123 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~~~~l 199 (364)
+-.+.++.|....+|+.. . .+..+.+|+-.... ...|..|++-|+.|. .-.+++++.+...++..||
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~-----~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL 89 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-T-----DGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL 89 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-T-----TS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred eeeEecCCCChhheEEEE-C-----CCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence 345578889999999876 2 36678889876322 234566888888773 3368899998887777899
Q ss_pred EEecCCCC
Q psy7023 200 IMELMGGG 207 (364)
Q Consensus 200 v~e~~~gg 207 (364)
||||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.038 Score=50.31 Aligned_cols=49 Identities=14% Similarity=0.135 Sum_probs=38.1
Q ss_pred HHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 233 RILQMAAEVADGMAYLADK--KFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 233 ~~~~i~~qil~~L~~LH~~--~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
.+...+..+-..+.-.+.. -++|.|+.|+|+|.++.+.++|+||..|..
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3444555555566655544 589999999999999999999999998863
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.02 Score=48.90 Aligned_cols=29 Identities=21% Similarity=0.245 Sum_probs=25.7
Q ss_pred CceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 252 KFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 252 ~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
-.+|+|+.|.||++++++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 358999999999998887 89999998864
|
|
| >PF00017 SH2: SH2 domain; InterPro: IPR000980 The Src homology 2 (SH2) domain is a protein domain of about 100 amino-acid residues first identified as a conserved sequence region between the oncoproteins Src and Fps [] | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.026 Score=40.61 Aligned_cols=37 Identities=24% Similarity=0.143 Sum_probs=27.7
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
+.+.|+||||.| +...+.+.|+++.-. .+.|+.|...
T Consensus 18 ~~~~G~FLvR~s-----~~~~~~~~Lsv~~~~----~v~h~~I~~~ 54 (77)
T PF00017_consen 18 GKPDGTFLVRPS-----SSKPGKYVLSVRFDG----KVKHFRINRT 54 (77)
T ss_dssp TSSTTEEEEEEE-----SSSTTSEEEEEEETT----EEEEEEEEEE
T ss_pred cCCCCeEEEEec-----ccccccccccccccc----ccEEEEEEec
Confidence 799999999999 444455666666543 7888888874
|
Similar sequences were later found in many other intracellular signal-transducing proteins []. SH2 domains function as regulatory modules of intracellular signalling cascades by interacting with high affinity to phosphotyrosine-containing target peptides in a sequence-specific, SH2 domains recognise between 3-6 residues C-terminal to the phosphorylated tyrosine in a fashion that differs from one SH2 domain to another, and strictly phosphorylation-dependent manner [, , , ]. They are found in a wide variety of protein contexts e.g., in association with catalytic domains of phospholipase Cy (PLCy) and the non-receptor protein tyrosine kinases; within structural proteins such as fodrin and tensin; and in a group of small adaptor molecules, i.e Crk and Nck. The domains are frequently found as repeats in a single protein sequence and will then often bind both mono- and di-phosphorylated substrates. The structure of the SH2 domain belongs to the alpha+beta class, its overall shape forming a compact flattened hemisphere. The core structural elements comprise a central hydrophobic anti-parallel beta-sheet, flanked by 2 short alpha-helices. The loop between strands 2 and 3 provides many of the binding interactions with the phosphate group of its phosphopeptide ligand, and is hence designated the phosphate binding loop, the phosphorylated ligand binds perpendicular to the beta-sheet and typically interacts with the phosphate binding loop and a hydrophobic binding pocket that interacts with a pY+3 side chain. The N- and C-termini of the domain are close together in space and on the opposite face from the phosphopeptide binding surface and it has been speculated that this has facilitated their integration into surface-exposed regions of host proteins [].; GO: 0005515 protein binding; PDB: 1M27_A 1KA6_A 1D4W_B 1D4T_A 1D1Z_B 1KA7_A 1UUR_A 1UUS_A 1BLJ_A 1BLK_A .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 364 | ||||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-97 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-96 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-96 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-96 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-96 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-95 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-95 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-95 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-95 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-95 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-95 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-95 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-95 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-94 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-94 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-94 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-94 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-94 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-93 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-92 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-54 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-54 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-54 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-53 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-51 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-51 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-51 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-50 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-50 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-50 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-50 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-50 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-50 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-50 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-50 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-50 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-50 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-50 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-49 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-49 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-47 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-46 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-46 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-46 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-46 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-45 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-45 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-45 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-45 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-45 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-45 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-45 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-45 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-45 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-45 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-45 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-45 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-45 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-45 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-45 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-45 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-45 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-45 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-45 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-45 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-44 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-44 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-44 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-44 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-44 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-44 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-44 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-44 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-44 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-43 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-43 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-43 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-43 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-43 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-43 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-43 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-43 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-43 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-43 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-42 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-42 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-42 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-42 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-42 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-42 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-42 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-42 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-42 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-42 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-42 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-42 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-42 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-42 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-42 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-42 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-42 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-42 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-42 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-42 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-42 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-42 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-42 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-42 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-42 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-42 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-42 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-42 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-42 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-42 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-42 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-42 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-42 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-41 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-41 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-41 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-41 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-41 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-41 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-41 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-41 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-41 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-41 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-41 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-41 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-41 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-41 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-41 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-40 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-40 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-40 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-40 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-40 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-40 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-40 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-40 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-40 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-40 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-40 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-40 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-40 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-40 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-40 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-40 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-40 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-40 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-40 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-39 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-39 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-39 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-39 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-39 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-39 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-39 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-38 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-38 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-38 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-38 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-38 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-38 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-38 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-38 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-38 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-38 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-38 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-38 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-38 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-38 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-38 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-38 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-37 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-37 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-37 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-37 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-37 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-37 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-37 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-37 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-37 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-37 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-37 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-37 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-37 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-37 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-37 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-37 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-37 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-37 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-37 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-37 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-37 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-36 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-36 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-36 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-36 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-36 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-36 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-36 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-36 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-36 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-36 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-36 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-36 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-36 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-36 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-36 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-36 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-36 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-36 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-36 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-36 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-36 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-36 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-36 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-36 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-36 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-36 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-36 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-36 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-36 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-36 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-36 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-36 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-36 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-35 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-35 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-35 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-35 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-35 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-35 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-35 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-35 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-35 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-35 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-35 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-35 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-35 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-35 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-35 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-35 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-35 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-35 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-35 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-35 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-35 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-35 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-35 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-35 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-35 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-35 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-35 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-35 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-35 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-35 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-35 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-35 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-34 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-34 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-34 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-34 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-34 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-34 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-34 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-33 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-33 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-32 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-32 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-32 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-32 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-32 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-32 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-32 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-32 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-31 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-31 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-31 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-31 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-31 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-31 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-31 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-31 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-31 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-31 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-31 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-31 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-31 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-31 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-31 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-31 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-30 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-27 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-27 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-26 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-26 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-26 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-26 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-26 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-26 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-26 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-26 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-26 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-26 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-26 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-26 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-26 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-26 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-26 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-26 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-26 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-26 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-25 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-25 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-25 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-25 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-25 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-25 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-24 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-16 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-15 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-15 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-13 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-04 |
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 364 | |||
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-147 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-141 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-140 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-139 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-138 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-137 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-136 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-136 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-135 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-135 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-134 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-132 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-132 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-131 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-131 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-130 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-128 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-124 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-124 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-123 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-122 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-121 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-121 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-120 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-119 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-117 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-116 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-115 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-115 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-114 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-113 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-109 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-109 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-107 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-106 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-106 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-106 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-105 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-103 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-103 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-102 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-102 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-101 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-100 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-99 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-98 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-98 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 7e-97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 9e-93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-92 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-71 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-69 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-69 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-67 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-66 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-64 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 8e-61 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-58 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-57 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-45 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-44 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-43 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-42 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-40 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-40 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-38 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-38 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-37 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-34 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 9e-34 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-33 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 7e-33 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 5e-32 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-31 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-31 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-31 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-31 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 5e-31 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 7e-30 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-29 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-29 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-29 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 9e-29 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-28 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-28 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-28 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-28 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-27 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-27 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-27 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-27 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-26 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 7e-26 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-26 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-25 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 7e-25 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 8e-25 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 8e-25 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-24 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-24 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-24 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-24 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-24 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-24 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 8e-24 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-23 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-23 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 4e-23 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-23 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-23 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-22 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-22 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-22 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-22 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-22 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 8e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 8e-22 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 9e-22 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-21 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-21 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-21 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-21 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-21 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-21 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-21 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 9e-21 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-20 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-20 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-20 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-20 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-20 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-20 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 5e-20 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-19 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-19 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-19 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-19 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 8e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 8e-19 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 8e-19 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-18 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-18 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-18 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-18 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-18 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-17 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-17 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-17 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-17 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-16 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-16 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-16 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 9e-16 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-15 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-14 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-14 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-14 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-14 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-14 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-14 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 6e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-14 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 8e-14 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-13 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-13 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-13 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-13 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-13 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-13 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-13 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-13 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 8e-13 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-12 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-12 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-12 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-12 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 8e-12 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 8e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-11 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-11 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-11 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-11 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-11 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-11 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-11 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-10 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-10 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-10 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-10 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 6e-10 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 6e-10 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-09 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-09 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-09 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-09 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-09 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-09 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-09 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-09 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-09 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 8e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 9e-09 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-08 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-08 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-08 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-08 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 5e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-08 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 8e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-07 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-05 |
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 417 bits (1073), Expect = e-147
Identities = 165/241 (68%), Positives = 192/241 (79%), Gaps = 1/241 (0%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSL-AEHPCAIKVANENASEREKA 167
+Y D WEV R K+T+ ELG GSFG+VY G+ K E AIK NE AS RE+
Sbjct: 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFLNEASVMK F+ HHVV+L GVVS+G PTLVIMELM GDLK+YLRS RP + +
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
PP+LS+++QMA E+ADGMAYL KFVHRDLAARNCMVA+D TVK+GDFGMTRDIYET+Y
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
YRKG +G LPVRWM+PESLKDGVFT++SDVWS+GVVLWE+ATLA QPYQGLSNEQVL +V
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 348 K 348
Sbjct: 254 M 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 405 bits (1043), Expect = e-141
Identities = 101/281 (35%), Positives = 152/281 (54%), Gaps = 7/281 (2%)
Query: 73 GSGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGS 132
G+ G + + T N D EV R +T++ LG+G+
Sbjct: 24 GAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGA 83
Query: 133 FGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191
FG VY G + + A+K E SE+++ +FL EA ++ F+ ++V+ GV
Sbjct: 84 FGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 143
Query: 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK 251
+ P +++ELM GGDLK++LR RP + S + +L +A ++A G YL +
Sbjct: 144 LQSLPRFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 252 KFVHRDLAARNCMV---ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD 308
F+HRD+AARNC++ K+GDFGM RDIY YYRKG LPV+WM PE+ +
Sbjct: 201 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME 260
Query: 309 GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349
G+FTS +D WS+GV+LWE+ +L PY SN++VL +V
Sbjct: 261 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-140
Identities = 101/256 (39%), Positives = 148/256 (57%), Gaps = 9/256 (3%)
Query: 98 PNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKV 156
PN G D EV R +T++ LG+G+FG VY G + + A+K
Sbjct: 10 PNYCFAGKTS--SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 67
Query: 157 ANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSC 216
E SE+++ +FL EA ++ F+ ++V+ GV + P ++MELM GGDLK++LR
Sbjct: 68 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127
Query: 217 RPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV---ADDLTVKV 273
RP + S + +L +A ++A G YL + F+HRD+AARNC++ K+
Sbjct: 128 RPRPS---QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184
Query: 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQ 333
GDFGM RDIY YYRKG LPV+WM PE+ +G+FTS +D WS+GV+LWE+ +L
Sbjct: 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 334 PYQGLSNEQVLNWVKG 349
PY SN++VL +V
Sbjct: 245 PYPSKSNQEVLEFVTS 260
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-139
Identities = 107/269 (39%), Positives = 151/269 (56%), Gaps = 7/269 (2%)
Query: 86 TPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF- 144
+ +P G + + + + R + + ELG G+FG V+ +
Sbjct: 7 SSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLL 66
Query: 145 RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELM 204
+ A+K E ASE + +F EA ++ H+V+ +GV +EG P L++ E M
Sbjct: 67 PEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125
Query: 205 GGGDLKNYLRSCRPDAE-----TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259
GDL +LRS PDA+ DV P L ++L +A++VA GM YLA FVHRDLA
Sbjct: 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 185
Query: 260 ARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWS 319
RNC+V L VK+GDFGM+RDIY T+YYR G R LP+RWM PES+ FT+ SDVWS
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245
Query: 320 YGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+GVVLWE+ T QP+ LSN + ++ +
Sbjct: 246 FGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-138
Identities = 100/290 (34%), Positives = 156/290 (53%), Gaps = 16/290 (5%)
Query: 75 GGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDS-WEVLRSKVTILDELGNGSF 133
G T+ T + PN + L K E R+ + + ++G G+F
Sbjct: 1 GAMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAF 60
Query: 134 GLVYRGLIKDFRSL-AEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192
G V++ A+K+ E AS +A+F EA++M FD ++VKL GV +
Sbjct: 61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120
Query: 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAE--------------TDVERSPPTLSRILQMA 238
G P ++ E M GDL +LRS P + P + + L +A
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
+VA GMAYL+++KFVHRDLA RNC+V +++ VK+ DFG++R+IY +YY+ +P+
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 240
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
RWM PES+ +T+ SDVW+YGVVLWE+ + QPY G+++E+V+ +V+
Sbjct: 241 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-137
Identities = 98/263 (37%), Positives = 148/263 (56%), Gaps = 15/263 (5%)
Query: 101 LMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH-PCAIKVANE 159
+ D K+ + WE R + + LG G FG V + + A + A+K+ E
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 160 NASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPD 219
NAS E + L+E +V+K + HV+KLYG S+ P L+I+E G L+ +LR R
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 220 A--------------ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265
+ T+ ++ A +++ GM YLA+ K VHRDLAARN +V
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV 183
Query: 266 ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLW 325
A+ +K+ DFG++RD+YE + Y K S+G +PV+WMA ESL D ++T+ SDVWS+GV+LW
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 243
Query: 326 EMATLASQPYQGLSNEQVLNWVK 348
E+ TL PY G+ E++ N +K
Sbjct: 244 EIVTLGGNPYPGIPPERLFNLLK 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-136
Identities = 85/241 (35%), Positives = 126/241 (52%), Gaps = 7/241 (2%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSL-AEHPCAIKVANENASEREKAEFLNEA 173
E+ S V ++ELG FG VY+G + AIK + A + EF +EA
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDV------ERS 227
+ +VV L GVV++ P +I GDL +L P ++ +S
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
+ + A++A GM YL+ VH+DLA RN +V D L VK+ D G+ R++Y +Y
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
Y+ LP+RWMAPE++ G F+ SD+WSYGVVLWE+ + QPY G SN+ V+ +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243
Query: 348 K 348
+
Sbjct: 244 R 244
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 389 bits (1001), Expect = e-136
Identities = 93/259 (35%), Positives = 147/259 (56%), Gaps = 10/259 (3%)
Query: 100 QLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGL---IKDFRSLAEHPCAIKV 156
L G + +L + WE R K+T+ LG G+FG V I + A+K+
Sbjct: 15 MLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 157 ANENASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRS 215
++A+E++ ++ ++E +MK H +++ L G ++ P VI+E G+L+ YLR+
Sbjct: 75 LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
Query: 216 CRPDA------ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269
RP V T ++ ++A GM YLA +K +HRDLAARN +V ++
Sbjct: 135 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 194
Query: 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
+K+ DFG+ RDI +YY+K + G LPV+WMAPE+L D V+T SDVWS+GV++WE+ T
Sbjct: 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 330 LASQPYQGLSNEQVLNWVK 348
L PY G+ E++ +K
Sbjct: 255 LGGSPYPGIPVEELFKLLK 273
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 390 bits (1004), Expect = e-135
Identities = 91/262 (34%), Positives = 147/262 (56%), Gaps = 10/262 (3%)
Query: 97 PPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH---PCA 153
L G + +L + WE+ R ++ + LG G+FG V + A
Sbjct: 46 FQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA 105
Query: 154 IKVANENASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNY 212
+K+ +A+E++ ++ ++E +MK H +++ L G ++ P VI+E G+L+ Y
Sbjct: 106 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 165
Query: 213 LRSCRPDAE------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266
L++ RP + + ++ A +VA GM YLA KK +HRDLAARN +V
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225
Query: 267 DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWE 326
+D +K+ DFG+ RDI+ +YY+K + G LPV+WMAPE+L D ++T SDVWS+GV+LWE
Sbjct: 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 285
Query: 327 MATLASQPYQGLSNEQVLNWVK 348
+ TL PY G+ E++ +K
Sbjct: 286 IFTLGGSPYPGVPVEELFKLLK 307
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 389 bits (1001), Expect = e-135
Identities = 98/296 (33%), Positives = 158/296 (53%), Gaps = 10/296 (3%)
Query: 63 FLIRVAVILTGSGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKV 122
+R V ++ ++ + T T +T L G + +L + WE R K+
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKL 83
Query: 123 TILDELGNGSFGLVYRGL---IKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
T+ LG G FG V I + A+K+ ++A+E++ ++ ++E +MK
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 180 DTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDA------ETDVERSPPTLS 232
H +++ L G ++ P VI+E G+L+ YLR+ RP V T
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGS 292
++ ++A GM YLA +K +HRDLAARN +V ++ +K+ DFG+ RDI +YY+K +
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
G LPV+WMAPE+L D V+T SDVWS+GV++WE+ TL PY G+ E++ +K
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-134
Identities = 97/245 (39%), Positives = 143/245 (58%), Gaps = 8/245 (3%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSL-AEHPCAIKVANENASEREKAEF 169
+ R + + ELG G+FG V+ + + A+K + + + +F
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDF 64
Query: 170 LNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
EA ++ H+VK YGV +G+P +++ E M GDL +LR+ PDA V+ P
Sbjct: 65 QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 230 ------TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
LS++L +A+++A GM YLA + FVHRDLA RNC+V +L VK+GDFGM+RD+Y
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
T+YYR G LP+RWM PES+ FT+ SDVWS+GV+LWE+ T QP+ LSN +V
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
Query: 344 LNWVK 348
+ +
Sbjct: 245 IECIT 249
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 380 bits (978), Expect = e-132
Identities = 95/250 (38%), Positives = 146/250 (58%), Gaps = 11/250 (4%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASE 163
++ K + + R+ + + LG G FG V G +K A+K + +N+S+
Sbjct: 19 SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG-TSLKVAVKTMKLDNSSQ 77
Query: 164 REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT-----LVIMELMGGGDLKNYLRSCRP 218
RE EFL+EA+ MK F +V++L GV E + +VI+ M GDL YL R
Sbjct: 78 REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137
Query: 219 DAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278
+ L +L+ ++A GM YL+++ F+HRDLAARNCM+ DD+TV V DFG+
Sbjct: 138 ETGP----KHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193
Query: 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338
++ IY +YYR+G +PV+W+A ESL D V+TS SDVW++GV +WE+AT PY G+
Sbjct: 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253
Query: 339 SNEQVLNWVK 348
N ++ +++
Sbjct: 254 QNHEMYDYLL 263
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-132
Identities = 93/254 (36%), Positives = 139/254 (54%), Gaps = 12/254 (4%)
Query: 102 MGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA 161
+G D+ K + + + T+ LG G FG V +K + A+K+ +
Sbjct: 5 LGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQ-EDGSFVKVAVKMLKADI 63
Query: 162 -SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT------LVIMELMGGGDLKNYLR 214
+ + EFL EA+ MK FD HV KL GV +VI+ M GDL +L
Sbjct: 64 IASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL 123
Query: 215 SCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274
+ R L +++ ++A GM YL+ + F+HRDLAARNCM+A+D+TV V
Sbjct: 124 ASRIGEN----PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179
Query: 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
DFG++R IY +YYR+G LPV+W+A ESL D ++T HSDVW++GV +WE+ T P
Sbjct: 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
Query: 335 YQGLSNEQVLNWVK 348
Y G+ N ++ N++
Sbjct: 240 YAGIENAEIYNYLI 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 376 bits (969), Expect = e-131
Identities = 95/261 (36%), Positives = 132/261 (50%), Gaps = 7/261 (2%)
Query: 95 TTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSL-AEHPCA 153
+ N D +L + WE R+ + LG G+FG V A A
Sbjct: 21 SYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 154 IKVANENASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNY 212
+K+ A EK ++E +M H ++V L G + G P LVI E GDL N+
Sbjct: 81 VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
Query: 213 LRSCRPDAETD----VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268
LR ETD + S + +L +++VA GMA+LA K +HRD+AARN ++ +
Sbjct: 141 LRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200
Query: 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMA 328
K+GDFG+ RDI Y LPV+WMAPES+ D V+T SDVWSYG++LWE+
Sbjct: 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
Query: 329 TLASQPYQG-LSNEQVLNWVK 348
+L PY G L N + VK
Sbjct: 261 SLGLNPYPGILVNSKFYKLVK 281
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 375 bits (966), Expect = e-131
Identities = 88/249 (35%), Positives = 136/249 (54%), Gaps = 10/249 (4%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH-PCAIKVANENASEREKAE 168
Y WE R ++ + LG G+FG V A A+K+ E A+ E
Sbjct: 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 169 FLNEASVMKAFDTH-HVVKLYGVVS-EGNPTLVIMELMGGGDLKNYLRSCRPDAE----- 221
++E ++ H +VV L G + G P +VI+E G+L YLRS R +
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 222 -TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280
D+ + TL ++ + +VA GM +LA +K +HRDLAARN ++++ VK+ DFG+ R
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 281 DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS- 339
DIY+ Y + LP++WMAPE++ D V+T SDVWS+GV+LWE+ +L + PY G+
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 340 NEQVLNWVK 348
+E+ +K
Sbjct: 257 DEEFCRRLK 265
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-130
Identities = 90/255 (35%), Positives = 129/255 (50%), Gaps = 11/255 (4%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASE 163
D +L WE R++++ LG G+FG V +S A A+K+ +A
Sbjct: 8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 164 REKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET 222
E+ ++E V+ H ++V L G + G PTLVI E GDL N+LR R
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 223 DV--------ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274
+ L +L + +VA GMA+LA K +HRDLAARN ++ K+
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
DFG+ RDI Y LPV+WMAPES+ + V+T SDVWSYG+ LWE+ +L S P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 335 YQGLS-NEQVLNWVK 348
Y G+ + + +K
Sbjct: 248 YPGMPVDSKFYKMIK 262
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-128
Identities = 89/266 (33%), Positives = 125/266 (46%), Gaps = 16/266 (6%)
Query: 99 NQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH-PCAIKVA 157
N+ D + WE R + LG+G+FG V A+K+
Sbjct: 24 NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 83
Query: 158 NENASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSC 216
E A E+ ++E +M +H ++V L G + P +I E GDL NYLRS
Sbjct: 84 KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 143
Query: 217 RPDAETDV-------------ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNC 263
R D + + T +L A +VA GM +L K VHRDLAARN
Sbjct: 144 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203
Query: 264 MVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVV 323
+V VK+ DFG+ RDI Y LPV+WMAPESL +G++T SDVWSYG++
Sbjct: 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 324 LWEMATLASQPYQGLS-NEQVLNWVK 348
LWE+ +L PY G+ + ++
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQ 289
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-124
Identities = 91/233 (39%), Positives = 132/233 (56%), Gaps = 13/233 (5%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA 178
V + +G G FG VY G + D + CA+K N E ++FL E +MK
Sbjct: 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 82
Query: 179 FDTHHVVKLYGVVSEG-NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
F +V+ L G+ LV++ M GDL+N++R+ + PT+ ++
Sbjct: 83 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---------PTVKDLIGF 133
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR--GF 295
+VA GM YLA KKFVHRDLAARNCM+ + TVKV DFG+ RD+Y+ EYY ++
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 296 LPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
LPV+WMA ESL+ FT+ SDVWS+GV+LWE+ T + PY ++ + ++
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-124
Identities = 87/249 (34%), Positives = 133/249 (53%), Gaps = 15/249 (6%)
Query: 105 DDDKLYKKDSWEVLRSKVTI--LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS 162
D L + + +V +G G FG+VY G D CAIK +
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQ-NRIQCAIKSLSRITE 62
Query: 163 EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT-LVIMELMGGGDLKNYLRSCRPDAE 221
++ FL E +M+ + +V+ L G++ V++ M GDL ++RS + +
Sbjct: 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-- 120
Query: 222 TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281
PT+ ++ +VA GM YLA++KFVHRDLAARNCM+ + TVKV DFG+ RD
Sbjct: 121 -------PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
Query: 282 IYETEYY--RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339
I + EYY ++ LPV+W A ESL+ FT+ SDVWS+GV+LWE+ T + PY+ +
Sbjct: 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233
Query: 340 NEQVLNWVK 348
+ +++
Sbjct: 234 PFDLTHFLA 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-123
Identities = 89/276 (32%), Positives = 135/276 (48%), Gaps = 13/276 (4%)
Query: 76 GPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGL 135
T + + + + V + +G G FG
Sbjct: 45 TSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGC 104
Query: 136 VYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG- 194
VY G + D + CA+K N E ++FL E +MK F +V+ L G+
Sbjct: 105 VYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163
Query: 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFV 254
LV++ M GDL+N++R+ + PT+ ++ +VA GM +LA KKFV
Sbjct: 164 GSPLVVLPYMKHGDLRNFIRNETHN---------PTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 255 HRDLAARNCMVADDLTVKVGDFGMTRDIYETEY--YRKGSRGFLPVRWMAPESLKDGVFT 312
HRDLAARNCM+ + TVKV DFG+ RD+Y+ E+ + LPV+WMA ESL+ FT
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 274
Query: 313 SHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+ SDVWS+GV+LWE+ T + PY ++ + ++
Sbjct: 275 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-122
Identities = 86/240 (35%), Positives = 136/240 (56%), Gaps = 13/240 (5%)
Query: 108 KLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA 167
+ KD W + + + +++G G+FG V+ G ++ A+K E KA
Sbjct: 102 RAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR----ADNTLVAVKSCRETLPPDLKA 157
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
+FL EA ++K + ++V+L GV ++ P ++MEL+ GGD +LR+ E +
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---------EGA 208
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
+ +LQM + A GM YL K +HRDLAARNC+V + +K+ DFGM+R+ + Y
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
G +PV+W APE+L G ++S SDVWS+G++LWE +L + PY LSN+Q +V
Sbjct: 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-121
Identities = 84/244 (34%), Positives = 128/244 (52%), Gaps = 12/244 (4%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
+ + + D +G G+FG V + IK AIK E AS+ + +F
Sbjct: 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGL--RMDAAIKRMKEYASKDDHRDFAG 74
Query: 172 EASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPD------AETDV 224
E V+ H +++ L G + +E G+L ++LR R A +
Sbjct: 75 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 134
Query: 225 ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
S + ++L AA+VA GM YL+ K+F+HRDLAARN +V ++ K+ DFG++R
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG--- 191
Query: 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
E Y K + G LPVRWMA ESL V+T++SDVWSYGV+LWE+ +L PY G++ ++
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251
Query: 345 NWVK 348
+
Sbjct: 252 EKLP 255
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-121
Identities = 81/236 (34%), Positives = 128/236 (54%), Gaps = 12/236 (5%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
+ + R V + LG G FG VY G+ + + A+K ++ + K +F++
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTN-HKGEKINVAVKTCKKDCTLDNKEKFMS 62
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
EA +MK D H+VKL G++ E PT +IMEL G+L +YL + +
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS---------LKV 112
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
++ + ++ MAYL VHRD+A RN +VA VK+GDFG++R I + +YY K
Sbjct: 113 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KA 171
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
S LP++WM+PES+ FT+ SDVW + V +WE+ + QP+ L N+ V+ +
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-120
Identities = 87/238 (36%), Positives = 140/238 (58%), Gaps = 12/238 (5%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF 169
+E+ R ++ + +G G FG V++G+ AIK S+ + +F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMS-PENPALAVAIKTCKNCTSDSVREKF 63
Query: 170 LNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
L EA M+ FD H+VKL GV++E NP +IMEL G+L+++L+ +
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---------L 113
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR 289
L+ ++ A +++ +AYL K+FVHRD+AARN +V+ + VK+GDFG++R + ++ YY
Sbjct: 114 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY- 172
Query: 290 KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
K S+G LP++WMAPES+ FTS SDVW +GV +WE+ +P+QG+ N V+ +
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-119
Identities = 94/259 (36%), Positives = 143/259 (55%), Gaps = 14/259 (5%)
Query: 92 GGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHP 151
MG D ++ K + E+ S VT +G G FG VY+G++K E P
Sbjct: 16 TTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP 75
Query: 152 CAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKN 211
AIK +E+++ +FL EA +M F H++++L GV+S+ P ++I E M G L
Sbjct: 76 VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 212 YLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271
+LR + ++ +++ M +A GM YLA+ +VHRDLAARN +V +L
Sbjct: 136 FLREKDGE---------FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 186
Query: 272 KVGDFGMTR---DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMA 328
KV DFG++R D E Y G + +P+RW APE++ FTS SDVWS+G+V+WE+
Sbjct: 187 KVSDFGLSRVLEDDPEATYTTSGGK--IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244
Query: 329 TLASQPYQGLSNEQVLNWV 347
T +PY LSN +V+ +
Sbjct: 245 TYGERPYWELSNHEVMKAI 263
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-117
Identities = 88/244 (36%), Positives = 143/244 (58%), Gaps = 12/244 (4%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER 164
D + +E+ R ++ + +G G FG V++G+ AIK S+
Sbjct: 375 DTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMS-PENPAMAVAIKTCKNCTSDS 433
Query: 165 EKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDV 224
+ +FL EA M+ FD H+VKL GV++E NP +IMEL G+L+++L+ +
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKF------ 486
Query: 225 ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
L+ ++ A +++ +AYL K+FVHRD+AARN +V+ + VK+GDFG++R + +
Sbjct: 487 ---SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543
Query: 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
+ YY K S+G LP++WMAPES+ FTS SDVW +GV +WE+ +P+QG+ N V+
Sbjct: 544 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602
Query: 345 NWVK 348
++
Sbjct: 603 GRIE 606
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 336 bits (863), Expect = e-116
Identities = 87/233 (37%), Positives = 129/233 (55%), Gaps = 17/233 (7%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
E+ R ++T+L ELG+G FG+V G K ++ A+K+ E + + EF EA
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKG-----QYDVAVKMIKEGSMSED--EFFQEAQ 55
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
M +VK YGV S+ P ++ E + G L NYLRS S++
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---------HGKGLEPSQL 106
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
L+M +V +GMA+L +F+HRDLAARNC+V DL VKV DFGMTR + + +Y
Sbjct: 107 LEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG-T 165
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
PV+W APE ++S SDVW++G+++WE+ +L PY +N +V+ V
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-115
Identities = 87/236 (36%), Positives = 126/236 (53%), Gaps = 17/236 (7%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
SWE+ +T L ELG G FG+V G + ++ AIK+ E + + EF+
Sbjct: 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSMSED--EFIE 68
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
EA VM +V+LYGV ++ P +I E M G L NYLR R
Sbjct: 69 EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---------RFQT 119
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
++L+M +V + M YL K+F+HRDLAARNC+V D VKV DFG++R + + EY
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
PVRW PE L F+S SD+W++GV++WE+ +L PY+ +N + +
Sbjct: 180 G-SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-115
Identities = 81/241 (33%), Positives = 137/241 (56%), Gaps = 17/241 (7%)
Query: 108 KLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA 167
K + +D WEV R + +++ LG G FG V+ G A+K + + +
Sbjct: 1 KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMSPD-- 53
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
FL EA++MK +V+LY VV++ P +I E M G L ++L++
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS--------GI 104
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
T++++L MAA++A+GMA++ ++ ++HRDL A N +V+D L+ K+ DFG+ R I + EY
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
+ P++W APE++ G FT SDVWS+G++L E+ T PY G++N +V+ +
Sbjct: 165 TAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
Query: 348 K 348
+
Sbjct: 224 E 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-114
Identities = 91/236 (38%), Positives = 132/236 (55%), Gaps = 15/236 (6%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNE 172
D WE+ R+ +T+ +LG G +G VY G+ K A+K E+ E E EFL E
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDTMEVE--EFLKE 59
Query: 173 ASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
A+VMK ++V+L GV + P +I E M G+L +YLR C R +
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--------RQEVSAV 111
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGS 292
+L MA +++ M YL K F+HRDLAARNC+V ++ VKV DFG++R + + Y +
Sbjct: 112 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHA 170
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
P++W APESL F+ SDVW++GV+LWE+AT PY G+ QV ++
Sbjct: 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-113
Identities = 82/244 (33%), Positives = 137/244 (56%), Gaps = 11/244 (4%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER 164
+ + + + E+ S++ I +G+G G V G ++ + P AIK +ER
Sbjct: 34 EPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRV-PGQRDVPVAIKALKAGYTER 92
Query: 165 EKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDV 224
++ +FL+EAS+M FD ++++L GVV+ G +++ E M G L +LR+
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--------- 143
Query: 225 ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY- 283
T+ +++ M V GM YL+D +VHRDLAARN +V +L KV DFG++R +
Sbjct: 144 HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203
Query: 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
+ + + G +P+RW APE++ F+S SDVWS+GVV+WE+ +PY ++N V
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263
Query: 344 LNWV 347
++ V
Sbjct: 264 ISSV 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-109
Identities = 81/242 (33%), Positives = 128/242 (52%), Gaps = 23/242 (9%)
Query: 108 KLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA 167
+ + W + ++ +L +G G FG V G + + A+K +A+ +
Sbjct: 9 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDATAQA-- 60
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVER 226
FL EASVM ++V+L GV+ E L ++ E M G L +YLRS R
Sbjct: 61 -FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--------R 111
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
S +L+ + +V + M YL FVHRDLAARN +V++D KV DFG+T++ T+
Sbjct: 112 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
K LPV+W APE+L++ F++ SDVWS+G++LWE+ + PY + + V+
Sbjct: 172 DTGK-----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226
Query: 347 VK 348
V+
Sbjct: 227 VE 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-109
Identities = 86/245 (35%), Positives = 137/245 (55%), Gaps = 11/245 (4%)
Query: 104 GDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE 163
D + + + E+ + ++I +G G FG V G +K S E AIK +E
Sbjct: 29 EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL-PSKKEISVAIKTLKVGYTE 87
Query: 164 REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETD 223
+++ +FL EAS+M FD ++++L GVV++ P +++ E M G L ++LR
Sbjct: 88 KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---- 143
Query: 224 VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
T+ +++ M +A GM YL+D +VHRDLAARN ++ +L KV DFG+ R +
Sbjct: 144 -----FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 284 -ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
+ E G +P+RW +PE++ FTS SDVWSYG+VLWE+ + +PY +SN+
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 343 VLNWV 347
V+ V
Sbjct: 259 VIKAV 263
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-107
Identities = 48/245 (19%), Positives = 110/245 (44%), Gaps = 28/245 (11%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKD---FRSLAEHPCAIKVANENASEREKAEFLN 171
++ + + LG G+F +++G+ ++ + L E +KV ++ + F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFE 61
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
AS+M H+V YGV G+ +++ E + G L YL+ ++ +
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---------NKNCINI 112
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA--------DDLTVKVGDFGMTRDIY 283
L++A ++A M +L + +H ++ A+N ++ + +K+ D G++ +
Sbjct: 113 LWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 284 ETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
+ ++ + W+ PE +++ +D WS+G LWE+ + +P L +++
Sbjct: 173 PKDILQE------RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
Query: 343 VLNWV 347
L +
Sbjct: 227 KLQFY 231
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-106
Identities = 67/254 (26%), Positives = 114/254 (44%), Gaps = 28/254 (11%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
D + + + +LG G FG V A+K +A + ++ +
Sbjct: 23 GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ 82
Query: 172 EASVMKAFDTHHVVKLYGVVSE--GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
E +++ H++K G + ++ME + G L++YL
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI----------- 131
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE-YY 288
L+++L A ++ +GMAYL + ++HRDLAARN ++ +D VK+GDFG+ + + E YY
Sbjct: 132 GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQ--------------P 334
R G PV W APE LK+ F SDVWS+GV L+E+ T
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
Query: 335 YQGLSNEQVLNWVK 348
++ ++ ++
Sbjct: 252 QGQMTVLRLTELLE 265
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-106
Identities = 79/230 (34%), Positives = 123/230 (53%), Gaps = 10/230 (4%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA 178
++ + LG+G+FG VY+GL + P AIK E S + E L+EA VM +
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
D HV +L G+ + +I +LM G L +Y+R + + +L
Sbjct: 74 VDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---------IGSQYLLNWC 123
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
++A GM YL D++ VHRDLAARN +V VK+ DFG+ + + E G +P+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+WMA ES+ ++T SDVWSYGV +WE+ T S+PY G+ ++ + ++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-106
Identities = 66/238 (27%), Positives = 115/238 (48%), Gaps = 10/238 (4%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL 170
K + +++ L LG+G FG V++G+ + P IKV + + +
Sbjct: 4 KVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT 63
Query: 171 NEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPT 230
+ + + D H+V+L G+ + ++ + + G L +++R R
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA---------LG 113
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK 290
+L ++A GM YL + VHR+LAARN ++ V+V DFG+ + +
Sbjct: 114 PQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
S P++WMA ES+ G +T SDVWSYGV +WE+ T ++PY GL +V + ++
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-105
Identities = 84/233 (36%), Positives = 127/233 (54%), Gaps = 17/233 (7%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
W + S++T + E+G+G FGLV+ G + + AIK E A E +F+ EA
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMSEE--DFIEEAE 55
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
VM +V+LYGV E P ++ E M G L +YLR+ +R +
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---------QRGLFAAETL 106
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
L M +V +GMAYL + +HRDLAARNC+V ++ +KV DFGMTR + + +Y
Sbjct: 107 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-T 165
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
PV+W +PE ++S SDVWS+GV++WE+ + PY+ SN +V+ +
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-103
Identities = 90/241 (37%), Positives = 132/241 (54%), Gaps = 15/241 (6%)
Query: 108 KLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA 167
D WE+ R+ +T+ +LG G +G VY G+ K A+K E+ E E
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDTMEVE-- 261
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
EFL EA+VMK ++V+L GV + P +I E M G+L +YLR C R
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--------RQ 313
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
+ +L MA +++ M YL K F+HR+LAARNC+V ++ VKV DFG++R + +
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR-LMTGDT 372
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
Y + P++W APESL F+ SDVW++GV+LWE+AT PY G+ QV +
Sbjct: 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
Query: 348 K 348
+
Sbjct: 433 E 433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-103
Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 17/239 (7%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF 169
++KD+WE+ R + + +LG G FG V+ A+K + E F
Sbjct: 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-----HTKVAVKTMKPGSMSVE--AF 230
Query: 170 LNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
L EA+VMK +VKL+ VV++ P +I E M G L ++L+S E S
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD--------EGSKQ 281
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR 289
L +++ +A++A+GMA++ + ++HRDL A N +V+ L K+ DFG+ R I + EY
Sbjct: 282 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
Query: 290 KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+ P++W APE++ G FT SDVWS+G++L E+ T PY G+SN +V+ ++
Sbjct: 342 REG-AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-102
Identities = 81/242 (33%), Positives = 128/242 (52%), Gaps = 23/242 (9%)
Query: 108 KLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA 167
+ + W + ++ +L +G G FG V G + + A+K +A+ +
Sbjct: 181 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDATAQA-- 232
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVER 226
FL EASVM ++V+L GV+ E L ++ E M G L +YLRS R
Sbjct: 233 -FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--------GR 283
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
S +L+ + +V + M YL FVHRDLAARN +V++D KV DFG+T++ T+
Sbjct: 284 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
K LPV+W APE+L++ F++ SDVWS+G++LWE+ + PY + + V+
Sbjct: 344 DTGK-----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398
Query: 347 VK 348
V+
Sbjct: 399 VE 400
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-102
Identities = 80/235 (34%), Positives = 125/235 (53%), Gaps = 11/235 (4%)
Query: 115 WEVL-RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEA 173
+L ++ + LG+G+FG VY+GL + P AIK E S + E L+EA
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
VM + D HV +L G+ + +I +LM G L +Y+R + +
Sbjct: 69 YVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---------IGSQY 118
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
+L ++A GM YL D++ VHRDLAARN +V VK+ DFG+ + + E
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
G +P++WMA ES+ ++T SDVWSYGV +WE+ T S+PY G+ ++ + ++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = e-101
Identities = 87/238 (36%), Positives = 123/238 (51%), Gaps = 17/238 (7%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF 169
KD+WE+ R + + +LG G FG V+ G AIK E F
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMSPEA--F 226
Query: 170 LNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
L EA VMK +V+LY VVSE P ++ E M G L ++L+
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--------KYL 277
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR 289
L +++ MAA++A GMAY+ +VHRDL A N +V ++L KV DFG+ R I + EY
Sbjct: 278 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337
Query: 290 KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
+ P++W APE+ G FT SDVWS+G++L E+ T PY G+ N +VL+ V
Sbjct: 338 R-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = e-100
Identities = 87/243 (35%), Positives = 124/243 (51%), Gaps = 17/243 (6%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER 164
+ KD+WE+ R + + +LG G FG V+ G AIK
Sbjct: 252 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMSP 306
Query: 165 EKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDV 224
E FL EA VMK +V+LY VVSE P ++ E M G L ++L+
Sbjct: 307 EA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET------- 356
Query: 225 ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
L +++ MAA++A GMAY+ +VHRDL A N +V ++L KV DFG+ R I +
Sbjct: 357 -GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415
Query: 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
EY + P++W APE+ G FT SDVWS+G++L E+ T PY G+ N +VL
Sbjct: 416 NEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474
Query: 345 NWV 347
+ V
Sbjct: 475 DQV 477
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 2e-99
Identities = 73/259 (28%), Positives = 112/259 (43%), Gaps = 26/259 (10%)
Query: 107 DKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK 166
+ D + + + +LG G FG V A+K +
Sbjct: 8 KPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI 67
Query: 167 AEFLNEASVMKAFDTHHVVKLYGVVSE--GNPTLVIMELMGGGDLKNYLRSCRPDAETDV 224
A+ E +++ ++VK G+ +E GN +IME + G LK YL +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----- 122
Query: 225 ERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
L + L+ A ++ GM YL +++VHRDLAARN +V + VK+GDFG+T+ I
Sbjct: 123 ----INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 285 -TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL------------- 330
EYY PV W APE L F SDVWS+GV L E+ T
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238
Query: 331 -ASQPYQGLSNEQVLNWVK 348
+ ++ +++N +K
Sbjct: 239 MIGPTHGQMTVTRLVNTLK 257
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 1e-98
Identities = 77/237 (32%), Positives = 128/237 (54%), Gaps = 14/237 (5%)
Query: 113 DSWEVLRSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
+ R + I D ELG G+FG V +G+ + + + AIKV + + + E +
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK--QIDVAIKVLKQGTEKADTEEMMR 59
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
EA +M D ++V+L GV +++ME+ GGG L +L +R +
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---------KREEIPV 109
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE-YYRK 290
S + ++ +V+ GM YL +K FVHRDLAARN ++ + K+ DFG+++ + + YY
Sbjct: 110 SNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
S G P++W APE + F+S SDVWSYGV +WE + +PY+ + +V+ ++
Sbjct: 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 2e-98
Identities = 69/254 (27%), Positives = 119/254 (46%), Gaps = 27/254 (10%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
+D + + +LG G+FG V A+K + ++++ +F
Sbjct: 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQR 73
Query: 172 EASVMKAFDTHHVVKLYGVVSE--GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
E ++KA + +VK GV ++ME + G L+++L+ R
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---------L 124
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI-YETEYY 288
SR+L ++++ GM YL ++ VHRDLAARN +V + VK+ DFG+ + + + +YY
Sbjct: 125 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 184
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ------------ 336
G P+ W APESL D +F+ SDVWS+GVVL+E+ T +
Sbjct: 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244
Query: 337 --GLSNEQVLNWVK 348
+ ++L ++
Sbjct: 245 RDVPALSRLLELLE 258
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 3e-97
Identities = 75/240 (31%), Positives = 127/240 (52%), Gaps = 16/240 (6%)
Query: 111 KKDSWEVLRSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE-KAE 168
+ + R +T+ D ELG+G+FG V +G + A+K+ A++ K E
Sbjct: 7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQ--MKKVVKTVAVKILKNEANDPALKDE 64
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
L EA+VM+ D ++V++ G+ +++ME+ G L YL+ +
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ----------QNRH 113
Query: 229 PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE-Y 287
I+++ +V+ GM YL + FVHRDLAARN ++ K+ DFG+++ + E Y
Sbjct: 114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
Y+ + G PV+W APE + F+S SDVWS+GV++WE + +PY+G+ +V +
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 3e-97
Identities = 80/240 (33%), Positives = 126/240 (52%), Gaps = 14/240 (5%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAE 168
+ + + + +L++LG+GSFG+V RG S A+K + +
Sbjct: 9 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDA-PSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
F+ E + M + D ++++LYGVV P ++ EL G L + LR +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH--------- 117
Query: 229 PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE-Y 287
L + + A +VA+GM YL K+F+HRDLAARN ++A VK+GDFG+ R + + + +
Sbjct: 118 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
Y +P W APESLK F+ SD W +GV LWEM T +P+ GL+ Q+L+ +
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 7e-97
Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 28/276 (10%)
Query: 91 AGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH 150
TT G +D + + L +LG G+FG V +
Sbjct: 12 YDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE 71
Query: 151 PCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV--SEGNPTLVIMELMGGGD 208
A+K + +E +F E ++K+ ++VK GV + +IME + G
Sbjct: 72 VVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130
Query: 209 LKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268
L++YL+ + ++LQ +++ GM YL K+++HRDLA RN +V ++
Sbjct: 131 LRDYLQKHKER---------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181
Query: 269 LTVKVGDFGMTRDI-YETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
VK+GDFG+T+ + + EYY+ G P+ W APESL + F+ SDVWS+GVVL+E+
Sbjct: 182 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241
Query: 328 AT---------------LASQPYQGLSNEQVLNWVK 348
T + + + ++ +K
Sbjct: 242 FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 4e-95
Identities = 69/255 (27%), Positives = 121/255 (47%), Gaps = 28/255 (10%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
D + + L +LG G+FG V + A+K + +E +F
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFER 60
Query: 172 EASVMKAFDTHHVVKLYGVV--SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
E ++K+ ++VK GV + +IME + G L++YL+ +
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---------I 111
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI-YETEYY 288
++LQ +++ GM YL K+++HRDLA RN +V ++ VK+GDFG+T+ + + E++
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT---------------LASQ 333
+ G P+ W APESL + F+ SDVWS+GVVL+E+ T + +
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 334 PYQGLSNEQVLNWVK 348
+ ++ +K
Sbjct: 232 KQGQMIVFHLIELLK 246
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 9e-93
Identities = 82/276 (29%), Positives = 137/276 (49%), Gaps = 14/276 (5%)
Query: 74 SGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILD-ELGNGS 132
S G + +P P D + K + R + I D ELG G+
Sbjct: 289 SDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGN 348
Query: 133 FGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192
FG V +G+ + + + AIKV + + + E + EA +M D ++V+L GV
Sbjct: 349 FGSVRQGVYRMRKK--QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406
Query: 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK 252
+++ME+ GGG L +L R + +S + ++ +V+ GM YL +K
Sbjct: 407 A-EALMLVMEMAGGGPLHKFLVGKREE---------IPVSNVAELLHQVSMGMKYLEEKN 456
Query: 253 FVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE-YYRKGSRGFLPVRWMAPESLKDGVF 311
FVHR+LAARN ++ + K+ DFG+++ + + YY S G P++W APE + F
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 312 TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
+S SDVWSYGV +WE + +PY+ + +V+ ++
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 3e-92
Identities = 87/299 (29%), Positives = 136/299 (45%), Gaps = 60/299 (20%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAE 168
Y WE R ++ + LG G+FG V ++ A+K+ E A+ E
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 169 FLNEASVMKAFDTH-HVVKLYGVVS-EGNPTLVIMELMGGG------------------- 207
++E ++ H +VV L G + G P +VI+E G
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
Query: 208 ----------------DLKNYLRSCRP---------------------DAETDVERSPPT 230
DLK L S +A D+ + T
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK 290
L ++ + +VA GM +LA +K +HRDLAARN ++++ VK+ DFG+ RDIY+ Y +
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS-NEQVLNWVK 348
LP++WMAPE++ D V+T SDVWS+GV+LWE+ +L + PY G+ +E+ +K
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 6e-69
Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 27/244 (11%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
S + + LG G FG + ++ +K E + FL
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRE----TGEVMVMKE-LIRFDEETQRTFLK 56
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
E VM+ + +V+K GV+ + I E + GG L+ ++S S
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---------MDSQYPW 107
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
S+ + A ++A GMAYL +HRDL + NC+V ++ V V DFG+ R + + + +G
Sbjct: 108 SQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167
Query: 292 SRGFLPV------------RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339
R WMAPE + + DV+S+G+VL E+
Sbjct: 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR-VNADPDYL 226
Query: 340 NEQV 343
+
Sbjct: 227 PRTM 230
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 7e-69
Identities = 62/245 (25%), Positives = 117/245 (47%), Gaps = 26/245 (10%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANE-NASEREKAEFL 170
D WE+ ++T+ +G+GSFG VY+G A+K+ N + ++ F
Sbjct: 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVTAPTPQQLQAFK 68
Query: 171 NEASVMKAFDTHH--VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
NE V++ T H ++ G + ++ + G L ++L + +
Sbjct: 69 NEVGVLRK--TRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHA---------SETK 116
Query: 229 PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY 288
+ +++ +A + A GM YL K +HRDL + N + +D TVK+GDFG+ +
Sbjct: 117 FEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176
Query: 289 RKGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+ + + WMAPE ++ ++ SDV+++G+VL+E+ T PY ++N +
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG-QLPYSNINNRDQII 235
Query: 346 WVKGK 350
+ G+
Sbjct: 236 EMVGR 240
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-67
Identities = 78/240 (32%), Positives = 114/240 (47%), Gaps = 23/240 (9%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLN 171
D ++ + I +++G GSFG V+R A+K+ ++ EFL
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG------SDVAVKILMEQDFHAERVNEFLR 83
Query: 172 EASVMKAFDTHH--VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
E ++MK H +V G V++ ++ E + G L L R
Sbjct: 84 EVAIMKR--LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-------REQL 134
Query: 230 TLSRILQMAAEVADGMAYLADKK--FVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY 287
R L MA +VA GM YL ++ VHR+L + N +V TVKV DFG++R T
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
K + G WMAPE L+D SDV+S+GV+LWE+ATL QP+ L+ QV+ V
Sbjct: 195 SSKSAAGTP--EWMAPEVLRDEPSNEKSDVYSFGVILWELATL-QQPWGNLNPAQVVAAV 251
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-66
Identities = 65/247 (26%), Positives = 106/247 (42%), Gaps = 36/247 (14%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE---REKAEFLN 171
E+ +++T+ + +G G FG VYR A+K A + E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIG------DEVAVKAARHDPDEDISQTIENVRQ 55
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
EA + +++ L GV + ++ME GG L L
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----------GKRIPP 104
Query: 232 SRILQMAAEVADGMAYL---ADKKFVHRDLAARNCMV--------ADDLTVKVGDFGMTR 280
++ A ++A GM YL A +HRDL + N ++ + +K+ DFG+ R
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 281 DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340
+ + T + G WMAPE ++ +F+ SDVWSYGV+LWE+ T P++G+
Sbjct: 165 EWHRTTK--MSAAG--AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG-EVPFRGIDG 219
Query: 341 EQVLNWV 347
V V
Sbjct: 220 LAVAYGV 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-64
Identities = 57/253 (22%), Positives = 102/253 (40%), Gaps = 36/253 (14%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLN 171
W++ ++ I + +G G FG VY G AI++ + E +E + F
Sbjct: 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-------EVAIRLIDIERDNEDQLKAFKR 78
Query: 172 EASVMKAFDTHH--VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
E + T H VV G +I L G L + +R +
Sbjct: 79 EVMAYRQ--TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---------AKIVL 127
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR 289
+++ Q+A E+ GM YL K +H+DL ++N D+ V + DFG+ + R
Sbjct: 128 DVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGR 186
Query: 290 KGSRGFLPV---RWMAPESLKDGV---------FTSHSDVWSYGVVLWEMATLASQPYQG 337
+ + + +APE ++ F+ HSDV++ G + +E+ P++
Sbjct: 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR-EWPFKT 245
Query: 338 LSNEQVLNWVKGK 350
E ++ W G
Sbjct: 246 QPAEAII-WQMGT 257
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 8e-61
Identities = 50/241 (20%), Positives = 96/241 (39%), Gaps = 30/241 (12%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEA 173
+ ++ L +L G +++G + + +KV + S R+ +F E
Sbjct: 5 SGIDFKQLNFLTKLNENHSGELWKGRWQG------NDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPT--LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
++ F +V+ + G +I M G L N L +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--------EGTNFVVDQ 110
Query: 232 SRILQMAAEVADGMAYL--ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR 289
S+ ++ A ++A GMA+L + L +R+ M+ +D+T ++ +
Sbjct: 111 SQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP---- 166
Query: 290 KGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
G W+APE+L+ +D+WS+ V+LWE+ T P+ LSN ++
Sbjct: 167 -GRMY--APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR-EVPFADLSNMEIGMK 222
Query: 347 V 347
V
Sbjct: 223 V 223
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-58
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 28/233 (12%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
+ ++ + + +G G+FG+V + + AIK SE E+ F+ E
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRA------KDVAIKQIE---SESERKAFIVELR 53
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+ + ++VKLYG NP ++ME GG L N L P T +
Sbjct: 54 QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEP-------LPYYTAAHA 104
Query: 235 LQMAAEVADGMAYL---ADKKFVHRDLAARNCMVADDLTV-KVGDFGMTRDIYETEYYRK 290
+ + + G+AYL K +HRDL N ++ TV K+ DFG DI K
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
GS WMAPE + ++ DV+S+G++LWE+ T +P+ +
Sbjct: 165 GS-----AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR-RKPFDEIGGPAF 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-57
Identities = 59/253 (23%), Positives = 114/253 (45%), Gaps = 36/253 (14%)
Query: 106 DDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV------ANE 159
+ K + +++ ++G G FGLV++G + + AIK E
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVK----DKSVVAIKSLILGDSEGE 60
Query: 160 NASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPD 219
+ EF E +M + ++VKLYG++ NP ++ME + GDL + L
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD---- 114
Query: 220 AETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLAARNCMVA-----DDLTVK 272
+ P S L++ ++A G+ Y+ ++ VHRDL + N + + K
Sbjct: 115 -----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL--KDGVFTSHSDVWSYGVVLWEMATL 330
V DFG+++ + G+ +WMAPE++ ++ +T +D +S+ ++L+ + T
Sbjct: 170 VADFGLSQQSVHSVSGLLGN-----FQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
Query: 331 ASQPYQGLSNEQV 343
P+ S ++
Sbjct: 225 -EGPFDEYSYGKI 236
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 51/262 (19%), Positives = 99/262 (37%), Gaps = 56/262 (21%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
+ ++ ++ ++G G +G V+ G + A+KV E+A + E
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRG------EKVAVKVF----FTTEEASWFRETE 81
Query: 175 VMKAFDTHH--VVKLYGVVSEGNPT----LVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
+ + H ++ +G + +I + G L +YL+ +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----------STT 130
Query: 229 PTLSRILQMAAEVADGMAYLADKKF--------VHRDLAARNCMVADDLTVKVGDFGMTR 280
+L++A G+ +L + F HRDL ++N +V + T + D G+
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 281 ----DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSH------SDVWSYGVVLWEMATL 330
D E + G R+M PE L + + +H +D++S+G++LWE+A
Sbjct: 191 KFISDTNEVDIPPNTRVGTK--RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
Query: 331 AS---------QPYQGLSNEQV 343
PY L
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDP 270
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-44
Identities = 58/264 (21%), Positives = 103/264 (39%), Gaps = 62/264 (23%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
+ + + + +G G FG V+RG + A+K+ S RE+ + EA
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRG------EEVAVKIF----SSREERSWFREAE 86
Query: 175 VMKAFDTHH--VVKLYGVVSEGNPT----LVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
+ + H ++ ++ N T ++ + G L +YL R
Sbjct: 87 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----------RYT 135
Query: 229 PTLSRILQMAAEVADGMAYL--------ADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280
T+ ++++A A G+A+L HRDL ++N +V + T + D G+
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195
Query: 281 -------DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSH------SDVWSYGVVLWEM 327
I +R G++ R+MAPE L D + H +D+++ G+V WE+
Sbjct: 196 RHDSATDTIDIAPNHRVGTK-----RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250
Query: 328 ATLAS---------QPYQGLSNEQ 342
A S PY L
Sbjct: 251 ARRCSIGGIHEDYQLPYYDLVPSD 274
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-42
Identities = 48/255 (18%), Positives = 92/255 (36%), Gaps = 56/255 (21%)
Query: 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT 181
+T+L+ +G G +G V+RG + A+K+ S R++ + E +
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQG------ENVAVKIF----SSRDEKSWFRETELYNTVML 59
Query: 182 HH--VVKLYGVVSEGNPT----LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
H ++ + +I G L +YL+ + L
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----------LTTLDTVSCL 108
Query: 236 QMAAEVADGMAYL--------ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET-- 285
++ +A G+A+L HRDL ++N +V + + D G+ ++
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 286 --EYYRKGSRGFLPVRWMAPESLKDGVFTSH------SDVWSYGVVLWEMATLAS----- 332
+ G R+MAPE L + + D+W++G+VLWE+A
Sbjct: 169 QLDVGNNPRVG--TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
Query: 333 ----QPYQGLSNEQV 343
P+ +
Sbjct: 227 EDYKPPFYDVVPNDP 241
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 59/262 (22%), Positives = 98/262 (37%), Gaps = 52/262 (19%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNE 172
+ + +L+ +G G +G VY+G SL E P A+KV S + F+NE
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKG------SLDERPVAVKVF----SFANRQNFINE 55
Query: 173 ASVMKAFDTHH--VVKLYGVVSEGNPT-----LVIMELMGGGDLKNYLRSCRPDAETDVE 225
++ + H + + L++ME G L YL
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----------- 104
Query: 226 RSPPTLSRILQMAAEVADGMAYL---------ADKKFVHRDLAARNCMVADDLTVKVGDF 276
++A V G+AYL HRDL +RN +V +D T + DF
Sbjct: 105 LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164
Query: 277 GMTRDIYETEYYRKGSRGFLP------VRWMAPESLKDGV-------FTSHSDVWSYGVV 323
G++ + R G +R+MAPE L+ V D+++ G++
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224
Query: 324 LWEMAT--LASQPYQGLSNEQV 343
WE+ P + + Q+
Sbjct: 225 YWEIFMRCTDLFPGESVPEYQM 246
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-40
Identities = 51/257 (19%), Positives = 103/257 (40%), Gaps = 47/257 (18%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNE 172
++ + +L+ G FG V++ + + A+K+ ++K + NE
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLN------EYVAVKIF----PIQDKQSWQNE 66
Query: 173 ASVMKAFDTHH--VVKLYGVVSEGNPT----LVIMELMGGGDLKNYLRSCRPDAETDVER 226
V H +++ G G +I G L ++L+
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----------A 115
Query: 227 SPPTLSRILQMAAEVADGMAYL----------ADKKFVHRDLAARNCMVADDLTVKVGDF 276
+ + + + +A +A G+AYL HRD+ ++N ++ ++LT + DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 277 GMTR--DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSH-----SDVWSYGVVLWEMAT 329
G+ + ++ G G R+MAPE L+ + D+++ G+VLWE+A+
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTR--RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 330 LASQPYQGLSNEQVLNW 346
G +E +L +
Sbjct: 234 -RCTAADGPVDEYMLPF 249
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 28/221 (12%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
L LG+GS+G V++ K+ L A+K + +++A L E +
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRL----YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 182 H-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS--RILQMA 238
H V+L EG + EL G L+ + E +L ++
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGP-SLQQHC-----------EAWGASLPEAQVWGYL 163
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR--KGSRGFL 296
+ +A+L + VH D+ N + K+GDFG+ ++ +G
Sbjct: 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP--- 220
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
R+MAPE L+ + + +DV+S G+ + E+A P+ G
Sbjct: 221 --RYMAPELLQGS-YGTAADVFSLGLTILEVACNMELPHGG 258
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 55/262 (20%), Positives = 103/262 (39%), Gaps = 33/262 (12%)
Query: 81 TTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGL 140
+ + P P MG + ++ I ++G G F VYR
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTLANFR------------IEKKIGRGQFSEVYRAA 52
Query: 141 IKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198
A+K + + +A+ + E ++K + +V+K Y E N
Sbjct: 53 CLLDGVP----VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108
Query: 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258
+++EL GDL ++ + E + + ++ + ++ ++ +HRD+
Sbjct: 109 IVLELADAGDLSRMIKHFKKQKRLIPE------RTVWKYFVQLCSALEHMHSRRVMHRDI 162
Query: 259 AARNCMVADDLTVKVGDFGMTRDIYETEYYRK---GSRGFLPVRWMAPESLKDGVFTSHS 315
N + VK+GD G+ R G+ P +M+PE + + + S
Sbjct: 163 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT----PY-YMSPERIHENGYNFKS 217
Query: 316 DVWSYGVVLWEMATLASQPYQG 337
D+WS G +L+EMA L S P+ G
Sbjct: 218 DIWSLGCLLYEMAALQS-PFYG 238
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 52/227 (22%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
L ++G GSFG + IK N S +E+ E E +V+
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQ----YVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++V+ E ++M+ GGDL + + + +IL ++
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK--------GVLFQEDQILDWFVQI 134
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK---GSRGFLPV 298
+ ++ D+K +HRD+ ++N + D TV++GDFG+ R + T + G+ P
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGT----PY 190
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+++PE ++ + + SD+W+ G VL+E+ TL ++ S + ++
Sbjct: 191 -YLSPEICENKPYNNKSDIWALGCVLYELCTLKH-AFEAGSMKNLVL 235
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 46/229 (20%), Positives = 88/229 (38%), Gaps = 33/229 (14%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
+ LG G FG+V+ + + AIK E + + + E + +
Sbjct: 8 EPIQCLGRGGFGVVFEAK----NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 183 HVVKLYGVVSEGNPTL------------VIMELMGGGDLKNYLRSCRPDAETDVERSPPT 230
+V+ + E N T + M+L +LK+++ E +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV---- 119
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK 290
L + ++A+ + +L K +HRDL N D VKVGDFG+ + + E +
Sbjct: 120 ---CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 291 GSRGFLPVR----------WMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
+M+PE + ++ D++S G++L+E+
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-34
Identities = 44/237 (18%), Positives = 86/237 (36%), Gaps = 38/237 (16%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDT 181
L+++G+G FG V++ + + + AIK A ++ L E
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCI----YAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 182 H-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
H HVV+ + +E + L+ E GG L + + E + + + +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE------AELKDLLLQ 123
Query: 241 VADGMAYLADKKFVHRDLAARNCMV-------------------ADDLTVKVGDFGMTRD 281
V G+ Y+ VH D+ N + ++ + K+GD G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 282 IYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQG 337
I + +G R++A E L++ +D+++ + + A P G
Sbjct: 184 ISSPQVE-EGD-----SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 52/241 (21%), Positives = 97/241 (40%), Gaps = 41/241 (17%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
+L +G GS+G + K + K + + +E EK ++E ++++
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKI----LVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 182 HHVVKLYGV-VSEGNPTLVI-MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
++V+ Y + N TL I ME GGDL + + + + E +L++
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE------EFVLRVMT 118
Query: 240 EVADGMAYLADKKF-----VHRDLAARNCMVADDLTVKVGDFGMTRDIYETE-------- 286
++ + + +HRDL N + VK+GDFG+ R +
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 287 --YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
YY M+PE + + SD+WS G +L+E+ L P+ S +++
Sbjct: 179 TPYY------------MSPEQMNRMSYNEKSDIWSLGCLLYELCAL-MPPFTAFSQKELA 225
Query: 345 N 345
Sbjct: 226 G 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 60/308 (19%), Positives = 113/308 (36%), Gaps = 39/308 (12%)
Query: 74 SGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKV---TILDELGN 130
S G + + + +G DDD + E + K +IL ++G+
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGS 66
Query: 131 GSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDTH--HVVKL 187
G V++ L + + AIK N E A + + NE + + H +++L
Sbjct: 67 GGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
Y ++ME G DL ++L+ + + + + + +
Sbjct: 122 YDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER-------KSYWK---NMLEAVHT 170
Query: 248 LADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY--ETEYYRKGSRGFLPVRWMAPES 305
+ VH DL N ++ D +K+ DFG+ + T + G + +M PE+
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN--YMPPEA 227
Query: 306 LKDGVFTSH-----------SDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354
+KD + SDVWS G +L+ M P+Q + N+ ++E
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLHAIIDPNHE 286
Query: 355 YKVNPPIS 362
+
Sbjct: 287 IEFPDIPE 294
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 52/256 (20%), Positives = 99/256 (38%), Gaps = 36/256 (14%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
+IL ++G+G V++ L + + AIK N E A + + NE + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 182 H--HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
H +++LY ++ME G DL ++L+ + + +
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWER-------KSYWK--- 115
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE--TEYYRKGSRGFLP 297
+ + + + VH DL N ++ D +K+ DFG+ + T + G +
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 298 VRWMAPESLKDGVFTSH-----------SDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
+M PE++KD + SDVWS G +L+ M P+Q + N+
Sbjct: 175 --YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLH 231
Query: 347 VKGKSSNEYKVNPPIS 362
++E +
Sbjct: 232 AIIDPNHEIEFPDIPE 247
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 52/256 (20%), Positives = 99/256 (38%), Gaps = 36/256 (14%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
+IL ++G+G V++ L + + AIK N E A + + NE + +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 182 H--HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
H +++LY ++ME G DL ++L+ + + +
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWER-------KSYWK--- 134
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY--ETEYYRKGSRGFLP 297
+ + + + VH DL N ++ D +K+ DFG+ + T + G +
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 298 VRWMAPESLKDGVFTSH-----------SDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
+M PE++KD + SDVWS G +L+ M P+Q + N+
Sbjct: 194 --YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLH 250
Query: 347 VKGKSSNEYKVNPPIS 362
++E +
Sbjct: 251 AIIDPNHEIEFPDIPE 266
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
T L+++G GSFG V++G+ + + AIK+ + +E E + E +V+ D+
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVV----AIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+V K YG + +IME +GGG + L P E ++ IL+ E+
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDE-------TQIATILR---EIL 129
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMA 302
G+ YL +K +HRD+ A N ++++ VK+ DFG+ + +T+ R G P WMA
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG-TP-FWMA 187
Query: 303 PESLKDGVFTSHSDVWSYGVVLWEMAT 329
PE +K + S +D+WS G+ E+A
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELAR 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 30/228 (13%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDTHHV 184
E+G GSF VY+GL D + E A + + ++ E+ F EA ++K ++
Sbjct: 32 IEIGRGSFKTVYKGL--DTETTVE--VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 185 VKLYG---VVSEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
V+ Y +G + ++ ELM G LK YL+ + + + +
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----------MKIKVLRSWCRQ 137
Query: 241 VADGMAYL--ADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYETEYYR-KGSRGFL 296
+ G+ +L +HRDL N + +VK+GD G+ + G+
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT---- 193
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
+MAPE ++ DV+++G+ + EMAT PY N +
Sbjct: 194 -PEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEY-PYSECQNAAQI 238
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 47/231 (20%), Positives = 89/231 (38%), Gaps = 36/231 (15%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
++ +G+G FG V++ + IK EKA E + D
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKT----YVIKRVK---YNNEKA--EREVKALAKLDHV 64
Query: 183 HVVKLYGVVSEGNPTL----------------VIMELMGGGDLKNYLRSCRPDAETDVER 226
++V G + + ME G L+ ++ R
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--------G 116
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
L++ ++ G+ Y+ KK ++RDL N + D VK+GDFG+ + +
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT-SLKND 175
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
R S+G L R+M+PE + + D+++ G++L E+ + ++
Sbjct: 176 GKRTRSKGTL--RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 57/282 (20%), Positives = 95/282 (33%), Gaps = 33/282 (11%)
Query: 74 SGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDD-------KLYKKDSWEVLRSKVTILD 126
S G A + ++A + ++ K + E + +T
Sbjct: 6 SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH-WMTHQP 64
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186
+G GSFG V+R K CA+K E E + +V
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQ----CAVKKVRLEVFRVE------ELVACAGLSSPRIVP 114
Query: 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA 246
LYG V EG + MEL+ GG L ++ E R L + +G+
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE----------DRALYYLGQALEGLE 164
Query: 247 YLADKKFVHRDLAARNCMVADD-LTVKVGDFGMTRDIYETEYYRKGSRGFLPV---RWMA 302
YL ++ +H D+ A N +++ D + DFG + + G MA
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 303 PESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
PE + + D+WS ++ M P+ +
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLC 265
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 22/233 (9%)
Query: 107 DKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK 166
+ W + R + + +G+G+ +V + AIK N +
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEK----VAIKRINLEKCQTSM 57
Query: 167 AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVER 226
E L E M ++V Y + ++M+L+ GG + + ++ E
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 227 SP-PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
T++ IL+ EV +G+ YL +HRD+ A N ++ +D +V++ DFG++ +
Sbjct: 118 LDESTIATILR---EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174
Query: 286 EYYRKGSRGFLPVR--------WMAPESLKDGV-FTSHSDVWSYGVVLWEMAT 329
+ R WMAPE ++ + +D+WS+G+ E+AT
Sbjct: 175 GDITRNKV-----RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 49/281 (17%), Positives = 101/281 (35%), Gaps = 38/281 (13%)
Query: 103 GGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS 162
G ++ ++ + + +LG G F V L++ H A+K +
Sbjct: 12 SGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVD--LVEGLHD--GHFYALKRILCH-E 66
Query: 163 EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT----LVIMELMGGGDLKNYLRSCRP 218
++++ E EA + + F+ ++++L +++ G L N + +
Sbjct: 67 QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK- 125
Query: 219 DAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG- 277
+ + T +IL + + G+ + K + HRDL N ++ D+ + D G
Sbjct: 126 -----DKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180
Query: 278 -----------MTRDIYETEYYRKGSRGFLPVRWMAPE--SLKDGVFTSH-SDVWSYGVV 323
+ ++ + + APE S++ +DVWS G V
Sbjct: 181 MNQACIHVEGSRQALTLQDWAAQRCTISY-----RAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 324 LWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPISLS 364
L+ M PY + Q + V N+ + S
Sbjct: 236 LYAMMFGEG-PYDMVF--QKGDSVALAVQNQLSIPQSPRHS 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 50/266 (18%), Positives = 100/266 (37%), Gaps = 47/266 (17%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
+ LG G+FG V + L AIK +E + + L+E ++ + +
Sbjct: 9 EEIAVLGQGAFGQVVKARNA----LDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQ 62
Query: 183 HVVKLYGVVSEGNPTLV-------------IMELMGGGDLKNYLRSCRPDAETDVERSPP 229
+VV+ Y E + ME G L + + S + + D
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD------ 116
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR 289
++ ++ + ++Y+ + +HRDL N + + VK+GDFG+ ++++ +
Sbjct: 117 ---EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 290 KGSRGFLPVR------------WMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQ 336
K LP ++A E L G + D++S G++ +EM
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FST 230
Query: 337 GLSNEQVLNWVKGKSSNEYKVNPPIS 362
G+ +L ++ + P
Sbjct: 231 GMERVNILKKLRSV---SIEFPPDFD 253
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 38/249 (15%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVANENASEREKAEFLNEASVMK 177
+ + LG G FG V H AIK + S + + + E +MK
Sbjct: 17 EMKERLGTGGFGYVL---------RWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 178 AFDTHHVVKLYGV------VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
+ +VV V ++ + L+ ME GGDL+ YL E +
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN----QFENCCGLKEGPI 123
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMV---ADDLTVKVGDFGMTRDIYETEYY 288
+L +++ + YL + + +HRDL N ++ L K+ D G +++ + E
Sbjct: 124 RTLLS---DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 289 RK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
+ G+ + +APE L+ +T D WS+G + +E T +P+ +
Sbjct: 181 TEFVGTLQY-----LAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLPNWQPVQWHG 234
Query: 347 VKGKSSNEY 355
+ SNE+
Sbjct: 235 KVREKSNEH 243
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 54/239 (22%), Positives = 98/239 (41%), Gaps = 20/239 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
+ ELG G+ G+V++ K + A K+ + + + + E V+ ++
Sbjct: 36 EKISELGAGNGGVVFKVSHKPSGLVM----ARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
++V YG + ME M GG L L+ E L ++ + V
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKV---SIAVI 141
Query: 243 DGMAYL-ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
G+ YL K +HRD+ N +V +K+ DFG++ + ++ G +M
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRS--YM 197
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360
+PE L+ ++ SD+WS G+ L EMA P +++ + + PP
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRY-PIPPPDAKELELMFGCQVEGDAAETPP 255
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-29
Identities = 54/230 (23%), Positives = 82/230 (35%), Gaps = 46/230 (20%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
+ D LG G+ V+RG K AIKV N + R + E V+K +
Sbjct: 12 LLSDILGQGATANVFRGRHKK----TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 183 HVVKLYGVVSEGNPTLV--IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
++VKL+ + E IME G L L + +L+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIVLR---D 120
Query: 241 VADGMAYLADKKFVHRDLAARNCMVA----DDLTVKVGDFGMTRDIYE---------TEY 287
V GM +L + VHR++ N M K+ DFG R++ + TE
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHS--------DVWSYGVVLWEMAT 329
Y + P+ + V D+WS GV + AT
Sbjct: 181 Y------------LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-29
Identities = 44/232 (18%), Positives = 84/232 (36%), Gaps = 23/232 (9%)
Query: 123 TILDELGNG--SFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAF 179
+L +G G V K ++ N E S E V K F
Sbjct: 28 ELLTVIGKGFEDLMTVNLARYKPTGEY----VTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+ ++V N V+ M G K+ + + D + ++ ILQ
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE-----LAIAYILQ--- 135
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299
V + Y+ +VHR + A + +++ D V + + ++ F
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 300 -----WMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
W++PE L+ + + + SD++S G+ E+A P++ + Q+L
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH-VPFKDMPATQML 246
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 18/218 (8%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
LG G++G+VY G + AIK E S + E ++ K ++V+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVR----IAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQY 84
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247
G SE + ME + GG L LRS I ++ +G+ Y
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRS-------KWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 248 LADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL 306
L D + VHRD+ N ++ +K+ DFG ++ + + G +++MAPE +
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG--TLQYMAPEII 195
Query: 307 KDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
G + +D+WS G + EMAT P+ L Q
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELGEPQ 232
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
++G GS G+V K A+K+ + +R + NE +M+ +
Sbjct: 48 DSYVKIGEGSTGIVCLAREKHSGRQV----AVKMMDLRKQQR-RELLFNEVVIMRDYQHF 102
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETD-VERSPPTLSRILQMAAEV 241
+VV++Y G V+ME + GG L TD V + +I + V
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGAL------------TDIVSQVRLNEEQIATVCEAV 150
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG--FLPVR 299
+AYL + +HRD+ + + ++ D VK+ DFG I + RK G +
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY---- 206
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMA 328
WMAPE + ++ + D+WS G+++ EM
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMV 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 54/230 (23%), Positives = 82/230 (35%), Gaps = 46/230 (20%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
+ D LG G+ V+RG K AIKV N + R + E V+K +
Sbjct: 12 LLSDILGQGATANVFRGRHKK----TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 183 HVVKLYGVVSEGNPTLV--IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
++VKL+ + E IME G L L + +L+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIVLR---D 120
Query: 241 VADGMAYLADKKFVHRDLAARNCMVA----DDLTVKVGDFGMTRDIYE---------TEY 287
V GM +L + VHR++ N M K+ DFG R++ + TE
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHS--------DVWSYGVVLWEMAT 329
Y + P+ + V D+WS GV + AT
Sbjct: 181 Y------------LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
I+ ELG+G+FG VY+ K+ +LA A KV + E E +++ E ++ D
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALA----AAKVIETKSEE-ELEDYIVEIEILATCDHP 76
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
++VKL G +++E GG + + T +I + ++
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---------DRGLTEPQIQVVCRQML 127
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG--FLPVRW 300
+ + +L K+ +HRDL A N ++ + +++ DFG++ +T R G + W
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY----W 183
Query: 301 MAPE-----SLKDGVFTSHSDVWSYGVVLWEMA 328
MAPE ++KD + +D+WS G+ L EMA
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
T +++G G+ G VY + AI+ N + K +NE VM+
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEV----AIRQMNLQQQPK-KELIINEILVMRENKNP 77
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETD-VERSPPTLSRILQMAAEV 241
++V G+ V+ME + GG L TD V + +I + E
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSL------------TDVVTETCMDEGQIAAVCREC 125
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG--FLPVR 299
+ +L + +HRD+ + N ++ D +VK+ DFG I + R G +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY---- 181
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMA 328
WMAPE + + D+WS G++ EM
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 51/260 (19%), Positives = 99/260 (38%), Gaps = 43/260 (16%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL-NEASVMKAF 179
D LG+G+ G + + D A+K E F E +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-----NRDVAVKRIL-----PECFSFADREVQLLRES 74
Query: 180 DTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
D H +V++ + + + +EL L+ Y+ + D +LQ
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYV------EQKDFAHLGLEPITLLQ-- 125
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVAD-----DLTVKVGDFGMTRDIYETEYYRK--- 290
+ G+A+L VHRDL N +++ + + DFG+ + + +
Sbjct: 126 -QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 291 ---GSRGFLPVRWMAPESLKDGVFTSHS---DVWSYGVVLWEMATLASQPYQGLSNEQVL 344
G+ G W+APE L + + + D++S G V + + + S P+ S ++
Sbjct: 185 GVPGTEG-----WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK-SLQRQA 238
Query: 345 NWVKGKSSNEYKVNPPISLS 364
N + G S + ++P
Sbjct: 239 NILLGACSLDC-LHPEKHED 257
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 51/237 (21%), Positives = 98/237 (41%), Gaps = 29/237 (12%)
Query: 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEA 173
++ + + L E+G+G+ G V++ + + A+K + ++ E L +
Sbjct: 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHV----IAVKQMRRSGNKEENKRILMDL 74
Query: 174 SV-MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
V +K+ D ++V+ +G + MELMG K R P E L
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE-------RILG 127
Query: 233 RILQMAAEVADGMAYL-ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK- 290
++ + + YL +HRD+ N ++ + +K+ DFG++ + + + +
Sbjct: 128 KMTV---AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS 184
Query: 291 -GSRGFLPVRWMAPE-----SLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341
G +MAPE + +DVWS G+ L E+AT PY+ +
Sbjct: 185 AGCAA-----YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF-PYKNCKTD 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 39/233 (16%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNE 172
W+ + L E+G G++G V + + K + A+K E+E+ + L +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIM----AVKRIRSTVDEKEQKQLLMD 70
Query: 173 ASV-MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
V M++ D ++V+ YG + + MELM K Y + E L
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE---EIL 127
Query: 232 SRILQMAAEVADGMAYL-ADKKFVHRDLAARNCMVADDLTVKVGDFG----------MTR 280
+I + +L + K +HRD+ N ++ +K+ DFG TR
Sbjct: 128 GKITL---ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 281 DIYETEYYRKGSRGFLPVRWMAPE----SLKDGVFTSHSDVWSYGVVLWEMAT 329
D G R +MAPE S + SDVWS G+ L+E+AT
Sbjct: 185 DA--------GCR-----PYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
+L++LG GS+G VY+ + K+ + AIK E + E + E S+M+ D+
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIV----AIKQVP---VESDLQEIIKEISIMQQCDSP 84
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA--- 239
HVVK YG + ++ME G G S +D+ R ++A
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAG-------SV-----SDIIRLRNKTLTEDEIATILQ 132
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG--FLP 297
G+ YL + +HRD+ A N ++ + K+ DFG+ + +T R G F
Sbjct: 133 STLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-- 190
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMA 328
WMAPE +++ + +D+WS G+ EMA
Sbjct: 191 --WMAPEVIQEIGYNCVADIWSLGITAIEMA 219
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
+++ +GNG++G VY+G LA AIKV + E E E E +++K + H
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLA----AIKVMDVTGDEEE--EIKQEINMLKKYSHH 80
Query: 183 -HVVKLYGVVSEGNPTL------VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
++ YG + NP ++ME G G + + +++ + + + ++ I
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYIC 135
Query: 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG- 294
+ E+ G+++L K +HRD+ +N ++ ++ VK+ DFG++ + T R G
Sbjct: 136 R---EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 295 -FLPVRWMAPE-----SLKDGVFTSHSDVWSYGVVLWEMAT 329
+ WMAPE D + SD+WS G+ EMA
Sbjct: 193 PY----WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV------ANENASEREKAEFLNEASVMK 177
I+D+LG G VY +D L AIK E +R F E
Sbjct: 15 IVDKLGGGGMSTVYLA--EDTI-L-NIKVAIKAIFIPPREKEETLKR----FEREVHNSS 66
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
++V + V E + ++ME + G L Y+ P ++ +
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----------SHGPLSVDTAINF 116
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK----GSR 293
++ DG+ + D + VHRD+ +N ++ + T+K+ DFG+ + + ET + G+
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT- 175
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
V++ +PE K +D++S G+VL+EM P+ G
Sbjct: 176 ----VQYFSPEQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNG 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 56/268 (20%), Positives = 93/268 (34%), Gaps = 44/268 (16%)
Query: 77 PAVTTTTVATPTTPAGGTTTPPNQLMGG-DDDKLYKKDSWEVLRSKVTILDELGNGSFGL 135
T P G D + + + + L E+G+GSFG
Sbjct: 10 HDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGA 69
Query: 136 VYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193
VY + AIK + S + + + E ++ + ++ G
Sbjct: 70 VYFARDVRNSEVV----AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 125
Query: 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA---EVADGMAYLAD 250
+ ++ME G +P E ++AA G+AYL
Sbjct: 126 EHTAWLVMEYCLGSASDLLEVHKKPLQEV-------------EIAAVTHGALQGLAYLHS 172
Query: 251 KKFVHRDLAARNCMVADDLTVKVGDFG----MTRDIYETEYYRKGSRG--FLPVRWMAPE 304
+HRD+ A N ++++ VK+GDFG M G + WMAPE
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANSFVGTPY----WMAPE 220
Query: 305 ---SLKDGVFTSHSDVWSYGVVLWEMAT 329
++ +G + DVWS G+ E+A
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAE 248
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
+G+G FG VY+G+++D A+K +S+ + EF E + H+V L
Sbjct: 47 IGHGVFGKVYKGVLRDGA-----KVALKRRTPESSQGIE-EFETEIETLSFCRHPHLVSL 100
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS---RILQMAAEVADG 244
G E N ++I + M G+LK +L + ++S R L++ A G
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLY--------GSDLPTMSMSWEQR-LEICIGAARG 151
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR-----KGSRGFLPVR 299
+ YL + +HRD+ + N ++ ++ K+ DFG+++ E + KG+ G++
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI--- 208
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
PE G T SDV+S+GVVL+E+
Sbjct: 209 --DPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 40/226 (17%), Positives = 81/226 (35%), Gaps = 43/226 (19%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH 183
+ + +G G +Y D R++ P +K + +A + E +
Sbjct: 84 VKGCIAHGGLGWIYLA--LD-RNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 184 VVKLYGVVSEGNPT------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
+V+++ V + +V ME +GG LK + ++ +
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIV-MEYVGGQSLK------------RSKGQKLPVAEAIAY 187
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG----MTRD--IYETEYYRKG 291
E+ ++YL V+ DL N M+ ++ +K+ D G + +Y T +
Sbjct: 188 LLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGF--- 243
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
APE ++ G T +D+++ G L + G
Sbjct: 244 ---------QAPEIVRTGP-TVATDIYTVGRTLAALTL-DLPTRNG 278
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 49/239 (20%), Positives = 94/239 (39%), Gaps = 42/239 (17%)
Query: 106 DDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV--------A 157
D L S + LG G +V R + K A+K+
Sbjct: 3 DAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTC----KEYAVKIIDVTGGGSF 58
Query: 158 NENASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSC 216
+ + + L E +++ H ++++L ++ +LM G+L +YL
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--- 115
Query: 217 RPDAETDVER---SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273
E+ S +I++ + + + L VHRDL N ++ DD+ +K+
Sbjct: 116 -------TEKVTLSEKETRKIMR---ALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 165
Query: 274 GDFGMTRDIYETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHS------DVWSYGVVL 324
DFG + + E R+ G+ + +APE ++ + +H D+WS GV++
Sbjct: 166 TDFGFSCQLDPGEKLREVCGTPSY-----LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 38/238 (15%), Positives = 78/238 (32%), Gaps = 28/238 (11%)
Query: 107 DKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHP-CAIKVANENASERE 165
+ K +++ V + LG G+F VY D +KV + A+ E
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV-QKPANPWE 110
Query: 166 KAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVE 225
+K H +K Y N ++++ EL G L N + + E +
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM- 169
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-----------DLTVKVG 274
++ A + + + D + +H D+ N ++ + + +
Sbjct: 170 ----PQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225
Query: 275 DFGMTRDIY-----ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
D G + D+ + + GF E L + + D + ++ M
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGF-----QCVEMLSNKPWNYQIDYFGVAATVYCM 278
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 58/237 (24%), Positives = 107/237 (45%), Gaps = 27/237 (11%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVM 176
L + +LG+G++G V K AIK+ + S ++ L E +V+
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKV----THVERAIKIIRKTSVSTSSNSKLLEEVAVL 90
Query: 177 KAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
K D +++KLY + ++ME GG+L + + E D + I++
Sbjct: 91 KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-------AVIIK 143
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDIYETEYYRK--G 291
+V G+ YL VHRDL N ++ D +K+ DFG++ + ++ G
Sbjct: 144 ---QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+ + +APE L+ + DVWS GV+L+ + P+ G +++++L V+
Sbjct: 201 TAYY-----IAPEVLR-KKYDEKCDVWSIGVILFILLA-GYPPFGGQTDQEILRKVE 250
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 53/285 (18%), Positives = 105/285 (36%), Gaps = 47/285 (16%)
Query: 85 ATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF 144
A P + G + + +G + E+ ++ + L G F VY +D
Sbjct: 2 AGPGSLGGASGRDQSDFVG---------QTVELGELRLRVRRVLAEGGFAFVY--EAQDV 50
Query: 145 RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPT------ 197
S A+K N E + + E MK H ++V+ S G
Sbjct: 51 GS--GREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107
Query: 198 --LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--F 253
L++ EL G + +L+ R P + +L++ + + ++ +K
Sbjct: 108 EFLLLTELCKGQLV-EFLKKME-------SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI 159
Query: 254 VHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR----------WMAP 303
+HRDL N ++++ T+K+ DFG I Y ++ V + P
Sbjct: 160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
Query: 304 E---SLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
E + D+W+ G +L+ + P++ + +++N
Sbjct: 220 EIIDLYSNFPIGEKQDIWALGCILYLLCFRQH-PFEDGAKLRIVN 263
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 42/233 (18%)
Query: 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEA 173
S EV + + ELG G++G+V + + A+K + +E+ L +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIM----AVKRIRATVNSQEQKRLLMDL 56
Query: 174 SV-MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGG---DLKNYLRSCRPDAETDVERSPP 229
+ M+ D V YG + + MELM K + + E
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPE-------D 109
Query: 230 TLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFG--------MTR 280
L +I A + + +L K +HRD+ N ++ VK+ DFG + +
Sbjct: 110 ILGKI---AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166
Query: 281 DIYETEYYRKGSRGFLPVRWMAPE----SLKDGVFTSHSDVWSYGVVLWEMAT 329
DI G + +MAPE L ++ SD+WS G+ + E+A
Sbjct: 167 DID------AGCK-----PYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 55/270 (20%), Positives = 107/270 (39%), Gaps = 44/270 (16%)
Query: 77 PAVTTTTVATPTTPAGGTTTPPNQLMG---GDDDKLYKKDSWEVLRSKVTILDELGNGSF 133
P+ + +A L G +D+L + + K D +G G
Sbjct: 48 PSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVS 107
Query: 134 GLVYRGLIKDFRSLAEHPCAIKV-------ANENASEREKAEFLNEASVMKAFDTH-HVV 185
+V R + + H A+K+ + E + E +++ H H++
Sbjct: 108 SVVRRCVHRATG----HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVER---SPPTLSRILQMAAEVA 242
L + ++ +LM G+L +YL E+ S I++ +
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYL----------TEKVALSEKETRSIMRS---LL 210
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK--GSRGFLPVRW 300
+ +++L VHRDL N ++ D++ +++ DFG + + E R+ G+ G+
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY----- 265
Query: 301 MAPESLKDGVFTSHS------DVWSYGVVL 324
+APE LK + +H D+W+ GV+L
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-24
Identities = 44/226 (19%), Positives = 84/226 (37%), Gaps = 37/226 (16%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEH---PCAIKVANENASEREKAEFL---------- 170
I+ L G F + L E A+K ++ E+++
Sbjct: 35 IIRTLNQGKFNKII---------LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 171 ------NEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDV 224
NE ++ + + G+++ + +I E M + + +
Sbjct: 86 KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 225 ERSPPTLSRILQMAAEVADGMAYL-ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
P + + + V + +Y+ +K HRD+ N ++ + VK+ DFG + Y
Sbjct: 146 CFIPIQVIK--CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE--Y 201
Query: 284 ETEYYRKGSRGFLPVRWMAPE--SLKDGVFTSHSDVWSYGVVLWEM 327
+ KGSRG +M PE S + + D+WS G+ L+ M
Sbjct: 202 MVDKKIKGSRGTYE--FMPPEFFSNESSYNGAKVDIWSLGICLYVM 245
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 57/278 (20%), Positives = 108/278 (38%), Gaps = 52/278 (18%)
Query: 118 LRSKVTILDELGNGSFG-LVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL-NEASV 175
L++ V LG GS G +V++G + P A+K + + E +
Sbjct: 13 LKNLVVSEKILGYGSSGTVVFQGSFQG------RPVAVKRML-----IDFCDIALMEIKL 61
Query: 176 MKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
+ D H +V++ Y + + +EL +L++ + S E + +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 235 LQMAAEVADGMAYLADKKFVHRDL-------------AARNCMVADDLTVKVGDFGMTRD 281
L+ ++A G+A+L K +HRDL A A++L + + DFG+ +
Sbjct: 121 LR---QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 282 IYETEYYRK-------GSRGFLPVRWMAPESLKDGVFTSHS-------DVWSYGVVLWEM 327
+ + + G+ G W APE L++ D++S G V + +
Sbjct: 178 LDSGQSSFRTNLNNPSGTSG-----WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 328 ATLASQPYQGLSNEQVLNWVKGK-SSNEYKVNPPISLS 364
+ P+ + N ++G S +E K SL
Sbjct: 233 LSKGKHPFGD-KYSRESNIIRGIFSLDEMKCLHDRSLI 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-24
Identities = 54/270 (20%), Positives = 95/270 (35%), Gaps = 47/270 (17%)
Query: 76 GPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGL 135
++ V + G + G Y+ + +G G G
Sbjct: 7 HHHHSSGLVPRGSHMDGTAESREGTQFGP-----YR------------LRRLVGRGGMGD 49
Query: 136 VYRGLIKDFRSLAEHPCAIKV------ANENASEREKAEFLNEASVMKAFDTHHVVKLYG 189
VY +D E A+K+ ++ R EA HVV ++
Sbjct: 50 VYEA--EDTV--RERIVALKLMSETLSSDPVFRTR----MQREARTAGRLQEPHVVPIHD 101
Query: 190 V-VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYL 248
+G + M L+ G DL LR + P R + + ++ +
Sbjct: 102 FGEIDGQLYVD-MRLINGVDLAAMLR----------RQGPLAPPRAVAIVRQIGSALDAA 150
Query: 249 ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL-PVRWMAPESLK 307
HRD+ N +V+ D + DFG+ + + + G+ + + +MAPE
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGTLYYMAPERFS 208
Query: 308 DGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
+ T +D+++ VL+E T S PYQG
Sbjct: 209 ESHATYRADIYALTCVLYECLT-GSPPYQG 237
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 43/237 (18%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIK---VANENASEREKAEFLNEASVMKAFDTHHV 184
+G G FG+VY+G + + A+K + +E K +F E VM ++
Sbjct: 39 MGEGGFGVVYKGYVNN------TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS---RILQMAAEV 241
V+L G S+G+ ++ M G L + L P LS R ++A
Sbjct: 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSC---------LDGTPPLSWHMR-CKIAQGA 142
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY----R-KGSRGFL 296
A+G+ +L + +HRD+ + N ++ + T K+ DFG+ R + R G+ +
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAY- 201
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEM-----ATLASQPYQGLSNEQVLNWVK 348
MAPE+L+ G T SD++S+GVVL E+ A + Q L L+ +
Sbjct: 202 ----MAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-----LDIKE 248
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 28/238 (11%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASV 175
+ LG GSFG V K CA+KV ++ + +K L E +
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKI----TGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 176 MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
+K D +++KLY + ++ E+ GG+L + + S + +E D +RI+
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-------ARII 132
Query: 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDIYETEYYRK-- 290
+ +V G+ Y+ K VHRDL N ++ D +++ DFG++ ++ +
Sbjct: 133 R---QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
G+ + +APE L G + DVWS GV+L+ + + P+ G + +L V+
Sbjct: 190 GTAYY-----IAPEVLH-GTYDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKVE 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 56/232 (24%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 99 NQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN 158
+ G ++ ++ + I+ LG GSFG V + + + A+KV N
Sbjct: 5 HHHSSGRENLYFQGT----FAERYNIVCMLGKGSFGEVLKCKDRI----TQQEYAVKVIN 56
Query: 159 -ENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCR 217
+A ++ + L E ++K D +++KL+ ++ + + ++ EL GG+L + + +
Sbjct: 57 KASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK 116
Query: 218 PDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVG 274
+E D +RI++ +V G+ Y+ VHRDL N ++ D +K+
Sbjct: 117 RFSEHDA-------ARIIK---QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 275 DFGMTRDIYETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
DFG++ + + G+ + +APE L+ G + DVWS GV+L
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYY-----IAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKL 187
LG G FG VY+G + D +A +K E ++ + +F E ++ ++++L
Sbjct: 38 LGRGGFGKVYKGRLADGTLVA-----VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP---PTLSRILQMAAEVADG 244
G L++ M G + + LR + P P RI A A G
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRERPES------QPPLDWPKRQRI---ALGSARG 143
Query: 245 MAYL---ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY---R-KGSRGFLP 297
+AYL D K +HRD+ A N ++ ++ VGDFG+ + + + + +G+ G
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH-- 201
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
+APE L G + +DV+ YGV+L E+ T
Sbjct: 202 ---IAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-23
Identities = 51/235 (21%), Positives = 96/235 (40%), Gaps = 33/235 (14%)
Query: 99 NQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN 158
+ G ++ ++ + +LG+G+FG V+ + + IK N
Sbjct: 5 HHHSSGRENLYFQGT----IDDLFIFKRKLGSGAFGDVHLVEERS----SGLERVIKTIN 56
Query: 159 ENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRP 218
++ S+ + E V+K+ D +++K++ V + + ++ME GG+L + S +
Sbjct: 57 KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 219 DAETDVERSPPTLSRILQMAAE----VADGMAYLADKKFVHRDLAARNCMVA---DDLTV 271
+ E AE + + +AY + VH+DL N + +
Sbjct: 117 RGKALSEG----------YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI 166
Query: 272 KVGDFGMTRDIYETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
K+ DFG+ E+ G+ + MAPE K T D+WS GVV+
Sbjct: 167 KIIDFGLAELFKSDEHSTNAAGTALY-----MAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 54/248 (21%), Positives = 103/248 (41%), Gaps = 42/248 (16%)
Query: 87 PTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS 146
+ G ++ M K + +ELG G+F +V R + K
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDN---------YDVKEELGKGAFSVVRRCVHKT--- 52
Query: 147 LAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205
A K+ N + S R+ + EA + + ++V+L+ + E + ++ +L+
Sbjct: 53 -TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111
Query: 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE----VADGMAYLADKKFVHRDLAAR 261
GG+L + V R S A+ + + +AY VHR+L
Sbjct: 112 GGELFEDI----------VARE--FYSE--ADASHCIQQILESIAYCHSNGIVHRNLKPE 157
Query: 262 NCMVA---DDLTVKVGDFGMTRDIYETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHSD 316
N ++A VK+ DFG+ ++ ++E + G+ G+ ++PE LK ++ D
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY-----LSPEVLKKDPYSKPVD 212
Query: 317 VWSYGVVL 324
+W+ GV+L
Sbjct: 213 IWACGVIL 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-23
Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVM 176
+ +ELG G+F +V R + K A K+ N S R+ + EA +
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKT----TGLEFAAKIINTKKLSARDFQKLEREARIC 59
Query: 177 KAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
+ ++V+L+ + E + ++ +L+ GG+L + V R S
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----------VARE--FYSE--A 105
Query: 237 MAAE----VADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDIYETEYYR 289
A+ + + +AY VHR+L N ++A VK+ DFG+ ++ ++E +
Sbjct: 106 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165
Query: 290 K--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
G+ G+ ++PE LK ++ D+W+ GV+L
Sbjct: 166 GFAGTPGY-----LSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 30/225 (13%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV------ANENASEREKAEFLNEASVMK 177
+ + LG G V+ +D R A+KV + + R F EA
Sbjct: 16 LGEILGFGGMSEVHLA--RDLR--DHRDVAVKVLRADLARDPSFYLR----FRREAQNAA 67
Query: 178 AFDTHHVVKLYGVVSEGNPTLVI----MELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
A + +V +Y P + ME + G L++ + P T R
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----------TEGPMTPKR 117
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
+++ A+ + + +HRD+ N M++ VKV DFG+ R I ++ +
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 294 GFL-PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337
+ ++++PE + + SDV+S G VL+E+ T P+ G
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 55/260 (21%), Positives = 96/260 (36%), Gaps = 34/260 (13%)
Query: 76 GPAVTTTTVA---TPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGS 132
GPA A P PP + + + + R LG G
Sbjct: 1 GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRF-------LGKGG 53
Query: 133 FGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFDTHHVVKLYGV 190
F + I D + + A K+ ++ + E S+ ++ HVV +G
Sbjct: 54 FAKCF--EISDADT--KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD 250
+ + V++EL L + + E + L+ ++ G YL
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------RYYLR---QIVLGCQYLHR 159
Query: 251 KKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK---GSRGFLPVRWMAPESLK 307
+ +HRDL N + +DL VK+GDFG+ + +K G+ ++ APE L
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI-----APEVLS 214
Query: 308 DGVFTSHSDVWSYGVVLWEM 327
+ DVWS G +++ +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTL 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 24/205 (11%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFDTHHVV 185
LG G F + I D + + A K+ ++ + E S+ ++ HVV
Sbjct: 23 LGKGGFAKCF--EISDADT--KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
+G + + V++EL L + + E + L+ ++ G
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------RYYLR---QIVLGC 128
Query: 246 AYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK---GSRGFLPVRWMA 302
YL + +HRDL N + +DL VK+GDFG+ + +K G+ ++ A
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI-----A 183
Query: 303 PESLKDGVFTSHSDVWSYGVVLWEM 327
PE L + DVWS G +++ +
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTL 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 54/240 (22%), Positives = 92/240 (38%), Gaps = 49/240 (20%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH-----PCAIKV--- 156
DD +Y K LR + + LG+G+ G V LA AI++
Sbjct: 124 DDQSVYPKA----LRDEYIMSKTLGSGACGEVK---------LAFERKTCKKVAIRIISK 170
Query: 157 ----ANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNY 212
E ++K + ++K+ + +V +ELM GG+L +
Sbjct: 171 RKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIV-LELMEGGELFDK 229
Query: 213 LRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDL 269
+ + E QM + YL + +HRDL N +++ +D
Sbjct: 230 VVGNKRLKEAT------CKLYFYQM----LLAVQYLHENGIIHRDLKPENVLLSSQEEDC 279
Query: 270 TVKVGDFGMTRDIYETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHS---DVWSYGVVL 324
+K+ DFG ++ + ET R G+ + +APE L ++ D WS GV+L
Sbjct: 280 LIKITDFGHSKILGETSLMRTLCGTPTY-----LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 50/219 (22%), Positives = 89/219 (40%), Gaps = 42/219 (19%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-----ANENASEREKAEFLNEASVMK 177
I +ELG+G F +V + K A K + + + E E S+++
Sbjct: 15 DIGEELGSGQFAIVKKCREKS----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDL------KNYLRSCRPDAETDVERSPPTL 231
+++ L+ V ++I+EL+ GG+L K L E +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS------EEEA------- 117
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA----DDLTVKVGDFGMTRDIYETEY 287
+ ++ + DG+ YL KK H DL N M+ +K+ DFG+ +I +
Sbjct: 118 TSFIKQ---ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 288 YRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
++ G+ F +APE + +D+WS GV+
Sbjct: 175 FKNIFGTPEF-----VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 37/224 (16%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV------------ANENASERE 165
+ + +LG+G++G V K+ AIKV + E+
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKN----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 166 KAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVE 225
E NE S++K+ D +++KL+ V + ++ E GG+L + + E D
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA- 148
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDI 282
+ I++ ++ G+ YL VHRD+ N ++ L +K+ DFG++
Sbjct: 149 ------ANIMK---QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 283 YETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ R G+ + +APE LK + DVWS GV++
Sbjct: 200 SKDYKLRDRLGTAYY-----IAPEVLK-KKYNEKCDVWSCGVIM 237
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-22
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-----ANENASEREKAEFLNEASVMK 177
I +ELG+G F +V + K A K + + + E E S+++
Sbjct: 15 DIGEELGSGQFAIVKKCREKS----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
H+V+ L+ V ++I+EL+ GG+L ++L ++ +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----------AQKESLSEEEATSF 120
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVA----DDLTVKVGDFGMTRDIYETEYYRK--G 291
++ DG+ YL KK H DL N M+ +K+ DFG+ +I + ++ G
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ F +APE + +D+WS GV+
Sbjct: 181 TPEF-----VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 8e-22
Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMK 177
+ IL+ELG+G+FG+V+R + K K N +K NE S+M
Sbjct: 49 VYDYYDILEELGSGAFGVVHRCVEKA----TGRVFVAKFINT-PYPLDKYTVKNEISIMN 103
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDL------KNYLRSCRPDAETDVERSPPTL 231
++ L+ + ++I+E + GG+L ++Y S E +V
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS-----EAEV------- 151
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA--DDLTVKVGDFGMTRDIYETEYYR 289
++ + +G+ ++ + VH D+ N M +VK+ DFG+ + E +
Sbjct: 152 INYMR---QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208
Query: 290 K--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ F APE + ++D+W+ GV+
Sbjct: 209 VTTATAEF-----AAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 9e-22
Identities = 43/249 (17%), Positives = 87/249 (34%), Gaps = 32/249 (12%)
Query: 106 DDKLY---------KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHP----- 151
DD Y ++ + E + +V L +L + + ++ +
Sbjct: 30 DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW 89
Query: 152 -CAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLK 210
+S + M F T + V S + M+L +LK
Sbjct: 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLK 149
Query: 211 NYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270
+++ + + L + ++A+ + +L K +HRDL N D
Sbjct: 150 DWMNRRCSLEDREHGV-------CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV 202
Query: 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVR----------WMAPESLKDGVFTSHSDVWSY 320
VKVGDFG+ + + E + +M+PE + ++ D++S
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262
Query: 321 GVVLWEMAT 329
G++L+E+
Sbjct: 263 GLILFELLY 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 50/232 (21%), Positives = 88/232 (37%), Gaps = 51/232 (21%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH-----PCAIKV-------ANENASE 163
+ LR + + LG+G+ G V LA AIK+
Sbjct: 6 KALRDEYIMSKTLGSGACGEVK---------LAFERKTCKKVAIKIISKRKFAIGSAREA 56
Query: 164 REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETD 223
E ++K + ++K+ + +V +ELM GG+L + +
Sbjct: 57 DPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIV-LELMEGGELFDKV---------- 105
Query: 224 VER---SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFG 277
V T ++ + YL + +HRDL N +++ +D +K+ DFG
Sbjct: 106 VGNKRLKEATCKLYFY---QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162
Query: 278 MTRDIYETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHS---DVWSYGVVL 324
++ + ET R G+ + +APE L ++ D WS GV+L
Sbjct: 163 HSKILGETSLMRTLCGTPTY-----LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-21
Identities = 44/206 (21%), Positives = 84/206 (40%), Gaps = 25/206 (12%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFDTHHVV 185
LG GSF VY + + AIK+ ++ A + NE + ++
Sbjct: 19 LGKGSFAGVY--RAESIHT--GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRS-CRPDAETDVERSPPTLSRILQMAAEVADG 244
+LY + N +++E+ G++ YL++ +P +E + ++ G
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE-------NEARHFMH---QIITG 124
Query: 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK---GSRGFLPVRWM 301
M YL +HRDL N ++ ++ +K+ DFG+ + G+ ++
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI----- 179
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEM 327
+PE SDVWS G + + +
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTL 205
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 22/219 (10%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE-- 168
KK W + I LG G FG VY L ++ +S + A+KV + E+ E
Sbjct: 2 KKRQWAL--EDFEIGRPLGKGKFGNVY--LAREKQS--KFILALKVLFKAQLEKAGVEHQ 55
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
E + ++++LYG + +I+E G + L+ E
Sbjct: 56 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-- 113
Query: 229 PTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY 288
E+A+ ++Y K+ +HRD+ N ++ +K+ DFG + ++
Sbjct: 114 --------YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 163
Query: 289 RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
R G L ++ PE ++ + D+WS GV+ +E
Sbjct: 164 RTDLCGTLD--YLPPEMIEGRMHDEKVDLWSLGVLCYEF 200
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 51/236 (21%), Positives = 91/236 (38%), Gaps = 33/236 (13%)
Query: 103 GGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN---- 158
GG L D + + + +G G F +V R + ++ A+K+ +
Sbjct: 7 GGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETG----QQFAVKIVDVAKF 62
Query: 159 ENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRP 218
++ + EAS+ H+V+L S ++ E M G DL +
Sbjct: 63 TSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI----- 117
Query: 219 DAETDVERSPPTLSRILQMAAE----VADGMAYLADKKFVHRDLAARNCMVA---DDLTV 271
V+R+ +A+ + + + Y D +HRD+ ++A + V
Sbjct: 118 -----VKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172
Query: 272 KVGDFGMTRDIYETEYYRK---GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
K+G FG+ + E+ G+ F MAPE +K + DVW GV+L
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRVGTPHF-----MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 55/243 (22%), Positives = 101/243 (41%), Gaps = 52/243 (21%)
Query: 99 NQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN 158
+ G ++ ++ + I+ LG GSFG V + + + A+KV N
Sbjct: 5 HHHSSGRENLYFQGT----FAERYNIVCMLGKGSFGEVLKCKDRI----TQQEYAVKVIN 56
Query: 159 -ENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCR 217
+A ++ + L E ++K D +++KL+ ++ + + ++ EL GG+L
Sbjct: 57 KASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-------- 108
Query: 218 PDAETDVERSPPTLSRILQ-------MAAE----VADGMAYLADKKFVHRDLAARNCMVA 266
I++ AA V G+ Y+ VHRDL N ++
Sbjct: 109 -------------FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155
Query: 267 ---DDLTVKVGDFGMTRDIYETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYG 321
D +K+ DFG++ + + G+ + +APE L+ G + DVWS G
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY-----IAPEVLR-GTYDEKCDVWSAG 209
Query: 322 VVL 324
V+L
Sbjct: 210 VIL 212
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 38/219 (17%), Positives = 85/219 (38%), Gaps = 36/219 (16%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASV 175
+ L K I ++LG G FG+V+R + ++ K +++ + E S+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETS----SKKTYMAKFVKVKGTDQVLVK--KEISI 54
Query: 176 MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDL------KNYLRSCRPDAETDVERSPP 229
+ +++ L+ ++I E + G D+ + + E ++
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELN-----EREI----- 104
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA--DDLTVKVGDFGMTRDIYETEY 287
+ V + + +L H D+ N + T+K+ +FG R + +
Sbjct: 105 --VSYVHQ---VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 288 YRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+R + + APE + V ++ +D+WS G ++
Sbjct: 160 FRLLFTAPEY-----YAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-21
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 26/212 (12%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMK 177
+ T+ + +G GS+G V + K A K + E F E +MK
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKG----TRIRRAAKKIPKYFVEDVDR-FKQEIEIMK 61
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
+ D ++++LY + ++MEL GG+L + V + S ++
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV----------VHKRVFRESDAARI 111
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDIYETEYYRK--GS 292
+V +AY HRDL N + D +K+ DFG+ + R G+
Sbjct: 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGT 171
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ ++P+ L+ G++ D WS GV++
Sbjct: 172 PYY-----VSPQVLE-GLYGPECDEWSAGVMM 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-21
Identities = 49/257 (19%), Positives = 88/257 (34%), Gaps = 58/257 (22%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV------ANENASEREKAEFLN 171
L+ K + +G GS+G+V + AIK+ N + E+ +
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQ----TRAIRAIKIMNKNKIRQINPKDVERIK--T 77
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
E +MK ++ +LY V + ++MEL GG L + L D+
Sbjct: 78 EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 232 SRILQM--------------------------AAE----VADGMAYLADKKFVHRDLAAR 261
+ + + YL ++ HRD+
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 262 NCMVA--DDLTVKVGDFGMTRDIYETEYYRK-------GSRGFLPVRWMAPESLKDGV-- 310
N + + +K+ DFG++++ Y+ G+ F +APE L
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF-----VAPEVLNTTNES 252
Query: 311 FTSHSDVWSYGVVLWEM 327
+ D WS GV+L +
Sbjct: 253 YGPKCDAWSAGVLLHLL 269
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 7e-21
Identities = 30/262 (11%), Positives = 58/262 (22%), Gaps = 59/262 (22%)
Query: 85 ATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF 144
P + + G + + +L G ++ D
Sbjct: 7 REPDRESSAPPDDVQLVPGA-----------RIANGRYRLLIFHGGVPPLQFWQA--LDT 53
Query: 145 RSLAEHPCAIKV--ANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIME 202
+ A+ + E L+ + D V ++ VV LV+ E
Sbjct: 54 A--LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111
Query: 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262
+ GG L+ +V + P+ ++ +A
Sbjct: 112 WIRGGSLQ------------EVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSR 159
Query: 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGV 322
V+ D V + D D+ G
Sbjct: 160 VRVSIDGDVVLAYPATMPDA-----------------------------NPQDDIRGIGA 190
Query: 323 VLWEMATLASQPYQGLSNEQVL 344
L+ + P L
Sbjct: 191 SLYALLV-NRWPLPEAGVRSGL 211
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-21
Identities = 48/228 (21%), Positives = 92/228 (40%), Gaps = 58/228 (25%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVANENASEREKAEFLNE 172
+R ++ LG+G+F V+ L + A+K ++ + R+ + NE
Sbjct: 7 IRKTFIFMEVLGSGAFSEVF---------LVKQRLTGKLFALKCIKKSPAFRDSS-LENE 56
Query: 173 ASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
+V+K ++V L + ++M+L+ GG+L +
Sbjct: 57 IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD--------------------- 95
Query: 233 RILQ-------MAAE----VADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGM 278
RIL+ A+ V + YL + VHRDL N + ++ + + DFG+
Sbjct: 96 RILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL 155
Query: 279 TRDIYETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
++ + + G+ G+ +APE L ++ D WS GV+
Sbjct: 156 SK-MEQNGIMSTACGTPGY-----VAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 47/227 (20%), Positives = 92/227 (40%), Gaps = 33/227 (14%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-----ANENASE 163
++++++ + +ELG+G F +V + K A K +
Sbjct: 3 VFRQEN---VDDYYDTGEELGSGQFAVVKKCREKS----TGLQYAAKFIKKRRTKSSRRG 55
Query: 164 REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETD 223
+ + E S++K +V+ L+ V ++I+EL+ GG+L ++L
Sbjct: 56 VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---------- 105
Query: 224 VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA----DDLTVKVGDFGMT 279
E+ T + ++ +G+ YL + H DL N M+ +K+ DFG+
Sbjct: 106 AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 280 RDIYETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
I ++ G+ F +APE + +D+WS GV+
Sbjct: 166 HKIDFGNEFKNIFGTPEF-----VAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 32/209 (15%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDTH-HV 184
ELG G F +V + + K A K + +AE L+E +V++ + V
Sbjct: 36 ELGRGKFAVVRQCISKS----TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE---- 240
+ L+ V + ++I+E GG++ + + +S
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLC----------LPELAEMVSE--NDVIRLIKQ 139
Query: 241 VADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDIYETEYYRK--GSRGF 295
+ +G+ YL VH DL +N +++ +K+ DFGM+R I R+ G+ +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199
Query: 296 LPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+APE L T+ +D+W+ G++
Sbjct: 200 -----LAPEILNYDPITTATDMWNIGIIA 223
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFDT 181
I LG G FG VY L ++ ++ + A+KV ++ E+E E E +
Sbjct: 18 IGRPLGKGKFGNVY--LAREKQN--KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+++++Y + +++E G+L L+ R S E+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--------RFDEQRSA--TFMEEL 123
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
AD + Y ++K +HRD+ N ++ +K+ DFG + ++ R+ G L ++
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLD--YL 179
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEM 327
PE ++ D+W GV+ +E
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEF 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 57/267 (21%), Positives = 100/267 (37%), Gaps = 51/267 (19%)
Query: 74 SGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSF 133
SG T + + P + D + L + ELG G+
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNR--DALSDFFEVESELGRGAT 66
Query: 134 GLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193
+VYR K + P A+KV + +K E V+ +++KL +
Sbjct: 67 SIVYRCKQKG----TQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ-------MAAE----VA 242
+++EL+ GG+L RI++ AA+ +
Sbjct: 120 PTEISLVLELVTGGEL---------------------FDRIVEKGYYSERDAADAVKQIL 158
Query: 243 DGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDIYETEYYRK--GSRGFLP 297
+ +AYL + VHRDL N + A D +K+ DFG+++ + + G+ G+
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGY-- 216
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVL 324
APE L+ + D+WS G++
Sbjct: 217 ---CAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-----ANENASEREKAEFLNE 172
+ + +ELG+G F +V + K A K + + + E E
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKG----TGKEYAAKFIKKRRLSSSRRGVSREEIERE 58
Query: 173 ASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
++++ +++ L+ + ++I+EL+ GG+L ++L E+ T
Sbjct: 59 VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----------AEKESLTED 108
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVA----DDLTVKVGDFGMTRDIYETEYY 288
Q ++ DG+ YL K+ H DL N M+ + +K+ DFG+ I +
Sbjct: 109 EATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 289 RK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ G+ F +APE + +D+WS GV+
Sbjct: 169 KNIFGTPEF-----VAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 35/242 (14%), Positives = 63/242 (26%), Gaps = 49/242 (20%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV--ANENASEREKAEFLNEASVMKA 178
K+ +++ L G +V+ + A+KV S E
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERL----EDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 179 FDTHHVVKLYG----------VVSEGNPTLV----------------IMELMGGGDLKNY 212
+ V + P +M DL+
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV-DLELL 177
Query: 213 LRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272
+ V R + + + A++ A L K VH N + D +
Sbjct: 178 FSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLM 234
Query: 273 VGDFGMTRDIYETEYYRKGSRGFLPV--RWMAPESL---KDGVFTSHSDVWSYGVVLWEM 327
+GD + G+RG AP FT + W G+ ++ +
Sbjct: 235 LGDVSALW--------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 328 AT 329
Sbjct: 287 WC 288
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 35/209 (16%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVV 185
+ LG G FG V++ A K+ + +K E NE SVM D +++
Sbjct: 95 EILGGGRFGQVHKCEETA----TGLKLAAKIIKTRGMK-DKEEVKNEISVMNQLDHANLI 149
Query: 186 KLYGVVSEGNPTLVIMELMGGGDL------KNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+LY N +++ME + GG+L ++Y + E D ++
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-----ELDT-------ILFMKQ-- 195
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVA--DDLTVKVGDFGMTRDIYETEYYRK--GSRGF 295
+ +G+ ++ +H DL N + D +K+ DFG+ R E + G+ F
Sbjct: 196 -ICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF 254
Query: 296 LPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+APE + + +D+WS GV+
Sbjct: 255 -----LAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-20
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 35/217 (16%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVAN-ENASEREKAEFLNEASVM 176
+L +G G+F V LA H AIK+ + + + E +M
Sbjct: 18 RLLKTIGKGNFAKVK---------LARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 177 KAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
K + ++VKL+ V+ +IME GG++ +YL + E R +
Sbjct: 69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEAR------SKFR 121
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL 296
++ + Y K+ VHRDL A N ++ D+ +K+ DFG + + G
Sbjct: 122 ---QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN-EFTVGGKLDAFCGAP 177
Query: 297 PVRWMAPESLK----DGVFTSHSDVWSYGVVLWEMAT 329
P + APE + DG DVWS GV+L+ + +
Sbjct: 178 P--YAAPELFQGKKYDG---PEVDVWSLGVILYTLVS 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 23/211 (10%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMK 177
+ I +ELG G+FG+V+R + + A K +K E M
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATG----NNFAAKFVMTPHES-DKETVRKEIQTMS 209
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
+V L+ + N ++I E M GG+L + E + + ++
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---------EHNKMSEDEAVEY 260
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVA--DDLTVKVGDFGMTRDIYETEYYRK--GSR 293
+V G+ ++ + +VH DL N M +K+ DFG+T + + + G+
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 320
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
F APE + ++D+WS GV+
Sbjct: 321 EF-----AAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 30/249 (12%), Positives = 63/249 (25%), Gaps = 34/249 (13%)
Query: 128 LGNGSFGLVYRGL---------IK-----------DFRSLAEHPCAIKVANENASEREKA 167
LG + + + E +++ ++++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 168 EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG----GGDLKNYLRSCRPDAETD 223
L K+ V + V+ +L+ + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS-- 203
Query: 224 VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
LQ+ +V +A L VH L + ++ V + F
Sbjct: 204 -THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 284 ETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338
+ G GF P A L + T D W+ G+ ++ + P
Sbjct: 263 ASAVSPIGR-GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL-PNTDD 320
Query: 339 SNEQVLNWV 347
+ W+
Sbjct: 321 AALGGSEWI 329
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 47/225 (20%), Positives = 92/225 (40%), Gaps = 48/225 (21%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVM 176
+ + +ELG G+F +V R + A A + N + S R+ + EA +
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVL----AGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 177 KAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
+ ++V+L+ +SE +I +L+ GG+L I+
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---------------------FEDIVA 103
Query: 237 M-------AAE----VADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDI 282
A+ + + + + VHR+L N ++A VK+ DFG+ ++
Sbjct: 104 REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163
Query: 283 -YETEYYRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
E + + G+ G+ ++PE L+ + D+W+ GV+L
Sbjct: 164 EGEQQAWFGFAGTPGY-----LSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 52/217 (23%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH-HV 184
LG GSF + + + K A+K+ ++ R +A E + +K + H ++
Sbjct: 17 KPLGEGSFSICRKCVHKKSN----QAFAVKIISK----RMEANTQKEITALKLCEGHPNI 68
Query: 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ-------M 237
VKL+ V + T ++MEL+ GG+L RI +
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGEL---------------------FERIKKKKHFSETE 107
Query: 238 AAEV----ADGMAYLADKKFVHRDLAARNCMVAD---DLTVKVGDFGMTRDIY-ETEYYR 289
A+ + ++++ D VHRDL N + D +L +K+ DFG R + + +
Sbjct: 108 ASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 290 K--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ + APE L + D+WS GV+L
Sbjct: 168 TPCFTLHY-----AAPELLNQNGYDESCDLWSLGVIL 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-19
Identities = 52/274 (18%), Positives = 88/274 (32%), Gaps = 59/274 (21%)
Query: 74 SGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSF 133
+ P T A P PA PP Q + ++ LG G
Sbjct: 16 APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGIN 75
Query: 134 GLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH-HVVKLYGV-- 190
G V + K + A+K+ + R E + H+V++ V
Sbjct: 76 GKVLQIFNKR----TQEKFALKMLQDCPKARR------EVELHWRASQCPHIVRIVDVYE 125
Query: 191 --VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ---------MAA 239
+ L++ME + GG+L SRI A+
Sbjct: 126 NLYAGRKCLLIVMECLDGGEL---------------------FSRIQDRGDQAFTEREAS 164
Query: 240 EV----ADGMAYLADKKFVHRDLAARNCMVAD---DLTVKVGDFGMTRDIYETEYYRK-- 290
E+ + + YL HRD+ N + + +K+ DFG ++
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ + +APE L + D+WS GV++
Sbjct: 225 YTPYY-----VAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 45/230 (19%), Positives = 85/230 (36%), Gaps = 58/230 (25%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEH-----PCAIKV-------ANENASEREKAEFL 170
+ + LG+G+FG V+ A +K + + + +
Sbjct: 27 STMSPLGSGAFGFVW---------TAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 171 NEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG-GGDLKNYLRSCRPDAETDVER--- 226
E +++ + +++K+ + ++ME G G DL ++
Sbjct: 78 LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI----------DRHPRL 127
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
P S I + ++ + YL K +HRD+ N ++A+D T+K+ DFG
Sbjct: 128 DEPLASYIFR---QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA------ 178
Query: 287 YYRKGSRGFLPV-----RWMAPESLK----DGVFTSHSDVWSYGVVLWEM 327
Y +G + APE L G ++WS GV L+ +
Sbjct: 179 YLERG--KLFYTFCGTIEYCAPEVLMGNPYRG---PELEMWSLGVTLYTL 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-19
Identities = 54/258 (20%), Positives = 100/258 (38%), Gaps = 41/258 (15%)
Query: 85 ATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF 144
++ P G P N L +K E L S+ + LG+G FG VY G
Sbjct: 11 SSGLVPRGSHMAPCNDLHATKLAPGKEK---EPLESQYQVGPLLGSGGFGSVYSG----I 63
Query: 145 RSLAEHPCAIKVAN-ENASEREKAEFLN----EASVMKAFDTH--HVVKLYGVVSEGNPT 197
R P AIK + S+ + E ++K + V++L +
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 198 LVIMEL-MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHR 256
++I+E DL +++ E ++ R +V + + + + +HR
Sbjct: 124 VLILERPEPVQDLFDFITERGALQE-ELAR------SFFW---QVLEAVRHCHNCGVLHR 173
Query: 257 DLAARNCMV-ADDLTVKVGDFGMTRDIYETEYYRK--GSRGFLPVRWMAPESLK----DG 309
D+ N ++ + +K+ DFG + + Y G+R + PE ++ G
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVY-----SPPEWIRYHRYHG 227
Query: 310 VFTSHSDVWSYGVVLWEM 327
+ VWS G++L++M
Sbjct: 228 ---RSAAVWSLGILLYDM 242
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 57/252 (22%), Positives = 92/252 (36%), Gaps = 46/252 (18%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVANENASEREKAEFLNEASVMKAFDTH 182
LG G++G V LA + A+K+ + + E + K +
Sbjct: 15 LGEGAYGEVQ---------LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+VVK YG EGN + +E GG+L + + E + R ++
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQ------RFFH---QLM 115
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR--- 299
G+ YL HRD+ N ++ + +K+ DFG+ T + L
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-----TVFRYNNRERLLNKMCGT 170
Query: 300 --WMAPESLK----DGVFTSHSDVWSYGVVLWEMATLA-SQPYQGLSNEQVLNWVKGKSS 352
++APE LK DVWS G+VL M LA P+ S+
Sbjct: 171 LPYVAPELLKRREFHA---EPVDVWSCGIVLTAM--LAGELPWDQPSDSCQE--YSDWKE 223
Query: 353 NEYKVNPPISLS 364
+ +NP +
Sbjct: 224 KKTYLNPWKKID 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 50/261 (19%), Positives = 87/261 (33%), Gaps = 48/261 (18%)
Query: 84 VATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKD 143
+ P P GG D + ++ + + + LG G FG V+ G
Sbjct: 3 LTKPLQGPPAPPGTPTPPPGGKDREAFEAE-YRLGP-------LLGKGGFGTVFAG---- 50
Query: 144 FRSLAEHPCAIKVAN-ENASEREKAEFLN----EASVMKAFDT---H-HVVKLYGVVSEG 194
R AIKV E +++ H V++L
Sbjct: 51 HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110
Query: 195 NPTLVIMEL-MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKF 253
++++E + DL +Y+ P E R +V + + +
Sbjct: 111 EGFMLVLERPLPAQDLFDYITEKGPLGE-GPSR------CFFG---QVVAAIQHCHSRGV 160
Query: 254 VHRDLAARNCMV-ADDLTVKVGDFGMTRDIYETEYYRK--GSRGFLPVRWMAPESLK--- 307
VHRD+ N ++ K+ DFG + E Y G+R + PE +
Sbjct: 161 VHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVY-----SPPEWISRHQ 214
Query: 308 -DGVFTSHSDVWSYGVVLWEM 327
+ VWS G++L++M
Sbjct: 215 YHA---LPATVWSLGILLYDM 232
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 57/237 (24%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVANENASEREKAEFLN------ 171
T+ DE+G GS+G+V LA + A+KV ++ R+
Sbjct: 16 TLKDEIGKGSYGVVK---------LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGT 66
Query: 172 -------------------EASVMKAFDTHHVVKLYGVVSEGNPTLV--IMELMGGGDLK 210
E +++K D +VVKL V+ + N + + EL+ G +
Sbjct: 67 RPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM 126
Query: 211 NYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270
+ Q ++ G+ YL +K +HRD+ N +V +D
Sbjct: 127 EVPTLKPLSEDQAR--------FYFQ---DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH 175
Query: 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL---KDGVFTSHSDVWSYGVVL 324
+K+ DFG++ + ++ + G +MAPESL + DVW+ GV L
Sbjct: 176 IKIADFGVSNEFKGSDALLSNTVGTPA--FMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-18
Identities = 47/225 (20%), Positives = 76/225 (33%), Gaps = 53/225 (23%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-ANENASEREKAEFLNEASVMKAFDTH-H 183
D LG G+ V + A+K+ + R + E ++ H +
Sbjct: 19 DVLGEGAHARVQTCINLI----TSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQGHRN 72
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM------ 237
V++L E + ++ E M GG + LS I +
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMRGGSI---------------------LSHIHKRRHFNEL 111
Query: 238 -AAEV----ADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDIYETEYYR 289
A+ V A + +L +K HRDL N + VK+ DF + I
Sbjct: 112 EASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 290 KGSRGFLPVR-----WMAPESLKDGVFTSHS-----DVWSYGVVL 324
S L +MAPE ++ + D+WS GV+L
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-18
Identities = 57/252 (22%), Positives = 92/252 (36%), Gaps = 46/252 (18%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVANENASEREKAEFLNEASVMKAFDTH 182
LG G++G V LA + A+K+ + + E + K +
Sbjct: 15 LGEGAYGEVQ---------LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+VVK YG EGN + +E GG+L + + E + R ++
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQ------RFFH---QLM 115
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR--- 299
G+ YL HRD+ N ++ + +K+ DFG+ T + L
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-----TVFRYNNRERLLNKMCGT 170
Query: 300 --WMAPESLK----DGVFTSHSDVWSYGVVLWEMATLA-SQPYQGLSNEQVLNWVKGKSS 352
++APE LK DVWS G+VL M LA P+ S+
Sbjct: 171 LPYVAPELLKRREFHA---EPVDVWSCGIVLTAM--LAGELPWDQPSDSCQE--YSDWKE 223
Query: 353 NEYKVNPPISLS 364
+ +NP +
Sbjct: 224 KKTYLNPWKKID 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 47/221 (21%), Positives = 88/221 (39%), Gaps = 54/221 (24%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
+ +++G GS+ + R + K A+K+ + + K + E ++ + H
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATN----MEFAVKIID-----KSKRDPTEEIEILLRYGQH 75
Query: 183 -HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM---- 237
+++ L V +G V+ ELM GG+L L +IL+
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGEL---------------------LDKILRQKFFS 114
Query: 238 ---AAEV----ADGMAYLADKKFVHRDLAARNCMVA----DDLTVKVGDFGMTRDIYETE 286
A+ V + YL + VHRDL N + + ++++ DFG + +
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 287 YYRK---GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ F +APE L+ + + D+WS GV+L
Sbjct: 175 GLLMTPCYTANF-----VAPEVLERQGYDAACDIWSLGVLL 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 52/219 (23%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVAN----ENASEREKAEFLNEASVMKA 178
LG G+FG V + EH A+K+ N + K + E +K
Sbjct: 19 LGVGTFGKVK---------IGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKL 67
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
F H++KLY V+S ++ME + GG+L +Y+ E + R+ Q
Sbjct: 68 FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-------RRLFQ-- 118
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL-- 296
++ + Y VHRDL N ++ + K+ DFG++ G FL
Sbjct: 119 -QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN------MMSDG--EFLRT 169
Query: 297 ----PVRWMAPESLK----DGVFTSHSDVWSYGVVLWEM 327
P + APE + G D+WS GV+L+ +
Sbjct: 170 SCGSP-NYAAPEVISGRLYAG---PEVDIWSCGVILYAL 204
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 52/219 (23%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVAN----ENASEREKAEFLNEASVMKA 178
LG G+FG V + +H A+K+ N + K E +K
Sbjct: 24 LGVGTFGKVK---------VGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKL 72
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
F H++KLY V+S + ++ME + GG+L +Y+ E R R+ Q
Sbjct: 73 FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE-KESR------RLFQ-- 123
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL-- 296
++ G+ Y VHRDL N ++ + K+ DFG++ G FL
Sbjct: 124 -QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN------MMSDG--EFLRT 174
Query: 297 ----PVRWMAPESLK----DGVFTSHSDVWSYGVVLWEM 327
P + APE + G D+WS GV+L+ +
Sbjct: 175 SCGSP-NYAAPEVISGRLYAG---PEVDIWSSGVILYAL 209
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 9e-17
Identities = 33/237 (13%), Positives = 62/237 (26%), Gaps = 48/237 (20%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKV------ANENASEREKAE------------- 168
LG ++ + V NA ++ K E
Sbjct: 81 LGQEDPYAYLEATDQETG----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 136
Query: 169 --------FLNEASVMKAFDTHHVVKLYGVVSEGN--PTLVIMELMGG--GDLKNYLRSC 216
F+ ++K ++++ + + M L S
Sbjct: 137 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 196
Query: 217 RPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276
LQ+ +V +A L VH L + ++ V + F
Sbjct: 197 S------STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 277 GMTRDIYETEYYRKGSRGFLPVRWMAPES------LKDGVFTSHSDVWSYGVVLWEM 327
SRGF P A + + + T D W+ G+V++ +
Sbjct: 251 EHLVRD-GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 46/221 (20%), Positives = 74/221 (33%), Gaps = 58/221 (26%)
Query: 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH-HV 184
LG G G V + CA+K+ ++ R+ E H+
Sbjct: 35 QVLGLGVNGKVLECFHRRTG----QKCALKLLYDSPKARQ------EVDHHWQASGGPHI 84
Query: 185 VKLYGV----VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ---- 236
V + V L+IME M GG+L SRI +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGEL---------------------FSRIQERGDQ 123
Query: 237 -----MAAEV----ADGMAYLADKKFVHRDLAARNCMVAD---DLTVKVGDFGMTRDIYE 284
AAE+ + +L HRD+ N + D +K+ DFG ++ +
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 285 TEYYRK-GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
+ + +APE L + D+WS GV++
Sbjct: 184 NALQTPCYTPYY-----VAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 53/219 (24%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVAN----ENASEREKAEFLNEASVMKA 178
LG GSFG V LA H A+K + + + + E E S +K
Sbjct: 17 LGEGSFGKVK---------LATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKL 65
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
H++KLY V++ ++++E GG +L +Y+ + E D R R Q
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEYAGG-ELFDYIVEKKRMTE-DEGR------RFFQ-- 115
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL-- 296
++ + Y K VHRDL N ++ D+L VK+ DFG++ G FL
Sbjct: 116 -QIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN------IMTDG--NFLKT 166
Query: 297 ----PVRWMAPESLK----DGVFTSHSDVWSYGVVLWEM 327
P + APE + G DVWS G+VL+ M
Sbjct: 167 SCGSP-NYAAPEVINGKLYAG---PEVDVWSCGIVLYVM 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 105 DDDKLYKKDSWEVL-RSKVTILD-----ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN 158
D + W+ L R VT LG G FG V ++ + A K
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKM----YACKKLE 218
Query: 159 ENASEREKAEF--LNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSC 216
+ ++ K E LNE +++ ++ VV L + +++ LM GGDLK ++
Sbjct: 219 KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278
Query: 217 RPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276
++ +R + AAE+ G+ L ++ V+RDL N ++ D +++ D
Sbjct: 279 G--------QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDL 330
Query: 277 GMTRDIYE--TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
G+ + E T R G+ G+ MAPE +K+ +T D W+ G +L+EM +A Q
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGY-----MAPEVVKNERYTFSPDWWALGCLLYEM--IAGQS 383
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-16
Identities = 42/230 (18%), Positives = 77/230 (33%), Gaps = 54/230 (23%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEH-----PCAIKVANENASEREKAEFLN---EASV 175
+ D LG GS+G V A+K+ + R N E +
Sbjct: 9 MGDLLGEGSYGKVK---------EVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59
Query: 176 MKAFDTHHVVKLYGVVSEGNPT--LVIMELMGGG--DLKNYLRSCR-PDAETDVERSPPT 230
++ +V++L V+ ++ME G ++ + + R P +
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA-------- 111
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK 290
++ DG+ YL + VH+D+ N ++ T+K+ G+ +
Sbjct: 112 -HGYFC---QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE---ALHPFAA 164
Query: 291 GSRGFL------PVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMAT 329
P + PE G D+WS GV L+ + T
Sbjct: 165 D--DTCRTSQGSPA-FQPPEIANGLDTFSG---FKVDIWSAGVTLYNITT 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 4e-15
Identities = 44/221 (19%), Positives = 76/221 (34%), Gaps = 42/221 (19%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDT 181
+ ++G GS+G+V++ +D + AIK K L E ++K
Sbjct: 6 EKIGKIGEGSYGVVFKCRNRDTGQI----VAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 182 HHVVKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
++V L V + LV E + + L + + I
Sbjct: 62 PNLVNLLEVFRRKRRLHLV-FEYCDH-TVLHELDRYQ------RGVPEHLVKSITWQ--- 110
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR------DIYETEY-----YR 289
+ + +HRD+ N ++ +K+ DFG R D Y + YR
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-DDEVATRWYR 169
Query: 290 KGSRGFLPVRWMAPESL-KDGVFTSHSDVWSYGVVLWEMAT 329
+PE L D + DVW+ G V E+ +
Sbjct: 170 ------------SPELLVGDTQYGPPVDVWAIGCVFAELLS 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/246 (22%), Positives = 108/246 (43%), Gaps = 33/246 (13%)
Query: 97 PPNQLMGGDDDKLYKKDSWEVLRSKVTILD-----ELGNGSFGLVYRGLIKDFRSLAEHP 151
+ + D + + L +T+ D +G G FG VY D +
Sbjct: 161 VFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM---- 216
Query: 152 CAIKVANENASEREKAEF--LNEASVMKAFDTHH---VVKL-YGVVSEGNPTLVIMELMG 205
A+K ++ + ++ E LNE ++ T +V + Y + + + ++LM
Sbjct: 217 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI-LDLMN 275
Query: 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265
GGDL +L +E + + AAE+ G+ ++ ++ V+RDL N ++
Sbjct: 276 GGDLHYHLSQHGVFSE----------ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 266 ADDLTVKVGDFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVV 323
+ V++ D G+ D + + + G+ G+ MAPE L+ GV + S +D +S G +
Sbjct: 326 DEHGHVRISDLGLACDFSKKKPHASVGTHGY-----MAPEVLQKGVAYDSSADWFSLGCM 380
Query: 324 LWEMAT 329
L+++
Sbjct: 381 LFKLLR 386
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 48/221 (21%), Positives = 82/221 (37%), Gaps = 42/221 (19%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDT 181
L +G GS+G+V + KD + AIK + + K + E ++K
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRI----VAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 182 HHVVKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
++V L V + LV E + + + L + + L
Sbjct: 84 ENLVNLLEVCKKKKRWYLV-FEFVDH-TILDDLELFPNGL------DYQVVQKYLFQ--- 132
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR------DIYETEY-----YR 289
+ +G+ + +HRD+ N +V+ VK+ DFG R ++Y + YR
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-DDEVATRWYR 191
Query: 290 KGSRGFLPVRWMAPESL-KDGVFTSHSDVWSYGVVLWEMAT 329
APE L D + DVW+ G ++ EM
Sbjct: 192 ------------APELLVGDVKYGKAVDVWAIGCLVTEMFM 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 39/210 (18%), Positives = 73/210 (34%), Gaps = 58/210 (27%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH-HVV 185
LG G G V + K + A+K+ + R E + H+V
Sbjct: 25 VLGLGINGKVLQIFNKRTQ----EKFALKMLQDCPKARR------EVELHWRASQCPHIV 74
Query: 186 KLYGV----VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++ V + L++ME + GG+L + + +R + + A+E+
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRI----------QDRGDQAFTE--REASEI 122
Query: 242 ----ADGMAYLADKKFVHRDLAARNCMVAD---DLTVKVGDFGMTRDIYETEYYRKGSRG 294
+ + YL HRD+ N + + +K+ DFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------- 165
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324
A E+ + + D+WS GV++
Sbjct: 166 ------FAKETTGEK-YDKSCDMWSLGVIM 188
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 51/258 (19%), Positives = 90/258 (34%), Gaps = 61/258 (23%)
Query: 84 VATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKD 143
+ G P ++ ++ +G+G+FG+
Sbjct: 1 MDRAPVTTGPLDMPIMHDSD----------RYDFVKD-------IGSGNFGVAR------ 37
Query: 144 FRSLAEHPC-----AIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198
L A+K A+ E + E ++ ++V+ V+
Sbjct: 38 ---LMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFKEVILTPTHLA 92
Query: 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258
+IME GG+L + + +E D R Q ++ G++Y + HRDL
Sbjct: 93 IIMEYASGGELYERICNAGRFSE-DEAR------FFFQ---QLLSGVSYCHSMQICHRDL 142
Query: 259 AARNCMVADDLT--VKVGDFGMTRDIYETEYYRK---GSRGFLPVRWMAPESLK----DG 309
N ++ +K+ DFG ++ K G+ + +APE L DG
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAY-----IAPEVLLRQEYDG 196
Query: 310 VFTSHSDVWSYGVVLWEM 327
+DVWS GV L+ M
Sbjct: 197 ---KIADVWSCGVTLYVM 211
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 4e-14
Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 42/237 (17%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDT 181
L+++G G++G V++ K+ + A+K V ++ E + L E ++K
Sbjct: 5 EKLEKIGEGTYGTVFKA--KNRET--HEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 182 HHVVKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
++V+L+ V+ S+ TLV E DLK Y SC D P + L
Sbjct: 61 KNIVRLHDVLHSDKKLTLV-FEFCDQ-DLKKYFDSCNGDL------DPEIVKSFLFQ--- 109
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF-LPVR 299
+ G+ + + +HRDL +N ++ + +K+ +FG+ +R F +PVR
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL-------------ARAFGIPVR 156
Query: 300 WM----------APESL-KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
P+ L ++++ D+WS G + E+A + G + L
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 5e-14
Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 45/222 (20%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEF--LNEASVMKAF 179
L+++G G++G+VY+ + A+K + + E E + E S++K
Sbjct: 24 QKLEKVGEGTYGVVYKA-----KDSQGRIVALKRIRLDA--EDEGIPSTAIREISLLKEL 76
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
++V L V+ ++ E M DLK L + + L
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGL------QDSQIKIYLYQ-- 127
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF-LPV 298
+ G+A+ + +HRDL +N ++ D +K+ DFG+ +R F +PV
Sbjct: 128 -LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL-------------ARAFGIPV 173
Query: 299 RWM----------APESL-KDGVFTSHSDVWSYGVVLWEMAT 329
R AP+ L +++ D+WS G + EM T
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 55/239 (23%), Positives = 100/239 (41%), Gaps = 24/239 (10%)
Query: 105 DDDKLYKKDSWEVL-RSKVTILD-----ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN 158
D + W+ L + LG G FG V+ +K L A K N
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKL----YACKKLN 219
Query: 159 ENA--SEREKAEFLNEASVMKAFDTHHVVKL-YGVVSEGNPTLVIMELMGGGDLKNYLRS 215
+ + + E ++ + +V L Y ++ + LV M +M GGD++ ++ +
Sbjct: 220 KKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV-MTIMNGGDIRYHIYN 278
Query: 216 CRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275
D E R + A++ G+ +L + ++RDL N ++ DD V++ D
Sbjct: 279 VDEDNPGFQE------PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISD 332
Query: 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
G+ ++ + KG G +MAPE L + D ++ GV L+EM +A++
Sbjct: 333 LGLAVELKAGQTKTKGYAG--TPGFMAPELLLGEEYDFSVDYFALGVTLYEM--IAARG 387
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 7e-14
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 47/222 (21%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEF--LNEASVMKAFD 180
L+++G G++G+VY+ ++ A+K + E E E + E S++K
Sbjct: 6 GLEKIGEGTYGVVYKA-----QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELK 58
Query: 181 THHVVKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
++VKLY V+ ++ LV E + DLK L C T L
Sbjct: 59 HSNIVKLYDVIHTKKRLVLV-FEHLDQ-DLKKLLDVCEGGL------ESVTAKSFLLQ-- 108
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF-LPV 298
+ +G+AY D++ +HRDL +N ++ + +K+ DFG+ +R F +PV
Sbjct: 109 -LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL-------------ARAFGIPV 154
Query: 299 RWM----------APESL-KDGVFTSHSDVWSYGVVLWEMAT 329
R AP+ L +++ D+WS G + EM
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 53/277 (19%), Positives = 91/277 (32%), Gaps = 71/277 (25%)
Query: 83 TVATPTTPAGGTTTPPNQLMGGDDDKLYK--KDSWEVLRSKVTILDELGNGSFGLVYRGL 140
+ P G P L K + T +GNGSFG+V++
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQR-EIAYTNCKVIGNGSFGVVFQAK 60
Query: 141 IKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL- 198
+ + AIK V + +R K E +M+ +VV L
Sbjct: 61 LVE-----SDEVAIKKVLQD---KRFK---NRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109
Query: 199 -----VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL------QMAAEVADGMAY 247
+++E + + R + T+ +L Q+ +AY
Sbjct: 110 EVFLNLVLEYV-PETVYRASRHYA--------KLKQTMPMLLIKLYMYQLLR----SLAY 156
Query: 248 LADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYETE---------YYRKGSRGFLP 297
+ HRD+ +N ++ +K+ DFG + + E YYR
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR-------- 208
Query: 298 VRWMAPESLKDGVFTSHS-----DVWSYGVVLWEMAT 329
APE + F + + D+WS G V+ E+
Sbjct: 209 ----APELI----FGATNYTTNIDIWSTGCVMAELMQ 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 54/262 (20%)
Query: 85 ATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF 144
T P G + + K + + ++ + LG GSF V L ++
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRK-KRPEDFKFGKI-------LGEGSFSTVV--LAREL 52
Query: 145 RSLAEHPCAIKVANENASEREK--AEFLNEASVMKAFDTHH--VVKLYGVVSEGNPTLVI 200
+ AIK+ + +E E VM H VKLY +
Sbjct: 53 AT--SREYAIKILEKRHIIKENKVPYVTRERDVMSR--LDHPFFVKLYFTFQDDEKLYFG 108
Query: 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAA 260
+ G+L Y+R T +R AE+ + YL K +HRDL
Sbjct: 109 LSYAKNGELLKYIRKIG--------SFDETCTRF--YTAEIVSALEYLHGKGIIHRDLKP 158
Query: 261 RNCMVADDLTVKVGDFGMTRDIYET-------------EYYRKGSRGFLPVRWMAPESLK 307
N ++ +D+ +++ DFG + + +Y ++PE L
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY-------------VSPELLT 205
Query: 308 DGVFTSHSDVWSYGVVLWEMAT 329
+ SD+W+ G +++++
Sbjct: 206 EKSACKSSDLWALGCIIYQLVA 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 57/242 (23%), Positives = 90/242 (37%), Gaps = 69/242 (28%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAF 179
T +GNGSFG+VY+ + D + AIK V + +R K E +M+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCD----SGELVAIKKVLQD---KRFK---NRELQIMRKL 104
Query: 180 DTHHVVKLYGVVSEGNPTL------VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
D ++V+L ++++ + + R R+ TL
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYS--------RAKQTLPV 155
Query: 234 IL------QMAAEVADGMAYLADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYETE 286
I Q+ +AY+ HRD+ +N ++ D +K+ DFG + + E
Sbjct: 156 IYVKLYMYQLFR----SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 287 ---------YYRKGSRGFLPVRWMAPESLKDGVFTSHS-----DVWSYGVVLWEMATLAS 332
YYR APE + F + DVWS G VL E+ L
Sbjct: 212 PNVSYICSRYYR------------APELI----FGATDYTSSIDVWSAGCVLAEL--LLG 253
Query: 333 QP 334
QP
Sbjct: 254 QP 255
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 48/224 (21%), Positives = 82/224 (36%), Gaps = 45/224 (20%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF----LNEASVMKA 178
LD LG G F VY+ +D + AIK K L E +++
Sbjct: 13 EKLDFLGEGQFATVYKA--RDKNT--NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 179 FDTHHVVKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
+++ L + N +LV + M DL+ ++ + +P + + M
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLV-FDFMET-DLEVIIKDNS------LVLTPSHIKAYMLM 120
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF-L 296
G+ YL +HRDL N ++ ++ +K+ DFG+ ++ F
Sbjct: 121 ---TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL-------------AKSFGS 164
Query: 297 PVRWM----------APESLKDGVFTSHS-DVWSYGVVLWEMAT 329
P R APE L D+W+ G +L E+
Sbjct: 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 51/251 (20%), Positives = 88/251 (35%), Gaps = 55/251 (21%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASE 163
++ +D +E KV G G++G VY+ KD + + A+K + S
Sbjct: 12 SSERERVEDLFEYEGCKV------GRGTYGHVYKAKRKDGKDDKD--YALKQIEGTGIS- 62
Query: 164 REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV--IMELMGGGDLKNYLRSCRPDAE 221
E ++++ +V+ L V V + + DL + ++ R
Sbjct: 63 ---MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKA 118
Query: 222 TDVER--SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL----TVKVGD 275
+ +L + DG+ YL +HRDL N +V + VK+ D
Sbjct: 119 NKKPVQLPRGMVKSLLYQ---ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175
Query: 276 FGMTRDIYE-------------TEYYRKGSRGFLPVRWMAPESL---KDGVFTSHSDVWS 319
G R T +YR APE L + +T D+W+
Sbjct: 176 MGFARLFNSPLKPLADLDPVVVTFWYR------------APELLLGARH--YTKAIDIWA 221
Query: 320 YGVVLWEMATL 330
G + E+ T
Sbjct: 222 IGCIFAELLTS 232
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 52/229 (22%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASE-------REKAEFLNEASV 175
+ E+G G++G V++ +D ++ A+K V + E RE L
Sbjct: 15 CVAEIGEGAYGKVFKA--RDLKNGGRF-VALKRVRVQTGEEGMPLSTIRE-VAVLRH--- 67
Query: 176 MKAFDTHHVVKLYGVV------SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
++ F+ +VV+L+ V E TLV E + DL YL +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLV-FEHVDQ-DLTTYLDKVP-----EPGVPTE 120
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE----- 284
T+ ++ + G+ +L + VHRDL +N +V +K+ DFG+ R
Sbjct: 121 TIKDMMFQ---LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 285 ----TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
T +YR APE L + + D+WS G + EM
Sbjct: 178 SVVVTLWYR------------APEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 41/218 (18%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV 184
LD+LG G++ VY+G K +L A+K E + E S++K ++
Sbjct: 7 LDKLGEGTYATVYKGKSKLTDNL----VALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 185 VKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
V L+ ++ +E + TLV E + DLK YL C + + L +
Sbjct: 63 VTLHDIIHTEKSLTLV-FEYLDK-DLKQYLDDCG------NIINMHNVKLFLFQ---LLR 111
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF-LPVRWM- 301
G+AY +K +HRDL +N ++ + +K+ DFG+ +R +P +
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL-------------ARAKSIPTKTYD 158
Query: 302 ---------APESL-KDGVFTSHSDVWSYGVVLWEMAT 329
P+ L +++ D+W G + +EMAT
Sbjct: 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 44/234 (18%), Positives = 89/234 (38%), Gaps = 52/234 (22%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA-------EFLNEASV 175
++ +LG G F V+ KD + A+K+ + E A + +N+A
Sbjct: 22 ILVRKLGWGHFSTVWLA--KDMVN--NTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 176 MK--AFDTHHVVKLYGVVSEGNPTLV----IMELMGGGDLKNYLRSCRPDAETDVERSPP 229
K + +H++KL + P V + E++G +L ++
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEH--------RGI 128
Query: 230 TLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVAD------DLTVKVGDFGMTRDI 282
L + Q++ ++ G+ Y+ + +H D+ N ++ + +K+ D G
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 283 YE-------TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
E T YR +PE L + +D+WS +++E+ T
Sbjct: 189 DEHYTNSIQTREYR------------SPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 6e-13
Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 48/226 (21%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-------REKAEFLNEASV 175
L++LGNG++ VY+G + + A+K ++ E R E S+
Sbjct: 8 KQLEKLGNGTYATVYKG--LNKTT--GVYVALKEVKLDSEEGTPSTAIR-------EISL 56
Query: 176 MKAFDTHHVVKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
MK ++V+LY V+ +E TLV E M DLK Y+ S R T +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLV-FEFM-DNDLKKYMDS-RTVGNTPRGLELNLVKYF 113
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
+ G+A+ + K +HRDL +N ++ +K+GDFG+ R G
Sbjct: 114 QWQLLQ---GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR--------AFGI-- 160
Query: 295 FLPVRWM----------APESL-KDGVFTSHSDVWSYGVVLWEMAT 329
PV AP+ L +++ D+WS G +L EM T
Sbjct: 161 --PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 46/240 (19%), Positives = 90/240 (37%), Gaps = 42/240 (17%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER 164
DD Y + + + + +L +G GSFG V + D + A+K+
Sbjct: 82 DDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKA--YDHKV--HQHVALKMVRNEKRFH 137
Query: 165 EKAEFLNEASVMK------AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRP 218
+A E +++ +T +V+ + + N + EL+ +L ++ +
Sbjct: 138 RQA--AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNK- 193
Query: 219 DAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV--ADDLTVKVGDF 276
+L + + A + + L + +H DL N ++ +KV DF
Sbjct: 194 -------FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 277 G----MTRDIYE---TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
G + +Y + +YR APE + + D+WS G +L E+ T
Sbjct: 247 GSSCYEHQRVYTYIQSRFYR------------APEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 39/231 (16%), Positives = 81/231 (35%), Gaps = 50/231 (21%)
Query: 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEA 173
W + ++ +LG G + V+ + +K+ ++K + E
Sbjct: 31 EWGN-QDDYQLVRKLGRGKYSEVFEAINITNNE----KVVVKILKP---VKKK-KIKREI 81
Query: 174 SVMKAFDTH-HVVKLYGVV---SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
+++ +++ L +V P LV + D K ++ D+ R
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT-DFKQLYQTLTDY---DI-RF-- 134
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYE---- 284
+ IL+ + Y +HRD+ N M+ + +++ D+G+ +
Sbjct: 135 YMYEILK-------ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187
Query: 285 -----TEYYRKGSRGFLPVRWMAPESLKDGVFTSHS-DVWSYGVVLWEMAT 329
+ Y++ PE L D +S D+WS G +L M
Sbjct: 188 NVRVASRYFK------------GPELLVDYQMYDYSLDMWSLGCMLASMIF 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 37/217 (17%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFD 180
+ LG GSFG V K+ + + A+K+ ++ ++ LNE +++A +
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKE----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
+VKL + + ++ME + GG++ ++LR R +R AA+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--------RFSEPHARF--YAAQ 149
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET--------EYYRKGS 292
+ YL ++RDL N ++ ++V DFG + + E
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEA----- 204
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
+APE + + D W+ GV+++EMA
Sbjct: 205 --------LAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 56/227 (24%), Positives = 87/227 (38%), Gaps = 48/227 (21%)
Query: 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF----LNEASVMK--A 178
+ E+G G++G VY+ +D S H A+K + E ++++
Sbjct: 14 VAEIGVGAYGTVYKA--RDPHS--GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 179 FDTH-HVVKLYGVVSEGNP------TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
H +VV+L V + TLV E + DL+ YL P T+
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLV-FEHVDQ-DLRTYLDKAPP-----PGLPAETI 122
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE------- 284
+++ G+ +L VHRDL N +V TVK+ DFG+ R
Sbjct: 123 KDLMRQ---FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179
Query: 285 --TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329
T +YR APE L + + D+WS G + EM
Sbjct: 180 VVTLWYR------------APEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-12
Identities = 50/261 (19%), Positives = 98/261 (37%), Gaps = 58/261 (22%)
Query: 87 PTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS 146
G + + Y++ + +LG G++G VY+ D +
Sbjct: 13 EAQTQGPGSMSVSAAPSATSIDRYRR------------ITKLGEGTYGEVYKA--IDTVT 58
Query: 147 LAEHPCAIK-VANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMG 205
AIK + E+ E + E S++K ++++L V+ + +I E
Sbjct: 59 --NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116
Query: 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN--- 262
DLK Y+ + ++ S + Q+ +G+ + ++ +HRDL +N
Sbjct: 117 N-DLKKYMDKNPDVSMRVIK------SFLYQLI----NGVNFCHSRRCLHRDLKPQNLLL 165
Query: 263 --CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF-LPVRWM----------APESL-KD 308
++ +K+GDFG+ +R F +P+R PE L
Sbjct: 166 SVSDASETPVLKIGDFGL-------------ARAFGIPIRQFTHEIITLWYRPPEILLGS 212
Query: 309 GVFTSHSDVWSYGVVLWEMAT 329
+++ D+WS + EM
Sbjct: 213 RHYSTSVDIWSIACIWAEMLM 233
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 5e-12
Identities = 62/244 (25%), Positives = 96/244 (39%), Gaps = 68/244 (27%)
Query: 128 LGNGSFG---LVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMK------ 177
LG GSFG LV + D R L A+KV R++ E ++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQL----YAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 178 ------AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
AF T KLY +I++ + GGDL L E DV
Sbjct: 88 IVKLHYAFQTEG--KLY----------LILDFLRGGDLFTRLSKEVMFTEEDV------- 128
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYE------ 284
+ AE+A + +L ++RDL N ++ ++ +K+ DFG+++ I
Sbjct: 129 -KF--YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
Query: 285 ----TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340
EY MAPE + T +D WS+GV+++EM T P+QG +
Sbjct: 186 FCGTVEY-------------MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL-PFQG-KD 230
Query: 341 EQVL 344
+
Sbjct: 231 RKET 234
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 53/241 (21%), Positives = 87/241 (36%), Gaps = 53/241 (21%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFL 170
+ + T+ + +GS+G V G+ + P AIK V N + R
Sbjct: 15 AELHAMQS-PYTVQRFISSGSYGAVCAGVDSEGI-----PVAIKRVFNTVSDGRTVNILS 68
Query: 171 N---------EASVMKAFDTHHVVKLYGVVSEGNPTL-----VIMELMGGGDLKNYLRSC 216
+ E ++ F +++ L + ++ ELM DL +
Sbjct: 69 DSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ 127
Query: 217 RPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276
R + + IL G+ L + VHRDL N ++AD+ + + DF
Sbjct: 128 RIVISPQHIQY--FMYHILL-------GLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178
Query: 277 GMTRDIYE----TEY-----YRKGSRGFLPVRWMAPES-LKDGVFTSHSDVWSYGVVLWE 326
+ R+ T Y YR APE ++ FT D+WS G V+ E
Sbjct: 179 NLAREDTADANKTHYVTHRWYR------------APELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 327 M 327
M
Sbjct: 227 M 227
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 42/243 (17%)
Query: 108 KLYKKDSWEVLRS--KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASER 164
K Y K L ++G G+FG V++ + ++ A+K V EN E
Sbjct: 3 KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKA--RHRKT--GQKVALKKVLMENEKEG 58
Query: 165 EKAEFLNEASVMKAFDTHHVVKLYGVVSE---------GNPTLVIMELMGGGDLKNYLRS 215
L E +++ +VV L + G+ LV + DL L +
Sbjct: 59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV-FDFCEH-DLAGLLSN 116
Query: 216 CRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275
V+ + + R++QM + +G+ Y+ K +HRD+ A N ++ D +K+ D
Sbjct: 117 V------LVKFTLSEIKRVMQM---LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167
Query: 276 FGMTRDIYETEYYRKGSRGFLPV-------RWM-APESL-KDGVFTSHSDVWSYGVVLWE 326
FG+ R + W PE L + + D+W G ++ E
Sbjct: 168 FGLAR------AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 221
Query: 327 MAT 329
M T
Sbjct: 222 MWT 224
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 52/263 (19%), Positives = 90/263 (34%), Gaps = 69/263 (26%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLN-EA 173
E K ++ LG GSFG+V + + A+K V + + N E
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE----SGKRFALKKVLQD-------PRYKNREL 51
Query: 174 SVMKAFDTHHVVKLYGVV-----------SEGNPTLVIMELMGGGDLKNYLRSCRPDAET 222
+MK D +++KL + + G + + P
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 223 DV----ERSPPTLSRILQMAAEVAD----------------GMAYLADKKFVHRDLAARN 262
+ E P TL ++L+ + ++ HRD+ +N
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 263 CMV-ADDLTVKVGDFGMTRDIYETE---------YYRKGSRGFLPVRWMAPE-SLKDGVF 311
+V + D T+K+ DFG + + +E +YR APE L +
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------------APELMLGATEY 219
Query: 312 TSHSDVWSYGVVLWEMATLASQP 334
T D+WS G V E+ + +P
Sbjct: 220 TPSIDLWSIGCVFGEL--ILGKP 240
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 50/242 (20%), Positives = 93/242 (38%), Gaps = 44/242 (18%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER 164
DD+ Y + E + I +G GSFG V + D + AIK+ +
Sbjct: 39 DDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKA--YDRVE--QEWVAIKIIKNKKAFL 94
Query: 165 EKAEFLNEASVMK------AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRP 218
+A E +++ +++V L N ++ E++ +L + LR+
Sbjct: 95 NQA--QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTN- 150
Query: 219 DAETDVERSPPTLSRILQMAAEVADGMAYLADKKF--VHRDLAARNCMVADDL--TVKVG 274
+L+ + A ++ + +LA + +H DL N ++ + +K+
Sbjct: 151 -------FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203
Query: 275 DFGMTRDIYETEY-------YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
DFG + + + Y YR +PE L + D+WS G +L EM
Sbjct: 204 DFGSSCQLGQRIYQYIQSRFYR------------SPEVLLGMPYDLAIDMWSLGCILVEM 251
Query: 328 AT 329
T
Sbjct: 252 HT 253
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 57/234 (24%), Positives = 95/234 (40%), Gaps = 33/234 (14%)
Query: 110 YKKDSWEVLRSKVTILD-----ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENAS 162
YK ++ ++ D +G G+FG V K R + A+K+ + E
Sbjct: 54 YKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV----YAMKLLSKFEMIK 109
Query: 163 EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET 222
+ A F E +M ++ VV+L+ + ++ME M GGDL N + +
Sbjct: 110 RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN------- 162
Query: 223 DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282
P +R AEV + + F+HRD+ N ++ +K+ DFG +
Sbjct: 163 --YDVPEKWARF--YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218
Query: 283 YETEYYRKGSRGFLPV---RWMAPESLKD-GVFTSHS---DVWSYGVVLWEMAT 329
+ R + V +++PE LK G + D WS GV L+EM
Sbjct: 219 NKEGMVRCDT----AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 57/257 (22%), Positives = 98/257 (38%), Gaps = 56/257 (21%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--S 162
D+++ D +E+LR+ +G GSFG V D + + A+K N+
Sbjct: 7 DENEDVNFDHFEILRA-------IGKGSFGKVCIVQKNDTKKM----YAMKYMNKQKCVE 55
Query: 163 EREKAEFLNEASVMKAFDTHH--VVKL-YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPD 219
E E +M+ H +V L Y E + +V ++L+ GGDL+ +L+
Sbjct: 56 RNEVRNVFKELQIMQG--LEHPFLVNLWYSFQDEEDMFMV-VDLLLGGDLRYHLQQNVHF 112
Query: 220 AETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279
E V ++ E+ + YL +++ +HRD+ N ++ + V + DF +
Sbjct: 113 KEETV--------KL--FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
Query: 280 RDIYE----------TEYYRKGSRGFLPVRWMAPESLKDGVFTSHS---DVWSYGVVLWE 326
+ Y MAPE +S D WS GV +E
Sbjct: 163 AMLPRETQITTMAGTKPY-------------MAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
Query: 327 MATLASQPYQGLSNEQV 343
+ PY S+
Sbjct: 210 LLRGRR-PYHIRSSTSS 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 49/238 (20%), Positives = 85/238 (35%), Gaps = 36/238 (15%)
Query: 110 YKKDSWEVLRSKVTILD-----ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--S 162
+ + ++ D +G G+F V +K + A+K+ N+
Sbjct: 46 AEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV----YAMKIMNKWDMLK 101
Query: 163 EREKAEFLNEASVMKAFDTHHVVKL-YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAE 221
E + F E V+ D + +L + E LV ME GGDL L +
Sbjct: 102 RGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV-MEYYVGGDLLTLLS--KFGER 158
Query: 222 TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281
E + R AE+ + + +VHRD+ N ++ +++ DFG
Sbjct: 159 IPAEMA-----RF--YLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 282 IYETEYYRKGSRGFLPV---RWMAPESLK-------DGVFTSHSDVWSYGVVLWEMAT 329
+ R V +++PE L+ G + D W+ GV +EM
Sbjct: 212 LRADGTVRSLV----AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 3e-11
Identities = 57/248 (22%), Positives = 89/248 (35%), Gaps = 74/248 (29%)
Query: 128 LGNGSFG---LVYRGLIKDFRSLAEHPCAIKV-------ANENASEREKAE--------- 168
LG G +G V + + + A+KV N + KAE
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKI----FAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 169 -FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS 227
F+ ++ AF T KLY +I+E + GG+L L
Sbjct: 81 PFI--VDLIYAFQTGG--KLY----------LILEYLSGGELFMQLEREG--------IF 118
Query: 228 PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYE-- 284
+ AE++ + +L K ++RDL N M+ VK+ DFG+ + I++
Sbjct: 119 MEDTACF--YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
Query: 285 --------TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336
EY MAPE L D WS G ++++M T A P+
Sbjct: 177 VTHTFCGTIEY-------------MAPEILMRSGHNRAVDWWSLGALMYDMLTGAP-PFT 222
Query: 337 GLSNEQVL 344
G N +
Sbjct: 223 G-ENRKKT 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 51/246 (20%), Positives = 97/246 (39%), Gaps = 50/246 (20%)
Query: 108 KLYKKDSWEVLRSKVTILD-----ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA- 161
+ K + +V + ++ D +G G+FG V +K+ + A+K+ N+
Sbjct: 57 EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV----FAMKILNKWEM 112
Query: 162 -SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDA 220
E A F E V+ D+ + L+ + N ++M+ GGDL L
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--- 169
Query: 221 ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM-T 279
+R P ++R AE+ + + +VHRD+ N ++ + +++ DFG
Sbjct: 170 ----DRLPEEMARF--YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 280 RDIYE-----------TEYYRKGSRGFLPVRWMAPESL--KDGVFTSHS---DVWSYGVV 323
+ + + +Y ++PE L +G + D WS GV
Sbjct: 224 KLMEDGTVQSSVAVGTPDY-------------ISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 324 LWEMAT 329
++EM
Sbjct: 271 MYEMLY 276
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 58/252 (23%), Positives = 103/252 (40%), Gaps = 49/252 (19%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEF-LNEASVMKAFDTHH-V 184
LG GSFG V K L A+K+ + + + E + E V+ +
Sbjct: 349 LGKGSFGKVMLSERKGTDEL----YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 185 VKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+L+ + V ME + GGDL +++ R + AAE+A
Sbjct: 405 TQLHSCFQTMDRLYFV-MEYVNGGDLMYHIQQVG--------RFKEPHAVFY--AAEIAI 453
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYE----------TEYYRKGS 292
G+ +L K ++RDL N M+ + +K+ DFGM + +I++ +Y
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY----- 508
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352
+APE + + D W++GV+L+EM + P++G +++ +
Sbjct: 509 --------IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA-PFEGEDEDELFQSIMEH-- 557
Query: 353 NEYKVNPPISLS 364
V P S+S
Sbjct: 558 ---NVAYPKSMS 566
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 50/231 (21%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VAN--ENASEREKAEFLN 171
+ VL+ + L +G+G+ G+V D + AIK ++ +N + ++A
Sbjct: 58 FTVLK-RYQNLKPIGSGAQGIVCAAY--DAVL--DRNVAIKKLSRPFQNQTHAKRA--YR 110
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTL------VIMELMGGGDLKNYLRSCRPDAETDVE 225
E +MK + +++ L V + ++MELM +L ++ E D E
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHE 164
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE- 284
R L ++L G+ +L +HRDL N +V D T+K+ DFG+ R
Sbjct: 165 RMSYLLYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 285 ---TEY-----YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327
T Y YR APE + + + D+WS G ++ EM
Sbjct: 218 FMMTPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGEM 256
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 43/224 (19%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFD 180
IL LG GSFG V+ + A+KV + ++ +E ++
Sbjct: 9 QILRTLGTGSFGRVHLIRSRH----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI-- 62
Query: 181 THH--VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
H +++++G + +IM+ + GG+L + LR + R P +++ A
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--------RFPNPVAKF--YA 112
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET--------EYYRK 290
AEV + YL K ++RDL N ++ + +K+ DFG + + + +Y
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDY--- 169
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
+APE + + D WS+G++++EM LA
Sbjct: 170 ----------IAPEVVSTKPYNKSIDWWSFGILIYEM--LAGYT 201
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVV 185
LG G+FG V K A+K+ + ++ E A L E V++ +
Sbjct: 156 LGKGTFGKVILVKEKATGRY----YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGM 245
L + +ME GG+L +L R +E +R+ R AE+ +
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE---DRA-----RFY--GAEIVSAL 261
Query: 246 AYL-ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL-PVRWMAP 303
YL ++K V+RDL N M+ D +K+ DFG+ + E + F ++AP
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAP 318
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
E L+D + D W GVV++EM + +
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEM--MCGRL 347
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 54/234 (23%), Positives = 84/234 (35%), Gaps = 70/234 (29%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKV------ANENASEREKAE----------FLN 171
LG G+FG V K A+K+ ++ E FL
Sbjct: 13 LGKGTFGKVILVREKATGRY----YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL- 67
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
++ AF TH +L +ME GG+L +L R
Sbjct: 68 -TALKYAFQTHD--RLC----------FVMEYANGGELFFHLSRER--------VFTEER 106
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYE------ 284
+R AE+ + YL + V+RD+ N M+ D +K+ DFG+ + I +
Sbjct: 107 ARFY--GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 285 ----TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
EY +APE L+D + D W GVV++EM + +
Sbjct: 165 FCGTPEY-------------LAPEVLEDNDYGRAVDWWGLGVVMYEM--MCGRL 203
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 58/314 (18%), Positives = 97/314 (30%), Gaps = 68/314 (21%)
Query: 74 SGGPAVTTTTVATPTTPAGGTTTPPNQLMGGDDDKLYK--KDSWEVLRSKVTILDELGNG 131
+ + + + Q W++ + I +G G
Sbjct: 6 AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD-RYEIRHLIGTG 64
Query: 132 SFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMKAFDTHHVVKLYGV 190
S+G V D + AIK + + L E +++ + HVVK+ +
Sbjct: 65 SYGHVCEA--YDKLE--KRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 191 VSEGNPTL-----VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR---------ILQ 236
V + V++E+ D K R+ L+ +L
Sbjct: 121 VIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY------------LTELHIKTLLYNLLV 167
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL 296
G+ Y+ +HRDL NC+V D +VKV DFG+ R + E
Sbjct: 168 -------GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 297 PV------------------------RWM-APE-SLKDGVFTSHSDVWSYGVVLWEMATL 330
RW APE L +T DVWS G + E+ +
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 331 ASQPYQGLSNEQVL 344
+ ++ L
Sbjct: 281 IKENVAYHADRGPL 294
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 51/244 (20%), Positives = 77/244 (31%), Gaps = 71/244 (29%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFD 180
+ G G+FG V G K AIK ++ RE L +
Sbjct: 26 QVERMAGQGTFGTVQLGKEKS----TGMSVAIKKVIQDPRFRNRE----LQIMQDLAVLH 77
Query: 181 THHVVKLYGVVSEGNPT-------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
++V+L V+ME + L R+ R
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYY--------RRQVAPPP 128
Query: 234 IL------QMAAEVADGMAYL--ADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYE 284
IL Q+ + L HRD+ N +V D T+K+ DFG + +
Sbjct: 129 ILIKVFLFQLIR----SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 285 TE---------YYRKGSRGFLPVRWMAPESLKDGVFTSHS-----DVWSYGVVLWEMATL 330
+E YYR APE + F + D+WS G + EM +
Sbjct: 185 SEPNVAYICSRYYR------------APELI----FGNQHYTTAVDIWSVGCIFAEM--M 226
Query: 331 ASQP 334
+P
Sbjct: 227 LGEP 230
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 44/228 (19%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VAN--ENASEREKAEFLN 171
+ VL+ + L +G+G+ G+V D E AIK ++ +N + ++A
Sbjct: 21 FTVLK-RYQNLKPIGSGAQGIVCAAY--DAIL--ERNVAIKKLSRPFQNQTHAKRA--YR 73
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTL------VIMELMGGGDLKNYLRSCRPDAETDVE 225
E +MK + +++ L V + ++MELM +L ++ E
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---------E 123
Query: 226 RSPPTLSRIL-QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
+S +L QM G+ +L +HRDL N +V D T+K+ DFG+ R
Sbjct: 124 LDHERMSYLLYQMLC----GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 285 ----TEYYRKGSRGFLPVRWM-APESLKDGVFTSHSDVWSYGVVLWEM 327
T Y + R+ APE + + + D+WS G ++ EM
Sbjct: 180 SFMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 51/242 (21%), Positives = 90/242 (37%), Gaps = 49/242 (20%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAE 168
+++ + L LG G GLV+ D + AIK + + + A
Sbjct: 2 MNIHGFDLGS-RYMDLKPLGCGGNGLVFSA--VDNDC--DKRVAIKKIVLTDPQSVKHA- 55
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTL--------------VIMELMGGGDLKNYLR 214
L E +++ D ++VK++ ++ L ++ E M DL N L
Sbjct: 56 -LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE 113
Query: 215 SCRPDAETDVERSPPTLSR------ILQMAAEVADGMAYLADKKFVHRDLAARNCMV-AD 267
L + Q+ G+ Y+ +HRDL N + +
Sbjct: 114 Q-------------GPLLEEHARLFMYQLLR----GLKYIHSANVLHRDLKPANLFINTE 156
Query: 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM-APE-SLKDGVFTSHSDVWSYGVVLW 325
DL +K+GDFG+ R + ++ L +W +P L +T D+W+ G +
Sbjct: 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216
Query: 326 EM 327
EM
Sbjct: 217 EM 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 54/231 (23%), Positives = 90/231 (38%), Gaps = 51/231 (22%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VAN--ENASEREKAEFLN 171
WE+ + +G+G++G V D RS AIK ++ ++ ++A
Sbjct: 20 WELPK-TYVSPTHVGSGAYGSVCSA--IDKRS--GEKVAIKKLSRPFQSEIFAKRA--YR 72
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTL------VIMELMGGGDLKNYLRSCRPDAETDVE 225
E ++K +V+ L V + + ++M M DL+ + +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL---------K 122
Query: 226 RSPPTLSRIL-QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284
S + ++ QM G+ Y+ VHRDL N V +D +K+ DFG+ R
Sbjct: 123 FSEEKIQYLVYQMLK----GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 285 --TEY-----YRKGSRGFLPVRWMAPES-LKDGVFTSHSDVWSYGVVLWEM 327
T Y YR APE L + D+WS G ++ EM
Sbjct: 179 EMTGYVVTRWYR------------APEVILSWMHYNQTVDIWSVGCIMAEM 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 55/227 (24%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHP-----CAIKVAN-ENASEREKAEF-LNEASVMKAFD 180
LG GSFG V L+E A+K+ + + + E + E V+
Sbjct: 28 LGKGSFGKVM---------LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 181 THH-VVKL-YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
+ +L + V ME + GGDL +++ R + A
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFV-MEYVNGGDLMYHIQQVG--------RFKEPHAVFY--A 127
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYE----------TEY 287
AE+A G+ +L K ++RDL N M+ + +K+ DFGM + +I++ +Y
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 187
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
+APE + + D W++GV+L+EM LA Q
Sbjct: 188 -------------IAPEIIAYQPYGKSVDWWAFGVLLYEM--LAGQA 219
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 62/275 (22%), Positives = 91/275 (33%), Gaps = 78/275 (28%)
Query: 88 TTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSL 147
PA +G + K + L KV +G GSFG V K
Sbjct: 13 ANPAPPPAPSQQINLGPSSNPHAKPSDFHFL--KV-----IGKGSFGKVLLARHKAEEVF 65
Query: 148 AEHPCAIKV------ANENASEREKAE-----------FLNEASVMKAFDTHHVVKLYGV 190
A+KV + + +E FL + +F T KLY V
Sbjct: 66 ----YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL--VGLHFSFQTAD--KLYFV 117
Query: 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD 250
++ + GG+L +L+ R +R AAE+A + YL
Sbjct: 118 ----------LDYINGGELFYHLQRER--------CFLEPRARFY--AAEIASALGYLHS 157
Query: 251 KKFVHRDLAARNCMVADDLTVKVGDFGMT-RDIYE----------TEYYRKGSRGFLPVR 299
V+RDL N ++ + + DFG+ +I EY
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEY------------ 205
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
+APE L + D W G VL+EM L P
Sbjct: 206 -LAPEVLHKQPYDRTVDWWCLGAVLYEM--LYGLP 237
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEF-LNEASVMKAFDTHH-V 184
LG GSFG V +K+ L A+KV + + + E + E ++ H +
Sbjct: 31 LGKGSFGKVMLARVKETGDL----YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 185 VKL-YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
+L + V ME + GGDL +++ R E R+ R AAE+
Sbjct: 87 TQLFCCFQTPDRLFFV-MEFVNGGDLMFHIQKSRRFDE---ARA-----RFY--AAEIIS 135
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYE----------TEYYRKGS 292
+ +L DK ++RDL N ++ + K+ DFGM + I +Y
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY----- 190
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
+APE L++ ++ D W+ GV+L+EM L
Sbjct: 191 --------IAPEILQEMLYGPAVDWWAMGVLLYEM--LCGHA 222
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 44/258 (17%), Positives = 81/258 (31%), Gaps = 60/258 (23%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV--ANE--- 159
D + + L+ + I+ LG G+FG V D A+K+
Sbjct: 4 DKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVE--CLDHARGKSQ-VALKIIRNVGKYR 60
Query: 160 NASEREKA--EFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCR 217
A+ E + + E + V + + + EL+ G + +L+
Sbjct: 61 EAARLEINVLKKIKEKD---KENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENN 116
Query: 218 PDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL------------------- 258
P L + MA ++ + +L + + H DL
Sbjct: 117 --------FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168
Query: 259 AARNCMVADDLTVKVGDFG----MTRDIYE---TEYYRKGSRGFLPVRWMAPESLKDGVF 311
+ + +++V DFG T +YR PE + + +
Sbjct: 169 KSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR------------PPEVILELGW 216
Query: 312 TSHSDVWSYGVVLWEMAT 329
DVWS G +L+E
Sbjct: 217 AQPCDVWSIGCILFEYYR 234
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 78/238 (32%)
Query: 128 LGNGSFG---LVYRGLIKDFRSLAEHPCAIKV-------ANENASEREKAE--------- 168
LG G++G LV + D L A+KV +E + E
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKL----YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 169 --FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVER 226
FL ++ AF T KL+ +I++ + GG+L +L E +V
Sbjct: 118 SPFL--VTLHYAFQTET--KLH----------LILDYINGGELFTHLSQRERFTEHEV-- 161
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT-RDIYE- 284
+I E+ + +L ++RD+ N ++ + V + DFG++ + +
Sbjct: 162 ------QI--YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213
Query: 285 ----------TEYYRKGSRGFLPVRWMAPESLKDGVFTSHS---DVWSYGVVLWEMAT 329
EY MAP+ ++ G + H D WS GV+++E+ T
Sbjct: 214 TERAYDFCGTIEY-------------MAPDIVR-GGDSGHDKAVDWWSLGVLMYELLT 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 47/285 (16%), Positives = 94/285 (32%), Gaps = 48/285 (16%)
Query: 80 TTTTVATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRG 139
+ + T TT L G W++ + G++Y
Sbjct: 9 SGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSF-------QTRDNQGILYEA 61
Query: 140 L----IKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195
+ + ++K+ ++ + F A+ K + KLY
Sbjct: 62 APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA--KPLQVNKWKKLYSTPLLAI 119
Query: 196 PTLV------------IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
PT + ++ + G L++ L + + +LQ+A + D
Sbjct: 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--------PKHVLSERSVLQVACRLLD 170
Query: 244 GMAYLADKKFVHRDLAARNCMV--ADDLTVKVGDFGMT---RDIYETEYYRKGSRGFLP- 297
+ +L + ++VH ++ A N V D V + +G + Y +GSR
Sbjct: 171 ALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEG 230
Query: 298 -VRWMAPESLKDGVFTS-HSDVWSYGVVL--WEMATLASQPYQGL 338
+ +++ + K G S SD+ S G + W L P+
Sbjct: 231 DLEFISMDLHK-GCGPSRRSDLQSLGYCMLKWLYGFL---PWTNC 271
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 53/265 (20%), Positives = 103/265 (38%), Gaps = 52/265 (19%)
Query: 85 ATPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF 144
+ N G +++L +V +G GS+ V +K
Sbjct: 24 GAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLL--RV-----IGRGSYAKVLLVRLKK- 75
Query: 145 RSLAEHPCAIKVAN-ENASEREKAEF-LNEASVMKAFDTHH-VVKLYGVV-SEGNPTLVI 200
+ A++V E ++ E ++ E V + H +V L+ +E V
Sbjct: 76 ---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV- 131
Query: 201 MELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAA 260
+E + GGDL +++ R E E +R +AE++ + YL ++ ++RDL
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPE---EH-----ARFY--SAEISLALNYLHERGIIYRDLKL 181
Query: 261 RNCMVADDLTVKVGDFGMTR-DIYE----------TEYYRKGSRGFLPVRWMAPESLKDG 309
N ++ + +K+ D+GM + + Y +APE L+
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY-------------IAPEILRGE 228
Query: 310 VFTSHSDVWSYGVVLWEMATLASQP 334
+ D W+ GV+++EM +A +
Sbjct: 229 DYGFSVDWWALGVLMFEM--MAGRS 251
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 55/227 (24%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHP-----CAIKVAN-ENASEREKAEF-LNEASVMKAFD 180
+G GS+ V L A+KV E ++ E ++ E V +
Sbjct: 17 IGRGSYAKVL---------LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 181 THH-VVKL-YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
H +V L +E V +E + GGDL +++ R E E +R +
Sbjct: 68 NHPFLVGLHSCFQTESRLFFV-IEYVNGGDLMFHMQRQRKLPE---EH-----ARFY--S 116
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYE----------TEY 287
AE++ + YL ++ ++RDL N ++ + +K+ D+GM + + Y
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
+APE L+ + D W+ GV+++EM +A +
Sbjct: 177 -------------IAPEILRGEDYGFSVDWWALGVLMFEM--MAGRS 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 63/236 (26%), Positives = 99/236 (41%), Gaps = 54/236 (22%)
Query: 128 LGNGSFGLVYRGLIKDFRSLAEHP-----CAIKVAN-ENASEREKAE-FLNEASVMKAFD 180
LG GSFG V+ LAE AIK + + E + E V+
Sbjct: 25 LGKGSFGKVF---------LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 181 THH-VVKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
H + ++ ++ N V ME + GGDL +++SC D+ R+ A
Sbjct: 76 EHPFLTHMFCTFQTKENLFFV-MEYLNGGDLMYHIQSCHK---FDLSRA-----TFY--A 124
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR-DIYE----------TEY 287
AE+ G+ +L K V+RDL N ++ D +K+ DFGM + ++ +Y
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
+APE L + D WS+GV+L+EM S P+ G E++
Sbjct: 185 -------------IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS-PFHGQDEEEL 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 50/266 (18%), Positives = 93/266 (34%), Gaps = 59/266 (22%)
Query: 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VAN--ENASEREKAEFL 170
+ V I +G GS+G VY D + E AIK V E+ + ++ L
Sbjct: 21 NVHVPD-NYIIKHLIGRGSYGYVYLA--YDKNT--EKNVAIKKVNRMFEDLIDCKRI--L 73
Query: 171 NEASVMKAFDTHHVVKLYGVVSEGNPTL-----VIMELMGGGDLKNYLRSCRPDAETDVE 225
E +++ + ++++LY ++ + +++E+ DLK ++
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF------- 125
Query: 226 RSPPTLSR------ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279
L+ + + G ++ + +HRDL NC++ D +VKV DFG+
Sbjct: 126 -----LTEEHIKTILYNLLL----GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSH---------------------SDVW 318
R I + + TSH D+W
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIW 236
Query: 319 SYGVVLWEMATLASQPYQGLSNEQVL 344
S G + E+ + +N L
Sbjct: 237 STGCIFAELLNMLQSHINDPTNRFPL 262
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 48/230 (20%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VAN--ENASEREKAEFLN 171
WEV + L +G+G++G V A+K ++ ++ ++
Sbjct: 25 WEVPE-RYQNLSPVGSGAYGSVCAAFDTK----TGLRVAVKKLSRPFQSIIHAKRT--YR 77
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTL------VIMELMGGGDLKNYLRSCRPDAETDVE 225
E ++K +V+ L V + ++ LMG DL N ++ + +
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKC----QKLTDD 132
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE- 284
+ +IL+ G+ Y+ +HRDL N V +D +K+ DFG+ R +
Sbjct: 133 HVQFLIYQILR-------GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 285 -TEY-----YRKGSRGFLPVRWMAPES-LKDGVFTSHSDVWSYGVVLWEM 327
T Y YR APE L + D+WS G ++ E+
Sbjct: 186 MTGYVATRWYR------------APEIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 37/232 (15%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF---LNEASVMKAF- 179
+ ++G+GSFG +Y G AIK+ E K + L E+ + +
Sbjct: 11 LGRKIGSGSFGEIYLGT----NIQTNEEVAIKL------ENVKTKHPQLLYESKIYRILQ 60
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+ + EG+ +++M+L+ G L++ C +L +L +A
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKL---------SLKTVLMLAD 110
Query: 240 EVADGMAYLADKKFVHRDLAARNCMV---ADDLTVKVGDFGMTRDIYETEY-----YRKG 291
++ + + ++ K F+HRD+ N ++ V + DFG+ + +T YR+
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 292 SRGFL-PVRWMAPESLKDGVFTS-HSDVWSYGVVLWEMATLASQPYQGLSNE 341
+ R+ + + G+ S D+ S G VL S P+QGL
Sbjct: 171 -KNLTGTARYASVNTHL-GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 219
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 1e-08
Identities = 39/259 (15%), Positives = 77/259 (29%), Gaps = 60/259 (23%)
Query: 114 SWEVL--RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-------ANENASER 164
+ K+ +++G G FG V++ + P AIK+ + ++
Sbjct: 12 PFSHCLPTEKLQRCEKIGEGVFGEVFQTIADH------TPVAIKIIAIEGPDLVNGSHQK 65
Query: 165 EKAEFLNEASVMKAF---------DTHHVVKLYGV-VSEGNPTLVIMELMGGGDLKNYLR 214
E L E + K T + L V +G+ ++++ +
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 215 SCRPDAETD------------------VERSPPTLSRILQMAAEVADGMAYLADK-KFVH 255
+ RPD D + +L+ + ++ +A +F H
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEH 185
Query: 256 RDLAARNCMVA-----------DDLTVKVGDFG---MTRDIYETEYYRKGSRGFLPVRWM 301
RDL N ++ + + + G D + R G F
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD--VS 243
Query: 302 APESLKDGVFTSHSDVWSY 320
E L G D++
Sbjct: 244 MDEDLFTGDGDYQFDIYRL 262
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 60/247 (24%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV--ANE---NASEREKA--E 168
+VL ++ I+D LG G+FG V D ++ H A+K+ + A+ E E
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVEC--IDHKAGGRH-VAVKIVKNVDRYCEAARSEIQVLE 66
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSP 228
LN T V++ ++ EL+ G ++++ P
Sbjct: 67 HLNTTD---PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG--------FLP 114
Query: 229 PTLSRILQMAAEVADGMAYLADKKFVHRDL-------------------AARNCMVADDL 269
L I +MA ++ + +L K H DL R+ +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 270 TVKVGDFGMTRDIYETEY-------YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGV 322
+KV DFG E YR APE + ++ DVWS G
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRHYR------------APEVILALGWSQPCDVWSIGC 222
Query: 323 VLWEMAT 329
+L E
Sbjct: 223 ILIEYYL 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 48/230 (20%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VAN--ENASEREKAEFLN 171
WEV R+ L +G+G++G V + D R+ AIK + ++ ++A
Sbjct: 21 WEV-RAVYRDLQPVGSGAYGAVCSAV--DGRT--GAKVAIKKLYRPFQSELFAKRA--YR 73
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTL------VIMELMGGGDLKNYLRSCRPDAETDVE 225
E ++K +V+ L V + ++M MG DL ++ + + +
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH---EKLGE-D 128
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR--DIY 283
R + ++L+ G+ Y+ +HRDL N V +D +K+ DFG+ R D
Sbjct: 129 RIQFLVYQMLK-------GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 284 ETEY-----YRKGSRGFLPVRWMAPE-SLKDGVFTSHSDVWSYGVVLWEM 327
T Y YR APE L +T D+WS G ++ EM
Sbjct: 182 MTGYVVTRWYR------------APEVILNWMRYTQTVDIWSVGCIMAEM 219
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 50/255 (19%), Positives = 98/255 (38%), Gaps = 71/255 (27%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VAN--ENASEREKAE 168
+ VLR K ++ +LG G++G+V++ D R+ A+K + + +N+++ ++
Sbjct: 2 RVDRHVLR-KYELVKKLGKGAYGIVWKS--IDRRT--GEVVAVKKIFDAFQNSTDAQRT- 55
Query: 169 FLNEASVMKAFDTH-HVVKLYGVV-SEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVE 225
E ++ H ++V L V+ ++ + + ++ + M DL +R+
Sbjct: 56 -FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA---------- 103
Query: 226 RSPPTLSR---------ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276
L +++ + YL +HRD+ N ++ + VKV DF
Sbjct: 104 ---NILEPVHKQYVVYQLIK-------VIKYLHSGGLLHRDMKPSNILLNAECHVKVADF 153
Query: 277 GMTRDIYETEYYRKGSRGFLPV------------------RWM-APESLKDGVFTSHS-- 315
G++R + RW APE L S
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL----LGSTKYT 209
Query: 316 ---DVWSYGVVLWEM 327
D+WS G +L E+
Sbjct: 210 KGIDMWSLGCILGEI 224
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 37/164 (22%), Positives = 70/164 (42%), Gaps = 27/164 (16%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF---LNEASVMKAFD 180
+ ++G+GSFG +Y G A AIK+ E K + E+ + K
Sbjct: 13 LGRKIGSGSFGDIYLG----TDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMMQ 62
Query: 181 -THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+ + +EG+ +++MEL+ G L++ C +L +L +A
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC---------SRKFSLKTVLLLAD 112
Query: 240 EVADGMAYLADKKFVHRDLAARNCMV---ADDLTVKVGDFGMTR 280
++ + Y+ K F+HRD+ N ++ V + DFG+ +
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 47/264 (17%), Positives = 88/264 (33%), Gaps = 68/264 (25%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER 164
D+ + +L + ++ ++G+G+FG V + + + A+KV
Sbjct: 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLC--QHIDN--KKYYAVKVVRNIKKYT 75
Query: 165 EKAEFLNEASVMKAF-----DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPD 219
A EA ++K + +++VK +G + +I E + G L +
Sbjct: 76 RSA--KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-- 130
Query: 220 AETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL--------------------- 258
+ + I E+ + YL H DL
Sbjct: 131 ------YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184
Query: 259 ----AARNCMVADDLTVKVGDFGMTRDIYETEY---------YRKGSRGFLPVRWMAPES 305
+K+ DFG ++++Y YR APE
Sbjct: 185 VTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYR------------APEV 230
Query: 306 LKDGVFTSHSDVWSYGVVLWEMAT 329
+ + + SD+WS+G VL E+ T
Sbjct: 231 ILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 53/251 (21%), Positives = 89/251 (35%), Gaps = 59/251 (23%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAE 168
K+ + + + LG G++G+V + AIK + +
Sbjct: 3 KRIVYNISS-DFQLKSLLGEGAYGVVCSA--THKPT--GEIVAIKKIEPFDKPLFALRT- 56
Query: 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTL-----VIMELMGGGDLKNYLRSCRPDAETD 223
L E ++K F +++ ++ + + +I ELM +TD
Sbjct: 57 -LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM----------------QTD 99
Query: 224 VER--SPPTLSR---------ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272
+ R S LS L+ + L +HRDL N ++ + +K
Sbjct: 100 LHRVISTQMLSDDHIQYFIYQTLR-------AVKVLHGSNVIHRDLKPSNLLINSNCDLK 152
Query: 273 VGDFGMTRDIYETEYYRKGSRGFLPV-------RWM-APE-SLKDGVFTSHSDVWSYGVV 323
V DFG+ R I E+ G RW APE L ++ DVWS G +
Sbjct: 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212
Query: 324 LWEMATLASQP 334
L E+ +P
Sbjct: 213 LAEL--FLRRP 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 46/231 (19%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNE 172
++V + T L +G G++G+V D + + AIK + E+ + ++ L E
Sbjct: 23 FDVGP-RYTNLSYIGEGAYGMVCSA--YDNLN--KVRVAIKKISPFEHQTYCQRT--LRE 75
Query: 173 ASVMKAFDTHHVVKLYGVVSEGNPTL-----VIMELMGGGDLKNYLRSCRPDAETDVERS 227
++ F +++ + ++ ++ +LM DL L++
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT------------ 122
Query: 228 PPTLSR---------ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278
LS IL+ G+ Y+ +HRDL N ++ +K+ DFG+
Sbjct: 123 -QHLSNDHICYFLYQILR-------GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 174
Query: 279 TRDIYETEYYRKGSRGFLPVRWM-APE-SLKDGVFTSHSDVWSYGVVLWEM 327
R + ++ RW APE L +T D+WS G +L EM
Sbjct: 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 33/166 (19%), Positives = 67/166 (40%), Gaps = 29/166 (17%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE---FLNEASVMKAFD 180
+ +G GSFG+++ G L AIK E +++ +E K
Sbjct: 14 VGRRIGEGSFGVIFEGT----NLLNNQQVAIK------FEPRRSDAPQLRDEYRTYKLLA 63
Query: 181 -THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+ +Y EG +++++L+ G L++ L C R ++ + A
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG--------RK-FSVKTVAMAAK 113
Query: 240 EVADGMAYLADKKFVHRDLAARNCMV-----ADDLTVKVGDFGMTR 280
++ + + +K V+RD+ N ++ + + V DFGM +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 35/207 (16%), Positives = 75/207 (36%), Gaps = 34/207 (16%)
Query: 91 AGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH 150
+ Q G+ +W+V +G G FG +Y + S+
Sbjct: 13 SSAKRHLAEQFAVGEIITDMAAAAWKVGLP-------IGQGGFGCIYLADMNSSESVGSD 65
Query: 151 -PCAIKVANENAS----EREKAEFLNEASVMKAFDTHHVVKLYGV----------VSEGN 195
PC +KV + E + + + ++ + +K GV + +
Sbjct: 66 APCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS 125
Query: 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVH 255
+IM+ G DL+ + + +LQ++ + D + Y+ + ++VH
Sbjct: 126 YRFMIMDRF-GSDLQKIYEAN---------AKRFSRKTVLQLSLRILDILEYIHEHEYVH 175
Query: 256 RDLAARNCMV--ADDLTVKVGDFGMTR 280
D+ A N ++ + V + D+G+
Sbjct: 176 GDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 32/166 (19%), Positives = 66/166 (39%), Gaps = 29/166 (17%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE---FLNEASVMKAFD 180
+ ++G G+FG + G K+ + AIK+ E K+ E K
Sbjct: 13 VGKKIGCGNFGELRLG--KNLYTNEY--VAIKL------EPMKSRAPQLHLEYRFYKQLG 62
Query: 181 -THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+ ++Y G +++EL+ G L++ C R+ +L +L +A
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--------RT-FSLKTVLMIAI 112
Query: 240 EVADGMAYLADKKFVHRDLAARNCMV-----ADDLTVKVGDFGMTR 280
++ M Y+ K ++RD+ N ++ + + DF + +
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 33/172 (19%), Positives = 64/172 (37%), Gaps = 34/172 (19%)
Query: 128 LGNGSFGLVYRGL-IKDFRSLAEHPCAIKVANENAS--ERE--------KAEFLNEASVM 176
+G+G FGL+Y A +KV + E K + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDA--RHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 177 KAFDTHHVVKLYG----VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
K D + YG + ++ME +G DL+ T
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNG------------TFK 149
Query: 233 R--ILQMAAEVADGMAYLADKKFVHRDLAARNCMV--ADDLTVKVGDFGMTR 280
+ +LQ+ + D + Y+ + ++VH D+ A N ++ + V + D+G++
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 53/318 (16%), Positives = 101/318 (31%), Gaps = 115/318 (36%)
Query: 96 TPPNQLMGGDDD-----KLYKKDSW------EVLRSKVTILDELGNGSFGLVYRGLIKDF 144
+++G DDD Y K + ++ + ++ +LG G F V+ L D
Sbjct: 2 EQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVW--LSWDI 59
Query: 145 RSLAEHPCAIKVANENASEREKAEFLNEASV---MKAFDTHH-----VVKLYGVVSEGNP 196
+ + A+KV E A L+E + ++ D + VV+L
Sbjct: 60 QG--KKFVAMKVVKSAEHYTETA--LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115
Query: 197 T-----LVIMELMGGGDLKNYLRSCRPDAETDVERSPP---TLSRILQMAAEVADGMAYL 248
+V E++G + +S L + ++ +V G+ YL
Sbjct: 116 NGTHICMV-FEVLG------------HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 249 -ADKKFVHRDLAARNCMV------------------------------------------ 265
+ +H D+ N ++
Sbjct: 163 HTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLV 222
Query: 266 -------ADDLTVKVGDFGMTRDIYE-------TEYYRKGSRGFLPVRWMAPESLKDGVF 311
A+ L VK+ D G +++ T YR + E L +
Sbjct: 223 NPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR------------SLEVLIGSGY 270
Query: 312 TSHSDVWSYGVVLWEMAT 329
+ +D+WS + +E+AT
Sbjct: 271 NTPADIWSTACMAFELAT 288
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 364 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.31 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.2 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.46 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.37 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.08 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.96 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.88 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.7 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.53 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 97.51 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 97.49 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.45 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.4 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.1 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 97.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.95 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.79 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 96.75 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 96.72 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 96.68 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 96.61 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 96.56 | |
| 2cr4_A | 126 | 3BP-2, SH3 domain-binding protein 2; structural ge | 96.56 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 96.54 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 96.46 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 96.38 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 96.36 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 96.21 | |
| 2hdv_A | 111 | SH2-B PH domain containing signaling mediator 1 ga | 96.06 | |
| 2eo3_A | 111 | CRK-like protein; phosphorylation, repeat, SH2 dom | 95.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.86 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 95.8 | |
| 2dx0_A | 138 | Phospholipase C, gamma 2; phosphoric diester hydro | 95.8 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 95.75 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.6 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 95.54 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 95.48 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 95.44 | |
| 3k2m_A | 112 | Proto-oncogene tyrosine-protein kinase ABL1; engin | 95.38 | |
| 3eaz_A | 106 | Tyrosine-protein kinase CSK; SH2, disulfide, oxidi | 95.35 | |
| 1ju5_A | 109 | CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid | 95.33 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.21 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 95.19 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 95.0 | |
| 3qwx_X | 174 | Cell death abnormality protein 2; cell engulfment, | 94.91 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 94.86 | |
| 1h9o_A | 112 | Phosphatidylinositol 3-kinase; transferase/recepto | 94.84 | |
| 1r1p_A | 100 | GRB2-related adaptor protein 2; SH2, GADS, phospho | 94.77 | |
| 2iug_A | 120 | Phosphatidylinositol 3-kinase regulatory alpha sub | 94.77 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 94.74 | |
| 2crh_A | 138 | VAV proto-oncogene; oncoprotein, structural genomi | 94.72 | |
| 2eo6_A | 141 | B-cell linker protein; SH2, cytoplasmic adapter pr | 94.67 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 94.62 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 94.59 | |
| 2ysx_A | 119 | Signaling inositol polyphosphate phosphatase SHIP | 94.57 | |
| 2kno_A | 131 | Tensin-like C1 domain-containing phosphatase; SH2 | 94.48 | |
| 1mil_A | 104 | SHC adaptor protein; SH2 domain, phosphorylation, | 94.37 | |
| 2hmh_A | 152 | Suppressor of cytokine signaling 3; SOCS3, GP130, | 94.36 | |
| 2eob_A | 124 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 94.32 | |
| 2kk6_A | 116 | Proto-oncogene tyrosine-protein kinase FER; method | 94.31 | |
| 2c9w_A | 169 | Suppressor of cytokine signaling 2; growth regulat | 94.22 | |
| 2ecd_A | 119 | Tyrosine-protein kinase ABL2; SH2 domain, phosphot | 94.21 | |
| 2vif_A | 141 | Suppressor of cytokine signalling 6; growth regula | 94.13 | |
| 2cs0_A | 119 | Hematopoietic SH2 domain containing; ALX, FLJ14886 | 94.12 | |
| 2dlz_A | 118 | Protein VAV-2; RHO family guanine nucleotide excha | 93.98 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 93.96 | |
| 2izv_A | 187 | Suppressor of cytokine signaling 4; signal transdu | 93.67 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 93.55 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 93.39 | |
| 2lnw_A | 122 | VAV-2, guanine nucleotide exchange factor VAV2; si | 93.37 | |
| 3s9k_A | 118 | Tyrosine-protein kinase ITK/TSK; proline isomeriza | 93.26 | |
| 2bbu_A | 164 | Suppressor of cytokine signaling 3; SH2 domain, ex | 92.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 92.73 | |
| 2dvj_A | 230 | V-CRK sarcoma virus CT10 oncogene homolog, isoform | 92.59 | |
| 1wqu_A | 114 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 92.57 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 92.5 | |
| 2eyz_A | 304 | V-CRK sarcoma virus CT10 oncogene homolog isoform | 92.36 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 92.28 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 91.81 | |
| 3qwy_A | 308 | Cell death abnormality protein 2; cell engulfment, | 91.25 | |
| 2y3a_B | 302 | Phosphatidylinositol 3-kinase regulatory subunit; | 90.74 | |
| 3hhm_B | 373 | NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil | 90.5 | |
| 1gri_A | 217 | Growth factor bound protein 2; SH2, SH3, signal tr | 88.43 | |
| 3ps5_A | 595 | Tyrosine-protein phosphatase non-receptor type 6; | 87.24 | |
| 2b3o_A | 532 | Tyrosine-protein phosphatase, non-receptor type 6; | 86.24 | |
| 3ps5_A | 595 | Tyrosine-protein phosphatase non-receptor type 6; | 86.14 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.5 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 85.42 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 84.32 | |
| 2lqn_A | 303 | CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT | 84.18 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 83.14 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 81.59 | |
| 2b3o_A | 532 | Tyrosine-protein phosphatase, non-receptor type 6; | 80.19 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-56 Score=413.74 Aligned_cols=246 Identities=43% Similarity=0.779 Sum_probs=200.1
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.+++.+++|.+.++||+|+||+||+|+++.. ...+++.||||+++.. .....++|.+|+++|++++|||||++++++.
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3456678899999999999999999998752 2334778999999754 4556778999999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCC-----CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAE-----TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~ 267 (364)
+.+.+|||||||++|+|.+++++...... ......++++.+++.|+.||+.||+|||+++||||||||+||||++
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 99999999999999999999987553321 1123457899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
++.+||+|||+|+.+.............+|+.|||||++.+..|+.++|||||||++|||+|.|+.||.+.+..++++.+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999997766555444555567999999999999999999999999999999999789999999999999999
Q ss_pred hcCccccccCCCC
Q psy7023 348 KGKSSNEYKVNPP 360 (364)
Q Consensus 348 ~~~~~~~~~~~~~ 360 (364)
.++...+.|..+|
T Consensus 274 ~~g~~~~~p~~~~ 286 (329)
T 4aoj_A 274 TQGRELERPRACP 286 (329)
T ss_dssp HHTCCCCCCTTCC
T ss_pred HcCCCCCCccccc
Confidence 9988777766554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=411.21 Aligned_cols=217 Identities=20% Similarity=0.346 Sum_probs=193.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|+++. +++.||+|++++... ....+.+.+|+++|++++|||||+++++|++++.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEecccCeEEEEEEECC----CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 579999999999999999999887 577899999975421 22346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|||||||+||+|.+++++. ..+++..++.++.||+.||+|||++|||||||||+|||+++++.+||+|||
T Consensus 108 yivmEy~~gG~L~~~i~~~----------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI----------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 9999999999999999762 357889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++++.|..+.
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~ 250 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEGLIFAKIIKLE 250 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTC
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Confidence 9997765443334445578999999999999999999999999999999999 899999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-56 Score=409.04 Aligned_cols=246 Identities=35% Similarity=0.633 Sum_probs=210.0
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.++..++++++++||+|+||+||+|.+... ....++.||||+++........++|.+|+.+|++++|||||++++++.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 456678899999999999999999997542 1224678999999876655566789999999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~ 267 (364)
++.++||||||++|+|.++|....+.... ......+++..+..|+.||+.||+|||+++||||||||+||||++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999865433221 112356899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
++.+||+|||+|+...............+|+.|||||++.++.|+.++|||||||++|||+|.|..||.+.+..++++.|
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999997766555444555678999999999999999999999999999999999889999999999999999
Q ss_pred hcCccccccCCCC
Q psy7023 348 KGKSSNEYKVNPP 360 (364)
Q Consensus 348 ~~~~~~~~~~~~~ 360 (364)
..+...+.|.++|
T Consensus 261 ~~~~~~~~p~~~~ 273 (308)
T 4gt4_A 261 RNRQVLPCPDDCP 273 (308)
T ss_dssp HTTCCCCCCTTCC
T ss_pred HcCCCCCCcccch
Confidence 9998877766655
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-56 Score=409.33 Aligned_cols=244 Identities=41% Similarity=0.759 Sum_probs=207.3
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
++.+++|.+.++||+|+||+||+|+++.. ...++..||||+++.. .....++|.+|+++|++++|||||++++++.++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 56678999999999999999999998643 2234778999999754 445577899999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCC---CCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDA---ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
+.+|||||||++|+|.+++++..+.. ........+++.+++.|+.||+.||+|||+++||||||||+||||++++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 99999999999999999998643210 001234568999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||+|+...............+|+.|||||++.+..|+.++|||||||++|||+|.|+.||.+.+..+++..+.++.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999877666655555555679999999999999999999999999999999998899999999999999999998
Q ss_pred cccccCCCC
Q psy7023 352 SNEYKVNPP 360 (364)
Q Consensus 352 ~~~~~~~~~ 360 (364)
..+.|..+|
T Consensus 248 ~~~~p~~~~ 256 (299)
T 4asz_A 248 VLQRPRTCP 256 (299)
T ss_dssp CCCCCTTCC
T ss_pred CCCCCccch
Confidence 877766654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=411.49 Aligned_cols=219 Identities=23% Similarity=0.372 Sum_probs=188.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|+++++||+|+||+||+|+++. +++.||||+++... .....+.+.+|+++|++++|||||++++++.+++.+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE----DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT----TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC----CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 689999999999999999999886 57789999987543 4556778999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
||||||+||+|.++|... ....+++..++.|+.||+.||+|||++|||||||||+||||+++|.+||+|||+
T Consensus 100 iVmEy~~gg~L~~~i~~~--------~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQ--------KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp EEEECCTTCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred EEEeCCCCCcHHHHHHHc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEccccc
Confidence 999999999999999762 234568889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|+.+....... ....||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+++.+|..+...
T Consensus 172 a~~~~~~~~~~--~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~ 243 (350)
T 4b9d_A 172 ARVLNSTVELA--RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT-LKHAFEAGSMKNLVLKIISGSFP 243 (350)
T ss_dssp ESCCCHHHHHH--HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTCCC
T ss_pred ceeecCCcccc--cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCC
Confidence 98765432211 12347999999999999999999999999999999999 89999999999999998877654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-56 Score=413.78 Aligned_cols=226 Identities=22% Similarity=0.392 Sum_probs=198.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.++.|+++++||+|+||+||+|+++. +++.||||+++..... ..+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~----tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRS----SGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECC----CCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35689999999999999999999887 5778999998754332 245688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|||||||+||+|.+++.+ ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||
T Consensus 147 ~ivmEy~~gg~L~~~l~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFG 215 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG 215 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCc
Confidence 999999999999999975 247889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
+|+.+...... .....||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..++++.|..+.....+.
T Consensus 216 la~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~~ 292 (346)
T 4fih_A 216 FCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPRLKN 292 (346)
T ss_dssp TCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCCCCSC
T ss_pred CceecCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCCc
Confidence 99876544322 234467999999999999999999999999999999999 899999999999999998876665555
Q ss_pred CCCCC
Q psy7023 358 NPPIS 362 (364)
Q Consensus 358 ~~~~s 362 (364)
+..+|
T Consensus 293 ~~~~s 297 (346)
T 4fih_A 293 LHKVS 297 (346)
T ss_dssp GGGSC
T ss_pred cccCC
Confidence 55554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=405.54 Aligned_cols=250 Identities=34% Similarity=0.615 Sum_probs=211.5
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCC-cceeEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT-HHVVKLY 188 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~ 188 (364)
....||+.+++|+++++||+|+||+||+|.++..+ ..+.+.||||+++........+++.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34579999999999999999999999999987653 335678999999887777778889999999999976 7999999
Q ss_pred EEEee-CCceEEEEecCCCCCHHHHHHhcCCCC------CCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 189 GVVSE-GNPTLVIMELMGGGDLKNYLRSCRPDA------ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 189 ~~~~~-~~~~~lv~e~~~ggsL~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
++|.+ ++.++||||||++|+|.++|++..... ........+++.+++.++.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 99875 467899999999999999998643211 01122456899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-H
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS-N 340 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~-~ 340 (364)
|||+++++.+||+|||+|+.+.............+|+.|||||++.+..|+.++|||||||++|||+|.|..||.+.+ .
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999977655444444455678999999999999999999999999999999997899999866 4
Q ss_pred HHHHHHHhcCccccccCCCC
Q psy7023 341 EQVLNWVKGKSSNEYKVNPP 360 (364)
Q Consensus 341 ~~~~~~i~~~~~~~~~~~~~ 360 (364)
.++...+.++..++.|..++
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~ 314 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTT 314 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCC
T ss_pred HHHHHHHHcCCCCCCCccCC
Confidence 66778888888777765543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=409.00 Aligned_cols=226 Identities=22% Similarity=0.392 Sum_probs=198.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.++.|+++++||+|+||+||+|+++. +++.||||+++..... ..+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~----tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRS----SGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECC----CCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence 45789999999999999999999887 5778999998754322 245688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|||||||+||+|.++++. ..+++.++..++.||+.||+|||++|||||||||+||||+.+|.+||+|||
T Consensus 224 ~iVmEy~~gG~L~~~i~~-----------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFG 292 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG 292 (423)
T ss_dssp EEEEECCTTEEHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCT
T ss_pred EEEEeCCCCCcHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCc
Confidence 999999999999999975 247889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
+|+.+...... .....||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..+++..|..+.....+.
T Consensus 293 la~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~~ 369 (423)
T 4fie_A 293 FCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPRLKN 369 (423)
T ss_dssp TCEECCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred cceECCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCcc
Confidence 99876544322 233457999999999999999999999999999999999 899999999999999998877666666
Q ss_pred CCCCC
Q psy7023 358 NPPIS 362 (364)
Q Consensus 358 ~~~~s 362 (364)
+..+|
T Consensus 370 ~~~~s 374 (423)
T 4fie_A 370 LHKVS 374 (423)
T ss_dssp TTSSC
T ss_pred cccCC
Confidence 65554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=392.34 Aligned_cols=223 Identities=28% Similarity=0.503 Sum_probs=184.4
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
...||+..+++++.++||+|+||+||+|++++ .||||+++.. ......++|.+|+.+|++++|||||+++++
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 35689999999999999999999999998653 3899998744 345567889999999999999999999998
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
+.+ +.+|||||||+||+|.+++.. ...++++.++..|+.||+.||+|||+++||||||||+||||++++.
T Consensus 101 ~~~-~~~~iVmEy~~gGsL~~~l~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~ 170 (307)
T 3omv_A 101 MTK-DNLAIVTQWCEGSSLYKHLHV---------QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT 170 (307)
T ss_dssp ECS-SSCEEEEECCSSCBHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE
T ss_pred EEC-CeEEEEEEcCCCCCHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc
Confidence 865 578999999999999999975 3346889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ-VLNW 346 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~-~~~~ 346 (364)
+||+|||+|+...............||+.|||||++.+ +.|+.++|||||||++|||+| |+.||.+.++.+ +...
T Consensus 171 ~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt-g~~Pf~~~~~~~~~~~~ 249 (307)
T 3omv_A 171 VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT-GELPYSHINNRDQIIFM 249 (307)
T ss_dssp EEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHHH
T ss_pred EEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH-CCCCCCCCChHHHHHHH
Confidence 99999999987655443333445568999999999964 458999999999999999999 899999876654 4455
Q ss_pred HhcCcc
Q psy7023 347 VKGKSS 352 (364)
Q Consensus 347 i~~~~~ 352 (364)
+..+..
T Consensus 250 ~~~~~~ 255 (307)
T 3omv_A 250 VGRGYA 255 (307)
T ss_dssp HHTTCC
T ss_pred HhcCCC
Confidence 555543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=397.28 Aligned_cols=222 Identities=23% Similarity=0.329 Sum_probs=187.7
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.+.|++.++||+|+||+||+|+++. +++.||||+++.... ..+|+.+|+.++|||||++++++.+++.+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~----~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQ----TGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECC----CCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3578999999999999999999887 577899999975432 246999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-TVKVGDFG 277 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kL~DFg 277 (364)
||||||+||+|.+++++. ..+++..++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||
T Consensus 127 ivmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFG 196 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM----------GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196 (336)
T ss_dssp EEECCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred EEEeccCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCC
Confidence 999999999999999762 3578899999999999999999999999999999999999987 69999999
Q ss_pred cccccCccceee---eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 278 MTRDIYETEYYR---KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 278 ~a~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
+|+.+....... ......||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+++..|..+....
T Consensus 197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 275 (336)
T 4g3f_A 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKIASEPPPI 275 (336)
T ss_dssp TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSTTTCCSCCHHHHHHSCCGG
T ss_pred CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHHcCCCCc
Confidence 998765433221 2233458999999999999999999999999999999999 899999988888888887765543
Q ss_pred ccCCCCC
Q psy7023 355 YKVNPPI 361 (364)
Q Consensus 355 ~~~~~~~ 361 (364)
...++.+
T Consensus 276 ~~~~~~~ 282 (336)
T 4g3f_A 276 REIPPSC 282 (336)
T ss_dssp GGSCTTS
T ss_pred hhcCccC
Confidence 3334433
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-54 Score=394.95 Aligned_cols=219 Identities=26% Similarity=0.368 Sum_probs=183.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++++.||+|+||+||+|++.... .+++.||+|++++.. ......++.+|+++|++++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGS-DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSST-TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCC-CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 68999999999999999999875422 246789999987542 1122345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|||||+||+|.+++++. ..+++..+..++.||+.||+|||++|||||||||+|||++++|.+||+|||+
T Consensus 103 ivmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGl 172 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE----------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL 172 (304)
T ss_dssp EEECCCTTCEEHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred EEEEcCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccc
Confidence 999999999999999762 3578899999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+....... ......||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+++..|..+..
T Consensus 173 a~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~ 243 (304)
T 3ubd_A 173 SKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPFQGKDRKETMTMILKAKL 243 (304)
T ss_dssp EEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCC
T ss_pred ceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCC
Confidence 986544332 2234467999999999999999999999999999999999 8999999999999999877643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=381.27 Aligned_cols=214 Identities=23% Similarity=0.441 Sum_probs=176.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|+++. +++.||+|++++... ......+.+|+++|++++|||||++++++.+++.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT----TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT----TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC----CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 589999999999999999999876 578899999875432 23356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||| +|+|.+++.+ ...+++..+..++.||+.||+|||++|||||||||+|||+++++.+||+|||
T Consensus 89 ~ivmEy~-~g~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQ----------RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp EEEEECC-CEEHHHHHHH----------SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred EEEEeCC-CCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecC
Confidence 9999999 6799999975 3458889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+|+....... .....||+.|||||++.+..| +.++|||||||++|+|+| |++||.+.+..++++.+..+..
T Consensus 158 la~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt-g~~PF~~~~~~~~~~~i~~~~~ 229 (275)
T 3hyh_A 158 LSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKNISNGVY 229 (275)
T ss_dssp CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCC
T ss_pred CCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCCC
Confidence 9986654332 223467999999999998887 579999999999999999 8999999999999998887653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=377.08 Aligned_cols=213 Identities=24% Similarity=0.439 Sum_probs=180.6
Q ss_pred cce-eEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee----
Q psy7023 120 SKV-TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE---- 193 (364)
Q Consensus 120 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~---- 193 (364)
.+| ++.++||+|+||+||+|.++. ++..||+|++.... .....+.|.+|+++|++++|||||+++++|.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE----TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred CceEEeeeEEecCcCcEEEEEEECC----CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 454 677889999999999999887 57789999986543 45556789999999999999999999999875
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEc-CCCc
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLAARNCMVA-DDLT 270 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NILl~-~~~~ 270 (364)
++.+|||||||+||+|.+++++. ..+++..+..++.||+.||+|||+++ ||||||||+||||+ +++.
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~ 170 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS 170 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC
T ss_pred CcEEEEEEeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC
Confidence 35689999999999999999762 35788899999999999999999998 99999999999998 4799
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhc
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL-SNEQVLNWVKG 349 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~-~~~~~~~~i~~ 349 (364)
+||+|||+|+....... ....||+.|||||++.+ .|+.++|||||||++|||+| |++||.+. +..++...+..
T Consensus 171 vKl~DFGla~~~~~~~~----~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~~i~~ 244 (290)
T 3fpq_A 171 VKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp EEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHTT
T ss_pred EEEEeCcCCEeCCCCcc----CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHH-CCCCCCCCCcHHHHHHHHHc
Confidence 99999999985443322 22357999999999875 69999999999999999999 89999764 45667777776
Q ss_pred Ccc
Q psy7023 350 KSS 352 (364)
Q Consensus 350 ~~~ 352 (364)
+..
T Consensus 245 ~~~ 247 (290)
T 3fpq_A 245 GVK 247 (290)
T ss_dssp TCC
T ss_pred CCC
Confidence 654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=372.79 Aligned_cols=216 Identities=23% Similarity=0.380 Sum_probs=170.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC----
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN---- 195 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~---- 195 (364)
++|++++.||+|+||+||+|+++. +++.||+|+++........+.+.+|+++|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV----DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT----TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred hhCEEeeEEecCCCeEEEEEEECC----CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 579999999999999999999886 477899999987666666788999999999999999999999987544
Q ss_pred --------ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7023 196 --------PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267 (364)
Q Consensus 196 --------~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~ 267 (364)
.+|+|||||+||+|.++++..... .......++.++.||+.||+|||++|||||||||+|||++.
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~-------~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI-------EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSG-------GGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCC-------ChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC
Confidence 379999999999999999864321 12345678899999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCccceee----------eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYR----------KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
++.+||+|||+|+.+....... ......||+.|||||++.+..|+.++|||||||++|||++ ||.+
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~----Pf~~ 229 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----PFST 229 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS----CCSS
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc----CCCC
Confidence 9999999999998765433211 1223458999999999999999999999999999999997 7765
Q ss_pred CCH-HHHHHHHhcC
Q psy7023 338 LSN-EQVLNWVKGK 350 (364)
Q Consensus 338 ~~~-~~~~~~i~~~ 350 (364)
..+ ...+..+...
T Consensus 230 ~~~~~~~~~~~~~~ 243 (299)
T 4g31_A 230 QMERVRTLTDVRNL 243 (299)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred ccHHHHHHHHHhcC
Confidence 322 2334444443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=388.81 Aligned_cols=316 Identities=30% Similarity=0.520 Sum_probs=242.0
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCcc-ceeeeeeeeeeeeeCCCCCCccccccCCCC---------
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKF-NIFLFLIRVAVILTGSGGPAVTTTTVATPT--------- 88 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~sg~~~~~~~~~~~~~--------- 88 (364)
|+..|++.|+||||+| +...+.|.+|++..+.... .++||.|... .++.............
T Consensus 86 L~~~~~~~G~FLvR~s-----~~~~g~y~lsv~~~~~~~~~~v~H~~I~~~----~~g~~~i~~~~~F~sl~eLv~~y~~ 156 (454)
T 1qcf_A 86 LLAPGNMLGSFMIRDS-----ETTKGSYSLSVRDYDPRQGDTVKHYKIRTL----DNGGFYISPRSTFSTLQELVDHYKK 156 (454)
T ss_dssp HHSTTCCTTCEEEEEC-----SSSTTSEEEEEEEEETTTEEEEEEEEEEEC----TTSCEESSSSSCBSSHHHHHHHHTS
T ss_pred hhcCCCCCceEEEEEC-----cCCCCeEEEEEEecccCCCCceEEEEEEEc----CCCcEEEeCccccCCHHHHHHHHHh
Confidence 5578999999999999 6777889999988765544 6899988763 2232221111000000
Q ss_pred CCCCCCCCCCCCCCCCCCcccccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHH
Q psy7023 89 TPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE 168 (364)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~ 168 (364)
...+....................+.|++..++|++.+.||+|+||+||+|.++. +..||+|+++.... ..+.
T Consensus 157 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~--~~~~ 229 (454)
T 1qcf_A 157 GNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-----HTKVAVKTMKPGSM--SVEA 229 (454)
T ss_dssp SCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-----TEEEEEEEECTTSB--CHHH
T ss_pred ccCCccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECC-----ccEEEEEEecCCCc--cHHH
Confidence 0000000000000000111123356789999999999999999999999999874 56799999976543 2567
Q ss_pred HHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHH
Q psy7023 169 FLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYL 248 (364)
Q Consensus 169 ~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~L 248 (364)
+.+|+.+|++++||||+++++++. .+..++||||+++|+|.++++.. ....+++..++.++.||+.||+||
T Consensus 230 ~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~L 300 (454)
T 1qcf_A 230 FLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFI 300 (454)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--------HHHTCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 899999999999999999999987 57889999999999999999752 123467888999999999999999
Q ss_pred HhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHH
Q psy7023 249 ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMA 328 (364)
Q Consensus 249 H~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 328 (364)
|+++|+||||||+|||++.++.+||+|||+++......... .....+++.|+|||++....++.++||||||+++|||+
T Consensus 301 H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 379 (454)
T 1qcf_A 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379 (454)
T ss_dssp HHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred HhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHH
Confidence 99999999999999999999999999999998765443222 22233477899999999899999999999999999999
Q ss_pred hCCCCCCCCCCHHHHHHHHhcCccccccCCCC
Q psy7023 329 TLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360 (364)
Q Consensus 329 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 360 (364)
|+|+.||.+.+..++.+.+..+..++.+.+++
T Consensus 380 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 411 (454)
T 1qcf_A 380 TYGRIPYPGMSNPEVIRALERGYRMPRPENCP 411 (454)
T ss_dssp TTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 98899999999999999998887766655543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=386.17 Aligned_cols=313 Identities=35% Similarity=0.543 Sum_probs=237.1
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCcc-ceeeeeeeeeeeeeCCCCCCccccccCCCC---------
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKF-NIFLFLIRVAVILTGSGGPAVTTTTVATPT--------- 88 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~sg~~~~~~~~~~~~~--------- 88 (364)
|++.||+.|+||||+| +...+.|.+|++.++.... .++||.|+.. .+|.............
T Consensus 81 L~~~~~~~G~FLvR~s-----~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~----~~g~~~~~~~~~F~Sl~~Li~~y~~ 151 (452)
T 1fmk_A 81 LLNAENPRGTFLVRES-----ETTKGAYCLSVSDFDNAKGLNVKHYKIRKL----DSGGFYITSRTQFNSLQQLVAYYSK 151 (452)
T ss_dssp HTCTTSCTTEEEEEEC-----SSSTTCEEEEEEEEETTTEEEEEEEEEEEC----TTSCEESSTTSEESSHHHHHHHHTT
T ss_pred hccCCCCCceEEEEeC-----CCCCCceEEEEEeeccCCCCcEEEEEEEEc----CCCCEEEecCcccCCHHHHHHHhhh
Confidence 5678999999999999 5677889999998775544 7999999873 2332211110000000
Q ss_pred CCCC----CCCCCCCCCCCCCCcccccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH
Q psy7023 89 TPAG----GTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER 164 (364)
Q Consensus 89 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~ 164 (364)
...+ .....+... ........+.|++..++|++.++||+|+||+||+|.++. ...||+|+++.....
T Consensus 152 ~~~~l~~~l~~~~~~~~---~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~- 222 (452)
T 1fmk_A 152 HADGLCHRLTTVCPTSK---PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMS- 222 (452)
T ss_dssp CCTTSSSCCCEECCCCC---CCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-----TEEEEEEECCTTSSC-
T ss_pred ccccchhhccccccccc---cccCCCCccccccChhHceeeeeecCCCCeEEEEEEECC-----CceEEEEEeccCCCC-
Confidence 0000 000011000 001112356789999999999999999999999999875 456999999865433
Q ss_pred HHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHH
Q psy7023 165 EKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244 (364)
Q Consensus 165 ~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~ 244 (364)
.+++.+|+.+|++++||||+++++++.+ +..++||||+++|+|.++++.. ....+++..+..++.||+.|
T Consensus 223 -~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~qi~~~ 292 (452)
T 1fmk_A 223 -PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASG 292 (452)
T ss_dssp -HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--------HHTTCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHH
Confidence 3578999999999999999999999876 7789999999999999999752 22457888999999999999
Q ss_pred HHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHH
Q psy7023 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324 (364)
Q Consensus 245 L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 324 (364)
|+|||+++|+||||||+|||+++++.+||+|||+++......... .....+++.|+|||++....++.++||||||+++
T Consensus 293 l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l 371 (452)
T 1fmk_A 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371 (452)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHH
Confidence 999999999999999999999999999999999998765443222 1222346789999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCCC
Q psy7023 325 WEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360 (364)
Q Consensus 325 ~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 360 (364)
|||+|+|..||.+.+..++++.+..+...+.+..++
T Consensus 372 ~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 407 (452)
T 1fmk_A 372 TELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407 (452)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 999998899999999999999999887766555443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=380.67 Aligned_cols=217 Identities=23% Similarity=0.397 Sum_probs=185.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee---
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--- 193 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--- 193 (364)
+.++|+++++||+|+||+||+|+++. +++.||||+++... .....+.+++|+++|+.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~----t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRL----TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECC----CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 34689999999999999999999887 57889999987543 34456778899999999999999999999763
Q ss_pred ---CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 194 ---GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 194 ---~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
.+.+|||||||+ |+|.+++.+ ...+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 128 ~~~~~~~~ivmE~~~-g~L~~~i~~----------~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~ 196 (398)
T 4b99_A 128 YGEFKSVYVVLDLME-SDLHQIIHS----------SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE 196 (398)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHTS----------SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC
T ss_pred cccCCEEEEEEeCCC-CCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC
Confidence 467899999995 689999964 346889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccce--eeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEY--YRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+||+|||+|+.+..... ........||+.|||||++.+.. |+.++||||+||++|||++ |++||.+.+..+.+..|
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~-G~~pF~g~~~~~~l~~I 275 (398)
T 4b99_A 197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFPGKNYVHQLQLI 275 (398)
T ss_dssp EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHH
T ss_pred EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 99999999987654322 12234456899999999988754 6999999999999999999 89999999999988877
Q ss_pred hcC
Q psy7023 348 KGK 350 (364)
Q Consensus 348 ~~~ 350 (364)
...
T Consensus 276 ~~~ 278 (398)
T 4b99_A 276 MMV 278 (398)
T ss_dssp HHH
T ss_pred HHh
Confidence 543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=389.08 Aligned_cols=312 Identities=35% Similarity=0.523 Sum_probs=241.3
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCcc-ceeeeeeeeeeeeeCCCCCCccccccC------------
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKF-NIFLFLIRVAVILTGSGGPAVTTTTVA------------ 85 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~sg~~~~~~~~~~------------ 85 (364)
|++.||+.|+||||+| +...+.|.+|++.++.... .++||.|+.. .+|..........
T Consensus 164 L~~~~~~~G~FLvR~S-----~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~----~~g~~~i~~~~~F~SL~eLv~~y~~ 234 (535)
T 2h8h_A 164 LLNAENPRGTFLVRES-----ETTKGAYCLSVSDFDNAKGLNVKHYKIRKL----DSGGFYITSRTQFNSLQQLVAYYSK 234 (535)
T ss_dssp HTCTTCCTTEEEEEEC-----SSSTTCEEEEEEEEETTTEEEEEEEEEBC-----CCSCEEEETTEEESSHHHHHHHHHH
T ss_pred hccCCCCCCeEEEEec-----CCCCCcEEEEEEeeccCCCCceEEEEEEEc----CCCcEEeeccccccChHHhheeecc
Confidence 5678999999999999 5667889999998776554 7899998863 2222211110000
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCcccccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH
Q psy7023 86 -TPTTPAGGTTTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER 164 (364)
Q Consensus 86 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~ 164 (364)
............+... ........+.|++..++|++.++||+|+||+||+|.++. ...||||+++.....
T Consensus 235 ~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~- 305 (535)
T 2h8h_A 235 HADGLCHRLTTVCPTSK---PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMS- 305 (535)
T ss_dssp CCTTSSSCCCEECCCCC---CCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-----TEEEEEEEECTTSSC-
T ss_pred ccCcccccccccccccc---ccccccCccceecchhhhhhheecccCCCeEEEEEEECC-----CceEEEEEeCCCCCC-
Confidence 0000000000000000 001112356799999999999999999999999999875 456999999865433
Q ss_pred HHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHH
Q psy7023 165 EKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADG 244 (364)
Q Consensus 165 ~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~ 244 (364)
.+++.+|+++|++++|+||+++++++.+ +..|+||||+++|+|.++++.. ....+++..++.++.||+.|
T Consensus 306 -~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~~ 375 (535)
T 2h8h_A 306 -PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--------TGKYLRLPQLVDMAAQIASG 375 (535)
T ss_dssp -HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--------HHTTCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--------CCCCCCHHHHHHHHHHHHHH
Confidence 3578999999999999999999999876 7789999999999999999752 22357888999999999999
Q ss_pred HHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHH
Q psy7023 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVL 324 (364)
Q Consensus 245 L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 324 (364)
|+|||+++||||||||+||||++++.+||+|||+++......... .....++..|+|||++....++.++|||||||++
T Consensus 376 L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l 454 (535)
T 2h8h_A 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454 (535)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT-TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec-ccCCcCcccccCHHHhccCCCCchhhHHHHHHHH
Confidence 999999999999999999999999999999999998765433221 2223357789999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCC
Q psy7023 325 WEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNP 359 (364)
Q Consensus 325 ~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 359 (364)
|||+|+|..||.+.+..++++.+..+..++.+..+
T Consensus 455 ~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 489 (535)
T 2h8h_A 455 TELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 489 (535)
T ss_dssp HHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 99999889999999999999999988776655544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=376.38 Aligned_cols=237 Identities=36% Similarity=0.692 Sum_probs=207.3
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
..+.|++..++|++.+.||+|+||+||+|.++. .+..||+|+++........+++.+|+++|++++||||++++++
T Consensus 105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRA----DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETT----TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccEEchHHeEEeeEeccCCCCeEEEEEEec----CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 356788888999999999999999999999875 4678999999876666667789999999999999999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
+...+..++||||+++|+|.++++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~ 251 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTE---------GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV 251 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc
Confidence 99999999999999999999999752 234778899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||+|+|..||.+.+..++.+.+..+
T Consensus 252 ~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 331 (377)
T 3cbl_A 252 LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331 (377)
T ss_dssp EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT
T ss_pred EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999987655443333333334678999999998899999999999999999999889999999999999999888
Q ss_pred ccccccCCCC
Q psy7023 351 SSNEYKVNPP 360 (364)
Q Consensus 351 ~~~~~~~~~~ 360 (364)
...+.+..+|
T Consensus 332 ~~~~~~~~~~ 341 (377)
T 3cbl_A 332 GRLPCPELCP 341 (377)
T ss_dssp CCCCCCTTCC
T ss_pred CCCCCCCCCC
Confidence 7776665543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=379.67 Aligned_cols=309 Identities=33% Similarity=0.552 Sum_probs=236.3
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeeeeeeeCCCCCCccccccCCCC--------C-CCCCC
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVAVILTGSGGPAVTTTTVATPT--------T-PAGGT 94 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sg~~~~~~~~~~~~~--------~-~~~~~ 94 (364)
++.|+||||+| +...+.|.+|++. ...++||.|... ..|............. . ..+..
T Consensus 124 ~~~G~fLvR~s-----~~~~~~~~lsv~~----~~~v~h~~I~~~----~~g~~~~~~~~~F~sl~eLv~~~~~~~~g~~ 190 (495)
T 1opk_A 124 GINGSFLVRES-----ESSPGQRSISLRY----EGRVYHYRINTA----SDGKLYVSSESRFNTLAELVHHHSTVADGLI 190 (495)
T ss_dssp CCTTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEECEEC----TTSCEESSTTSCBSSHHHHHHHHTTCCTTSS
T ss_pred CCCceEEEEeC-----CCCCCceEEEEee----CCeEEEEEEEec----CCCceEeccCccchhHHHHhhhhcccccccc
Confidence 57799999999 5566677888774 347899988762 2222111100000000 0 00000
Q ss_pred ----CCCCCCCCCCCCcccccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHH
Q psy7023 95 ----TTPPNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFL 170 (364)
Q Consensus 95 ----~~~~~~~~~~~~~~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~ 170 (364)
.+.+..............+.|++...+|++.++||+|+||.||+|.++. .+..||+|+++..... .+++.
T Consensus 191 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~--~~~~~ 264 (495)
T 1opk_A 191 TTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDTME--VEEFL 264 (495)
T ss_dssp SCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGG----GTEEEEEEECCSSSSC--HHHHH
T ss_pred hhccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcC----CCeEEEEEEecCcccc--hHHHH
Confidence 0000000000000111245688899999999999999999999999886 4678999999865433 46789
Q ss_pred HHHHHHHhcCCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh
Q psy7023 171 NEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD 250 (364)
Q Consensus 171 ~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~ 250 (364)
+|+.+|++++||||+++++++...+..++||||+++|+|.++++.. ....+++..++.++.||+.||+|||+
T Consensus 265 ~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~ 336 (495)
T 1opk_A 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEK 336 (495)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--------CTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999999999999999863 23457888999999999999999999
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhC
Q psy7023 251 KKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATL 330 (364)
Q Consensus 251 ~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~ 330 (364)
++|+||||||+|||++.++.+||+|||+++......... .....+++.|+|||++....++.++|||||||++|||+|+
T Consensus 337 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~ 415 (495)
T 1opk_A 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415 (495)
T ss_dssp TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCcccCCCChhhEEECCCCcEEEeecccceeccCCceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence 999999999999999999999999999998765543322 2233457789999999988999999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhcCccccccCCCC
Q psy7023 331 ASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360 (364)
Q Consensus 331 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 360 (364)
|..||.+.+..++.+.+..+...+.+..++
T Consensus 416 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (495)
T 1opk_A 416 GMSPYPGIDLSQVYELLEKDYRMERPEGCP 445 (495)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 899999999999999998887776655443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=388.15 Aligned_cols=214 Identities=21% Similarity=0.294 Sum_probs=178.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-----CHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-----SEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
-.++|+++++||+|+||+||+|+++. +++.||+|++++.. .........+++.+++.++|||||+++++|+
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~----tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred chHHeEEEEEEecccCeEEEEEEECC----CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 34789999999999999999999887 57889999986432 1111222334566777789999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+.+.+|||||||+||+|.++|.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+|
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~----------~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQH----------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEE
T ss_pred ECCEEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEE
Confidence 999999999999999999999762 3578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLS---NEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~---~~~~~~~i~ 348 (364)
|+|||+|+.+.... .....||+.|||||++.. ..|+.++|||||||++|||++ |.+||.+.+ ..++...+.
T Consensus 333 L~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLt-G~~PF~~~~~~~~~~i~~~i~ 407 (689)
T 3v5w_A 333 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTL 407 (689)
T ss_dssp ECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCGGGCCCHHHHHHHHH
T ss_pred ecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhc
Confidence 99999998765443 223468999999999975 579999999999999999999 899997643 334444444
Q ss_pred cC
Q psy7023 349 GK 350 (364)
Q Consensus 349 ~~ 350 (364)
..
T Consensus 408 ~~ 409 (689)
T 3v5w_A 408 TM 409 (689)
T ss_dssp HC
T ss_pred CC
Confidence 33
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=384.40 Aligned_cols=227 Identities=23% Similarity=0.358 Sum_probs=196.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..++|++++.||+|+||+||+|+++. +++.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~----tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERA----TGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECC----CCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 34689999999999999999999887 57789999986543 34467788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC--CcEEEee
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD--LTVKVGD 275 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~--~~~kL~D 275 (364)
|||||||+||+|.+++.. ....+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus 230 ~iv~E~~~gg~L~~~i~~---------~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~D 300 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 300 (573)
T ss_dssp EEEEECCCCCBHHHHHTC---------TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred EEEEeecCCCcHHHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEee
Confidence 999999999999999964 33568899999999999999999999999999999999999854 8999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc-cc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS-NE 354 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~ 354 (364)
||+|+.+....... ...||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..+++..|..+.. ++
T Consensus 301 FG~a~~~~~~~~~~---~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~-G~~Pf~~~~~~~~~~~i~~~~~~~~ 376 (573)
T 3uto_A 301 FGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMD 376 (573)
T ss_dssp CSSCEECCTTSEEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred ccceeEccCCCcee---eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHhCCCCCC
Confidence 99999876554332 2247899999999999999999999999999999999 8999999999999999877643 33
Q ss_pred ccCCCCCC
Q psy7023 355 YKVNPPIS 362 (364)
Q Consensus 355 ~~~~~~~s 362 (364)
.+.+..+|
T Consensus 377 ~~~~~~~s 384 (573)
T 3uto_A 377 DSAFSGIS 384 (573)
T ss_dssp SGGGTTSC
T ss_pred cccccCCC
Confidence 44444444
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=363.37 Aligned_cols=212 Identities=17% Similarity=0.253 Sum_probs=176.2
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~ 196 (364)
+.++|+++++||+|+||+||+|+++.. ..+++.||+|.+..... ..++.+|+++|+.+ +||||++++++|.+.+.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~-~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQ-VGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBT-TSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEccc-CCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 567899999999999999999987631 22467899998865543 34677899999998 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEee
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD-LTVKVGD 275 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~-~~~kL~D 275 (364)
+|+|||||+||+|.++++ .+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECc
Confidence 999999999999999984 26788999999999999999999999999999999999876 8999999
Q ss_pred cccccccCcccee--------------------------eeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHH
Q psy7023 276 FGMTRDIYETEYY--------------------------RKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMA 328 (364)
Q Consensus 276 Fg~a~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~ 328 (364)
||+|+...+.... .......||+.|||||++.+. .|+.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 9999755432110 112234689999999999876 4899999999999999999
Q ss_pred hCCCCCC-CCCCHHHHHHHH
Q psy7023 329 TLASQPY-QGLSNEQVLNWV 347 (364)
Q Consensus 329 t~g~~P~-~~~~~~~~~~~i 347 (364)
| |++|| .+.++.+.+..|
T Consensus 242 ~-G~~Pf~~~~~~~~~l~~I 260 (361)
T 4f9c_A 242 S-GRYPFYKASDDLTALAQI 260 (361)
T ss_dssp H-TCSSSSCCSSHHHHHHHH
T ss_pred H-CCCCCCCCCCHHHHHHHH
Confidence 9 78888 456666666555
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=355.48 Aligned_cols=196 Identities=22% Similarity=0.352 Sum_probs=159.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC----
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN---- 195 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~---- 195 (364)
.+|.+.++||+|+||+||+|+++ ++.||||+++..... ...+..|+..+.+++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~------g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR------GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET------TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC------CEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 57899999999999999999874 567999998754322 222334666667889999999999998654
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEcC
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK--------KFVHRDLAARNCMVAD 267 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--------~iiHrDlkp~NILl~~ 267 (364)
.+|||||||++|+|.++++. .++++..+.+++.|++.||+|||++ +||||||||+||||++
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~-----------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~ 143 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred EEEEEecCCCCCcHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC
Confidence 57999999999999999975 2478889999999999999999987 9999999999999999
Q ss_pred CCcEEEeecccccccCccceee--eCCCCCCCccccCcccccCC------CCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYR--KGSRGFLPVRWMAPESLKDG------VFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
++++||+|||+|+......... ......||+.|||||++.+. .|+.++|||||||+||||+| |.+||
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t-g~~~~ 218 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIG 218 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBT
T ss_pred CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH-CCCCC
Confidence 9999999999998765433221 22334679999999999764 36779999999999999999 65443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=356.96 Aligned_cols=247 Identities=36% Similarity=0.687 Sum_probs=209.1
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcc---cccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR---SLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLY 188 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~ 188 (364)
..|+...++|++++.||+|+||+||+|.+...+ ...+..||+|+++........+.+.+|+.+++++ +||||++++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 446677889999999999999999999875422 2246679999998777777778899999999999 899999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
+++...+.+|+||||+++|+|.+++......... ......+++..++.++.||+.||+|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 9999999999999999999999999875432110 1123457899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 263 ILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||+|+|..||.+.+..+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999999876654443344445567889999999999999999999999999999998899999999999
Q ss_pred HHHHHhcCccccccCCC
Q psy7023 343 VLNWVKGKSSNEYKVNP 359 (364)
Q Consensus 343 ~~~~i~~~~~~~~~~~~ 359 (364)
+...+..+...+.+..+
T Consensus 314 ~~~~~~~~~~~~~~~~~ 330 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANC 330 (370)
T ss_dssp HHHHHHTTCCCCCCTTS
T ss_pred HHHHHhcCCCCCCCCCC
Confidence 99999888766555443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=378.26 Aligned_cols=235 Identities=33% Similarity=0.633 Sum_probs=195.3
Q ss_pred ceeeeccceeEec-eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 114 SWEVLRSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 114 ~~e~~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.+.+.+.++.+.+ +||+|+||+||+|.++... .+..||||+++........+++.+|+++|++++||||+++++++.
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSS--CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCC--CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 3445566777777 8999999999999886432 356799999987655555678999999999999999999999997
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
. +..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++||||||||+||||++++.+|
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vk 476 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAK 476 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred c-CCeEEEEEeCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEE
Confidence 6 679999999999999999964 234578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 273 VGDFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 273 L~DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||+|.|..||.+.+..++.+.+..+.
T Consensus 477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~ 556 (613)
T 2ozo_A 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556 (613)
T ss_dssp ECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC
T ss_pred EeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987654322 1222233446789999999999999999999999999999987899999999999999999998
Q ss_pred cccccCCCC
Q psy7023 352 SNEYKVNPP 360 (364)
Q Consensus 352 ~~~~~~~~~ 360 (364)
..+.+..++
T Consensus 557 ~~~~p~~~~ 565 (613)
T 2ozo_A 557 RMECPPECP 565 (613)
T ss_dssp CCCCCTTCC
T ss_pred CCCCCCcCC
Confidence 777766554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=364.97 Aligned_cols=227 Identities=36% Similarity=0.651 Sum_probs=195.8
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
...|++..++|++++.||+|+||+||+|.++ +..||+|+++... ..+.+.+|+.+|++++||||+++++++
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~ 255 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVI 255 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEET------TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEec------CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEE
Confidence 4568888999999999999999999999875 4579999997654 346788999999999999999999998
Q ss_pred eeCC-ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 192 SEGN-PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 192 ~~~~-~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
.+.. ..++||||+++|+|.++++... ...++...++.++.||+.||+|||+++|+||||||+|||+++++.
T Consensus 256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~ 327 (450)
T 1k9a_A 256 VEEKGGLYIVTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 327 (450)
T ss_dssp ECTTSCEEEEEECCTTCBHHHHHHHHC--------TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC
T ss_pred EcCCCceEEEEEecCCCcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC
Confidence 7654 7999999999999999998632 234678899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||+|||+++...... ....+++.|+|||++.+..++.++||||||+++|||+|.|..||.+.+..++...+..+
T Consensus 328 ~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 402 (450)
T 1k9a_A 328 AKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402 (450)
T ss_dssp EEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT
T ss_pred EEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998543321 12235778999999999999999999999999999998789999999999999999988
Q ss_pred ccccccCCCC
Q psy7023 351 SSNEYKVNPP 360 (364)
Q Consensus 351 ~~~~~~~~~~ 360 (364)
..++.+..++
T Consensus 403 ~~~~~p~~~~ 412 (450)
T 1k9a_A 403 YKMDAPDGCP 412 (450)
T ss_dssp CCCCCCTTCC
T ss_pred CCCCCCCcCC
Confidence 8776665544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.75 Aligned_cols=233 Identities=32% Similarity=0.598 Sum_probs=190.5
Q ss_pred eeeeccceeEec-eeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
+++.+..+.+.+ +||+|+||+||+|.++... .++.||||+++... .....+++.+|+++|++++||||+++++++.
T Consensus 363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SBCCGGGEEEEEEEEEECSSEEEEEEEEECSS--CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccchhccccCCEeccCCCEEEEEEEEcCCC--cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 344445555544 7999999999999765422 46789999997643 2334578999999999999999999999997
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
. +..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++||||||||+||||+.++.+|
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~k 509 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK 509 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred c-CCEEEEEEccCCCCHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEE
Confidence 5 568999999999999999975 23578889999999999999999999999999999999999999999
Q ss_pred EeecccccccCccce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 273 VGDFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 273 L~DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|||++.|+.||.+.+..++.+.+..+.
T Consensus 510 L~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~ 589 (635)
T 4fl3_A 510 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 589 (635)
T ss_dssp ECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred EEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987654332 2223334457889999999999999999999999999999987899999999999999999988
Q ss_pred cccccCCCC
Q psy7023 352 SNEYKVNPP 360 (364)
Q Consensus 352 ~~~~~~~~~ 360 (364)
....+..++
T Consensus 590 ~~~~p~~~~ 598 (635)
T 4fl3_A 590 RMGCPAGCP 598 (635)
T ss_dssp CCCCCTTCC
T ss_pred CCCCCCCCC
Confidence 776665543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=341.77 Aligned_cols=247 Identities=36% Similarity=0.673 Sum_probs=211.2
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCccc---ccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS---LAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKL 187 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l 187 (364)
...|++..++|++.++||+|+||+||+|.+..... .....||+|+++.........++.+|+++++++ +||||+++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 45678888999999999999999999999764322 235679999998877777778899999999999 99999999
Q ss_pred EEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 188 ~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
++++...+..++||||+++|+|.+++......... ......+++..++.++.||+.||+|||+++|+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 99999999999999999999999999875432110 112346899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
|||+++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|+++|..||.+.+..
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987765443334444556788999999999999999999999999999999889999999999
Q ss_pred HHHHHHhcCccccccCC
Q psy7023 342 QVLNWVKGKSSNEYKVN 358 (364)
Q Consensus 342 ~~~~~i~~~~~~~~~~~ 358 (364)
++.+.+..+...+.+..
T Consensus 301 ~~~~~~~~~~~~~~~~~ 317 (382)
T 3tt0_A 301 ELFKLLKEGHRMDKPSN 317 (382)
T ss_dssp HHHHHHHTTCCCCCCSS
T ss_pred HHHHHHHcCCCCCCCcc
Confidence 99999988876655443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=346.83 Aligned_cols=244 Identities=40% Similarity=0.771 Sum_probs=206.6
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
...++..++|++++.||+|+||+||+|.+... +...+..||+|+++.........++.+|+.++++++||||+++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34567788999999999999999999997643 22357789999998776777778899999999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC--
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-- 269 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-- 269 (364)
......++||||+++|+|.+++........ ....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccC---ccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 999999999999999999999987543322 234688999999999999999999999999999999999999555
Q ss_pred -cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 270 -TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 270 -~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+++|..||.+.+..++++.+.
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 5999999999865444333334444568899999999999999999999999999999987899999999999999998
Q ss_pred cCccccccCCC
Q psy7023 349 GKSSNEYKVNP 359 (364)
Q Consensus 349 ~~~~~~~~~~~ 359 (364)
.+...+.+..+
T Consensus 301 ~~~~~~~~~~~ 311 (367)
T 3l9p_A 301 SGGRMDPPKNC 311 (367)
T ss_dssp TTCCCCCCTTC
T ss_pred cCCCCCCCccC
Confidence 88766655443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=336.56 Aligned_cols=234 Identities=35% Similarity=0.623 Sum_probs=200.0
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
.++..++|++.+.||+|+||+||+|.++.... .+..||+|+++........+.+.+|+.+++.++||||+++++++.++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ-RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTS-CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCC-CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 45667899999999999999999999875332 25569999998777777778899999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..++||||+++++|.++++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 193 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRT---------HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEeeCCCCCcHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEEC
Confidence 999999999999999999975 23467889999999999999999999999999999999999999999999
Q ss_pred ecccccccCccce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 275 DFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 275 DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|||+++....... ........+|+.|+|||++.+..++.++||||||+++|+|+++|..||.+.+..++...+..+...
T Consensus 194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 273 (325)
T 3kul_A 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL 273 (325)
T ss_dssp CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC
Confidence 9999987654322 122233345778999999998899999999999999999999789999999999999999888665
Q ss_pred cccCC
Q psy7023 354 EYKVN 358 (364)
Q Consensus 354 ~~~~~ 358 (364)
+.+..
T Consensus 274 ~~~~~ 278 (325)
T 3kul_A 274 PAPMG 278 (325)
T ss_dssp CCCTT
T ss_pred CCCCC
Confidence 55443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=335.68 Aligned_cols=248 Identities=67% Similarity=1.077 Sum_probs=210.4
Q ss_pred ccccceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEE
Q psy7023 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLY 188 (364)
Q Consensus 110 ~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~ 188 (364)
...+.|++..++|++.+.||+|+||.||+|.++.. ....+..||+|++...........+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 44567888999999999999999999999987631 22246789999998777767777899999999999999999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
+++.+.+..++||||+++++|.+++...............+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 99999999999999999999999997632111111122456889999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+|+|..||.+.+..++...+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999999877665544444555567889999999988999999999999999999998899999999999999888
Q ss_pred cCccccccC
Q psy7023 349 GKSSNEYKV 357 (364)
Q Consensus 349 ~~~~~~~~~ 357 (364)
.+.....+.
T Consensus 255 ~~~~~~~~~ 263 (322)
T 1p4o_A 255 EGGLLDKPD 263 (322)
T ss_dssp TTCCCCCCT
T ss_pred cCCcCCCCC
Confidence 776554443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=337.38 Aligned_cols=245 Identities=39% Similarity=0.731 Sum_probs=204.8
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCccc-ccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS-LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.++...++|++++.||+|+||.||+|.++.... ..+..||+|+++........+.+.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456778999999999999999999999874221 2457899999987777777788999999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCC--------------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAET--------------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~--------------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl 258 (364)
+.+..++||||+++++|.+++......... ......+++..++.++.||+.||+|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999874322110 011256889999999999999999999999999999
Q ss_pred CCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 259 AARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
||+|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+|+|..||.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986654443333334456888999999998899999999999999999999789999999
Q ss_pred CHHHHHHHHhcCccccccCC
Q psy7023 339 SNEQVLNWVKGKSSNEYKVN 358 (364)
Q Consensus 339 ~~~~~~~~i~~~~~~~~~~~ 358 (364)
+..++...+..+.....+..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~ 300 (343)
T 1luf_A 281 AHEEVIYYVRDGNILACPEN 300 (343)
T ss_dssp CHHHHHHHHHTTCCCCCCTT
T ss_pred ChHHHHHHHhCCCcCCCCCC
Confidence 99999999988876555443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=330.67 Aligned_cols=246 Identities=39% Similarity=0.696 Sum_probs=208.5
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
...|+...++|++.+.||+|+||.||+|.+.... ...+..||+|++.........+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 4566778899999999999999999999875433 234578999999877777777889999999999999999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCC--------------CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAE--------------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHR 256 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHr 256 (364)
+.+.+..++||||+++++|.+++........ .......+++..++.++.||+.||+|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987543110 00112357899999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 257 DLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 257 Dlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
||||+|||+++++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+|+|..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999877655444444555567889999999988899999999999999999997899999
Q ss_pred CCCHHHHHHHHhcCccccccC
Q psy7023 337 GLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 337 ~~~~~~~~~~i~~~~~~~~~~ 357 (364)
+.+..++.+.+..+...+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~ 275 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERPD 275 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCCT
T ss_pred CCCHHHHHHHhhcCCcCCCCc
Confidence 999999999888876555443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=334.68 Aligned_cols=231 Identities=34% Similarity=0.584 Sum_probs=189.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..++|++++.||+|+||+||+|++..+......+||+|.+..........++.+|+.++++++||||+++++++..+ ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-Ce
Confidence 34789999999999999999999877655556678999887655555567899999999999999999999999875 47
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++|+||+.+|+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 92 ~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg 162 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---------STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred EEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCc
Confidence 899999999999999986 23457889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
+++...............+|+.|+|||++.+..++.++||||||+++|||+|+|..||.+.+..++.+.+..+...+.+.
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc
Confidence 99876554433333444557789999999999999999999999999999998899999999999999888876655443
Q ss_pred C
Q psy7023 358 N 358 (364)
Q Consensus 358 ~ 358 (364)
.
T Consensus 243 ~ 243 (327)
T 3poz_A 243 I 243 (327)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.12 Aligned_cols=217 Identities=23% Similarity=0.400 Sum_probs=190.8
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
..++|++++.||+|+||.||+|.++. +++.||+|++.... .....+++.+|+++++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHIL----TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECC----CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 34789999999999999999999876 47789999987543 44556778899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.|+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH----------GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECST
T ss_pred EEEEEECCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeec
Confidence 99999999999999999752 35778899999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFT-SHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|++........ .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++.+.+..+..
T Consensus 159 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~ 231 (328)
T 3fe3_A 159 GFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRERVLRGKY 231 (328)
T ss_dssp TCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCC
T ss_pred cCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC
Confidence 99976554322 2334578899999999988875 78999999999999999 8999999999999988877643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=325.40 Aligned_cols=234 Identities=37% Similarity=0.697 Sum_probs=188.8
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
..+++..++|++.+.||+|+||+||+|.+..... ....||+|+..........+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN-PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCC-CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 4567888999999999999999999999865322 356799999887666677788999999999999999999999985
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
++..|+||||+++++|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 156 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 156 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred -cCccEEEEecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEE
Confidence 4678999999999999999975 233578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|+++|..||.+.+..++...+..+..
T Consensus 157 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~ 235 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235 (281)
T ss_dssp ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred ECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC
Confidence 9999999876544322 222334577899999999889999999999999999999778999999999999998887765
Q ss_pred ccccCC
Q psy7023 353 NEYKVN 358 (364)
Q Consensus 353 ~~~~~~ 358 (364)
.+.+..
T Consensus 236 ~~~~~~ 241 (281)
T 1mp8_A 236 LPMPPN 241 (281)
T ss_dssp CCCCTT
T ss_pred CCCCCC
Confidence 554433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=338.58 Aligned_cols=218 Identities=22% Similarity=0.376 Sum_probs=185.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEG 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~ 194 (364)
..++|++++.||+|+||+||+|+++. +++.||+|++++.. .......+.+|..+++.+ .||||+++++++.+.
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKE----TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcC----CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 34789999999999999999999886 47789999987542 122345678899999988 799999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS----------RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEc
Confidence 9999999999999999999762 357888999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|||+++....... ......+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++++.|..+..
T Consensus 167 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3txo_A 167 DFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILNDEV 241 (353)
T ss_dssp CCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCC
T ss_pred cccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Confidence 9999985433322 2223456899999999999899999999999999999999 8999999999999998877643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=333.61 Aligned_cols=215 Identities=24% Similarity=0.330 Sum_probs=187.0
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.++|++++.||+|+||+||+|+++. +++.||+|++++.. .......+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE
Confidence 3689999999999999999999876 47789999987542 11234568899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeec
Confidence 99999999999999999752 35778899999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
|+++........ .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++.+.+..+
T Consensus 150 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~ 220 (337)
T 1o6l_A 150 GLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME 220 (337)
T ss_dssp TTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC
T ss_pred cchhhcccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc-CCCCCCCCCHHHHHHHHHcC
Confidence 999864332221 223346889999999999999999999999999999999 89999999988888877654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=343.78 Aligned_cols=231 Identities=23% Similarity=0.323 Sum_probs=194.3
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.....++|+++++||+|+||+||+|+++. +++.||+|++++.... .....+.+|+.+++.++||||+++++++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~----~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKS----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECC----CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34456799999999999999999999886 4778999998653211 11234778999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+.+.+|+||||++||+|.++++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-----------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEE
Confidence 999999999999999999999752 367889999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV----FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|+|||+++........ ......+|+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..++...|.
T Consensus 209 L~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~ 286 (410)
T 3v8s_A 209 LADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIM 286 (410)
T ss_dssp ECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHH
T ss_pred EeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh-CCCCCCCCChhhHHHHHH
Confidence 9999999876554332 233446799999999998765 7899999999999999999 899999999999998887
Q ss_pred cCc-cccccCCCCCC
Q psy7023 349 GKS-SNEYKVNPPIS 362 (364)
Q Consensus 349 ~~~-~~~~~~~~~~s 362 (364)
.+. ...+|.+..+|
T Consensus 287 ~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 287 NHKNSLTFPDDNDIS 301 (410)
T ss_dssp THHHHCCCCTTCCCC
T ss_pred hccccccCCCccccc
Confidence 653 34555554444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=329.22 Aligned_cols=247 Identities=36% Similarity=0.689 Sum_probs=206.8
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcc---cccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR---SLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVK 186 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~ 186 (364)
....|++..++|++.+.||+|+||+||+|.+...+ ...+..||+|+++..........+.+|+.+++++ +||||++
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 34567788899999999999999999999986432 1346789999998777777778899999999999 9999999
Q ss_pred EEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7023 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAA 260 (364)
Q Consensus 187 l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp 260 (364)
+++++...+..++||||+++++|.+++......... ......+++..++.++.||+.||+|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 999999999999999999999999999875421110 01223578999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 261 RNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 261 ~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
+|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+++|..||.+.+.
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999999998776554444444555678899999999888999999999999999999988999999999
Q ss_pred HHHHHHHhcCccccccC
Q psy7023 341 EQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 341 ~~~~~~i~~~~~~~~~~ 357 (364)
.++.+.+..+...+.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~ 282 (334)
T 2pvf_A 266 EELFKLLKEGHRMDKPA 282 (334)
T ss_dssp HHHHHHHHHTCCCCCCT
T ss_pred HHHHHHHhcCCCCCCCc
Confidence 99998888776554443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.36 Aligned_cols=215 Identities=24% Similarity=0.404 Sum_probs=186.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
...+|++++.||+|+||+||+|.+.. .++.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA----TGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT----TCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC----CCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 45789999999999999999998765 4778999998654332 245688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 161 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEECCCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999752 46788999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++......... .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||.+.+..+.+..+....
T Consensus 162 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~ 232 (297)
T 3fxz_A 162 FCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNG 232 (297)
T ss_dssp TCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHHC
T ss_pred CceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 98866544322 223456889999999999999999999999999999999 899999888877666554443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=334.41 Aligned_cols=217 Identities=24% Similarity=0.399 Sum_probs=190.3
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH-----HHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER-----EKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
.+.++|++++.||+|+||+||+|.++. ++..||+|+++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~----~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECC----CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 356789999999999999999999886 47789999987543321 246788999999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC--
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-- 269 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-- 269 (364)
.+.+..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+++++
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~ 154 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQ----------KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT----------CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSS
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCC
Confidence 999999999999999999999964 34688999999999999999999999999999999999998877
Q ss_pred --cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 270 --TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 270 --~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+++..+
T Consensus 155 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~-g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 155 IPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANI 230 (361)
T ss_dssp SCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred ccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 799999999987654322 223457899999999999999999999999999999999 89999999999999888
Q ss_pred hcCc
Q psy7023 348 KGKS 351 (364)
Q Consensus 348 ~~~~ 351 (364)
..+.
T Consensus 231 ~~~~ 234 (361)
T 2yab_A 231 TAVS 234 (361)
T ss_dssp HTTC
T ss_pred HhcC
Confidence 7654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=323.41 Aligned_cols=218 Identities=23% Similarity=0.400 Sum_probs=184.0
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.+++.++|++++.||+|+||.||+|.++. .+..||+|++... ......+.+.+|+.++++++||||+++++++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 81 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTI----LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE 81 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETT----TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECC----CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence 35677899999999999999999998876 4778999987543 34455678999999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+++..|+||||+++++|.+++... .++++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESH----------GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 999999999999999999999752 3578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||.+.+..+......
T Consensus 152 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~~~ 225 (294)
T 4eqm_A 152 IFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIKHI 225 (294)
T ss_dssp ECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH-SSCSSCSSCHHHHHHHHH
T ss_pred EEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Confidence 9999999876543322 1223346889999999999999999999999999999999 899999888766554443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.85 Aligned_cols=217 Identities=25% Similarity=0.356 Sum_probs=179.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHH-HHhcCCcceeEEEEEEeeC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASV-MKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~i-l~~l~h~~iv~l~~~~~~~ 194 (364)
..++|++++.||+|+||+||+|+++. ++..||+|++++... ......+.+|..+ ++.++||||+++++++.+.
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKA----EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETT----TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcC----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 34789999999999999999999876 467899999876532 2334566677776 5778999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+.+|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~ 181 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRE----------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT 181 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999752 346778899999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++.+.+..+.
T Consensus 182 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~~ 255 (373)
T 2r5t_A 182 DFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNKP 255 (373)
T ss_dssp CCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSBHHHHHHHHHHSC
T ss_pred eCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc
Confidence 9999986433221 2233457899999999999999999999999999999999 899999999999998887653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=319.73 Aligned_cols=227 Identities=37% Similarity=0.662 Sum_probs=195.6
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
..|.+..++|++++.||+|+||+||+|.+.. +..||+|++...... .+++.+|+.++++++||||+++++++.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETT-----TEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecC-----CCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3467777899999999999999999999875 566999998765433 356889999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+.+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k 146 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK 146 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEE
T ss_pred cCCceEEEEEeCCCCcHHHHHHh---------cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEE
Confidence 99999999999999999999975 334578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|+++|..||.+.+..++.+.+..+..
T Consensus 147 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~ 225 (269)
T 4hcu_A 147 VSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR 225 (269)
T ss_dssp ECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred eccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc
Confidence 9999999866544322 222334567899999999899999999999999999999988999999999999998887755
Q ss_pred cccc
Q psy7023 353 NEYK 356 (364)
Q Consensus 353 ~~~~ 356 (364)
...+
T Consensus 226 ~~~~ 229 (269)
T 4hcu_A 226 LYKP 229 (269)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 4433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=343.53 Aligned_cols=221 Identities=24% Similarity=0.345 Sum_probs=189.8
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH--HHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--EKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.....++|+++++||+|+||+||+|+++. +++.||+|++++..... ....+.+|..+++.++||||+++++++.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKN----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcC----CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556899999999999999999999886 46789999986532111 1233788999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+.+.+|+|||||+||+|.+++.+ ....+++..++.++.||+.||+|||+++||||||||+|||++.++.+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~---------~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK---------FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEE
Confidence 99999999999999999999975 234578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
|+|||+++........ ......+|+.|+|||++. ...|+.++|||||||++|||++ |.+||.+.+..+++..|
T Consensus 216 L~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 216 LADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKI 293 (437)
T ss_dssp ECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHH
T ss_pred EcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh-CCCCCCCCChhHHHHhh
Confidence 9999999766544332 223345799999999997 5678999999999999999999 89999999999988887
Q ss_pred hcC
Q psy7023 348 KGK 350 (364)
Q Consensus 348 ~~~ 350 (364)
...
T Consensus 294 ~~~ 296 (437)
T 4aw2_A 294 MNH 296 (437)
T ss_dssp HTH
T ss_pred hhc
Confidence 653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=333.96 Aligned_cols=246 Identities=34% Similarity=0.615 Sum_probs=201.1
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLY 188 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~ 188 (364)
....|++..++|++++.||+|+||.||+|.+... ...+++.||+|+++........+.+.+|+++++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 4567888999999999999999999999986542 23357889999998877777778899999999999 789999999
Q ss_pred EEEeeCC-ceEEEEecCCCCCHHHHHHhcCCCCCC---------------------------------------------
Q psy7023 189 GVVSEGN-PTLVIMELMGGGDLKNYLRSCRPDAET--------------------------------------------- 222 (364)
Q Consensus 189 ~~~~~~~-~~~lv~e~~~ggsL~~~l~~~~~~~~~--------------------------------------------- 222 (364)
+++.+.+ ..++||||+++|+|.+++.........
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998754 489999999999999999875421100
Q ss_pred -----------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeC
Q psy7023 223 -----------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291 (364)
Q Consensus 223 -----------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~ 291 (364)
......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 001223889999999999999999999999999999999999999999999999999876554433334
Q ss_pred CCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCcccccc
Q psy7023 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQVLNWVKGKSSNEYK 356 (364)
Q Consensus 292 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~~~~~i~~~~~~~~~ 356 (364)
....+|+.|+|||++.+..++.++||||||+++|||+|+|..||.+... ..+...+..+.....+
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 318 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC
Confidence 4445678899999999999999999999999999999878999987664 4555666666554443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=340.11 Aligned_cols=229 Identities=19% Similarity=0.325 Sum_probs=194.5
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
.+.++|++++.||+|+||+||+|.++. ++..+|+|++..... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~----~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVL----AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETT----TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECC----CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 356799999999999999999999876 577899999875543 344567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCcEE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVK 272 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~---~~~~~k 272 (364)
..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ +++.+|
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~----------~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vk 153 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVA----------REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVK 153 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEE
T ss_pred EEEEEEEeCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEE
Confidence 99999999999999999975 23578899999999999999999999999999999999998 568899
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++......... .....+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+.+..++++.+..+..
T Consensus 154 L~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~ 230 (444)
T 3soa_A 154 LADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV-GYPPFWDEDQHRLYQQIKAGAY 230 (444)
T ss_dssp ECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTCC
T ss_pred EccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCC
Confidence 9999999866544322 223457899999999999999999999999999999999 8999999999999998877654
Q ss_pred c-cccCCCCCC
Q psy7023 353 N-EYKVNPPIS 362 (364)
Q Consensus 353 ~-~~~~~~~~s 362 (364)
. +.+.|+.+|
T Consensus 231 ~~~~~~~~~~s 241 (444)
T 3soa_A 231 DFPSPEWDTVT 241 (444)
T ss_dssp CCCTTTTTTSC
T ss_pred CCCccccccCC
Confidence 3 444444443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=331.13 Aligned_cols=218 Identities=22% Similarity=0.397 Sum_probs=190.7
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
.+.++|++.+.||+|+||.||+|.++. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKT----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECC----CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 456789999999999999999999876 47789999987543 4455678899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD---LTVK 272 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~---~~~k 272 (364)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~----------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVA----------REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTT----------CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEE
T ss_pred EEEEEEecCCCCCHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEE
Confidence 99999999999999999964 3457889999999999999999999999999999999999865 4599
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..++...+..+..
T Consensus 172 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i~~~~~ 247 (362)
T 2bdw_A 172 LADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY 247 (362)
T ss_dssp ECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCC
T ss_pred EeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCC
Confidence 999999987654322 223456889999999999999999999999999999999 8999999999999988876643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=331.60 Aligned_cols=217 Identities=26% Similarity=0.427 Sum_probs=187.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAF-DTHHVVKLYGVVSEG 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~ 194 (364)
..++|++++.||+|+||+||+|+++. +++.||+|+++.... ......+..|..+++.+ +||||+++++++.+.
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKK----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETT----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECC----CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 44789999999999999999999886 477899999875421 12245677899999887 999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+.+|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSC----------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999999752 347788999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|||+++........ .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++++.+..+.
T Consensus 161 DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~ 234 (345)
T 1xjd_A 161 DFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMDN 234 (345)
T ss_dssp CCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred EChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhCC
Confidence 99999864332221 233456899999999999999999999999999999999 899999999999998887664
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=327.44 Aligned_cols=233 Identities=38% Similarity=0.662 Sum_probs=193.6
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
.++..++|++.+.||+|+||+||+|.++.........||+|++...........+.+|+.+++.++||||+++++++...
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 46677899999999999999999999876554456679999998776666777899999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 189 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 189 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred CCcEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEEC
Confidence 999999999999999999975 23457889999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceee-eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 275 DFGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 275 DFg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++.|..||.+.+..++.+.+..+...
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 269 (333)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred CCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC
Confidence 999998765432211 1222334678999999999999999999999999999998789999999999999988877655
Q ss_pred ccc
Q psy7023 354 EYK 356 (364)
Q Consensus 354 ~~~ 356 (364)
+.+
T Consensus 270 ~~~ 272 (333)
T 1mqb_A 270 PTP 272 (333)
T ss_dssp CCC
T ss_pred CCc
Confidence 443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=327.38 Aligned_cols=215 Identities=20% Similarity=0.380 Sum_probs=188.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.++|++++.||+|+||+||+|.++. ++..||+|++.... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETS----SKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECC----CCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence 45799999999999999999999876 47789999987543 3456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCcEEEee
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD--DLTVKVGD 275 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~--~~~~kL~D 275 (364)
++||||++|++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 77 ~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~D 147 (321)
T 1tki_A 77 VMIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp EEEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEE
Confidence 999999999999999964 2346788999999999999999999999999999999999997 78999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||++.......... ...+++.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..++++.+..+.
T Consensus 148 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 219 (321)
T 1tki_A 148 FGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp CTTCEECCTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTC
T ss_pred CCCCeECCCCCccc---cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHcCC
Confidence 99998765543322 2245789999999998889999999999999999999 899999999998888876554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=316.50 Aligned_cols=226 Identities=38% Similarity=0.669 Sum_probs=195.6
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.+++..++|++++.||+|+||+||+|.++. +..||+|++...... .+++.+|+.++++++||||+++++++.+
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKG-----QYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecC-----ceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 346677899999999999999999998775 567999998765433 3568899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+..++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l 145 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSH---------GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKV 145 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEE
T ss_pred CCceEEEEEccCCCcHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEE
Confidence 99999999999999999999762 235788999999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|+|+|..||...+..+....+..+...
T Consensus 146 ~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 224 (268)
T 3sxs_A 146 SDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL 224 (268)
T ss_dssp CCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC
Confidence 9999998765554333 233345678999999998889999999999999999999789999999999988888777655
Q ss_pred ccc
Q psy7023 354 EYK 356 (364)
Q Consensus 354 ~~~ 356 (364)
..+
T Consensus 225 ~~~ 227 (268)
T 3sxs_A 225 YRP 227 (268)
T ss_dssp CCC
T ss_pred CCC
Confidence 443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=324.27 Aligned_cols=222 Identities=34% Similarity=0.524 Sum_probs=181.5
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYG 189 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~ 189 (364)
....+++...+|++.+.||+|+||+||+|.+. +..||+|++.... .....+++.+|+.++++++||||+++++
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 101 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEET------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEEC------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34566778899999999999999999999764 5679999987554 4455678899999999999999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcC
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLAARNCMVAD 267 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NILl~~ 267 (364)
++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||++| |+||||||+|||++.
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~ 174 (309)
T 3p86_A 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSG-------AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK 174 (309)
T ss_dssp EECSTTCCEEEEECCTTCBHHHHHHSTT-------HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT
T ss_pred EEEECCceEEEEecCCCCcHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC
Confidence 9999999999999999999999997521 1123788899999999999999999999 999999999999999
Q ss_pred CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|+|+| |..||.+.+..+....+
T Consensus 175 ~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 175 KYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp TCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHH-CCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 99999999999975443322 1223346889999999999999999999999999999999 89999999988888776
Q ss_pred h
Q psy7023 348 K 348 (364)
Q Consensus 348 ~ 348 (364)
.
T Consensus 252 ~ 252 (309)
T 3p86_A 252 G 252 (309)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=326.02 Aligned_cols=213 Identities=22% Similarity=0.372 Sum_probs=186.7
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.++|++++.||+|+||+||+|+++. +++.||+|++++.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE
Confidence 3689999999999999999999876 4778999998754211 124567789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKS----------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHT----------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeec
Confidence 99999999999999999752 35778899999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|+++...... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.++.+..+.
T Consensus 151 g~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 219 (318)
T 1fot_A 151 GFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNAE 219 (318)
T ss_dssp SSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHCC
T ss_pred CcceecCCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 9998654322 23356889999999999999999999999999999999 899999998888888776653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=331.70 Aligned_cols=217 Identities=23% Similarity=0.360 Sum_probs=187.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAF-DTHHVVKLYGVVSEG 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~ 194 (364)
..++|++++.||+|+||+||+|+++. +++.||+|+++.... ....+.+.+|..+++.+ +||+|+++++++.+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT----EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC----CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 34789999999999999999999876 467899999875421 12245678899999987 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV----------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEE
Confidence 9999999999999999999752 347788999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|||+++........ .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++++.|..+.
T Consensus 164 DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~~ 237 (353)
T 2i0e_A 164 DFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEHN 237 (353)
T ss_dssp CCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred eCCcccccccCCcc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc-CCCCCCCCCHHHHHHHHHhCC
Confidence 99999864332221 223456899999999999999999999999999999999 899999999999998887654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=332.09 Aligned_cols=232 Identities=28% Similarity=0.487 Sum_probs=193.5
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|++++.||+|+||+||+|.++.+......+|++|.+...........+.+|+.+++.++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 47899999999999999999998876555556688998765443333456778999999999999999999987 46789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 91 ~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---------RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---------GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred EEEEeCCCCCHHHHHHHc---------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence 999999999999999752 23567788999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVN 358 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 358 (364)
++...............+++.|+|||++.+..++.++||||||+++|+|+|+|..||.+....++.+.+..+.....+..
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI 241 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc
Confidence 98765544333333444577899999999999999999999999999999978999999999999999988876655544
Q ss_pred CC
Q psy7023 359 PP 360 (364)
Q Consensus 359 ~~ 360 (364)
++
T Consensus 242 ~~ 243 (325)
T 3kex_A 242 CT 243 (325)
T ss_dssp BC
T ss_pred Cc
Confidence 43
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=328.93 Aligned_cols=231 Identities=34% Similarity=0.584 Sum_probs=189.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
...+|++++.||+|+||+||+|.++.+......+|++|.+...........+.+|+.++++++||||+++++++..+ ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SE
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cc
Confidence 34789999999999999999999887655556667888887655545567889999999999999999999999875 48
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++|+|++.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 92 ~~v~~~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG 162 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp EEEECCCSSCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred eEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCc
Confidence 899999999999999986 23457889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccC
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 357 (364)
+++...............+++.|+|||++.+..++.++||||||+++|+|+++|..||.+.+..++.+.+..+...+.+.
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 99876554433333344457789999999999999999999999999999998899999999999999888877655543
Q ss_pred C
Q psy7023 358 N 358 (364)
Q Consensus 358 ~ 358 (364)
.
T Consensus 243 ~ 243 (327)
T 3lzb_A 243 I 243 (327)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=333.02 Aligned_cols=221 Identities=20% Similarity=0.363 Sum_probs=184.6
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC----HHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS----EREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.+.++|++.+.||+|+||+||+|.++. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 96 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRE----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS 96 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECC----CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456799999999999999999999876 477899999864321 112467889999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT-- 270 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~-- 270 (364)
+.+..|+||||+++++|.+++.... .....+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRA------DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhc------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCC
Confidence 9999999999999999998886532 12345788999999999999999999999999999999999987654
Q ss_pred -EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 271 -VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 271 -~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+||+|||++......... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+. ..++.+.+..
T Consensus 171 ~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~-~~~~~~~i~~ 246 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS-GCLPFYGT-KERLFEGIIK 246 (351)
T ss_dssp CEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCSS-HHHHHHHHHH
T ss_pred cEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH-CCCCCCCc-HHHHHHHHHc
Confidence 999999999876554322 223357899999999999999999999999999999999 89999875 4556665554
Q ss_pred Cc
Q psy7023 350 KS 351 (364)
Q Consensus 350 ~~ 351 (364)
+.
T Consensus 247 ~~ 248 (351)
T 3c0i_A 247 GK 248 (351)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=319.66 Aligned_cols=227 Identities=38% Similarity=0.701 Sum_probs=193.9
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
..|++..++|++++.||+|+||+||+|.++. +..||+|++...... .+++.+|+.++++++||||+++++++.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETT-----TEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcC-----CCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 4567778899999999999999999998774 667999999865433 356889999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+.+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~k 160 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 160 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHC---------GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEE
T ss_pred cCCCeEEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEE
Confidence 99999999999999999999975 234578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|+|+|..||...+..+..+.+..+..
T Consensus 161 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (283)
T 3gen_A 161 VSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239 (283)
T ss_dssp ECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred Eccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC
Confidence 9999999866544322 222334577899999999889999999999999999999878999999999999998887765
Q ss_pred cccc
Q psy7023 353 NEYK 356 (364)
Q Consensus 353 ~~~~ 356 (364)
...+
T Consensus 240 ~~~~ 243 (283)
T 3gen_A 240 LYRP 243 (283)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 5443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=334.19 Aligned_cols=232 Identities=36% Similarity=0.627 Sum_probs=187.4
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
++...+|++.+.||+|+||+||+|+++... ..+..||+|+++........+++.+|+.++++++||||+++++++.+.+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPS-KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTT-SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCC-CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 455679999999999999999999876321 2367899999987766777788999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+++++|.++++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRK---------HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECc
Confidence 99999999999999999975 234578899999999999999999999999999999999999999999999
Q ss_pred cccccccCccceee-eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 276 FGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 276 Fg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
||+++......... ......+++.|+|||++.+..++.++||||||+++|||++.|..||.+.+..++.+.+..+...+
T Consensus 191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP 270 (373)
T ss_dssp C----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC
T ss_pred CccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99998765432211 11222346789999999999999999999999999999987899999999999999988876555
Q ss_pred ccC
Q psy7023 355 YKV 357 (364)
Q Consensus 355 ~~~ 357 (364)
.+.
T Consensus 271 ~~~ 273 (373)
T 2qol_A 271 PPM 273 (373)
T ss_dssp CCT
T ss_pred CCc
Confidence 443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.88 Aligned_cols=222 Identities=21% Similarity=0.310 Sum_probs=180.0
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC---HHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS---EREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
++..++|++++.||+|+||.||+|++... ...++.||+|+++.... ......+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTG-ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSS-TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEecc-CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 34557999999999999999999987532 12478899999876532 233456788999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
..+..|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLERE----------GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEE
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEE
Confidence 999999999999999999999752 3467888999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|+|||+++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++++.+..+.
T Consensus 162 l~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~ 237 (327)
T 3a62_A 162 LTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT-GAPPFTGENRKKTIDKILKCK 237 (327)
T ss_dssp ECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTC
T ss_pred EEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCC
Confidence 999999875433222 1223356889999999999999999999999999999999 899999999888888776654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.92 Aligned_cols=221 Identities=21% Similarity=0.293 Sum_probs=189.4
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.....++|++++.||+|+||+||+|+++. +++.||+|++++... ......+.+|..+++.++||||+++++++.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQ----TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECC----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34556899999999999999999999876 577899999875321 112345788999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+.+.+|+||||++||+|.+++.+. ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---------GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEE
Confidence 999999999999999999999762 23578889999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCccccc-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK-------DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
|+|||+++........ ......+|+.|+|||++. ...|+.++|||||||++|||++ |++||.+.+..+++.
T Consensus 203 L~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~ 280 (412)
T 2vd5_A 203 LADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY-GQTPFYADSTAETYG 280 (412)
T ss_dssp ECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHH
T ss_pred EeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 9999999876544322 223345799999999997 4568999999999999999999 899999999998888
Q ss_pred HHhcC
Q psy7023 346 WVKGK 350 (364)
Q Consensus 346 ~i~~~ 350 (364)
.|...
T Consensus 281 ~i~~~ 285 (412)
T 2vd5_A 281 KIVHY 285 (412)
T ss_dssp HHHTH
T ss_pred HHHhc
Confidence 77653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=329.61 Aligned_cols=208 Identities=24% Similarity=0.396 Sum_probs=177.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.++|++++.||+|+||+||+|.++. +++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV----TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECC----CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 34789999999999999999999876 47789999987655444456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp EEEEECCTTEEGGGGSBT----------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEee
Confidence 999999999999998853 3457889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 213 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSD 213 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSCT
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCch
Confidence 9986654443333344567899999999988776 678999999999999999 8999986554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=320.42 Aligned_cols=241 Identities=36% Similarity=0.614 Sum_probs=198.9
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
...|+...++|++.+.||+|+||.||+|.+... +...+..||+|++.........+.+.+|+.+++++ +||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 456788889999999999999999999986432 23357789999998776666678899999999999 9999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCC--------CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAE--------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
++..++..++||||+++|+|.+++........ .......+++..++.++.||+.||+|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 99999999999999999999999987432110 0012235889999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+|+|..||.+....
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987765543333334445778999999998999999999999999999999889999876644
Q ss_pred -HHHHHHhcCcc
Q psy7023 342 -QVLNWVKGKSS 352 (364)
Q Consensus 342 -~~~~~i~~~~~ 352 (364)
.+...+..+..
T Consensus 255 ~~~~~~~~~~~~ 266 (313)
T 1t46_A 255 SKFYKMIKEGFR 266 (313)
T ss_dssp HHHHHHHHHTCC
T ss_pred hHHHHHhccCCC
Confidence 44445555443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=330.51 Aligned_cols=214 Identities=22% Similarity=0.323 Sum_probs=188.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
..++|++++.||+|+||.||+|+++. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKE----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECC----CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34789999999999999999999876 477899999865421 122457889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcc
Confidence 999999999999999999762 3478889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+++...... ....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++.+.+..+.
T Consensus 185 Fg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~ 254 (350)
T 1rdq_E 185 FGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSGK 254 (350)
T ss_dssp CTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred cccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhh-CCCCCCCCCHHHHHHHHHcCC
Confidence 99998664432 22346889999999999999999999999999999999 899999999999998887764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=325.08 Aligned_cols=202 Identities=21% Similarity=0.341 Sum_probs=177.5
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCC
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGN 195 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~ 195 (364)
.++|++++.||+|+||.||+|+++. +++.||+|++++.. .....+.+.+|..+++++ +||||+++++++.+.+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK----TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhheEEEEEEEecCCeEEEEEEECC----CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 4689999999999999999999876 47789999987543 344566788999999988 8999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999752 3578889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 154 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~ 212 (345)
T 3a8x_A 154 YGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDI 212 (345)
T ss_dssp GGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTT
T ss_pred ccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh-CCCCcCC
Confidence 999986433222 1223456899999999999999999999999999999999 8999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=325.70 Aligned_cols=240 Identities=38% Similarity=0.695 Sum_probs=180.7
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
..+.+..++|++++.||+|+||+||+|.++.... ....||+|+++... .....+++.+|+.++++++||||+++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDG-SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC--------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCC-cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3455677899999999999999999998776322 12379999987543 334467899999999999999999999999
Q ss_pred eeCCce------EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7023 192 SEGNPT------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265 (364)
Q Consensus 192 ~~~~~~------~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl 265 (364)
...... ++||||+++++|.+++....... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli 170 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE----NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML 170 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccc----cccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE
Confidence 876655 99999999999999997532111 22357889999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 266 ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 266 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|+++|..||.+.+..++.+
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 250 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence 99999999999999876655444444444557789999999999999999999999999999998899999999999998
Q ss_pred HHhcCccccccC
Q psy7023 346 WVKGKSSNEYKV 357 (364)
Q Consensus 346 ~i~~~~~~~~~~ 357 (364)
.+..+.....+.
T Consensus 251 ~~~~~~~~~~~~ 262 (323)
T 3qup_A 251 YLIGGNRLKQPP 262 (323)
T ss_dssp HHHTTCCCCCCT
T ss_pred HHhcCCCCCCCC
Confidence 888776554443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=325.94 Aligned_cols=243 Identities=41% Similarity=0.786 Sum_probs=197.7
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
+..++..++|++++.||+|+||.||+|.+... +...+..||+|++..........++.+|+.++++++||||+++++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 34466778999999999999999999986532 22357789999998766677778899999999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---C
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---D 268 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~ 268 (364)
......|+||||+++++|.+++........ ....+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSS---STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhccccc---ccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 999999999999999999999987543221 2345788999999999999999999999999999999999994 4
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
..+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+|+|..||.+.+..++.+.+.
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 56999999999765544433334444567889999999988999999999999999999998899999999999999888
Q ss_pred cCccccccCC
Q psy7023 349 GKSSNEYKVN 358 (364)
Q Consensus 349 ~~~~~~~~~~ 358 (364)
.+.....+..
T Consensus 260 ~~~~~~~~~~ 269 (327)
T 2yfx_A 260 SGGRMDPPKN 269 (327)
T ss_dssp TTCCCCCCTT
T ss_pred cCCCCCCCCC
Confidence 8766554433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=326.44 Aligned_cols=245 Identities=35% Similarity=0.598 Sum_probs=194.7
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
...|++..++|++.+.||+|+||+||+|.+... ....+..||+|++.........+.+.+|+.+++++ +||||+++++
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 345788889999999999999999999997432 12246789999998665555567899999999999 9999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC-------------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET-------------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHR 256 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHr 256 (364)
++...+..++||||+++|+|.+++......... ......+++..++.++.||+.||+|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 999999999999999999999999864321100 0112357899999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 257 DLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 257 Dlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|+|+|..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876544333333333457789999999989999999999999999999987899998
Q ss_pred CCCHH-HHHHHHhcCcccccc
Q psy7023 337 GLSNE-QVLNWVKGKSSNEYK 356 (364)
Q Consensus 337 ~~~~~-~~~~~i~~~~~~~~~ 356 (364)
+.... .+...+..+...+.+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~ 297 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQP 297 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCC
T ss_pred cCCcHHHHHHHHhcCCCCCCC
Confidence 76644 445556665544443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.72 Aligned_cols=203 Identities=20% Similarity=0.329 Sum_probs=175.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAF-DTHHVVKLYGVVSEG 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~ 194 (364)
..++|+++++||+|+||+||+|+++. +++.||+|++++... ......+.+|..+++++ +||||+++++++.+.
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~----~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKK----TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECC----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 34789999999999999999999887 477899999876432 23345677899999887 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEe
Confidence 9999999999999999999752 357889999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
|||+++....... ......+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+
T Consensus 196 DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~-G~~Pf~~ 255 (396)
T 4dc2_A 196 DYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDI 255 (396)
T ss_dssp CCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSTT
T ss_pred ecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh-CCCCCcc
Confidence 9999986433222 1233457899999999999999999999999999999999 8999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=332.37 Aligned_cols=216 Identities=22% Similarity=0.377 Sum_probs=182.3
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
++..++|++++.||+|+||.||+|.++. +++.||+|++..... ......+.+|+.+|+.++||||+++++++.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKND----TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECC----CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4455899999999999999999999876 477899999865321 1224678899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+..|+||||+.||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL 156 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQ----------NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHI 156 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHT----------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred CCEEEEEEecCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEE
Confidence 9999999999999999999974 345788999999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHH
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGL---SNEQVLNWV 347 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~t~g~~P~~~~---~~~~~~~~i 347 (364)
+|||++........ .....+|+.|+|||++.. ..|+.++|||||||++|+|++ |..||... ...++...+
T Consensus 157 ~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~ 232 (384)
T 4fr4_A 157 TDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPYHIRSSTSSKEIVHTF 232 (384)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCCTTSCHHHHHHHH
T ss_pred eccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh-CCCCCCCCCCccHHHHHHHH
Confidence 99999986654322 233457899999999974 458999999999999999999 89999743 344455544
Q ss_pred hc
Q psy7023 348 KG 349 (364)
Q Consensus 348 ~~ 349 (364)
..
T Consensus 233 ~~ 234 (384)
T 4fr4_A 233 ET 234 (384)
T ss_dssp HH
T ss_pred hh
Confidence 43
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=315.60 Aligned_cols=233 Identities=33% Similarity=0.638 Sum_probs=197.5
Q ss_pred ceeeeccceeEec-eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 114 SWEVLRSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 114 ~~e~~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.+...+++|.+.+ .||+|+||.||+|.++... .+..||+|+++........+++.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC-----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCC--CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 3455677888887 9999999999999875422 36779999998776677778899999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
..+..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~k 150 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK 150 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEE
T ss_pred cCCCcEEEEEeCCCCCHHHHHHh---------CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEE
Confidence 45679999999999999999964 234578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 273 VGDFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 273 L~DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|+|+|..||.+.+..++.+.+..+.
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~ 230 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC
Confidence 999999987654332 2223334457889999999988899999999999999999987899999999999999988877
Q ss_pred cccccCC
Q psy7023 352 SNEYKVN 358 (364)
Q Consensus 352 ~~~~~~~ 358 (364)
..+.+..
T Consensus 231 ~~~~~~~ 237 (287)
T 1u59_A 231 RMECPPE 237 (287)
T ss_dssp CCCCCTT
T ss_pred cCCCCCC
Confidence 6555443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=328.44 Aligned_cols=216 Identities=16% Similarity=0.200 Sum_probs=178.4
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC---CcceeE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD---THHVVK 186 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~ 186 (364)
....++...++|.+.+.||+|+||+||+|.++.. +...++.||+|++.... ..++.+|+++++.++ |+||++
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 3455677778999999999999999999964431 23358889999987643 345667788888876 899999
Q ss_pred EEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 187 l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
+++++...+..|+||||+++|+|.+++..... .....+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKN-----TPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHT-----STTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhc-----ccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence 99999999999999999999999999986321 1234688999999999999999999999999999999999999
Q ss_pred C-----------CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 267 D-----------DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 267 ~-----------~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
. ++.+||+|||+++.+.............+|+.|+|||++.+..|+.++|||||||++|||+| |+.||
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf 285 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF-GTYMK 285 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCCC
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh-CCCcc
Confidence 8 89999999999976543222233344557899999999999999999999999999999999 77777
Q ss_pred C
Q psy7023 336 Q 336 (364)
Q Consensus 336 ~ 336 (364)
.
T Consensus 286 ~ 286 (365)
T 3e7e_A 286 V 286 (365)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=317.85 Aligned_cols=231 Identities=39% Similarity=0.719 Sum_probs=200.8
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
+.|++..++|++.+.||+|+||+||+|.++. .+..||+|++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGG----GTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecC----CCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 5678888999999999999999999999886 477899999876543 3567889999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+.+..++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~ 151 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 151 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHC--------CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEE
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhc--------ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEE
Confidence 999999999999999999999863 334578899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||++........... ....+++.|+|||++.+..++.++||||||+++|+|+++|.+||.+.+..++.+.+.....
T Consensus 152 l~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~ 230 (288)
T 3kfa_A 152 VADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 230 (288)
T ss_dssp ECCCCGGGTSCSSSSEEE-TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred EccCccceeccCCccccc-cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC
Confidence 999999987654433222 2223467899999999899999999999999999999988999999999999998887766
Q ss_pred ccccCC
Q psy7023 353 NEYKVN 358 (364)
Q Consensus 353 ~~~~~~ 358 (364)
.+.+..
T Consensus 231 ~~~~~~ 236 (288)
T 3kfa_A 231 MERPEG 236 (288)
T ss_dssp CCCCTT
T ss_pred CCCCCC
Confidence 555433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=320.20 Aligned_cols=216 Identities=24% Similarity=0.393 Sum_probs=181.5
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
+.+.++|+++++||+|+||+||+|.+++ ++.||+|++..... ......+.+|+.++++++||||+++++++.++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-----GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETT-----SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECC-----CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 5577899999999999999999998854 67899999875432 22346788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 161 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDE---------NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLA 161 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHT---------CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred CEEEEEEcCCCC-CHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEc
Confidence 999999999975 89988875 23457889999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
|||++......... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 162 Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 162 DFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp CCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSTTTHHHHHHH
T ss_pred cCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence 99999866433221 223345889999999876 568999999999999999999 8999998887777766543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=324.02 Aligned_cols=242 Identities=36% Similarity=0.631 Sum_probs=198.1
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCccc-ccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS-LAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGV 190 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~ 190 (364)
..|+...++|++.+.||+|+||+||+|.+..... .....||+|++.........+.+.+|+.+++.+ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4577888999999999999999999999876432 244679999998777666778899999999999 89999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCC----ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAET----DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
+...+..++||||+++|+|.+++.......+. ......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999999764211110 01234678899999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH
Q psy7023 267 DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ-VLN 345 (364)
Q Consensus 267 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~-~~~ 345 (364)
.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+|+|..||.+....+ +..
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 9999999999999866544333333334457789999999988999999999999999999998899998766544 444
Q ss_pred HHhcCcccc
Q psy7023 346 WVKGKSSNE 354 (364)
Q Consensus 346 ~i~~~~~~~ 354 (364)
.+..+....
T Consensus 279 ~~~~~~~~~ 287 (333)
T 2i1m_A 279 LVKDGYQMA 287 (333)
T ss_dssp HHHHTCCCC
T ss_pred HHhcCCCCC
Confidence 555554433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=315.34 Aligned_cols=214 Identities=20% Similarity=0.373 Sum_probs=183.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++++.||+|+||+||+|.++. +++.||+|++.... .......+.+|+.++++++||||+++++++.+++..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE----THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT----TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC----CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence 589999999999999999999876 46789999987543 3334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++ +|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 lv~e~~~~-~l~~~~~~---------~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDS---------CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEECCSE-EHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEecCCC-CHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 99999965 77777764 234678899999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+........ ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.++|.+.+..+.+..+.+
T Consensus 148 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred ceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 986643322 223345688999999998766 799999999999999999977777888888888877644
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=322.21 Aligned_cols=222 Identities=21% Similarity=0.294 Sum_probs=191.7
Q ss_pred ccccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-----Cc
Q psy7023 108 KLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-----TH 182 (364)
Q Consensus 108 ~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-----h~ 182 (364)
..+.......+.++|+++++||+|+||+||+|.++. .++.||+|++... ......+..|+.+++.+. ||
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID----NKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC----CCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 345566677889999999999999999999999876 4678999998743 344566778999999996 99
Q ss_pred ceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 183 ~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
||+++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 167 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--------NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCccc
Confidence 9999999999999999999999 89999999863 23457889999999999999999999999999999999
Q ss_pred EEEcC-------------------------CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhH
Q psy7023 263 CMVAD-------------------------DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDV 317 (364)
Q Consensus 263 ILl~~-------------------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 317 (364)
||++. ++.+||+|||++....... ....+|+.|+|||++.+..++.++||
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di 242 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDM 242 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccch
Confidence 99975 7899999999997544322 23356889999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 318 WSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 318 wslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
|||||++|+|+| |..||.+.+..+.+..+...
T Consensus 243 wslG~il~ell~-g~~pf~~~~~~~~~~~~~~~ 274 (360)
T 3llt_A 243 WSFGCVLAELYT-GSLLFRTHEHMEHLAMMESI 274 (360)
T ss_dssp HHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH-CCCCCCCCcHHHHHHHHHHh
Confidence 999999999999 89999999888888776543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=314.27 Aligned_cols=228 Identities=35% Similarity=0.691 Sum_probs=195.4
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
.+.|++..++|++++.||+|+||.||+|.+++ +..||+|++...... .+.+.+|+++++.++||||+++++++
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 77 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcC-----CcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 46789999999999999999999999998764 567999998765433 46788999999999999999999998
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
.. +..++||||+++++|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||+++++.+
T Consensus 78 ~~-~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 148 (279)
T 1qpc_A 78 TQ-EPIYIITEYMENGSLVDFLKTP--------SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 148 (279)
T ss_dssp CS-SSCEEEEECCTTCBHHHHTTSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred cC-CCcEEEEecCCCCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCE
Confidence 74 5689999999999999998641 12357888999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|+++|..||.+.+..++.+.+..+.
T Consensus 149 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 227 (279)
T 1qpc_A 149 KIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227 (279)
T ss_dssp EECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCcccccccCccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc
Confidence 999999998766544322 2233346789999999988899999999999999999998899999999999998888776
Q ss_pred ccccc
Q psy7023 352 SNEYK 356 (364)
Q Consensus 352 ~~~~~ 356 (364)
....+
T Consensus 228 ~~~~~ 232 (279)
T 1qpc_A 228 RMVRP 232 (279)
T ss_dssp CCCCC
T ss_pred CCCCc
Confidence 55443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=311.10 Aligned_cols=225 Identities=37% Similarity=0.660 Sum_probs=194.2
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.|.+..++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.++++++||||+++++++.+
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecC-----CCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 456677899999999999999999999864 567999998865433 3578899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+..++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+|+||||+|||++.++.+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl 145 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 145 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEE
T ss_pred CCCeEEEEeCCCCCcHHHHHhhC---------cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEE
Confidence 99999999999999999999862 345788899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|+++|..||.+.+..++.+.+..+...
T Consensus 146 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~ 224 (267)
T 3t9t_A 146 SDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 224 (267)
T ss_dssp CCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC
Confidence 999999866543221 2223345678999999998899999999999999999999889999999999999988877554
Q ss_pred cc
Q psy7023 354 EY 355 (364)
Q Consensus 354 ~~ 355 (364)
..
T Consensus 225 ~~ 226 (267)
T 3t9t_A 225 YK 226 (267)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=330.82 Aligned_cols=210 Identities=19% Similarity=0.324 Sum_probs=167.6
Q ss_pred ccceeEe-ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHH-hcCCcceeEEEEEEee---
Q psy7023 119 RSKVTIL-DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMK-AFDTHHVVKLYGVVSE--- 193 (364)
Q Consensus 119 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~l~~~~~~--- 193 (364)
.++|.+. +.||+|+||+||+|.++. +++.||+|+++.. ..+.+|+.++. ..+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~----~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR----TQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccceeccceeeeccCeEEEEEEECC----CCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 3566666 789999999999999876 4778999998632 24567888774 4589999999999875
Q ss_pred -CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CC
Q psy7023 194 -GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---DL 269 (364)
Q Consensus 194 -~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~~ 269 (364)
...+|+||||++||+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++. ++
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTC
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCc
Confidence 56789999999999999999752 2345889999999999999999999999999999999999997 78
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ----VLN 345 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~----~~~ 345 (364)
.+||+|||+++....... .....+|+.|+|||++.+..|+.++|||||||++|+|++ |..||.+.+..+ +..
T Consensus 202 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~ 277 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKT 277 (400)
T ss_dssp CEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH-SSCSCCCCTTCSSCCSHHH
T ss_pred cEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCccccccHHHHH
Confidence 999999999986543321 223346889999999999999999999999999999999 899997655432 444
Q ss_pred HHhcC
Q psy7023 346 WVKGK 350 (364)
Q Consensus 346 ~i~~~ 350 (364)
.+..+
T Consensus 278 ~i~~~ 282 (400)
T 1nxk_A 278 RIRMG 282 (400)
T ss_dssp HHHHT
T ss_pred HHHcC
Confidence 55443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=320.66 Aligned_cols=217 Identities=23% Similarity=0.382 Sum_probs=188.3
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH-----HHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER-----EKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
.+.++|++.+.||+|+||+||+|.++. ++..||+|++....... ..+.+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 83 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKS----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 83 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETT----TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECC----CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 356789999999999999999999876 47789999987543221 246788999999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC--
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-- 269 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-- 269 (364)
.+....++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~ 153 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAE----------KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVP 153 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT----------SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSS
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHh----------cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCC
Confidence 999999999999999999999964 34578899999999999999999999999999999999999887
Q ss_pred --cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 270 --TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 270 --~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
.+||+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+
T Consensus 154 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 154 KPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANV 229 (326)
T ss_dssp SCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred CCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHH
Confidence 899999999986654322 223356889999999999999999999999999999999 89999998888888777
Q ss_pred hcCc
Q psy7023 348 KGKS 351 (364)
Q Consensus 348 ~~~~ 351 (364)
....
T Consensus 230 ~~~~ 233 (326)
T 2y0a_A 230 SAVN 233 (326)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 6543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=313.63 Aligned_cols=228 Identities=37% Similarity=0.655 Sum_probs=194.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce-E
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT-L 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~-~ 198 (364)
..|.+.+.||+|+||+||+|.+..... ....||+|++.........+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQ-NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSS-CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCC-ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 366778999999999999998765332 34579999998777777778899999999999999999999999866655 9
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+.+++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 100 ~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRS---------PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp EEECCCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred EEEecccCCCHHHHHhc---------cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 99999999999999975 334678899999999999999999999999999999999999999999999999
Q ss_pred ccccCcccee--eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccccc
Q psy7023 279 TRDIYETEYY--RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 279 a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 356 (364)
++........ .......+++.|+|||.+.+..++.++||||||+++|+|++|+.+||...+..++.+.+..+.....+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP 250 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC
Confidence 9866543321 22233445788999999999999999999999999999999889999999999999988887765544
Q ss_pred C
Q psy7023 357 V 357 (364)
Q Consensus 357 ~ 357 (364)
.
T Consensus 251 ~ 251 (298)
T 3pls_A 251 E 251 (298)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.33 Aligned_cols=227 Identities=41% Similarity=0.731 Sum_probs=190.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE-eeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV-SEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-~~~~~~~ 198 (364)
.+|++.+.||+|+||+||+|.+..... ....+|+|.+.........+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCC-ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 579999999999999999998765322 24568999998777777778899999999999999999999985 4567889
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.++++. ....+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 104 ~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp EEEECCTTCBHHHHHHC---------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred EEEeCCCCCCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccc
Confidence 99999999999999974 234578889999999999999999999999999999999999999999999999
Q ss_pred ccccCcccee--eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccccc
Q psy7023 279 TRDIYETEYY--RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 279 a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 356 (364)
+......... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.+||.+.+..+....+..+.....+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 254 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence 9876544321 12223345778999999999999999999999999999999899999998888888887777655443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=312.51 Aligned_cols=231 Identities=35% Similarity=0.648 Sum_probs=192.7
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.+.+..++|++.+.||+|+||+||+|.+..... ....||+|++.........+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKG-EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTC-CEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCC-CcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 456677899999999999999999998765322 3557999999877666677889999999999999999999999875
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
+..++||||+++++|.+++... ...++...+..++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 154 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERN---------KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKL 154 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHH---------TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEE
T ss_pred -CCCEEEEecCCCCCHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEe
Confidence 4678999999999999999762 345788899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|+|.|..||...+..++.+.+..+...
T Consensus 155 ~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~ 233 (281)
T 3cc6_A 155 GDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL 233 (281)
T ss_dssp CCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC
T ss_pred CccCCCcccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC
Confidence 9999998665443222 222335778999999998899999999999999999998688999988888888888776554
Q ss_pred ccc
Q psy7023 354 EYK 356 (364)
Q Consensus 354 ~~~ 356 (364)
..+
T Consensus 234 ~~~ 236 (281)
T 3cc6_A 234 PKP 236 (281)
T ss_dssp CCC
T ss_pred CCC
Confidence 443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.74 Aligned_cols=220 Identities=25% Similarity=0.334 Sum_probs=180.3
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
..+..++|++++.||+|+||.||+|.++. +++.||+|++... ........+.+|+.+++.++||||+++++++.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKA----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcC----CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 34455789999999999999999999876 5778999998754 23334567788999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ 271 (364)
..+.+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ +|||||||||+|||++.++.+
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSR----------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCE
T ss_pred eCCEEEEEEeeCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCE
Confidence 99999999999999999999975 2357888999999999999999998 999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||+++........ .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++.+.+....
T Consensus 289 kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~ 365 (446)
T 4ejn_A 289 KITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILMEE 365 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred EEccCCCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCC
Confidence 99999999864433222 233457899999999999999999999999999999999 899999999988888776553
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.68 Aligned_cols=219 Identities=23% Similarity=0.354 Sum_probs=179.7
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
..+.++|++++.||+|+||+||+|.++. .++.||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLR----DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECC----CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 4467899999999999999999999876 47789999987643 34456678899999999999999999999876
Q ss_pred CCc----eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 194 GNP----TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 194 ~~~----~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
... .|+||||+++++|.+++... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 153 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTE----------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN 153 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC
Confidence 544 39999999999999999752 3578889999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 270 TVKVGDFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
.+||+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|+| |..||.+.+..+...++.
T Consensus 154 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~~~ 232 (311)
T 3ork_A 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHV 232 (311)
T ss_dssp CEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Confidence 9999999999866543221 12223346889999999999999999999999999999999 899999988877765544
Q ss_pred c
Q psy7023 349 G 349 (364)
Q Consensus 349 ~ 349 (364)
.
T Consensus 233 ~ 233 (311)
T 3ork_A 233 R 233 (311)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=325.44 Aligned_cols=216 Identities=23% Similarity=0.387 Sum_probs=187.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.++|++++.||+|+||+||+|.++. ++..||+|++.... ......+.+|+.+|+.++||||+++++++.+....
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~----~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKA----TGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECC----CCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 34689999999999999999999876 46789999987543 33456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCcEEEee
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD--DLTVKVGD 275 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~--~~~~kL~D 275 (364)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 124 ~lv~E~~~gg~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~D 194 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194 (387)
T ss_dssp EEEEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEe
Confidence 999999999999999864 2345789999999999999999999999999999999999974 57899999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||++........... ..+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+..+.
T Consensus 195 FG~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~ 266 (387)
T 1kob_A 195 FGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCD 266 (387)
T ss_dssp CTTCEECCTTSCEEE---ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHCC
T ss_pred cccceecCCCcceee---eccCCCccCchhccCCCCCCcccEeeHhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 999987654432221 235889999999999999999999999999999999 899999999888888776553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.15 Aligned_cols=230 Identities=39% Similarity=0.685 Sum_probs=184.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe-eCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS-EGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-~~~~~~ 198 (364)
..|++.+.||+|+||+||+|.+..... ....||+|.++........+++.+|+.++++++||||+++++++. .++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTT-EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCC-cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 468889999999999999998764321 245789999987666667788999999999999999999999865 456889
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++|+|.++++. ....+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 168 lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp EEEECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEEECCCCCCHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccc
Confidence 99999999999999975 234578889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceee--eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccccc
Q psy7023 279 TRDIYETEYYR--KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356 (364)
Q Consensus 279 a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 356 (364)
++......... ......+++.|+|||++.+..++.++||||||+++|||+|++.+||.+.+..++...+..+.....+
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p 318 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 318 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 98665433221 1222345778999999999999999999999999999999899999998888888888877765554
Q ss_pred CCC
Q psy7023 357 VNP 359 (364)
Q Consensus 357 ~~~ 359 (364)
..+
T Consensus 319 ~~~ 321 (373)
T 3c1x_A 319 EYC 321 (373)
T ss_dssp TTC
T ss_pred CCC
Confidence 433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=315.97 Aligned_cols=212 Identities=31% Similarity=0.563 Sum_probs=175.6
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE-- 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-- 193 (364)
+...++|++++.||+|+||+||+|+++..+...++.||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 456689999999999999999999976555556889999998754 34456788999999999999999999999864
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
...+++||||+++++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH---------KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC---------GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred CCceEEEEEeCCCCCHHHHHHhc---------ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEE
Confidence 45689999999999999999862 234788899999999999999999999999999999999999999999
Q ss_pred eecccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 274 GDFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~ 220 (295)
T 3ugc_A 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSP 220 (295)
T ss_dssp CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH-TTCTTCSH
T ss_pred ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHh-cccccCCC
Confidence 999999876543221 22233345678999999999999999999999999999999 77777643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=313.55 Aligned_cols=205 Identities=28% Similarity=0.459 Sum_probs=177.2
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..++|++.+.||+|+||+||+|.++. ++..||+|++... .....+.+.+|+.++++++||||+++++++.+++..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRE----TGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT----TCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECC----CCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 34799999999999999999999876 4778999987543 455677899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.++++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 153 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKS---------MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFG 153 (310)
T ss_dssp EEEEECCTTCBHHHHHHH---------CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCT
T ss_pred EEEEEecCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecc
Confidence 999999999999999986 23457889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeee------------CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 278 MTRDIYETEYYRK------------GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 278 ~a~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
++........... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~~~~~ 224 (310)
T 3s95_A 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPD 224 (310)
T ss_dssp TCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-TCCSSTT
T ss_pred cceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc-CCCCCcc
Confidence 9986654332211 113457889999999999999999999999999999999 7888765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=317.42 Aligned_cols=245 Identities=34% Similarity=0.617 Sum_probs=198.8
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
...|+...++|++.+.||+|+||+||+|.+... +...++.||+|++.........+.+.+|+.+++++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 345677889999999999999999999987542 22357889999998777777778899999999999 7899999999
Q ss_pred EEeeCC-ceEEEEecCCCCCHHHHHHhcCCCCC------CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 190 VVSEGN-PTLVIMELMGGGDLKNYLRSCRPDAE------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 190 ~~~~~~-~~~lv~e~~~ggsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
++...+ ..++||||+++++|.+++........ .......+++..++.++.|++.||+|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 988654 58999999999999999986432110 00112347899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-H
Q psy7023 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-E 341 (364)
Q Consensus 263 ILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~ 341 (364)
||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+|+|..||.+... .
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 999999999999999998765443333333334577899999999999999999999999999999878999987663 4
Q ss_pred HHHHHHhcCcccccc
Q psy7023 342 QVLNWVKGKSSNEYK 356 (364)
Q Consensus 342 ~~~~~i~~~~~~~~~ 356 (364)
++...+..+.....+
T Consensus 259 ~~~~~~~~~~~~~~~ 273 (316)
T 2xir_A 259 EFCRRLKEGTRMRAP 273 (316)
T ss_dssp HHHHHHHHTCCCCCC
T ss_pred HHHHHhccCccCCCC
Confidence 555666666544433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.82 Aligned_cols=219 Identities=18% Similarity=0.239 Sum_probs=185.3
Q ss_pred eccceeEeceeeee--cceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 118 LRSKVTILDELGNG--SFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G--~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
..++|+++++||+| +||+||+|+++. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKP----TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETT----TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcC----CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 34799999999999 999999999886 47789999987554 344567788899999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..|+||||+++++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTH--------FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHT--------CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhh--------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEc
Confidence 9999999999999999999863 23457889999999999999999999999999999999999999999999
Q ss_pred ecccccccCcccee-----eeCCCCCCCccccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 275 DFGMTRDIYETEYY-----RKGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 275 DFg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
|||.+......... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTCCSTTHHHHC
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 99988654332211 11222356888999999987 579999999999999999999 89999987776666544
Q ss_pred hc
Q psy7023 348 KG 349 (364)
Q Consensus 348 ~~ 349 (364)
..
T Consensus 250 ~~ 251 (389)
T 3gni_B 250 LN 251 (389)
T ss_dssp --
T ss_pred hc
Confidence 43
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=314.40 Aligned_cols=216 Identities=24% Similarity=0.387 Sum_probs=178.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-------------------------HHHHHHHHH
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-------------------------REKAEFLNE 172 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~E 172 (364)
..++|++.+.||+|+||+||+|.++. +++.||+|++...... ...+.+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNEN----DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETT----TTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECC----CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 34789999999999999999999876 4778999998654311 123568899
Q ss_pred HHHHHhcCCcceeEEEEEEee--CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh
Q psy7023 173 ASVMKAFDTHHVVKLYGVVSE--GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD 250 (364)
Q Consensus 173 ~~il~~l~h~~iv~l~~~~~~--~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~ 250 (364)
++++++++||||+++++++.+ .+..|+||||+++++|.+++ ....+++..+..++.||+.||+|||+
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~ 155 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----------TLKPLSEDQARFYFQDLIKGIEYLHY 155 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----------CSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----------hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999986 56899999999999987653 23468899999999999999999999
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCC---CCCchhHHHHHHHHHHH
Q psy7023 251 KKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV---FTSHSDVWSYGVVLWEM 327 (364)
Q Consensus 251 ~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~el 327 (364)
+||+||||||+|||++.++.+||+|||++.......... ....+|+.|+|||++.+.. ++.++||||||+++|+|
T Consensus 156 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred CCeeccCCCHHHEEECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 999999999999999999999999999998765443222 2335688999999998765 37789999999999999
Q ss_pred HhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 328 ATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 328 ~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++ |..||.+.+..++...+....
T Consensus 234 ~~-g~~pf~~~~~~~~~~~~~~~~ 256 (298)
T 2zv2_A 234 VF-GQCPFMDERIMCLHSKIKSQA 256 (298)
T ss_dssp HH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred HH-CCCCCCCccHHHHHHHHhccc
Confidence 99 899999988888877776543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.49 Aligned_cols=216 Identities=24% Similarity=0.424 Sum_probs=187.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
..|...+.||+|+||+||+|+++. .++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKH----SGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECC----CCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 357788899999999999999875 4778999998754332 34668899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 120 v~e~~~~~~L~~~l~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ-----------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188 (321)
T ss_dssp EECCCCSCBHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeee
Confidence 9999999999999853 24788999999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.......
T Consensus 189 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2c30_A 189 AQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSPPPK 260 (321)
T ss_dssp EECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCCC
T ss_pred eecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCC
Confidence 866543222 223456889999999999999999999999999999999 899999988888888887665433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=320.00 Aligned_cols=218 Identities=28% Similarity=0.475 Sum_probs=171.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++++.||+|+||+||+|.++. +++.||+|+++..........+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKT----TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp --------------CEEEEEECSS----SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECC----CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 689999999999999999998776 4778999998755444344678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||++ ++|.+++...... .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 v~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVG----NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSS----SCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EEEecC-CCHHHHHHhcccc----ccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 999997 5999999763211 12245788999999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
........ ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+.+..+.+
T Consensus 156 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~ 223 (317)
T 2pmi_A 156 RAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGTNDEEQLKLIFD 223 (317)
T ss_dssp EETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred eecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence 86643321 12233468899999999764 58999999999999999999 8999999998888876643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=314.40 Aligned_cols=241 Identities=39% Similarity=0.679 Sum_probs=189.4
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
...+.+..++|++.+.||+|+||.||+|.+..... .+..||+|+++... .....+.+.+|+.++++++||||++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG-TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTS-CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCC-ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34456677899999999999999999998765322 35689999987543 44556788999999999999999999999
Q ss_pred EeeCC-----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7023 191 VSEGN-----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265 (364)
Q Consensus 191 ~~~~~-----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl 265 (364)
+.+.+ ..++||||+++++|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 180 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE----TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBT----TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhh----cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 87654 459999999999999999653211 133568899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 266 ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 266 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
+.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|+++|.+||.+.+..++.+
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 99999999999999876554433334444557889999999999999999999999999999998899999999999988
Q ss_pred HHhcCccccccC
Q psy7023 346 WVKGKSSNEYKV 357 (364)
Q Consensus 346 ~i~~~~~~~~~~ 357 (364)
.+..+.....+.
T Consensus 261 ~~~~~~~~~~~~ 272 (313)
T 3brb_A 261 YLLHGHRLKQPE 272 (313)
T ss_dssp HHHTTCCCCCBT
T ss_pred HHHcCCCCCCCc
Confidence 888776555443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=321.03 Aligned_cols=216 Identities=22% Similarity=0.387 Sum_probs=170.2
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
.+.+.++|++.+.||+|+||+||+|.++. .++.||+|+++... ..+.+.+|+.++++++||||+++++++...
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKG----TQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECC----CCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 34566889999999999999999999876 46789999987543 345678899999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcE
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---DLTV 271 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~~~~ 271 (364)
+..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVE----------KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTT----------CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCE
T ss_pred CeEEEEEEeCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCE
Confidence 999999999999999999964 235788999999999999999999999999999999999975 8899
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhcC
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE-QVLNWVKGK 350 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~-~~~~~i~~~ 350 (364)
||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... .++..+..+
T Consensus 191 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~i~~~ 266 (349)
T 2w4o_A 191 KIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDERGDQFMFRRILNC 266 (349)
T ss_dssp EECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCTTCHHHHHHHHHTT
T ss_pred EEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCcccHHHHHHHHhC
Confidence 9999999986544322 122346889999999999999999999999999999999 78888765544 466666554
Q ss_pred c
Q psy7023 351 S 351 (364)
Q Consensus 351 ~ 351 (364)
.
T Consensus 267 ~ 267 (349)
T 2w4o_A 267 E 267 (349)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=316.91 Aligned_cols=217 Identities=21% Similarity=0.326 Sum_probs=188.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
...+|++.+.||+|+||.||++.++. .+..||+|++.... .....+.+.+|+.+++.++|+||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDAD----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECC----CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34789999999999999999999876 46789999986543 3455677889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~D 184 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR----------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD 184 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecCCCCCHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEee
Confidence 999999999999999998752 3577889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.+..+..+.
T Consensus 185 fg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 257 (335)
T 2owb_A 185 FGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKNE 257 (335)
T ss_dssp CTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTC
T ss_pred ccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHhcCC
Confidence 9999866433221 222346888999999999999999999999999999999 899999988888777666543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=317.69 Aligned_cols=220 Identities=25% Similarity=0.383 Sum_probs=183.0
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
....++|++.+.||+|+||+||+|.++. +++.||+|++.........+.+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKK----TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECC----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 4566899999999999999999999876 467899999986554444567889999999999999999999998655
Q ss_pred --ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCC
Q psy7023 196 --PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV----ADDL 269 (364)
Q Consensus 196 --~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl----~~~~ 269 (364)
..++||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 153 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS 153 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGG-------GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE
T ss_pred CceEEEEEeCCCCCCHHHHHHHhc-------cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc
Confidence 7899999999999999998632 22348899999999999999999999999999999999999 7788
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCccccc--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK--------DGVFTSHSDVWSYGVVLWEMATLASQPYQGLS-- 339 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~t~g~~P~~~~~-- 339 (364)
.+||+|||+++........ ....+++.|+|||++. +..++.++|||||||++|||+| |..||....
T Consensus 154 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~ 229 (319)
T 4euu_A 154 VYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGP 229 (319)
T ss_dssp EEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH-SSCSEECTTCG
T ss_pred eEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcc
Confidence 8999999999876544321 2234688999999986 5678999999999999999999 899996433
Q ss_pred --HHHHHHHHhcC
Q psy7023 340 --NEQVLNWVKGK 350 (364)
Q Consensus 340 --~~~~~~~i~~~ 350 (364)
..+++..+..+
T Consensus 230 ~~~~~~~~~~~~~ 242 (319)
T 4euu_A 230 RRNKEVMYKIITG 242 (319)
T ss_dssp GGCHHHHHHHHHH
T ss_pred chhHHHHHHHhcC
Confidence 24444444443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=305.96 Aligned_cols=217 Identities=22% Similarity=0.390 Sum_probs=189.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+.++|++.+.||+|+||.||+|.++. .+..||+|++.... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKT----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcC----CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence 56899999999999999999999876 47789999987543 45556788899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---EEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT---VKV 273 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~---~kL 273 (364)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++. +||
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl 149 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAR----------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 149 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEE
Confidence 99999999999999998752 35788899999999999999999999999999999999986655 999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++...+..+..
T Consensus 150 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 224 (284)
T 3kk8_A 150 ADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAY 224 (284)
T ss_dssp CCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCC
T ss_pred eeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHH-CCCCCCCCchhHHHHHHHhccc
Confidence 99999976654332 122346889999999999999999999999999999999 8999999999998888876643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=322.24 Aligned_cols=214 Identities=25% Similarity=0.395 Sum_probs=179.1
Q ss_pred cceeE--eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTI--LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~--~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.|.+ .+.||+|+||.||+|.++. .+..||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETA----TGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETT----TCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcC----CCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 44444 6789999999999999876 47789999987643 34467889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE--cCCCcEEEee
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV--ADDLTVKVGD 275 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl--~~~~~~kL~D 275 (364)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|
T Consensus 162 ~lv~E~~~~~~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~D 232 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIID---------ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID 232 (373)
T ss_dssp EEEEECCTTCEEHHHHHH---------TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECC
T ss_pred EEEEeCCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEe
Confidence 999999999999999975 22357788999999999999999999999999999999999 5678999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+++....... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+....
T Consensus 233 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 304 (373)
T 2x4f_A 233 FGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDNDAETLNNILACR 304 (373)
T ss_dssp CSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTC
T ss_pred CCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Confidence 999987654332 223346889999999999899999999999999999999 899999999888888776543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.54 Aligned_cols=211 Identities=24% Similarity=0.431 Sum_probs=176.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++++.||+|+||+||+|.++. +..||+|++..... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNY-----GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETT-----SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCC-----CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEE
Confidence 579999999999999999998743 67899998865432 222356789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++ +|.+++.. ....++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDV---------CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EEEECCSE-EHHHHHHT---------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEecCC-CHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 99999975 99999975 234578889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+........ ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+.+..+.
T Consensus 147 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 214 (288)
T 1ob3_A 147 ARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIF 214 (288)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred ccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence 976543221 12223458889999999764 58999999999999999999 899999988877776654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=311.03 Aligned_cols=223 Identities=21% Similarity=0.485 Sum_probs=187.3
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccc---cccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSL---AEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
++..++|++.+.||+|+||+||+|.++.+... ....||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 45668999999999999999999998764321 235799999865432 34567899999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT-- 270 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~-- 270 (364)
+.+..++||||+++++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN---------KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT---------GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGG
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccc
Confidence 999999999999999999999862 234788899999999999999999999999999999999998887
Q ss_pred ------EEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy7023 271 ------VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343 (364)
Q Consensus 271 ------~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~ 343 (364)
+||+|||++......... .+++.|+|||++.+ ..++.++||||||+++|+|++|+.+||...+....
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~ 227 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLPKDIL------QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSCHHHH------HHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ccccceeeeccCcccccccCcccc------CCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH
Confidence 999999999765443221 23567999999987 67899999999999999999988899988888777
Q ss_pred HHHHhcCcccc
Q psy7023 344 LNWVKGKSSNE 354 (364)
Q Consensus 344 ~~~i~~~~~~~ 354 (364)
..........+
T Consensus 228 ~~~~~~~~~~~ 238 (289)
T 4fvq_A 228 LQFYEDRHQLP 238 (289)
T ss_dssp HHHHHTTCCCC
T ss_pred HHHhhccCCCC
Confidence 77666554433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.92 Aligned_cols=218 Identities=22% Similarity=0.406 Sum_probs=185.7
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH------------HHHHHHHHHHHHHHhcCCcc
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE------------REKAEFLNEASVMKAFDTHH 183 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~E~~il~~l~h~~ 183 (364)
..+.++|+++++||+|+||+||+|.++. ++..||+|++...... ...+.+.+|+.++++++|||
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 107 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKN----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN 107 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETT----TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred CCcccceEEEeEecccCCeEEEEEEECC----CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence 3466899999999999999999999876 4678999998754322 22467889999999999999
Q ss_pred eeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7023 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNC 263 (364)
Q Consensus 184 iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI 263 (364)
|+++++++.+....|+|||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 177 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR----------HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence 999999999999999999999999999999752 3578899999999999999999999999999999999
Q ss_pred EEcCCC---cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 264 MVADDL---TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 264 Ll~~~~---~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
|++.++ .+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |.+||.+.+.
T Consensus 178 l~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 252 (504)
T 3q5i_A 178 LLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC-GYPPFGGQND 252 (504)
T ss_dssp EESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSH
T ss_pred EEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHh-CCCCCCCCCH
Confidence 999776 699999999986654322 22335688999999987 569999999999999999999 8999999999
Q ss_pred HHHHHHHhcCcc
Q psy7023 341 EQVLNWVKGKSS 352 (364)
Q Consensus 341 ~~~~~~i~~~~~ 352 (364)
.+++..+..+..
T Consensus 253 ~~~~~~i~~~~~ 264 (504)
T 3q5i_A 253 QDIIKKVEKGKY 264 (504)
T ss_dssp HHHHHHHHHCCC
T ss_pred HHHHHHHHcCCC
Confidence 999998877654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.60 Aligned_cols=220 Identities=24% Similarity=0.385 Sum_probs=184.2
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.++|.+.+.||+|+||+||+|.++. .+..||+|++.........+.+.+|++++++++||||+++++++.+....
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERS----SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeccCCCeEEEEEEEcc----CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 45799999999999999999999876 47789999987665444467788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEEe
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV---ADDLTVKVG 274 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kL~ 274 (364)
++||||+++++|.+++.... .....+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQ------ARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHhhh------hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEE
Confidence 99999999999999996521 123568889999999999999999999999999999999999 456889999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|||++........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+.+..++...+.....
T Consensus 170 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 242 (285)
T 3is5_A 170 DFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT-GCLPFTGTSLEEVQQKATYKEP 242 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCC
T ss_pred eeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHh-CCCCCCCCCHHHHHhhhccCCc
Confidence 9999976554322 22334688999999886 568999999999999999999 8999999988888877655443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=323.02 Aligned_cols=211 Identities=25% Similarity=0.419 Sum_probs=178.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH--HHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--EKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
..++|++.+.||+|+||+||+|.+.. +++.||+|++....... ....+.+|+.+++.++||||+++++++...+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYK----TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECC----CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 34789999999999999999999876 47789999986432111 1346889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+ +|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 151 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEK----------KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIAD 151 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECC
T ss_pred EEEEEEECC-CCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEE
Confidence 999999999 78999999752 3578889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
||++........ .....+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....++...+
T Consensus 152 FG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i 220 (336)
T 3h4j_B 152 FGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV-GRLPFDDEFIPNLFKKV 220 (336)
T ss_dssp SSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH-SSCSSBCSSSTTCBCCC
T ss_pred eccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh-CCCCCCCccHHHHHHHH
Confidence 999986654432 223346889999999998876 689999999999999999 89999876554444333
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=334.48 Aligned_cols=228 Identities=24% Similarity=0.392 Sum_probs=187.5
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
..+.++|+++++||+|+||+||+|+++. ++..||+|++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 108 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKV----THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK 108 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETT----TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECC----CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 3466789999999999999999999876 467899999875432 22246788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcE
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---DLTV 271 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~~~~ 271 (364)
...|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 178 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR----------MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred CEEEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcE
Confidence 9999999999999999998752 35778899999999999999999999999999999999976 4559
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||++........ .....+|+.|+|||++. ..|+.++|||||||++|+|++ |.+||.+.+..+++..+..+.
T Consensus 179 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 253 (494)
T 3lij_A 179 KIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA-GYPPFGGQTDQEILRKVEKGK 253 (494)
T ss_dssp EECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTC
T ss_pred EEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 9999999986654322 22345788999999886 569999999999999999999 899999999999999887665
Q ss_pred cc-cccCCCCCC
Q psy7023 352 SN-EYKVNPPIS 362 (364)
Q Consensus 352 ~~-~~~~~~~~s 362 (364)
.. ..+.|..+|
T Consensus 254 ~~~~~~~~~~~s 265 (494)
T 3lij_A 254 YTFDSPEWKNVS 265 (494)
T ss_dssp CCCCSGGGTTSC
T ss_pred CCCCchhcccCC
Confidence 43 344444443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.49 Aligned_cols=231 Identities=32% Similarity=0.599 Sum_probs=191.1
Q ss_pred ceeeeccceeEec-eeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 114 SWEVLRSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 114 ~~e~~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
.+.+..++|++.+ .||+|+||+||+|.+.... .+..||+|+++.... ....+++.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSS--SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCC--ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455668999998 9999999999999764322 467899999875432 33367789999999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
..+..++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~ 156 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQN----------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 156 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhC----------cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcE
Confidence 567889999999999999999752 347788999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 272 KVGDFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
||+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|+|+|..||.+.+..++.+.+..+
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 236 (291)
T 1xbb_A 157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236 (291)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred EEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999986654332 222333445788999999998889999999999999999998789999999999999998887
Q ss_pred ccccccC
Q psy7023 351 SSNEYKV 357 (364)
Q Consensus 351 ~~~~~~~ 357 (364)
.....+.
T Consensus 237 ~~~~~~~ 243 (291)
T 1xbb_A 237 ERMGCPA 243 (291)
T ss_dssp CCCCCCT
T ss_pred CCCCCCC
Confidence 6655443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=319.65 Aligned_cols=207 Identities=18% Similarity=0.314 Sum_probs=177.9
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~ 195 (364)
++.++|++++.||+|+||+||+|.++. +++.||+|++..... ...+.+|+.+++.+ +||||+++++++..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLY----TNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETT----TTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECC----CCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 456789999999999999999999766 478899999865432 23577899999999 9999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc-----
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT----- 270 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~----- 270 (364)
..++||||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~ 148 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLC---------DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV 148 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTS
T ss_pred ccEEEEEeC-CCCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCce
Confidence 999999999 99999999862 346889999999999999999999999999999999999999887
Q ss_pred EEEeecccccccCccceee-----eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 271 VKVGDFGMTRDIYETEYYR-----KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..
T Consensus 149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~Pf~~~~~~ 223 (330)
T 2izr_A 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLR-GSLPWQGLKAD 223 (330)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCS
T ss_pred EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhc-CCCCccccccc
Confidence 9999999998654432211 1234457899999999999999999999999999999999 89999875443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=335.45 Aligned_cols=221 Identities=21% Similarity=0.321 Sum_probs=187.4
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
+..++|++++.||+|+||+||+|+++. +++.||+|++.+.... .....+.+|+.++++++||||+++++++...
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKA----TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECC----CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 345789999999999999999999876 4778999998754321 1245688999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+.+|+||||++||+|.+++.... .....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~------~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVD------EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSS------TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEEeccCCCHHHHHHHhh------cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEe
Confidence 99999999999999999997632 123468899999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcC
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL----SNEQVLNWVKGK 350 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~----~~~~~~~~i~~~ 350 (364)
|||+++.+...... .....+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+. ...++.+.+...
T Consensus 332 DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt-G~~PF~~~~~~~~~~~~~~~i~~~ 408 (543)
T 3c4z_A 332 DLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQRVLEQ 408 (543)
T ss_dssp CCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred ecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh-CCCCCCCCccchhHHHHHHHHhhc
Confidence 99999876544322 122357899999999999999999999999999999999 89999865 345666666544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.78 Aligned_cols=215 Identities=21% Similarity=0.373 Sum_probs=173.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~ 195 (364)
+.++|++++.||+|+||+||+|.++. +++.||+|++... .......++.+|+.+++.+. ||||+++++++...+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRR----TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETT----TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECC----CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 45799999999999999999999876 4778999988643 34455677889999999997 999999999997544
Q ss_pred --ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 196 --PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 196 --~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+|+|||||+ ++|.++++. ..++...+..++.||+.||+|||+.||+||||||+|||++.++.+||
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-----------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-----------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred CCEEEEEecccC-cCHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEe
Confidence 7899999997 599999975 24677889999999999999999999999999999999999999999
Q ss_pred eecccccccCccc-------------------eeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCC
Q psy7023 274 GDFGMTRDIYETE-------------------YYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQ 333 (364)
Q Consensus 274 ~DFg~a~~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~ 333 (364)
+|||+++...... .........+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~ 229 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKP 229 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSC
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh-CCC
Confidence 9999998653311 0111233457899999999986 678999999999999999999 899
Q ss_pred CCCCCCHHHHHHHHhc
Q psy7023 334 PYQGLSNEQVLNWVKG 349 (364)
Q Consensus 334 P~~~~~~~~~~~~i~~ 349 (364)
||.+.+..+.++.+.+
T Consensus 230 pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 230 IFPGSSTMNQLERIIG 245 (388)
T ss_dssp SCCCSSHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHH
Confidence 9999998888877653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.06 Aligned_cols=218 Identities=26% Similarity=0.399 Sum_probs=185.6
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
+..++|++++.||+|+||.||+|+++. +++.||+|++..... ......+.+|+.+|+.++||||+++++++.+.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~----tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 256 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK 256 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECC----CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence 456789999999999999999999876 477899999865321 11245678999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+.+|+||||++||+|.+++... ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~--------~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~ 328 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHM--------GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRIS 328 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSS--------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEE
Confidence 9999999999999999999752 23457889999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHhcC
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS----NEQVLNWVKGK 350 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~----~~~~~~~i~~~ 350 (364)
|||+++......... ...+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+ ..++...+...
T Consensus 329 DFGla~~~~~~~~~~---~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLlt-G~~PF~~~~~~~~~~~i~~~i~~~ 404 (576)
T 2acx_A 329 DLGLAVHVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIKREEVERLVKEV 404 (576)
T ss_dssp CCTTCEECCTTCCEE---CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHH-SSCSSSCSSSCCCHHHHHHHHHHC
T ss_pred ecccceecccCcccc---ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCcccccchhHHHHHHHhhcc
Confidence 999998765443221 2357899999999999999999999999999999999 899998753 34555555543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=330.48 Aligned_cols=207 Identities=27% Similarity=0.402 Sum_probs=161.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee---
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--- 193 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--- 193 (364)
+.++|++++.||+|+||+||+|.++. +++.||+|++.... .....+++.+|+.+|+.++||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKL----EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECC----CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 34789999999999999999999876 47789999886543 34456788999999999999999999999843
Q ss_pred --CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 194 --GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 194 --~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
...+|+||||+ +++|.++++. ...+++..+..++.||+.||+|||++|||||||||+||||+.++.+
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRT----------PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHS----------SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCE
T ss_pred ccCceEEEEEecc-ccchhhhccc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCE
Confidence 35789999998 5699999974 3457889999999999999999999999999999999999999999
Q ss_pred EEeecccccccCcccee-------------------------eeCCCCCCCccccCcccc-cCCCCCCchhHHHHHHHHH
Q psy7023 272 KVGDFGMTRDIYETEYY-------------------------RKGSRGFLPVRWMAPESL-KDGVFTSHSDVWSYGVVLW 325 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~ 325 (364)
||+|||+++........ .......+|+.|+|||++ ....|+.++|||||||++|
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 99999999876432110 112334568899999986 4566999999999999999
Q ss_pred HHHhC----------CCCCCCCCC
Q psy7023 326 EMATL----------ASQPYQGLS 339 (364)
Q Consensus 326 el~t~----------g~~P~~~~~ 339 (364)
||+|| +.++|.+.+
T Consensus 276 elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 276 ELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp HHHTTSTTTCSSGGGCCCSCC---
T ss_pred HHHHhccccccccccccccCCCCc
Confidence 99984 678887654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=319.56 Aligned_cols=213 Identities=23% Similarity=0.444 Sum_probs=176.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++++.||+|+||+||+|.++. ++..||+|++...........+.+|+.+++.++||||+++++++...+..++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL----TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC----CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 579999999999999999999876 4678999998765444333356679999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 78 v~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDC---------GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp EEECCS-EEHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred Eecccc-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccc
Confidence 999996 5999999862 345788899999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+..
T Consensus 148 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 148 RAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred ccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence 765433221 222345889999999876 568999999999999999999 8999999999888877654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=311.89 Aligned_cols=209 Identities=32% Similarity=0.524 Sum_probs=176.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-- 194 (364)
....+|++++.||+|+||.||+|++...+...++.||+|++.........+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 345789999999999999999999765555578999999998655444457788999999999999999999999876
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKN---------KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHH---------TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ceEEEEEEeCCCCcHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEEC
Confidence 6789999999999999999752 3457889999999999999999999999999999999999999999999
Q ss_pred ecccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 275 DFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 275 DFg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
|||++......... .......+|..|+|||++.+..++.++||||||+++|+|+| |..|+
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~ 229 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSD 229 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGG
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHH-ccCCC
Confidence 99999876544322 23334456778999999999899999999999999999999 66654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=320.16 Aligned_cols=233 Identities=23% Similarity=0.409 Sum_probs=185.8
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc----CHHHHHHHHHHHHHHHhcCCcceeEEEE
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA----SEREKAEFLNEASVMKAFDTHHVVKLYG 189 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~il~~l~h~~iv~l~~ 189 (364)
....+.++|++.+.||+|+||+||+|.++. .+..||+|++.... .....+.+.+|+.++++++||||+++++
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 95 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQ----TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECC----CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence 344567899999999999999999999876 47789999986432 2334578899999999999999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCC------------------------------CccCCCCccHHHHHHHHH
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAE------------------------------TDVERSPPTLSRILQMAA 239 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~------------------------------~~~~~~~~~~~~~~~i~~ 239 (364)
++.+.+..++||||+++|+|.+++........ .......+++..++.++.
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 99999999999999999999999863211100 000122346778899999
Q ss_pred HHHHHHHHHHhCCceecCCCCCCEEEcCCC--cEEEeecccccccCccce--eeeCCCCCCCccccCcccccC--CCCCC
Q psy7023 240 EVADGMAYLADKKFVHRDLAARNCMVADDL--TVKVGDFGMTRDIYETEY--YRKGSRGFLPVRWMAPESLKD--GVFTS 313 (364)
Q Consensus 240 qil~~L~~LH~~~iiHrDlkp~NILl~~~~--~~kL~DFg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~ 313 (364)
||+.||+|||+++|+||||||+|||++.++ .+||+|||++..+..... ........+++.|+|||++.+ ..++.
T Consensus 176 qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 999999999999999999999999998776 899999999986543221 112233456889999999975 67899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 314 HSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 314 ~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
++||||||+++|+|++ |..||.+.+..+....+..+.
T Consensus 256 ~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 292 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLM-GAVPFPGVNDADTISQVLNKK 292 (345)
T ss_dssp HHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHH-CCCCCCCCChHHHHHHHHhcc
Confidence 9999999999999999 899999998888887765544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.16 Aligned_cols=217 Identities=23% Similarity=0.363 Sum_probs=177.1
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC----HHHHHHHHHHHHHHHhc---CCcceeEEE
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS----EREKAEFLNEASVMKAF---DTHHVVKLY 188 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~il~~l---~h~~iv~l~ 188 (364)
+.+.++|+++++||+|+||+||+|+++. +++.||+|++..... ......+.+|+.+++.+ +||||++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPH----SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTT----TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECC----CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 4566899999999999999999998766 477899999864321 11123455677777666 599999999
Q ss_pred EEEeeCC-----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7023 189 GVVSEGN-----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNC 263 (364)
Q Consensus 189 ~~~~~~~-----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI 263 (364)
+++.... ..++||||+. ++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 151 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA--------PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 151 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC--------CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTE
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 9998755 4899999996 5999999862 233488999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy7023 264 MVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343 (364)
Q Consensus 264 Ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~ 343 (364)
|++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.
T Consensus 152 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~ 227 (308)
T 3g33_A 152 LVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 227 (308)
T ss_dssp EECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTT-SSCSCCCSSHHHH
T ss_pred EEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999999999999986543322 223346889999999999999999999999999999999 8999999998888
Q ss_pred HHHHhc
Q psy7023 344 LNWVKG 349 (364)
Q Consensus 344 ~~~i~~ 349 (364)
+..+..
T Consensus 228 ~~~i~~ 233 (308)
T 3g33_A 228 LGKIFD 233 (308)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=313.06 Aligned_cols=217 Identities=25% Similarity=0.415 Sum_probs=188.9
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH-----HHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER-----EKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
.+.++|++.+.||+|+||.||+|.++. ++..||+|++....... ..+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECC----CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 356789999999999999999999876 47789999987543221 256788999999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC--
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-- 269 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-- 269 (364)
.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+++++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQ----------KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHT----------CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSS
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCC
Confidence 999999999999999999999974 23578899999999999999999999999999999999999888
Q ss_pred --cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 270 --TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 270 --~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.+..+
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i 230 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANI 230 (321)
T ss_dssp SCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred cCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 799999999986654322 223346889999999999999999999999999999999 89999998888888877
Q ss_pred hcCc
Q psy7023 348 KGKS 351 (364)
Q Consensus 348 ~~~~ 351 (364)
....
T Consensus 231 ~~~~ 234 (321)
T 2a2a_A 231 TSVS 234 (321)
T ss_dssp HTTC
T ss_pred Hhcc
Confidence 6654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.39 Aligned_cols=205 Identities=21% Similarity=0.352 Sum_probs=171.6
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC---
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN--- 195 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--- 195 (364)
.++|++++.||+|+||+||+|+++. +++.||+|++.........+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV----DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT----TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC----CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 4689999999999999999999876 477899999876555556778999999999999999999999986543
Q ss_pred ------------------------------------------------------ceEEEEecCCCCCHHHHHHhcCCCCC
Q psy7023 196 ------------------------------------------------------PTLVIMELMGGGDLKNYLRSCRPDAE 221 (364)
Q Consensus 196 ------------------------------------------------------~~~lv~e~~~ggsL~~~l~~~~~~~~ 221 (364)
..++||||+++++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--- 157 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--- 157 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---
Confidence 28999999999999999986432
Q ss_pred CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCcccee----------eeC
Q psy7023 222 TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYY----------RKG 291 (364)
Q Consensus 222 ~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~----------~~~ 291 (364)
....++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ...
T Consensus 158 ----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 158 ----LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp ----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred ----ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 223456678999999999999999999999999999999999999999999999876554211 122
Q ss_pred CCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 292 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
....+|+.|+|||++.+..++.++||||||+++|+|++ +..|+
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~~~~~ 276 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-SFSTQ 276 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHS-CCCCH
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHH-cCCCh
Confidence 33457899999999999999999999999999999999 65554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=309.73 Aligned_cols=223 Identities=28% Similarity=0.534 Sum_probs=173.7
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
.+.+|+..++|++.++||+|+||+||+|.++. .||+|+++... .....+.+.+|+.++++++||||++++++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS-------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC-------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence 45668888999999999999999999997553 38999987544 44556789999999999999999999996
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
. .....++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~ 158 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT 158 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTT---------C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred c-cCCccEEEEEecCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence 5 45678999999999999999964 3345788999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQVLNW 346 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~~~~~ 346 (364)
+||+|||++................+++.|+|||++. +..++.++||||||+++|+|++ |..||.+... .++.+.
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~ 237 (289)
T 3og7_A 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIEM 237 (289)
T ss_dssp EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH-SSCTTSSCCCHHHHHHH
T ss_pred EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH-CCCCccccchHHHHHHH
Confidence 9999999997654332222233345688999999986 5668889999999999999999 8999987554 455555
Q ss_pred HhcCcc
Q psy7023 347 VKGKSS 352 (364)
Q Consensus 347 i~~~~~ 352 (364)
+..+..
T Consensus 238 ~~~~~~ 243 (289)
T 3og7_A 238 VGRGSL 243 (289)
T ss_dssp HHHTSC
T ss_pred hccccc
Confidence 555443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=340.52 Aligned_cols=236 Identities=37% Similarity=0.693 Sum_probs=199.1
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
...+++..++|++.+.||+|+||+||+|.++.... ....||+|.++........+.+.+|+.++++++||||+++++++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN-PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSS-CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCC-ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34567788999999999999999999999875332 35679999988766667778899999999999999999999998
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
.+ +..|+||||+++|+|.++++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 461 ~~-~~~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~v 530 (656)
T 2j0j_A 461 TE-NPVWIIMELCTLGELRSFLQV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530 (656)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHH---------TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred ec-CceEEEEEcCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCE
Confidence 54 678999999999999999975 23357888999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||+++|..||.+.+..+++..+..+.
T Consensus 531 kL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~ 609 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609 (656)
T ss_dssp EECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC
T ss_pred EEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999876544322 22334457789999999988999999999999999999987899999999999999998877
Q ss_pred cccccCCC
Q psy7023 352 SNEYKVNP 359 (364)
Q Consensus 352 ~~~~~~~~ 359 (364)
..+.+.++
T Consensus 610 ~~~~~~~~ 617 (656)
T 2j0j_A 610 RLPMPPNC 617 (656)
T ss_dssp CCCCCTTC
T ss_pred CCCCCccc
Confidence 66555444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.19 Aligned_cols=218 Identities=22% Similarity=0.363 Sum_probs=188.5
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEee
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSE 193 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~ 193 (364)
...++|++++.||+|+||+||+|+++. +++.||+|++++.. .....+.+..|..++..+ +||+|+++++++.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKG----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESS----SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred ccccceEEEEEEccCCCEEEEEEEECC----CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence 345789999999999999999999887 46789999987532 112245677899999987 78999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL 483 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQV----------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKI 483 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEE
T ss_pred CCEEEEEEeCcCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEE
Confidence 99999999999999999999862 35788899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+|||+++........ .....+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++++.|..+.
T Consensus 484 ~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~ 558 (674)
T 3pfq_A 484 ADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEHN 558 (674)
T ss_dssp CCCTTCEECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHSSC
T ss_pred eecceeeccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc-CCCCCCCCCHHHHHHHHHhCC
Confidence 999999854333222 233457899999999999999999999999999999999 899999999999999887764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.35 Aligned_cols=214 Identities=21% Similarity=0.403 Sum_probs=180.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~ 195 (364)
.+.++|++++.||+|+||+||+|.++. +++.||+|++..... ...+|++++.++ +||||+++++++.+++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKA----TNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECC----CCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 356789999999999999999999876 477899999875432 234588888888 7999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----CcE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD----LTV 271 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~----~~~ 271 (364)
..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+.++ +.+
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~----------~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~ 159 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILR----------QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESI 159 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHT----------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGE
T ss_pred EEEEEEeCCCCCcHHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeE
Confidence 99999999999999999975 2357889999999999999999999999999999999998543 359
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHh
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG---LSNEQVLNWVK 348 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~---~~~~~~~~~i~ 348 (364)
||+|||++......... .....+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+ .+..++++.+.
T Consensus 160 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~i~ 236 (342)
T 2qr7_A 160 RICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT-GYTPFANGPDDTPEEILARIG 236 (342)
T ss_dssp EECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH-SSCSSCSSTTSCHHHHHHHHH
T ss_pred EEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc-CCCCCCCCCcCCHHHHHHHHc
Confidence 99999999866543321 123346889999999988889999999999999999999 8999975 45677888877
Q ss_pred cCcc
Q psy7023 349 GKSS 352 (364)
Q Consensus 349 ~~~~ 352 (364)
.+..
T Consensus 237 ~~~~ 240 (342)
T 2qr7_A 237 SGKF 240 (342)
T ss_dssp HCCC
T ss_pred cCCc
Confidence 6654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=308.09 Aligned_cols=219 Identities=29% Similarity=0.507 Sum_probs=191.0
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..+.|++++.||+|+||.||+|.++. .++.||+|++.........+.+.+|+.+++.++||||+++++++......
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNR----TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETT----TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECC----CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 44689999999999999999998776 47789999987655445567889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 96 ~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecc
Confidence 999999999999999853 357889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+..+....
T Consensus 165 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 238 (303)
T 3a7i_A 165 VAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR-GEPPHSELHPMKVLFLIPKNNPPT 238 (303)
T ss_dssp TCEECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cceecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHcc-CCCCCCCcCHHHHHHHhhcCCCCC
Confidence 99766544322 223346888999999999999999999999999999999 899999988888888776655443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.50 Aligned_cols=212 Identities=22% Similarity=0.311 Sum_probs=177.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC-
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG- 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~- 194 (364)
.+.++|++++.||+|+||+||+|.++. +++.||+|++.... .....+++.+|+.+|+.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAV----LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETT----TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECC----CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 356899999999999999999999876 47789999987543 445567888999999999999999999999654
Q ss_pred -----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 195 -----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 195 -----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
..+|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 135 ~~~~~~~~~lv~E~~~~-~l~~~~~~------------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~ 201 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201 (464)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHTS------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred ccccCCeEEEEEeCCCC-CHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC
Confidence 356999999965 67777642 367889999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
.+||+|||+++....... .....+|+.|+|||++.+..|+.++|||||||++|||++ |++||.+.+..+.+..+.+
T Consensus 202 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 202 TLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp CEEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred CEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence 999999999986654321 233456889999999999999999999999999999999 8999999988877776643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.93 Aligned_cols=228 Identities=25% Similarity=0.438 Sum_probs=193.3
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
..+.++|++.+.||+|+||+||+|.++. ++..||+|++.... .......+.+|+.++++++||||+++++++.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKI----TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECC----CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4567899999999999999999999876 47789999986432 12335678899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCc
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV---ADDLT 270 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl---~~~~~ 270 (364)
.+..|+||||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIIS----------RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT----------CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC
T ss_pred CCEEEEEEecCCCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCc
Confidence 9999999999999999999974 3457889999999999999999999999999999999999 56789
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||+|||++......... ....+|+.|+|||++.+ .|+.++|||||||++|+|++ |.+||.+.+..+++..+..+
T Consensus 168 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 242 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKVEKG 242 (484)
T ss_dssp EEECCTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC
T ss_pred EEEEeeeeeEEccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcC
Confidence 999999999765543221 12246889999999876 69999999999999999999 89999999999999988766
Q ss_pred cc-ccccCCCCCC
Q psy7023 351 SS-NEYKVNPPIS 362 (364)
Q Consensus 351 ~~-~~~~~~~~~s 362 (364)
.. .+.+.|..+|
T Consensus 243 ~~~~~~~~~~~~s 255 (484)
T 3nyv_A 243 KYTFELPQWKKVS 255 (484)
T ss_dssp CCCCCSGGGGGSC
T ss_pred CCCCCCcccccCC
Confidence 53 3444444443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=312.95 Aligned_cols=210 Identities=32% Similarity=0.567 Sum_probs=180.3
Q ss_pred eeccce-eEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--
Q psy7023 117 VLRSKV-TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE-- 193 (364)
Q Consensus 117 ~~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-- 193 (364)
++..+| +++++||+|+||+||++.++..+...++.||+|+++........+.+.+|+.++++++||||+++++++.+
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 344555 99999999999999999887666667899999999887777777889999999999999999999999987
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
...+++||||+++++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecccCCcHHHHHhh-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEE
Confidence 4678999999999999999964 23788999999999999999999999999999999999999999999
Q ss_pred eecccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 274 GDFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~ 240 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSP 240 (318)
T ss_dssp CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSH
T ss_pred CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh-CCCccccc
Confidence 999999876554322 22333446778999999998889999999999999999999 78888654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=330.65 Aligned_cols=218 Identities=23% Similarity=0.426 Sum_probs=189.2
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
...++|.+++.||+|+||+||+|.++. +++.||+|++...... .....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHEL----TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETT----TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECC----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 445789999999999999999999876 4778999998754221 1245788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..|+||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~ 158 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICK----------NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIA 158 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTS----------SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEE
Confidence 999999999999999999863 3457889999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|||++......... ....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..++...+..+..
T Consensus 159 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 233 (476)
T 2y94_A 159 DFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC-GTLPFDDDHVPTLFKKICDGIF 233 (476)
T ss_dssp CCSSCEECCTTCCB---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSSCCSSSHHHHHHHHTTCC
T ss_pred eccchhhccccccc---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCCc
Confidence 99999876544322 23346889999999998776 679999999999999999 8999999888888888877653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=314.84 Aligned_cols=233 Identities=35% Similarity=0.582 Sum_probs=187.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCce
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~ 197 (364)
.++|++.+.||+|+||.||+|+++.+.. ...+++|.+.........+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGL--RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTE--EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCc--ccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 3789999999999999999999876321 1245899887655555667789999999999 999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCC------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAET------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
++||||+++++|.+++......... ......+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 9999999999999999863210000 0123468899999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|+|.|..||.+.+..++.+.+..+.
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 99999998743322 122233457789999999988899999999999999999987899999999999999888776
Q ss_pred ccccc
Q psy7023 352 SNEYK 356 (364)
Q Consensus 352 ~~~~~ 356 (364)
..+.+
T Consensus 259 ~~~~~ 263 (327)
T 1fvr_A 259 RLEKP 263 (327)
T ss_dssp CCCCC
T ss_pred CCCCC
Confidence 55443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=332.31 Aligned_cols=226 Identities=24% Similarity=0.439 Sum_probs=189.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+.++|+++++||+|+||+||+|.++. +++.||+|++.... .......+.+|+.++++++||||+++++++.+...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI----TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETT----TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECC----CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 55799999999999999999999876 47789999986432 12234678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCcEEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKV 273 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~---~~~~~kL 273 (364)
.|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKR----------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEE
Confidence 99999999999999999752 3578899999999999999999999999999999999995 5668999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc-
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS- 352 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~- 352 (364)
+|||++........ .....+|+.|+|||++.+ .|+.++|||||||++|+|++ |.+||.+.+..+++..+..+..
T Consensus 166 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 240 (486)
T 3mwu_A 166 IDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETGKYA 240 (486)
T ss_dssp CSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999986654322 223457899999999975 59999999999999999999 8999999999999988876643
Q ss_pred ccccCCCCCC
Q psy7023 353 NEYKVNPPIS 362 (364)
Q Consensus 353 ~~~~~~~~~s 362 (364)
...+.|..+|
T Consensus 241 ~~~~~~~~~s 250 (486)
T 3mwu_A 241 FDLPQWRTIS 250 (486)
T ss_dssp SCSGGGGGSC
T ss_pred CCCcccCCCC
Confidence 3444444443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=309.00 Aligned_cols=214 Identities=20% Similarity=0.309 Sum_probs=179.5
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.++|++++.||+|+||+||+|.++. +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD----TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRL 77 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCC----CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeE
Confidence 3689999999999999999999876 477899998865543 33456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 78 ~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRY----------QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp EEEEECCSEEHHHHHHHT----------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEeCCCchHHHHHhh----------hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 999999999999888864 3457888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
++......... .....+++.|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+..+.+..+..
T Consensus 148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 217 (311)
T 4agu_A 148 FARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS-GVPLWPGKSDVDQLYLIRK 217 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred CchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence 99866533222 122345888999999976 568999999999999999999 8999999988877766543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.62 Aligned_cols=215 Identities=21% Similarity=0.363 Sum_probs=186.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.++|++.+.||+|+||+||+|.++. .+..||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKG----TRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCC----CCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 45789999999999999999999876 4667999988754332 246788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEEe
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV---ADDLTVKVG 274 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kL~ 274 (364)
++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~ 151 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHK----------RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLI 151 (277)
T ss_dssp EEEEECCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEeccCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEE
Confidence 9999999999999999752 347888999999999999999999999999999999999 788999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|||++........ .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..++...+..+..
T Consensus 152 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 224 (277)
T 3f3z_A 152 DFGLAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLC-GYPPFSAPTDSEVMLKIREGTF 224 (277)
T ss_dssp CCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCC
T ss_pred ecccceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCC
Confidence 9999976654332 122346888999999865 48999999999999999999 8999999999888888776643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.19 Aligned_cols=215 Identities=20% Similarity=0.365 Sum_probs=183.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH--HHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--EKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
..++|++.+.||+|+||+||+|.++. .+..||+|++....... ....+.+|+.++++++||||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 34789999999999999999999876 46779999986543221 2456889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+++++|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKL----------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECS
T ss_pred EEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEe
Confidence 999999999999999999752 3477889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||++........ ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+..+.+....
T Consensus 153 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 223 (279)
T 3fdn_A 153 FGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRVE 223 (279)
T ss_dssp CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTC
T ss_pred ccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHH-CCCCCCCCcHHHHHHHHHhCC
Confidence 999865443321 22345788999999999999999999999999999999 899999999888888776554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=303.70 Aligned_cols=217 Identities=21% Similarity=0.326 Sum_probs=188.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
..++|++.+.||+|+||+||+|.++. .++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDAD----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeecCCEEEEEEEECC----CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 44789999999999999999999876 46789999886543 3455678889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 158 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRR----------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD 158 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEe
Confidence 999999999999999998752 3577889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+..+.
T Consensus 159 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 231 (294)
T 2rku_A 159 FGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKNE 231 (294)
T ss_dssp CTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTTC
T ss_pred ccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcc
Confidence 9999865433221 222346888999999999899999999999999999999 899999988888777776553
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=307.34 Aligned_cols=218 Identities=22% Similarity=0.288 Sum_probs=177.6
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.+.||+|+||.||+|.++. .++.||+|++.... .....+.+.+|+.++++++||||+++++++..++..
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTV----RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETT----TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcC----CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 689999999999999999999876 47789999987543 334457889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 110 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ----------GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred EEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCc
Confidence 9999999999999999752 357888999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+...+...+......
T Consensus 180 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 253 (309)
T 2h34_A 180 IASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT-GSPPYQGDQLSVMGAHINQAIPR 253 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHH-SSCSSCSCHHHHHHHHHHSCCCC
T ss_pred cCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHH-CCCCCCCchHHHHHHHhccCCCC
Confidence 98765543221 1223346888999999999999999999999999999999 89999988777666666655443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.23 Aligned_cols=215 Identities=22% Similarity=0.360 Sum_probs=173.4
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcC--CcceeEEEEEEe
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFD--THHVVKLYGVVS 192 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~--h~~iv~l~~~~~ 192 (364)
.+...+|++++.||+|+||+||+|.++. +..||+|++.... .....+.+.+|+.+|++++ ||||+++++++.
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-----CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-----CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 3445679999999999999999998654 6779999986543 4555678999999999996 489999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
..+.+|+||| +.+++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++ ++.+|
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKK----------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHC----------SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEE
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEE
Confidence 9999999999 5688999999862 2567788999999999999999999999999999999995 58999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-H
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-----------GVFTSHSDVWSYGVVLWEMATLASQPYQGLS-N 340 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~t~g~~P~~~~~-~ 340 (364)
|+|||+++.+.............+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.. .
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 273 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQ 273 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCCH
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH-CCCcchhhhHH
Confidence 999999987654433333344567999999999865 368889999999999999999 899998653 3
Q ss_pred HHHHHHHh
Q psy7023 341 EQVLNWVK 348 (364)
Q Consensus 341 ~~~~~~i~ 348 (364)
.+.+..+.
T Consensus 274 ~~~~~~~~ 281 (390)
T 2zmd_A 274 ISKLHAII 281 (390)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 34444443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.41 Aligned_cols=213 Identities=24% Similarity=0.399 Sum_probs=182.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
...+|++++.||+|+||+||+|++.. .++.||+|++.... .....+.+.+|+.++++++||||+++++++..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVR----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhhheeeeeEEccCCCEEEEEEEEcc----CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 44679999999999999999999765 47789999986543 2334567899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+. |+|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~---------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D 197 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGD 197 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECC
T ss_pred eEEEEEecCC-CCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEee
Confidence 9999999996 689888864 234678899999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||++...... ....+|+.|+|||++. ...++.++|||||||++|||++ |..||.+.+..+.+..+..+.
T Consensus 198 fG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~ 269 (348)
T 1u5q_A 198 FGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNE 269 (348)
T ss_dssp CTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSC
T ss_pred ccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Confidence 9999765432 2234688999999984 5678999999999999999999 899999888777766665543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=317.21 Aligned_cols=213 Identities=26% Similarity=0.414 Sum_probs=180.8
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
.+...++|++.+.||+|+||+||+|.+++ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRD-----GAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTT-----CCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECC-----CCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34466899999999999999999998653 67899998876543 3456788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSD------LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSC------CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEEC
T ss_pred CeEEEEEEcCCCCcHHHHHhccC------CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999886422 123458899999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
|||++................+++.|+|||++.+..++.++||||||+++|+|+| |+.||.+..+
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~p~~~~~~ 246 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC-ARSAIVQSLP 246 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHH-CCTTCSCSSS
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHh-CCCcccccCc
Confidence 9999976543332222233346788999999998999999999999999999999 8889876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=305.28 Aligned_cols=207 Identities=24% Similarity=0.395 Sum_probs=179.6
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|++++.||+|+||.||+|.++. +++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV----TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT----TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC----CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 4689999999999999999999876 467899999876555455678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+++++|.+++.. ...++...+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||+
T Consensus 82 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp EEEECCTTEEGGGGSBT----------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEecCCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCC
Confidence 99999999999998853 33578899999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
+................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~ 213 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSD 213 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH-SSCCCSCSCT
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCch
Confidence 986554333333334456889999999988775 678999999999999999 8999987554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=313.97 Aligned_cols=206 Identities=23% Similarity=0.383 Sum_probs=169.5
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCC--cceeEEEEEEe
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDT--HHVVKLYGVVS 192 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h--~~iv~l~~~~~ 192 (364)
++...+|++++.||+|+||+||+|.++. +..||+|++.... .....+.+.+|+.+++.++| +||+++++++.
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTT-----SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCC-----CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 4566889999999999999999998753 6779999986543 44556788999999999987 89999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
..+..++|||+ .+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ ++.+|
T Consensus 80 ~~~~~~lv~e~-~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~k 147 (343)
T 3dbq_A 80 TDQYIYMVMEC-GNIDLNSWLKK----------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLK 147 (343)
T ss_dssp CSSEEEEEECC-CSEEHHHHHHH----------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEE
T ss_pred eCCEEEEEEeC-CCCCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEE
Confidence 99999999995 58899999975 23577889999999999999999999999999999999997 57899
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-----------GVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
|+|||+++...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+..
T Consensus 148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~ 224 (343)
T 3dbq_A 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII 224 (343)
T ss_dssp ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH-SSCTTTTCC
T ss_pred EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh-CCCcchhhh
Confidence 999999987655443333334457899999999864 668899999999999999999 899998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.13 Aligned_cols=211 Identities=23% Similarity=0.410 Sum_probs=161.3
Q ss_pred cceeEe---ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCC
Q psy7023 120 SKVTIL---DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGN 195 (364)
Q Consensus 120 ~~y~~~---~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~ 195 (364)
++|++. +.||+|+||+||+|.++. +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKK----SNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETT----TCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hccccccCCCccccCCCeEEEEEEECC----CCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 566665 689999999999999876 4778999998653 2356678999999997 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL---TVK 272 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~---~~k 272 (364)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~k 149 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKK----------KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIK 149 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHH----------CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEE
T ss_pred EEEEEEEccCCCcHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEE
Confidence 99999999999999999975 24578899999999999999999999999999999999998766 899
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHH
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS-------NEQVLN 345 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~-------~~~~~~ 345 (364)
|+|||+++........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+ ..++++
T Consensus 150 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 226 (325)
T 3kn6_A 150 IIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS-GQVPFQSHDRSLTCTSAVEIMK 226 (325)
T ss_dssp ECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHH-SSCTTC-------CCCHHHHHH
T ss_pred EeccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCccccccccHHHHHH
Confidence 9999999765443221 122345888999999999999999999999999999999 899998643 346666
Q ss_pred HHhcCc
Q psy7023 346 WVKGKS 351 (364)
Q Consensus 346 ~i~~~~ 351 (364)
.+..+.
T Consensus 227 ~i~~~~ 232 (325)
T 3kn6_A 227 KIKKGD 232 (325)
T ss_dssp HHTTTC
T ss_pred HHHcCC
Confidence 666554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.19 Aligned_cols=209 Identities=24% Similarity=0.367 Sum_probs=174.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN- 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~- 195 (364)
+.++|++++.||+|+||.||+|.++. +++.||+|++.... .....+++.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGR----TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETT----TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ecceEEEeEEeeecCCeEEEEEEECC----CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 45799999999999999999999876 47789999986543 4445678899999999999999999999998653
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 196 -----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 196 -----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
.+|+||||+ +++|.++++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 166 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE 166 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred cccCceEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC
Confidence 469999999 8899999975 24678899999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+.+..+.
T Consensus 167 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i~ 239 (367)
T 1cm8_A 167 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEIM 239 (367)
T ss_dssp EEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred EEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence 999999999865432 223356889999999987 679999999999999999999 899999988877776554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=313.35 Aligned_cols=214 Identities=21% Similarity=0.377 Sum_probs=174.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
..++|+++++||+|+||+||+|.++. .++.||+|++...... .....+.+|+.++++++||||+++++++.+++.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTV----TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT----TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECC----CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34789999999999999999998876 4778999999755432 334567899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-----CCCcE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA-----DDLTV 271 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~-----~~~~~ 271 (364)
.++||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKN----------PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEE
T ss_pred EEEEEecCCC-CHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceE
Confidence 9999999974 999999752 3478889999999999999999999999999999999994 55569
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
||+|||++......... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+..
T Consensus 177 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 177 KIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp EECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred EECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH-CCCCcCCCCHHHHHHHHHH
Confidence 99999999765433221 22234588899999998754 8999999999999999999 8999999888877766643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=307.70 Aligned_cols=205 Identities=22% Similarity=0.302 Sum_probs=169.4
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhc-CCcceeEEEEEE
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAF-DTHHVVKLYGVV 191 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~ 191 (364)
..+.+.++|+++++||+|+||+||+|.++. .++.||+|++.... ......+...|+..+.++ +|+||+++++++
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKE----DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETT----TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECC----CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 345567899999999999999999999876 47789999876532 334445566666666655 999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
.+++..++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAW---------GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHH---------CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCE
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCE
Confidence 9999999999999 67999998762 3458899999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
||+|||++........ .....+|+.|+|||++.+ .++.++|||||||++|||++|..+|+.
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 197 KLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp EECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred EEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999876644322 223346889999999876 799999999999999999995455553
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=312.85 Aligned_cols=206 Identities=21% Similarity=0.398 Sum_probs=174.1
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
..+....++|+++++||+|+||+||+|++. ++.||+|++.... .......+|+.++++++||||+++++++.
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL------NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET------TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEEC------CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 344556689999999999999999999865 5679999987543 33445567999999999999999999998
Q ss_pred eCCc----eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC----------CceecCC
Q psy7023 193 EGNP----TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK----------KFVHRDL 258 (364)
Q Consensus 193 ~~~~----~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~----------~iiHrDl 258 (364)
.... +++||||+++|+|.++++. ..+++..+..++.|++.||+|||+. +|+||||
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dl 157 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKA-----------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCC
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCC
Confidence 7543 6999999999999999975 2378899999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCC-----CCCCchhHHHHHHHHHHHHhCCCC
Q psy7023 259 AARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-----VFTSHSDVWSYGVVLWEMATLASQ 333 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~t~g~~ 333 (364)
||+|||++.++.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|||+| |..
T Consensus 158 kp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~ 236 (322)
T 3soc_A 158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS-RCT 236 (322)
T ss_dssp SGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TBT
T ss_pred ChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHh-CCC
Confidence 999999999999999999999876554433334445678999999999863 45668899999999999999 888
Q ss_pred CCCCC
Q psy7023 334 PYQGL 338 (364)
Q Consensus 334 P~~~~ 338 (364)
||.+.
T Consensus 237 pf~~~ 241 (322)
T 3soc_A 237 AADGP 241 (322)
T ss_dssp TSSSC
T ss_pred CCCCC
Confidence 98754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=306.46 Aligned_cols=225 Identities=20% Similarity=0.379 Sum_probs=187.9
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEe--eCC
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVS--EGN 195 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~ 195 (364)
.++|++++.||+|+||.||+|.++. +++.||+|++.... .....+.+.+|+.++++++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS----DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT----TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred hhheeeehhccCCCCcEEEEEEECC----CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 3689999999999999999999876 47789999987543 4455678999999999999999999999875 467
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEcCCCc
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK-----FVHRDLAARNCMVADDLT 270 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~-----iiHrDlkp~NILl~~~~~ 270 (364)
..++||||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~ 154 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 154 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC
T ss_pred eEEEEEeCCCCCCHHHHHHhhc------ccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC
Confidence 8999999999999999997632 12345788999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||+|||++.......... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..++.+.+..+
T Consensus 155 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i~~~ 231 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIREG 231 (279)
T ss_dssp EEECCCCHHHHC---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT
T ss_pred EEEecCchheeeccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCcccCHHHHHHHHhhc
Confidence 9999999987654332111 11234778999999999899999999999999999999 89999999999998888877
Q ss_pred cccccc
Q psy7023 351 SSNEYK 356 (364)
Q Consensus 351 ~~~~~~ 356 (364)
.....+
T Consensus 232 ~~~~~~ 237 (279)
T 2w5a_A 232 KFRRIP 237 (279)
T ss_dssp CCCCCC
T ss_pred ccccCC
Confidence 654443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=317.33 Aligned_cols=203 Identities=20% Similarity=0.340 Sum_probs=165.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..++|++++.||+|+||+||+|+++. +++.||+|++...... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKL----TKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETT----TCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECC----CCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 34789999999999999999999876 4778999998754322 25677899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--EEEee
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT--VKVGD 275 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~--~kL~D 275 (364)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 92 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~D 161 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNA----------GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161 (361)
T ss_dssp EEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEee
Confidence 9999999999999999752 35788999999999999999999999999999999999987765 99999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSH-SDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
||+++...... ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+...
T Consensus 162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 223 (361)
T 3uc3_A 162 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 223 (361)
T ss_dssp CCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH-SSCSCC----
T ss_pred cCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh-CCCCCCCCcc
Confidence 99987433222 1223346889999999988888665 899999999999999 8999987544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.22 Aligned_cols=212 Identities=23% Similarity=0.392 Sum_probs=181.9
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
+++..++|++.+.||+|+||+||+|.++ +..||+|++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 3455689999999999999999999875 5669999987553 44556789999999999999999999999987
Q ss_pred C--CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCC
Q psy7023 194 G--NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLAARNCMVADDL 269 (364)
Q Consensus 194 ~--~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NILl~~~~ 269 (364)
. ...++||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~ 150 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEG--------TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSC--------SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS
T ss_pred CCCCCeEeeecccCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc
Confidence 6 7889999999999999999852 2335789999999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCC---chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTS---HSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
.++|+|||++...... ...+|+.|+|||++.+..++. ++||||||+++|+|++ |..||.+.+..+....
T Consensus 151 ~~~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~ 222 (271)
T 3kmu_A 151 TARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNMEIGMK 222 (271)
T ss_dssp CEEEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH-CSCTTTTSCHHHHHHH
T ss_pred ceeEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCccccChHHHHHH
Confidence 9999999987643222 234578899999998776555 7999999999999999 8999999888887665
Q ss_pred Hh
Q psy7023 347 VK 348 (364)
Q Consensus 347 i~ 348 (364)
+.
T Consensus 223 ~~ 224 (271)
T 3kmu_A 223 VA 224 (271)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=302.01 Aligned_cols=216 Identities=23% Similarity=0.407 Sum_probs=184.2
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-----HHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-----REKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
+.++|++++.||+|+||.||+|.++. .++.||+|+++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKG----TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE 78 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcC----CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec
Confidence 45789999999999999999999876 4678999988654321 12567889999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL--- 269 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~--- 269 (364)
..+..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEK----------ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSS
T ss_pred CCCeEEEEEeecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCC
Confidence 999999999999999999999752 3578889999999999999999999999999999999999877
Q ss_pred -cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 270 -TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 270 -~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.+..+.
T Consensus 149 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~ 224 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGETKQETLTNIS 224 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHH
T ss_pred CceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH-CCCCCCCcchHHHHHHhH
Confidence 899999999986644322 122346888999999999999999999999999999999 899999988888887776
Q ss_pred cCc
Q psy7023 349 GKS 351 (364)
Q Consensus 349 ~~~ 351 (364)
...
T Consensus 225 ~~~ 227 (283)
T 3bhy_A 225 AVN 227 (283)
T ss_dssp TTC
T ss_pred hcc
Confidence 543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=304.25 Aligned_cols=215 Identities=20% Similarity=0.322 Sum_probs=180.8
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~ 193 (364)
..++.++|++.+.||+|+||+||+|.+.. .++.||+|++..... ...+.+|+.+++.+ +|+|++++++++..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLL----NNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETT----TTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECC----CCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 35677899999999999999999999765 477899998864432 24577899999999 79999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT--- 270 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~--- 270 (364)
....++||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~ 147 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLC---------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNA 147 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTT
T ss_pred CceeEEEEEec-CCCHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCC
Confidence 99999999999 99999999862 335788999999999999999999999999999999999987776
Q ss_pred --EEEeecccccccCcccee-----eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---CH
Q psy7023 271 --VKVGDFGMTRDIYETEYY-----RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL---SN 340 (364)
Q Consensus 271 --~kL~DFg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~---~~ 340 (364)
+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+. ..
T Consensus 148 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~ 226 (298)
T 1csn_A 148 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKAATN 226 (298)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCSCCH
T ss_pred CeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHc-CCCCcchhhcccc
Confidence 999999999866543221 12233456889999999999999999999999999999999 89999874 34
Q ss_pred HHHHHHH
Q psy7023 341 EQVLNWV 347 (364)
Q Consensus 341 ~~~~~~i 347 (364)
.+.+..+
T Consensus 227 ~~~~~~~ 233 (298)
T 1csn_A 227 KQKYERI 233 (298)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 4444444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=315.79 Aligned_cols=215 Identities=24% Similarity=0.381 Sum_probs=188.1
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
..++..++|++++.||+|+||+||+|.++. ++..||+|++.........+.+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKP----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECC----CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 345667899999999999999999999876 4778999999877667777889999999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~k 272 (364)
++..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+|
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~k 172 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 172 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEE
Confidence 99999999999999999999762 2467889999999999999999996 999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
|+|||++....... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..++...+
T Consensus 173 l~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~ 242 (360)
T 3eqc_A 173 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMF 242 (360)
T ss_dssp ECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHH-TSCCSSCCCHHHHHHHH
T ss_pred EEECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Confidence 99999987553322 122346888999999999999999999999999999999 89999988877765543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=304.72 Aligned_cols=224 Identities=36% Similarity=0.647 Sum_probs=182.4
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
...|.+..++|++.+.||+|+||+||+|.++ +..||+|+++... ..+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVI 83 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEET------TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEc------CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4456777789999999999999999999764 5679999987543 346788999999999999999999997
Q ss_pred ee-CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 192 SE-GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 192 ~~-~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
.+ .+..++||||+++++|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 155 (278)
T 1byg_A 84 VEEKGGLYIVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 155 (278)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred EcCCCceEEEEecCCCCCHHHHHHhc--------ccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc
Confidence 54 45789999999999999999762 1223677889999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||+|||++........ ...+++.|+|||++.+..++.++||||||+++|+|+|+|..||...+..++...+..+
T Consensus 156 ~~l~Dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 230 (278)
T 1byg_A 156 AKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230 (278)
T ss_dssp EEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred EEEeecccccccccccc-----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 99999999875543321 2234678999999998899999999999999999998789999999988998888877
Q ss_pred ccccccC
Q psy7023 351 SSNEYKV 357 (364)
Q Consensus 351 ~~~~~~~ 357 (364)
...+.+.
T Consensus 231 ~~~~~~~ 237 (278)
T 1byg_A 231 YKMDAPD 237 (278)
T ss_dssp CCCCCCT
T ss_pred CCCCCcc
Confidence 6554443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=322.52 Aligned_cols=221 Identities=25% Similarity=0.357 Sum_probs=183.1
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
.....+|++.+.||+|+||+||+|.++. +++.||+|++.........+.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKK----TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECC----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 4567899999999999999999999876 477899999986554444567789999999999999999999998655
Q ss_pred --ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCC
Q psy7023 196 --PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV----ADDL 269 (364)
Q Consensus 196 --~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl----~~~~ 269 (364)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 153 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS 153 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGG-------GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE
T ss_pred CCeeEEEEecCCCCCHHHHHHhhh-------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce
Confidence 7899999999999999997521 22348899999999999999999999999999999999999 7788
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccC--------CCCCCchhHHHHHHHHHHHHhCCCCCCCC----
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD--------GVFTSHSDVWSYGVVLWEMATLASQPYQG---- 337 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~t~g~~P~~~---- 337 (364)
.+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 154 ~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t-g~~Pf~~~~~~ 229 (396)
T 4eut_A 154 VYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGP 229 (396)
T ss_dssp EEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH-SSCSEECTTCT
T ss_pred eEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCcc
Confidence 899999999987654432 223456889999999865 457889999999999999999 8999964
Q ss_pred CCHHHHHHHHhcCc
Q psy7023 338 LSNEQVLNWVKGKS 351 (364)
Q Consensus 338 ~~~~~~~~~i~~~~ 351 (364)
....+++..+..+.
T Consensus 230 ~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 230 RRNKEVMYKIITGK 243 (396)
T ss_dssp TTCHHHHHHHHHSC
T ss_pred cchHHHHHHHhcCC
Confidence 23345555555444
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=309.71 Aligned_cols=210 Identities=32% Similarity=0.550 Sum_probs=179.9
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe--eCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS--EGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~ 196 (364)
.++|++++.||+|+||.||+|+++..+...+..||+|++.... ....+.+.+|++++++++||||+++++++. +...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 3699999999999999999999765555578899999987653 445677899999999999999999999886 4567
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRH---------RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHH---------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred EEEEEeecCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence 89999999999999999752 234788999999999999999999999999999999999999999999999
Q ss_pred ccccccCccce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 277 GMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 277 g~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
|++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~ 234 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPS 234 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHh-CCCCCcccc
Confidence 99987654332 223344456788999999998889999999999999999999 778875443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=318.28 Aligned_cols=207 Identities=24% Similarity=0.426 Sum_probs=171.6
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-- 194 (364)
+.++|++++.||+|+||+||+|.++. +++.||+|++.... .....+++.+|+.+|+.++|+||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKN----TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETT----TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECC----CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 45799999999999999999999876 47789999987543 344567889999999999999999999999765
Q ss_pred ---CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 195 ---NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 195 ---~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
...|+||||++ ++|.++++. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKT----------PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHS----------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred CcCCeEEEEEecCC-cCHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCE
Confidence 57999999996 599999974 3457889999999999999999999999999999999999999999
Q ss_pred EEeecccccccCcccee--------------------eeCCCCCCCccccCcccc-cCCCCCCchhHHHHHHHHHHHHh-
Q psy7023 272 KVGDFGMTRDIYETEYY--------------------RKGSRGFLPVRWMAPESL-KDGVFTSHSDVWSYGVVLWEMAT- 329 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~t- 329 (364)
||+|||+++........ .......+|+.|+|||++ ....|+.++|||||||++|||++
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999999876543211 112445678999999986 55669999999999999999996
Q ss_pred ---------CCCCCCCCCC
Q psy7023 330 ---------LASQPYQGLS 339 (364)
Q Consensus 330 ---------~g~~P~~~~~ 339 (364)
++.++|.+.+
T Consensus 249 ~~p~~~~~~~~~p~f~g~~ 267 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSS 267 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSC
T ss_pred ccccccccccccccCCCcc
Confidence 3666666643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=304.83 Aligned_cols=216 Identities=20% Similarity=0.346 Sum_probs=185.0
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.+.++|++.+.||+|+||+||+|.++. .++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRL----TGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred chhccceeeeeccCCCCceEEEEEECC----CCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 356799999999999999999999876 477899999875432 234568899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV---ADDLTVKV 273 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kL 273 (364)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||+ ++++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl 150 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILER----------GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMI 150 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred EEEEEEcCCCccHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEE
Confidence 99999999999999999752 357788999999999999999999999999999999999 78899999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+|||++........ ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++.+.+..+..
T Consensus 151 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 224 (304)
T 2jam_A 151 TDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYEETESKLFEKIKEGYY 224 (304)
T ss_dssp CSCSTTCCCCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHCCC
T ss_pred ccCCcceecCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCCC
Confidence 99999875443211 11235778999999999999999999999999999999 8999999999998888876653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.81 Aligned_cols=210 Identities=17% Similarity=0.284 Sum_probs=171.5
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccc-cccceEEEEcccccCHHH----------HHHHHHHHHHHHhcCCccee
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSL-AEHPCAIKVANENASERE----------KAEFLNEASVMKAFDTHHVV 185 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~-~~~~vaiK~~~~~~~~~~----------~~~~~~E~~il~~l~h~~iv 185 (364)
...++|++++.||+|+||+||+|.++.+... .++.||+|++........ ...+..|+..++.++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456999999999999999999998764322 367899999865432111 11234566677788999999
Q ss_pred EEEEEEeeC----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 186 KLYGVVSEG----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 186 ~l~~~~~~~----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
++++++... ...|+||||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~ 181 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---------NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKAS 181 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHH
Confidence 999998764 4589999999 9999999986 2346889999999999999999999999999999999
Q ss_pred CEEEc--CCCcEEEeecccccccCccceeee-----CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy7023 262 NCMVA--DDLTVKVGDFGMTRDIYETEYYRK-----GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334 (364)
Q Consensus 262 NILl~--~~~~~kL~DFg~a~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P 334 (364)
|||++ .++.+||+|||+++.+........ .....+|+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~P 260 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT-GHLP 260 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SCCT
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh-CCCC
Confidence 99999 889999999999986654332211 123347889999999999999999999999999999999 8999
Q ss_pred CCC
Q psy7023 335 YQG 337 (364)
Q Consensus 335 ~~~ 337 (364)
|.+
T Consensus 261 f~~ 263 (364)
T 3op5_A 261 WED 263 (364)
T ss_dssp TGG
T ss_pred ccc
Confidence 985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=312.68 Aligned_cols=213 Identities=21% Similarity=0.327 Sum_probs=183.5
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC----
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG---- 194 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~---- 194 (364)
..+|++++.||+|+||.||+|.++. .+..||+|++.........+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL----NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECC----CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 4799999999999999999999876 47789999998766666678899999999999999999999999754
Q ss_pred -CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 195 -NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 195 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
...|+||||++ ++|.++++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred cceEEEEEcccC-cCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEE
Confidence 46899999996 599999865 24788899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceee-eCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 274 GDFGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+|||++.......... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+.+..+.
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH-SSCSSCCSSGGGHHHHHH
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH-CCCCCCCCChHHHHHHHH
Confidence 9999998665433222 12334578899999987654 48999999999999999999 899999988888777664
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.53 Aligned_cols=215 Identities=21% Similarity=0.322 Sum_probs=175.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH----HHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER----EKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
..++|++++.||+|+||.||+|.++. +++.||+|++....... ....+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC----CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 34789999999999999999999876 46789999987543221 12467899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl 153 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKD---------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL 153 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTT---------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCceEEEEEcCCC-CHHHHHHh---------cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEE
Confidence 9999999999976 89998865 2234667789999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+|||+++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+.+..+..
T Consensus 154 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~~~~~~~~~~~~~~i~~ 227 (346)
T 1ua2_A 154 ADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFE 227 (346)
T ss_dssp CCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred EecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHH
Confidence 99999987654322 22334568899999999764 48899999999999999999 8999999988887776654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=312.49 Aligned_cols=216 Identities=23% Similarity=0.371 Sum_probs=180.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEee----
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSE---- 193 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~---- 193 (364)
.++|++++.||+|+||+||+|+++. +++.||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK----TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT----TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccceeEEEEEecCCCcEEEEEEECC----CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 3799999999999999999999876 477899998865432 2224567789999999999999999999986
Q ss_pred ----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 194 ----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 194 ----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
.+..++||||+++ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~ 161 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSN---------VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 161 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred cccCCceEEEEEeccCC-CHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC
Confidence 4568999999975 88888864 234588899999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCccc--eeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 270 TVKVGDFGMTRDIYETE--YYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
.+||+|||+++...... .........+|+.|+|||++.+ ..++.++|||||||++|+|+| |.+||.+.+..+.+..
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~ 240 (351)
T 3mi9_A 162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 240 (351)
T ss_dssp CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence 99999999998654322 1122234456889999999876 457999999999999999999 8999999998888877
Q ss_pred Hhc
Q psy7023 347 VKG 349 (364)
Q Consensus 347 i~~ 349 (364)
+.+
T Consensus 241 i~~ 243 (351)
T 3mi9_A 241 ISQ 243 (351)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=318.55 Aligned_cols=214 Identities=19% Similarity=0.284 Sum_probs=184.6
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc------CCcceeEEE
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF------DTHHVVKLY 188 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l------~h~~iv~l~ 188 (364)
.+.+..+|++++.||+|+||+||+|.++. .++.||+|++... ......+.+|+.+++.+ .|+||++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~----~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHK----VHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETT----TTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECC----CCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 35677899999999999999999999876 4778999998753 34456777899988888 566999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
+++...+..++||||+. ++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~ 236 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKN--------KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ 236 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC
Confidence 99999999999999995 6999999863 23457889999999999999999999999999999999999998
Q ss_pred Cc--EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 269 LT--VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 269 ~~--~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
+. +||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+.+..
T Consensus 237 ~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~l~~ 310 (429)
T 3kvw_A 237 GRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT-GYPLLPGEDEGDQLAC 310 (429)
T ss_dssp TSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred CCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 87 9999999997544322 23356888999999999999999999999999999999 8999999998888776
Q ss_pred Hhc
Q psy7023 347 VKG 349 (364)
Q Consensus 347 i~~ 349 (364)
+.+
T Consensus 311 i~~ 313 (429)
T 3kvw_A 311 MIE 313 (429)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.16 Aligned_cols=214 Identities=25% Similarity=0.443 Sum_probs=181.2
Q ss_pred ccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEE
Q psy7023 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYG 189 (364)
Q Consensus 110 ~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~ 189 (364)
+.....+...++|++.+.||+|+||+||+|.+++ +..||+|++...........+.+|+.+++.++||||+++++
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-----GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-----SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecC-----CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3445566677899999999999999999997553 67899999986554444446889999999999999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEc
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK---KFVHRDLAARNCMVA 266 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~---~iiHrDlkp~NILl~ 266 (364)
++...+..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ ||+||||||+|||++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERP------ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCS------TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence 9999999999999999999999998633 1334588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 267 DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 267 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
+++.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 236 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 236 (326)
T ss_dssp TTCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH-CCCSBC
T ss_pred CCCCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh-CCCccc
Confidence 99999999999998665433222 223346889999999998889999999999999999999 899995
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=312.69 Aligned_cols=212 Identities=22% Similarity=0.322 Sum_probs=174.3
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN- 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~- 195 (364)
+.++|++++.||+|+||+||+|.++. .++.||+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAI----LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred hhhheeEeeeeEecCCEEEEEEEECC----CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 45799999999999999999998876 46789999987543 3445677889999999999999999999997654
Q ss_pred -----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 196 -----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 196 -----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
..|+||||+++ +|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~~------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC
T ss_pred cccccceEEEEEcCCC-CHHHHHhh------------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC
Confidence 68999999964 88888852 3677889999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.+.
T Consensus 166 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~ 241 (371)
T 2xrw_A 166 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKVIEQ 241 (371)
T ss_dssp EEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHC-
T ss_pred EEEEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Confidence 99999999986543321 223356888999999999999999999999999999999 89999999888877766543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=302.59 Aligned_cols=212 Identities=22% Similarity=0.395 Sum_probs=159.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++.+.||+|+||.||+|.+.. .++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH----TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc----CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 679999999999999999999865 4778999998643211 1236788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||
T Consensus 87 ~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKN---------RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp EEEEECCTTEEHHHHHHT---------CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeec
Confidence 999999999999999975 23467889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.+..+
T Consensus 158 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~ 224 (278)
T 3cok_A 158 LATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI-GRPPFDTDTVKNTLNKV 224 (278)
T ss_dssp TCEECC------------------------------CTHHHHHHHHHHHHHH-SSCSSCCCSCC-----C
T ss_pred ceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCChhHHHHHHHH
Confidence 99765433221 122345788999999999889999999999999999999 89999876655555444
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=299.58 Aligned_cols=214 Identities=20% Similarity=0.345 Sum_probs=185.2
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH--HHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER--EKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
..++|++.+.||+|+||.||+|.++. .+..||+|++....... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQ----NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhceeeheecCCCCeEEEEEEEcC----CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 34789999999999999999999876 46789999986432111 2356889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+|||++.++.+||+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~D 157 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKH----------GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIAD 157 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEec
Confidence 999999999999999999762 2477889999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
||++....... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+...
T Consensus 158 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 227 (284)
T 2vgo_A 158 FGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV-GMPPFDSPSHTETHRRIVNV 227 (284)
T ss_dssp CTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT
T ss_pred ccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHH-CCCCCCCCCHhHHHHHHhcc
Confidence 99986554322 122346889999999999999999999999999999999 89999998888887777654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=307.50 Aligned_cols=214 Identities=21% Similarity=0.302 Sum_probs=178.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
..++|++++.||+|+||.||+|.++. +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKD----TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETT----TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECC----CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 45799999999999999999999876 47789999876543 34445678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 99 ~~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Df 168 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF----------PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDF 168 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS----------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecCCcchHHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeC
Confidence 9999999999888887653 345788999999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|++......... .....+++.|+|||++.+. .++.++||||||+++|+|++ |.+||.+.+..+.+..+.
T Consensus 169 g~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 169 GFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp TTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred CCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Confidence 999765543221 2223468889999999875 68999999999999999999 899999988877665543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=297.68 Aligned_cols=213 Identities=30% Similarity=0.533 Sum_probs=172.0
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH---HHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE---REKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
+..++|++.+.||+|+||.||+|.+. +..||+|++...... ...+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK 77 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 44579999999999999999999865 567999998754322 224678899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEEcC---
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK---FVHRDLAARNCMVAD--- 267 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~---iiHrDlkp~NILl~~--- 267 (364)
++..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLSG-----------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHTS-----------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS
T ss_pred CCceEEEEEcCCCCCHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc
Confidence 9999999999999999999842 35788999999999999999999999 999999999999986
Q ss_pred -----CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 268 -----DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 268 -----~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
++.+||+|||++......... ...+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 221 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLA 221 (271)
T ss_dssp SSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH-CCCTTTTSCHHH
T ss_pred cccccCcceEEccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 778999999999765443221 2346889999999999899999999999999999999 899999988877
Q ss_pred HHHHHhcCc
Q psy7023 343 VLNWVKGKS 351 (364)
Q Consensus 343 ~~~~i~~~~ 351 (364)
....+....
T Consensus 222 ~~~~~~~~~ 230 (271)
T 3dtc_A 222 VAYGVAMNK 230 (271)
T ss_dssp HHHHHHTSC
T ss_pred HHHhhhcCC
Confidence 776665443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=303.72 Aligned_cols=218 Identities=26% Similarity=0.463 Sum_probs=180.6
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
+...++|++++.||+|+||.||+|.++. ++..||+|++..... .+.+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKE----TGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETT----TCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECC----CCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 4456889999999999999999999876 467899999875432 356788999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 168 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRL---------RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLAD 168 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHH---------HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEEEeecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEee
Confidence 99999999999999999974 234678899999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
||++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 169 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 242 (314)
T 3com_A 169 FGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE-GKPPYADIHPMRAIFMIPTNPP 242 (314)
T ss_dssp CTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCC
T ss_pred cccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC
Confidence 9999765543221 223346888999999999999999999999999999999 8999998887776666555443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=309.44 Aligned_cols=223 Identities=22% Similarity=0.371 Sum_probs=186.6
Q ss_pred cceeeeccceeEe-ceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 113 DSWEVLRSKVTIL-DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 113 ~~~e~~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
...+.+.++|.+. +.||+|+||+||+|.++. +++.||+|++..... ......+.+|+.+++.+ .||||+++++
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKS----TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECC----CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3446678899998 899999999999999876 477899999875432 22356788999999999 4699999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-- 267 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-- 267 (364)
++...+..++||||+++|+|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLP--------ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSS--------CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC
Confidence 99999999999999999999998854 12356888999999999999999999999999999999999998
Q ss_pred -CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 268 -DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 268 -~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
++.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 244 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT-HTSPFVGEDNQETYLN 244 (327)
T ss_dssp TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred CCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHH
Confidence 78999999999986654322 122346889999999999999999999999999999999 8999999998888777
Q ss_pred HhcCc
Q psy7023 347 VKGKS 351 (364)
Q Consensus 347 i~~~~ 351 (364)
+....
T Consensus 245 i~~~~ 249 (327)
T 3lm5_A 245 ISQVN 249 (327)
T ss_dssp HHHTC
T ss_pred HHhcc
Confidence 66543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=308.93 Aligned_cols=229 Identities=23% Similarity=0.405 Sum_probs=167.3
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.|.+..++|++.+.||+|+||.||+|.+.. .+..||+|++.........+++.+|+.++++++||||+++++++..
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAP----KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC--------CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred ccccchhhhhhhheeccccceEEEEEEECC----CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 456677899999999999999999998765 4678999998765545556778899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+..++||||+++++|.+++........ .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGE--HKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTT--TTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 9999999999999999999975321111 12345789999999999999999999999999999999999999999999
Q ss_pred eecccccccCcccee---eeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 274 GDFGMTRDIYETEYY---RKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+|||++......... .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+.+.....
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 241 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT-GAAPYHKYPPMKVLMLTLQ 241 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGHHHHHHT
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh-CCCCCccCchhhHHHHHhc
Confidence 999998765432211 11223346888999999876 568999999999999999999 8999998777666554443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=303.02 Aligned_cols=220 Identities=21% Similarity=0.307 Sum_probs=181.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC---HHHHHHHHHHHHHHHhcCCcceeEEEEEE--e
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS---EREKAEFLNEASVMKAFDTHHVVKLYGVV--S 192 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~--~ 192 (364)
+.++|++++.||+|+||.||+|.++. .+..||+|+++.... ......+.+|+.+++.++||||+++++++ .
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE----TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT----TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred cccceeEeeEEecCCCeEEEEEEECC----CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 45789999999999999999998765 467899999875431 22356788999999999999999999998 4
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+....++||||++++ |.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSV--------PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHS--------TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred CCCeEEEEehhccCC-HHHHHHhC--------cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEE
Confidence 556899999999875 88888762 334678899999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
|+|||++................+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..++.+.+..+
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i~~~ 228 (305)
T 2wtk_C 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT-GLYPFEGDNIYKLFENIGKG 228 (305)
T ss_dssp ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHC
T ss_pred eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHHHhcC
Confidence 99999998665332222223345688999999997644 3779999999999999999 89999999888888887765
Q ss_pred c
Q psy7023 351 S 351 (364)
Q Consensus 351 ~ 351 (364)
.
T Consensus 229 ~ 229 (305)
T 2wtk_C 229 S 229 (305)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=304.66 Aligned_cols=218 Identities=26% Similarity=0.432 Sum_probs=180.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
...++|++++.||+|+||.||+|.++. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKE----TGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETT----TCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred CCccceeecceeccCCCeEEEEEEEcC----CCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 456899999999999999999999876 467899999865432 235678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+||
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 161 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLEL---------DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF 161 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEEC
Confidence 99999999999999998752 345788999999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccc-----cCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESL-----KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
|++........ ......+++.|+|||++ .+..++.++||||||+++|+|++ |..||...+..+.+..+..+.
T Consensus 162 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 238 (302)
T 2j7t_A 162 GVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSD 238 (302)
T ss_dssp HHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSC
T ss_pred CCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc-CCCCCccCCHHHHHHHHhccC
Confidence 98754322211 11223467889999998 46678999999999999999999 899999988887776665544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=306.50 Aligned_cols=206 Identities=20% Similarity=0.340 Sum_probs=169.1
Q ss_pred eccceeEe-ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTIL-DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~ 195 (364)
+.++|++. +.||+|+||+||+|.++. +++.||+|++..... .....+.+|+++++++ +||||+++++++.+++
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLI----TSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSS----SCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cceeEEecCceecCCceEEEEEEEEcC----CCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 45788885 789999999999998765 477899999875432 2346788999999985 7999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---EE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT---VK 272 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~---~k 272 (364)
..|+||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~k 154 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKR----------RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVK 154 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEE
T ss_pred EEEEEEEcCCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceE
Confidence 999999999999999999762 35778899999999999999999999999999999999998776 99
Q ss_pred EeecccccccCccce-----eeeCCCCCCCccccCcccccC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 273 VGDFGMTRDIYETEY-----YRKGSRGFLPVRWMAPESLKD-----GVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 273 L~DFg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
|+|||++........ ........+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.+
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~ 230 (316)
T 2ac3_A 155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS-GYPPFVGRC 230 (316)
T ss_dssp ECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH-SSCSCCCCC
T ss_pred EEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHH-CCCCCcccc
Confidence 999999876543211 111122346889999999975 558899999999999999999 899998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=302.39 Aligned_cols=216 Identities=23% Similarity=0.347 Sum_probs=184.7
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc------eeE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH------VVK 186 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~------iv~ 186 (364)
...+.+.++|++++.||+|+||+||+|.+... .++.||+|+++.. ....+.+.+|+.+++.++|++ +++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKA---GGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTT---TTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCC---CCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 34567889999999999999999999987431 3678999998653 344577889999999997765 999
Q ss_pred EEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 187 l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
+++++...+..++||||+ +++|.+++... ...++++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 152 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKEN--------GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFV 152 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhc--------CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 999999999999999999 88999999862 234578899999999999999999999999999999999998
Q ss_pred C-------------------CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHH
Q psy7023 267 D-------------------DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEM 327 (364)
Q Consensus 267 ~-------------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el 327 (364)
. ++.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (339)
T 1z57_A 153 QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227 (339)
T ss_dssp CCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred ccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence 7 668999999999764432 1233568899999999999999999999999999999
Q ss_pred HhCCCCCCCCCCHHHHHHHHh
Q psy7023 328 ATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 328 ~t~g~~P~~~~~~~~~~~~i~ 348 (364)
++ |..||...+..+.+..+.
T Consensus 228 ~~-g~~pf~~~~~~~~~~~~~ 247 (339)
T 1z57_A 228 YL-GFTVFPTHDSKEHLAMME 247 (339)
T ss_dssp HH-SSCSCCCSCHHHHHHHHH
T ss_pred Hh-CCCCCCCCChHHHHHHHH
Confidence 99 899999988887776554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=301.25 Aligned_cols=203 Identities=18% Similarity=0.334 Sum_probs=171.8
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEee--C
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSE--G 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~--~ 194 (364)
..++|++++.||+|+||+||+|.++. .++.||+|+++... .+.+.+|+.+++.++ ||||+++++++.+ .
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT----NNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECC----CCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 34789999999999999999999876 47789999987533 356789999999997 9999999999987 6
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEE
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-TVKV 273 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kL 273 (364)
...++||||+++++|.++++. ++...+..++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl 172 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT-------------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 172 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG-------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred CceEEEEeccCchhHHHHHHh-------------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEE
Confidence 788999999999999998753 56788999999999999999999999999999999999776 8999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHH
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPY-QGLSNEQVLN 345 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~-~~~~~~~~~~ 345 (364)
+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+.+.
T Consensus 173 ~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~l~ 242 (330)
T 3nsz_A 173 IDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLV 242 (330)
T ss_dssp CCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCCSSHHHHHH
T ss_pred EeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHh-CCCCcccCCchHHHHH
Confidence 99999986554332 223346788999999987 668999999999999999999 77777 4444444443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=317.32 Aligned_cols=208 Identities=19% Similarity=0.290 Sum_probs=172.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc---CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEee
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSE 193 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~ 193 (364)
..++|++++.||+|+||+||+|++... ...++.||+|+++... .......+.+|+++++.+ .||||+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISG-HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSS-TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEccc-CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 347999999999999999999987532 1247889999987532 112234566799999999 69999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR----------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEE
Confidence 99999999999999999999752 35778899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...
T Consensus 201 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~ 265 (355)
T 1vzo_A 201 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVD 265 (355)
T ss_dssp SCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCT
T ss_pred eeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH-CCCCCccC
Confidence 999999865433221 1223346889999999986 347899999999999999999 89999743
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=313.41 Aligned_cols=214 Identities=23% Similarity=0.391 Sum_probs=166.5
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
..|++ .++|++++.||+|+||.||+|.++. +++.||+|++.... ......++.+|+.+++.++||||+++++++
T Consensus 23 ~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 97 (367)
T 2fst_X 23 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTK----TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 97 (367)
T ss_dssp EEEEE-ETTEEEEEECC----CCEEEEEETT----TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred cccCC-CCceEEeeEEeecCCeEEEEEEECC----CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34443 4799999999999999999998876 57789999987543 445567888999999999999999999998
Q ss_pred eeC------CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7023 192 SEG------NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265 (364)
Q Consensus 192 ~~~------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl 265 (364)
... ...|+|+|++ +++|.++++. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll 165 (367)
T 2fst_X 98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165 (367)
T ss_dssp CSCSSGGGCCCCEEEEECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred ecCCccccCCeEEEEeccc-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE
Confidence 653 5689999999 7899988853 357889999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 266 ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 266 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+.+
T Consensus 166 ~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l 239 (367)
T 2fst_X 166 NEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQL 239 (367)
T ss_dssp CTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHH
T ss_pred CCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence 99999999999999865432 222346888999999987 678999999999999999999 89999999887777
Q ss_pred HHHhc
Q psy7023 345 NWVKG 349 (364)
Q Consensus 345 ~~i~~ 349 (364)
..+.+
T Consensus 240 ~~i~~ 244 (367)
T 2fst_X 240 KLILR 244 (367)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 66543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=299.45 Aligned_cols=218 Identities=22% Similarity=0.345 Sum_probs=167.1
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHH-HHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE-FLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
+++..++|++++.||+|+||+||+|.++. .++.||+|++..........+ +.++...++.++||||+++++++.+
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVP----SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecC----CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 45677899999999999999999999876 477899999986654444444 4455556888899999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~~~k 272 (364)
++..++||||++ |+|.+++.... .....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+|
T Consensus 78 ~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~k 150 (290)
T 3fme_A 78 EGDVWICMELMD-TSLDKFYKQVI------DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVK 150 (290)
T ss_dssp SSSEEEEEECCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEE
T ss_pred cCCEEEEEehhc-cchHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEE
Confidence 999999999997 59988876421 1345688999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccc----cCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL----KDGVFTSHSDVWSYGVVLWEMATLASQPYQG-LSNEQVLNWV 347 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~el~t~g~~P~~~-~~~~~~~~~i 347 (364)
|+|||++......... ....+++.|+|||++ .+..++.++||||||+++|+|+| |..||.. ....+.+..+
T Consensus 151 l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~ 226 (290)
T 3fme_A 151 MCDFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGTPFQQLKQV 226 (290)
T ss_dssp BCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH-TSCSSCCCSCHHHHHHHH
T ss_pred EeecCCcccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH-CCCCccccCchHHHHHHH
Confidence 9999999766543221 222467889999996 55668899999999999999999 8899985 3444444333
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=297.56 Aligned_cols=218 Identities=23% Similarity=0.440 Sum_probs=180.8
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.+..++|++.+.||+|+||.||+|.++. .++.||+|++...... ...+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQL----TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECC----CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 4456899999999999999999999875 4778999998653211 124578899999999999999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+..++||||+++++|.+++... ..++...+..++.||+.||+|||++||+|+||||+|||++.++.+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l 152 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH----------GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKI 152 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEE
Confidence 99999999999999999999752 34678899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+|||++......... ....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..++.+.+..+.
T Consensus 153 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 227 (276)
T 2h6d_A 153 ADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC-GTLPFDDEHVPTLFKKIRGGV 227 (276)
T ss_dssp CCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred eecccccccCCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc
Confidence 999999876543321 22345788999999988776 579999999999999999 899999988888888877654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=317.80 Aligned_cols=210 Identities=22% Similarity=0.295 Sum_probs=171.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC---
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG--- 194 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--- 194 (364)
...+|++++.||+|+||+||+|+++. +++.||||++..... ...+|+++|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCD----SGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECC----CCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 34589999999999999999999876 467899998865421 234699999999999999999998532
Q ss_pred ---CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-Cc
Q psy7023 195 ---NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD-LT 270 (364)
Q Consensus 195 ---~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~-~~ 270 (364)
..+++||||+++ +|.+.+.... .....+++..+..++.||+.||+|||++||+||||||+||||+.+ +.
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~ 195 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYS------RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTE
T ss_pred CcceeEEeehhcccc-cHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCe
Confidence 236799999975 7777765421 123567889999999999999999999999999999999999955 67
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
+||+|||+++....... .....+|+.|+|||++.+. .|+.++|||||||++|||++ |++||.+.+..+.+..+
T Consensus 196 ~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~l~~i 269 (420)
T 1j1b_A 196 LKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEI 269 (420)
T ss_dssp EEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred EEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 89999999986644322 1233568899999999765 68999999999999999999 89999998876665544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=310.65 Aligned_cols=209 Identities=20% Similarity=0.336 Sum_probs=177.8
Q ss_pred ccccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC--------C
Q psy7023 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD--------T 181 (364)
Q Consensus 110 ~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~--------h 181 (364)
......+.+.++|+++++||+|+||+||+|++.. +++.||+|++... ....+.+.+|+.+++.++ |
T Consensus 27 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~ 100 (397)
T 1wak_A 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ----GKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNR 100 (397)
T ss_dssp CSSCTTCEETTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred eEEehhhhcCCeEEEEEEeeecCCeeEEEEEecC----CCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCc
Confidence 3444556788999999999999999999998876 4778999998753 344577889999999996 7
Q ss_pred cceeEEEEEEe----eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-Cceec
Q psy7023 182 HHVVKLYGVVS----EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHR 256 (364)
Q Consensus 182 ~~iv~l~~~~~----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHr 256 (364)
+||+++++++. .....++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ ||+||
T Consensus 101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr 171 (397)
T 1wak_A 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--------NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171 (397)
T ss_dssp GGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC
T ss_pred ceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 78999999987 556899999999 66888877652 234588899999999999999999998 99999
Q ss_pred CCCCCCEEEcCCC-------------------------------------------------cEEEeecccccccCccce
Q psy7023 257 DLAARNCMVADDL-------------------------------------------------TVKVGDFGMTRDIYETEY 287 (364)
Q Consensus 257 Dlkp~NILl~~~~-------------------------------------------------~~kL~DFg~a~~~~~~~~ 287 (364)
||||+|||++.++ .+||+|||++......
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-- 249 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-- 249 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--
Confidence 9999999999775 7999999999865433
Q ss_pred eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 288 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
.....+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+.+
T Consensus 250 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 297 (397)
T 1wak_A 250 ---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELAT-GDYLFEPHS 297 (397)
T ss_dssp ---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCCC
T ss_pred ---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhh-CCCCCCCCc
Confidence 223356889999999999999999999999999999999 899998655
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=307.53 Aligned_cols=217 Identities=21% Similarity=0.366 Sum_probs=185.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-------HHHHHHHHHHHHHHHhc-CCcceeEEE
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-------EREKAEFLNEASVMKAF-DTHHVVKLY 188 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~il~~l-~h~~iv~l~ 188 (364)
.+.++|++.+.||+|+||.||+|.++. +++.||||++..... ....+.+.+|+.+++++ +||||++++
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRA----TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECC----CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 345789999999999999999999875 477899999865431 12245678999999999 899999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
+++...+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++++
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK----------VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999999999999999999999752 357888999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD------GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
+.+||+|||++..+..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~ 312 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQIL 312 (365)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH-CCCCCCCCCHHH
Confidence 9999999999987654332 223456889999999863 358899999999999999999 899999988888
Q ss_pred HHHHHhcCc
Q psy7023 343 VLNWVKGKS 351 (364)
Q Consensus 343 ~~~~i~~~~ 351 (364)
.+..+..+.
T Consensus 313 ~~~~i~~~~ 321 (365)
T 2y7j_A 313 MLRMIMEGQ 321 (365)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHHhCC
Confidence 888776554
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=313.91 Aligned_cols=213 Identities=23% Similarity=0.317 Sum_probs=174.2
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE-- 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-- 193 (364)
+....+|++++.||+|+||+||+|.++. +++.||+|++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~----~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE----SGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTG 73 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETT----TCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECC----CCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecC
Confidence 4556899999999999999999999876 4778999988654321 2369999999999999999999843
Q ss_pred ------------------------------------CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHH
Q psy7023 194 ------------------------------------GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237 (364)
Q Consensus 194 ------------------------------------~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i 237 (364)
....++||||++ ++|.+.+.... .....+++..+..+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~l~~~~~~~i 146 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI------RSGRSIPMNLISIY 146 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHH------HTTCCCCHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH------hcCCCCCHHHHHHH
Confidence 334889999997 58888876421 13456888999999
Q ss_pred HHHHHHHHHHHHhCCceecCCCCCCEEEc-CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCC-CCCch
Q psy7023 238 AAEVADGMAYLADKKFVHRDLAARNCMVA-DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHS 315 (364)
Q Consensus 238 ~~qil~~L~~LH~~~iiHrDlkp~NILl~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~ 315 (364)
+.||+.||+|||++||+||||||+|||++ +++.+||+|||+++....... .....+++.|+|||++.+.. ++.++
T Consensus 147 ~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 147 IYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence 99999999999999999999999999998 689999999999986654432 22234578899999987754 89999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 316 DVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 316 DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|||||||++|+|++ |++||.+.+..+.+..+.
T Consensus 224 DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~ 255 (383)
T 3eb0_A 224 DLWSIGCVFGELIL-GKPLFSGETSIDQLVRII 255 (383)
T ss_dssp HHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred hhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Confidence 99999999999999 899999988887776654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=300.69 Aligned_cols=223 Identities=35% Similarity=0.609 Sum_probs=178.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
+..++|++++.||+|+||+||+|.++.... ....||+|+++... .....+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTS-CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCC-ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 345799999999999999999998754221 23468999887543 234567889999999999999999999999875
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
. .++||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+|||++.++.+||+
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~ 163 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKH---------QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 163 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHH---------GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred C-ceeeEecccCCCHHHHHHhc---------cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEc
Confidence 4 89999999999999999762 2357788999999999999999999999999999999999999999999
Q ss_pred ecccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 275 DFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 275 DFg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
|||++......... .......+++.|+|||++.+..++.++||||||+++|+|+++|..||.+.+..+++..+...
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 240 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc
Confidence 99999876543322 22223345678999999998889999999999999999999789999999999888877654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.78 Aligned_cols=219 Identities=24% Similarity=0.460 Sum_probs=178.2
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEee-
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSE- 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~- 193 (364)
....++|++++.||+|+||.||+|.+.. .++.||+|++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVK----TGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECC----CCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3456899999999999999999999875 4678999998654332 35688899999999 89999999999976
Q ss_pred -----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 194 -----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 194 -----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
.+..++||||+++++|.+++... ....++...+..++.||+.||+|||++||+|+||||+|||++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC
Confidence 46889999999999999999862 23457888999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~ 343 (364)
+.+||+|||++........ ......+++.|+|||++. +..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~ 242 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRA 242 (326)
T ss_dssp CCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHH
T ss_pred CCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHH
Confidence 9999999999876543321 122234688999999987 5668999999999999999999 8999998888777
Q ss_pred HHHHhcCc
Q psy7023 344 LNWVKGKS 351 (364)
Q Consensus 344 ~~~i~~~~ 351 (364)
+..+....
T Consensus 243 ~~~~~~~~ 250 (326)
T 2x7f_A 243 LFLIPRNP 250 (326)
T ss_dssp HHHHHHSC
T ss_pred HHHhhcCc
Confidence 76665543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.85 Aligned_cols=216 Identities=19% Similarity=0.284 Sum_probs=176.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~ 195 (364)
+.++|++++.||+|+||+||+|.++. +++.||+|++.... ......++.+|+.++..+ +||||+++++++.+.+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRL----DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcC----CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 45789999999999999999999876 47789999987542 334467788999999999 9999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-------
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD------- 268 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~------- 268 (364)
..++||||+++++|.+++.... .....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENY------RIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred eEEEEEEecCCCcHHHHHHhhc------ccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccc
Confidence 9999999999999999997632 122467889999999999999999999999999999999999844
Q ss_pred ------------CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 269 ------------LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 269 ------------~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
..+||+|||.+....... ...+++.|+|||++.+. .++.++||||||+++|+|++ +.+|+
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~~~ 231 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG-AEPLP 231 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT-CCCCC
T ss_pred cccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc-CCCCC
Confidence 479999999998665432 12368889999999876 56689999999999999998 66665
Q ss_pred CCCCHHHHHHHHhcCccc
Q psy7023 336 QGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 336 ~~~~~~~~~~~i~~~~~~ 353 (364)
... +....+..+...
T Consensus 232 ~~~---~~~~~~~~~~~~ 246 (289)
T 1x8b_A 232 RNG---DQWHEIRQGRLP 246 (289)
T ss_dssp SSS---HHHHHHHTTCCC
T ss_pred cch---hHHHHHHcCCCC
Confidence 433 234445444443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=295.95 Aligned_cols=217 Identities=19% Similarity=0.333 Sum_probs=185.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--------CHHHHHHHHHHHHHHHhcC-CcceeEE
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--------SEREKAEFLNEASVMKAFD-THHVVKL 187 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~il~~l~-h~~iv~l 187 (364)
.+.++|++.+.||+|+||.||+|.++. +++.||+|+++... .....+.+.+|+.+++++. ||||+++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhccceeeeecCCCceEEEEEEEcC----cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 356899999999999999999999876 47789999986442 1233567889999999995 9999999
Q ss_pred EEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7023 188 YGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267 (364)
Q Consensus 188 ~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~ 267 (364)
++++...+..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+|||++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEK----------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC
Confidence 99999999999999999999999999752 35788899999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCccceeeeCCCCCCCccccCccccc------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK------DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
++.+||+|||++........ .....+++.|+|||++. ...++.++||||||+++|+|++ |..||.+.+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~ 235 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQM 235 (298)
T ss_dssp TCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHH
T ss_pred CCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH-CCCCCcCccHH
Confidence 99999999999986654322 12234688999999985 4568899999999999999999 89999998888
Q ss_pred HHHHHHhcCc
Q psy7023 342 QVLNWVKGKS 351 (364)
Q Consensus 342 ~~~~~i~~~~ 351 (364)
+....+..+.
T Consensus 236 ~~~~~~~~~~ 245 (298)
T 1phk_A 236 LMLRMIMSGN 245 (298)
T ss_dssp HHHHHHHHTC
T ss_pred HHHHHHhcCC
Confidence 8888776654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=305.76 Aligned_cols=215 Identities=22% Similarity=0.321 Sum_probs=181.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC--
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-- 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-- 194 (364)
.+.++|++.+.||+|+||+||+|.++. +++.||+|++...........+.+|+.+++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKP----TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECC----CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 356899999999999999999999876 47789999997666666677889999999999999999999988654
Q ss_pred ---CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 195 ---NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 195 ---~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
...++||||+. ++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~ 151 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-----------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDL 151 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE
T ss_pred CccceEEEEEeccC-ccHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcE
Confidence 67899999996 599999875 247888999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceee--------eCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 272 KVGDFGMTRDIYETEYYR--------KGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
||+|||++.......... ......+|+.|+|||++.. ..++.++|||||||++|+|++ |.+||.+.+..+
T Consensus 152 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~ 230 (353)
T 2b9h_A 152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRH 230 (353)
T ss_dssp EECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHH
T ss_pred EEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Confidence 999999998665332111 1122356889999998765 678999999999999999999 899999988777
Q ss_pred HHHHHh
Q psy7023 343 VLNWVK 348 (364)
Q Consensus 343 ~~~~i~ 348 (364)
.+..+.
T Consensus 231 ~~~~~~ 236 (353)
T 2b9h_A 231 QLLLIF 236 (353)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 665543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=299.10 Aligned_cols=221 Identities=21% Similarity=0.387 Sum_probs=174.1
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
...+|++.+.||+|+||.||+|.+.. .+..||+|++... ........+.+|+.++++++||||+++++++...+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLL----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETT----TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceEEEEeecCCCCceEEEEEEcC----CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 44689999999999999999999875 4678999998742 34555678899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+++++|.+++.... .....++...++.++.|++.||.|||++||+|+||||+|||++.++.+||+|
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFK------KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred cEEEEEecCCCCCHHHHHHHhc------ccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEe
Confidence 9999999999999999997532 1234578899999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL--SNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~--~~~~~~~~i~~~~ 351 (364)
||++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+. +..++...+..+.
T Consensus 180 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 254 (310)
T 2wqm_A 180 LGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQCD 254 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTC---CCHHHHHHHHHTTC
T ss_pred ccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccchhHHHHHHHhhccc
Confidence 9998765443221 122345788999999999999999999999999999999 78888653 3445556665544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=294.15 Aligned_cols=214 Identities=24% Similarity=0.419 Sum_probs=179.6
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee----
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE---- 193 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~---- 193 (364)
...|++.+.||+|+||+||+|.+.. .+..||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE----TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC----CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 3568999999999999999999876 46789999887543 45556788999999999999999999999875
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEc-CCCc
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLAARNCMVA-DDLT 270 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NILl~-~~~~ 270 (364)
....++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+|+||||+|||++ +++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~ 170 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS 170 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC
T ss_pred CceEEEEEEecCCCCHHHHHHHc----------cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC
Confidence 45689999999999999999752 35678899999999999999999999 99999999999998 7899
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhc
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG-LSNEQVLNWVKG 349 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~-~~~~~~~~~i~~ 349 (364)
+||+|||++......... ...+++.|+|||++. +.++.++||||||+++|+|++ |..||.+ .+..+....+..
T Consensus 171 ~kl~Dfg~~~~~~~~~~~----~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 171 VKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp EEECCTTGGGGCCTTSBE----ESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHTT
T ss_pred EEEeeCCCcccccccccc----cccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHh-CCCCCCCcCcHHHHHHHHhc
Confidence 999999999755443222 123578899999887 458999999999999999999 8899987 455666666665
Q ss_pred Ccc
Q psy7023 350 KSS 352 (364)
Q Consensus 350 ~~~ 352 (364)
+..
T Consensus 245 ~~~ 247 (290)
T 1t4h_A 245 GVK 247 (290)
T ss_dssp TCC
T ss_pred cCC
Confidence 543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=296.41 Aligned_cols=205 Identities=28% Similarity=0.496 Sum_probs=171.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH---HHH---HHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE---REK---AEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~---~~~---~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
...++|++.+.||+|+||+||+|.++. .++.||+|++...... ... +.+.+|+.++++++||||++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVK----DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETT----TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcC----CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 345799999999999999999999876 4778999998644321 111 678899999999999999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCC
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLAARNCMVADD 268 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NILl~~~ 268 (364)
+.+.. ++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~ 160 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLD---------KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL 160 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC
T ss_pred ecCCC--eEEEEecCCCCHHHHHhc---------ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc
Confidence 97644 799999999999999875 3346888999999999999999999999 9999999999999887
Q ss_pred Cc-----EEEeecccccccCccceeeeCCCCCCCccccCccccc--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 269 LT-----VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK--DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 269 ~~-----~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
+. +||+|||+++...... ....+++.|+|||++. ...++.++||||||+++|+|++ |..||...+..
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 234 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYG 234 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSSCE-----ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH-SSCTTTTCCCC
T ss_pred CCCCceeEEeCCCCccccccccc-----cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc-CCCCCcccccc
Confidence 76 9999999997544322 1234578899999994 4557889999999999999999 89999876544
Q ss_pred H
Q psy7023 342 Q 342 (364)
Q Consensus 342 ~ 342 (364)
+
T Consensus 235 ~ 235 (287)
T 4f0f_A 235 K 235 (287)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=303.30 Aligned_cols=211 Identities=32% Similarity=0.574 Sum_probs=178.1
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC-
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG- 194 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~- 194 (364)
.....+|++++.||+|+||.||+|++...+...+..||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 3445789999999999999999998754444468899999987654 34567889999999999999999999998754
Q ss_pred -CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 195 -NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 195 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL 186 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKH---------KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHS---------TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred CCceEEEEECCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEE
Confidence 3789999999999999999862 235788899999999999999999999999999999999999999999
Q ss_pred eecccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 274 GDFGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
+|||++......... .......++..|+|||++.+..++.++||||||+++|+|+| |..||..
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~~~~~ 250 (326)
T 2w1i_A 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKS 250 (326)
T ss_dssp CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHH-TTCGGGS
T ss_pred ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHh-cCCCCCC
Confidence 999999876544322 22333445778999999998889999999999999999999 7777753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=301.16 Aligned_cols=218 Identities=21% Similarity=0.322 Sum_probs=184.6
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc------ee
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH------VV 185 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~------iv 185 (364)
....+.+.++|++++.||+|+||+||+|.++... +..||+|+++.. ....+.+.+|+.+++.++|++ ++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARG---KSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTT---TEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCC---ceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 3445667899999999999999999999987532 367999998753 344567888999999998765 89
Q ss_pred EEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy7023 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV 265 (364)
Q Consensus 186 ~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl 265 (364)
.+++++...+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll 156 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKEN--------NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 9999999999999999999 67888888752 23467889999999999999999999999999999999999
Q ss_pred -------------------cCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHH
Q psy7023 266 -------------------ADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWE 326 (364)
Q Consensus 266 -------------------~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e 326 (364)
+.++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 231 (355)
T 2eu9_A 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231 (355)
T ss_dssp SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred ecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHH
Confidence 567899999999997543322 23356889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 327 MATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 327 l~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
|++ |..||.+.+..+.+..+..
T Consensus 232 l~~-g~~pf~~~~~~~~~~~~~~ 253 (355)
T 2eu9_A 232 YYR-GFTLFQTHENREHLVMMEK 253 (355)
T ss_dssp HHH-SSCSCCCSSHHHHHHHHHH
T ss_pred HHh-CCCCCCCCCHHHHHHHHHH
Confidence 999 8999999888777665543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=318.26 Aligned_cols=217 Identities=19% Similarity=0.337 Sum_probs=171.7
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-------CHHHHHHHHHHHHHHHhcCCcceeEEE
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-------SEREKAEFLNEASVMKAFDTHHVVKLY 188 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~il~~l~h~~iv~l~ 188 (364)
..+.++|.+.+.||+|+||+||+|.++. +++.||+|++.... .......+.+|+.+|++++||||++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 206 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERK----TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETT----TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCC
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECC----CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3456899999999999999999999877 46789999987532 112233578999999999999999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
+++.. +..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 207 NFFDA-EDYYIVLELMEGGELFDKVVG----------NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275 (419)
T ss_dssp EEEES-SEEEEEEECCTTCBGGGGTSS----------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred EEEec-CceEEEEEcCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC
Confidence 99865 568999999999999988753 3467889999999999999999999999999999999999754
Q ss_pred C---cEEEeecccccccCccceeeeCCCCCCCccccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-H
Q psy7023 269 L---TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-E 341 (364)
Q Consensus 269 ~---~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~ 341 (364)
+ .+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+... .
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~ 351 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQV 351 (419)
T ss_dssp SSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH-SSCSSCCCSSSC
T ss_pred CCcceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCcchH
Confidence 4 599999999987654322 123346889999999864 567889999999999999999 8999976543 3
Q ss_pred HHHHHHhcCc
Q psy7023 342 QVLNWVKGKS 351 (364)
Q Consensus 342 ~~~~~i~~~~ 351 (364)
.+.+.+..+.
T Consensus 352 ~~~~~i~~~~ 361 (419)
T 3i6u_A 352 SLKDQITSGK 361 (419)
T ss_dssp CHHHHHHTTC
T ss_pred HHHHHHhcCC
Confidence 4555665554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=321.53 Aligned_cols=214 Identities=13% Similarity=0.104 Sum_probs=166.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc--cCHHHHHHHHHHH---HHHHhcCCcceeEEE---
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEA---SVMKAFDTHHVVKLY--- 188 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~---~il~~l~h~~iv~l~--- 188 (364)
...++|++.+.||+|+||+||+|+++. +++.||+|++... ......+.+.+|+ +++++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQE----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-C----CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred CCCceEEEcceeecCCCEEEEEEEECC----CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence 345789999999999999999999765 4778999998743 2333457788999 555556899999988
Q ss_pred ----EEEeeCC-----------------ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHH
Q psy7023 189 ----GVVSEGN-----------------PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAY 247 (364)
Q Consensus 189 ----~~~~~~~-----------------~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~ 247 (364)
+++...+ ..|+||||+ +|+|.+++.......+ ....+++..++.++.||+.||+|
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS---THKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT---TTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc---ccccccHHHHHHHHHHHHHHHHH
Confidence 7776554 389999999 6799999986432221 12345567888999999999999
Q ss_pred HHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCC-----------CCCCchh
Q psy7023 248 LADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-----------VFTSHSD 316 (364)
Q Consensus 248 LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~D 316 (364)
||++||+||||||+|||++.++.+||+|||+++...... ....+ +.|+|||++.+. .++.++|
T Consensus 222 LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 222 LHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV-----VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp HHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEE-----ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred HHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcc-----cCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 999999999999999999999999999999998543321 12234 679999999887 7999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 317 VWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 317 iwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
||||||++|||++ |..||.+.+..+..+
T Consensus 296 vwSlG~il~ellt-g~~Pf~~~~~~~~~~ 323 (377)
T 3byv_A 296 AWALGLVIYWIWC-ADLPITKDAALGGSE 323 (377)
T ss_dssp HHHHHHHHHHHHH-SSCCC------CCSG
T ss_pred HHHHHHHHHHHHH-CCCCCcccccccchh
Confidence 9999999999999 899998765444333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=305.64 Aligned_cols=217 Identities=20% Similarity=0.282 Sum_probs=184.1
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-Cc-----cee
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-TH-----HVV 185 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~-----~iv 185 (364)
....+.+.++|++.+.||+|+||+||+|.++. +++.||+|+++.. .....++.+|+.+++.++ |+ +|+
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV----EQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETT----TTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcC----CCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 34456678999999999999999999999876 4678999998743 344567778999988885 44 499
Q ss_pred EEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCE
Q psy7023 186 KLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA--DKKFVHRDLAARNC 263 (364)
Q Consensus 186 ~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH--~~~iiHrDlkp~NI 263 (364)
++++++...+..++||||++ ++|.+++... ....+++..+..++.|++.||.||| +.||+||||||+||
T Consensus 120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NI 190 (382)
T 2vx3_A 120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT--------NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190 (382)
T ss_dssp CEEEEEEETTEEEEEEECCC-CBHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGE
T ss_pred EeeeeeccCCceEEEEecCC-CCHHHHHhhc--------CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccE
Confidence 99999999999999999995 5999999863 2345788999999999999999999 57999999999999
Q ss_pred EEc--CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 264 MVA--DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 264 Ll~--~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
|++ .++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..
T Consensus 191 ll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~ 264 (382)
T 2vx3_A 191 LLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEV 264 (382)
T ss_dssp EESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHH
T ss_pred EEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHH
Confidence 995 4788999999999866432 223456888999999999999999999999999999999 89999999988
Q ss_pred HHHHHHhc
Q psy7023 342 QVLNWVKG 349 (364)
Q Consensus 342 ~~~~~i~~ 349 (364)
+.+..+.+
T Consensus 265 ~~~~~i~~ 272 (382)
T 2vx3_A 265 DQMNKIVE 272 (382)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 88877654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=311.17 Aligned_cols=202 Identities=20% Similarity=0.400 Sum_probs=173.9
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-------HHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-------REKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
+.++|++++.||+|+||+||+|.++. .+..||+|++...... .....+.+|+.++++++||||++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 97 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE----KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT----TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred cccceEEEeEEEecCCEEEEEEEECC----CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45799999999999999999999876 4778999998754321 123456789999999999999999999
Q ss_pred EeeCCceEEEEecCCCC-CHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 191 VSEGNPTLVIMELMGGG-DLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
+.+.+..++||||+.+| +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 98 ~~~~~~~~lv~e~~~~g~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 98 FENQGFFQLVMEKHGSGLDLFAFIDR----------HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp EECSSEEEEEEECCTTSCBHHHHHHT----------CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS
T ss_pred EeeCCEEEEEEEeCCCCccHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC
Confidence 99999999999998776 99999975 33578899999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
.+||+|||++......... ....+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||..
T Consensus 168 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~ 232 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF-EENPFCE 232 (335)
T ss_dssp CEEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSCSS
T ss_pred cEEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh-CCCchhh
Confidence 9999999999866544321 12346889999999998887 789999999999999999 8889965
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=298.97 Aligned_cols=213 Identities=27% Similarity=0.502 Sum_probs=170.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
..++|++.+.||+|+||+||+|.++ ++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 74 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR------AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPV 74 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET------TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTT
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC------CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCc
Confidence 3478999999999999999999875 456999998643 34567889999999999999999999887 458
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCCEEEcCCCc-EEE
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD---KKFVHRDLAARNCMVADDLT-VKV 273 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~---~~iiHrDlkp~NILl~~~~~-~kL 273 (364)
++||||+++++|.+++.... ....++...++.++.|++.||+|||+ +||+||||||+|||++.++. +||
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl 147 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAE-------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSS-------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred EEEEEcCCCCCHHHHHhccC-------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence 99999999999999998532 12246788899999999999999999 89999999999999998886 799
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS--NEQVLNWVKGKS 351 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~--~~~~~~~i~~~~ 351 (364)
+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|+| |+.||.... ..++...+..+.
T Consensus 148 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 221 (307)
T 2eva_A 148 CDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAVHNGT 221 (307)
T ss_dssp CCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH-TCCTTTTTCSSHHHHHHHHHTTC
T ss_pred ccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH-CCCCchhhCccHHHHHHHHhcCC
Confidence 9999997554322 12246888999999999999999999999999999999 899997543 333444455544
Q ss_pred ccc
Q psy7023 352 SNE 354 (364)
Q Consensus 352 ~~~ 354 (364)
..+
T Consensus 222 ~~~ 224 (307)
T 2eva_A 222 RPP 224 (307)
T ss_dssp CCC
T ss_pred CCC
Confidence 433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.47 Aligned_cols=205 Identities=27% Similarity=0.450 Sum_probs=173.9
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc---CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
.|...+.||+|+||+||+|.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 105 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVN------NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL 105 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESS------SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccccCCccccCCCeEEEEEEEC------CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce
Confidence 3445588999999999999753 5679999886532 234467789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+++++|.+++.... ...++++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 178 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLD-------GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFG 178 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGG-------GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCcHHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 99999999999999997521 23468899999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
++................+++.|+|||++.+ .++.++||||||+++|+|++ |.+||.+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~ 239 (307)
T 2nru_A 179 LARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT-GLPAVDEHRE 239 (307)
T ss_dssp TCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH-CCCSBCTTBS
T ss_pred cccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH-CCCCcccCcc
Confidence 9986654433333344457889999998865 58999999999999999999 8999986554
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=302.01 Aligned_cols=219 Identities=20% Similarity=0.372 Sum_probs=163.2
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGV 190 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~ 190 (364)
...+++...+|++.+.||+|+||.||+|.++. .++.||+|++... .......+.+|+.+++++. ||||++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVG----SGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETT----TCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECC----CCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 44566777899999999999999999999876 4778999988544 3445677889999999996 9999999999
Q ss_pred Ee--------eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC--ceecCCCC
Q psy7023 191 VS--------EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLAA 260 (364)
Q Consensus 191 ~~--------~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp 260 (364)
+. .....++||||+. |+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp 166 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-------SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-------TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCG
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCc
Confidence 94 3445899999995 69999997532 2345889999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEeecccccccCccceee----------eCCCCCCCccccCcccc---cCCCCCCchhHHHHHHHHHHH
Q psy7023 261 RNCMVADDLTVKVGDFGMTRDIYETEYYR----------KGSRGFLPVRWMAPESL---KDGVFTSHSDVWSYGVVLWEM 327 (364)
Q Consensus 261 ~NILl~~~~~~kL~DFg~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~el 327 (364)
+|||++.++.+||+|||++.......... ......+++.|+|||++ .+..++.++||||||+++|+|
T Consensus 167 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el 246 (337)
T 3ll6_A 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246 (337)
T ss_dssp GGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred ccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHH
Confidence 99999999999999999998765432211 11123467889999998 566788999999999999999
Q ss_pred HhCCCCCCCCCCHHHHH
Q psy7023 328 ATLASQPYQGLSNEQVL 344 (364)
Q Consensus 328 ~t~g~~P~~~~~~~~~~ 344 (364)
+| |..||.+....+++
T Consensus 247 ~~-g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 247 CF-RQHPFEDGAKLRIV 262 (337)
T ss_dssp HH-SSCCC---------
T ss_pred Hh-CCCCCcchhHHHhh
Confidence 99 89999876554443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=298.28 Aligned_cols=217 Identities=25% Similarity=0.409 Sum_probs=174.5
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe---
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS--- 192 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--- 192 (364)
..+.++|++++.||+|+||.||+|.++. +++.||+|++... .....+++.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDND----CDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETT----TTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECC----CCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 4567899999999999999999999876 4778999988654 3455678899999999999999999999873
Q ss_pred -----------eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 193 -----------EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 193 -----------~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
+....++||||++ |+|.+++.. .+++...++.++.|++.||+|||++||+||||||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 149 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPA 149 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGG
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc-----------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 3467899999997 599999853 34778899999999999999999999999999999
Q ss_pred CEEEc-CCCcEEEeecccccccCccce-eeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 262 NCMVA-DDLTVKVGDFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 262 NILl~-~~~~~kL~DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
|||++ +++.+||+|||++........ ........+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.
T Consensus 150 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~ 228 (320)
T 2i6l_A 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKTLFAGA 228 (320)
T ss_dssp GEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHH-SSCSSCCS
T ss_pred HEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHh-CCCCCCCC
Confidence 99997 567999999999986643221 112223345778999998865 678999999999999999999 89999998
Q ss_pred CHHHHHHHHhcC
Q psy7023 339 SNEQVLNWVKGK 350 (364)
Q Consensus 339 ~~~~~~~~i~~~ 350 (364)
+..+.+..+...
T Consensus 229 ~~~~~~~~~~~~ 240 (320)
T 2i6l_A 229 HELEQMQLILES 240 (320)
T ss_dssp SHHHHHHHHHHH
T ss_pred CHHHHHHHHHHh
Confidence 887777666543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=296.82 Aligned_cols=200 Identities=22% Similarity=0.423 Sum_probs=165.5
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHh--cCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA--FDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~--l~h~~iv~l~~~~~~ 193 (364)
..+.++|++++.||+|+||+||+|.+. ++.||+|++.... ...+..|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSWQ------GENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEET------TEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEEC------CEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence 346689999999999999999999863 5679999986542 3445567777766 799999999998654
Q ss_pred ----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCC
Q psy7023 194 ----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA--------DKKFVHRDLAAR 261 (364)
Q Consensus 194 ----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH--------~~~iiHrDlkp~ 261 (364)
....++||||+++|+|.++++. ..+++..++.++.|++.||+||| +++|+||||||+
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~ 142 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTT-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGG
T ss_pred ccCCCceeEEehhhccCCCHHHHHhh-----------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChH
Confidence 3568999999999999999953 35788999999999999999999 999999999999
Q ss_pred CEEEcCCCcEEEeecccccccCccceee--eCCCCCCCccccCcccccCC------CCCCchhHHHHHHHHHHHHhCC--
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYYR--KGSRGFLPVRWMAPESLKDG------VFTSHSDVWSYGVVLWEMATLA-- 331 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~el~t~g-- 331 (364)
|||++.++.+||+|||+++......... ......+|+.|+|||++.+. .++.++||||||+++|||+| |
T Consensus 143 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t-g~~ 221 (301)
T 3q4u_A 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMV 221 (301)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBC
T ss_pred hEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh-hhc
Confidence 9999999999999999997654433221 12233578999999999876 45578999999999999999 6
Q ss_pred --------CCCCCC
Q psy7023 332 --------SQPYQG 337 (364)
Q Consensus 332 --------~~P~~~ 337 (364)
..||..
T Consensus 222 ~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 222 SNGIVEDYKPPFYD 235 (301)
T ss_dssp BTTBCCCCCCTTTT
T ss_pred Cccccccccccccc
Confidence 788854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=309.90 Aligned_cols=213 Identities=21% Similarity=0.263 Sum_probs=171.0
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
.+....+|++++.||+|+||+||+|.++. ...||+|.+..... ...+|+++++.++||||+++++++...
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~-----~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVE-----SDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECC-----CCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 45566799999999999999999999876 23377776654321 123699999999999999999999654
Q ss_pred Cc------eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-C
Q psy7023 195 NP------TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA-D 267 (364)
Q Consensus 195 ~~------~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~-~ 267 (364)
+. +++||||+++ ++.+.+.... .....+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~ 177 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYA------KLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP 177 (394)
T ss_dssp SSSSSCEEEEEEEECCSE-EHHHHHHHHH------HTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT
T ss_pred CCCCCceEEEEEeeccCc-cHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCC
Confidence 33 8899999976 5554443211 1234678899999999999999999999999999999999999 7
Q ss_pred CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
++.+||+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|||++ |++||.+.+..+.+..
T Consensus 178 ~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~l~~ 253 (394)
T 4e7w_A 178 SGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ-GQPLFPGESGIDQLVE 253 (394)
T ss_dssp TTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred CCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 99999999999986644332 2233468899999998765 58999999999999999999 8999999888776665
Q ss_pred Hh
Q psy7023 347 VK 348 (364)
Q Consensus 347 i~ 348 (364)
+.
T Consensus 254 i~ 255 (394)
T 4e7w_A 254 II 255 (394)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.01 Aligned_cols=215 Identities=23% Similarity=0.323 Sum_probs=174.7
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc----------CHHHHHHHHHHHHHHHhcCCcce
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA----------SEREKAEFLNEASVMKAFDTHHV 184 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~E~~il~~l~h~~i 184 (364)
.+.+.++|++++.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.++++++||||
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-----GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-----SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-----CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 45567899999999999999999998754 7789999886432 22334788999999999999999
Q ss_pred eEEEEEEee-----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7023 185 VKLYGVVSE-----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLA 259 (364)
Q Consensus 185 v~l~~~~~~-----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlk 259 (364)
+++++++.. ....|+||||++ |+|.+++.. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 161 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---------QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLH 161 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---------cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCC
Confidence 999999853 346899999997 699999874 33467889999999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 260 ARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 260 p~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
|+|||++.++.+||+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~ 237 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKALFRGS 237 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCS
T ss_pred hHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh-CCCCCCCC
Confidence 9999999999999999999975443322 223345788999999887 678999999999999999999 89999998
Q ss_pred CHHHHHHHHh
Q psy7023 339 SNEQVLNWVK 348 (364)
Q Consensus 339 ~~~~~~~~i~ 348 (364)
+..+.+..+.
T Consensus 238 ~~~~~~~~i~ 247 (362)
T 3pg1_A 238 TFYNQLNKIV 247 (362)
T ss_dssp SHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 8888777664
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=305.39 Aligned_cols=208 Identities=23% Similarity=0.346 Sum_probs=176.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+.++|.+.+.||+|+||+||+|.++. +++.||+|++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKR----SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccEEEEeEEecCCCeEEEEEEECC----CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 45799999999999999999999876 57789999987543 34446788899999999999999999999987665
Q ss_pred e------EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 197 T------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 197 ~------~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
. ++||||+. ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMGM------------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTTS------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred cccceeEEEEEcccc-ccHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC
Confidence 5 99999996 588877632 3788999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.
T Consensus 183 ~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~ 255 (371)
T 4exu_A 183 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQIL 255 (371)
T ss_dssp EEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred EEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Confidence 999999999755432 222345888999999987 678999999999999999999 899999988888776664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=306.15 Aligned_cols=208 Identities=18% Similarity=0.274 Sum_probs=167.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHH----------HHHHHHHHHHHHhcCCcceeE
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASERE----------KAEFLNEASVMKAFDTHHVVK 186 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~E~~il~~l~h~~iv~ 186 (364)
...++|++.+.||+|+||+||+|.++.... .+..+|+|+......... ...+.+|+.+++.++||||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPE-KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCG-GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCC-ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 345799999999999999999999875322 367899998875533211 123667889999999999999
Q ss_pred EEEEEee----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 187 LYGVVSE----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 187 l~~~~~~----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
+++++.. ....|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 181 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----------GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAAN 181 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----------GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHH
Confidence 9999987 78899999999 99999998642 267889999999999999999999999999999999
Q ss_pred EEEcCCC--cEEEeecccccccCccceee-----eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 263 CMVADDL--TVKVGDFGMTRDIYETEYYR-----KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 263 ILl~~~~--~~kL~DFg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
||++.++ .+||+|||+++.+....... ......+++.|+|||++.+..++.++|||||||++|||+| |..||
T Consensus 182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~pf 260 (345)
T 2v62_A 182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC-GKLPW 260 (345)
T ss_dssp EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCTT
T ss_pred EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCc
Confidence 9999887 99999999998665432111 1123456889999999999999999999999999999999 89999
Q ss_pred CC
Q psy7023 336 QG 337 (364)
Q Consensus 336 ~~ 337 (364)
.+
T Consensus 261 ~~ 262 (345)
T 2v62_A 261 EQ 262 (345)
T ss_dssp GG
T ss_pred cc
Confidence 64
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.09 Aligned_cols=215 Identities=20% Similarity=0.270 Sum_probs=174.9
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
....+.+..++|++++.||+|+||.||+|.++. .++.||+|++... .....+.+.+|+.+++.++||||++++++
T Consensus 20 ~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (317)
T 2buj_A 20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLH----DGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAY 94 (317)
T ss_dssp EEEEEEETTEEEEEEEEEEC--CEEEEEEEETT----TCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred cccEEEECCeEEEEEEEecCCCCeEEEEEEecC----CCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 344556667899999999999999999999865 4778999988653 34556788999999999999999999999
Q ss_pred Ee----eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 191 VS----EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 191 ~~----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
+. .....++||||+++++|.+++.... .....+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~ 168 (317)
T 2buj_A 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLK------DKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG 168 (317)
T ss_dssp EEEEETTEEEEEEEEECCTTCBHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred EEeccCCCceeEEEEEeCCCCcHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence 86 2357899999999999999998632 1235688999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCccceee-------eCCCCCCCccccCcccccCCC---CCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 267 DDLTVKVGDFGMTRDIYETEYYR-------KGSRGFLPVRWMAPESLKDGV---FTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 267 ~~~~~kL~DFg~a~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
.++.+||+|||++.......... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.
T Consensus 169 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~ 247 (317)
T 2buj_A 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF-GEGPYD 247 (317)
T ss_dssp TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHH-SSCTTH
T ss_pred CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHh-CCCChh
Confidence 99999999999987543221100 001122477899999997654 6889999999999999999 889995
Q ss_pred C
Q psy7023 337 G 337 (364)
Q Consensus 337 ~ 337 (364)
.
T Consensus 248 ~ 248 (317)
T 2buj_A 248 M 248 (317)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=295.90 Aligned_cols=204 Identities=23% Similarity=0.339 Sum_probs=167.5
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE-EeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV-VSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~-~~~~~~ 196 (364)
+.++|++.+.||+|+||+||+|.+.. .++.||+|+..... ...++.+|+.+++.++|++++..+.. +...+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA----AGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT----TTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC----CCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 45789999999999999999999866 47789999865432 22457789999999998876655554 467788
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV---ADDLTVKV 273 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kL 273 (364)
.++||||+ +++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+ ++++.+||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL 149 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp EEEEEECC-CCBHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEE
T ss_pred eEEEEEcc-CCCHHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEE
Confidence 89999999 8999999985 23457889999999999999999999999999999999999 78899999
Q ss_pred eecccccccCcccee-----eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 274 GDFGMTRDIYETEYY-----RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~ 219 (296)
T 4hgt_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLK 219 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCC
T ss_pred ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc-CCCCCcccc
Confidence 999999866543221 12234456889999999999999999999999999999999 899998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=295.10 Aligned_cols=218 Identities=23% Similarity=0.450 Sum_probs=184.9
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
..+.++|++++.||+|+||.||+|.++. .++.||+|++..... ....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~----~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI----TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC----CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 3456899999999999999999999875 477899999865432 23356788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcE
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD---LTV 271 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~---~~~ 271 (364)
+..++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.+ +.+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKR----------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CeEEEEEEccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccE
Confidence 9999999999999999998752 247788999999999999999999999999999999999754 479
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||++........ .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..++++.+..+.
T Consensus 164 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 238 (287)
T 2wei_A 164 KIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETGK 238 (287)
T ss_dssp EECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred EEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876543321 112234678999999875 48999999999999999999 899999999999888887664
Q ss_pred c
Q psy7023 352 S 352 (364)
Q Consensus 352 ~ 352 (364)
.
T Consensus 239 ~ 239 (287)
T 2wei_A 239 Y 239 (287)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=310.90 Aligned_cols=201 Identities=16% Similarity=0.195 Sum_probs=153.6
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhc--CCcceeEEE------
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAF--DTHHVVKLY------ 188 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l--~h~~iv~l~------ 188 (364)
...|++++.||+|+||+||+|.++. +++.||+|++..... ....+.+.+|+.+++.+ +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE----RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC----CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 3469999999999999999999876 477899999986543 34456677886555555 699988865
Q ss_pred -EEEeeC-----------------CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHH------HHHHHHHHHH
Q psy7023 189 -GVVSEG-----------------NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI------LQMAAEVADG 244 (364)
Q Consensus 189 -~~~~~~-----------------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~------~~i~~qil~~ 244 (364)
+++... ...|+||||++ ++|.+++..... .+....+ ..++.||+.|
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~vk~~i~~qi~~a 206 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---------VYVFRGDEGILALHILTAQLIRL 206 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---------SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---------ccchhhhhhhhhHHHHHHHHHHH
Confidence 555433 23899999998 899999986321 1122233 5777999999
Q ss_pred HHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccC--CCCCCchhHHHHHH
Q psy7023 245 MAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGV 322 (364)
Q Consensus 245 L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~ 322 (364)
|+|||++||+||||||+|||++.++.+||+|||+++....... ...+++.|+|||++.+ ..++.++|||||||
T Consensus 207 L~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 207 AANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGL 281 (371)
T ss_dssp HHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred HHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence 9999999999999999999999999999999999986643321 2234578999999987 67999999999999
Q ss_pred HHHHHHhCCCCCCCCCC
Q psy7023 323 VLWEMATLASQPYQGLS 339 (364)
Q Consensus 323 il~el~t~g~~P~~~~~ 339 (364)
++|+|+| |+.||.+..
T Consensus 282 il~ellt-g~~Pf~~~~ 297 (371)
T 3q60_A 282 SIYRVWC-LFLPFGLVT 297 (371)
T ss_dssp HHHHHHH-SSCSTTBCC
T ss_pred HHHHHHh-CCCCCCCcC
Confidence 9999999 899998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=302.10 Aligned_cols=216 Identities=20% Similarity=0.348 Sum_probs=174.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-------HHHHHHHHHHHHHHHhcCCcceeEEEE
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-------EREKAEFLNEASVMKAFDTHHVVKLYG 189 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~il~~l~h~~iv~l~~ 189 (364)
.+.++|++.+.||+|+||.||+|.++. +++.||+|++..... ......+.+|+.++++++||||+++++
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 82 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERK----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 82 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcC----CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEee
Confidence 356799999999999999999999876 467899999875421 122345789999999999999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
++..+. .|+||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 83 ~~~~~~-~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 83 FFDAED-YYIVLELMEGGELFDKVVG----------NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 151 (322)
T ss_dssp EEESSS-EEEEEECCTTEETHHHHST----------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS
T ss_pred EEcCCc-eEEEEecCCCCcHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC
Confidence 997654 8999999999999999864 34578889999999999999999999999999999999998765
Q ss_pred c---EEEeecccccccCccceeeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HH
Q psy7023 270 T---VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN-EQ 342 (364)
Q Consensus 270 ~---~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~-~~ 342 (364)
. +||+|||++.......... ...+++.|+|||++. ...++.++||||||+++|+|++ |..||..... .+
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~ 227 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVS 227 (322)
T ss_dssp SSCCEEECCCTTCEECCCCHHHH---HHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH-SSCSSCSTTCSSC
T ss_pred CCCeEEEccCccceecccccccc---cccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccchHHH
Confidence 4 9999999998665432211 123577899999974 5668999999999999999999 8999976543 34
Q ss_pred HHHHHhcCc
Q psy7023 343 VLNWVKGKS 351 (364)
Q Consensus 343 ~~~~i~~~~ 351 (364)
+.+.+..+.
T Consensus 228 ~~~~~~~~~ 236 (322)
T 2ycf_A 228 LKDQITSGK 236 (322)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHHhCc
Confidence 555555443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=298.93 Aligned_cols=216 Identities=22% Similarity=0.377 Sum_probs=179.0
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhc---CCcceeEEEEEEe-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAF---DTHHVVKLYGVVS- 192 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l---~h~~iv~l~~~~~- 192 (364)
..++|++++.||+|+||+||+|.+... .++.||+|++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN---GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT---TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC---CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 457899999999999999999998521 3678999988644321 1123455677777766 8999999999987
Q ss_pred ----eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 193 ----EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 193 ----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
.....++||||++ |+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 156 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHS--------CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC
Confidence 5577899999997 5999999863 23357889999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+.+..+.
T Consensus 157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~ 232 (326)
T 1blx_A 157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKIL 232 (326)
T ss_dssp CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Confidence 999999999998655332 1223346888999999999999999999999999999999 899999988888777665
Q ss_pred c
Q psy7023 349 G 349 (364)
Q Consensus 349 ~ 349 (364)
.
T Consensus 233 ~ 233 (326)
T 1blx_A 233 D 233 (326)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=305.70 Aligned_cols=211 Identities=14% Similarity=0.225 Sum_probs=173.3
Q ss_pred ccceeEeceeeeecceEEEEEEEcCccc----ccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeE--------
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRS----LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK-------- 186 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~-------- 186 (364)
.++|++.+.||+|+||.||+|.++.+.. ..++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4799999999999999999999876321 02678999998654 35778999999999999887
Q ss_pred -------EEEEEee-CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7023 187 -------LYGVVSE-GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258 (364)
Q Consensus 187 -------l~~~~~~-~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl 258 (364)
+++++.. ++..|+||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Di 185 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--------PKHVLSERSVLQVACRLLDALEFLHENEYVHGNV 185 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--------GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--------CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 6677765 77889999999 99999999862 2356889999999999999999999999999999
Q ss_pred CCCCEEEcCCC--cEEEeecccccccCccceee-----eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCC
Q psy7023 259 AARNCMVADDL--TVKVGDFGMTRDIYETEYYR-----KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLA 331 (364)
Q Consensus 259 kp~NILl~~~~--~~kL~DFg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g 331 (364)
||+|||++.++ .+||+|||+++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g 264 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY-G 264 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-S
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-C
Confidence 99999999998 99999999998765433211 1123357889999999999999999999999999999999 8
Q ss_pred CCCCCCC--CHHHHHH
Q psy7023 332 SQPYQGL--SNEQVLN 345 (364)
Q Consensus 332 ~~P~~~~--~~~~~~~ 345 (364)
..||.+. +..++..
T Consensus 265 ~~pf~~~~~~~~~~~~ 280 (352)
T 2jii_A 265 FLPWTNCLPNTEDIMK 280 (352)
T ss_dssp CCTTGGGTTCHHHHHH
T ss_pred CCCcccCCcCHHHHHH
Confidence 9999865 3344443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=293.41 Aligned_cols=203 Identities=23% Similarity=0.339 Sum_probs=170.7
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE-EeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV-VSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~-~~~~~~ 196 (364)
+.++|++.+.||+|+||+||+|+++. .++.||+|++...... .++.+|+.+++.++|++++..+.. ....+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA----AGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT----TTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcC----CCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 56899999999999999999999865 4778999988654332 357789999999998876555544 467788
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV---ADDLTVKV 273 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl---~~~~~~kL 273 (364)
.++||||+ +++|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||+ ++++.+||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl 149 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp EEEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred eEEEEEec-CCCHHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEE
Confidence 89999999 8999999975 23457889999999999999999999999999999999999 48899999
Q ss_pred eecccccccCcccee-----eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 274 GDFGMTRDIYETEYY-----RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~ 218 (296)
T 3uzp_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGL 218 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSC
T ss_pred eeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCc
Confidence 999999866543321 11233456889999999999999999999999999999999 89999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=294.33 Aligned_cols=210 Identities=23% Similarity=0.370 Sum_probs=170.9
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccc-cCHHHHHHHHHHHHHHHhcCC--cceeEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN-ASEREKAEFLNEASVMKAFDT--HHVVKLY 188 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~il~~l~h--~~iv~l~ 188 (364)
....++...+|++++.||+|+||.||+|.++. +..||+|++... ......+.+.+|+.++++++| +||++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCC-----CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 44566677899999999999999999998754 677999998654 344556788999999999974 8999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
+++...+..++||| +.+++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~- 162 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKK----------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD- 162 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHC----------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-
Confidence 99999999999999 4588999999852 35678899999999999999999999999999999999965
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-----------GVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
+.+||+|||++................+++.|+|||++.+ ..++.++||||||+++|+|++ |..||..
T Consensus 163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~ 241 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQ 241 (313)
T ss_dssp TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH-SSCTTTT
T ss_pred CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh-CCCchhh
Confidence 8999999999987654433222333456889999999875 467889999999999999999 8899976
Q ss_pred CC
Q psy7023 338 LS 339 (364)
Q Consensus 338 ~~ 339 (364)
..
T Consensus 242 ~~ 243 (313)
T 3cek_A 242 II 243 (313)
T ss_dssp CC
T ss_pred HH
Confidence 53
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.65 Aligned_cols=217 Identities=19% Similarity=0.306 Sum_probs=160.4
Q ss_pred eeeccceeE-eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe--
Q psy7023 116 EVLRSKVTI-LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS-- 192 (364)
Q Consensus 116 e~~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-- 192 (364)
+.+.+.|++ .++||+|+||+||+|++++.. .+..||+|++...... ..+.+|+.+|+.++||||+++++++.
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~--~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGK--DDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSS--CCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCC--CCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 345567877 458999999999999977432 4678999999755432 35778999999999999999999995
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCC
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV----ADD 268 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl----~~~ 268 (364)
.....|+||||+. ++|.+++......... .....+++..++.++.||+.||+|||++||+||||||+|||| +.+
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 4678999999996 5898888643211100 122358899999999999999999999999999999999999 678
Q ss_pred CcEEEeecccccccCccce-eeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 269 LTVKVGDFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
+.+||+|||+++....... ........+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+...
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~ 241 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQE 241 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH-SSCTTCCCC-
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh-CCCCCCCccc
Confidence 8999999999987654321 1122334568899999999874 48999999999999999999 8999986654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=293.63 Aligned_cols=199 Identities=21% Similarity=0.381 Sum_probs=170.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee---
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--- 193 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--- 193 (364)
.+..+|++++.||+|+||.||+|.++. .++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRI----DGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETT----TCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEcC----CCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 456789999999999999999999875 47789999987543 245689999999999999999998854
Q ss_pred -------------CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7023 194 -------------GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAA 260 (364)
Q Consensus 194 -------------~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp 260 (364)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+|+||||
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 150 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--------RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKP 150 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHG--------GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCH
Confidence 45689999999999999999862 234678889999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 261 RNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 261 ~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
+|||+++++.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ +..||.
T Consensus 151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~ 222 (284)
T 2a19_B 151 SNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-VCDTAF 222 (284)
T ss_dssp GGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS-CCSSHH
T ss_pred HHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh-cCCcch
Confidence 999999999999999999986654322 223346889999999999999999999999999999999 666653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.68 Aligned_cols=214 Identities=21% Similarity=0.394 Sum_probs=171.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee----
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE---- 193 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~---- 193 (364)
+.++|++++.||+|+||.||+|.++. .++.||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL----DSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcC----CCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence 34689999999999999999999875 4778999998643 3456788899999999999999999998864
Q ss_pred ---------CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7023 194 ---------GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCM 264 (364)
Q Consensus 194 ---------~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIL 264 (364)
.+..|+||||+++++|.+++... ...++...++.++.|++.||+|||++||+||||||+|||
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil 148 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---------NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF 148 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHS---------CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhcc---------ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEE
Confidence 45789999999999999999852 234667889999999999999999999999999999999
Q ss_pred EcCCCcEEEeecccccccCccce------------eeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCC
Q psy7023 265 VADDLTVKVGDFGMTRDIYETEY------------YRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLA 331 (364)
Q Consensus 265 l~~~~~~kL~DFg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g 331 (364)
++.++.+||+|||++........ ........+++.|+|||++.+. .++.++||||||+++|+|++
T Consensus 149 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 99999999999999986543211 1112233467889999999864 68999999999999999998
Q ss_pred CCCCC-CCCHHHHHHHHhcC
Q psy7023 332 SQPYQ-GLSNEQVLNWVKGK 350 (364)
Q Consensus 332 ~~P~~-~~~~~~~~~~i~~~ 350 (364)
||. +.+..++...+...
T Consensus 227 --p~~~~~~~~~~~~~~~~~ 244 (303)
T 1zy4_A 227 --PFSTGMERVNILKKLRSV 244 (303)
T ss_dssp --CCSSHHHHHHHHHHHHST
T ss_pred --ccCCchhHHHHHHhcccc
Confidence 554 33445566666554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=305.15 Aligned_cols=223 Identities=18% Similarity=0.297 Sum_probs=185.1
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH----------------HHHHHHHHHHHHHhc
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER----------------EKAEFLNEASVMKAF 179 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~E~~il~~l 179 (364)
+...++|++++.||+|+||.||+|.+ . +..||+|++....... ..+.+.+|+.+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-D-----NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-T-----TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-C-----CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 44568999999999999999999987 2 7789999986432110 116788999999999
Q ss_pred CCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCC
Q psy7023 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDL 258 (364)
Q Consensus 180 ~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDl 258 (364)
+||||+++++++.+.+..++||||+++++|.+++........ .....+++..++.++.|++.||+|||+ +||+|+||
T Consensus 101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl 178 (348)
T 2pml_X 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178 (348)
T ss_dssp CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCC
T ss_pred CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCC
Confidence 999999999999999999999999999999988432110000 124578899999999999999999999 99999999
Q ss_pred CCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCC-CCCC-chhHHHHHHHHHHHHhCCCCCCC
Q psy7023 259 AARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTS-HSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~il~el~t~g~~P~~ 336 (364)
||+|||++.++.+||+|||++....... .....+++.|+|||++.+. .++. ++||||||+++|+|++ |..||.
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 253 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY-NVVPFS 253 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH-SSCSSC
T ss_pred ChHhEEEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh-CCCCCC
Confidence 9999999999999999999998664431 2233468899999999887 6666 9999999999999999 899998
Q ss_pred CCCH-HHHHHHHhcCc
Q psy7023 337 GLSN-EQVLNWVKGKS 351 (364)
Q Consensus 337 ~~~~-~~~~~~i~~~~ 351 (364)
..+. .++.+.+..+.
T Consensus 254 ~~~~~~~~~~~i~~~~ 269 (348)
T 2pml_X 254 LKISLVELFNNIRTKN 269 (348)
T ss_dssp CSSCSHHHHHHHTSCC
T ss_pred CCCcHHHHHHHHhccC
Confidence 8776 78888887664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=292.37 Aligned_cols=205 Identities=27% Similarity=0.428 Sum_probs=169.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|.....||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLS----NQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETT----TCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECC----CCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 444455589999999999999876 467899999876533 345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeeccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-DLTVKVGDFGM 278 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-~~~~kL~DFg~ 278 (364)
||||+++++|.+++.... ....+++..+..++.|++.||+|||++||+|+||||+|||++. ++.+||+|||+
T Consensus 97 v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKW-------GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EEECCSEEEHHHHHHHTT-------CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred EEEeCCCCCHHHHHHhhc-------cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence 999999999999998632 2234567889999999999999999999999999999999987 89999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
+......... .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||....
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~ 229 (295)
T 2clq_A 170 SKRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELG 229 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHH-TSCTTGGGS
T ss_pred ccccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHH-CCCCccCCC
Confidence 9865443221 22334688999999997654 7889999999999999999 899997543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=296.26 Aligned_cols=215 Identities=24% Similarity=0.433 Sum_probs=162.3
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHH-HHHhcCCcceeEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS-VMKAFDTHHVVKLYG 189 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-il~~l~h~~iv~l~~ 189 (364)
....|+...++|++++.||+|+||.||+|.++. +++.||+|++..........++..|+. +++.++||||+++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP----SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETT----TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcC----CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 345677778999999999999999999999876 477899999987666666666666766 777789999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCC
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADD 268 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~ 268 (364)
++...+..++||||+++ +|.+++..... .....+++..+..++.|++.||.|||+. ||+||||||+|||++.+
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~ 162 (327)
T 3aln_A 89 ALFREGDCWICMELMST-SFDKFYKYVYS-----VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162 (327)
T ss_dssp EEECSSEEEEEECCCSE-EHHHHHHHHHH-----TTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT
T ss_pred EEEeCCceEEEEeecCC-ChHHHHHHHHh-----hhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC
Confidence 99999999999999975 88888764210 1234678899999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccc----cCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL----KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~ 339 (364)
+.+||+|||++........ .....+++.|+|||++ .+..++.++||||||+++|+|++ |..||.+..
T Consensus 163 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~ 233 (327)
T 3aln_A 163 GNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWN 233 (327)
T ss_dssp TEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHH-SCCCSSCC-
T ss_pred CCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH-CCCCCCCcc
Confidence 9999999999986654322 1222467889999998 45668999999999999999999 899998654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.61 Aligned_cols=208 Identities=23% Similarity=0.346 Sum_probs=175.2
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
+.++|.+.+.||+|+||.||+|.++. +++.||+|++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKR----SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cCceEEEeeeEecCCCeEEEEEEECC----CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 45789999999999999999999876 47789999987543 34446778899999999999999999999987654
Q ss_pred ------eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 197 ------TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 197 ------~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
.|+||||+. ++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~ 164 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE 164 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC
T ss_pred cccceeEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc
Confidence 499999996 58877653 23788999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+||+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+.+..+.
T Consensus 165 ~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 165 LKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp EEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSSBSSCHHHHHHHHH
T ss_pred EEEeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Confidence 9999999997654321 22345788999999887 678999999999999999999 899999988877776554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.44 Aligned_cols=206 Identities=23% Similarity=0.387 Sum_probs=174.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCc-ceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~-~iv~l~~~~~~~~ 195 (364)
.+.++|+++++||+|+||.||+|.+.. .++.||||++...... .++.+|+++++.+.|+ +|..+..++...+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGD 76 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT----TCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC----CCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence 456899999999999999999999876 4778999987654332 3477899999999875 6666667777888
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEE
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV---ADDLTVK 272 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl---~~~~~~k 272 (364)
..++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++||||||||+|||| +.++.+|
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 146 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFC---------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHT---------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEEECC-CCCHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEE
Confidence 999999999 89999999852 3468899999999999999999999999999999999999 6889999
Q ss_pred EeecccccccCcccee-----eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 273 VGDFGMTRDIYETEYY-----RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
|+|||+++........ .......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~ 218 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh-CCCCCccccc
Confidence 9999999876543321 12224457889999999999999999999999999999999 8999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=303.28 Aligned_cols=225 Identities=23% Similarity=0.341 Sum_probs=183.0
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYG 189 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~ 189 (364)
....|++..++|++.+.||+|+||.||+|.++. .+|+|+++.... ....+.+.+|+.++++++|+||+++++
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 96 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence 456678888999999999999999999998753 489998875432 222345678999999999999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
++.+.+..++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++ ++
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~ 166 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRD---------AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG 166 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTS---------SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---
T ss_pred EEecCCceEEEeecccCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC
Confidence 99999999999999999999999964 233577889999999999999999999999999999999998 67
Q ss_pred cEEEeecccccccCccce---eeeCCCCCCCccccCcccccC---------CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 270 TVKVGDFGMTRDIYETEY---YRKGSRGFLPVRWMAPESLKD---------GVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
.+||+|||++........ ........+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+
T Consensus 167 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~ 245 (319)
T 2y4i_B 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKT 245 (319)
T ss_dssp CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH-SSCSSSS
T ss_pred CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh-CCCCCCC
Confidence 999999999875432211 112223346788999999874 347889999999999999999 8999999
Q ss_pred CCHHHHHHHHhcCccc
Q psy7023 338 LSNEQVLNWVKGKSSN 353 (364)
Q Consensus 338 ~~~~~~~~~i~~~~~~ 353 (364)
.+..++...+..+...
T Consensus 246 ~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 246 QPAEAIIWQMGTGMKP 261 (319)
T ss_dssp CCHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHhccCCCC
Confidence 9999888888776544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=291.01 Aligned_cols=227 Identities=23% Similarity=0.408 Sum_probs=169.3
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHH-HHHHHHHHHhcCCcceeEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE-FLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~E~~il~~l~h~~iv~l~~~ 190 (364)
...+....++|++++.||+|+||.||+|.++. .++.||+|++..........+ +.++..+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 92 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRK----TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETT----TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEec----CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEE
Confidence 44566667899999999999999999999876 467899999976655444444 4455567888899999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCC
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADDL 269 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NILl~~~~ 269 (364)
+.+.+..++||||+ ++.+..+... ....+++..+..++.|++.||+|||++ ||+|+||||+|||++.++
T Consensus 93 ~~~~~~~~lv~e~~-~~~~~~l~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~ 162 (318)
T 2dyl_A 93 FITNTDVFIAMELM-GTCAEKLKKR---------MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG 162 (318)
T ss_dssp EECSSEEEEEECCC-SEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS
T ss_pred EecCCcEEEEEecc-CCcHHHHHHH---------hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC
Confidence 99999999999999 5556555543 234578899999999999999999995 999999999999999999
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCHHHH
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQG-LSNEQV 343 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~-~~~~~~ 343 (364)
.+||+|||++........ .....+++.|+|||++. ...++.++||||||+++|+|++ |..||.. ....+.
T Consensus 163 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 238 (318)
T 2dyl_A 163 QIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCKTDFEV 238 (318)
T ss_dssp CEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH-SSCTTTTCCSHHHH
T ss_pred CEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccHHH
Confidence 999999999976544322 12234678899999994 4568899999999999999999 8899986 456667
Q ss_pred HHHHhcCcccccc
Q psy7023 344 LNWVKGKSSNEYK 356 (364)
Q Consensus 344 ~~~i~~~~~~~~~ 356 (364)
+..+..+.....+
T Consensus 239 ~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 239 LTKVLQEEPPLLP 251 (318)
T ss_dssp HHHHHHSCCCCCC
T ss_pred HHHHhccCCCCCC
Confidence 7766665544443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=298.58 Aligned_cols=215 Identities=21% Similarity=0.279 Sum_probs=165.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc-
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP- 196 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~- 196 (364)
..++|++.+.||+|+||+||+|.++. ++..||+|++...... .....+|++.++.++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKS----TGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHTTEEEC----------CEEEEETT----TCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hccceEEEEEEecCCCeEEEEEEECC----CCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34789999999999999999999876 4678999987543221 2345678888899999999999999975443
Q ss_pred ------eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEEcC-
Q psy7023 197 ------TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA--DKKFVHRDLAARNCMVAD- 267 (364)
Q Consensus 197 ------~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH--~~~iiHrDlkp~NILl~~- 267 (364)
.++||||+++ +|.+.+.... .....++...+..++.|++.||.||| ++||+||||||+|||++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYY------RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHH------TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHh------hcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC
Confidence 8899999976 6666554321 13446788899999999999999999 999999999999999996
Q ss_pred CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
++.+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHE 243 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCcCCCChHHHHHH
Confidence 89999999999987654432 22334688999999987655 8999999999999999999 8999999888887776
Q ss_pred Hhc
Q psy7023 347 VKG 349 (364)
Q Consensus 347 i~~ 349 (364)
+..
T Consensus 244 ~~~ 246 (360)
T 3e3p_A 244 IVR 246 (360)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=294.94 Aligned_cols=201 Identities=23% Similarity=0.474 Sum_probs=164.2
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc--CCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF--DTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l--~h~~iv~l~~~~~~ 193 (364)
..+.++|++++.||+|+||.||+|.++ +..||+|++.... ...+..|.+++..+ +||||+++++++..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR------GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET------TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC------CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 445689999999999999999999875 5679999986432 23344555665554 99999999999987
Q ss_pred C----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCC
Q psy7023 194 G----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK--------KFVHRDLAAR 261 (364)
Q Consensus 194 ~----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~--------~iiHrDlkp~ 261 (364)
. ...++||||+++|+|.++++. ..+++..++.++.|++.||+|||++ +|+||||||+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~ 171 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS-----------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGG
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchH
Confidence 7 789999999999999999975 2478889999999999999999999 9999999999
Q ss_pred CEEEcCCCcEEEeecccccccCccceee--eCCCCCCCccccCcccccCCCCCCc------hhHHHHHHHHHHHHhCC--
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYYR--KGSRGFLPVRWMAPESLKDGVFTSH------SDVWSYGVVLWEMATLA-- 331 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~il~el~t~g-- 331 (364)
|||++.++.+||+|||++.......... ......+|+.|+|||++.+..++.. +|||||||++|||+| |
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~ 250 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCV 250 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT-TBC
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh-ccC
Confidence 9999999999999999997654433221 1223457899999999988777665 999999999999999 6
Q ss_pred --------CCCCCCC
Q psy7023 332 --------SQPYQGL 338 (364)
Q Consensus 332 --------~~P~~~~ 338 (364)
..||...
T Consensus 251 ~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 251 SGGIVEEYQLPYHDL 265 (337)
T ss_dssp BTTBCCCCCCTTTTT
T ss_pred cccccccccccHhhh
Confidence 7787653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=297.28 Aligned_cols=201 Identities=17% Similarity=0.336 Sum_probs=169.2
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-----------CcceeE
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-----------THHVVK 186 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-----------h~~iv~ 186 (364)
...+|++++.||+|+||+||+|.++. .++.||+|++... ......+.+|+.+++++. |+||++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMV----NNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecC----CCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 34799999999999999999999876 4778999998753 334567888999999886 789999
Q ss_pred EEEEEeeCC----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC-CceecCCCCC
Q psy7023 187 LYGVVSEGN----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK-KFVHRDLAAR 261 (364)
Q Consensus 187 l~~~~~~~~----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~ 261 (364)
+++++...+ ..++|||++ +++|.+++... ....+++..+..++.||+.||+|||++ ||+||||||+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~ 161 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--------EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 161 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGG
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--------hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChH
Confidence 999988644 789999999 88999999863 234578899999999999999999998 9999999999
Q ss_pred CEEEc------CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 262 NCMVA------DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 262 NILl~------~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
|||++ ..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|||+| |..||
T Consensus 162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf 235 (373)
T 1q8y_A 162 NVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLF 235 (373)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC
T ss_pred HeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh-CCCCC
Confidence 99994 4458999999999765433 223356889999999999999999999999999999999 89999
Q ss_pred CCCC
Q psy7023 336 QGLS 339 (364)
Q Consensus 336 ~~~~ 339 (364)
.+.+
T Consensus 236 ~~~~ 239 (373)
T 1q8y_A 236 EPDE 239 (373)
T ss_dssp ----
T ss_pred CCCc
Confidence 8654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=299.23 Aligned_cols=202 Identities=26% Similarity=0.474 Sum_probs=159.8
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHH--HHhcCCcceeEEEEEEee-
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASV--MKAFDTHHVVKLYGVVSE- 193 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~i--l~~l~h~~iv~l~~~~~~- 193 (364)
+..++|++++.||+|+||+||+|++. ++.||+|++..... ..+..|.++ ++.++|+||+++++.+..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSLD------ERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEET------TEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEEC------CeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 34479999999999999999999763 67899999865432 233334444 455899999999986542
Q ss_pred ----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhC---------CceecCCCC
Q psy7023 194 ----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADK---------KFVHRDLAA 260 (364)
Q Consensus 194 ----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~---------~iiHrDlkp 260 (364)
...+++||||+++|+|.+++... ..++..+..++.||+.||+|||+. +|+||||||
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp 148 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-----------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSG
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-----------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeeccccc
Confidence 33578999999999999999752 236788899999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEeecccccccCccce------eeeCCCCCCCccccCcccccC-------CCCCCchhHHHHHHHHHHH
Q psy7023 261 RNCMVADDLTVKVGDFGMTRDIYETEY------YRKGSRGFLPVRWMAPESLKD-------GVFTSHSDVWSYGVVLWEM 327 (364)
Q Consensus 261 ~NILl~~~~~~kL~DFg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el 327 (364)
+|||++.++.+||+|||+++.+..... ........+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 149 ~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~el 228 (336)
T 3g2f_A 149 RNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228 (336)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHH
Confidence 999999999999999999986654321 112223457899999999987 3566789999999999999
Q ss_pred HhCCCCCCCCCC
Q psy7023 328 ATLASQPYQGLS 339 (364)
Q Consensus 328 ~t~g~~P~~~~~ 339 (364)
++|+.+||.+..
T Consensus 229 l~g~~p~~~~~~ 240 (336)
T 3g2f_A 229 FMRCTDLFPGES 240 (336)
T ss_dssp HTTBGGGSTTSC
T ss_pred HhcCCcCCCccc
Confidence 996566665443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.29 Aligned_cols=205 Identities=20% Similarity=0.302 Sum_probs=163.5
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-----HHHHHHHHHHHHHHhc----CCcce
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-----REKAEFLNEASVMKAF----DTHHV 184 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~il~~l----~h~~i 184 (364)
..+.+.++|++.+.||+|+||.||+|.++. .++.||+|++...... .....+.+|+.+++++ +|+||
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i 100 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLT----DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTT----TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEcc----CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe
Confidence 345677899999999999999999998765 4678999998754321 1233456799999999 89999
Q ss_pred eEEEEEEeeCCceEEEEec-CCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7023 185 VKLYGVVSEGNPTLVIMEL-MGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNC 263 (364)
Q Consensus 185 v~l~~~~~~~~~~~lv~e~-~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI 263 (364)
+++++++...+..++|||+ +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 170 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEK----------GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENI 170 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGE
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhE
Confidence 9999999999999999999 7899999999752 3478899999999999999999999999999999999
Q ss_pred EEc-CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCC-CchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 264 MVA-DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFT-SHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 264 Ll~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
|++ +++.+||+|||++........ ....+++.|+|||++.+..+. .++||||||+++|+|++ |..||..
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~ 241 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC-GDIPFER 241 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCS
T ss_pred EEeCCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH-CCCCCCC
Confidence 999 899999999999987654332 223467889999999877764 48999999999999999 8899965
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=294.82 Aligned_cols=204 Identities=20% Similarity=0.387 Sum_probs=147.6
Q ss_pred eccceeEec-eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee---
Q psy7023 118 LRSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--- 193 (364)
Q Consensus 118 ~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--- 193 (364)
+.++|.+++ .||+|+||+||+|.++. +++.||+|++... ..... +....++.+.||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~--~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRR----TGQKCALKLLYDS--PKARQ---EVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEESS--HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeEecceeeeeCCCeEEEEEEECC----CCCEEEEEEecCc--HHHHH---HHHHHHHhcCCCChHHHHHHHhhccC
Confidence 557899865 59999999999999886 4778999998653 22222 22334567799999999999876
Q ss_pred -CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CC
Q psy7023 194 -GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---DL 269 (364)
Q Consensus 194 -~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~~ 269 (364)
+...++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQER--------GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC---------CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTC
T ss_pred CCceEEEEEeccCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCc
Confidence 45589999999999999999862 2346889999999999999999999999999999999999986 45
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~ 343 (364)
.+||+|||++........ ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+......
T Consensus 169 ~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GFPPFYSNTGQAI 237 (336)
T ss_dssp CEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHH-SSCCC--------
T ss_pred eEEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCccchhh
Confidence 599999999976543321 22345788999999988889999999999999999999 8999987665544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=292.81 Aligned_cols=201 Identities=23% Similarity=0.453 Sum_probs=169.5
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHh--cCCcceeEEEEEEee
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA--FDTHHVVKLYGVVSE 193 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~--l~h~~iv~l~~~~~~ 193 (364)
+.+.++|++.+.||+|+||+||+|.+. ++.||+|++.... ...+.+|+++++. ++||||+++++++..
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR------GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET------TEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc------CccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 445689999999999999999999874 5689999986432 3567788899888 799999999999987
Q ss_pred CC----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCC
Q psy7023 194 GN----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA--------DKKFVHRDLAAR 261 (364)
Q Consensus 194 ~~----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH--------~~~iiHrDlkp~ 261 (364)
.. ..++||||+++|+|.+++.+ ..+++..++.++.|++.||+||| +.+|+||||||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~ 176 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGG
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHH
Confidence 65 78999999999999999975 24778899999999999999999 899999999999
Q ss_pred CEEEcCCCcEEEeecccccccCcccee--eeCCCCCCCccccCcccccCCC------CCCchhHHHHHHHHHHHHhCC--
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYY--RKGSRGFLPVRWMAPESLKDGV------FTSHSDVWSYGVVLWEMATLA-- 331 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~el~t~g-- 331 (364)
|||++.++.+||+|||++......... .......+++.|+|||++.+.. ++.++||||||+++|||+| |
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t-g~~ 255 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCS 255 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBC
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh-ccC
Confidence 999999999999999999765543321 1233445788999999998753 3468999999999999999 5
Q ss_pred --------CCCCCCC
Q psy7023 332 --------SQPYQGL 338 (364)
Q Consensus 332 --------~~P~~~~ 338 (364)
..||...
T Consensus 256 ~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 256 IGGIHEDYQLPYYDL 270 (342)
T ss_dssp BTTBCCCCCCTTTTT
T ss_pred cCCcccccccCcccc
Confidence 7888754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=284.83 Aligned_cols=179 Identities=15% Similarity=0.144 Sum_probs=156.4
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
++.++|++.+.||+|+||.||+|.+.. .++.||+|++..... ....+.+.+|+.++++++||||+++++++.++
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTA----LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETT----TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecC----CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 566899999999999999999999876 477899999986543 45567889999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+..|+||||++|++|.++++.. ....++..++.||+.||+|||++||+||||||+|||+++++.+||+
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS------------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred CcEEEEEEecCCCCHHHHHhcC------------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEE
Confidence 9999999999999999998531 2345688899999999999999999999999999999999999998
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
+++ |++| ++.++|||||||++|+|+| |+.||.+.+..
T Consensus 172 ~~~----------------------~~~~-------~~~~~Di~slG~il~ellt-g~~Pf~~~~~~ 208 (286)
T 3uqc_A 172 YPA----------------------TMPD-------ANPQDDIRGIGASLYALLV-NRWPLPEAGVR 208 (286)
T ss_dssp SCC----------------------CCTT-------CCHHHHHHHHHHHHHHHHH-SEECSCCCSBC
T ss_pred ecc----------------------ccCC-------CCchhHHHHHHHHHHHHHH-CCCCCCcCCcc
Confidence 554 3333 6889999999999999999 89999876543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.34 Aligned_cols=208 Identities=21% Similarity=0.301 Sum_probs=172.8
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH-----HHHHHHHHHHHHHhcC--Ccce
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER-----EKAEFLNEASVMKAFD--THHV 184 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~il~~l~--h~~i 184 (364)
....+.+.++|++.+.||+|+||.||+|.++. .++.||+|++....... ....+.+|+.++++++ |+||
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVS----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETT----TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECC----CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 34556678999999999999999999998876 47789999987543211 1245667999999996 5999
Q ss_pred eEEEEEEeeCCceEEEEecCCC-CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7023 185 VKLYGVVSEGNPTLVIMELMGG-GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNC 263 (364)
Q Consensus 185 v~l~~~~~~~~~~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI 263 (364)
+++++++...+..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 180 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER----------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHE
Confidence 9999999999999999999976 8999999752 3567889999999999999999999999999999999
Q ss_pred EEc-CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 264 MVA-DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 264 Ll~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
|++ +++.+||+|||++........ ....+++.|+|||++.+..+ +.++||||||+++|||++ |..||...
T Consensus 181 ll~~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~ 252 (320)
T 3a99_A 181 LIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHD 252 (320)
T ss_dssp EEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSH
T ss_pred EEeCCCCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH-CCCCCCCh
Confidence 999 789999999999986654322 22346889999999987776 678999999999999999 88999653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=319.96 Aligned_cols=200 Identities=19% Similarity=0.330 Sum_probs=170.9
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
..+.+.++|++++.||+|+||+||+|.++.. .++.||+|++...........+.+|+.++++++||||+++++++..
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNV---NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGG---TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCC---CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 3456779999999999999999999998642 2678999998776666667788999999999999999999999987
Q ss_pred CCc-----eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7023 194 GNP-----TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD 268 (364)
Q Consensus 194 ~~~-----~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~ 268 (364)
.+. .|+||||++|++|.+++.. .+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~------------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~ 218 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ------------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE 218 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC
Confidence 665 7999999999999887642 57889999999999999999999999999999999999986
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
.+||+|||+++..... ....+|+.|+|||++.+. ++.++|||||||++|+|++ |.+||.+
T Consensus 219 -~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~-g~~~~~~ 278 (681)
T 2pzi_A 219 -QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTL-DLPTRNG 278 (681)
T ss_dssp -CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHS-CCCEETT
T ss_pred -cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHh-CCCCCcc
Confidence 8999999999865443 233468899999998765 4889999999999999999 7888764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=300.74 Aligned_cols=212 Identities=22% Similarity=0.294 Sum_probs=161.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~ 195 (364)
.+.+.|.+.+.||+|+||+||.+... .++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+++
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~~-----~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGSF-----QGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEES-----SSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred hhhheeeccCeEeeCCCeEEEEEEEE-----CCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 35567788899999999999865433 37889999886532 24567899999886 8999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-------
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD------- 268 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~------- 268 (364)
..|+||||++ |+|.+++......... ....++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDEN---LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchh---hhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999995 6999999864322111 0111233467899999999999999999999999999999754
Q ss_pred ------CcEEEeecccccccCcccee--eeCCCCCCCccccCcccccC-------CCCCCchhHHHHHHHHHHHHhCCCC
Q psy7023 269 ------LTVKVGDFGMTRDIYETEYY--RKGSRGFLPVRWMAPESLKD-------GVFTSHSDVWSYGVVLWEMATLASQ 333 (364)
Q Consensus 269 ------~~~kL~DFg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~t~g~~ 333 (364)
+.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|||+|+|..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999876543221 11223456889999999976 5689999999999999999998899
Q ss_pred CCCCCCHH
Q psy7023 334 PYQGLSNE 341 (364)
Q Consensus 334 P~~~~~~~ 341 (364)
||.+....
T Consensus 239 Pf~~~~~~ 246 (434)
T 2rio_A 239 PFGDKYSR 246 (434)
T ss_dssp TTCSTTTH
T ss_pred CCCCchhh
Confidence 99765443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=300.41 Aligned_cols=211 Identities=19% Similarity=0.257 Sum_probs=161.4
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~ 193 (364)
+.+-..+|.+.+.||+|+||+||..... .++.||||++..... ..+.+|+++|+.+ +||||+++++++.+
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~-----~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMF-----DNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEES-----SSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEe-----CCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 3444568999999999999997643333 367899999865332 2345799999999 89999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-----C
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-----D 268 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-----~ 268 (364)
....|+|||||. |+|.+++..... ......++.++.||+.||+|||++||+||||||+|||++. .
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~ 159 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDF---------AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGK 159 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSC---------CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTB
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCC---------CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCc
Confidence 999999999996 599999986321 2222345689999999999999999999999999999953 2
Q ss_pred CcEEEeecccccccCccce-eeeCCCCCCCccccCccccc---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy7023 269 LTVKVGDFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~ 344 (364)
..+||+|||+++....... ........+|+.|+|||++. ...++.++|||||||++|||+|+|.+||......+..
T Consensus 160 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~ 239 (432)
T 3p23_A 160 IKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239 (432)
T ss_dssp CCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH
T ss_pred eeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH
Confidence 3688999999987654321 12223345789999999997 4567889999999999999999889999766554443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.20 Aligned_cols=204 Identities=25% Similarity=0.445 Sum_probs=175.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee------
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE------ 193 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------ 193 (364)
++|++.+.||+|+||+||+|.++. .+..||+|++.........+.+.+|+.++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~----tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD----TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT----TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC----CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 689999999999999999998765 4778999999877677777889999999999999999999999765
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT--- 270 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~--- 270 (364)
++..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.||+||||||+|||++.++.
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~-------~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFE-------NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSS-------CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCE
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcc-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCcee
Confidence 678899999999999999998632 2234677789999999999999999999999999999999997765
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 163 vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt-G~~Pf~~~ 226 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLPN 226 (676)
T ss_dssp EEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS-SCSSCCSS
T ss_pred EEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH-CCCCCCcc
Confidence 99999999987654432 223456889999999999999999999999999999999 88899654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=299.95 Aligned_cols=194 Identities=19% Similarity=0.258 Sum_probs=159.2
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-------HHHHHHHHHHHHHHHhcC---------C
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-------EREKAEFLNEASVMKAFD---------T 181 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~il~~l~---------h 181 (364)
..++|++++.||+|+||+||+|++. ++.||+|++..... ....+.+.+|+.+++.++ |
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h 91 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIAD------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT 91 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEET------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred ccccchheeeecccCceEEEEEEeC------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence 3478999999999999999999873 57899999875431 222366788999998885 7
Q ss_pred cceeEEEEEEe------------------------------eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccH
Q psy7023 182 HHVVKLYGVVS------------------------------EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231 (364)
Q Consensus 182 ~~iv~l~~~~~------------------------------~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~ 231 (364)
|||+++.+++. ..+..|+||||+++|++.+.+.+ ..+++
T Consensus 92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~ 160 (336)
T 2vuw_A 92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSL 160 (336)
T ss_dssp CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCH
T ss_pred CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCH
Confidence 77777777642 26889999999999987766632 34688
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCC--------------------cEEEeecccccccCccceeee
Q psy7023 232 SRILQMAAEVADGMAYLA-DKKFVHRDLAARNCMVADDL--------------------TVKVGDFGMTRDIYETEYYRK 290 (364)
Q Consensus 232 ~~~~~i~~qil~~L~~LH-~~~iiHrDlkp~NILl~~~~--------------------~~kL~DFg~a~~~~~~~~~~~ 290 (364)
..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 161 ~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----- 235 (336)
T 2vuw_A 161 ATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----
Confidence 999999999999999999 99999999999999999887 9999999999865433
Q ss_pred CCCCCCCccccCcccccCCCCCCchhHHHHHHH-HHHHHhCCCCCCCC
Q psy7023 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVV-LWEMATLASQPYQG 337 (364)
Q Consensus 291 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i-l~el~t~g~~P~~~ 337 (364)
...+|+.|+|||++.+.. +.++|||||+++ .+++++ |..||.+
T Consensus 236 --~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~-g~~p~~~ 279 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWG-EYHPYSN 279 (336)
T ss_dssp --EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTT-SCCTHHH
T ss_pred --cEEEeecccChhhhcCCC-ccceehhhhhCCCCccccc-ccCCCcc
Confidence 124678899999998766 889999998777 677887 8889854
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=272.22 Aligned_cols=182 Identities=20% Similarity=0.372 Sum_probs=151.1
Q ss_pred ccceeEe-ceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHH-HhcCCcceeEEEEEEee---
Q psy7023 119 RSKVTIL-DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVM-KAFDTHHVVKLYGVVSE--- 193 (364)
Q Consensus 119 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il-~~l~h~~iv~l~~~~~~--- 193 (364)
.++|.++ +.||+|+||.||+|.++. .++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKR----TQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccchhhcCcccccCCCeEEEEEEEcC----CCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 3567776 789999999999999876 4778999998642 3456788887 55699999999999886
Q ss_pred -CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CC
Q psy7023 194 -GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---DL 269 (364)
Q Consensus 194 -~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~~ 269 (364)
....++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++. ++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHC--------TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC
T ss_pred CCceEEEEEeecCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCC
Confidence 67899999999999999999862 2346889999999999999999999999999999999999998 78
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~ 343 (364)
.+||+|||++.... +..++.++|||||||++|+|+| |..||.+.+..+.
T Consensus 158 ~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~ 206 (299)
T 3m2w_A 158 ILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAI 206 (299)
T ss_dssp CEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHH-SSCSCCC------
T ss_pred cEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHH-CCCCCCCCcchhh
Confidence 99999999885322 2447789999999999999999 8999977654443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=291.41 Aligned_cols=213 Identities=13% Similarity=0.101 Sum_probs=159.6
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH--HHHHHHHHHHHHHHhcCCc-c---------e--
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE--REKAEFLNEASVMKAFDTH-H---------V-- 184 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~il~~l~h~-~---------i-- 184 (364)
...|++.+.||+|+||+||+|.+.. +++.||||++...... ...+.+.+|+.+++.+.|. | +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred ceeEEEecccccCCCEEEEEEEecC----CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 3468889999999999999999876 4678999998743322 2256788999999999772 1 1
Q ss_pred ----------eEEEEEEee-----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH
Q psy7023 185 ----------VKLYGVVSE-----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA 249 (364)
Q Consensus 185 ----------v~l~~~~~~-----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH 249 (364)
..+..++.. ....+++|+++ +++|.++++...... .....+++..++.++.||+.||+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---STHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc---ccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 111111121 23467888876 679999996321100 12345678889999999999999999
Q ss_pred hCCceecCCCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccc----------cCCCCCCchhHHH
Q psy7023 250 DKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESL----------KDGVFTSHSDVWS 319 (364)
Q Consensus 250 ~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Diws 319 (364)
++|||||||||+||||+.++.+||+|||+++..... .....+ +.|+|||++ .+..++.++||||
T Consensus 229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 999999999999999999999999999998765433 122234 789999999 5566889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 320 YGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 320 lG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
|||++|||+| |+.||.+.+..+..+.
T Consensus 303 lGvil~ellt-g~~Pf~~~~~~~~~~~ 328 (413)
T 3dzo_A 303 LGLAIYWIWC-ADLPNTDDAALGGSEW 328 (413)
T ss_dssp HHHHHHHHHH-SSCCCCTTGGGSCSGG
T ss_pred HHHHHHHHHH-CCCCCCCcchhhhHHH
Confidence 9999999999 8999987665544433
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-34 Score=285.54 Aligned_cols=183 Identities=15% Similarity=0.076 Sum_probs=125.6
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEccccc---------CHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCc
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---------SEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~ 196 (364)
..+.|++|.+..++..- .+..+++|++.... .+...+++.+|+++|+++ .|+||+++++++++++.
T Consensus 241 ~~~~~~~~~h~~~rr~~----fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF----FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp C-C--------CCEEEE----ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred ccccCCccccccccccc----ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 35666666665544333 47789999986542 233456799999999999 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.||||||++|++|.++|++.. +++.. +|+.||+.||+|||++|||||||||+|||++++|.+||+||
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~----------~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGE----------EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTC----------CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecCCCCcHHHHHHhCC----------CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeec
Confidence 999999999999999998632 33333 47899999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHh
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMAT 329 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 329 (364)
|+|+........ .....+|+.|||||++.+ .+..++|+||+|+++++|.+
T Consensus 384 GlAr~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 384 GSIVTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp TTEESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred ccCeeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence 999876543321 122346899999999975 46778999999998877644
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-30 Score=254.72 Aligned_cols=187 Identities=16% Similarity=0.140 Sum_probs=141.4
Q ss_pred eEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-------HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-------EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 123 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
...+.||+|+||+||+|... +..+++|....... ....+++.+|++++++++||||+++..++...+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD 412 (540)
T ss_dssp ---------CCEEEEEEECS------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred CCCCEEeeCCCEEEEEEEEC------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence 34568999999999999543 45677886543211 112456889999999999999995555555667
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..|+||||++|++|.+++.. +..++.|++.||+|||+++|+||||||+|||+++ .+||+|
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECC
T ss_pred ccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEE
Confidence 88999999999999999864 3469999999999999999999999999999999 999999
Q ss_pred cccccccCccceee-----eCCCCCCCccccCcccccC--CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy7023 276 FGMTRDIYETEYYR-----KGSRGFLPVRWMAPESLKD--GVFTSHSDVWSYGVVLWEMATLASQPYQ 336 (364)
Q Consensus 276 Fg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t~g~~P~~ 336 (364)
||+++......... ......+|+.|||||++.. ..|+...|+|+..+-..+.+. .+.+|.
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~-~r~rY~ 539 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE-RRARYV 539 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH-TCSCCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH-hccccC
Confidence 99998775532211 0112345889999999986 568888999999999988887 677774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-27 Score=214.03 Aligned_cols=146 Identities=18% Similarity=0.184 Sum_probs=116.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-----------------HHHHHHHHHHHHHHhcCCc
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-----------------REKAEFLNEASVMKAFDTH 182 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~~E~~il~~l~h~ 182 (364)
..|.+.+.||+|+||.||+|.+. ++..||+|+++..... .....+.+|+.++++++|
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~-----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSE-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEET-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred eEEEecCEeccCCCceEEEEEeC-----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 45667799999999999999983 3778999998643221 235678899999999984
Q ss_pred ceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 183 ~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
+++.+++.. +..|+||||++|++|.+ +.. .....++.|++.||+|||++||+||||||+|
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~N 223 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYN 223 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cch----------------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHH
Confidence 555554444 56799999999999987 421 1244699999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCccccc
Q psy7023 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLK 307 (364)
Q Consensus 263 ILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 307 (364)
||++ ++.+||+|||+++. +..++|||.+.
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999 99999999999862 23478999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=180.77 Aligned_cols=139 Identities=19% Similarity=0.181 Sum_probs=106.2
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccc--eEEEEcccccCH-----------------------HHHHHHHHHHHH
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHP--CAIKVANENASE-----------------------REKAEFLNEASV 175 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~--vaiK~~~~~~~~-----------------------~~~~~~~~E~~i 175 (364)
-|++.+.||+|+||.||+|.+.. .+.. ||+|+++..... .....+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~----~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF----DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE----TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC----CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 47788999999999999998743 3667 999987543211 112467889999
Q ss_pred HHhcCCcce--eEEEEEEeeCCceEEEEecCCC-C----CHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHH
Q psy7023 176 MKAFDTHHV--VKLYGVVSEGNPTLVIMELMGG-G----DLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYL 248 (364)
Q Consensus 176 l~~l~h~~i--v~l~~~~~~~~~~~lv~e~~~g-g----sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~L 248 (364)
|+++.|+++ +.+++. +..+|||||+.+ | +|.++... .+...+..++.|++.+|.||
T Consensus 124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHHH
Confidence 999988754 444442 367899999942 3 67665432 11234678999999999999
Q ss_pred H-hCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 249 A-DKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 249 H-~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
| +.|||||||||+|||+++ .++|+|||+|...
T Consensus 187 H~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9 999999999999999998 9999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=7.8e-20 Score=172.18 Aligned_cols=137 Identities=12% Similarity=0.125 Sum_probs=100.7
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC----------------HH-----HHHHHHHHHHHHHhc
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS----------------ER-----EKAEFLNEASVMKAF 179 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~----------------~~-----~~~~~~~E~~il~~l 179 (364)
-|.+.+.||+|+||.||+|.+.. ++.||||+++.... .. .......|...|.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~-----G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK-----GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT-----CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCC-----CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 38899999999999999998764 77899998753210 00 011223577888888
Q ss_pred CCcce--eEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7023 180 DTHHV--VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRD 257 (364)
Q Consensus 180 ~h~~i--v~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrD 257 (364)
.+.++ ...++. ...+|||||++|++|..+... .....++.||+.+|.+||+.||||||
T Consensus 171 ~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------------~~~~~l~~qll~~l~~lH~~gIVHrD 230 (397)
T 4gyi_A 171 YEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------------PDPASLYADLIALILRLAKHGLIHGD 230 (397)
T ss_dssp HHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------------SCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HhcCCCCCeeeec----cCceEEEEecCCccHhhhccc----------------HHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 65544 233332 234799999999887543210 12356889999999999999999999
Q ss_pred CCCCCEEEcCCC----------cEEEeeccccccc
Q psy7023 258 LAARNCMVADDL----------TVKVGDFGMTRDI 282 (364)
Q Consensus 258 lkp~NILl~~~~----------~~kL~DFg~a~~~ 282 (364)
|||.|||+++++ .+.|+||+-+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999999876 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2.6e-13 Score=121.78 Aligned_cols=139 Identities=15% Similarity=0.107 Sum_probs=108.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~ 198 (364)
..|++...++.|+.+.||++... +..+++|+...... .....+.+|+.+++.+. +..++++++++...+..|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~------~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE------NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS------SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC------CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 45788888898999999988633 45789999864321 11235778999999985 567889999999888999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh----------------------------
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD---------------------------- 250 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~---------------------------- 250 (364)
+|||+++|.+|.+.+.. ......++.+++++|+.||+
T Consensus 87 lv~e~i~G~~l~~~~~~---------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp EEEECCSSEEHHHHCCT---------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred EEEEecCCeehhhccCC---------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 99999999998765311 01123678899999999998
Q ss_pred -------------------------------CCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 251 -------------------------------KKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 251 -------------------------------~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876666799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=7.2e-13 Score=118.22 Aligned_cols=132 Identities=20% Similarity=0.137 Sum_probs=93.8
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc--eeEEEEEEeeCCceEE
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH--VVKLYGVVSEGNPTLV 199 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~~~~~~~~l 199 (364)
+.+....+.|..+.||++...+ +..+++|+..... ...+.+|+.+++.+.+.+ +++++.+...++..++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~-----g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQG-----RPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTT-----SCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CceEecccCCCCceEEEEecCC-----CCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 3333333455669999986432 5679999876531 235667999999886544 5668888888788999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--------------------------- 252 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--------------------------- 252 (364)
||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~~~-------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH-------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD 154 (264)
T ss_dssp EEECCSSEETT--TSC-------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC
T ss_pred EEEecCCcccC--cCc-------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCcc
Confidence 99999998773 110 00 1245566666777777543
Q ss_pred -------------------------------ceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 253 -------------------------------FVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 253 -------------------------------iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
++|+|++|.|||+++++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 155 QDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999887667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.31 E-value=6.7e-12 Score=117.89 Aligned_cols=140 Identities=16% Similarity=0.194 Sum_probs=102.1
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcc--cccCHHHHHHHHHHHHHHHhcCC--cceeEEEEEEeeC---Cc
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN--ENASEREKAEFLNEASVMKAFDT--HHVVKLYGVVSEG---NP 196 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~E~~il~~l~h--~~iv~l~~~~~~~---~~ 196 (364)
-++.|+.|.++.||+.... +..+++|+.. ..........+.+|+.+++.+.. ..+++++.++.+. +.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp EEEECCC-CCSCEEEEECS------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred eEEEcCCcccceEEEEEEC------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 3567899999999988654 3467888776 33222234567889999999974 4578899888766 45
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh--------------------------
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-------------------------- 250 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-------------------------- 250 (364)
.|+||||++|..+.+. ....++......++.+++..|+.||+
T Consensus 116 ~~~vme~v~G~~l~~~------------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQ------------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT 183 (359)
T ss_dssp CEEEEECCCCBCCCCT------------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred eEEEEEecCCeecCCC------------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence 8999999998766431 11234566777889999999999997
Q ss_pred --------------------------------CCceecCCCCCCEEEcCCCc--EEEeecccccc
Q psy7023 251 --------------------------------KKFVHRDLAARNCMVADDLT--VKVGDFGMTRD 281 (364)
Q Consensus 251 --------------------------------~~iiHrDlkp~NILl~~~~~--~kL~DFg~a~~ 281 (364)
..++|+|++|.|||+++++. +.|+||+.+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1.8e-11 Score=112.37 Aligned_cols=183 Identities=13% Similarity=0.136 Sum_probs=114.4
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-Cc--ceeEEEEEEeeCC---ceE
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-TH--HVVKLYGVVSEGN---PTL 198 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~--~iv~l~~~~~~~~---~~~ 198 (364)
++.++.|....||+.. ..+++|+.... .....+.+|..+|+.+. +. .+.+++......+ ..|
T Consensus 25 i~~~~~G~~n~v~~v~---------~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~ 92 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---------RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF 92 (304)
T ss_dssp CCEEEECSSEEEEEST---------TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred eEecCCCCcceEEEEC---------CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence 3468999999999752 45888986532 34567888999999884 33 2455555543333 358
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh----------------------------
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD---------------------------- 250 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~---------------------------- 250 (364)
+||++++|.+|.+.... .++..+...++.|++..|+.||+
T Consensus 93 ~vm~~i~G~~l~~~~~~------------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLLN------------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKL 160 (304)
T ss_dssp EEEECCCCEECCHHHHH------------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHH
T ss_pred EEEcccCCeECCccccc------------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHH
Confidence 99999999887653321 23344555666666666666664
Q ss_pred ------------------------------CCceecCCCCCCEEEcC--CCcEEEeecccccccCccceeeeCCCCCCCc
Q psy7023 251 ------------------------------KKFVHRDLAARNCMVAD--DLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298 (364)
Q Consensus 251 ------------------------------~~iiHrDlkp~NILl~~--~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~ 298 (364)
..++|+|++|.||++++ +..+.|+||+.+..-.... ........ .
T Consensus 161 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~-~- 237 (304)
T 3sg8_A 161 LSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMED-D- 237 (304)
T ss_dssp HTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCT-T-
T ss_pred hcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhh-c-
Confidence 24799999999999998 5567899999876432211 10000000 0
Q ss_pred cccCcccccC-----CC---------CCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 299 RWMAPESLKD-----GV---------FTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 299 ~y~aPE~~~~-----~~---------~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
.-..|+.... +. .....+.|+++.++|.+.+ |..+|
T Consensus 238 ~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~-g~~~~ 287 (304)
T 3sg8_A 238 EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEY-GYMDW 287 (304)
T ss_dssp TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHT-TCHHH
T ss_pred cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHc-CCHHH
Confidence 0012221110 00 1122689999999999999 66665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=9.8e-08 Score=87.45 Aligned_cols=75 Identities=11% Similarity=0.116 Sum_probs=54.9
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCc---ceeEEEEEEe-eCCceEEE
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH---HVVKLYGVVS-EGNPTLVI 200 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~---~iv~l~~~~~-~~~~~~lv 200 (364)
++.++.|....||+. +..+++|+... ......+.+|..+|+.+.+. .+.+++.+.. ..+..|+|
T Consensus 24 v~~l~~G~~n~v~~v---------g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v 91 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---------NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG 91 (306)
T ss_dssp EEEEEECSSEEEEEE---------TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred eeecCCCcceeEEEE---------CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence 345788888899976 34578888532 23456788999999999753 4667777664 45567899
Q ss_pred EecCCCCCHHH
Q psy7023 201 MELMGGGDLKN 211 (364)
Q Consensus 201 ~e~~~ggsL~~ 211 (364)
||+++|.+|.+
T Consensus 92 ~e~i~G~~l~~ 102 (306)
T 3tdw_A 92 YRKVQGQILGE 102 (306)
T ss_dssp EECCCSEECHH
T ss_pred EeccCCeECch
Confidence 99999987765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=9.9e-08 Score=85.41 Aligned_cols=131 Identities=12% Similarity=0.097 Sum_probs=90.5
Q ss_pred eeeecce-EEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCC-cceeEEEEEEeeCCceEEEEecCC
Q psy7023 128 LGNGSFG-LVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT-HHVVKLYGVVSEGNPTLVIMELMG 205 (364)
Q Consensus 128 lG~G~~g-~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lv~e~~~ 205 (364)
+..|..+ .||+..... .+..+.+|+.... ....+.+|..+|+.+.. -.+.+++.++.+.+..|+|||+++
T Consensus 32 ~~~G~S~~~v~rl~~~~----~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKP----NAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EECSSSSCEEEEEECCT----TCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred ccCCCcCCeEEEEEecC----CCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 4445554 689876543 3556888986432 34567789999998843 247788999998899999999999
Q ss_pred CCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q psy7023 206 GGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD----------------------------------- 250 (364)
Q Consensus 206 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~----------------------------------- 250 (364)
|.++.+...... .....++.++...|..||+
T Consensus 104 G~~~~~~~~~~~--------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 104 GKTAFQVLEEYP--------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp SEEHHHHHHHCG--------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred CccccccccCCH--------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 988776543210 0112234444444444442
Q ss_pred ----------------C-------CceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 251 ----------------K-------KFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 251 ----------------~-------~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
. .++|+|+++.|||+++++.+-|+||+.+.
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1 27899999999999988777899999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=3.7e-07 Score=86.58 Aligned_cols=77 Identities=17% Similarity=0.169 Sum_probs=49.0
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccC--H----HHHHHHHHHHHHHHhcCC--c-ceeEEEEEEeeCC
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--E----REKAEFLNEASVMKAFDT--H-HVVKLYGVVSEGN 195 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~----~~~~~~~~E~~il~~l~h--~-~iv~l~~~~~~~~ 195 (364)
.+.||.|.++.||++.... .+..+++|....... . ....++..|.++++.+.. + .+++++.+ +.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~----~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~ 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC--------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred EEECCCCceEEEEEEEECC----CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC
Confidence 4579999999999996543 246789997653211 0 012345678888888742 3 45566644 345
Q ss_pred ceEEEEecCCCC
Q psy7023 196 PTLVIMELMGGG 207 (364)
Q Consensus 196 ~~~lv~e~~~gg 207 (364)
..++|||++++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 678999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-07 Score=87.49 Aligned_cols=87 Identities=9% Similarity=0.033 Sum_probs=54.7
Q ss_pred Eecee-eeecceEEEEEEEcCc--ccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCC---cceeEEEEEEeeC-
Q psy7023 124 ILDEL-GNGSFGLVYRGLIKDF--RSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDT---HHVVKLYGVVSEG- 194 (364)
Q Consensus 124 ~~~~l-G~G~~g~V~~a~~~~~--~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h---~~iv~l~~~~~~~- 194 (364)
..+.| +.|....+|+...... ....+..+++|+...... ......+.+|+.+++.+.. -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 35567 7888899998764300 000145688888654320 0001345678888888843 2577788877655
Q ss_pred --CceEEEEecCCCCCHH
Q psy7023 195 --NPTLVIMELMGGGDLK 210 (364)
Q Consensus 195 --~~~~lv~e~~~ggsL~ 210 (364)
+..|+|||+++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999986543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.37 E-value=5.7e-06 Score=76.22 Aligned_cols=30 Identities=17% Similarity=0.329 Sum_probs=27.5
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 251 KKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 251 ~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.08 E-value=2.6e-05 Score=74.41 Aligned_cols=32 Identities=25% Similarity=0.294 Sum_probs=28.2
Q ss_pred HhCCceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 249 ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 249 H~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456899999999999999876 99999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.96 E-value=6.9e-05 Score=68.54 Aligned_cols=76 Identities=13% Similarity=0.221 Sum_probs=58.3
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC---CcceeEEEEEEeeCCceEEE
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD---THHVVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~~~~lv 200 (364)
-.+.|+.|....+|+.... +..+++|+.... ....+..|...|+.+. ...+++++.+....+..|+|
T Consensus 40 ~~~~l~gG~~n~~y~v~~~------~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv 109 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE------VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL 109 (312)
T ss_dssp EEEEECCSSSSEEEEEESS------SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred eeEEeCCccceeeeEEEEC------CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence 3567899999999987632 456888886543 2456778999999884 24688899888877889999
Q ss_pred EecCCCCCH
Q psy7023 201 MELMGGGDL 209 (364)
Q Consensus 201 ~e~~~ggsL 209 (364)
||+++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.91 E-value=5.1e-05 Score=68.40 Aligned_cols=79 Identities=20% Similarity=0.195 Sum_probs=55.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCc---ceeEEEEEEeeCCc
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH---HVVKLYGVVSEGNP 196 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~---~iv~l~~~~~~~~~ 196 (364)
.+..-++.+|.|..+.||+.+..+ ++.|.+|+....... ....+..|+..|+.+... .+++++.+. .
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~D-----G~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~ 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELAD-----GTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETT-----SCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T
T ss_pred CCeEEEEecCCCCCeEEEEEEECC-----CCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEecc----C
Confidence 455667889999999999998765 677999986543221 123466799999988432 355555542 3
Q ss_pred eEEEEecCCCCC
Q psy7023 197 TLVIMELMGGGD 208 (364)
Q Consensus 197 ~~lv~e~~~ggs 208 (364)
-++||||++++.
T Consensus 85 ~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 RTLAMEWVDERP 96 (288)
T ss_dssp TEEEEECCCCCC
T ss_pred ceEEEEeecccC
Confidence 478999998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.88 E-value=3.7e-05 Score=69.79 Aligned_cols=71 Identities=17% Similarity=0.199 Sum_probs=43.4
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce-eEEEEEEeeCCceEEEEec
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV-VKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lv~e~ 203 (364)
++.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++... .+.-++|+||
T Consensus 23 i~~l~gG~tN~~~~~----------~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----------GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE----------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEEC
T ss_pred eeEcCCcccccccee----------eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEee
Confidence 567888999999987 24788887643211 1122457777777743333 3555443 3345789999
Q ss_pred C-CCCCH
Q psy7023 204 M-GGGDL 209 (364)
Q Consensus 204 ~-~ggsL 209 (364)
+ +|.+|
T Consensus 89 i~~g~~l 95 (301)
T 3dxq_A 89 IAGAQTM 95 (301)
T ss_dssp CTTCEEC
T ss_pred cCCCccC
Confidence 9 66444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00012 Score=67.36 Aligned_cols=32 Identities=38% Similarity=0.445 Sum_probs=27.5
Q ss_pred hCCceecCCCCCCEEEcCC----CcEEEeecccccc
Q psy7023 250 DKKFVHRDLAARNCMVADD----LTVKVGDFGMTRD 281 (364)
Q Consensus 250 ~~~iiHrDlkp~NILl~~~----~~~kL~DFg~a~~ 281 (364)
...++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999875 6899999998763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00019 Score=65.51 Aligned_cols=148 Identities=12% Similarity=0.100 Sum_probs=78.3
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc--eeEEEEE------EeeCC
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH--VVKLYGV------VSEGN 195 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~------~~~~~ 195 (364)
-++.|+.|....+|+....+ ..+++|+..... ....+..|..+++.+...+ +.+++.. ....+
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~------g~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTK------DPLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEECC---EEEEEEEESS------CCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred EeeccCCCcccceEEEEeCC------ccEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 34567888889999886542 258889876521 1234456777777774322 2333321 12245
Q ss_pred ceEEEEecCCCCCHH--------------HHHHhcC-CCCCCccCCCC-ccHHHHHH------------HHHHHHHHHHH
Q psy7023 196 PTLVIMELMGGGDLK--------------NYLRSCR-PDAETDVERSP-PTLSRILQ------------MAAEVADGMAY 247 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~--------------~~l~~~~-~~~~~~~~~~~-~~~~~~~~------------i~~qil~~L~~ 247 (364)
..++++++++|..+. ..++... ........... ..+..... +...+...++.
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 678999999885431 1122211 11110000000 01111000 00113344555
Q ss_pred HHh-------CCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 248 LAD-------KKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 248 LH~-------~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
+++ .+++|+|+++.|||+++++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 542 368999999999999987666899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00062 Score=62.22 Aligned_cols=142 Identities=16% Similarity=0.160 Sum_probs=77.4
Q ss_pred eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc--eeEEEEE-----EeeCCceEE
Q psy7023 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH--VVKLYGV-----VSEGNPTLV 199 (364)
Q Consensus 127 ~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~-----~~~~~~~~l 199 (364)
.|+ |....||+....+ +..+++|+....... ...+..|..+++.+.... +++++.. ...++..++
T Consensus 33 ~l~-g~~n~~y~v~~~~-----g~~~vlK~~~~~~~~--~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDED-----RRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEC-CSSSEEEEECCTT-----CCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred eec-CcccceEEEEcCC-----CCEEEEEEcCCCCCC--HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 456 7788999875432 456889998643211 234556888888774322 3444432 122456688
Q ss_pred EEecCCCCCHH-----------HH---HHhc-CCCCCCccCCCCccHH----------------------HHHHHHHHHH
Q psy7023 200 IMELMGGGDLK-----------NY---LRSC-RPDAETDVERSPPTLS----------------------RILQMAAEVA 242 (364)
Q Consensus 200 v~e~~~ggsL~-----------~~---l~~~-~~~~~~~~~~~~~~~~----------------------~~~~i~~qil 242 (364)
||++++|..+. .. ++.. ...... ........ .....+.+++
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 182 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFI--HRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI 182 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCS--SSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCc--cCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHH
Confidence 99999874321 11 1111 110000 00011111 1112222333
Q ss_pred HHHHHH----HhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 243 DGMAYL----ADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 243 ~~L~~L----H~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
..++-+ ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 183 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 183 AAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 333322 234589999999999999 4 89999998775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00015 Score=68.07 Aligned_cols=149 Identities=15% Similarity=0.228 Sum_probs=82.1
Q ss_pred eceeeeecceEEEEEEEcCc---ccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc-eeEEEEEEeeCCceEEE
Q psy7023 125 LDELGNGSFGLVYRGLIKDF---RSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH-VVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~~~~lv 200 (364)
++.|..|-...+|+....+. .......+++|+...... ....+.+|..+++.+...+ ..++++.+.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ--GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 34677788889999875421 011246788998643211 2345568999998884333 3566666653 289
Q ss_pred EecCCCCCHH--------------HHHHhcCCCCCCccCCCCc-cHHHHHHHHHHHHH-------------------HHH
Q psy7023 201 MELMGGGDLK--------------NYLRSCRPDAETDVERSPP-TLSRILQMAAEVAD-------------------GMA 246 (364)
Q Consensus 201 ~e~~~ggsL~--------------~~l~~~~~~~~~~~~~~~~-~~~~~~~i~~qil~-------------------~L~ 246 (364)
|||++|..|. +.+.+.-.... .....+. -+.++.++..++-. .++
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~-~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM-PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC-SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC-CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999985432 11111000000 0111111 23455555544422 233
Q ss_pred HHH----h----CCceecCCCCCCEEEcCC----CcEEEeeccccc
Q psy7023 247 YLA----D----KKFVHRDLAARNCMVADD----LTVKVGDFGMTR 280 (364)
Q Consensus 247 ~LH----~----~~iiHrDlkp~NILl~~~----~~~kL~DFg~a~ 280 (364)
.|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 2 258999999999999876 789999999876
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=97.51 E-value=1.1e-05 Score=78.14 Aligned_cols=63 Identities=13% Similarity=0.185 Sum_probs=17.5
Q ss_pred eEeceeeeecceEEEEEEEcCcccccccceEE------EEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAI------KVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 123 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vai------K~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.+.+.|| ||.||+|.++.. ..+||+ |..+... .......+.+|..+++.+.|+|+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~----~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKK----HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC-------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhccccccc----CCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456776 999999988652 346777 6655432 2333456888999999999999999887753
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.49 E-value=4.6e-05 Score=59.06 Aligned_cols=43 Identities=14% Similarity=0.044 Sum_probs=33.4
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
||..+|+.|+||||+| ++.. .|++|++.+.. ...++||+|+..
T Consensus 30 lL~~~~~~GaFLVR~S-----e~~~-~ySLSVR~~~~-~~~VKHYkI~~~ 72 (125)
T 3maz_A 30 MLQKNPSLGNMILRPG-----SDSR-NYSITIRQEID-IPRIKHYKVMSV 72 (125)
T ss_dssp HHHHCGGGCSEEEEEC-----TTSS-SEEEEEEECSS-SCEEEEEEEEEE
T ss_pred HHhccCCCCcEEEEeC-----CCCC-CEEEEEEecCC-CCCEeeeEEEEe
Confidence 3456889999999999 3444 68888888754 457999999974
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00069 Score=64.75 Aligned_cols=78 Identities=13% Similarity=0.263 Sum_probs=50.0
Q ss_pred EeceeeeecceEEEEEEEcCccc---ccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce-eEEEEEEeeCCceEE
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRS---LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV-VKLYGVVSEGNPTLV 199 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~l 199 (364)
-++.|+.|....||++...+... ..+..+++|+...... ...+.+|..+++.+...++ +++++.+.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 35678888889999987643110 0145788998743222 1344579999988854444 567766543 38
Q ss_pred EEecCCCCC
Q psy7023 200 IMELMGGGD 208 (364)
Q Consensus 200 v~e~~~ggs 208 (364)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998733
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00021 Score=66.72 Aligned_cols=78 Identities=13% Similarity=0.135 Sum_probs=43.9
Q ss_pred eceeeeecceEEEEEEEcCccc----ccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc-eeEEEEEEeeCCceEE
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRS----LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH-VVKLYGVVSEGNPTLV 199 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~~~~l 199 (364)
+..|+.|..-.+|+....+... .....+++|+....... ......|..+++.+...+ ..++++.+. -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence 4567788888999887543100 01257888987543211 112346888888775444 346665442 278
Q ss_pred EEecCCCCC
Q psy7023 200 IMELMGGGD 208 (364)
Q Consensus 200 v~e~~~ggs 208 (364)
||||++|..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0013 Score=63.41 Aligned_cols=75 Identities=16% Similarity=0.170 Sum_probs=46.5
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce-eEEEEEEeeCCceEEEEec
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV-VKLYGVVSEGNPTLVIMEL 203 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lv~e~ 203 (364)
++.|+.|-...+|+....+ .+..+++|+....... .....+|..+++.+...++ +++++.+. + .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~----~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS----KQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETT----TTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECC----CCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence 4568888889999987643 1356889987532211 0111468899998865554 56777663 2 259999
Q ss_pred CCCCCH
Q psy7023 204 MGGGDL 209 (364)
Q Consensus 204 ~~ggsL 209 (364)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987443
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00028 Score=53.54 Aligned_cols=44 Identities=32% Similarity=0.434 Sum_probs=35.4
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCC-ccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSST-KFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| +...+.|.||++.+... ...+.|+.|..
T Consensus 21 L~~~g~~~G~FLVR~S-----~~~~g~~~LSv~~~~~~~~~~v~H~~I~~ 65 (106)
T 1aot_F 21 LLSFGNPRGTFLIRES-----ETTKGAYSLSIRDWDDMKGDHVKHYKIRK 65 (106)
T ss_dssp HHTTTCCTTEECCBCB-----SSSSSBBCCEEECCBTTTBCCEEECCBEE
T ss_pred HhhCCCCCcEEEEEeC-----CCCCCCEEEEEEecccCCCCcEEEEEEEE
Confidence 4457899999999999 55667889999987754 34799999886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0026 Score=58.70 Aligned_cols=31 Identities=19% Similarity=0.288 Sum_probs=27.5
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeecccccc
Q psy7023 251 KKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281 (364)
Q Consensus 251 ~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~ 281 (364)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888899999987753
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0014 Score=49.54 Aligned_cols=44 Identities=20% Similarity=0.153 Sum_probs=33.7
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCC-ccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSST-KFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| +...+.|.+|++..... ...+.||.|..
T Consensus 20 L~~~~~~~G~FLVR~S-----~~~~g~~~LSv~~~~~~~~~~v~H~~I~~ 64 (105)
T 1lkk_A 20 LLAPGNTHGSFLIRES-----ESTAGSFSLSVRDFDQNQGEVVKHYKIRN 64 (105)
T ss_dssp HTSTTCCTTCEEEEEC-----SSSTTCEEEEEEEEETTTEEEEEEEEEEE
T ss_pred HHhcCCCCceEEEEEC-----CCCCCcEEEEEEEcccCCCCcEEEEEEEE
Confidence 4456899999999999 55567788888865433 34789999886
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0011 Score=50.18 Aligned_cols=40 Identities=20% Similarity=0.121 Sum_probs=31.0
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|...|++.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 21 L~~~g~~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 60 (105)
T 1nrv_A 21 IKQQGLVDGLFLLRDS-----QSNPKAFVLTLCH----HQKIKNFQILP 60 (105)
T ss_dssp HHHTTCCTTEEEEEEC-----SSCTTCEEEEEEE----TTEEEEEEEEE
T ss_pred HHhcCCCCceEEEEeC-----CCCCCCEEEEEEe----CCEEEEEEEEE
Confidence 3456899999999999 4556677888875 35789998876
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00065 Score=52.20 Aligned_cols=44 Identities=18% Similarity=0.010 Sum_probs=32.9
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| +...+.|.||++..+.....+.||.|..
T Consensus 28 L~~~g~~~G~FLVR~S-----~~~~g~y~LSv~~~~~~~~~v~H~~I~~ 71 (114)
T 1blj_A 28 LLAPMNKAGSFLIRES-----ESNKGAFSLSVKDITTQGEVVKHYKIRS 71 (114)
T ss_dssp HSSTTCCTTCEEBCBC-----TTCSSCEEEEECBCCTTTCBCCCEEEEE
T ss_pred HhhCCCCCceEEEEeC-----CCCCCCEEEEEEEecCCCCcEEEEEEEE
Confidence 4557899999999999 4556677777775443345789998876
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.00094 Score=49.99 Aligned_cols=40 Identities=20% Similarity=0.093 Sum_probs=30.4
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|.+.|++.|+||||+| +...+.|.+|++. ...+.|+.|..
T Consensus 18 L~~~g~~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 57 (100)
T 1rja_A 18 LQAEGNATGAFLIRVS-----EKPSADYVLSVRD----TQAVRHYKIWR 57 (100)
T ss_dssp HSSTTCSSCCEEEEEC-----SSSSSCEEEEECT----TSSCEEEEEEE
T ss_pred HhccCCCCCEEEEEeC-----CCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 4557899999999999 4555666777764 35789998886
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0015 Score=50.70 Aligned_cols=40 Identities=20% Similarity=0.017 Sum_probs=31.4
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| +...+.|.||++. ...+.||.|..
T Consensus 32 L~~~~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 71 (121)
T 2dly_A 32 LLYSENQTGAFLIRES-----ESQKGDFSLSVLD----EGVVKHYRIRR 71 (121)
T ss_dssp HTSSSCCTTCEEEEEC-----SSSSSCEEEEEES----SSCEEEEEEEE
T ss_pred HhcCCCCCCEEEEEcC-----CCCCCceEEEEEE----CCeEEEEEEEE
Confidence 5567899999999999 4556667788775 35789998876
|
| >2cr4_A 3BP-2, SH3 domain-binding protein 2; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0012 Score=51.61 Aligned_cols=43 Identities=16% Similarity=-0.025 Sum_probs=33.1
Q ss_pred cccccCCCc-ceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 18 GFLNFGPPR-GTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 18 ~~~~~~~~~-~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
+||..|++. |+||||+| + ..+.|.||++.- ....++||.|+..
T Consensus 35 ~Ll~~g~~~dG~FLVR~S-----~-~~g~y~LSv~~~--~~~~vkH~rI~~~ 78 (126)
T 2cr4_A 35 ATSPRGEPQDGLYCIRNS-----S-TKSGKVLVVWDE--TSNKVRNYRIFEK 78 (126)
T ss_dssp HHSTTSCCCTTCEEEEEC-----S-STTCEEEEEEET--TTTEECCEECEEE
T ss_pred HHhhCCCCCCCeEEEEec-----C-CCCCEEEEEEeC--CCCCEEEEEEEEC
Confidence 667788886 99999999 5 677788888762 2357899998863
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0018 Score=50.67 Aligned_cols=40 Identities=20% Similarity=0.074 Sum_probs=31.3
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|...|+|.|+||||+| +...+.|.||++. ...++||.|..
T Consensus 42 L~~~g~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 81 (126)
T 2aug_A 42 IIQQGLVDGVFLVRDS-----QSNPKTFVLSMSH----GQKIKHFQIIP 81 (126)
T ss_dssp HHTTTCCTTEEEEEEC-----SSSSCCEEEEEEE----TTEEEEEEEEE
T ss_pred HhccCCCCCEEEEeec-----CCCCCCEEEEEEc----CCeEEEEEEEE
Confidence 4456899999999999 4556677888875 34789998876
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0019 Score=49.77 Aligned_cols=40 Identities=20% Similarity=0.111 Sum_probs=30.5
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|...|++.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 30 L~~~g~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 69 (117)
T 3pqz_A 30 IGQQGLVDGLFLVRES-----QRNPQGFVLSLCH----LQKVKHYLILP 69 (117)
T ss_dssp HHHTTCCTTEEEEEEC-----CC-CCCEEEEEEE----TTEEEEEEEEE
T ss_pred HhcCCCCCCEEEEEec-----CCCCCcEEEEEEe----CCeeEEEEEEE
Confidence 3446899999999999 4555677788776 45799999876
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.00096 Score=51.62 Aligned_cols=41 Identities=5% Similarity=-0.009 Sum_probs=32.0
Q ss_pred ccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 21 NFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 21 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
..| +.|+||||+| +...+.|.||++...+....++||.|..
T Consensus 39 ~~~-~~G~FLVR~S-----~~~~g~y~LSv~~~~~~~~~v~H~~I~~ 79 (118)
T 2el8_A 39 RYP-ECGNLLLRPS-----GDGADGVSVTTRQMHNGTHVVRHYKVKR 79 (118)
T ss_dssp HSS-TTCSBEEEEC-----CSSSSSEEEEECCCBTTBCCCEEECBCC
T ss_pred hCC-CCcEEEEeeC-----CCCCCceEEEEEEecCCCCcEEEEEEEE
Confidence 456 9999999999 5566778888887654456799998875
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0027 Score=52.65 Aligned_cols=44 Identities=20% Similarity=0.173 Sum_probs=35.1
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCc-cceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTK-FNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| +...+.|.||++..+... ..+.||+|..
T Consensus 90 L~~~~~~~G~FLVR~S-----~~~~g~y~LSv~~~~~~~~~~v~H~~I~~ 134 (175)
T 4d8k_A 90 LLAPGNTHGSFLIRES-----ESTAGSFSLSVRDFDQNQGEVVKHYKIRN 134 (175)
T ss_dssp HHSTTCCTTCEEEEEC-----SSSTTCEEEEEEEECTTSCEEEEEEEEEE
T ss_pred HhcCCCCCCEEEEEEC-----CCCCCeEEEEEEeCcccCCCceEEEEEEE
Confidence 4557899999999999 566777889998766544 3799999876
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0029 Score=48.75 Aligned_cols=40 Identities=18% Similarity=0.031 Sum_probs=30.6
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+|..+++.|+||||+| +...+.|.||++. ...++|+.|..
T Consensus 21 lL~~~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 60 (117)
T 3ov1_A 21 MLSKQRHDGAFLIRES-----ESAPGDFSLSVKF----GNDVQHFKVLR 60 (117)
T ss_dssp HHHTCCSTTBEEEEEC-----SSSTTCEEEEEEE----TTEEEEEECEE
T ss_pred HHhCCCCCCcEEEEeC-----CCCCCCEEEEEec----CCceEEEEEEE
Confidence 3444889999999999 5666678888875 34689998875
|
| >2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0026 Score=48.56 Aligned_cols=40 Identities=18% Similarity=0.112 Sum_probs=30.0
Q ss_pred ccccCC-CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGP-PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~-~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|...|+ +.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 25 L~~~g~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 65 (111)
T 2hdv_A 25 VLEGGTGSHGVFLVRQS-----ETRRGECVLTFNF----QGKAKHLRLSL 65 (111)
T ss_dssp HHTTGGGGTTEEEEEEC-----SSCTTEEEEEEEE----TTEEEEEEEEE
T ss_pred HHHcCCCCCCeEEEEec-----CCCCCCEEEEEEe----CCeEEEEEEEE
Confidence 334565 9999999999 4555667788775 45789999876
|
| >2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0049 Score=46.96 Aligned_cols=36 Identities=17% Similarity=0.112 Sum_probs=28.9
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+++.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 37 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 72 (111)
T 2eo3_A 37 GQRHGMFLVRDS-----STCPGDYVLSVSE----NSRVSHYIINS 72 (111)
T ss_dssp SCCTTCEEEEEC-----SSSSSCEEEEEEE----TTEEEEEEEEE
T ss_pred CCCCceEEEEee-----cCCCCCEEEEEEe----CCeEEEEEEEE
Confidence 789999999999 4555677888875 35789999886
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.86 E-value=0.043 Score=46.88 Aligned_cols=117 Identities=15% Similarity=0.111 Sum_probs=75.8
Q ss_pred CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCCcEEEeecccccccCcc
Q psy7023 207 GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLA-DKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285 (364)
Q Consensus 207 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH-~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~~ 285 (364)
-+|.+.|+. ...++++.+++.++.|.+.+|.-+- ++.-..+=+.|..|++..+|.|-+.+ ..+. .
T Consensus 33 vSL~eIL~~---------~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----~ 98 (229)
T 2yle_A 33 LSLEEILRL---------YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----A 98 (229)
T ss_dssp EEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------
T ss_pred ccHHHHHHH---------cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----c
Confidence 479999985 5678999999999999999987762 22222444567999999999988875 2111 0
Q ss_pred ceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHh
Q psy7023 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL----SNEQVLNWVK 348 (364)
Q Consensus 286 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~----~~~~~~~~i~ 348 (364)
. ...+.+||... ...+.+.=|||||++||.-+-.|-++-... .-+.++..+.
T Consensus 99 -----~-----~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 99 -----G-----EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMA 154 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHT
T ss_pred -----c-----ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHH
Confidence 0 11367888763 345678899999999999998655544322 2244555554
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=95.80 E-value=0.0058 Score=45.79 Aligned_cols=35 Identities=17% Similarity=0.032 Sum_probs=27.3
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.+.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 23 ~~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 57 (103)
T 1i3z_A 23 GVDGNFLIRDS-----ESVPGALCLCVSF----KKLVYSYRIFR 57 (103)
T ss_dssp CSTTEEEEEEC-----SSSTTCEEEEEEC----SSSEEEEEEEE
T ss_pred CCCceEEEEeC-----CCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 38899999999 4555667777774 35789999886
|
| >2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.0074 Score=47.93 Aligned_cols=38 Identities=26% Similarity=0.127 Sum_probs=29.6
Q ss_pred cCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 22 FGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 22 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
.|++.|+||||+| +...+.|.||++. ...++||.|...
T Consensus 46 ~g~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~~ 83 (138)
T 2dx0_A 46 TGAKDGTFLVRES-----ETFPNDYTLSFWR----SGRVQHCRIRST 83 (138)
T ss_dssp TTCCTTCEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEEE
T ss_pred cCCCCCEEEEEeC-----CCCCCCeEEEEEE----CCeEEEEEEEEe
Confidence 3899999999999 4555667777774 357899998864
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=95.75 E-value=0.006 Score=45.83 Aligned_cols=34 Identities=15% Similarity=-0.004 Sum_probs=27.1
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|+||||+| +...+.|.+|++. ...+.|+.|..
T Consensus 25 ~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 58 (104)
T 1d4t_A 25 LDGSYLLRDS-----ESVPGVYCLCVLY----HGYIYTYRVSQ 58 (104)
T ss_dssp CTTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred CCCEEEEeeC-----CCCCCCEEEEEEE----CCeEEEEEEEE
Confidence 7899999999 5556677888875 34789998886
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.021 Score=54.17 Aligned_cols=78 Identities=10% Similarity=0.086 Sum_probs=46.2
Q ss_pred eceeeeecceEEEEEEEcCccc---ccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc-eeEEEEEEeeCCceEEE
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRS---LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH-VVKLYGVVSEGNPTLVI 200 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~~~~lv 200 (364)
++.|..|-...+|+........ .....+++|+...... ......+|..+++.+...+ ..++++.+. -++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 4567668888999887652110 0146788888654321 1112346888888774333 345565332 2789
Q ss_pred EecCCCCC
Q psy7023 201 MELMGGGD 208 (364)
Q Consensus 201 ~e~~~ggs 208 (364)
|||++|..
T Consensus 149 ~efI~G~~ 156 (424)
T 3mes_A 149 EEFIDGEP 156 (424)
T ss_dssp EECCCSEE
T ss_pred EEEeCCcc
Confidence 99999855
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A | Back alignment and structure |
|---|
Probab=95.54 E-value=0.0079 Score=45.59 Aligned_cols=34 Identities=15% Similarity=-0.036 Sum_probs=27.1
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|+||||+| +...+.|.+|++. ...++|++|..
T Consensus 28 ~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 61 (109)
T 3tkz_A 28 VDGSFLARPS-----KSNPGDFTLSVRR----NGAVTHIKIQN 61 (109)
T ss_dssp CTTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred CCCEEEEEec-----CCCCCCEEEEEEE----CCEEEEEEEEe
Confidence 8999999999 5566777888875 45789998875
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=95.48 E-value=0.0078 Score=52.80 Aligned_cols=40 Identities=23% Similarity=0.189 Sum_probs=31.9
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
++..|++.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 29 ~~~~~~~dG~FLVR~S-----~s~~G~y~LSv~~----~~~v~H~~I~~ 68 (246)
T 4fbn_A 29 CIETGAPDGSFLVRES-----ETFVGDYTLSFWR----NGKVQHCRIHS 68 (246)
T ss_dssp HHHHTCCTTCEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred hhccCCCCCEEEEEcC-----CCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 3457999999999999 6777888888864 34688998875
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A | Back alignment and structure |
|---|
Probab=95.44 E-value=0.012 Score=43.53 Aligned_cols=36 Identities=11% Similarity=0.029 Sum_probs=28.5
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.+.|+||||+| +...+.|.+|++. ...+.|+.|..
T Consensus 23 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 58 (98)
T 3us4_A 23 PPEDGLFLVRES-----ARHPGDYVLCVSF----GRDVIHYRVLH 58 (98)
T ss_dssp SCCTTCEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred CCCCcEEEEEeC-----CCCCCcEEEEEEE----CCceEEEEEEE
Confidence 458999999999 5666777888876 45689998876
|
| >3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A | Back alignment and structure |
|---|
Probab=95.38 E-value=0.013 Score=44.52 Aligned_cols=36 Identities=17% Similarity=0.144 Sum_probs=28.7
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+++.|+||||+| +...+.|.+|++. ...+.|+.|..
T Consensus 23 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 58 (112)
T 3k2m_A 23 SGINGSFLVRES-----ESSPGQRSISLRY----EGRVYHYRINT 58 (112)
T ss_dssp TCCTTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred cCCCceEEEEeC-----CCCCCCEEEEEEe----CCcEEEEEEEE
Confidence 578999999999 5566777888776 34789999876
|
| >3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A | Back alignment and structure |
|---|
Probab=95.35 E-value=0.013 Score=44.07 Aligned_cols=36 Identities=14% Similarity=-0.025 Sum_probs=28.1
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.+.|+||||+| +...+.|.+|++. ...+.|+.|..
T Consensus 26 ~~~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 61 (106)
T 3eaz_A 26 PPETGLFLVRES-----TNYPGDYTLCVSS----DGKVEHYRIMY 61 (106)
T ss_dssp SCCTTEEEEEEC-----TTSTTCEEEEEEE----TTEEEEEECEE
T ss_pred CCCCCEEEEEEC-----CCCCCcEEEEEEe----CCceEEEEEEe
Confidence 468999999999 5566677788775 45789998875
|
| >1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=95.33 E-value=0.0089 Score=45.33 Aligned_cols=36 Identities=19% Similarity=0.137 Sum_probs=27.5
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+++.|+||||+| +...+.|.||++. ...+.||.|..
T Consensus 18 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 53 (109)
T 1ju5_A 18 GQRHGVFLVRDS-----STSPGDYVLSVSE----NSRVSHYIINS 53 (109)
T ss_dssp TCCTTEEEEEEC-----SSSTTEEEEEEEC----SSCEEEEEEEC
T ss_pred CCCCCEEEEEec-----CCCCCCEEEEEEE----CCeEEEEEEEE
Confidence 589999999999 4455567777764 34689998876
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.21 E-value=0.093 Score=49.29 Aligned_cols=28 Identities=21% Similarity=0.419 Sum_probs=24.5
Q ss_pred ceecCCCCCCEEE------cCCCcEEEeeccccc
Q psy7023 253 FVHRDLAARNCMV------ADDLTVKVGDFGMTR 280 (364)
Q Consensus 253 iiHrDlkp~NILl------~~~~~~kL~DFg~a~ 280 (364)
++|+|+.+.|||+ +++..+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456789999999886
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* | Back alignment and structure |
|---|
Probab=95.19 E-value=0.013 Score=43.22 Aligned_cols=34 Identities=18% Similarity=0.023 Sum_probs=26.9
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|+||||+| +...+.|.+|++. ...+.|+.|..
T Consensus 24 ~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 57 (96)
T 1jyr_A 24 HDGAFLIRES-----ESAPGDFSLSVKF----GNDVQHFKVLR 57 (96)
T ss_dssp STTBEEEEEC-----SSSTTCEEEEEEE----TTEEEEEECEE
T ss_pred CCcEEEEEec-----CCCCCCEEEEEEe----CCeEEEEEEEE
Confidence 4999999999 5556678888876 34789998876
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A | Back alignment and structure |
|---|
Probab=95.00 E-value=0.0094 Score=46.64 Aligned_cols=34 Identities=15% Similarity=-0.004 Sum_probs=26.9
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|+||||+| +...+.|.+|++. ...++||.|..
T Consensus 25 ~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 58 (128)
T 1ka6_A 25 LDGSYLLRDS-----ESVPGVYCLCVLY----HGYIYTYRVSQ 58 (128)
T ss_dssp CTTCEEEEEC-----SSSTTCEEEEEES----SSCEEEEEEEE
T ss_pred CCCEEEEeec-----CCCCCCEEEEEEe----CCEEEEEEEEE
Confidence 7899999999 4556677788774 34789999886
|
| >3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=94.91 E-value=0.017 Score=47.68 Aligned_cols=42 Identities=14% Similarity=-0.037 Sum_probs=29.3
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| . ..+.|.||++.-.. ...++||.|+.
T Consensus 28 L~~~~~~~G~FLVR~S-~-----~~g~y~LSv~~~~~-~~~v~H~~I~~ 69 (174)
T 3qwx_X 28 LGEPQVSIGTFLMRDS-S-----RPGEYSLTVREADE-GNAVCHYLIER 69 (174)
T ss_dssp HHSTTCCTTEEEEEEC-S-----STTCEEEEEECCSS-SSCEEEEEEEE
T ss_pred HhccCCCCCeEEEEec-C-----CCCCEEEEEEECCC-CCceEEEEEEe
Confidence 4456899999999999 2 34556777775211 12489999876
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=94.86 E-value=0.008 Score=44.99 Aligned_cols=35 Identities=17% Similarity=0.008 Sum_probs=25.9
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.+.|+||||+| +...+.|.+|++. ...+.|+.|..
T Consensus 25 ~~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 59 (102)
T 2cia_A 25 GVEGDFLIRDS-----ESSPSDFSVSLKA----SGKNKHFKVQL 59 (102)
T ss_dssp CCTTEEEEEEC-----SSSTTCEEEEECC----SSSCEEEEEEE
T ss_pred CCCcEEEEEEC-----CCCCCCEEEEEEe----CCeeEEEEEEe
Confidence 37899999999 4555667777764 34688888873
|
| >1h9o_A Phosphatidylinositol 3-kinase; transferase/receptor, complex (phosphotransferase/receptor), phosphotransferase, SH2 domain; HET: PTR; 1.79A {Homo sapiens} SCOP: d.93.1.1 PDB: 1pic_A* 1bfi_A 1bfj_A 1qad_A | Back alignment and structure |
|---|
Probab=94.84 E-value=0.022 Score=43.36 Aligned_cols=36 Identities=19% Similarity=0.048 Sum_probs=27.2
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
+++.|+||||+| . ..+.|.||++. ...+.|+.|...
T Consensus 28 ~~~~G~FLVR~S-~-----~~g~y~LSv~~----~~~v~H~~I~~~ 63 (112)
T 1h9o_A 28 GKRDGTFLVRES-S-----KQGCYACSVVV----DGEVKHCVINKT 63 (112)
T ss_dssp TCCTTEEEEEEC-S-----STTCEEEEEEE----TTEEEEEEEEEE
T ss_pred CCCCceEEEeec-C-----CCCCEEEEEEE----CCEEEEEEEEEc
Confidence 689999999999 3 23456777775 347899998863
|
| >1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A* | Back alignment and structure |
|---|
Probab=94.77 E-value=0.017 Score=42.99 Aligned_cols=35 Identities=14% Similarity=-0.015 Sum_probs=27.2
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.|.|+||||+| +...+.+.+|++. ...+.|+.|..
T Consensus 28 ~~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 62 (100)
T 1r1p_A 28 KDIGFFIIRAS-----QSSPGDFSISVRH----EDDVQHFKVMR 62 (100)
T ss_dssp SCTTBEEEEEC-----SSSTTCEEEEEEC----SSSEEEEECEE
T ss_pred CCCCEEEEEec-----CCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 48999999999 4555667777775 34689998876
|
| >2iug_A Phosphatidylinositol 3-kinase regulatory alpha subunit; transferase, polymorphism, UBL conjugation, phosphorylation, SH2, PI3K, SH2 domain; 1.89A {Homo sapiens} PDB: 2iuh_A* 2iui_A* 1fu5_A* 1fu6_A 1oo3_A 1oo4_A* 2pna_A 2pnb_A | Back alignment and structure |
|---|
Probab=94.77 E-value=0.022 Score=43.95 Aligned_cols=36 Identities=17% Similarity=-0.036 Sum_probs=27.5
Q ss_pred CCCcceEEEecccccccccc-CCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEIS-CLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|.|+||||+| +.. .+.|.||++. ...+.|+.|..
T Consensus 29 ~~~~G~FLVR~S-----~~~~~g~y~LSv~~----~~~v~H~~I~~ 65 (120)
T 2iug_A 29 DTADGTFLVRDA-----STKMHGDYTLTLRK----GGNNKLIKIFH 65 (120)
T ss_dssp TCCTTEEEEEEC-----SSGGGCSEEEEEEE----TTEEEEEEEEE
T ss_pred CCCCcEEEEECC-----CCCCCCcEEEEEEE----CCEEEEEEEEE
Confidence 478999999999 444 5677888775 34688998876
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.012 Score=45.31 Aligned_cols=37 Identities=22% Similarity=0.076 Sum_probs=27.0
Q ss_pred ccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 21 NFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 21 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
..| +.|+||||+| +...+.|.||++. ...++||.|..
T Consensus 34 ~~g-~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 70 (119)
T 2gsb_A 34 TVG-QVCSFLVRPS-----DNTPGDYSLYFRT----NENIQRFKICP 70 (119)
T ss_dssp HTC-CSSEEEEEEC-----SSSTTCEEEEEEC----SSCBCCCCEEE
T ss_pred hcC-CCCeEEEEeC-----CCCCCceEEEEEE----CCEEEEEEEEE
Confidence 345 4599999999 4556677777764 24688888876
|
| >2crh_A VAV proto-oncogene; oncoprotein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2ror_A* 2lct_A* | Back alignment and structure |
|---|
Probab=94.72 E-value=0.027 Score=44.64 Aligned_cols=35 Identities=11% Similarity=0.025 Sum_probs=27.7
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIR 66 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 66 (364)
+.+.|+||||+| +...+.|.||++. ...++||.|+
T Consensus 44 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~ 78 (138)
T 2crh_A 44 NRSDGTFLVRQR-----VKDAAEFAISIKY----NVEVKHIKIM 78 (138)
T ss_dssp TSCTTEEEEECC-----SSTTCCCEEEEEE----TTEEEEEECE
T ss_pred CCCCCEEEEEEC-----CCCCCCEEEEEEE----CCeEEEEEEE
Confidence 368899999999 4556778888886 3478999885
|
| >2eo6_A B-cell linker protein; SH2, cytoplasmic adapter protein, B-cell adapter containing SH2 domain protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=94.67 E-value=0.0094 Score=47.50 Aligned_cols=36 Identities=17% Similarity=0.148 Sum_probs=27.7
Q ss_pred CCCcceEEEeccccccccc--cCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEI--SCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.+.|+||||+| +. ..+.|.||++. ...++|+.|+.
T Consensus 42 ~~~~G~FLVR~S-----~~~~~~g~y~LSv~~----~~~v~H~~I~~ 79 (141)
T 2eo6_A 42 SNKDGSFLIRKS-----SGHDSKQPYTLVAFF----NKRVYNIPVRF 79 (141)
T ss_dssp HCCTTCBCEEEC-----STTCSSCSEEEEEEE----TTEEEEEEECE
T ss_pred cCCCceEEEEEC-----CCCCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 457999999999 44 45677888875 34789998875
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=94.62 E-value=0.02 Score=50.37 Aligned_cols=40 Identities=18% Similarity=0.017 Sum_probs=31.5
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| +...+.|.||++. ...+.||.|..
T Consensus 22 L~~~~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 61 (254)
T 2oq1_A 22 LKLAGMADGLFLLRQC-----LRSLGGYVLSLVH----DVRFHHFPIER 61 (254)
T ss_dssp HHHTTCCTTCEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred HhccCCCCcEEEEEeC-----CCCCCCEEEEEEE----CCeEEEEEEEE
Confidence 3347899999999999 5566778888874 45799999886
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=94.59 E-value=0.022 Score=50.20 Aligned_cols=40 Identities=15% Similarity=-0.018 Sum_probs=31.6
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 21 L~~~g~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 60 (254)
T 1a81_A 21 LVQGGMSDGLYLLRQS-----RNYLGGFALSVAH----GRKAHHYTIER 60 (254)
T ss_dssp HHHTTCCTTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred HhcCCCCCcEEEEEec-----CCCCCCEEEEEEE----CCeeEEEEEEE
Confidence 4457899999999999 5566777888874 34799999986
|
| >2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.57 E-value=0.015 Score=44.77 Aligned_cols=34 Identities=15% Similarity=0.146 Sum_probs=26.7
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|+||||+| +...+.|.||++. ...+.||.|..
T Consensus 31 ~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 64 (119)
T 2ysx_A 31 KDGSFLVRAS-----ESISRAYALCVLY----RNCVYTYRILP 64 (119)
T ss_dssp CTTEEEEEEC-----SSCTTSEEEEEEC----SSCEEEEEEEE
T ss_pred CCCEEEEEeC-----CCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 8899999999 4556677777775 35789998876
|
| >2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A | Back alignment and structure |
|---|
Probab=94.48 E-value=0.017 Score=45.32 Aligned_cols=40 Identities=18% Similarity=0.049 Sum_probs=30.0
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCC-----------ccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSST-----------KFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ 67 (364)
+.+.|+||||+| +...+.|.||++..+.. ...+.||.|..
T Consensus 38 ~~~~G~FLVR~S-----~s~~g~y~LSv~~~~~~~~~~~~~g~~~~~~v~H~~I~~ 88 (131)
T 2kno_A 38 DKDPGAFLIRDS-----HSFQGAYGLALKVATPPPSAQPWKGDPVEQLVRHFLIET 88 (131)
T ss_dssp TSCTTBEEEEEC-----SSSTTEEEEEEECSCCSSSSSSCCSCHHHHHEEEEEEEC
T ss_pred CCCCCeEEEecC-----CCCCCCEEEEEEeCCCCcccccccccccCCceEEEEEEE
Confidence 468999999999 55666788888875321 24699999886
|
| >1mil_A SHC adaptor protein; SH2 domain, phosphorylation, collagen, growth regulation, transforming protein, alternative initiation; 2.70A {Homo sapiens} SCOP: d.93.1.1 PDB: 1tce_A* | Back alignment and structure |
|---|
Probab=94.37 E-value=0.031 Score=41.89 Aligned_cols=33 Identities=12% Similarity=-0.133 Sum_probs=25.2
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIR 66 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 66 (364)
+.|+||||+| +...+.|.+|++. ...+.|+.|.
T Consensus 25 ~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~ 57 (104)
T 1mil_A 25 LNGDFLVRES-----TTTPGQYVLTGLQ----SGQPKHLLLV 57 (104)
T ss_dssp STTEEEEEEC-----CSSCSSEEEEEEE----TTEEEEEEEB
T ss_pred cCCcEEEEeC-----CCCCCCEEEEEEE----CCEEEEEEEE
Confidence 6799999999 4556677788775 3468888775
|
| >2hmh_A Suppressor of cytokine signaling 3; SOCS3, GP130, PTyr, peptide complex, cytokine regulator; HET: PTR; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.36 E-value=0.031 Score=45.03 Aligned_cols=36 Identities=19% Similarity=0.026 Sum_probs=28.2
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+++.|+||||+| +...+.|.||++. ...++|+.|..
T Consensus 52 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~rI~~ 87 (152)
T 2hmh_A 52 AEPAGTFLIRDS-----SDQRHFFTLSVKT----QSGTKNLRIQX 87 (152)
T ss_dssp TSCTTEEEEEEC-----CSTTCSEEEEEEE----TTEEEEEEEEC
T ss_pred CCCCCcEEEEeC-----CCCCCcEEEEEEc----CCceEEEEEEe
Confidence 478899999999 4556677888875 34789998875
|
| >2eob_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2; SH2, phosphoinositide phospholipase C, PLC-gamma-2, phospholipase C-gamma-2; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=94.32 E-value=0.028 Score=43.65 Aligned_cols=34 Identities=15% Similarity=0.136 Sum_probs=26.4
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
++.|+||||+| + ..+.|.||++. ...++||.|..
T Consensus 39 ~~~G~FLVR~S-----~-~~g~y~LSv~~----~~~v~H~~I~~ 72 (124)
T 2eob_A 39 PRDGAFLIRKR-----E-GTDSYAITFRA----RGKVKHCRINR 72 (124)
T ss_dssp CSSSEEEEECC-----T-TSSCEEEEEEE----TTEEEEEEEEE
T ss_pred CCCCEEEEEec-----C-CCCCEEEEEEe----CCeEEEEEEEE
Confidence 46799999999 5 56677888775 34789998875
|
| >2kk6_A Proto-oncogene tyrosine-protein kinase FER; methods development, SH2, NESG, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.31 E-value=0.033 Score=42.65 Aligned_cols=34 Identities=18% Similarity=0.001 Sum_probs=26.3
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|+||||+| +...+.|.||++. ...+.||.|..
T Consensus 35 ~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 68 (116)
T 2kk6_A 35 KQGDFLVRES-----HGKPGEYVLSVYS----DGQRRHFIIQY 68 (116)
T ss_dssp STTCEEEEEC-----TTCTTCEEEEEEE----TTEEEEEEEEE
T ss_pred cCCcEEEEEC-----CCCCCcEEEEEEE----CCeEEEEEEEe
Confidence 5799999999 4555677888875 34789998874
|
| >2c9w_A Suppressor of cytokine signaling 2; growth regulation, SH2 domain, signal transduction inhibitor nuclear protein; 1.9A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=94.22 E-value=0.031 Score=45.89 Aligned_cols=37 Identities=19% Similarity=0.019 Sum_probs=28.2
Q ss_pred cCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 22 FGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 22 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.+++.|+||||+| +...+.+.+|++. ...+.|+.|..
T Consensus 34 ~~~~~G~FLVR~S-----~~~~~~~~LSv~~----~~~v~H~rI~~ 70 (169)
T 2c9w_A 34 KEAPEGTFLIRDS-----SHSDYLLTISVKT----SAGPTNLRIEY 70 (169)
T ss_dssp TTSCTTCEEEEEC-----CSTTCSEEEEEEE----TTEEEEEEEEE
T ss_pred CCCCCcEEEEecC-----CCCCCeEEEEEEE----CCeeEEEEEEE
Confidence 3689999999999 4556667777764 24688998876
|
| >2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.21 E-value=0.02 Score=44.07 Aligned_cols=36 Identities=17% Similarity=0.124 Sum_probs=27.8
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.+.|+||||+| +...+.|.||++. ...+.||.|..
T Consensus 34 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 69 (119)
T 2ecd_A 34 SLINGSFLVRES-----ESSPGQLSISLRY----EGRVYHYRINT 69 (119)
T ss_dssp TSCTTBEEEEEE-----SSSTTEEEEEEEC----SSCEEEECCCC
T ss_pred CCCCCeEEEEeC-----CCCCCCEEEEEEE----CCeEEEEEEEE
Confidence 468899999999 4556667777774 34689998875
|
| >2vif_A Suppressor of cytokine signalling 6; growth regulation, signal transduction inhibitor, KIT regula phosphotyrosine, signaling protein; HET: PTR; 1.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.13 E-value=0.038 Score=43.90 Aligned_cols=36 Identities=19% Similarity=0.082 Sum_probs=27.2
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.+.|+||||+| +...+.|.+|++. ...++|+.|..
T Consensus 42 ~~~~G~FLVR~S-----~~~~~~~~LSv~~----~~~v~H~~I~~ 77 (141)
T 2vif_A 42 NVPDGSFLVRDS-----SDDRYLLSLSFRS----HGKTLHTRIEH 77 (141)
T ss_dssp TSCTTCEEEEEC-----SSTTCSEEEEEEE----TTEEEEEEEEE
T ss_pred CCCCceEEEEec-----CCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 358899999999 4555667777764 34789998886
|
| >2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=94.12 E-value=0.02 Score=44.14 Aligned_cols=36 Identities=19% Similarity=0.247 Sum_probs=26.4
Q ss_pred cCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 22 FGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 22 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.++|.|+||||+|. ...+ |.||++. ...+.|+.|..
T Consensus 33 ~~~~~G~FLVR~S~-----~~~~-y~LSv~~----~~~v~H~~I~~ 68 (119)
T 2cs0_A 33 ESQPLGSFLIRVSH-----SHVG-YTLSYKA----QSSCCHFMVKL 68 (119)
T ss_dssp HTSCTTCEEEEECS-----SSSS-EEEEECC----SSSCEEEEEEE
T ss_pred cCCCCCEEEEEecC-----CCCC-EEEEEEE----CCEEEEEEEEE
Confidence 37899999999993 4444 6666653 24689998886
|
| >2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.98 E-value=0.04 Score=42.28 Aligned_cols=35 Identities=9% Similarity=-0.063 Sum_probs=27.6
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.+.|+||||+| +...+.|.||++. ...+.||.|..
T Consensus 35 ~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 69 (118)
T 2dlz_A 35 HASGTYLIRER-----PAEAERFAISIKF----NDEVKHIKVVE 69 (118)
T ss_dssp SCTTBEEEECC-----SCSSCCEEEEEEC----SSSEEEEEEEE
T ss_pred CCCCEEEEEeC-----CCCCCCEEEEEEE----CCcEEEEEEEE
Confidence 48899999999 4556677888874 35789999886
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.96 E-value=0.024 Score=42.91 Aligned_cols=38 Identities=11% Similarity=0.009 Sum_probs=26.3
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeec--CCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWS--STKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 67 (364)
++.|+||||+|. +.+.|.||++..+ .....++||.|..
T Consensus 31 ~~~G~FLVR~S~------~~g~y~LSv~~~~~~~~~~~v~H~~I~~ 70 (110)
T 2ekx_A 31 GKEGAFMVRNSS------QVGMYTVSLFSKAVNDKKGTVKHYHVHT 70 (110)
T ss_dssp CCTTEEEEEECS------STTCEEEEECCCCSSCSSCCCEEEECEE
T ss_pred CCCceEEEEecC------CCCCEEEEEEeccccCCCCcEEEEEEEE
Confidence 378999999992 2455667766543 1234789999886
|
| >2izv_A Suppressor of cytokine signaling 4; signal transduction inhibitor, growth regulation, signal transduction, SH2 domain, nuclear protein; 2.55A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=93.67 E-value=0.045 Score=45.70 Aligned_cols=37 Identities=22% Similarity=0.064 Sum_probs=25.1
Q ss_pred cCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 22 FGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 22 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.+.|.|+||||+|+ ...+.+++|++. ...++|+.|..
T Consensus 51 ~~~~dGtFLVR~S~-----~~~~~lsLSvr~----~~~v~H~rI~~ 87 (187)
T 2izv_A 51 EGKPEGTFLLRDSA-----QEDYLFSVSFRR----YSRSLHARIEQ 87 (187)
T ss_dssp TTCCTTEEEEEECS-----STTCSEEEEEEE----TTEEEEEECEE
T ss_pred cCCCCCcEEEEECC-----CCCceEEEEEee----CCeEEEEEEEE
Confidence 35789999999993 333344444442 34789998876
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.55 E-value=0.045 Score=42.48 Aligned_cols=38 Identities=13% Similarity=0.021 Sum_probs=27.4
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecC--Cccceeeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSS--TKFNIFLFLIRVA 68 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 68 (364)
+.|+||||+|. ..+.|.||++..+. ....+.||.|...
T Consensus 32 ~~G~FLVR~Ss------~~g~y~LSv~~~~~~~~~~~v~H~~I~~~ 71 (125)
T 2ge9_A 32 KEGGFIVRDSS------KAGKYTVSVFAKSTGDPQGVIRHYVVCST 71 (125)
T ss_dssp CTTEEEEEECS------SSCCEEEEEEESSSSSTTCEEEEEECEEE
T ss_pred CCceEEEEecC------CCCCEEEEEEeccccCCCCeEEEEEEEEc
Confidence 78999999992 25567788876432 2347999998763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.39 E-value=0.049 Score=54.33 Aligned_cols=40 Identities=18% Similarity=0.017 Sum_probs=32.6
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| +...+.|.||++. ...+.||+|..
T Consensus 24 L~~~~~~~G~fLvR~s-----~~~~g~~~ls~~~----~~~~~h~~i~~ 63 (613)
T 2ozo_A 24 LKLAGMADGLFLLRQC-----LRSLGGYVLSLVH----DVRFHHFPIER 63 (613)
T ss_dssp HHTTTCCTTEEEEEEC-----TTBTTCEEEEEEE----TTEEEEEEEEE
T ss_pred HhccCCCCCeEEEEec-----CCCCCCEEEEEEE----CCeEEEEEEEE
Confidence 4457899999999999 6777888888885 34789999876
|
| >2lnw_A VAV-2, guanine nucleotide exchange factor VAV2; signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2lnx_A | Back alignment and structure |
|---|
Probab=93.37 E-value=0.038 Score=42.73 Aligned_cols=35 Identities=9% Similarity=-0.063 Sum_probs=26.5
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
++.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 41 ~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 75 (122)
T 2lnw_A 41 HASGTYLIRER-----PAEAERFAISIKF----NDEVKHIKVVE 75 (122)
T ss_dssp SCTTBEEEEEC-----CCSSEEEEEEEEC----SSCEEEEEEEE
T ss_pred CCCCeEEEEeC-----CCCCCcEEEEEEe----CCcEEEEEEEE
Confidence 58999999999 4455566777765 35689998875
|
| >3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B | Back alignment and structure |
|---|
Probab=93.26 E-value=0.04 Score=42.16 Aligned_cols=38 Identities=13% Similarity=-0.005 Sum_probs=27.0
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecC--Cccceeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSS--TKFNIFLFLIR 66 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 66 (364)
.++.|+||||+| . ..+.|.||++.... ....++||.|+
T Consensus 28 ~~~~G~FLVR~S-~-----~~g~y~LSv~~~~~~~~~~~v~H~~I~ 67 (118)
T 3s9k_A 28 TGKEGAFMVRDS-R-----TPGTYTVSVFTKAIISENPCIKHYHIK 67 (118)
T ss_dssp HCCTTCEEEEEC-S-----STTCEEEEEEECCSCSSSCEEEEEEEE
T ss_pred cCCCCeEEEEee-C-----CCCCEEEEEEecccccCCCceEEEEEe
Confidence 358999999999 3 24567788776532 23579999994
|
| >2bbu_A Suppressor of cytokine signaling 3; SH2 domain, extended SH2 subdomain, PEST motif, protein complex, cytokine regulator; HET: PTR; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=92.95 E-value=0.036 Score=45.24 Aligned_cols=36 Identities=19% Similarity=0.024 Sum_probs=27.6
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+++.|+||||+| +...+.|.||++. ...++|+.|..
T Consensus 41 ~~~~GtFLVR~S-----~s~~g~y~LSvr~----~~~v~H~rI~~ 76 (164)
T 2bbu_A 41 AEPAGTFLIRDS-----SDQRHFFTLSVKT----QSGTKNLRIQC 76 (164)
T ss_dssp HSSTTCCEEEEC-----STTSCCEEEEECC----TTCCEEEECEE
T ss_pred CCCCCCEEEEEC-----CCCCCCEEEEEEE----CCceEEEEEEe
Confidence 378999999999 4556677777764 34688888875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=92.73 E-value=0.064 Score=53.72 Aligned_cols=41 Identities=15% Similarity=-0.017 Sum_probs=32.5
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
|+..|++.|+||||+| +...+.|.||++. ...++||+|...
T Consensus 29 L~~~~~~~G~FLvR~S-----~~~~g~y~lsv~~----~~~v~h~~i~~~ 69 (635)
T 4fl3_A 29 LVQGGMSDGLYLLRQS-----RNYLGGFALSVAH----GRKAHHYTIERE 69 (635)
T ss_dssp HHHTTCCTTEEEEEEC-----TTSSSCEEEEEEE----TTEEEEEEEEEC
T ss_pred HhcCCCCCceEEEeec-----ccCCCCEEEEEEe----CCEEEeEEEEEc
Confidence 4567899999999999 5667778888875 447999998763
|
| >2dvj_A V-CRK sarcoma virus CT10 oncogene homolog, isoform A; SH3, SH2, signal transduction, adapter molecule, signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2eyy_A 2eyv_A 2eyw_A | Back alignment and structure |
|---|
Probab=92.59 E-value=0.032 Score=48.30 Aligned_cols=36 Identities=19% Similarity=0.137 Sum_probs=27.9
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+++.|+||||+| +...+.|.||++. ...++||.|..
T Consensus 31 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 66 (230)
T 2dvj_A 31 GQRHGVFLVRDS-----STSPGDYVLSVSE----NSRVSHYIINS 66 (230)
T ss_dssp TSSSSCBEEECC-----SSCTTSCEEECCC----SSSCCCEECBC
T ss_pred CCCCceEEEEeC-----CCCCCCEEEEEEE----CCEEEEEEEEe
Confidence 578999999999 5556677777764 34688988875
|
| >1wqu_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; SH2 domain, feline sarcoma oncogene, structural genomics; NMR {Homo sapiens} PDB: 2dcr_A | Back alignment and structure |
|---|
Probab=92.57 E-value=0.093 Score=39.94 Aligned_cols=33 Identities=18% Similarity=-0.057 Sum_probs=24.2
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|+||||+|+ ... .|.||++. ...+.|+.|..
T Consensus 34 ~~G~FLVR~S~-----~~~-~y~LSv~~----~~~v~H~~I~~ 66 (114)
T 1wqu_A 34 HSGDFLVRESQ-----GKQ-EYVLSVLW----DGLPRHFIIQS 66 (114)
T ss_dssp STTEEEEEECS-----SSC-CEEEEEEE----TTEEEEEECEE
T ss_pred cCCeEEEEEcC-----CCC-CEEEEEEE----CCEEEEEEEEe
Confidence 47999999994 333 56777765 34689998876
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=92.50 E-value=0.074 Score=46.70 Aligned_cols=39 Identities=13% Similarity=0.127 Sum_probs=29.5
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|...|++.|+||||+| . ..+.|.||++. ...++||.|..
T Consensus 175 L~~~g~~~G~FLVR~S-~-----~~g~~~LSv~~----~~~v~H~~I~~ 213 (254)
T 2oq1_A 175 LYSGAQTDGKFLLRPR-K-----EQGTYALSLIY----GKTVYHYLISQ 213 (254)
T ss_dssp HHSSCCCTTEEEEEEC-S-----STTEEEEEEEE----TTEEEEEEEEE
T ss_pred HHhcCCCCceEEEEec-C-----CCCCEEEEEEE----CCeEEEEEEEE
Confidence 4466899999999999 2 23456777775 45799999886
|
| >2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A | Back alignment and structure |
|---|
Probab=92.36 E-value=0.048 Score=49.31 Aligned_cols=36 Identities=19% Similarity=0.137 Sum_probs=28.6
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+++.|+||||+| +...+.|.||++. ...++||.|..
T Consensus 29 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 64 (304)
T 2eyz_A 29 GQRHGVFLVRDS-----STSPGDYVLSVSE----NSRVSHYIINS 64 (304)
T ss_dssp TCCSSCEECCSC-----CSSSSCCEEEECS----SSSCEEEECCC
T ss_pred CCCCCEEEEEeC-----CCCCCCEEEEEEE----CCEEEEEEEee
Confidence 789999999999 4556677888764 34789998876
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=92.28 E-value=0.096 Score=45.99 Aligned_cols=39 Identities=10% Similarity=0.050 Sum_probs=29.3
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|...|++.|+||||+| . ..+.|.||++. ...+.|+.|..
T Consensus 174 L~~~g~~~G~FLVR~S-~-----~~g~~~LSv~~----~~~v~H~~I~~ 212 (254)
T 1a81_A 174 VLIGSKTNGKFLIRAR-D-----NNGSYALCLLH----EGKVLHYRIDK 212 (254)
T ss_dssp HHSSCCCTTCEEEEEC-S-----SSSCEEEEEEE----TTEEEEEEEEE
T ss_pred HHhcCCCCceEEEEec-C-----CCCCEEEEEEE----CCEEEEEEEEE
Confidence 3456899999999999 2 23566777774 34789999886
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.81 E-value=0.033 Score=43.21 Aligned_cols=37 Identities=19% Similarity=0.105 Sum_probs=26.0
Q ss_pred CcceEEEeccccccccccCCCCcceEEeec--CCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWS--STKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 67 (364)
+.|+||||+|. ..+.|.||++..+ .....++||.|..
T Consensus 37 ~~G~FLVR~S~------~~g~y~LSv~~~~~~~~~~~v~H~~I~~ 75 (125)
T 2dm0_A 37 KEGAFIVRDSR------HLGSYTISVFMGARRSTEAAIKHYQIKK 75 (125)
T ss_dssp STTCBCEEEET------TEEEEEEEEECCCSSSSSCCEEEEEEEE
T ss_pred CCCEEEEEecC------CCCCEEEEEEeccccCCCCcEEEEEEEE
Confidence 77999999993 1345677777543 1234799999886
|
| >3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=91.25 E-value=0.14 Score=46.34 Aligned_cols=42 Identities=14% Similarity=-0.053 Sum_probs=29.2
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|+..+++.|+||||+| ...+.|.||++.-.. ...++||.|+.
T Consensus 57 L~~~~~~~G~FLVR~S------~~~g~y~LSv~~~~~-~~~v~H~~I~~ 98 (308)
T 3qwy_A 57 LGEPQVSIGTFLMRDS------SRPGEYSLTVREADE-GNAVCHYLIER 98 (308)
T ss_dssp HHSTTCCTTEEEEEEC------SSTTCEEEEEECCSS-SSCEEEEEEEE
T ss_pred HhccCCCCceEEEEcc------CCCCCEEEEEEeCCC-CCceEEEEEee
Confidence 3445899999999999 234566777775321 12489999876
|
| >2y3a_B Phosphatidylinositol 3-kinase regulatory subunit; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=90.74 E-value=0.12 Score=46.44 Aligned_cols=37 Identities=19% Similarity=-0.023 Sum_probs=27.8
Q ss_pred cCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 22 FGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 22 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
.|+|.|+||||+| . ..+.|.||++. ...+.||.|...
T Consensus 211 ~~~~~GtFLVR~S-s-----~~g~y~LSv~~----~~~V~H~rI~~~ 247 (302)
T 2y3a_B 211 SGKRDGTFLIRES-S-----QRGCYACSVVV----DGDTKHCVIYRT 247 (302)
T ss_dssp TTSCTTBEEBCCC-S-----STTCEEEEEEC----SSSEEEEEEEEE
T ss_pred cCCCCCcEEEEec-c-----CCCceEEEEEe----CCeeEEEEEEEC
Confidence 4789999999999 2 23566777774 347999998863
|
| >3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A | Back alignment and structure |
|---|
Probab=90.50 E-value=0.16 Score=47.00 Aligned_cols=36 Identities=17% Similarity=-0.036 Sum_probs=27.5
Q ss_pred CCCcceEEEecccccccccc-CCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEIS-CLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+++.|+||||+| +.. .+.|.||++. ...+.|+.|..
T Consensus 28 ~~~dG~FLVR~S-----~s~~~g~y~LSvr~----~~~v~H~rI~~ 64 (373)
T 3hhm_B 28 DTADGTFLVRDA-----STKMHGDYTLTLRK----GGNNKLIKIFH 64 (373)
T ss_dssp TCCTTEEEEEEC-----SCC--CCEEEEEEE----TTEEEEEEECC
T ss_pred CCCCCCEEEecc-----CCCCCCCEEEEEEE----CCeeEEEEEEe
Confidence 679999999999 454 6777888775 24688998875
|
| >1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A | Back alignment and structure |
|---|
Probab=88.43 E-value=0.3 Score=41.46 Aligned_cols=40 Identities=18% Similarity=0.031 Sum_probs=30.0
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+|..+++.|+||||+| +...+.+.+|++. ...+.|+.|..
T Consensus 73 lL~~~~~~G~fLvR~S-----~~~~g~~~LSv~~----~~~v~h~~I~~ 112 (217)
T 1gri_A 73 MLSKQRHDGAFLIRES-----ESAPGDFSLSVKF----GNDVQHFKVLR 112 (217)
T ss_dssp HHHTCSSTTCEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred HHhccCCCceEEEEcc-----CCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 3457789999999999 5666777788774 33678887765
|
| >3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.24 E-value=0.25 Score=49.02 Aligned_cols=40 Identities=10% Similarity=-0.176 Sum_probs=30.6
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCc-----cceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTK-----FNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 67 (364)
..+.|+||||+| +...+.|.||++...... ..+.|+.|..
T Consensus 127 ~~~~G~FLVR~S-----~~~~g~y~LSv~~~~~~~~~~~~~~v~H~~I~~ 171 (595)
T 3ps5_A 127 KGEPWTFLVRES-----LSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMC 171 (595)
T ss_dssp HCCTTEEEEEEC-----SSSTTCEEEEEEEEEESSSTTSCEEEEEEEEBC
T ss_pred cCCCceEEEEec-----CCCCCcEEEEEEECCccccccCCCceEEEEEEE
Confidence 337899999999 677788899998776322 2688888875
|
| >2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A* | Back alignment and structure |
|---|
Probab=86.24 E-value=0.31 Score=47.60 Aligned_cols=37 Identities=19% Similarity=0.053 Sum_probs=28.2
Q ss_pred ccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 21 NFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 21 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
..| +.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 20 ~~~-~~G~FLvR~S-----~~~~g~~~Lsv~~----~~~v~H~~I~~ 56 (532)
T 2b3o_A 20 GRG-VHGSFLARPS-----RKNQGDFSLSVRV----GDQVTHIRIQN 56 (532)
T ss_dssp HHC-CTTEEEEEEC-----SSSSSEEEEEEEE----TTEEEEEEEEC
T ss_pred hcC-CCCCEEEecC-----CCCCCceEEEEEE----CCEEEEEEEEe
Confidence 345 7899999999 5566778888875 34688888874
|
| >3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.14 E-value=0.29 Score=48.50 Aligned_cols=35 Identities=17% Similarity=0.004 Sum_probs=27.7
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
++.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 22 ~~~G~FLvR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 56 (595)
T 3ps5_A 22 GVHGSFLARPS-----RKNQGDFSLSVRV----GDQVTHIRIQN 56 (595)
T ss_dssp CCTTCEEEEEC-----SSSTTSEEEEEEE----TTEEEEEEEEE
T ss_pred CCCCEEEEeec-----CCCCCceEEEEEE----CCEEEEEEEEe
Confidence 37899999999 5667778888876 34689998874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.50 E-value=2.2 Score=36.20 Aligned_cols=83 Identities=11% Similarity=0.015 Sum_probs=58.0
Q ss_pred CCcceeEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHH-HHHhCCceecCC
Q psy7023 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMA-YLADKKFVHRDL 258 (364)
Q Consensus 180 ~h~~iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~-~LH~~~iiHrDl 258 (364)
.||++ -..+-.+++.+.+.++.-+++.-+..++. .+....++++.+|+.... ++ ..-+|--|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------------~~~~eKlrll~nl~~L~~~~~--~~r~tf~l 110 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------------TTLLSRIRAAIHLVSKVKHHS--ARRLIFIV 110 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------------SCHHHHHHHHHHHHHHHSSCC--SSSEECCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------------cCHHHHHHHHHHHHHHHHHhh--hCceeEEE
Confidence 57777 44444666777777776544433444442 456677888888877655 33 44578889
Q ss_pred CCCCEEEcCCCcEEEeecccc
Q psy7023 259 AARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a 279 (364)
+|+||+++.++.++|.-.|+-
T Consensus 111 ~P~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 111 CPENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp CGGGEEECTTCCEEESCCEET
T ss_pred eCceEEEeCCCcEEEEEcCCc
Confidence 999999999999999988864
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=85.42 E-value=6.3 Score=39.49 Aligned_cols=43 Identities=19% Similarity=0.161 Sum_probs=30.7
Q ss_pred HHHHHHHHHH--HHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 234 ILQMAAEVAD--GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 234 ~~~i~~qil~--~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
...++.+++. .+.|+=.. +|=+++||||+.+|++.-+|||.+-
T Consensus 531 r~nF~~SlA~~Svv~YILGl----GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 531 MDTYIKSCAGYCVITYLLGV----GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHHTC----CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHccC----CCCCCcceEEeCCCCEEEEeehhhh
Confidence 3444444432 24444333 5999999999999999999999874
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=84.32 E-value=6.2 Score=38.88 Aligned_cols=45 Identities=16% Similarity=0.126 Sum_probs=32.1
Q ss_pred HHHHHHHHHHHH--HHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 232 SRILQMAAEVAD--GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 232 ~~~~~i~~qil~--~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
.....+++.++. .+.|+=.. +|=+++||||+.+|++.=+|||..-
T Consensus 455 ~a~~nF~~S~A~ySvv~YILGi----gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 455 EVMDTYVKSCAGYCVITYILGV----GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTC----CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred HHHHHHHHHHHHHhHhheeeec----cCCCCcceeEcCCCCEeeeehHHhh
Confidence 344455555443 34454433 4899999999999999999999874
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* | Back alignment and structure |
|---|
Probab=84.18 E-value=0.22 Score=44.94 Aligned_cols=35 Identities=14% Similarity=0.053 Sum_probs=27.3
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.+.|+||||+| +...+.|.||++. ...++||.|..
T Consensus 31 ~~~G~FLvR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 65 (303)
T 2lqn_A 31 QRHGMFLVRDS-----STCPGDYVLSVSE----NSRVSHYIINS 65 (303)
Confidence 49999999999 4556667888875 34688998876
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=83.14 E-value=0.61 Score=45.41 Aligned_cols=37 Identities=16% Similarity=0.016 Sum_probs=27.8
Q ss_pred ccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 21 NFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 21 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
..| +.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 22 ~~~-~~G~FLvR~S-----~~~~g~~~Lsv~~----~~~v~H~~I~~ 58 (525)
T 2shp_A 22 TRG-VDGSFLARPS-----KSNPGDLTLSVRR----NGAVTHIKIQN 58 (525)
T ss_dssp HHC-CTTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEC
T ss_pred hCC-CCCcEEeecc-----CCCCCcEEEEEEE----CCEEEEEEEEe
Confidence 345 7899999999 5566677888874 34688888864
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=81.59 E-value=0.91 Score=44.17 Aligned_cols=38 Identities=18% Similarity=0.069 Sum_probs=28.9
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecC------Cccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSS------TKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 67 (364)
+.|+||||+| +...+.|.||++.... ....+.|+.|..
T Consensus 131 ~~G~FLVR~S-----~~~~g~y~LSv~~~~~~~~~~~~~~~v~H~~I~~ 174 (525)
T 2shp_A 131 KHGSFLVRES-----QSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRC 174 (525)
T ss_dssp CTTEEEEEEC-----SSSTTCEEEEEEECC-----CCCCCEEEEEEEEE
T ss_pred CCceEEEEec-----CCCCCCEEEEEEECCccccccccccceEEEEEEe
Confidence 7799999999 5667778888887552 223688998876
|
| >2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A* | Back alignment and structure |
|---|
Probab=80.19 E-value=0.78 Score=44.71 Aligned_cols=41 Identities=12% Similarity=-0.116 Sum_probs=29.0
Q ss_pred ccCCCcceEEEeccccccccccCCCCcceEEeecC-----Cccceeeeeeee
Q psy7023 21 NFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSS-----TKFNIFLFLIRV 67 (364)
Q Consensus 21 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 67 (364)
..| +.|+||||+| +...+.|.||++.... ....+.|+.|..
T Consensus 126 ~~~-~~G~FLVR~S-----~~~~g~y~Lsv~~~~~~~~~~~~~~v~h~~I~~ 171 (532)
T 2b3o_A 126 AKG-EPWTFLVRES-----LSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMC 171 (532)
T ss_dssp HHC-CTTEEEEEEC-----SSSTTCEEEEEEEEEEC----CCEEEEEEEEBC
T ss_pred cCC-CCceEEEecC-----CCCCCceEEEEEecCccccccCCCceEEEEEEE
Confidence 344 5599999999 5666778888886542 123678887765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 364 | ||||
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-71 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-60 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-13 |
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 8e-71
Identities = 165/243 (67%), Positives = 193/243 (79%), Gaps = 1/243 (0%)
Query: 107 DKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKD-FRSLAEHPCAIKVANENASERE 165
+Y D WEV R K+T+ ELG GSFG+VY G+ K + E AIK NE AS RE
Sbjct: 7 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 66
Query: 166 KAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVE 225
+ EFLNEASVMK F+ HHVV+L GVVS+G PTLVIMELM GDLK+YLRS RP +
Sbjct: 67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 126
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
+PP+LS+++QMA E+ADGMAYL KFVHRDLAARNCMVA+D TVK+GDFGMTRDIYET
Sbjct: 127 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+YYRKG +G LPVRWM+PESLKDGVFT++SDVWS+GVVLWE+ATLA QPYQGLSNEQVL
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246
Query: 346 WVK 348
+V
Sbjct: 247 FVM 249
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 8e-62
Identities = 92/282 (32%), Positives = 132/282 (46%), Gaps = 18/282 (6%)
Query: 98 PNQLMGGDDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKV 156
N+ D + WE R + LG+G+FG V ++ A+K+
Sbjct: 15 DNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM 74
Query: 157 ANENASEREKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRS 215
E A E+ ++E +M +H ++V L G + P +I E GDL NYLRS
Sbjct: 75 LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134
Query: 216 CRPDAETDVER-------------SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262
R D + T +L A +VA GM +L K VHRDLAARN
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194
Query: 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGV 322
+V VK+ DFG+ RDI Y LPV+WMAPESL +G++T SDVWSYG+
Sbjct: 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 254
Query: 323 VLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPISLS 364
+LWE+ +L PY G+ + + N +K++ P +
Sbjct: 255 LLWEIFSLGVNPYPGIPVDANFYKLI---QNGFKMDQPFYAT 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (496), Expect = 1e-60
Identities = 96/253 (37%), Positives = 149/253 (58%), Gaps = 15/253 (5%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEH-PCAIKVANENASEREKAEF 169
K S E R+ + + ++G G+FG V++ A+K+ E AS +A+F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 170 LNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERS-- 227
EA++M FD ++VKL GV + G P ++ E M GDL +LRS P + S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 228 ------------PPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275
P + + L +A +VA GMAYL+++KFVHRDLA RNC+V +++ VK+ D
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPY 335
FG++R+IY +YY+ +P+RWM PES+ +T+ SDVW+YGVVLWE+ + QPY
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 336 QGLSNEQVLNWVK 348
G+++E+V+ +V+
Sbjct: 244 YGMAHEEVIYYVR 256
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-60
Identities = 62/242 (25%), Positives = 116/242 (47%), Gaps = 22/242 (9%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLN 171
D WE+ ++T+ +G+GSFG VY+G A+K+ N + ++ F N
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVTAPTPQQLQAFKN 53
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
E V++ +++ G + +V + G L ++L + +
Sbjct: 54 EVGVLRKTRHVNILLFMGYSTAPQLAIV-TQWCEGSSLYHHLHI---------IETKFEM 103
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
+++ +A + A GM YL K +HRDL + N + +DLTVK+GDFG+ +
Sbjct: 104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 292 SRGFLPVRWMAPESLK---DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+ + WMAPE ++ ++ SDV+++G+VL+E+ T PY ++N + ++
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIFMV 222
Query: 349 GK 350
G+
Sbjct: 223 GR 224
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-58
Identities = 92/270 (34%), Positives = 134/270 (49%), Gaps = 11/270 (4%)
Query: 105 DDDKLYKKDSWEVLRSKVTILDELGNGSFGLVYRG-LIKDFRSLAEHPCAIKVANENASE 163
D +L WE R++++ LG G+FG V +S A A+K+ +A
Sbjct: 8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 164 REKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPD--- 219
E+ ++E V+ H ++V L G + G PTLVI E GDL N+LR R
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 220 -----AETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274
A + + L +L + +VA GMA+LA K +HRDLAARN ++ K+
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQP 334
DFG+ RDI Y LPV+WMAPES+ + V+T SDVWSYG+ LWE+ +L S P
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 335 YQGLS-NEQVLNWVKGKSSNEYKVNPPISL 363
Y G+ + + +K + P +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEM 277
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-57
Identities = 79/237 (33%), Positives = 135/237 (56%), Gaps = 17/237 (7%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
+D WEV R + +++ LG G FG V+ G A+K + + + FL
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMSPD--AFLA 57
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
EA++MK +V+LY VV++ ++ E M G L ++L++ T+
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIYII-TEYMENGSLVDFLKTPS--------GIKLTI 108
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
+++L MAA++A+GMA++ ++ ++HRDL A N +V+D L+ K+ DFG+ R I + EY +
Sbjct: 109 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
F P++W APE++ G FT SDVWS+G++L E+ T PY G++N +V+ ++
Sbjct: 169 GAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-57
Identities = 80/235 (34%), Positives = 125/235 (53%), Gaps = 23/235 (9%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
W + ++ +L +G G FG V G + + A+K +A+ + FL EAS
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDATAQA---FLAEAS 52
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTL-VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
VM ++V+L GV+ E L ++ E M G L +YLRS RS
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--------RSVLGGDC 104
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
+L+ + +V + M YL FVHRDLAARN +V++D KV DFG+T++ T+ K
Sbjct: 105 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-- 162
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
PV+W APE+L++ F++ SDVWS+G++LWE+ + PY + + V+ V+
Sbjct: 163 ---PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 4e-57
Identities = 89/264 (33%), Positives = 149/264 (56%), Gaps = 14/264 (5%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF---RSLAEHPCAIKVANENASEREKA 167
+ WE+ R ++ + LG G+FG V + A+K+ +A+E++ +
Sbjct: 4 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63
Query: 168 EFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDA------ 220
+ ++E +MK H +++ L G ++ P VI+E G+L+ YL++ RP
Sbjct: 64 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123
Query: 221 ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280
+ + ++ A +VA GM YLA KK +HRDLAARN +V +D +K+ DFG+ R
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 281 DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340
DI+ +YY+K + G LPV+WMAPE+L D ++T SDVWS+GV+LWE+ TL PY G+
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 341 EQVLNWVKGKSSNEYKVNPPISLS 364
E++ +K ++++ P + +
Sbjct: 244 EELFKLLK----EGHRMDKPSNCT 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-56
Identities = 88/237 (37%), Positives = 124/237 (52%), Gaps = 17/237 (7%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLN 171
KD+WE+ R + + +LG G FG V+ G AIK E FL
Sbjct: 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMSPE--AFLQ 61
Query: 172 EASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
EA VMK +V+LY VVSE +V E M G L ++L+ L
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEEPIYIV-TEYMSKGSLLDFLKGET--------GKYLRL 112
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
+++ MAA++A GMAY+ +VHRDL A N +V ++L KV DFG+ R I + EY +
Sbjct: 113 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
F P++W APE+ G FT SDVWS+G++L E+ T PY G+ N +VL+ V+
Sbjct: 173 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-56
Identities = 79/232 (34%), Positives = 127/232 (54%), Gaps = 14/232 (6%)
Query: 119 RSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMK 177
R + I D ELG G+FG V +G+ + + + AIKV + + + E + EA +M
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKK--QIDVAIKVLKQGTEKADTEEMMREAQIMH 64
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
D ++V+L GV LV ME+ GGG L +L +R +S + ++
Sbjct: 65 QLDNPYIVRLIGVCQAEALMLV-MEMAGGGPLHKFLVG---------KREEIPVSNVAEL 114
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE-YYRKGSRGFL 296
+V+ GM YL +K FVHRDLAARN ++ + K+ DFG+++ + + YY S G
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 297 PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
P++W APE + F+S SDVWSYGV +WE + +PY+ + +V+ +++
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (463), Expect = 8e-56
Identities = 92/254 (36%), Positives = 143/254 (56%), Gaps = 17/254 (6%)
Query: 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEA 173
+ E+ S V I +G G FG V G +K E AIK +E+++ +FL+EA
Sbjct: 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKR-EIFVAIKTLKSGYTEKQRRDFLSEA 78
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
S+M FD +V+ L GVV++ P ++I E M G L ++LR T+ +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---------QFTVIQ 129
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE---TEYYRK 290
++ M +A GM YLAD +VHRDLAARN +V +L KV DFG++R + + Y
Sbjct: 130 LVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 189
Query: 291 GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350
G +P+RW APE+++ FTS SDVWSYG+V+WE+ + +PY ++N+ V+N ++
Sbjct: 190 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-- 247
Query: 351 SSNEYKVNPPISLS 364
+Y++ PP+
Sbjct: 248 --QDYRLPPPMDCP 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-55
Identities = 75/225 (33%), Positives = 113/225 (50%), Gaps = 10/225 (4%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH 183
+ LG+G+FG VY+GL + P AIK E S + E L+EA VM + D H
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 184 VVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVAD 243
V +L G+ L+ + G L + +L ++A
Sbjct: 73 VCRLLGICLTSTVQLITQLMPFGCLLDYVRE----------HKDNIGSQYLLNWCVQIAK 122
Query: 244 GMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAP 303
GM YL D++ VHRDLAARN +V VK+ DFG+ + + E G +P++WMA
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 304 ESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
ES+ ++T SDVWSYGV +WE+ T S+PY G+ ++ + ++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 5e-54
Identities = 86/244 (35%), Positives = 133/244 (54%), Gaps = 9/244 (3%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSL-AEHPCAIKVANENASEREKAE 168
Y WE R ++ + LG G+FG V A+K+ E A+ E
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 169 FLNEASVMKAFDTHH-VVKLYGVVSE-GNPTLVIMELMGGGDLKNYLRSCRPD------A 220
++E ++ H VV L G ++ G P +VI+E G+L YLRS R + A
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 221 ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280
D+ + TL ++ + +VA GM +LA +K +HRDLAARN ++++ VK+ DFG+ R
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 281 DIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340
DIY+ Y + LP++WMAPE++ D V+T SDVWS+GV+LWE+ +L + PY G+
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242
Query: 341 EQVL 344
++
Sbjct: 243 DEEF 246
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-54
Identities = 88/251 (35%), Positives = 140/251 (55%), Gaps = 10/251 (3%)
Query: 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEA 173
+ E+ S VT +G G FG VY+G++K E P AIK +E+++ +FL EA
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
+M F H++++L GV+S+ P ++I E M G L +LR ++ +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---------EFSVLQ 111
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
++ M +A GM YLA+ +VHRDLAARN +V +L KV DFG++R + + +
Sbjct: 112 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 294 GF-LPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352
G +P+RW APE++ FTS SDVWS+G+V+WE+ T +PY LSN +V+ +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231
Query: 353 NEYKVNPPISL 363
++ P ++
Sbjct: 232 LPTPMDCPSAI 242
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (449), Expect = 7e-54
Identities = 93/251 (37%), Positives = 133/251 (52%), Gaps = 15/251 (5%)
Query: 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNE 172
D WE+ R+ +T+ +LG G +G VY G+ K + A+K E+ E E EFL E
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTMEVE--EFLKE 63
Query: 173 ASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLS 232
A+VMK ++V+L GV + P +I E M G+L +YLR C R +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--------RQEVSAV 115
Query: 233 RILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGS 292
+L MA +++ M YL K F+HRDLAARNC+V ++ VKV DFG++R + Y
Sbjct: 116 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175
Query: 293 RGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352
F +W APESL F+ SDVW++GV+LWE+AT PY G+ QV ++
Sbjct: 176 AKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 234
Query: 353 NEYKVNPPISL 363
E P +
Sbjct: 235 MERPEGCPEKV 245
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-53
Identities = 84/234 (35%), Positives = 141/234 (60%), Gaps = 12/234 (5%)
Query: 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEAS 174
+E+ R ++ + +G G FG V++G+ + A AIK S+ + +FL EA
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAL-AVAIKTCKNCTSDSVREKFLQEAL 60
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
M+ FD H+VKL GV++E ++ MEL G+L+++L+ + L+ +
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVWII-MELCTLGELRSFLQVRKY---------SLDLASL 110
Query: 235 LQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
+ A +++ +AYL K+FVHRD+AARN +V+ + VK+GDFG++R + ++ YY+ S+G
Sbjct: 111 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKG 169
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
LP++WMAPES+ FTS SDVW +GV +WE+ +P+QG+ N V+ ++
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-53
Identities = 85/230 (36%), Positives = 123/230 (53%), Gaps = 17/230 (7%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA 178
+T L ELG G FG+V G + ++ AIK+ E + + EF+ EA VM
Sbjct: 3 PKDLTFLKELGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSMSED--EFIEEAKVMMN 55
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
+V+LYGV ++ P +I E M G L NYLR R ++L+M
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---------RFQTQQLLEMC 106
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
+V + M YL K+F+HRDLAARNC+V D VKV DFG++R + + EY F PV
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PV 165
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
RW PE L F+S SD+W++GV++WE+ +L PY+ +N + +
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-52
Identities = 86/253 (33%), Positives = 133/253 (52%), Gaps = 16/253 (6%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA 178
+ + D +G G+FG V + IK AIK E AS+ + +F E V+
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKK--DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 179 FDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPD------AETDVERSPPTL 231
H +++ L G + +E G+L ++LR R A + S +
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 232 SRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKG 291
++L AA+VA GM YL+ K+F+HRDLAARN +V ++ K+ DFG++R E Y K
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351
+ G LPVRWMA ESL V+T++SDVWSYGV+LWE+ +L PY G++ ++ +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 240
Query: 352 SNEYKVNPPISLS 364
Y++ P++
Sbjct: 241 -QGYRLEKPLNCD 252
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-52
Identities = 84/230 (36%), Positives = 125/230 (54%), Gaps = 17/230 (7%)
Query: 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKA 178
S++T + E+G+G FGLV+ G + + AIK E A E +F+ EA VM
Sbjct: 4 PSELTFVQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMSEE--DFIEEAEVMMK 56
Query: 179 FDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
+V+LYGV E P ++ E M G L +YLR+ R +L M
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---------LFAAETLLGMC 107
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPV 298
+V +GMAYL + +HRDLAARNC+V ++ +KV DFGMTR + + +Y F PV
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF-PV 166
Query: 299 RWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+W +PE ++S SDVWS+GV++WE+ + PY+ SN +V+ +
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 8e-52
Identities = 78/233 (33%), Positives = 125/233 (53%), Gaps = 16/233 (6%)
Query: 119 RSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-ANENASEREKAEFLNEASVM 176
R +T+ D ELG+G+FG V +G + + + A+K+ NE K E L EA+VM
Sbjct: 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKT--VAVKILKNEANDPALKDELLAEANVM 62
Query: 177 KAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
+ D ++V++ G+ + LV ME+ G L YL+ R + I++
Sbjct: 63 QQLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKD----------KNIIE 111
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFL 296
+ +V+ GM YL + FVHRDLAARN ++ K+ DFG+++ + E Y K
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 297 -PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
PV+W APE + F+S SDVWS+GV++WE + +PY+G+ +V ++
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-51
Identities = 55/247 (22%), Positives = 104/247 (42%), Gaps = 22/247 (8%)
Query: 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASV 175
E+ + ELG G+ G+V++ K + A K+ + + + + E V
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKP----SGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 176 MKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
+ ++ ++V YG + ME M GG L L+ + +
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----------KAGRIPEQILG 107
Query: 236 QMAAEVADGMAYLADK-KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR-KGSR 293
+++ V G+ YL +K K +HRD+ N +V +K+ DFG++ + ++ G+R
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 167
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353
+M+PE L+ ++ SD+WS G+ L EMA P +++ +
Sbjct: 168 S-----YMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQVEG 221
Query: 354 EYKVNPP 360
+ PP
Sbjct: 222 DAAETPP 228
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 9e-51
Identities = 69/245 (28%), Positives = 107/245 (43%), Gaps = 22/245 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
I+ ELG+G+FG VY+ K+ A KV + SE E +++ E ++ + D
Sbjct: 15 EIIGELGDGAFGKVYKAQNKE----TSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHP 69
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
++VKL N +++E GG + + P T S+I + +
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---------RPLTESQIQVVCKQTL 120
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMA 302
D + YL D K +HRDL A N + D +K+ DFG++ T R G WMA
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT--PYWMA 178
Query: 303 PESL-----KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357
PE + KD + +DVWS G+ L EMA + P+ L+ +VL +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEI-EPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 358 NPPIS 362
S
Sbjct: 238 PSRWS 242
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-50
Identities = 88/249 (35%), Positives = 133/249 (53%), Gaps = 15/249 (6%)
Query: 105 DDDKLYKKDSWEVLRSKVTI--LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS 162
+ + + + S + + + +G G FG VY G + D + CA+K N
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLD-NDGKKIHCAVKSLNRITD 68
Query: 163 EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG-NPTLVIMELMGGGDLKNYLRSCRPDAE 221
E ++FL E +MK F +V+ L G+ LV++ M GDL+N+
Sbjct: 69 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF--------- 119
Query: 222 TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRD 281
E PT+ ++ +VA GM +LA KKFVHRDLAARNCM+ + TVKV DFG+ RD
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179
Query: 282 IYETEYYR--KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339
+Y+ E+ + LPV+WMA ESL+ FT+ SDVWS+GV+LWE+ T + PY ++
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239
Query: 340 NEQVLNWVK 348
+ ++
Sbjct: 240 TFDITVYLL 248
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-48
Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 19/256 (7%)
Query: 107 DKLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREK 166
+KL S + K T +++G G+ G VY + AI+ N + +K
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVA----TGQEVAIRQMNLQ-QQPKK 61
Query: 167 AEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVER 226
+NE VM+ ++V G+ V+ME + GG L + +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----------E 110
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
+ +I + E + +L + +HRD+ + N ++ D +VK+ DFG I +
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
R G WMAPE + + D+WS G++ EM PY + + L
Sbjct: 171 SKRSTMVGTP--YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYL 227
Query: 347 VKGKSSNEYKVNPPIS 362
+ + E + +S
Sbjct: 228 IATNGTPELQNPEKLS 243
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-47
Identities = 49/234 (20%), Positives = 98/234 (41%), Gaps = 21/234 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
+L +G GS+G + K K + + +E EK ++E ++++
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKS----DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 182 HHVVKLYGVVSEGNPTLV--IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
++V+ Y + + T + +ME GGDL + + ER +L++
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK------ERQYLDEEFVLRVMT 116
Query: 240 EVADGMAYLADK-----KFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRG 294
++ + + +HRDL N + VK+GDFG+ R + + K
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-- 174
Query: 295 FLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
+M+PE + + SD+WS G +L+E+ L P+ S +++ ++
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL-MPPFTAFSQKELAGKIR 227
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-47
Identities = 81/228 (35%), Positives = 124/228 (54%), Gaps = 14/228 (6%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA--EFLNEASVMKAFD 180
+L++LG+GSFG+V RG S A+K + + +A +F+ E + M + D
Sbjct: 11 RLLEKLGDGSFGVVRRGEWDA-PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
++++LYGVV +V EL G L + LR + L + + A +
Sbjct: 70 HRNLIRLYGVVLTPPMKMV-TELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQ 119
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET-EYYRKGSRGFLPVR 299
VA+GM YL K+F+HRDLAARN ++A VK+GDFG+ R + + ++Y +P
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
W APESLK F+ SD W +GV LWEM T +P+ GL+ Q+L+ +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-47
Identities = 45/229 (19%), Positives = 88/229 (38%), Gaps = 23/229 (10%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAE--FLNEASVMKAFD 180
I LG G FG VY K ++ A+KV + E+ E E +
Sbjct: 9 EIGRPLGKGKFGNVYLAREKQ----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
++++LYG + +I+E G + L+ R E
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----------FDEQRTATYITE 114
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYR-KGSRGFLPVR 299
+A+ ++Y K+ +HRD+ N ++ +K+ DFG + + G+
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLD----- 169
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
++ PE ++ + D+WS GV+ +E P++ + ++ +
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRIS 217
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 4e-46
Identities = 58/262 (22%), Positives = 97/262 (37%), Gaps = 32/262 (12%)
Query: 108 KLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SERE 165
+L+ KD E + L E+G+GSFG VY AIK + + S +
Sbjct: 6 ELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVR----NSEVVAIKKMSYSGKQSNEK 58
Query: 166 KAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVE 225
+ + E ++ + ++ G + ++ME G
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----------H 108
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
+ P I + G+AYL +HRD+ A N ++++ VK+GDFG +
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 286 EYYRKGSRGFLPVRWMAPESL---KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342
+ G+ WMAPE + +G + DVWS G+ E+A P ++
Sbjct: 169 NSFV-GTPY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMS 221
Query: 343 VLNWVKGKSSNEYKVNPPISLS 364
L + NE S
Sbjct: 222 ALYHIA---QNESPALQSGHWS 240
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 158 bits (401), Expect = 5e-46
Identities = 49/243 (20%), Positives = 102/243 (41%), Gaps = 21/243 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
IL+ELG+G+FG+V+R + K K N +K NE S+M
Sbjct: 32 DILEELGSGAFGVVHRCVEKA----TGRVFVAKFIN-TPYPLDKYTVKNEISIMNQLHHP 86
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
++ L+ + ++I+E + GG+L + + + E + + ++ +
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQAC 137
Query: 243 DGMAYLADKKFVHRDLAARNCMVA--DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300
+G+ ++ + VH D+ N M +VK+ DFG+ + E + + +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA---TAEF 194
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL-NWVKGKSSNEYKVNP 359
APE + ++D+W+ GV+ + + + P+ G + + L N + +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 360 PIS 362
+S
Sbjct: 254 SVS 256
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-45
Identities = 54/243 (22%), Positives = 95/243 (39%), Gaps = 18/243 (7%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
++ LG G++G V + + E A+K+ + + E + K +
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRV----TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+VVK YG EGN + +E GG+L + + + ++
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLM 113
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMA 302
G+ YL HRD+ N ++ + +K+ DFG+ R ++ + ++A
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 303 PESLKDGVFTSH-SDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPPI 361
PE LK F + DVWS G+VL M Q + Q + K K + +NP
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWK 230
Query: 362 SLS 364
+
Sbjct: 231 KID 233
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (389), Expect = 3e-44
Identities = 52/243 (21%), Positives = 99/243 (40%), Gaps = 21/243 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
I +ELG G+FG+V+R + + A K E +K E M
Sbjct: 29 DIHEELGTGAFGVVHRVTERA----TGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHP 83
Query: 183 HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVA 242
+V L+ + N ++I E M GG+L + E + + ++ +V
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVC 134
Query: 243 DGMAYLADKKFVHRDLAARNCMVADDL--TVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300
G+ ++ + +VH DL N M +K+ DFG+T + + + + +
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG---TAEF 191
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL-NWVKGKSSNEYKVNP 359
APE + ++D+WS GV+ + + + P+ G ++++ L N + +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMDDSAFS 250
Query: 360 PIS 362
IS
Sbjct: 251 GIS 253
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 8e-44
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 20/229 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFD 180
+ LG GSFG V+ K AIK ++ + + + E V+
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKK----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 181 TH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
H + ++ +ME + GGDL +++SC LSR AA
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----------FDLSRATFYAA 110
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299
E+ G+ +L K V+RDL N ++ D +K+ DFGM ++ + G
Sbjct: 111 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG--TPD 168
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348
++APE L + D WS+GV+L+EM S P+ G E++ + ++
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS-PFHGQDEEELFHSIR 216
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-43
Identities = 44/248 (17%), Positives = 100/248 (40%), Gaps = 22/248 (8%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMK 177
L K I ++LG G FG+V+R + ++ K +++ E S++
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETS----SKKTYMAKFVKVKGTDQV--LVKKEISILN 56
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
+++ L+ ++I E + G D+ + + I+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---------SAFELNEREIVSY 107
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVA--DDLTVKVGDFGMTRDIYETEYYRKGSRGF 295
+V + + +L H D+ N + T+K+ +FG R + + +R
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 296 LPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL-NWVKGKSSNE 354
+ APE + V ++ +D+WS G +++ + + P+ +N+Q++ N + + + +
Sbjct: 168 ---EYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAEYTFD 223
Query: 355 YKVNPPIS 362
+ IS
Sbjct: 224 EEAFKEIS 231
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 3e-43
Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 30/257 (11%)
Query: 110 YKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEF 169
+K+ E +R D LG G+F V K + AIK + A E ++
Sbjct: 1 WKQA--EDIRDIYDFRDVLGTGAFSEVILAEDKR----TQKLVAIKCIAKKALEGKEGSM 54
Query: 170 LNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPP 229
NE +V+ ++V L + G +IM+L+ GG+L + + E+
Sbjct: 55 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----------EKGFY 104
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDIYETE 286
T ++ +V D + YL D VHRDL N + +D + + DFG+++
Sbjct: 105 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164
Query: 287 YYRK--GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
G+ G ++APE L ++ D WS GV+ + + P+ ++ ++
Sbjct: 165 VLSTACGTPG-----YVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLF 218
Query: 345 NWVKGKSSNEYKVNPPI 361
+ EY+ + P
Sbjct: 219 EQIL---KAEYEFDSPY 232
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 8e-43
Identities = 46/242 (19%), Positives = 85/242 (35%), Gaps = 20/242 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEASVMKAFD 180
LG GSF V AIK+ + E + E VM D
Sbjct: 11 KFGKILGEGSFSTVVLARELA----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 66
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
VKLY + + G+L Y+R + AE
Sbjct: 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----------FDETCTRFYTAE 116
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300
+ + YL K +HRDL N ++ +D+ +++ DFG + + + + ++
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360
++PE L + SD+W+ G +++++ P++ + + + EY
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKII---KLEYDFPEK 232
Query: 361 IS 362
Sbjct: 233 FF 234
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (364), Expect = 2e-41
Identities = 48/251 (19%), Positives = 96/251 (38%), Gaps = 30/251 (11%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV--------ANENASEREKAEFLNEAS 174
+ LG G +V R + K A+K+ + + + L E
Sbjct: 6 EPKEILGRGVSSVVRRCIHKP----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 175 VMKAFDTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
+++ H ++++L ++ +LM G+L +YL E+ +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKE 111
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK--G 291
++ + + + L VHRDL N ++ DD+ +K+ DFG + + E R+ G
Sbjct: 112 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 171
Query: 292 SRGFL-PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350
+ +L P + + D+WS GV+++ + S P+ +L +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLRMIM-- 228
Query: 351 SSNEYKVNPPI 361
S Y+ P
Sbjct: 229 -SGNYQFGSPE 238
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 4e-40
Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 30/245 (12%)
Query: 127 ELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-ANENASEREKAEFLNEASVMKAFDTHHVV 185
E+G GSF VY+GL + A + ++ E+ F EA ++K ++V
Sbjct: 16 EIGRGSFKTVYKGLDTE----TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 186 KLYGV----VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+ Y V +++ ELM G LK YL+ + + ++
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQI 121
Query: 242 ADGMAYLADKK--FVHRDLAARNCMVAD-DLTVKVGDFGMTRDIYETEYYR-KGSRGFLP 297
G+ +L + +HRDL N + +VK+GD G+ + G+
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE--- 178
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKV 357
+MAPE + + DV+++G+ + EMAT + PY N +
Sbjct: 179 --FMAPEMYE-EKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVKPASF 234
Query: 358 NPPIS 362
+
Sbjct: 235 DKVAI 239
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (356), Expect = 7e-40
Identities = 52/242 (21%), Positives = 101/242 (41%), Gaps = 25/242 (10%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA--EFLNEASVMKAFD 180
IL LG GSFG V+ + A+KV + R K +E ++
Sbjct: 7 QILRTLGTGSFGRVHLIRSRH----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
+++++G + +IM+ + GG+L + LR + + AAE
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF----------YAAE 112
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300
V + YL K ++RDL N ++ + +K+ DFG + + + Y G+ +
Sbjct: 113 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD-----Y 167
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360
+APE + + D WS+G++++EM + P+ + + + + E + P
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT-PFYDSNTMKTYEKIL---NAELRFPPF 223
Query: 361 IS 362
+
Sbjct: 224 FN 225
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-39
Identities = 60/272 (22%), Positives = 102/272 (37%), Gaps = 52/272 (19%)
Query: 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD 180
+ + + +G G FG V+RG + A+K+ S RE+ + EA + +
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRG------EEVAVKIF----SSREERSWFREAEIYQTVM 53
Query: 181 THH--VVKLYGVVSEGNPTLV----IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRI 234
H ++ ++ N T + + G L +YL R T+ +
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----------RYTVTVEGM 102
Query: 235 LQMAAEVADGMAYL--------ADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
+++A A G+A+L HRDL ++N +V + T + D G+
Sbjct: 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162
Query: 287 YYRKGSRGFL--PVRWMAPESLKDGVFTSH------SDVWSYGVVLWEMATLAS------ 332
+ R+MAPE L D + H +D+++ G+V WE+A S
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 333 ---QPYQGLSNEQVLNWVKGKSSNEYKVNPPI 361
PY L K E K+ P I
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 138 bits (349), Expect = 3e-39
Identities = 52/254 (20%), Positives = 97/254 (38%), Gaps = 23/254 (9%)
Query: 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA--EFLNEAS 174
L + + + LG G V+ A+KV + + F EA
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLR----LHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 175 VMKAFDTHHVVKLYGVVSEGNPTL----VIMELMGGGDLKNYLRSCRPDAETDVERSPPT 230
A + +V +Y P ++ME + G L++ + + P
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP--------- 110
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRK 290
R +++ A+ + + +HRD+ N M++ VKV DFG+ R I ++
Sbjct: 111 -KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169
Query: 291 GSRGFL-PVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL-NWVK 348
+ + ++++PE + + SDV+S G VL+E+ T P+ G S V V+
Sbjct: 170 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVR 228
Query: 349 GKSSNEYKVNPPIS 362
+ +S
Sbjct: 229 EDPIPPSARHEGLS 242
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 138 bits (348), Expect = 3e-38
Identities = 50/246 (20%), Positives = 96/246 (39%), Gaps = 25/246 (10%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-----ANENASEREKAEFLNEASVMK 177
++ +G G FG VY D A+K E S++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 178 AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQM 237
D +V + + I++LM GGDL +L +E D +
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD----------MRFY 112
Query: 238 AAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLP 297
AAE+ G+ ++ ++ V+RDL N ++ + V++ D G+ D + + +
Sbjct: 113 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 168
Query: 298 VRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYK 356
+MAPE L+ GV + S +D +S G +L+++ P++ + + + +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAVE 227
Query: 357 VNPPIS 362
+ S
Sbjct: 228 LPDSFS 233
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 2e-37
Identities = 46/249 (18%), Positives = 94/249 (37%), Gaps = 29/249 (11%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
+ ++G+GSFG +Y G A AIK+ + + + E+ + K
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIA----AGEEVAIKLECV---KTKHPQLHIESKIYKMMQGG 62
Query: 183 HVVKLYGVV-SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
+ +EG+ +++MEL+G + R +L +L +A ++
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----------FSLKTVLLLADQM 112
Query: 242 ADGMAYLADKKFVHRDLAARNCMVAD---DLTVKVGDFGMTRDI-----YETEYYRKGSR 293
+ Y+ K F+HRD+ N ++ V + DFG+ + ++ YR+
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353
R+ + + + D+ S G VL + + + + +
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS--- 229
Query: 354 EYKVNPPIS 362
E K++ PI
Sbjct: 230 EKKMSTPIE 238
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-37
Identities = 52/264 (19%), Positives = 105/264 (39%), Gaps = 31/264 (11%)
Query: 109 LYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-----ANENASE 163
++++++ + +ELG+G F +V + K A K +
Sbjct: 2 VFRQEN---VDDYYDTGEELGSGQFAVVKKCREKS----TGLQYAAKFIKKRRTKSSRRG 54
Query: 164 REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETD 223
+ + E S++K +V+ L+ V ++I+EL+ GG+L ++L E
Sbjct: 55 VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-- 112
Query: 224 VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD----LTVKVGDFGMT 279
+ ++ +G+ YL + H DL N M+ D +K+ DFG+
Sbjct: 113 --------EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164
Query: 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS 339
I ++ F ++APE + +D+WS GV+ + + + + P+ G +
Sbjct: 165 HKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDT 220
Query: 340 NEQVL-NWVKGKSSNEYKVNPPIS 362
++ L N E + S
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTS 244
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-36
Identities = 46/233 (19%), Positives = 88/233 (37%), Gaps = 29/233 (12%)
Query: 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-----ANENASEREKAEFLNE 172
L S+ + LG+G FG VY G+ P AIK ++ E
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVS----DNLPVAIKHVEKDRISDWGELPNGTRVPME 57
Query: 173 ASVMKAFDTHH--VVKLYGVVSEGNPTLVIMELM-GGGDLKNYLRSCRPDAETDVERSPP 229
++K + V++L + ++I+E DL +++ ER
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT----------ERGAL 107
Query: 230 TLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTRDIYETEYY 288
+V + + + + +HRD+ N ++ + +K+ DFG + +T Y
Sbjct: 108 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 167
Query: 289 -RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340
G+R + P W+ + VWS G++L++M P++
Sbjct: 168 DFDGTRVYSPPEWIRYH----RYHGRSAAVWSLGILLYDMVC-GDIPFEHDEE 215
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-35
Identities = 45/234 (19%), Positives = 88/234 (37%), Gaps = 22/234 (9%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF 179
+ T L +G G++G+V + AIK + + L E ++ F
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNV----NKVRVAIKKISPFEHQTYCQRTLREIKILLRF 63
Query: 180 DTHHVVKLYGVVSEGN----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRIL 235
+++ + ++ + ++ + G DL L+ + I
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----------TQHLSNDHIC 112
Query: 236 QMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF 295
++ G+ Y+ +HRDL N ++ +K+ DFG+ R + +
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172
Query: 296 LPVRW-MAPESLKDGVFTSHS-DVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
+ RW APE + + + S D+WS G +L EM + + G LN +
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHI 225
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-35
Identities = 40/237 (16%), Positives = 85/237 (35%), Gaps = 31/237 (13%)
Query: 123 TILDE-LGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT 181
+ + LG G G V + K + A+K+ ++ + E +
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKR----TQEKFALKML------QDCPKARREVELHWRASQ 63
Query: 182 H-HVVKLYGV----VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
H+V++ V + L++ME + GG+L + ++ T +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--------AFTEREASE 115
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKVGDFGMTRDIYETEYYRKGSR 293
+ + + + YL HRD+ N + + +K+ DFG ++
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---T 172
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350
++APE L + D+WS GV+++ + P+ + +K +
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKTR 228
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 126 bits (318), Expect = 1e-34
Identities = 43/224 (19%), Positives = 87/224 (38%), Gaps = 18/224 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
L+++G G++G+VY+ A+K E E + + E S++K
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNY-----GETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++VKLY V+ +++ E + K ++
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----------EGGLESVTAKSFLLQL 109
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
+G+AY D++ +HRDL +N ++ + +K+ DFG+ R + +
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRA 168
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+ +++ D+WS G + EM + + G+S L
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLM 211
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-34
Identities = 59/249 (23%), Positives = 98/249 (39%), Gaps = 27/249 (10%)
Query: 121 KVT-----ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANEN--ASEREKAEFLNEA 173
KVT L LG G+FG V K A+K+ + ++ E A + E+
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA----TGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 174 SVMKAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
V++ + L + +ME GG+L +L R E R
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----------ER 106
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSR 293
AE+ + YL + V+RD+ N M+ D +K+ DFG+ ++ K
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 294 GFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353
G ++APE L+D + D W GVV++EM P+ +E++ +
Sbjct: 167 G--TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELIL---ME 220
Query: 354 EYKVNPPIS 362
E + +S
Sbjct: 221 EIRFPRTLS 229
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-33
Identities = 49/225 (21%), Positives = 92/225 (40%), Gaps = 18/225 (8%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
++++G G++G+VY+ K A+K + +E + + E S++K +
Sbjct: 5 QKVEKIGEGTYGVVYKARNKL----TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++VKL V+ N ++ E + K S + L I ++
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL---------TGIPLPLIKSYLFQL 111
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
G+A+ + +HRDL +N ++ + +K+ DFG+ R L +
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW--YR 169
Query: 302 APESL-KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
APE L +++ D+WS G + EM T + G S L
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLF 213
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-33
Identities = 39/226 (17%), Positives = 70/226 (30%), Gaps = 20/226 (8%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV----ANENASEREKAEFLNEASVMKAF 179
LD LG G F VY+ K+ AIK A + L E +++
Sbjct: 2 KLDFLGEGQFATVYKARDKN----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 180 DTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAA 239
+++ L + ++ + M + S I
Sbjct: 58 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP----------SHIKAYML 107
Query: 240 EVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVR 299
G+ YL +HRDL N ++ ++ +K+ DFG+ +
Sbjct: 108 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT-RWY 166
Query: 300 WMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
++ D+W+ G +L E+ G S+ L
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLT 211
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 8e-33
Identities = 43/246 (17%), Positives = 88/246 (35%), Gaps = 18/246 (7%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV---ANENASEREKAEFLNEASVMKAF 179
+L LG G++G V+ + A+KV A + E V++
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGK-LYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 180 DTH-HVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMA 238
+V L+ +I++ + GG+L +L E +V+
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI----------YV 135
Query: 239 AEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEY-YRKGSRGFLP 297
E+ + +L ++RD+ N ++ + V + DFG++++ E G +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 298 VRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV-KGKSSNEYK 356
D D WS GV+++E+ T + P+ + + + +E
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISRRILKSEPP 254
Query: 357 VNPPIS 362
+S
Sbjct: 255 YPQEMS 260
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-32
Identities = 49/238 (20%), Positives = 90/238 (37%), Gaps = 27/238 (11%)
Query: 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKA 178
SK L ++G G+FG V++ + A+K EN E L E +++
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRK----TGQKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 179 FDTHHVVKLYGVVSEGNPT--------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPT 230
+VV L + ++ + T
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----------VLVKFT 115
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI--YETEYY 288
LS I ++ + +G+ Y+ K +HRD+ A N ++ D +K+ DFG+ R +
Sbjct: 116 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 289 RKGSRGFLPVRWMAPESL-KDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+ + + + + PE L + + D+W G ++ EM T S QG + + L
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQHQLA 232
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 4e-32
Identities = 34/224 (15%), Positives = 82/224 (36%), Gaps = 16/224 (7%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVAN-ENASEREKAEFLNEASVMKAFDT 181
L+++G G++G V++ ++ A+K ++ E + L E ++K
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRE----THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 182 HHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEV 241
++V+L+ V+ ++ E K + + ++
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP----------EIVKSFLFQL 110
Query: 242 ADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWM 301
G+ + + +HRDL +N ++ + +K+ +FG+ R +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS-AEVVTLWYRP 169
Query: 302 APESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
++++ D+WS G + E+A + G + L
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 119 bits (299), Expect = 8e-32
Identities = 42/256 (16%), Positives = 88/256 (34%), Gaps = 29/256 (11%)
Query: 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVM 176
V+ + +G GSFG+++ G AIK + + + ++
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLL----NNQQVAIKFEPRRSDAPQLRDEYRTYKLL 57
Query: 177 KAFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
+ +Y EG +++++L+G R ++ +
Sbjct: 58 AGC--TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----------FSVKTVAM 105
Query: 237 MAAEVADGMAYLADKKFVHRDLAARNCMVADDLT-----VKVGDFGMTRDIYETE----- 286
A ++ + + +K V+RD+ N ++ + + V DFGM + +
Sbjct: 106 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346
YR+ R+M+ + + D+ + G V S P+QGL
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKAATNKQK 224
Query: 347 VKGKSSNEYKVNPPIS 362
+ E K + P+
Sbjct: 225 Y--ERIGEKKQSTPLR 238
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-31
Identities = 45/230 (19%), Positives = 79/230 (34%), Gaps = 26/230 (11%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH 182
T +GNGSFG+VY+ + D + AIK ++K E +M+ D
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCD----SGELVAIKKVL-----QDKRFKNRELQIMRKLDHC 73
Query: 183 HVVKLYGVVSEGNPT------LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQ 236
++V+L ++++ + + R + + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-------AKQTLPVIYVKL 126
Query: 237 MAAEVADGMAYLADKKFVHRDL-AARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGF 295
++ +AY+ HRD+ + D +K+ DFG + + E S
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYIC 184
Query: 296 LPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+TS DVWS G VL E+ + G S L
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLV 233
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (296), Expect = 5e-31
Identities = 50/242 (20%), Positives = 97/242 (40%), Gaps = 25/242 (10%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV--ANENASEREKAEFLNEASVMKAFD 180
+ LG GSFG V K+ + + A+K+ + ++ LNE +++A +
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKE----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 181 THHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAE 240
+VKL + + ++ME + GG++ ++LR + AA+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQ 149
Query: 241 VADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRW 300
+ YL ++RDL N ++ ++V DFG + + + G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEA 204
Query: 301 MAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360
+APE + + D W+ GV+++EMA P+ Q+ + S + +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYP-PFFADQPIQIYEKIV---SGKVRFPSH 260
Query: 361 IS 362
S
Sbjct: 261 FS 262
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 6e-31
Identities = 52/244 (21%), Positives = 88/244 (36%), Gaps = 29/244 (11%)
Query: 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-ANENASEREKAEF 169
K +WEV R+ L +G+G++G V + AIK SE
Sbjct: 10 TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGR----TGAKVAIKKLYRPFQSELFAKRA 64
Query: 170 LNEASVMKAFDTHHVVKLYGVVSEGNPT------LVIMELMGGGDLKNYLRSCRPDAETD 223
E ++K +V+ L V + ++M MG K
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL------------ 112
Query: 224 VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIY 283
++ RI + ++ G+ Y+ +HRDL N V +D +K+ DFG+ R
Sbjct: 113 MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172
Query: 284 ETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343
+R + L +T D+WS G ++ EM T ++G +
Sbjct: 173 SEMTGYVVTRWY----RAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQ 227
Query: 344 LNWV 347
L +
Sbjct: 228 LKEI 231
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-31
Identities = 48/236 (20%), Positives = 92/236 (38%), Gaps = 29/236 (12%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIK-VANENASEREKAEFLNEASVMK---A 178
+ E+G G++G V++ +D ++ A+K V + E + E +V++
Sbjct: 10 ECVAEIGEGAYGKVFKA--RDLKNGGRF-VALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 179 FDTHHVVKLYGVVSEG-----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSR 233
F+ +VV+L+ V + ++ E + + P
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---------GVPTET 117
Query: 234 ILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTR--DIYETEYYRKG 291
I M ++ G+ +L + VHRDL +N +V +K+ DFG+ R
Sbjct: 118 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 177
Query: 292 SRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347
+ + APE L + + D+WS G + EM ++G S+ L +
Sbjct: 178 TLW-----YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKI 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 1e-29
Identities = 47/239 (19%), Positives = 91/239 (38%), Gaps = 29/239 (12%)
Query: 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-ANENASEREKAEFLNE 172
++ VL+ + L +G+G+ G+V + AIK + ++ E
Sbjct: 12 TFTVLK-RYQNLKPIGSGAQGIVCAAYDAV----LDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 173 ASVMKAFDTHHVVKLYGVVS------EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVER 226
+MK + +++ L V + E ++MELM + +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------- 119
Query: 227 SPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYETE 286
R+ + ++ G+ +L +HRDL N +V D T+K+ DFG+ R +
Sbjct: 120 ------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
Query: 287 YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+ + + APE + + + D+WS G ++ EM + G N
Sbjct: 174 MM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWN 228
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (270), Expect = 2e-27
Identities = 37/247 (14%), Positives = 82/247 (33%), Gaps = 34/247 (13%)
Query: 108 KLYKKDSWEV---LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER 164
+ + +S V + ++ +LG G + V+ + +K+ ++
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINIT----NNEKVVVKILKPVKKKK 75
Query: 165 EKAEFLNEASVMKAFDTH-HVVKLYGVVSEGNPTLV--IMELMGGGDLKNYLRSCRPDAE 221
E +++ +++ L +V + + E + D K ++
Sbjct: 76 ----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----- 126
Query: 222 TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMV-ADDLTVKVGDFGMTR 280
T I E+ + Y +HRD+ N M+ + +++ D+G+
Sbjct: 127 --------TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 281 DIYETE--YYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338
+ + R SR F + ++ D+WS G +L M + G
Sbjct: 179 FYHPGQEYNVRVASRYF----KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
Query: 339 SNEQVLN 345
N L
Sbjct: 235 DNYDQLV 241
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-26
Identities = 46/240 (19%), Positives = 85/240 (35%), Gaps = 27/240 (11%)
Query: 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKV-ANENASEREKAEFL 170
K WEV + L +G+G++G V A+K + S
Sbjct: 11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTK----TGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 171 NEASVMKAFDTHHVVKLYGVVSEGNPT-----LVIMELMGGGDLKNYLRSCRPDAETDVE 225
E ++K +V+ L V + + ++ + G DL N ++
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----------- 114
Query: 226 RSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYET 285
T + + ++ G+ Y+ +HRDL N V +D +K+ DFG+ R +
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 286 EYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345
+R + L + D+WS G ++ E+ T + G + L
Sbjct: 175 MTGYVATRWY----RAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLK 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.3 bits (220), Expect = 2e-20
Identities = 39/241 (16%), Positives = 87/241 (36%), Gaps = 35/241 (14%)
Query: 123 TILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMK----- 177
++ +LG G F V+ A+K+ + E AE +E +++
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMV----NNTHVAMKIVRGDKVYTEAAE--DEIKLLQRVNDA 69
Query: 178 ------AFDTHHVVKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTL 231
+ +H++KL + P V + ++ +N L + E L
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK-----KYEHRGIPL 124
Query: 232 SRILQMAAEVADGMAYLADK-KFVHRDLAARNCMVADD------LTVKVGDFGMTRDIYE 284
+ Q++ ++ G+ Y+ + +H D+ N ++ + +K+ D G E
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 285 TEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVL 344
+R + +PE L + +D+WS +++E+ T ++
Sbjct: 185 HYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPDEGHSYT 238
Query: 345 N 345
Sbjct: 239 K 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.2 bits (158), Expect = 4e-13
Identities = 32/212 (15%), Positives = 65/212 (30%), Gaps = 47/212 (22%)
Query: 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKA---------EFLNEAS 174
I +G G V+ + F C +K + +K F A
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFG-----ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58
Query: 175 VMKAFDTHHVVKLYGVVS----EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPT 230
+ + KL G+ V+MEL+ +L
Sbjct: 59 RSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP------------- 105
Query: 231 LSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE---TEY 287
++ + + +A + VH DL+ N +V + + + DF + ++ E E
Sbjct: 106 ----DEVLDMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREI 160
Query: 288 YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWS 319
+ R + + + + + D+ S
Sbjct: 161 LERDVRNII--TYFSRT------YRTEKDINS 184
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 364 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.25 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.09 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.28 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 97.17 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 97.17 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 97.1 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 96.74 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 96.73 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 96.72 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 96.58 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 96.25 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 96.18 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 96.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.86 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 95.78 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 95.63 | |
| d2oq1a2 | 124 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 95.36 | |
| d2c9wa2 | 103 | Suppressor of cytokine signaling 2, SOCS-2 {Human | 95.35 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 95.24 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 95.2 | |
| d1a81a2 | 125 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 95.16 | |
| d1jwoa_ | 97 | Csk homologous kinase Chk {Human (Homo sapiens) [T | 95.14 | |
| d1opka2 | 101 | Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: | 94.77 | |
| d2eyva1 | 109 | Crk proto-oncogen {Human (Homo sapiens) [TaxId: 96 | 94.72 | |
| d1k9aa2 | 101 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 94.49 | |
| d2izva2 | 112 | Suppressor of cytokine signaling 4, SOCS-4 {Human | 94.46 | |
| d1luia_ | 108 | Itk/tsk protein tyrosine kinase {Mouse (Mus muscul | 93.69 | |
| d1d4ta_ | 104 | The Xlp protein Sap {Human (Homo sapiens) [TaxId: | 93.31 | |
| d2shpa3 | 108 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 93.23 | |
| d1xa6a2 | 141 | Beta-chimaerin, N-terminal domain {Human (Homo sap | 93.21 | |
| d2shpa2 | 109 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 92.9 | |
| d1qada_ | 107 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 92.56 | |
| d1uura3 | 131 | STAT homologue {Dictyostelium discoideum [TaxId: 4 | 92.34 | |
| d1mila_ | 104 | Shc adaptor protein {Human (Homo sapiens) [TaxId: | 92.31 | |
| d2fcia1 | 105 | Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: | 89.25 | |
| d2cs0a1 | 106 | Hematopoietic SH2 domain containing protein HSH2D | 86.08 | |
| d1fu6a_ | 111 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 85.0 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=385.98 Aligned_cols=208 Identities=24% Similarity=0.393 Sum_probs=179.9
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|++++.||+|+||+||+|+++. +++.||+|+++........+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~----~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV----TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC----CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 3689999999999999999999886 477899999876655555667899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|||||++|+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||+++++.+||+|||+
T Consensus 80 ivmEy~~gg~L~~~l~~----------~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp EEEECCTTEEGGGGSBT----------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEeccCCCcHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchh
Confidence 99999999999999853 34678899999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
|+...............||+.|||||++.+..+ +.++|||||||++|||+| |++||...+..
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~-G~~pf~~~~~~ 212 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDS 212 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSSTT
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh-CCCCCCCCChH
Confidence 987765544444455678999999999988876 568999999999999999 89999765543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-52 Score=383.71 Aligned_cols=233 Identities=39% Similarity=0.705 Sum_probs=204.6
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
.+.||+..++|++.++||+|+||+||+|+++. +++.||||+++..... .+++.+|+++|++++|||||++++++
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGG----GTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECC----CCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccE
Confidence 45689999999999999999999999999886 4678999998765443 46789999999999999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
.+++..++|||||++|+|.+++... ....+++..++.++.||+.||+|||++|||||||||+||||++++.+
T Consensus 83 ~~~~~~~iv~E~~~~g~l~~~l~~~--------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~ 154 (287)
T d1opja_ 83 TREPPFYIITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 154 (287)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHS--------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred eeCCeeEEEeecccCcchHHHhhhc--------cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcE
Confidence 9999999999999999999999762 34567889999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||+|+.......... ....+++.|+|||++.+..|+.++|||||||++|||++++.+||.+.+..++.+.+..+.
T Consensus 155 Kl~DFG~a~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~ 233 (287)
T d1opja_ 155 KVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 233 (287)
T ss_dssp EECCCCCTTTCCSSSSEEE-TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EEccccceeecCCCCceee-ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC
Confidence 9999999987765443322 223357889999999999999999999999999999998888888999999999998887
Q ss_pred cccccCCC
Q psy7023 352 SNEYKVNP 359 (364)
Q Consensus 352 ~~~~~~~~ 359 (364)
..+.+..+
T Consensus 234 ~~~~~~~~ 241 (287)
T d1opja_ 234 RMERPEGC 241 (287)
T ss_dssp CCCCCTTC
T ss_pred CCCCCccc
Confidence 76665443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-52 Score=382.46 Aligned_cols=235 Identities=38% Similarity=0.642 Sum_probs=193.2
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
++..++|++.+.||+|+||+||+|.++.+.. ....||||.+.........++|.+|+++|++++|||||++++++.+++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGK-REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC----CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 4556889999999999999999999875432 234689999887777777888999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
.+++|||||++|+|.+++.. ....+++.++..++.||+.||+|||+++||||||||+||||+.++.+||+|
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~---------~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~D 171 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQ---------NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSD 171 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHT---------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred EEEEEEEecCCCcceeeecc---------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECC
Confidence 99999999999999999875 344688999999999999999999999999999999999999999999999
Q ss_pred cccccccCccceeee---CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 276 FGMTRDIYETEYYRK---GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
||+++.+........ .....+|+.|||||++.++.|+.++|||||||++|||+|+|.+||.+.+..++++.+..+..
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999987654432221 12234588999999999999999999999999999999988999999999999999998877
Q ss_pred ccccCCCC
Q psy7023 353 NEYKVNPP 360 (364)
Q Consensus 353 ~~~~~~~~ 360 (364)
.+.+.+++
T Consensus 252 ~~~~~~~~ 259 (299)
T d1jpaa_ 252 LPPPMDCP 259 (299)
T ss_dssp CCCCTTCC
T ss_pred CCCCccch
Confidence 76655543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=378.24 Aligned_cols=232 Identities=35% Similarity=0.671 Sum_probs=201.6
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
..+.||+.+++|+++++||+|+||+||+|.+++ +..||||+++..... .+++.+|+.+|++++|||||+++++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECC-----CCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEee
Confidence 357899999999999999999999999999874 567999999765433 3578999999999999999999998
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
+.+ +..++||||+++|+|.+++... ...++++..++.++.||+.||+|||+++|+||||||+||||++++.
T Consensus 77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~--------~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~ 147 (272)
T d1qpca_ 77 VTQ-EPIYIITEYMENGSLVDFLKTP--------SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147 (272)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSH--------HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc
Confidence 865 6679999999999999987541 2335789999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||+|||+|+.+....... .....+++.|||||++.++.++.++|||||||++|||+|++.+||...+..++++.+..+
T Consensus 148 ~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~ 226 (272)
T d1qpca_ 148 CKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (272)
T ss_dssp EEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred eeeccccceEEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 9999999998776554332 333456889999999999999999999999999999999889999999999999999988
Q ss_pred ccccccCCC
Q psy7023 351 SSNEYKVNP 359 (364)
Q Consensus 351 ~~~~~~~~~ 359 (364)
.....|.++
T Consensus 227 ~~~~~p~~~ 235 (272)
T d1qpca_ 227 YRMVRPDNC 235 (272)
T ss_dssp CCCCCCTTC
T ss_pred CCCCCcccC
Confidence 776665444
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=381.44 Aligned_cols=224 Identities=24% Similarity=0.401 Sum_probs=192.3
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|+++++||+|+||+||+|+++. +++.||+|+++..... ..+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~----~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA----TGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT----TCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC----CCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 4689999999999999999999876 4778999998754332 2467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|||||+||+|.+++.+ ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 94 ivmEy~~gg~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~ 162 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (293)
T ss_dssp EEEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEecCCCcHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchh
Confidence 99999999999998864 2478899999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVN 358 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 358 (364)
|+.+...... .....||+.|+|||++.+..|+.++|||||||++|+|+| |.+||.+.+..+.+..+..+.....+.+
T Consensus 163 a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T d1yhwa1 163 CAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQNP 239 (293)
T ss_dssp CEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHHCSCCCSSG
T ss_pred heeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCc
Confidence 9876544322 233457999999999999999999999999999999999 8999999888887776665544444333
Q ss_pred CCC
Q psy7023 359 PPI 361 (364)
Q Consensus 359 ~~~ 361 (364)
..+
T Consensus 240 ~~~ 242 (293)
T d1yhwa1 240 EKL 242 (293)
T ss_dssp GGS
T ss_pred ccC
Confidence 333
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-52 Score=376.78 Aligned_cols=232 Identities=34% Similarity=0.651 Sum_probs=200.7
Q ss_pred eeccceeEec-eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
+.+++|.+.+ +||+|+||+||+|.++... .+..||||+++........++|.+|+++|++++|||||++++++.. +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC-----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCC--CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 3456788888 4999999999999876533 3557999999877777778899999999999999999999999875 5
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
.+|+|||||++|+|.+++.. ....+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~D 152 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISD 152 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECC
T ss_pred eEEEEEEeCCCCcHHHHhhc---------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeecc
Confidence 68999999999999999864 334688999999999999999999999999999999999999999999999
Q ss_pred cccccccCcccee-eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 276 FGMTRDIYETEYY-RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 276 Fg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
||+++.+...... .......+|+.|+|||++..+.++.++|||||||++|||+|.|++||.+.+..++...+..+...+
T Consensus 153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~ 232 (285)
T d1u59a_ 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232 (285)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred chhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999877654332 233344578899999999999999999999999999999987899999999999999999998887
Q ss_pred ccCCCC
Q psy7023 355 YKVNPP 360 (364)
Q Consensus 355 ~~~~~~ 360 (364)
.|.++|
T Consensus 233 ~p~~~~ 238 (285)
T d1u59a_ 233 CPPECP 238 (285)
T ss_dssp CCTTCC
T ss_pred CCCcCC
Confidence 766654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=372.91 Aligned_cols=214 Identities=20% Similarity=0.352 Sum_probs=189.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|+++. +++.||+|++.+... ....+.+.+|++++++++||||+++++++.+++.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC----CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 689999999999999999999886 477899999864322 12246788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+|||||++|+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+|||+++++.+||+|||
T Consensus 82 ~ivmEy~~~g~L~~~l~~~----------~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL----------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEeecCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccc
Confidence 9999999999999999752 357889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+|+........ ...||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++++.+.++..
T Consensus 152 ~a~~~~~~~~~----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~ 221 (263)
T d2j4za1 152 WSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRVEF 221 (263)
T ss_dssp SCSCCCCCCCE----ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTTCC
T ss_pred eeeecCCCccc----ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc-CCCCCCCCCHHHHHHHHHcCCC
Confidence 99876544322 2346899999999999999999999999999999999 8999999999999998877653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=380.33 Aligned_cols=217 Identities=20% Similarity=0.345 Sum_probs=188.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|+++. +++.||+|+++.... ....+.+.+|+++|++++||||+++++++.+++.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC----CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 579999999999999999999876 477899999875321 22346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+|||||+||+|.+++... ..+++..++.++.|++.||+|||++|||||||||+|||+++++.+||+|||
T Consensus 84 ~ivmEy~~gg~L~~~~~~~----------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI----------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEccCCCCHHHhhhcc----------CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccc
Confidence 9999999999999998752 357889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+|+.+.............||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..++++.+..+.
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~~ 226 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKIIKLE 226 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHTTC
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh-CCCCCCCcCHHHHHHHHHcCC
Confidence 9987765443333444567999999999999999999999999999999999 899999999999999887764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=376.89 Aligned_cols=224 Identities=21% Similarity=0.386 Sum_probs=183.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee--CCc
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE--GNP 196 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~ 196 (364)
++|++++.||+|+||+||+|+++. +++.||+|+++... .+...+.+.+|+++|++++||||+++++++.+ ++.
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS----DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred hhCEEeEEEecCCCeEEEEEEECC----CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence 689999999999999999999886 46789999987654 45556788999999999999999999999864 567
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEcCCCcE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK-----FVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~-----iiHrDlkp~NILl~~~~~~ 271 (364)
+|+|||||++|+|.+++.+.. .....+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHH------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 899999999999999997532 13456889999999999999999999876 9999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+|||+|+.+...... .....+|+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+..+.
T Consensus 154 kl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~t-g~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 154 KLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTC
T ss_pred EEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhh-CCCCCCCCCHHHHHHHHHcCC
Confidence 99999999876544322 223456899999999999999999999999999999999 899999999999999998876
Q ss_pred ccccc
Q psy7023 352 SNEYK 356 (364)
Q Consensus 352 ~~~~~ 356 (364)
..+.+
T Consensus 231 ~~~~~ 235 (269)
T d2java1 231 FRRIP 235 (269)
T ss_dssp CCCCC
T ss_pred CCCCC
Confidence 65443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=385.59 Aligned_cols=248 Identities=34% Similarity=0.585 Sum_probs=201.4
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGV 190 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~ 190 (364)
..||+.+++|+++++||+|+||+||+|+++... ......||+|.+...........+.+|+.+|+++ +|||||+++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 458899999999999999999999999987643 2335579999987766666677899999999998 89999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCC-------------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAET-------------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRD 257 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrD 257 (364)
+.+.+.+|+|||||++|+|.++++..+..... ......+++..++.++.||+.||+|||+++|||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999999999999865422110 11234688999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy7023 258 LAARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQG 337 (364)
Q Consensus 258 lkp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~ 337 (364)
|||+|||++.++.+||+|||+|+...............+|+.|||||++.+..|+.++|||||||++|||+|+|.+||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998766554444444445688999999999999999999999999999999878999998
Q ss_pred CCHH-HHHHHHhcCccccccCCCC
Q psy7023 338 LSNE-QVLNWVKGKSSNEYKVNPP 360 (364)
Q Consensus 338 ~~~~-~~~~~i~~~~~~~~~~~~~ 360 (364)
.+.. ++.+.++.+..++.|.+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~p~~~~ 293 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQPFYAT 293 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCC
Confidence 6654 4556667776666655543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=373.86 Aligned_cols=236 Identities=38% Similarity=0.670 Sum_probs=197.6
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
|+..+.|++.+.||+|+||+||+|.++.........||||+++.........+|++|+++|++++|||||++++++.+.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 44557899999999999999999998876555567899999987777777788999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++|||||.++++.+++.. ....+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEEEecccCcchhhhhc---------ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcc
Confidence 99999999999999998875 345688899999999999999999999999999999999999999999999
Q ss_pred cccccccCccceee-eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 276 FGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 276 Fg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
||+++......... ......+|+.|||||++.++.++.++|||||||++|||++++.+||.+.+..++++.+..+...+
T Consensus 154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233 (283)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred cchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC
Confidence 99998765443222 22233468899999999999999999999999999999998888899999999999999988777
Q ss_pred ccCCCC
Q psy7023 355 YKVNPP 360 (364)
Q Consensus 355 ~~~~~~ 360 (364)
.+.+++
T Consensus 234 ~~~~~~ 239 (283)
T d1mqba_ 234 TPMDCP 239 (283)
T ss_dssp CCTTCB
T ss_pred CchhhH
Confidence 665543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=379.45 Aligned_cols=223 Identities=28% Similarity=0.440 Sum_probs=191.3
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
+.|++++.||+|+||+||+|+++. ++..||+|+++.... ...+.+.+|+++|++++|||||++++++.+++.+|+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~----~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE----TSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC----CCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 579999999999999999999887 467899999875533 335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
|||||++|+|.+++.+ ....+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus 87 vmEy~~~g~L~~~~~~---------~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a 157 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE---------LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS 157 (288)
T ss_dssp EEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhh
Confidence 9999999999999875 2346888999999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCccccc-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcccc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLK-----DGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNE 354 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 354 (364)
+....... ......+|+.|+|||++. +..|+.++|||||||++|||+| |++||.+.+..+++..+..+....
T Consensus 158 ~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt-g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (288)
T d2jfla1 158 AKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRVLLKIAKSEPPT 234 (288)
T ss_dssp EECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGHHHHHHHSCCCC
T ss_pred hccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCCCC
Confidence 76543321 223345789999999984 4568999999999999999999 899999999999998887775544
Q ss_pred ccCCC
Q psy7023 355 YKVNP 359 (364)
Q Consensus 355 ~~~~~ 359 (364)
.+.+.
T Consensus 235 ~~~~~ 239 (288)
T d2jfla1 235 LAQPS 239 (288)
T ss_dssp CSSGG
T ss_pred CCccc
Confidence 43333
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=379.79 Aligned_cols=228 Identities=24% Similarity=0.345 Sum_probs=180.5
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.++++|++++.||+|+||+||+|+++. +++.||+|++...........+.+|+.+|++++||||+++++++.+++.
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKR----TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETT----TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECC----CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 456889999999999999999999876 4678999999866555556678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCcEEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA---DDLTVKV 273 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~---~~~~~kL 273 (364)
+|+|||||+||+|.+++.+ ...+++..+..++.||+.||+|||++|||||||||+|||+. +++.+||
T Consensus 82 ~~lvmE~~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl 151 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVE----------KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMI 151 (307)
T ss_dssp EEEEECCCCSCBHHHHHHT----------CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEeccCCCcHHHhhhc----------ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEE
Confidence 9999999999999999974 34688999999999999999999999999999999999995 5789999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||+|+....... .....||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..++...+..+...
T Consensus 152 ~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~~~~ 227 (307)
T d1a06a_ 152 SDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLFEQILKAEYE 227 (307)
T ss_dssp CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHTTCCC
T ss_pred eccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCC
Confidence 99999986654332 223457899999999999999999999999999999999 89999999999999888766543
Q ss_pred -cccCCCCCC
Q psy7023 354 -EYKVNPPIS 362 (364)
Q Consensus 354 -~~~~~~~~s 362 (364)
+.+.++.+|
T Consensus 228 ~~~~~~~~~s 237 (307)
T d1a06a_ 228 FDSPYWDDIS 237 (307)
T ss_dssp CCTTTTTTSC
T ss_pred CCCccccCCC
Confidence 334444443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=370.20 Aligned_cols=223 Identities=37% Similarity=0.651 Sum_probs=186.9
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|+++++||+|+||+||+|.+++ +..||||+++..... .+++.+|++++++++||||+++++++.+++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-----TEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-----CCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 689999999999999999999875 557999999765443 3578999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 78 v~E~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp EEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred EEEecCCCcHHHHhhc---------cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchh
Confidence 9999999999999875 3356788899999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNP 359 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 359 (364)
+......... .....+|+.|+|||++.+..|+.++|||||||++|||+|+|.+||...+..++++.+..+.....|..+
T Consensus 149 ~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~ 227 (263)
T d1sm2a_ 149 RFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcccc
Confidence 8765543322 223346889999999999999999999999999999999889999999999999999888776665544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=371.83 Aligned_cols=234 Identities=38% Similarity=0.699 Sum_probs=193.5
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
.||+.+++|++++.||+|+||+||+|++..... ....||+|.++........+.+.+|+.+|++++||||+++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN-PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCc-eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 488999999999999999999999999875432 2467999999877777777889999999999999999999999964
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
+.+|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++||||||||+|||+++++.+||
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~---------~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl 149 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 149 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred -CeEEEEEEeccCCcHHhhhhc---------cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEE
Confidence 678999999999999999875 3446788999999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||+|+........ ......+|+.|+|||++.+..|+.++|||||||++|||+|+|.+||.+.+..++++.+..+...
T Consensus 150 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~ 228 (273)
T d1mp8a_ 150 GDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228 (273)
T ss_dssp CC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred ccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999876544332 2334456889999999999999999999999999999999889999999999999999988776
Q ss_pred cccCCC
Q psy7023 354 EYKVNP 359 (364)
Q Consensus 354 ~~~~~~ 359 (364)
+.+.++
T Consensus 229 ~~~~~~ 234 (273)
T d1mp8a_ 229 PMPPNC 234 (273)
T ss_dssp CCCTTC
T ss_pred CCCCCC
Confidence 665544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=374.04 Aligned_cols=222 Identities=28% Similarity=0.510 Sum_probs=182.5
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
+.||+..++|+++++||+|+||+||+|+++. .||||+++... .....+.|.+|+.+|++++||||+++++++
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence 4689999999999999999999999997543 49999987543 344567899999999999999999999987
Q ss_pred eeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 192 SEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 192 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
.+ +.+++|||||++|+|.+++.. ....+++..+..++.||+.||+|||+++||||||||+||||++++.+
T Consensus 74 ~~-~~~~lv~Ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~ 143 (276)
T d1uwha_ 74 TA-PQLAIVTQWCEGSSLYHHLHI---------IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTV 143 (276)
T ss_dssp CS-SSCEEEEECCCEEEHHHHHHT---------SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSE
T ss_pred ec-cEEEEEEecCCCCCHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCE
Confidence 65 678999999999999999975 23468899999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE-QVLNWV 347 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~-~~~~~i 347 (364)
||+|||+|+...............+|+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+.. ++...+
T Consensus 144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~t-g~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHHHH
T ss_pred EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHH-CCCCCCCCChHHHHHHHH
Confidence 9999999987665444334444567999999999864 348899999999999999999 89999987655 444555
Q ss_pred hcCcc
Q psy7023 348 KGKSS 352 (364)
Q Consensus 348 ~~~~~ 352 (364)
.++..
T Consensus 223 ~~~~~ 227 (276)
T d1uwha_ 223 GRGYL 227 (276)
T ss_dssp HHTSC
T ss_pred hcCCC
Confidence 55543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=382.32 Aligned_cols=209 Identities=24% Similarity=0.406 Sum_probs=184.3
Q ss_pred eeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC
Q psy7023 116 EVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN 195 (364)
Q Consensus 116 e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 195 (364)
|+..++|+++++||+|+||+||+|+++. +++.||+|+++.........++.+|+.+|++++|||||+++++|.+.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~----~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKP----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETT----TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECC----CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4567899999999999999999999876 477899999987655566678999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEe
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
.+|+|||||+||+|.+++.+. ..+++..+..++.|++.||.|||+ +||+||||||+|||+++++.+||+
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~----------~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~ 147 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEEEcCCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEe
Confidence 999999999999999999752 357889999999999999999997 599999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~ 343 (364)
|||+|+...+.. .....||+.|+|||++.+..|+.++||||+||++|||++ |+.||.+.+..+.
T Consensus 148 DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~-G~~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 148 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKEL 211 (322)
T ss_dssp CCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHH-SSCCSSCCCTTHH
T ss_pred eCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHH
Confidence 999998664432 223467899999999999999999999999999999999 8999987665443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-50 Score=372.51 Aligned_cols=246 Identities=39% Similarity=0.721 Sum_probs=208.7
Q ss_pred ceeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 114 SWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 114 ~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
.+|..+++|++++.||+|+||+||+|+++... ..+++.||||+++........+++.+|+.+|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 47788899999999999999999999987532 23467899999988777777788999999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCc--------------cCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETD--------------VERSPPTLSRILQMAAEVADGMAYLADKKFVHRDL 258 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~--------------~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDl 258 (364)
..+..++||||+++|+|.+++.......... .....+++..++.++.|++.||+|||+++||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999998654322111 12345788999999999999999999999999999
Q ss_pred CCCCEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 259 AARNCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 259 kp~NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
||+||||+.++.+||+|||+|+...............+++.|+|||.+.+..|+.++|||||||++|||++++.+||.+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999999999987665544444444556889999999999999999999999999999999778999999
Q ss_pred CHHHHHHHHhcCccccccCCC
Q psy7023 339 SNEQVLNWVKGKSSNEYKVNP 359 (364)
Q Consensus 339 ~~~~~~~~i~~~~~~~~~~~~ 359 (364)
+..+++..++.+...+.+..+
T Consensus 247 ~~~e~~~~v~~~~~~~~p~~~ 267 (301)
T d1lufa_ 247 AHEEVIYYVRDGNILACPENC 267 (301)
T ss_dssp CHHHHHHHHHTTCCCCCCTTC
T ss_pred CHHHHHHHHHcCCCCCCCccc
Confidence 999999999998876655443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=376.24 Aligned_cols=215 Identities=24% Similarity=0.334 Sum_probs=190.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|+++. +++.||+|++++... ....+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKA----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECC----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 689999999999999999999877 577899999875421 22356788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+|||||+||+|.+++.+ ...+++..++.++.||+.||+|||++|||||||||+|||++++|.+||+|||
T Consensus 81 ~iv~ey~~gg~L~~~~~~----------~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSR----------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EEEEECCTTCBHHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccceeccCCCchhhhhhc----------ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecc
Confidence 999999999999999986 3357788999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
+|+........ .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++.+.+..+.
T Consensus 151 ~a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~-G~~pf~~~~~~~~~~~i~~~~ 221 (337)
T d1o6la_ 151 LCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILMEE 221 (337)
T ss_dssp TCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred cccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHH-CCCCCCCcCHHHHHHHHhcCC
Confidence 99866543322 223457899999999999999999999999999999999 899999999999999887765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=375.31 Aligned_cols=231 Identities=34% Similarity=0.583 Sum_probs=193.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+|+++++||+|+||+||+|.++.+......+||+|.++........+++.+|+.++++++|||||++++++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46999999999999999999988766555668999998766555556789999999999999999999999986 46788
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
++|++.+|+|.+++.. ....+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|
T Consensus 88 v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp EEECCTTCBHHHHHHH---------TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred EEEeccCCcccccccc---------cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccc
Confidence 8999999999999876 3456788999999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNP 359 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 359 (364)
+...............+|+.|+|||++.++.|+.++|||||||++|||+|+|.+||.+.+..++...++.+...+.|..+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~ 238 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 238 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTB
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 87765544444444457889999999999999999999999999999999899999999999999999988877665544
Q ss_pred C
Q psy7023 360 P 360 (364)
Q Consensus 360 ~ 360 (364)
+
T Consensus 239 ~ 239 (317)
T d1xkka_ 239 T 239 (317)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=366.02 Aligned_cols=222 Identities=32% Similarity=0.622 Sum_probs=188.1
Q ss_pred ceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEEEEecC
Q psy7023 126 DELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLVIMELM 204 (364)
Q Consensus 126 ~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 204 (364)
++||+|+||+||+|.++... .++.||||+++... .....+++.+|+.+|++++|||||++++++.. +..++|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS--SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCC--cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 36999999999999876532 36789999987543 33446789999999999999999999999965 5679999999
Q ss_pred CCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccccccCc
Q psy7023 205 GGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDIYE 284 (364)
Q Consensus 205 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~~~ 284 (364)
++|+|.+++++ ...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~~g~L~~~l~~----------~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 90 ELGPLNKYLQQ----------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp TTEEHHHHHHH----------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCCcHHHHHhh----------ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 99999999975 34578899999999999999999999999999999999999999999999999987654
Q ss_pred cce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCCC
Q psy7023 285 TEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360 (364)
Q Consensus 285 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 360 (364)
... ........+|+.|||||++.+..++.++|||||||++|||+|.|++||.+.+..++...+.++...+.|..+|
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 236 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 236 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 432 2333445678999999999999999999999999999999987899999999999999999988777665543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=367.32 Aligned_cols=232 Identities=37% Similarity=0.634 Sum_probs=195.8
Q ss_pred cccceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEE
Q psy7023 111 KKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGV 190 (364)
Q Consensus 111 ~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 190 (364)
..+.||+..++|++.+.||+|+||+||+|++++ +..||||+++..... .+.|.+|+.+|++++|||||+++++
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-----~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-----TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECC-----CCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEE
Confidence 467899999999999999999999999999876 456999999765443 3679999999999999999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 191 VSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
+.+ +..++||||+++|+|.+++.. .....+++.+++.++.||+.||+|||+++|+||||||+||||++++.
T Consensus 81 ~~~-~~~~lv~Ey~~~g~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~ 151 (285)
T d1fmka3 81 VSE-EPIYIVTEYMSKGSLLDFLKG--------ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 151 (285)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSH--------HHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred Eec-CCeEEEEEecCCCchhhhhhh--------cccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc
Confidence 865 568999999999999999875 23346889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 271 VKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
+||+|||+++........ ......+|+.|+|||++.++.++.++|||||||++|||+||+.+||.+....++++.+..+
T Consensus 152 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~ 230 (285)
T d1fmka3 152 CKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 230 (285)
T ss_dssp EEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred EEEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 999999999876544332 2233456889999999999999999999999999999999889999999999999999988
Q ss_pred ccccccCCC
Q psy7023 351 SSNEYKVNP 359 (364)
Q Consensus 351 ~~~~~~~~~ 359 (364)
...+.+..+
T Consensus 231 ~~~~~~~~~ 239 (285)
T d1fmka3 231 YRMPCPPEC 239 (285)
T ss_dssp CCCCCCTTS
T ss_pred CCCCCCccc
Confidence 766655443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=372.11 Aligned_cols=253 Identities=66% Similarity=1.063 Sum_probs=219.0
Q ss_pred ccccccceeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeE
Q psy7023 108 KLYKKDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVK 186 (364)
Q Consensus 108 ~~~~~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~ 186 (364)
..+.++.||+..++|++.++||+|+||+||+|.++... ......||||+++..........+.+|+.++++++||||++
T Consensus 8 ~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 87 (308)
T d1p4oa_ 8 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87 (308)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEee
Confidence 45566789999999999999999999999999986432 22457899999987777777788999999999999999999
Q ss_pred EEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 187 LYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 187 l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
+++++..++..++||||+++|+|.+++...............+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 88 ~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 167 (308)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec
Confidence 99999999999999999999999999975432221112334578889999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 267 DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 267 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
+++++||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+|++.+||.+.+..++++.
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999999877766656566667789999999999999999999999999999999977899999999999999
Q ss_pred HhcCccccccCCCC
Q psy7023 347 VKGKSSNEYKVNPP 360 (364)
Q Consensus 347 i~~~~~~~~~~~~~ 360 (364)
+..+...+.+.+++
T Consensus 248 i~~~~~~~~p~~~~ 261 (308)
T d1p4oa_ 248 VMEGGLLDKPDNCP 261 (308)
T ss_dssp HHTTCCCCCCTTCC
T ss_pred HHhCCCCCCcccch
Confidence 99888776655543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=360.61 Aligned_cols=223 Identities=38% Similarity=0.679 Sum_probs=197.0
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|+++++||+|+||+||+|++++ +..||||+++..... .+++++|+.++++++||||+++++++.+++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETT-----TEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECC-----CCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 578899999999999999999864 678999998865443 3578999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+++|+|.+++.. ....+++..+.+++.|+++||+|||++||+||||||+|||+++++.+||+|||++
T Consensus 77 v~Ey~~~g~l~~~~~~---------~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147 (258)
T ss_dssp EEECCTTEEHHHHHHS---------GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EEEccCCCcHHHhhhc---------cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhh
Confidence 9999999999999874 3446788899999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCC
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNP 359 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 359 (364)
+.+....... .....+|+.|+|||.+.+..++.++|||||||++|||+|+|+.||.+.+..++...+..+.....|..+
T Consensus 148 ~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 148 RYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp CBCSSSSCCC-CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred eeccCCCcee-ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 8766554332 333456889999999999999999999999999999999789999999999999999988776665544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.4e-50 Score=374.65 Aligned_cols=216 Identities=24% Similarity=0.373 Sum_probs=190.7
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
.++|++++.||+|+||+||+|+++. +++.||+|++.... ....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~----~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA----TGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT----TTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC----CCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3689999999999999999999876 47789999987553 345678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCcEEEeec
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD--DLTVKVGDF 276 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~--~~~~kL~DF 276 (364)
+|||||+||+|.+++.+ ....+++..+..++.||+.||+|||++|||||||||+|||++. ++.+||+||
T Consensus 100 ivmE~~~gg~L~~~l~~---------~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 100 MIYEFMSGGELFEKVAD---------EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp EEECCCCSCBHHHHHTC---------TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred EEEEcCCCCCHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeec
Confidence 99999999999999964 3346899999999999999999999999999999999999964 678999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+++.+....... ...+|+.|||||++.+..|+.++|||||||++|+|+| |.+||.+.+..+++..+..+..
T Consensus 171 G~a~~~~~~~~~~---~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~ 242 (350)
T d1koaa2 171 GLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDW 242 (350)
T ss_dssp TTCEECCTTSCEE---EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCC
T ss_pred chheecccccccc---eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC
Confidence 9998766543322 2345889999999999999999999999999999999 8999999999999988876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.2e-50 Score=374.18 Aligned_cols=215 Identities=23% Similarity=0.385 Sum_probs=190.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
++|++++.||+|+||+||+|+++. +++.||+|+++... ......+.+|+.+|++++||||++++++|.+++.+|+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~----~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA----TGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECC----CCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 579999999999999999999876 47789999987653 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc--CCCcEEEeecc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA--DDLTVKVGDFG 277 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~--~~~~~kL~DFg 277 (364)
|||||+||+|.+++.. ...++++.+++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||
T Consensus 104 vmE~~~gg~L~~~~~~---------~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 104 ILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEcCCCChHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecc
Confidence 9999999999998764 334689999999999999999999999999999999999998 67899999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+|..+........ ..+|+.|+|||++.+..|+.++|||||||++|+|+| |++||.+.+..+++..+..+..
T Consensus 175 la~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~ 245 (352)
T d1koba_ 175 LATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCDW 245 (352)
T ss_dssp TCEECCTTSCEEE---ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHCCC
T ss_pred cceecCCCCceee---ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC
Confidence 9987765433221 235789999999999999999999999999999999 8999999999999988876653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-50 Score=369.36 Aligned_cols=213 Identities=22% Similarity=0.370 Sum_probs=188.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|+++++||+|+||+||+|+++. +++.||+|++++... ....+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 579999999999999999999876 477899999875422 12346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
|+|||||+||+|..++.. ...++...+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||
T Consensus 80 ~ivmE~~~gg~l~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRK----------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EEEECCCCSCBHHHHHHH----------TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eeEeeecCCccccccccc----------cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCc
Confidence 999999999999999875 3346678888999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+|+...... ....||+.|||||++.+..|+.++|||||||++|+|+| |+.||.+.+..+++..+..+..
T Consensus 150 ~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~~~ 218 (316)
T d1fota_ 150 FAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNAEL 218 (316)
T ss_dssp SCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHCCC
T ss_pred cceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHh-CCCCCCCcCHHHHHHHHHcCCC
Confidence 998765432 23457889999999999999999999999999999999 8999999999999998877643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-50 Score=367.95 Aligned_cols=214 Identities=24% Similarity=0.375 Sum_probs=186.0
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
...|+++++||+|+||+||+|+++. +++.||||++.... .....+.+.+|+.+|++++|||||++++++.+++.
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 89 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVR----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT----TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECC----CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE
Confidence 4579999999999999999999876 47789999987543 23445678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+|+|||||.+|+|..++.. ..++++..++.++.||+.||+|||++|||||||||+|||+++++.+||+||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~----------~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DF 159 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVH----------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159 (309)
T ss_dssp EEEEEECCSEEHHHHHHHH----------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred EEEEEEecCCCchHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeec
Confidence 9999999999988776653 346889999999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKD---GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|+|...... ....||+.|||||++.+ +.|+.++|||||||++|||++ |..||.+.+..+.+..+..+...
T Consensus 160 G~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~-g~~Pf~~~~~~~~~~~i~~~~~~ 232 (309)
T d1u5ra_ 160 GSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESP 232 (309)
T ss_dssp TTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCC
T ss_pred ccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCCC
Confidence 999865433 23457999999999864 458999999999999999999 89999998888888777665443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=365.68 Aligned_cols=247 Identities=36% Similarity=0.671 Sum_probs=208.4
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCccc---ccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS---LAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLY 188 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~ 188 (364)
..|++..++|+++++||+|+||.||+|++..++. .....||||+++.........++.+|...++++ +||||++++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 3589999999999999999999999998766432 234579999998888877788899999999998 899999999
Q ss_pred EEEeeCCceEEEEecCCCCCHHHHHHhcCCCCC------CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAE------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
+++.+++..++|||||++|+|.+++........ .......+++..++.++.||+.||+|||+++||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 999999999999999999999999987543211 11234568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy7023 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQ 342 (364)
Q Consensus 263 ILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~ 342 (364)
||++.++.+||+|||+++...............+++.|+|||.+.++.|+.++|||||||++|||+++|.+||.+.+..+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 99999999999999999987765554445555678899999999999999999999999999999998899999999999
Q ss_pred HHHHHhcCccccccCCC
Q psy7023 343 VLNWVKGKSSNEYKVNP 359 (364)
Q Consensus 343 ~~~~i~~~~~~~~~~~~ 359 (364)
+.+.+..+...+.|.+.
T Consensus 246 ~~~~i~~~~~~~~p~~~ 262 (299)
T d1fgka_ 246 LFKLLKEGHRMDKPSNC 262 (299)
T ss_dssp HHHHHHTTCCCCCCSSC
T ss_pred HHHHHHcCCCCCCCccc
Confidence 99999988877776554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=365.59 Aligned_cols=217 Identities=23% Similarity=0.371 Sum_probs=190.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-----HHHHHHHHHHHHHHhcCCcceeEEEEEEe
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-----REKAEFLNEASVMKAFDTHHVVKLYGVVS 192 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 192 (364)
+.++|++++.||+|+||+||+|+++. +++.||+|++++.... ...+.+.+|+.+|++++|||||++++++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKS----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECC----CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 45789999999999999999999876 4778999998643221 22567889999999999999999999999
Q ss_pred eCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---
Q psy7023 193 EGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL--- 269 (364)
Q Consensus 193 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~--- 269 (364)
+.+.+|+|||||+||+|.+++... ..+++..++.++.|++.||+|||+++||||||||+|||++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~----------~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEK----------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSS
T ss_pred ECCEEEEEEEcCCCccccchhccc----------cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcc
Confidence 999999999999999999999752 3578899999999999999999999999999999999998776
Q ss_pred -cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 270 -TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 270 -~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
.+||+|||+|........ .....+|+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..+++..+.
T Consensus 154 ~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~ 229 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANVS 229 (293)
T ss_dssp CCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred cceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc-CCCCCCCCCHHHHHHHHH
Confidence 599999999987654432 233456889999999999999999999999999999999 899999999999998887
Q ss_pred cCcc
Q psy7023 349 GKSS 352 (364)
Q Consensus 349 ~~~~ 352 (364)
.+..
T Consensus 230 ~~~~ 233 (293)
T d1jksa_ 230 AVNY 233 (293)
T ss_dssp TTCC
T ss_pred hcCC
Confidence 7653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=367.58 Aligned_cols=247 Identities=34% Similarity=0.620 Sum_probs=195.4
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCcc-cccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDFR-SLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
...||+.+++|+++++||+|+||+||+|.++... ..+++.||+|+++........+.+.+|..++.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 4578899999999999999999999999987643 3356789999998777777778888899888887 6789999999
Q ss_pred EEee-CCceEEEEecCCCCCHHHHHHhcCCCCC------CccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7023 190 VVSE-GNPTLVIMELMGGGDLKNYLRSCRPDAE------TDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARN 262 (364)
Q Consensus 190 ~~~~-~~~~~lv~e~~~ggsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N 262 (364)
++.+ +..+++|||||++|+|.++++....... .......+++.+++.++.||+.||+|||+++||||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 8765 4568999999999999999986432111 11223468899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-HH
Q psy7023 263 CMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLS-NE 341 (364)
Q Consensus 263 ILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~-~~ 341 (364)
|||++++.+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||+|++.+||.+.+ ..
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876655444444555679999999999999999999999999999999997788998765 45
Q ss_pred HHHHHHhcCccccccCC
Q psy7023 342 QVLNWVKGKSSNEYKVN 358 (364)
Q Consensus 342 ~~~~~i~~~~~~~~~~~ 358 (364)
++...+..+...+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~ 261 (299)
T d1ywna1 245 EFCRRLKEGTRMRAPDY 261 (299)
T ss_dssp HHHHHHHHTCCCCCCTT
T ss_pred HHHHHHhcCCCCCCCcc
Confidence 56677787776665544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-49 Score=354.74 Aligned_cols=211 Identities=25% Similarity=0.437 Sum_probs=178.8
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee----CCc
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE----GNP 196 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~ 196 (364)
|++.++||+|+||+||+|+++. ++..||+|++.... .....+.+.+|+++|++++||||+++++++.+ +..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~----~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE----TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT----TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EEeeeEEecCcCcEEEEEEECC----CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 3677789999999999999876 46789999887543 45556789999999999999999999999874 356
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEc-CCCcEEE
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKK--FVHRDLAARNCMVA-DDLTVKV 273 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NILl~-~~~~~kL 273 (364)
+|+|||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++ +++.+||
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred EEEEEeCCCCCcHHHHHhcc----------ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEE
Confidence 89999999999999999752 35778899999999999999999998 99999999999996 5789999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCcc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGL-SNEQVLNWVKGKSS 352 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~-~~~~~~~~i~~~~~ 352 (364)
+|||+|+........ ...||+.|||||++.+ .|+.++|||||||++|||++ |+.||.+. +..++.+.+..+..
T Consensus 157 ~DFGla~~~~~~~~~----~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~-g~~Pf~~~~~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 157 GDLGLATLKRASFAK----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVK 230 (270)
T ss_dssp CCTTGGGGCCTTSBE----ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHTTTCC
T ss_pred eecCcceeccCCccC----CcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHH-CCCCCCCcccHHHHHHHHHcCCC
Confidence 999999865443221 2356899999999875 69999999999999999999 89999764 45667777777654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-49 Score=369.53 Aligned_cols=213 Identities=22% Similarity=0.329 Sum_probs=189.5
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
++|++++.||+|+||+||+|+++. +++.||+|++.+... ....+.+.+|+.+|+.++||||+++++++.+....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~----~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 689999999999999999999876 477899999864321 12245788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecc
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFG 277 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg 277 (364)
++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||
T Consensus 117 ~~v~e~~~~g~l~~~l~~~----------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI----------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ccccccccccchhhhHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeece
Confidence 9999999999999999752 357889999999999999999999999999999999999999999999999
Q ss_pred cccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 278 MTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 278 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
+|+.+.... ....||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+++..+..+..
T Consensus 187 ~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~~~ 255 (350)
T d1rdqe_ 187 FAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSGKV 255 (350)
T ss_dssp TCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCC
T ss_pred eeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHh-CCCCCCCcCHHHHHHHHhcCCC
Confidence 998765432 23356889999999999999999999999999999999 8999999999999998877653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-48 Score=354.98 Aligned_cols=231 Identities=22% Similarity=0.329 Sum_probs=186.7
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
.+.++|++++.||+|+||+||+|+++. +++.||+|+++... .....+.+.+|+++++.++||||+++++++...
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLR----LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECC----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence 356889999999999999999999876 47789999987543 345567899999999999999999999999764
Q ss_pred C----ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7023 195 N----PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLT 270 (364)
Q Consensus 195 ~----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~ 270 (364)
+ ..|+||||++|++|.+++.. ..++++.+++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~----------~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~ 149 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHT----------EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 149 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC
T ss_pred cCCCceEEEEEECCCCCEehhhhcc----------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc
Confidence 4 38999999999999999875 235788999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCccce-eeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-h
Q psy7023 271 VKVGDFGMTRDIYETEY-YRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV-K 348 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i-~ 348 (364)
.+|+|||.+........ ........||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+++..+ .
T Consensus 150 ~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHh-CCCCCCCcCHHHHHHHHHh
Confidence 99999999876543322 222334457899999999999999999999999999999999 89999999888877655 4
Q ss_pred cCccccccCCCCCC
Q psy7023 349 GKSSNEYKVNPPIS 362 (364)
Q Consensus 349 ~~~~~~~~~~~~~s 362 (364)
.+...+...++.+|
T Consensus 229 ~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 229 EDPIPPSARHEGLS 242 (277)
T ss_dssp CCCCCGGGTSSSCC
T ss_pred cCCCCCchhccCCC
Confidence 44443444444443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=362.28 Aligned_cols=216 Identities=26% Similarity=0.451 Sum_probs=187.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--HHHHHHHHHHHHHHH-hcCCcceeEEEEEEeeCCc
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--EREKAEFLNEASVMK-AFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~il~-~l~h~~iv~l~~~~~~~~~ 196 (364)
++|++++.||+|+||+||+|+++. +++.||+|++++... ....+.+..|..++. .++||||+++++++.+++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~----t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC----CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc
Confidence 579999999999999999999886 578899999875321 122345666777665 6899999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
+|+|||||++|+|.+++... ..+++.++..++.||+.||+|||+++||||||||+|||+++++.+||+||
T Consensus 78 ~yivmEy~~~g~L~~~i~~~----------~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSC----------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred eeEEEeecCCCcHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceecccc
Confidence 99999999999999999763 34678899999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 277 GMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 277 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+++........ .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+++..++.+..
T Consensus 148 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~ 220 (320)
T d1xjda_ 148 GMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMDNP 220 (320)
T ss_dssp TTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCC
T ss_pred chhhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Confidence 999866544322 233457899999999999999999999999999999999 8999999999999999876643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=362.51 Aligned_cols=215 Identities=20% Similarity=0.379 Sum_probs=189.0
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCce
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPT 197 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 197 (364)
+.++|++++.||+|+||+||+|.++. +++.||+|+++... .....+.+|+++|+.++||||+++++++++++.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~----~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETS----SKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECC----CCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 45789999999999999999999887 46789999997653 3345688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC--CcEEEee
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADD--LTVKVGD 275 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~--~~~kL~D 275 (364)
|+|||||+||+|.+++.. ...++++.+++.++.||+.||+|||++||+||||||+|||++.+ ..+||+|
T Consensus 77 ~lvmE~~~gg~L~~~i~~---------~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~D 147 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINT---------SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp EEEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred EEEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcc
Confidence 999999999999999964 23468899999999999999999999999999999999999854 5899999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKS 351 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~ 351 (364)
||+++.......... ..+++.|+|||.+.+..|+.++|||||||++|+|++ |.+||.+.+..+++..|..+.
T Consensus 148 FG~~~~~~~~~~~~~---~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~-G~~Pf~~~~~~~~~~~i~~~~ 219 (321)
T d1tkia_ 148 FGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp CTTCEECCTTCEEEE---EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTC
T ss_pred cchhhccccCCcccc---cccccccccchhccCCCCCchhhcccHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Confidence 999987655433221 235788999999999999999999999999999999 899999999999998887654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=357.85 Aligned_cols=246 Identities=35% Similarity=0.588 Sum_probs=208.3
Q ss_pred ccceeeeccceeEeceeeeecceEEEEEEEcCc-ccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEE
Q psy7023 112 KDSWEVLRSKVTILDELGNGSFGLVYRGLIKDF-RSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYG 189 (364)
Q Consensus 112 ~~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~ 189 (364)
...||+..++|++.++||+|+||.||+|+++.. +...++.||||+++.........++.+|+.+++++ +|||||++++
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 457999999999999999999999999997642 34467899999998877777778899999999999 6999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCC--------ccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAET--------DVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAAR 261 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~ 261 (364)
++.+....++|||||++|+|.++++........ ......+++..+..++.||+.||+|||++++|||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 999999999999999999999999875432111 112346889999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy7023 262 NCMVADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNE 341 (364)
Q Consensus 262 NILl~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~ 341 (364)
|||++.++.+||+|||.++...............+|+.|+|||++.++.++.++|||||||++|||+|+|.+||.+.+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998776555455555667999999999999999999999999999999999888889877665
Q ss_pred H-HHHHHhcCccccccC
Q psy7023 342 Q-VLNWVKGKSSNEYKV 357 (364)
Q Consensus 342 ~-~~~~i~~~~~~~~~~ 357 (364)
+ +.+.+.++.....+.
T Consensus 255 ~~~~~~i~~~~~~~~~~ 271 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPE 271 (311)
T ss_dssp HHHHHHHHHTCCCCCCT
T ss_pred HHHHHHHhcCCCCCCcc
Confidence 4 445666666555443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5e-48 Score=350.61 Aligned_cols=216 Identities=19% Similarity=0.339 Sum_probs=188.0
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC--------HHHHHHHHHHHHHHHhcC-CcceeEEEE
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS--------EREKAEFLNEASVMKAFD-THHVVKLYG 189 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~il~~l~-h~~iv~l~~ 189 (364)
.++|++++.||+|+||+||+|+++. +++.||+|+++.... ....+.+.+|+.++++++ ||||+++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECC----CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 4789999999999999999999876 478899999865421 223456889999999997 999999999
Q ss_pred EEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 190 VVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 190 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
++.+++.+|+|||||++|+|.++++. ..++++.+++.++.||+.||+|||++||+||||||+|||+++++
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~----------~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTE----------KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM 147 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred ecccCcceEEEEEcCCCchHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC
Confidence 99999999999999999999999975 23578999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD------GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQV 343 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~ 343 (364)
.+||+|||+++.+..... .....+|+.|+|||.+.+ ..++.++||||+||++|+|+| |++||.+.+..++
T Consensus 148 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~-g~~Pf~~~~~~~~ 223 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLM 223 (277)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred CeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc-CCCCCCCCCHHHH
Confidence 999999999987665432 223457889999999853 347889999999999999999 8999999999999
Q ss_pred HHHHhcCcc
Q psy7023 344 LNWVKGKSS 352 (364)
Q Consensus 344 ~~~i~~~~~ 352 (364)
.+.+..+..
T Consensus 224 ~~~i~~~~~ 232 (277)
T d1phka_ 224 LRMIMSGNY 232 (277)
T ss_dssp HHHHHHTCC
T ss_pred HHHHHhCCC
Confidence 888876643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=352.32 Aligned_cols=224 Identities=36% Similarity=0.649 Sum_probs=188.3
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee-
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE- 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~- 193 (364)
|++..++|++++.||+|+||.||+|.++ +..||||+++.+. ..+++.+|++++++++||||+++++++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET------TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC------CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 7888899999999999999999999986 4569999997643 34678899999999999999999999854
Q ss_pred CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7023 194 GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKV 273 (364)
Q Consensus 194 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL 273 (364)
.+.+|+||||+++|+|.+++.+. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl 144 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKV 144 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCcEEEEEeccCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEee
Confidence 56789999999999999999752 2234788899999999999999999999999999999999999999999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
+|||+++....... ...+++.|+|||++.++.++.++|||||||++|||+|+|.+||...+..++.+++..+...
T Consensus 145 ~dfg~s~~~~~~~~-----~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~ 219 (262)
T d1byga_ 145 SDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219 (262)
T ss_dssp CCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC
T ss_pred cccccceecCCCCc-----cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986544322 2234778999999999999999999999999999999889999999999999999998887
Q ss_pred cccCCCC
Q psy7023 354 EYKVNPP 360 (364)
Q Consensus 354 ~~~~~~~ 360 (364)
+.+.+.+
T Consensus 220 ~~~~~~~ 226 (262)
T d1byga_ 220 DAPDGCP 226 (262)
T ss_dssp CCCTTCC
T ss_pred CCCccCC
Confidence 7766543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-48 Score=364.66 Aligned_cols=223 Identities=20% Similarity=0.279 Sum_probs=181.7
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-----HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeC
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-----EREKAEFLNEASVMKAFDTHHVVKLYGVVSEG 194 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 194 (364)
++|++++.||+|+||+||+|+++. +++.||+|++.+... ........+|+.+++.++||||+++++++.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~----t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred HhCeeeeEEecCCCeEEEEEEECC----CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 689999999999999999999886 477899999864321 11122223456777778899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
+.+|+|||||+||+|.+++.+. ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH----------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEEC
T ss_pred CEEEEEEEecCCCcHHHHHHhc----------ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEe
Confidence 9999999999999999999752 356778999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccc
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSN 353 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 353 (364)
|||+|+.+.... .....||+.|+|||++.. ..|+.++|||||||++|||+| |+.||.+.+..+..+..+.....
T Consensus 150 DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~~~~ 224 (364)
T d1omwa3 150 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTM 224 (364)
T ss_dssp CCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCSSCSSCHHHHHHHSSSC
T ss_pred eeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccC
Confidence 999998765543 223457999999999975 468999999999999999999 89999877665555544444444
Q ss_pred cccCCCCC
Q psy7023 354 EYKVNPPI 361 (364)
Q Consensus 354 ~~~~~~~~ 361 (364)
..+.+..+
T Consensus 225 ~~~~~~~~ 232 (364)
T d1omwa3 225 AVELPDSF 232 (364)
T ss_dssp CCCCCSSS
T ss_pred CCCCCCCC
Confidence 44333333
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=350.64 Aligned_cols=221 Identities=35% Similarity=0.633 Sum_probs=179.7
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc--CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCc
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA--SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNP 196 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 196 (364)
.++|++++.||+|+||+||+|+++.... ....||||+++... .....++|.+|+.+|++++||||+++++++.+ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~-~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTS-CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCC-cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 3679999999999999999998765322 24579999987543 23445689999999999999999999999976 57
Q ss_pred eEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7023 197 TLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDF 276 (364)
Q Consensus 197 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DF 276 (364)
.++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 85 ~~lv~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp CEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred hheeeeeecCcchhhhhhc---------ccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 8999999999999998875 3346889999999999999999999999999999999999999999999999
Q ss_pred ccccccCccceeee-CCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 277 GMTRDIYETEYYRK-GSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 277 g~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
|+++.......... .....++..|+|||++.+..++.++||||||+++|||+|+|.+||.+.+..++++++...
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 99997765443222 223345778999999999999999999999999999999789999999999999888544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=354.88 Aligned_cols=235 Identities=34% Similarity=0.574 Sum_probs=193.1
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~ 198 (364)
++|++.++||+|+||+||+|+++.+. ....||||.++........+++.+|+++|+++ +||||+++++++.+++.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT--EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCC--eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 68999999999999999999987632 13358888887655555677899999999998 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCC------CCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDA------ETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVK 272 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~k 272 (364)
+||||+++|+|.++++...... ........+++..+..++.||+.||.|||+++||||||||+|||++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 9999999999999997532100 0012345789999999999999999999999999999999999999999999
Q ss_pred EeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCcc
Q psy7023 273 VGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSS 352 (364)
Q Consensus 273 L~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~ 352 (364)
|+|||+++....... .....+|..|+|||.+.++.|+.++|||||||++|||++|+.+||.+.+..++.+.+.++..
T Consensus 168 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 168 IADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp ECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred Ecccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 999999975543322 22334678899999999999999999999999999999988889999999999999998877
Q ss_pred ccccCCC
Q psy7023 353 NEYKVNP 359 (364)
Q Consensus 353 ~~~~~~~ 359 (364)
.+.+.++
T Consensus 245 ~~~~~~~ 251 (309)
T d1fvra_ 245 LEKPLNC 251 (309)
T ss_dssp CCCCTTB
T ss_pred CCCCccC
Confidence 6665443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=349.79 Aligned_cols=209 Identities=21% Similarity=0.287 Sum_probs=173.7
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHH----HHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceEE
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASER----EKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTLV 199 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 199 (364)
.+++||+|+||+||+|+++. +++.||||+++...... ....+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~i 77 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 77 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cceEeccCcCeEEEEEEECC----CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceee
Confidence 46789999999999999876 47789999987543222 23468899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecccc
Q psy7023 200 IMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMT 279 (364)
Q Consensus 200 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a 279 (364)
||||+.++++..+.. ....+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||++
T Consensus 78 vmE~~~~~~~~~~~~----------~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKD----------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp EEECCSEEHHHHHTT----------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred hhhhhcchHHhhhhh----------cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccc
Confidence 999998876665543 2345667789999999999999999999999999999999999999999999999
Q ss_pred cccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 280 RDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+........ .....+|+.|+|||++... .|+.++|||||||++|||+| |.+||.+.++.+.+..|.+
T Consensus 148 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~~~l~~i~~ 215 (299)
T d1ua2a_ 148 KSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFE 215 (299)
T ss_dssp STTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred cccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHh-CcCCCCCCCHHHHHHHHHH
Confidence 876554322 2234568899999998755 57999999999999999999 8999999999888877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=346.56 Aligned_cols=227 Identities=39% Similarity=0.707 Sum_probs=186.9
Q ss_pred EeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee-CCceEEEEe
Q psy7023 124 ILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE-GNPTLVIME 202 (364)
Q Consensus 124 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~e 202 (364)
+.++||+|+||+||+|++..... ....||||.++........++|.+|+++|++++||||+++++++.+ ++..++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC-----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCC-EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 35789999999999999876432 2456899999876677778899999999999999999999999765 567899999
Q ss_pred cCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccccccc
Q psy7023 203 LMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGMTRDI 282 (364)
Q Consensus 203 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~~~ 282 (364)
||++|+|.+++.. .....++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++..
T Consensus 110 ~~~~g~l~~~~~~---------~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 110 YMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp CCTTCBHHHHHHC---------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EeecCchhhhhcc---------ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 9999999999875 3445677889999999999999999999999999999999999999999999999876
Q ss_pred Cccceee--eCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCccccccCCCC
Q psy7023 283 YETEYYR--KGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGKSSNEYKVNPP 360 (364)
Q Consensus 283 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 360 (364)
....... ......+|+.|+|||.+....++.++||||||+++|||+|++.+|+...+..++...+..+.....|.+++
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~ 260 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 260 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCC
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCc
Confidence 6543322 22234568899999999999999999999999999999997777777888888889998888776665543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=353.13 Aligned_cols=208 Identities=19% Similarity=0.324 Sum_probs=172.1
Q ss_pred ccceeEec-eeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhc-CCcceeEEEEEEee---
Q psy7023 119 RSKVTILD-ELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAF-DTHHVVKLYGVVSE--- 193 (364)
Q Consensus 119 ~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~--- 193 (364)
.++|.+++ .||+|+||+||+|+++. +++.||||+++.. ..+.+|+.++.++ +||||++++++|++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~----~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR----TQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT----TCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC----CCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 46788875 59999999999999876 4678999998642 3456799887655 89999999999875
Q ss_pred -CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CC
Q psy7023 194 -GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---DL 269 (364)
Q Consensus 194 -~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~~ 269 (364)
+..+|+|||||+||+|.+++.+. ....+++.+++.++.||+.||+|||++||+||||||+|||+++ ++
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~--------~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDR--------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSC--------SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTC
T ss_pred CCCEEEEEEECCCCCcHHHHHHhc--------CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccc
Confidence 46789999999999999999752 2346899999999999999999999999999999999999985 56
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
.+||+|||+|+....... .....+|+.|||||++.+..|+.++|||||||++|+|+| |++||.+.+..+....+.
T Consensus 152 ~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt-g~~Pf~~~~~~~~~~~~~ 226 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMK 226 (335)
T ss_dssp CEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT-SSCSCEETTCC-------
T ss_pred cccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh-CCCCCCCCCHHHHHHHHH
Confidence 799999999987654432 233457999999999999999999999999999999999 899998877665555443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=344.77 Aligned_cols=213 Identities=23% Similarity=0.402 Sum_probs=179.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|+++++||+|+||+||+|.++. +++.||+|+++..... ...+++.+|+++|++++||||+++++++.+++.+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL----TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT----TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC----CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 589999999999999999999876 4678999998754332 23567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+||||+.+ ++.+++.. .....+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 78 iv~e~~~~-~~~~~~~~--------~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 78 LVFEFLHQ-DLKKFMDA--------SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEEECCSE-EHHHHHHH--------TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred EEEeecCC-chhhhhhh--------hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCc
Confidence 99999965 66666654 2345688999999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|+....... ......+|+.|+|||++....+ +.++|||||||++|+|++ |+.||.+.+..+.+..+.
T Consensus 149 a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~-G~~Pf~~~~~~~~~~~i~ 216 (298)
T d1gz8a_ 149 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIF 216 (298)
T ss_dssp HHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred ceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhh-CCCCCCCCCHHHHHHHHH
Confidence 986654332 2333456889999999877664 789999999999999999 899999988888776653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=341.31 Aligned_cols=215 Identities=20% Similarity=0.331 Sum_probs=177.1
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-HHHHHHHHHHHHHHhc---CCcceeEEEEEEee-
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-REKAEFLNEASVMKAF---DTHHVVKLYGVVSE- 193 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~il~~l---~h~~iv~l~~~~~~- 193 (364)
.++|+++++||+|+||+||+|+++.+ .++.||||+++..... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN---GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT---TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC---CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 47899999999999999999998642 2567999998654322 1223455677777766 79999999999853
Q ss_pred ----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 194 ----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 194 ----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
...++++|||++++.+...... ....+++..++.++.|++.||+|||+++||||||||+|||+++++
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKV---------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHS---------CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred ccccCceEEEEEEeccCCchhhhhhc---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC
Confidence 3578999999988666544432 445678899999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 270 TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
.+||+|||+++...... ......+|+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+..+.+..+..
T Consensus 154 ~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 154 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred Ceeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHH-CCCCCCCCCHHHHHHHHHH
Confidence 99999999988654433 2334457899999999999999999999999999999999 8999999999888877643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.3e-46 Score=337.90 Aligned_cols=212 Identities=22% Similarity=0.380 Sum_probs=177.8
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|+++++||+|+||+||+|+++. ++.||+|+++.... ....+++.+|+.+|++++||||+++++++..++..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNY-----GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETT-----SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCC-----CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCcee
Confidence 589999999999999999998864 67899999875432 223567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
++||++.++.+..+.+ ....+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||.
T Consensus 77 i~~e~~~~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDV----------CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEECCSEEHHHHHHT----------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEeehhhhHHHHHh----------hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEeccccc
Confidence 9999997755555543 345689999999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
+.......... ....+++.|+|||.+.+. .++.++|||||||++|||++ |++||.+.+..+.+.++..
T Consensus 147 a~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~-G~~pf~~~~~~~~~~~i~~ 215 (286)
T d1ob3a_ 147 ARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFR 215 (286)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred ceecccCcccc--ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH-CCCCCCCCCHHHHHHHHHH
Confidence 98765443322 223457889999998765 46899999999999999999 8999999998888776643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=337.01 Aligned_cols=202 Identities=21% Similarity=0.294 Sum_probs=170.4
Q ss_pred eccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCH-----HHHHHHHHHHHHHHhcC--CcceeEEEEE
Q psy7023 118 LRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASE-----REKAEFLNEASVMKAFD--THHVVKLYGV 190 (364)
Q Consensus 118 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~il~~l~--h~~iv~l~~~ 190 (364)
+.++|++.+.||+|+||+||+|+++. +++.||+|+++..... ....++.+|+.+|++++ ||||++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~ 77 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVS----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECC----CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence 45789999999999999999999876 4778999998643211 11234668999999996 8999999999
Q ss_pred EeeCCceEEEEecCCC-CCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-C
Q psy7023 191 VSEGNPTLVIMELMGG-GDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-D 268 (364)
Q Consensus 191 ~~~~~~~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-~ 268 (364)
+.+.+..|+||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++. +
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~----------~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITE----------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 147 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH----------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT
T ss_pred EeeCCeEEEEEEeccCcchHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC
Confidence 9999999999999976 678888875 235788999999999999999999999999999999999985 5
Q ss_pred CcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 269 LTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVF-TSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 269 ~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
+.+||+|||+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.
T Consensus 148 ~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~ 213 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHD 213 (273)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSH
T ss_pred CeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh-CCCCCCCc
Confidence 799999999998654432 223457899999999987776 567899999999999999 89999763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=338.42 Aligned_cols=213 Identities=20% Similarity=0.322 Sum_probs=176.5
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC---
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN--- 195 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--- 195 (364)
.++|+++++||+|+||+||+|+++. +++.||||+++........+++++|+.+|++++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNV----NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETT----TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCCeEEEEEEeeccCeEEEEEEECC----CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 4689999999999999999999876 477899999987666677788999999999999999999999997543
Q ss_pred -ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7023 196 -PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVG 274 (364)
Q Consensus 196 -~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~ 274 (364)
..+++++++.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||+++++.+||+
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~-----------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred cceEEEEEeecCCchhhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEc
Confidence 23444455668999999974 247889999999999999999999999999999999999999999999
Q ss_pred ecccccccCccceee-eCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy7023 275 DFGMTRDIYETEYYR-KGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWV 347 (364)
Q Consensus 275 DFg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i 347 (364)
|||++.......... ......+|+.|+|||++.. ..++.++||||+||++|+|++ |..||.+.+..+.....
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~-g~~pf~~~~~~~~~~~~ 225 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHI 225 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh-CCCCCCCCCHHHHHHHH
Confidence 999998665443222 2334457889999999855 457889999999999999999 89999988877666544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=332.78 Aligned_cols=217 Identities=22% Similarity=0.333 Sum_probs=175.8
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-HHHHHHHHHHHHHHHhcCCcceeEEEEEEee----
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-EREKAEFLNEASVMKAFDTHHVVKLYGVVSE---- 193 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~---- 193 (364)
.++|+++++||+|+||+||+|+++. +++.||||++..... .....++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK----TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT----TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC----CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 3799999999999999999999876 477899999864432 2334668899999999999999999998854
Q ss_pred ----CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7023 194 ----GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL 269 (364)
Q Consensus 194 ----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~ 269 (364)
...+|+||||+.++.+..+.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~----------~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSN----------VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 154 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTC----------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred ccccCceEEEEEeccCCCccchhhh----------cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC
Confidence 456899999997755543332 345678889999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCccceee--eCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 270 TVKVGDFGMTRDIYETEYYR--KGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 270 ~~kL~DFg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
.+||+|||+++.+....... ......+|+.|+|||++.+. .|+.++|||||||++|||++ |++||.+.+..+.+..
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~-g~~pf~~~~~~~~~~~ 233 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 233 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh-CCCCCCCCCHHHHHHH
Confidence 99999999998665433221 22234578999999998765 58999999999999999999 8999999998888877
Q ss_pred HhcC
Q psy7023 347 VKGK 350 (364)
Q Consensus 347 i~~~ 350 (364)
+.+.
T Consensus 234 i~~~ 237 (318)
T d3blha1 234 ISQL 237 (318)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 6543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-44 Score=329.11 Aligned_cols=206 Identities=20% Similarity=0.296 Sum_probs=175.1
Q ss_pred eeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCC-cceeEEEEEEeeCC
Q psy7023 117 VLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDT-HHVVKLYGVVSEGN 195 (364)
Q Consensus 117 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~ 195 (364)
++.++|+++++||+|+||+||+|+++. +++.||+|++..... ...+.+|+++++.+.| +|++.+++++..+.
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~----~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLL----NNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETT----TTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECC----CCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 466899999999999999999999876 477899999865432 2346678999999976 79999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-----CCc
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD-----DLT 270 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~-----~~~ 270 (364)
..++||||+ +++|.+++.. ....++...+..++.|++.||+|||++|||||||||+|||++. ++.
T Consensus 75 ~~~~vme~~-~~~l~~~~~~---------~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~ 144 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM 144 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred ccEEEEEec-CCCHHHHHHh---------hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCc
Confidence 999999999 7899999876 3346788999999999999999999999999999999999974 578
Q ss_pred EEEeecccccccCcccee-----eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy7023 271 VKVGDFGMTRDIYETEYY-----RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSN 340 (364)
Q Consensus 271 ~kL~DFg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~ 340 (364)
+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |..||.+...
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~Pf~~~~~ 218 (293)
T d1csna_ 145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKA 218 (293)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCS
T ss_pred eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHh-CCCcCCCccc
Confidence 999999999876543211 12233457999999999999999999999999999999999 8999976443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=335.79 Aligned_cols=211 Identities=25% Similarity=0.393 Sum_probs=175.5
Q ss_pred eeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee
Q psy7023 115 WEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE 193 (364)
Q Consensus 115 ~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 193 (364)
|+ ++++|+++++||+|+||+||+|.++. +++.||||+++... .....+.+.+|+++|+.++|||||+++++|..
T Consensus 14 ~~-~~~~Y~~i~~lG~G~fg~V~~~~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~ 88 (346)
T d1cm8a_ 14 WE-VRAVYRDLQPVGSGAYGAVCSAVDGR----TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88 (346)
T ss_dssp EC-CBSSEEEEEEC------CEEEEEETT----TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred ee-cCCcEEEEEEEecCCCeEEEEEEECC----CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEecc
Confidence 44 47899999999999999999999876 47789999997543 44556788999999999999999999999976
Q ss_pred CC------ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7023 194 GN------PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD 267 (364)
Q Consensus 194 ~~------~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~ 267 (364)
.+ .+|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 89 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~ 156 (346)
T d1cm8a_ 89 DETLDDFTDFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 156 (346)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CccccccceEEEEEecc-cccHHHHHHh-----------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc
Confidence 54 579999999 6678777754 35788999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDG-VFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNW 346 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~ 346 (364)
++.+||+|||+|+...... ....+|+.|+|||++.+. .++.++||||+||++|+|++ |.+||.+.+..+.+..
T Consensus 157 ~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~ 230 (346)
T d1cm8a_ 157 DCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKE 230 (346)
T ss_dssp TCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred ccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHH-CcCCCCCCChHHHHHH
Confidence 9999999999998664432 334568899999998764 46899999999999999999 8999999888777665
Q ss_pred Hh
Q psy7023 347 VK 348 (364)
Q Consensus 347 i~ 348 (364)
+.
T Consensus 231 ~~ 232 (346)
T d1cm8a_ 231 IM 232 (346)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=326.27 Aligned_cols=215 Identities=18% Similarity=0.334 Sum_probs=183.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 198 (364)
++|+++++||+|+||+||+|+++. +++.||||+++... ......++.+|+.+|+.++||||+++++++.+....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE----THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT----TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC----CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 589999999999999999999876 47789999986543 3345678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeeccc
Q psy7023 199 VIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGDFGM 278 (364)
Q Consensus 199 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~DFg~ 278 (364)
+|+|++.+++|..++.. ...+++..+..++.|++.||+|||++|||||||||+|||++.++.+||+|||.
T Consensus 78 iv~~~~~~~~l~~~~~~----------~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSC----------NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEECCSEEHHHHHHHT----------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEeeecccccccccccc----------ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecch
Confidence 99999999888887764 34567889999999999999999999999999999999999999999999999
Q ss_pred ccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q psy7023 279 TRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKGK 350 (364)
Q Consensus 279 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~~ 350 (364)
++........ .....+++.|+|||++.... ++.++|||||||++|||++|+.++|.+.+..+.+..+...
T Consensus 148 a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 218 (292)
T d1unla_ 148 ARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_dssp CEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHH
T ss_pred hhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhh
Confidence 9876544322 22233467899999987765 6899999999999999999666667888888877766543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=334.02 Aligned_cols=208 Identities=23% Similarity=0.289 Sum_probs=171.1
Q ss_pred ceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEee------C
Q psy7023 121 KVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSE------G 194 (364)
Q Consensus 121 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------~ 194 (364)
+|+.+++||+|+||+||+|+++. +++.||||++..... ...+|+++|++++||||++++++|.. .
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~----~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD----SGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT----TCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECC----CCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 79999999999999999999887 477899999875432 23469999999999999999999853 2
Q ss_pred CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEE
Q psy7023 195 NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-TVKV 273 (364)
Q Consensus 195 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kL 273 (364)
..+|+|||||+++ +.+.+.... .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 92 ~~~~lv~Ey~~~~-~~~~l~~~~------~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 92 VYLNLVLDYVPET-VYRVARHYS------RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CEEEEEEECCSEE-HHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEE
T ss_pred eEEEEEEeccCCc-cHHHHHhhh------hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeE
Confidence 3578999999764 444443211 1345688999999999999999999999999999999999999775 8999
Q ss_pred eecccccccCccceeeeCCCCCCCccccCcccccC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 274 GDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKD-GVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 274 ~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
+|||+++.+...... ....+++.|+|||.+.+ ..|+.++||||+||++|||++ |.+||.+.+..+.+..+.
T Consensus 165 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~-g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp CCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHHH
T ss_pred ecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhh-CCCCCCCCCHHHHHHHHH
Confidence 999999876554322 23456888999998875 468999999999999999999 899999988877776653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=335.30 Aligned_cols=217 Identities=19% Similarity=0.294 Sum_probs=180.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc---CHHHHHHHHHHHHHHHhcCC-cceeEEEEEEeeCC
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA---SEREKAEFLNEASVMKAFDT-HHVVKLYGVVSEGN 195 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~ 195 (364)
++|++++.||+|+||+||+|.+.... .+++.||+|+++... .....+.+.+|+++|++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSST-TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hceEEEEEEecCCCeEEEEEEECccC-CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 78999999999999999999875422 247789999987532 12234567889999999977 79999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTVKVGD 275 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~kL~D 275 (364)
..++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~----------~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR----------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred ceeeeeecccccHHHHHHHhc----------ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEee
Confidence 999999999999999999763 2456778899999999999999999999999999999999999999999
Q ss_pred cccccccCccceeeeCCCCCCCccccCcccccCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q psy7023 276 FGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV--FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVKG 349 (364)
Q Consensus 276 Fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~~ 349 (364)
||+++.+........ ....+++.|+|||.+.+.. ++.++|||||||+||+|+| |..||.+.+..+....+..
T Consensus 173 FG~a~~~~~~~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt-G~~PF~~~~~~~~~~~i~~ 246 (322)
T d1vzoa_ 173 FGLSKEFVADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISR 246 (322)
T ss_dssp SSEEEECCGGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCHHHHHH
T ss_pred ccchhhhcccccccc-cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence 999987654433222 2334678899999997654 6889999999999999999 8999988776666655544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-43 Score=324.32 Aligned_cols=209 Identities=22% Similarity=0.323 Sum_probs=169.9
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcc-eeEEEEEEeeCCce
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHH-VVKLYGVVSEGNPT 197 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~~~ 197 (364)
.++|+++++||+|+||+||+|+++. +++.||||++..... ..++..|+++++.++|+| |+.+..++.+++..
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~----~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIA----AGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETT----TTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECC----CCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 4689999999999999999999876 467899998765432 235778999999998775 55566667788899
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEEEe
Q psy7023 198 LVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVAD---DLTVKVG 274 (364)
Q Consensus 198 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~---~~~~kL~ 274 (364)
++||||+ +++|.+.+.. ....+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+
T Consensus 79 ~ivme~~-~~~l~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp EEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred EEEEEEc-CCchhhhhhh---------ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeee
Confidence 9999999 5678777764 3456889999999999999999999999999999999999864 5579999
Q ss_pred ecccccccCcccee-----eeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 275 DFGMTRDIYETEYY-----RKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 275 DFg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
|||+|+.+...... .......+|+.|||||++.+..++.++|||||||++|||+| |..||......+...
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t-g~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKRQ 223 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH-SSCTTCCCC------
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh-CCCcccccchHHHHH
Confidence 99999876543321 22334467999999999999999999999999999999999 899998766655443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=323.89 Aligned_cols=196 Identities=22% Similarity=0.357 Sum_probs=159.4
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcceeEEEEEEeeCC----
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHVVKLYGVVSEGN---- 195 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~---- 195 (364)
.+|.+.+.||+|+||+||+|+++ ++.||||+++..... ......|+..+++++||||+++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~------g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR------GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET------TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC------CEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 57899999999999999999864 568999998654322 222234555666789999999999997643
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCEEEcC
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD--------KKFVHRDLAARNCMVAD 267 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~--------~~iiHrDlkp~NILl~~ 267 (364)
.+|+|||||++|+|.+++++ ..+++..+..++.|++.||+|||+ +|||||||||+||||++
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~-----------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~ 143 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNR-----------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-----------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT
T ss_pred EEEEEEecccCCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC
Confidence 57999999999999999975 247788999999999999999996 59999999999999999
Q ss_pred CCcEEEeecccccccCccceee--eCCCCCCCccccCcccccCCC------CCCchhHHHHHHHHHHHHhCCCCCC
Q psy7023 268 DLTVKVGDFGMTRDIYETEYYR--KGSRGFLPVRWMAPESLKDGV------FTSHSDVWSYGVVLWEMATLASQPY 335 (364)
Q Consensus 268 ~~~~kL~DFg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~el~t~g~~P~ 335 (364)
++.+||+|||+++......... ......+|+.|+|||++.+.. ++.++|||||||+||||+| |.+||
T Consensus 144 ~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t-g~~~~ 218 (303)
T d1vjya_ 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIG 218 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBT
T ss_pred CCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh-CCCCC
Confidence 9999999999998765443222 233446799999999987643 5678999999999999999 66665
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-42 Score=321.55 Aligned_cols=195 Identities=17% Similarity=0.308 Sum_probs=165.9
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEee--CC
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSE--GN 195 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~--~~ 195 (364)
.++|+++++||+|+||+||+|+++. +++.||+|+++... .+++.+|+.+|+.+. ||||++++++|.. ..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~----~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT----NNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC----CCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 4689999999999999999999876 57889999987543 356788999999995 9999999999974 45
Q ss_pred ceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEe
Q psy7023 196 PTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDL-TVKVG 274 (364)
Q Consensus 196 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~-~~kL~ 274 (364)
.+++|||||.+++|..+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+
T Consensus 106 ~~~~v~e~~~~~~L~~~~-------------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY-------------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp SEEEEEECCCSCBGGGTT-------------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred ceeEEEeecCCCcHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeec
Confidence 799999999999986543 2478899999999999999999999999999999999998654 69999
Q ss_pred ecccccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy7023 275 DFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGL 338 (364)
Q Consensus 275 DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~ 338 (364)
|||+|+....... .....+|+.|+|||.+.+.. ++.++||||+||++|+|++ |..||...
T Consensus 173 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~-g~~pf~~~ 233 (328)
T d3bqca1 173 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHG 233 (328)
T ss_dssp CGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCC
T ss_pred ccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc-CCCCCCCC
Confidence 9999987654432 23345688999999987654 7999999999999999999 77888643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-43 Score=326.15 Aligned_cols=216 Identities=21% Similarity=0.364 Sum_probs=178.3
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVV 191 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~ 191 (364)
..|++ .++|+++++||+|+||+||+|+++. +++.||||+++... .....+++.+|+++|++++||||+++++++
T Consensus 12 ~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~ 86 (348)
T d2gfsa1 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTK----TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 86 (348)
T ss_dssp SEEEE-ETTEEEEEECGGGTTSSEEEEEETT----TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ccccC-CCCeEEEEEEecCCCeEEEEEEECC----CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34665 4789999999999999999999876 47889999997553 344566788999999999999999999998
Q ss_pred eeC-----CceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7023 192 SEG-----NPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVA 266 (364)
Q Consensus 192 ~~~-----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~ 266 (364)
... ...+++++++.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~ 155 (348)
T d2gfsa1 87 TPARSLEEFNDVYLVTHLMGADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 155 (348)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred eeccccccCceEEEEEeecCCchhhhccc-----------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc
Confidence 632 334666677789999999853 3588899999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCccceeeeCCCCCCCccccCcccccCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy7023 267 DDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGV-FTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLN 345 (364)
Q Consensus 267 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~ 345 (364)
.++.+|++|||++....... ....+++.|+|||++.+.. ++.++|||||||++|+|++ |++||.+.+..+...
T Consensus 156 ~~~~~kl~dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~-g~~pF~~~~~~~~~~ 229 (348)
T d2gfsa1 156 EDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLK 229 (348)
T ss_dssp TTCCEEECCC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHH
T ss_pred ccccccccccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 99999999999997654332 2334678899999877655 5889999999999999999 899999999888887
Q ss_pred HHhcC
Q psy7023 346 WVKGK 350 (364)
Q Consensus 346 ~i~~~ 350 (364)
.+...
T Consensus 230 ~i~~~ 234 (348)
T d2gfsa1 230 LILRL 234 (348)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 76543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=327.21 Aligned_cols=209 Identities=22% Similarity=0.307 Sum_probs=169.9
Q ss_pred ccceeEeceeeeecceEEEEEEEcCcccccccceEEEEccccc-CHHHHHHHHHHHHHHHhcCCcceeEEEEEEee----
Q psy7023 119 RSKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA-SEREKAEFLNEASVMKAFDTHHVVKLYGVVSE---- 193 (364)
Q Consensus 119 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~---- 193 (364)
.++|+++++||+|+||+||+|+++. +++.||||++.... ......++.+|+.+|++++||||++++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~----t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAV----LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETT----TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred cCCeEEEEEeecCcCeEEEEEEECC----CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence 4789999999999999999999886 47889999987543 34455678899999999999999999999963
Q ss_pred --CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7023 194 --GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCMVADDLTV 271 (364)
Q Consensus 194 --~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 271 (364)
...+|+|||||.+ ++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 92 ~~~~~~~iv~Ey~~~-~l~~~~~------------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 92 EEFQDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred ccCceeEEEEeccch-HHHHhhh------------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccce
Confidence 3678999999965 5555542 246789999999999999999999999999999999999999999
Q ss_pred EEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q psy7023 272 KVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLASQPYQGLSNEQVLNWVK 348 (364)
Q Consensus 272 kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~~P~~~~~~~~~~~~i~ 348 (364)
|++|||+++....... .....+|+.|+|||++.+..++.++||||+||++|+|++ |++||.+.+.......+.
T Consensus 159 kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~-g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 159 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp EECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHH
T ss_pred eeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhh-CCCCCCCCCHHHHHHHHH
Confidence 9999999876554332 233346889999999999999999999999999999999 899999988877776654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-36 Score=285.64 Aligned_cols=207 Identities=18% Similarity=0.251 Sum_probs=162.8
Q ss_pred ceeeec-cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-----------C
Q psy7023 114 SWEVLR-SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-----------T 181 (364)
Q Consensus 114 ~~e~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-----------h 181 (364)
..+++. .+|+++++||+|+||+||+|+++. +++.||||+++... ...+.+.+|+.+++.+. |
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~----~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~ 79 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMV----NNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGA 79 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETT----TTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECC----CCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence 345565 579999999999999999999876 47789999997543 33456778999998885 4
Q ss_pred cceeEEEEEEee--CCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHh-CCceecCC
Q psy7023 182 HHVVKLYGVVSE--GNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLAD-KKFVHRDL 258 (364)
Q Consensus 182 ~~iv~l~~~~~~--~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~-~~iiHrDl 258 (364)
+||+++++++.. ....+++++++..+......... .....+++..+..++.||+.||+|||+ .||+||||
T Consensus 80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDl 152 (362)
T d1q8ya_ 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK-------YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDI 152 (362)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH-------TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCC
T ss_pred CceEEEEEEeeeccccceeeeeeeccccccccccccc-------ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccC
Confidence 689999988764 45566777776554433333221 244567888999999999999999997 89999999
Q ss_pred CCCCEEEcCCC------cEEEeecccccccCccceeeeCCCCCCCccccCcccccCCCCCCchhHHHHHHHHHHHHhCCC
Q psy7023 259 AARNCMVADDL------TVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAPESLKDGVFTSHSDVWSYGVVLWEMATLAS 332 (364)
Q Consensus 259 kp~NILl~~~~------~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t~g~ 332 (364)
||+|||++.++ .++++|||.+....... ....+|+.|+|||++....|+.++||||+||++++|++ |+
T Consensus 153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~ 226 (362)
T d1q8ya_ 153 KPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GD 226 (362)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SS
T ss_pred ChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHH-CC
Confidence 99999998655 49999999987654332 33456889999999999999999999999999999999 89
Q ss_pred CCCCCCC
Q psy7023 333 QPYQGLS 339 (364)
Q Consensus 333 ~P~~~~~ 339 (364)
.||...+
T Consensus 227 ~pF~~~~ 233 (362)
T d1q8ya_ 227 FLFEPDE 233 (362)
T ss_dssp CCC----
T ss_pred CCCCCCc
Confidence 9997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=5.9e-27 Score=199.70 Aligned_cols=166 Identities=17% Similarity=0.218 Sum_probs=119.4
Q ss_pred eeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccC-----------------HHHHHHHHHHHHHHHhcCCcce
Q psy7023 122 VTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENAS-----------------EREKAEFLNEASVMKAFDTHHV 184 (364)
Q Consensus 122 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~-----------------~~~~~~~~~E~~il~~l~h~~i 184 (364)
+.+.++||+|+||+||+|++.+ ++.||||+++.... .........|...+.++.|.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~-----g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK-----FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT-----TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS
T ss_pred chhCCEeeeCcceEEEEEECCC-----CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc
Confidence 3578899999999999998764 67899998753211 1112345578899999999999
Q ss_pred eEEEEEEeeCCceEEEEecCCCCCHHHHHHhcCCCCCCccCCCCccHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7023 185 VKLYGVVSEGNPTLVIMELMGGGDLKNYLRSCRPDAETDVERSPPTLSRILQMAAEVADGMAYLADKKFVHRDLAARNCM 264 (364)
Q Consensus 185 v~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIL 264 (364)
+..+++.. .+++|||+++..+.+ ++......++.|++.+|+|||++||+||||||+|||
T Consensus 77 ~~~~~~~~----~~lvme~~~~~~~~~-----------------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NIL 135 (191)
T d1zara2 77 PKVYAWEG----NAVLMELIDAKELYR-----------------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 135 (191)
T ss_dssp CCEEEEET----TEEEEECCCCEEGGG-----------------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred ceEEEecC----CEEEEEeeccccccc-----------------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhhee
Confidence 98876532 379999998755432 122335678999999999999999999999999999
Q ss_pred EcCCCcEEEeecccccccCccceeeeCCCCCCCccccCc--c---cccCCCCCCchhHHHHHHHH
Q psy7023 265 VADDLTVKVGDFGMTRDIYETEYYRKGSRGFLPVRWMAP--E---SLKDGVFTSHSDVWSYGVVL 324 (364)
Q Consensus 265 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~~~~~y~aP--E---~~~~~~~~~~~DiwslG~il 324 (364)
++++ .++|+|||.|.....+... .|... + .+....|+.++|+||+.--+
T Consensus 136 v~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred eeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9975 5899999998755432211 11111 0 01135688899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=1.6e-07 Score=81.42 Aligned_cols=86 Identities=13% Similarity=0.055 Sum_probs=57.2
Q ss_pred cceeEeceeeeecceEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcC-CcceeEEEEEEeeCCceE
Q psy7023 120 SKVTILDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFD-THHVVKLYGVVSEGNPTL 198 (364)
Q Consensus 120 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~ 198 (364)
+.|++.+..+.++.+.||+.... +..+.+|........ ....+.+|...++.+. +--+.+++.+...++..+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~------~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGE------NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECS------SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEeC------CCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 45666665554556789987533 445677876543221 1234567888888774 334678888888888999
Q ss_pred EEEecCCCCCHHHH
Q psy7023 199 VIMELMGGGDLKNY 212 (364)
Q Consensus 199 lv~e~~~ggsL~~~ 212 (364)
+||++++|.++.+.
T Consensus 87 lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 87 LLMSEADGVLCSEE 100 (263)
T ss_dssp EEEECCSSEEHHHH
T ss_pred EEEEeccccccccc
Confidence 99999999776543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.25 E-value=1.4e-06 Score=74.98 Aligned_cols=73 Identities=21% Similarity=0.216 Sum_probs=50.2
Q ss_pred eeeecc-eEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCc--ceeEEEEEEeeCCceEEEEecC
Q psy7023 128 LGNGSF-GLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTH--HVVKLYGVVSEGNPTLVIMELM 204 (364)
Q Consensus 128 lG~G~~-g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~--~iv~l~~~~~~~~~~~lv~e~~ 204 (364)
+..|.. +.||+....+ +..+.+|....... ..+..|...++.+... .+.+++.+..+++..++||+++
T Consensus 18 ~~~G~s~~~v~r~~~~~-----~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG-----RPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp CSCTTSSCEEEEEECTT-----SCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred cCCcccCCeEEEEEeCC-----CCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 344543 6789887553 55678887654432 2355678888777433 4667888888888999999999
Q ss_pred CCCCH
Q psy7023 205 GGGDL 209 (364)
Q Consensus 205 ~ggsL 209 (364)
+|.++
T Consensus 89 ~G~~~ 93 (255)
T d1nd4a_ 89 PGQDL 93 (255)
T ss_dssp SSEET
T ss_pred ecccc
Confidence 88554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.09 E-value=4.6e-06 Score=76.71 Aligned_cols=78 Identities=18% Similarity=0.186 Sum_probs=47.4
Q ss_pred eceeeeecceEEEEEEEcCcccccccceEEEEccccc------CHHHHHHHHHHHHHHHhcC-C--cceeEEEEEEeeCC
Q psy7023 125 LDELGNGSFGLVYRGLIKDFRSLAEHPCAIKVANENA------SEREKAEFLNEASVMKAFD-T--HHVVKLYGVVSEGN 195 (364)
Q Consensus 125 ~~~lG~G~~g~V~~a~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~E~~il~~l~-h--~~iv~l~~~~~~~~ 195 (364)
.+.||.|..-.||+....+ +++.+++|...... ......+...|.+.|+.+. + ..+++++.+ +.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~----~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC--------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred EEEeCCCceEeEEEEEeCC----CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC
Confidence 4468999999999987554 35678888654210 0111233456787777662 2 356666654 345
Q ss_pred ceEEEEecCCCCC
Q psy7023 196 PTLVIMELMGGGD 208 (364)
Q Consensus 196 ~~~lv~e~~~ggs 208 (364)
..++|||++.+..
T Consensus 105 ~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 MAVTVMEDLSHLK 117 (392)
T ss_dssp TTEEEECCCTTSE
T ss_pred CCEEEEeccCCcc
Confidence 6689999997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.31 E-value=0.00043 Score=61.33 Aligned_cols=138 Identities=14% Similarity=0.102 Sum_probs=75.2
Q ss_pred eEEEEEEEcCcccccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce--eEEE-----EEEeeCCceEEEEecCCC
Q psy7023 134 GLVYRGLIKDFRSLAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV--VKLY-----GVVSEGNPTLVIMELMGG 206 (364)
Q Consensus 134 g~V~~a~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i--v~l~-----~~~~~~~~~~lv~e~~~g 206 (364)
-.||++...+ +..+++|+....... .+++..|...+..|....+ +..+ ..+..++..+.++++++|
T Consensus 36 N~vy~v~~~d-----g~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDED-----RRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTT-----CCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCC-----CCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 4799887664 677999998765322 3556778888888743322 1111 123445677889999977
Q ss_pred CCH--------------HHHHHhc-CCCCCCc-cC----------------CCCc---cHHHHHHHHHHHHHHHHHHH--
Q psy7023 207 GDL--------------KNYLRSC-RPDAETD-VE----------------RSPP---TLSRILQMAAEVADGMAYLA-- 249 (364)
Q Consensus 207 gsL--------------~~~l~~~-~~~~~~~-~~----------------~~~~---~~~~~~~i~~qil~~L~~LH-- 249 (364)
..+ ...++.. ....... .. ...+ ........+.+++..+.-.-
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred cCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccc
Confidence 321 1111111 1000000 00 0001 11122333334443333221
Q ss_pred --hCCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 250 --DKKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 250 --~~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
..++||+|+.+.|||++++ ..++||+.+.
T Consensus 189 ~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred cCCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 1368999999999999754 4589999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.28 E-value=0.00054 Score=62.41 Aligned_cols=89 Identities=13% Similarity=0.289 Sum_probs=55.1
Q ss_pred cceeeeccceeEeceeeeecceEEEEEEEcCccc---ccccceEEEEcccccCHHHHHHHHHHHHHHHhcCCcce-eEEE
Q psy7023 113 DSWEVLRSKVTILDELGNGSFGLVYRGLIKDFRS---LAEHPCAIKVANENASEREKAEFLNEASVMKAFDTHHV-VKLY 188 (364)
Q Consensus 113 ~~~e~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~ 188 (364)
+.|..+...-.-++.|+.|-.=.+|++....... .....|.+++.-..... ....+|..+++.+.-.++ .+++
T Consensus 35 ~~W~~~~~~~l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~---idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 35 GAWKTVPLEHLRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE---SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp THHHHCCGGGEEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH---HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred ccccCCCccceEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh---hHHHHHHHHHHHHHhCCCCCeEE
Confidence 3354433333334678878888999988664321 12456777776532221 234578999998854444 4677
Q ss_pred EEEeeCCceEEEEecCCCCC
Q psy7023 189 GVVSEGNPTLVIMELMGGGD 208 (364)
Q Consensus 189 ~~~~~~~~~~lv~e~~~ggs 208 (364)
+++.+ .+|+||++|..
T Consensus 112 ~~~~~----g~I~efi~g~~ 127 (395)
T d1nw1a_ 112 GIFSG----GRLEEYIPSRP 127 (395)
T ss_dssp EEETT----EEEECCCCEEE
T ss_pred EEcCC----ceEEEEecccc
Confidence 77653 68999998744
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.17 E-value=0.00016 Score=52.92 Aligned_cols=44 Identities=20% Similarity=0.163 Sum_probs=35.9
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCcc-ceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKF-NIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 67 (364)
|+..|+|.|+||||.| +...+.|.++++....... .+.|+.+..
T Consensus 20 L~~~~~~~GtFLVR~S-----~~~~g~~~lsv~~~~~~~~~~v~h~~i~~ 64 (105)
T d1lkka_ 20 LLAPGNTHGSFLIRES-----ESTAGSFSLSVRDFDQNQGEVVKHYKIRN 64 (105)
T ss_dssp HTSTTCCTTCEEEEEC-----SSSTTCEEEEEEEEETTTEEEEEEEEEEE
T ss_pred HHhcCCCCCcEEEEcc-----CCCCCCEEEEEEEcccCCCccEEEEEEEE
Confidence 5678999999999999 5677778899988877654 578888776
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.17 E-value=0.00016 Score=52.92 Aligned_cols=44 Identities=34% Similarity=0.466 Sum_probs=36.6
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCc-cceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTK-FNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 67 (364)
|+..|+|.|+||||.| +...+.|.+|++...... ..+.|+.|..
T Consensus 22 L~~~g~~~G~FLVR~S-----~~~~g~~~Lsv~~~~~~~~~~v~h~~i~~ 66 (104)
T d1g83a2 22 LLSFGNPRGTFLIRES-----ETTKGAYSLSIRDWDDMKGDHVKHYKIRK 66 (104)
T ss_dssp HHSTTCCTTCEEEEEC-----SSSTTCEEEEEEEECSSSCEEEEEEEEEE
T ss_pred HHhcCCCCCcEEEecc-----CCCCCCeEEEEEEeecCcCCeEEEEEEEE
Confidence 5678999999999999 567778899999888764 4789998876
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.10 E-value=0.00019 Score=52.42 Aligned_cols=45 Identities=20% Similarity=0.134 Sum_probs=35.5
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCc-cceeeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTK-FNIFLFLIRVA 68 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 68 (364)
|+..|+|.|+||||+| ++..+.|.+++++..... ..+.|+.|...
T Consensus 17 L~~~~~~~G~FLVR~S-----~~~~g~~~Lsv~~~~~~~~~~v~H~~i~~~ 62 (103)
T d1qcfa2 17 LLAPGNMLGSFMIRDS-----ETTKGSYSLSVRDYDPRQGDTVKHYKIRTL 62 (103)
T ss_dssp HHSTTCCTTCEEEEEC-----SSSTTSEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred HhhcCCCCCcEEEEcc-----CCCCCCeEEEEEecCCCcCceEEEEEEEEc
Confidence 4667899999999999 677778888888765544 46888888763
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.74 E-value=0.00064 Score=49.68 Aligned_cols=44 Identities=32% Similarity=0.368 Sum_probs=34.2
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCc-cceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTK-FNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 67 (364)
|++.|+|.|+||||+| +...+.|.||++...... ..+.|+.+..
T Consensus 21 L~~~~~~~G~FLVR~S-----~~~~g~y~LSv~~~~~~~~~~i~h~~i~~ 65 (106)
T d1o48a_ 21 LLNAENPRGTFLVRES-----ETTKGAYCLSVSDFDNAKGLNVKHYKIRK 65 (106)
T ss_dssp HCCTTCCTTCEEEEEC-----SSSTTCEEEEEEEEETTTEEEEEEEEEEE
T ss_pred HHhcCCCCCcEEEEcc-----cCCCCCEEEEEEecccCcccceEEEEEEE
Confidence 5678999999999999 566677888888766554 3677877765
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.73 E-value=0.00027 Score=52.58 Aligned_cols=45 Identities=18% Similarity=0.001 Sum_probs=34.3
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
|+..++|.|+||||+| ++..+.|.+++++.......+.|+.+...
T Consensus 28 L~~~~~~~G~FLVR~S-----~~~~g~~~Lsv~~~~~~~~~v~H~~i~~~ 72 (114)
T d1blja_ 28 LLAPMNKAGSFLIRES-----ESNKGAFSLSVKDITTQGEVVKHYKIRSL 72 (114)
T ss_dssp HSSTTCCTTCEEBCBC-----TTCSSCEEEEECBCCTTTCBCCCEEEEEE
T ss_pred HHhcCCCCceEEEecc-----CCCCCCeEEEEEeeccCCCEEEEEEEEEc
Confidence 5668899999999999 56667777777765444446888888763
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.72 E-value=0.0004 Score=50.24 Aligned_cols=40 Identities=20% Similarity=0.093 Sum_probs=30.2
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|+..|++.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 18 L~~~~~~~G~FLvR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 57 (100)
T d1rjaa_ 18 LQAEGNATGAFLIRVS-----EKPSADYVLSVRD----TQAVRHYKIWR 57 (100)
T ss_dssp HSSTTCSSCCEEEEEC-----SSSSSCEEEEECT----TSSCEEEEEEE
T ss_pred HhccCCCCCeEEeecC-----CCCCCCEEEEEEc----CCCceEEEEEE
Confidence 4567899999999999 4566667777653 34688998875
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.58 E-value=0.00066 Score=51.55 Aligned_cols=40 Identities=18% Similarity=0.017 Sum_probs=31.2
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|...|++.|+||||+| ++..+.|.||++. ...+.||+|..
T Consensus 22 L~~~g~~~G~FLVR~S-----~~~~g~yvLSv~~----~~~v~H~~I~~ 61 (130)
T d2oq1a1 22 LKLAGMADGLFLLRQC-----LRSLGGYVLSLVH----DVRFHHFPIER 61 (130)
T ss_dssp HHHTTCCTTCEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred HHhcCCCCceEEEEec-----CCCCccEEEEEee----CCceEEEEEEE
Confidence 3457899999999999 5566667888874 34689999975
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.25 E-value=0.0014 Score=49.59 Aligned_cols=40 Identities=15% Similarity=-0.018 Sum_probs=31.0
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|...|++.|+||||+| +...+.|.||++. ...+.|++|..
T Consensus 21 L~~~g~~dG~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 60 (129)
T d1a81a1 21 LVQGGMSDGLYLLRQS-----RNYLGGFALSVAH----GRKAHHYTIER 60 (129)
T ss_dssp HHHTTCCTTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred HHhcCCCCccEEEEcc-----CCCCcceEEEeee----cccceEEEEEE
Confidence 3456889999999999 5666777888773 35689998875
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.18 E-value=0.0017 Score=47.24 Aligned_cols=40 Identities=20% Similarity=0.117 Sum_probs=29.6
Q ss_pred cccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 20 LNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 20 ~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
...|.|.|+||||+| +..-+.|.||++. ...+.|++|...
T Consensus 22 ~~~g~~dG~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~~ 61 (105)
T d1nrva_ 22 KQQGLVDGLFLLRDS-----QSNPKAFVLTLCH----HQKIKNFQILPC 61 (105)
T ss_dssp HHTTCCTTEEEEEEC-----SSCTTCEEEEEEE----TTEEEEEEEEEC
T ss_pred hhcCCCCceEEEEeC-----CCCCCCEEEEEEE----CCceeEEEEEEe
Confidence 346889999999999 4555567777763 346889988763
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.01 E-value=0.0022 Score=46.45 Aligned_cols=40 Identities=20% Similarity=0.080 Sum_probs=29.6
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+|..+++.|+||||+| +...+.+.+|++. ...+.|++|..
T Consensus 18 lL~~~~~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 57 (103)
T d1i3za_ 18 LLLKGGVDGNFLIRDS-----ESVPGALCLCVSF----KKLVYSYRIFR 57 (103)
T ss_dssp HHHTTCSTTEEEEEEC-----SSSTTCEEEEEEC----SSSEEEEEEEE
T ss_pred HHHhCCCCCeEEEEec-----CCCCCCEEEEEEe----CCeEEEEEeEE
Confidence 3445568899999999 5566677787773 34689999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.86 E-value=0.079 Score=45.57 Aligned_cols=30 Identities=23% Similarity=0.234 Sum_probs=27.1
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeeccccc
Q psy7023 251 KKFVHRDLAARNCMVADDLTVKVGDFGMTR 280 (364)
Q Consensus 251 ~~iiHrDlkp~NILl~~~~~~kL~DFg~a~ 280 (364)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999998777899999875
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.78 E-value=0.003 Score=45.05 Aligned_cols=39 Identities=18% Similarity=0.018 Sum_probs=28.3
Q ss_pred cccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 20 LNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 20 ~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|..++|.|+||||+| +...+.+.||++. ...+.|++|..
T Consensus 19 L~~~~~~G~FLvR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 57 (96)
T d1jyra_ 19 LSKQRHDGAFLIRES-----ESAPGDFSLSVKF----GNDVQHFKVLR 57 (96)
T ss_dssp HHTCCSTTBEEEEEC-----SSSTTCEEEEEEE----TTEEEEEECEE
T ss_pred HhhCCCCCeEEEEec-----CCCCCCEEEEEEe----CCceEEEEEEE
Confidence 334557899999999 5566667777774 33588998875
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.63 E-value=0.0034 Score=46.22 Aligned_cols=38 Identities=21% Similarity=0.147 Sum_probs=28.6
Q ss_pred ccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 21 NFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 21 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
..|.+.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 28 ~~g~~dG~FLvR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 65 (113)
T d2qmsa1 28 QQGLVDGLFLVRES-----QRNPQGFVLSLCH----LQKVKHYLILP 65 (113)
T ss_dssp HTTCCTTEEEEEEC-----SSCTTCEEEEEEE----TTEEEEEEEEE
T ss_pred ccCCCCccEEEEec-----cCCCCCEEEEEEe----CCeEEEEEEEE
Confidence 46889999999999 4555567777763 34688998875
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.36 E-value=0.005 Score=46.07 Aligned_cols=39 Identities=13% Similarity=0.074 Sum_probs=28.6
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|...|++.|+||||.|. + .+.|.||++. ...++|++|..
T Consensus 45 L~~~~~~dGtFLVR~S~-----~-~g~yvLSv~~----~~~v~H~~I~~ 83 (124)
T d2oq1a2 45 LYSGAQTDGKFLLRPRK-----E-QGTYALSLIY----GKTVYHYLISQ 83 (124)
T ss_dssp HHSSCCCTTEEEEEECS-----S-TTEEEEEEEE----TTEEEEEEEEE
T ss_pred HhhcCCCCceEEeEecC-----C-CCCEEEEeec----CCceEEEEEEE
Confidence 44678999999999993 2 3456676663 34689999876
|
| >d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 2, SOCS-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.35 E-value=0.0064 Score=43.78 Aligned_cols=37 Identities=19% Similarity=0.019 Sum_probs=27.7
Q ss_pred cCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 22 FGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 22 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
-+.|.|+||||+| +...+.+.||++. ...+.|+.|..
T Consensus 32 ~~~~~GtFLVR~S-----~~~~~~~~LSv~~----~~~v~H~~I~~ 68 (103)
T d2c9wa2 32 KEAPEGTFLIRDS-----SHSDYLLTISVKT----SAGPTNLRIEY 68 (103)
T ss_dssp TTSCTTCEEEEEC-----CSTTCSEEEEEEE----TTEEEEEEEEE
T ss_pred cCCCCCceEEecc-----CCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 3788999999999 4556667777774 34688888865
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=95.24 E-value=0.0037 Score=43.47 Aligned_cols=35 Identities=17% Similarity=0.048 Sum_probs=25.6
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
++.|+||||+| +...+.+.||++. ...+.|+.|..
T Consensus 27 ~~dG~FLvR~S-----~~~~g~~~Lsv~~----~~~v~h~~I~~ 61 (86)
T d1rpya_ 27 RSHGLFVIRQS-----ETRPGECVLTFNF----QGKAKHLRLSL 61 (86)
T ss_dssp GGTTCEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEC--
T ss_pred CCCceEEEEec-----CCCCCcEEEEEEE----CCceEEEEEEE
Confidence 57799999999 5666777888773 34688888865
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.20 E-value=0.007 Score=43.08 Aligned_cols=36 Identities=17% Similarity=0.047 Sum_probs=28.0
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|.|+||||+| +...+.+.||++. ...+.|++|..
T Consensus 24 ~~~~G~FLVR~S-----~~~~g~~~LSv~~----~~~v~H~~I~~ 59 (97)
T d1r1qa_ 24 GKDIGFFIIRAS-----QSSPGDFSISVRH----EDDVQHFKVMR 59 (97)
T ss_dssp TSCTTCEEEEEC-----SSSTTCEEEEEEC----SSSEEEEECEE
T ss_pred cCCCCCEEEeec-----CCCCCCEEEEEEe----cCCeEEEEEEE
Confidence 678999999999 5566667888773 34689998876
|
| >d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.16 E-value=0.0073 Score=45.17 Aligned_cols=39 Identities=10% Similarity=-0.037 Sum_probs=28.6
Q ss_pred ccccCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 19 FLNFGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 19 ~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
|+..|++.|+||||.|+ . .+.|.+|++. ...+.|+.|..
T Consensus 45 L~~~g~~~G~FLVR~S~-----~-~~~yvLSv~~----~~~v~H~~I~~ 83 (125)
T d1a81a2 45 VLIGSKTNGKFLIRARD-----N-NGSYALCLLH----EGKVLHYRIDK 83 (125)
T ss_dssp HHSSCCCTTCEEEEECS-----S-SSCEEEEEEE----TTEEEEEEEEE
T ss_pred HHhcCCCCceEEEEecC-----C-CCCEEEEeec----cccceeEeeeE
Confidence 45678999999999993 2 3456777663 34689998875
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.14 E-value=0.0085 Score=42.62 Aligned_cols=36 Identities=11% Similarity=0.029 Sum_probs=27.2
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.+.|+||||+| +...+.|.+|++. ...+.|+.|..
T Consensus 22 ~~~~G~FLVR~S-----~~~~g~~vLSv~~----~~~v~H~~I~~ 57 (97)
T d1jwoa_ 22 PPEDGLFLVRES-----ARHPGDYVLCVSF----GRDVIHYRVLH 57 (97)
T ss_dssp SCCTTCEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred CCCCCeEEEEec-----CCCCccEEEEEEe----cCceEEEEEEE
Confidence 567899999999 4556667777763 34689999865
|
| >d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Abl tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.77 E-value=0.009 Score=42.80 Aligned_cols=36 Identities=17% Similarity=0.144 Sum_probs=27.5
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.+.|+||||+| ++..+.|.||++. ...+.|+.|..
T Consensus 23 ~~~~G~FLVR~S-----~~~~~~~~LSv~~----~~~v~H~~I~~ 58 (101)
T d1opka2 23 SGINGSFLVRES-----ESSPGQRSISLRY----EGRVYHYRINT 58 (101)
T ss_dssp GCCTTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEECEE
T ss_pred CCCCCeEEEEec-----CCCCCCEEEEEEc----CcceEEEEeEE
Confidence 357899999999 5566667777774 34688998876
|
| >d2eyva1 d.93.1.1 (A:12-120) Crk proto-oncogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Crk proto-oncogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.72 E-value=0.0096 Score=43.18 Aligned_cols=37 Identities=19% Similarity=0.143 Sum_probs=27.4
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
+.|.|+||||+| +...+.+.||++. ...+.|+.|...
T Consensus 18 ~~~~G~FLVR~S-----~~~~~~~~LS~~~----~~~v~H~~I~~~ 54 (109)
T d2eyva1 18 GQRHGVFLVRDS-----STSPGDYVLSVSE----NSRVSHYIINSS 54 (109)
T ss_dssp SCSTTCEEEECC-----CSSSSCEEEEEEE----TTEEEEEEEECC
T ss_pred CCCCCeEEeeec-----CCCCCCEEEEEEE----CCEEEEEEEEEc
Confidence 578899999999 4455567777762 346889988763
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.49 E-value=0.015 Score=41.57 Aligned_cols=36 Identities=14% Similarity=-0.010 Sum_probs=26.3
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.+.|+||||+| +...+.|.||++. ...+.|++|..
T Consensus 22 ~~~~G~FLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 57 (101)
T d1k9aa2 22 PPETGLFLVRES-----TNYPGDYTLCVSC----EGKVEHYRIMY 57 (101)
T ss_dssp SCCTTEEEEEEC-----SSSTTSEEEEEEC----SSSEEEEEEEE
T ss_pred CCCCCCEEEecc-----CCCCCCEEEEEEe----CCccEEEEEEE
Confidence 457899999999 4455556777763 34689998865
|
| >d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 4, SOCS-4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.46 E-value=0.012 Score=42.94 Aligned_cols=37 Identities=22% Similarity=0.072 Sum_probs=27.2
Q ss_pred cCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 22 FGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 22 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.+.+.|+||||+| +...+.+.+|++. ...+.|+.|..
T Consensus 28 ~~~~~GtFLVR~S-----~~~~~~~~LSv~~----~~~v~H~~I~~ 64 (112)
T d2izva2 28 EGKPEGTFLLRDS-----AQEDYLFSVSFRR----YSRSLHARIEQ 64 (112)
T ss_dssp TTCCTTEEEEEEC-----SSTTCSEEEEEEE----TTEEEEEECEE
T ss_pred ccCCCCcEEEeec-----CCCCCCeEEEEEe----cCCceEEEEEE
Confidence 3678899999999 4555566777764 34678888865
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.69 E-value=0.014 Score=42.38 Aligned_cols=38 Identities=13% Similarity=-0.066 Sum_probs=26.5
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCCc--cceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTK--FNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 67 (364)
.+.|+||||+|+ + .+.|.||++.-+... ..+.|+.|..
T Consensus 26 ~~~G~FLVR~S~-----~-~g~y~LSv~~~~~~~~~~~i~h~~I~~ 65 (108)
T d1luia_ 26 GKEGAFMVRDSR-----T-PGTYTVSVFTKAIISENPCIKHYHIKE 65 (108)
T ss_dssp CCTTEEEEEECC-----T-TTCEEEEEECSCCTTTCSCEEEEECEE
T ss_pred CCCCeEEEEecC-----C-CCCEEEEEEecCCcccCCceeEEEEEE
Confidence 367999999993 2 355677777655433 3688998875
|
| >d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: The Xlp protein Sap species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.31 E-value=0.023 Score=40.63 Aligned_cols=33 Identities=15% Similarity=0.018 Sum_probs=23.9
Q ss_pred cceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 26 RGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 26 ~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.|+||||+| +...+.+.++++. ...+.|++|..
T Consensus 26 ~G~FLVR~S-----~~~~g~~~Lsv~~----~~~v~H~~I~~ 58 (104)
T d1d4ta_ 26 DGSYLLRDS-----ESVPGVYCLCVLY----HGYIYTYRVSQ 58 (104)
T ss_dssp TTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEE
T ss_pred CCeEEEEec-----CCCCCCEEEEEec----CCCceEEEEEE
Confidence 499999999 4555666777663 23688888876
|
| >d2shpa3 d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.23 E-value=0.026 Score=40.69 Aligned_cols=39 Identities=18% Similarity=0.064 Sum_probs=26.0
Q ss_pred CCcceEEEeccccccccccCCCCcceEEeecCC------ccceeeeeeee
Q psy7023 24 PPRGTMVRNVSIELCVEISCLPPHLSFCVWSST------KFNIFLFLIRV 67 (364)
Q Consensus 24 ~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 67 (364)
++.|+||||+| +...+.+.||++..... ...+.|+.+..
T Consensus 20 ~~~G~FLVR~S-----~~~~g~~~LSv~~~~~~~~~~~~~~~~~h~~i~~ 64 (108)
T d2shpa3 20 GKHGSFLVRES-----QSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRC 64 (108)
T ss_dssp CCTTEEEEEEC-----SSSTTCEEEEEEECC-----CCCCCEEEEEEEEE
T ss_pred CCCCeEEEEec-----CCCCCCeEEEEEecCccccccccccceeeEEEEe
Confidence 36799999999 56667778888764432 23456666654
|
| >d1xa6a2 d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Beta-chimaerin, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.21 E-value=0.027 Score=42.85 Aligned_cols=34 Identities=9% Similarity=-0.066 Sum_probs=25.6
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|+||||+| +...+.|.||++. ...++|++|..
T Consensus 54 ~dGsFLVR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 87 (141)
T d1xa6a2 54 VEGAYILRES-----QRQPGCYTLALRF----GNQTLNYRLFH 87 (141)
T ss_dssp CTTBEEEEEC-----SSSTTCEEEEEEE----TTEEEECCCEE
T ss_pred CCCeEEEEec-----CCCCCCEEEEEEE----CCEEEEEEEEE
Confidence 4699999999 5566678888774 34588887754
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.90 E-value=0.02 Score=41.52 Aligned_cols=33 Identities=15% Similarity=-0.004 Sum_probs=24.9
Q ss_pred cceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 26 RGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 26 ~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.|+||||+| +...+.|.||++. ...+.|+.|..
T Consensus 25 ~G~FLvR~S-----~~~~g~y~LSv~~----~~~v~H~~I~~ 57 (109)
T d2shpa2 25 DGSFLARPS-----KSNPGDLTLSVRR----NGAVTHIKIQN 57 (109)
T ss_dssp TTEEEEEEC-----SSSTTCEEEEEEE----TTEEEEEEEEC
T ss_pred CCeEEEEec-----CCCCCCEEEEEEe----CCcEEEEEEEE
Confidence 599999999 5556667777763 34688998875
|
| >d1qada_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Cow (Bos taurus) [TaxId: 9913]
Probab=92.56 E-value=0.04 Score=39.64 Aligned_cols=37 Identities=19% Similarity=-0.020 Sum_probs=25.4
Q ss_pred cCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeeee
Q psy7023 22 FGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRVA 68 (364)
Q Consensus 22 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (364)
-|.|.|+||||.|. . .+.|.+|++. ...+.|+.|...
T Consensus 26 ~~~~~G~FLVR~S~-----~-~~~y~Lsv~~----~~~v~H~~I~~~ 62 (107)
T d1qada_ 26 RGKRDGTFLVRESS-----K-QGCYACSVVV----DGEVKHCVINKT 62 (107)
T ss_dssp TTCCTTEEEEEEC---------CCEEEEEEE----TTEEEEEEEEEE
T ss_pred cCCCCCcEEEEecC-----C-CCCEEEEEEe----cCCeEEEEEEEC
Confidence 36789999999993 2 3456777654 246889988763
|
| >d1uura3 d.93.1.1 (A:577-707) STAT homologue {Dictyostelium discoideum [TaxId: 44689]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT homologue species: Dictyostelium discoideum [TaxId: 44689]
Probab=92.34 E-value=0.043 Score=41.11 Aligned_cols=40 Identities=15% Similarity=0.076 Sum_probs=28.1
Q ss_pred cCCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 22 FGPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 22 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
-+.|.||||||.| +...+.+.++++.- +....+.|+.|..
T Consensus 26 ~~~~~GtFLvR~S-----~s~~g~~~ls~~~~-~~~~~v~h~~i~~ 65 (131)
T d1uura3 26 QNQDPGTFIIRFS-----ERNPGQFGIAYIGV-EMPARIKHYLVQP 65 (131)
T ss_dssp SSCCTTCEEEEEC-----SSSTTCEEEEEECS-SSSCCEEEEECCG
T ss_pred hcCCCCeEEEEec-----CCCCCcEEEEEEEe-cCCCcEEEEEEee
Confidence 3568899999999 55566667766533 3345788888754
|
| >d1mila_ d.93.1.1 (A:) Shc adaptor protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Shc adaptor protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.31 E-value=0.039 Score=39.51 Aligned_cols=34 Identities=12% Similarity=-0.158 Sum_probs=24.3
Q ss_pred CcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 25 PRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 25 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|+||||+| +...+.+.+|++. ...+.|+.|..
T Consensus 25 ~~G~FLVR~S-----~~~~g~~vLSv~~----~~~v~H~~I~~ 58 (104)
T d1mila_ 25 LNGDFLVRES-----TTTPGQYVLTGLQ----SGQPKHLLLVD 58 (104)
T ss_dssp STTEEEEEEC-----CSSCSSEEEEEEE----TTEEEEEEEBC
T ss_pred cCCcEEEEec-----CCCCCCEEEEEEE----ccccceEEEEe
Confidence 5799999999 4555667777763 34688887753
|
| >d2fcia1 d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phospholipase C-gamma-1 species: Cow (Bos taurus) [TaxId: 9913]
Probab=89.25 E-value=0.076 Score=37.98 Aligned_cols=32 Identities=13% Similarity=-0.027 Sum_probs=22.0
Q ss_pred cceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 26 RGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 26 ~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
.|+||||+|. . .+.|.||++. ...+.|++|..
T Consensus 31 ~G~FLVR~S~-----~-~~~yvLSv~~----~~~v~H~~I~~ 62 (105)
T d2fcia1 31 DGAFLVRKRN-----E-PNSYAISFRA----EGKIKHCRVQQ 62 (105)
T ss_dssp SCCEEEEECS-----S-TTCEEEEEEE----TTEECCCEEBC
T ss_pred CCeEEEEecC-----C-CCCEEEEEEe----ccccEEEEEEe
Confidence 5999999993 2 3456777663 34688887753
|
| >d2cs0a1 d.93.1.1 (A:8-113) Hematopoietic SH2 domain containing protein HSH2D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hematopoietic SH2 domain containing protein HSH2D species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.08 E-value=0.19 Score=35.70 Aligned_cols=35 Identities=20% Similarity=0.318 Sum_probs=23.4
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|.|+||||.|. ..- .|.++++. ...+.|+.|..
T Consensus 27 ~~~~G~FLvR~S~-----~~~-~y~Lsv~~----~~~~~h~~I~~ 61 (106)
T d2cs0a1 27 SQPLGSFLIRVSH-----SHV-GYTLSYKA----QSSCCHFMVKL 61 (106)
T ss_dssp TSCTTCEEEEECS-----SSS-SEEEEECC----SSSCEEEEEEE
T ss_pred CCCCCcEEEEecC-----CCC-CEEEEEEe----cCCceeEEEEE
Confidence 5689999999993 222 25555553 23578888876
|
| >d1fu6a_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=85.00 E-value=0.19 Score=36.07 Aligned_cols=37 Identities=14% Similarity=-0.136 Sum_probs=23.4
Q ss_pred CCCcceEEEeccccccccccCCCCcceEEeecCCccceeeeeeee
Q psy7023 23 GPPRGTMVRNVSIELCVEISCLPPHLSFCVWSSTKFNIFLFLIRV 67 (364)
Q Consensus 23 ~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 67 (364)
+.|.|+||||+|+. .....+.++++. ...+.|+.|..
T Consensus 29 ~~~~G~FLVR~S~~----~~~~~~~ls~~~----~~~~~H~~I~~ 65 (111)
T d1fu6a_ 29 DTADGTFLVRDAST----KMHGDYTLTLRK----GGNNKSIKIFH 65 (111)
T ss_dssp SCSSCCCCCBSSCC----SSSCCSBCEEEE----TTEEEECCCCC
T ss_pred cCCCCEEEEEeccC----CCCccEEEEEec----CCceEEEEEEE
Confidence 56789999999942 223345565543 23577777754
|